##CREATION_DATE=2021-07-16
##ANALYSISTYPE=GERMLINE_TRIO
##PIPELINE=megSAP 0.2-629-gc37c800d
##SAMPLE=<ID=GS140127_01,Gender=male,ExternalSampleName=131787,IsTumor=no,IsFFPE=no,DiseaseGroup=n/a,DiseaseStatus=affected>
##SAMPLE=<ID=GS140550_01,Gender=male,ExternalSampleName=131751,IsTumor=no,IsFFPE=no,DiseaseGroup=n/a,DiseaseStatus=control>
##SAMPLE=<ID=GS140549_01,Gender=female,ExternalSampleName=131752,IsTumor=no,IsFFPE=no,DiseaseGroup=n/a,DiseaseStatus=control>
##FILTER=off-target=Variant marked as 'off-target'.
##FILTER=low_conf_region=Variant marked as 'low_conf_region'.
##DESCRIPTION=GS140127_01=genotype of sample GS140127_01
##DESCRIPTION=GS140550_01=genotype of sample GS140550_01
##DESCRIPTION=GS140549_01=genotype of sample GS140549_01
##DESCRIPTION=filter=Annotations for filtering and ranking variants.
##DESCRIPTION=quality=Quality parameters - variant quality (QUAL), depth (DP), allele frequency (AF), mean mapping quality of alternate allele (MQM), probability of strand bias for alternate bases as phred score (SAP), probability of allele ballance as phred score (ABP)
##DESCRIPTION=gene=Affected gene list (comma-separated).
##DESCRIPTION=variant_type=Variant type.
##DESCRIPTION=coding_and_splicing=Coding and splicing details (Gene, ENST number, type, impact, exon/intron number, HGVS.c, HGVS.p, Pfam domain).
##DESCRIPTION=coding_and_splicing_refseq=Coding and splicing details based on RefSeq (Gene, RefSeq id, type, impact, exon/intron number, HGVS.c, HGVS.p, Pfam domain).
##DESCRIPTION=regulatory=Regulatory consequence details.
##DESCRIPTION=OMIM=OMIM database annotation.
##DESCRIPTION=ClinVar=ClinVar database annotation.
##DESCRIPTION=HGMD=HGMD database annotation.
##DESCRIPTION=RepeatMasker=RepeatMasker annotation.
##DESCRIPTION=dbSNP=Identifier in dbSNP database.
##DESCRIPTION=1000g=Allele frequency in 1000 genomes project.
##DESCRIPTION=gnomAD=Allele frequency in gnomAD project.
##DESCRIPTION=gnomAD_hom_hemi=Homoyzgous counts and hemizygous counts of gnomAD project (genome data).
##DESCRIPTION=gnomAD_sub=Sub-population allele frequenciens (AFR,AMR,EAS,NFE,SAS) in gnomAD project.
##DESCRIPTION=phyloP=phyloP (100way vertebrate) annotation. Deleterious threshold > 1.6.
##DESCRIPTION=Sift=Sift effect prediction and score for each transcript: D=damaging, T=tolerated.
##DESCRIPTION=PolyPhen=PolyPhen (humVar) effect prediction and score for each transcript: D=probably damaging, P=possibly damaging, B=benign.
##DESCRIPTION=fathmm-MKL=fathmm-MKL score (for coding/non-coding regions). Deleterious threshold > 0.5.
##DESCRIPTION=CADD=CADD pathogenicity prediction scores (scaled phred-like). Deleterious threshold > 10-20.
##DESCRIPTION=REVEL=REVEL pathogenicity prediction score. Deleterious threshold > 0.5.
##DESCRIPTION=MaxEntScan=MaxEntScan splicing prediction (reference bases score/alternate bases score).
##DESCRIPTION=dbscSNV=dbscSNV splicing prediction (ADA/RF score).
##DESCRIPTION=COSMIC=COSMIC somatic variant database anntotation.
##DESCRIPTION=MMSplice_DeltaLogitPSI=MMsplice delta Logit PSI score: variant's effect on the exon inclusion - positive score shows higher exon inclusion, negative higher exclusion rate. A score greater than 2 or less than -2 can be considered strong.
##DESCRIPTION=MMSplice_pathogenicity=MMsplice pathogenicity score: probability of pathogenic effect of the variant on splicing
##DESCRIPTION=SpliceAI=SpliceAI prediction of splice-site variations. Probability of the variant being splice-altering (range from 0-1). The score is the maximum value of acceptor/donor gain/loss of all effected genes.
##DESCRIPTION=NGSD_hom=Homozygous variant count in NGSD.
##DESCRIPTION=NGSD_het=Heterozygous variant count in NGSD.
##DESCRIPTION=NGSD_group=Homozygous / heterozygous variant count in NGSD with the same disease group.
##DESCRIPTION=classification=Classification from the NGSD.
##DESCRIPTION=classification_comment=Classification comment from the NGSD.
##DESCRIPTION=validation=Validation information from the NGSD. Validation results of other samples are listed in brackets!
##DESCRIPTION=comment=Variant comments from the NGSD.
##DESCRIPTION=gene_info=Gene information from NGSD (inheritance mode, gnomAD o/e scores).
##FILTER=low_conf_region=Low confidence region for small variant calling based on gnomAD AC0/RF filters and IMGAG trio/twin data.
#chr	start	end	ref	obs	GS140127_01	GS140550_01	GS140549_01	filter	quality	gene	variant_type	coding_and_splicing	coding_and_splicing_refseq	regulatory	OMIM	ClinVar	HGMD	RepeatMasker	dbSNP	1000g	gnomAD	gnomAD_hom_hemi	gnomAD_sub	phyloP	Sift	PolyPhen	fathmm-MKL	CADD	REVEL	MaxEntScan	dbscSNV	COSMIC	MMSplice_DeltaLogitPSI	MMSplice_pathogenicity	SpliceAI	NGSD_hom	NGSD_het	NGSD_group	classification	classification_comment	validation	comment	gene_info
chr1	957898	957898	G	T	hom	het	hom	off-target	QUAL=3705;DP=62,56,45;AF=0.98,0.64,1.00;MQM=60;SAP=303;ABP=13	AGRN	intron	AGRN:ENST00000379370.2:intron_variant:MODIFIER:intron2/35:c.463+56G>T::	AGRN:NM_001305275.2:intron_variant:MODIFIER:intron2/38:c.463+56G>T::,AGRN:NM_198576.4:intron_variant:MODIFIER:intron2/35:c.463+56G>T::		103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];	677944 [benign DISEASE=not provided];			rs2799064	0.3285	0.3627	2084,.		-2.0720			0.00,0.12	4.18					-0.2646	0.1476	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	977330	977330	T	C	hom	hom	hom		QUAL=1743;DP=13,26,20;AF=1.00,1.00,1.00;MQM=60;SAP=84;ABP=0	AGRN	splice_region&intron	AGRN:ENST00000379370.2:splice_region_variant&intron_variant:LOW:intron6/35:c.1178-6T>C::	AGRN:NM_001305275.2:splice_region_variant&intron_variant:LOW:intron6/38:c.1178-6T>C::,AGRN:NM_001364727.2:splice_region_variant&intron_variant:LOW:intron5/35:c.863-6T>C::,AGRN:NM_198576.4:splice_region_variant&intron_variant:LOW:intron6/35:c.1178-6T>C::		103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];	128292 [benign DISEASE=not specified];			rs2799066	0.8852	0.9233	12149,.	0.7112,0.9515,0.9998,0.9180,0.9530	-0.8450			0.01,0.17	0.63		6.81>6.95	0.000/0.002		0.1949	0.0869	0.12	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	977570	977570	G	A	hom	hom	hom	off-target	QUAL=1516;DP=18,21,15;AF=1.00,1.00,1.00;MQM=60;SAP=104;ABP=0	AGRN	intron	AGRN:ENST00000379370.2:intron_variant:MODIFIER:intron7/35:c.1384+28G>A::	AGRN:NM_001305275.2:intron_variant:MODIFIER:intron7/38:c.1384+28G>A::,AGRN:NM_001364727.2:intron_variant:MODIFIER:intron6/35:c.1069+28G>A::,AGRN:NM_198576.4:intron_variant:MODIFIER:intron7/35:c.1384+28G>A::		103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];	263159 [benign DISEASE=not specified,not provided];			rs2710876	0.7941	0.8973	10585,.	0.4355,0.9316,0.9726,0.9149,0.9451	-1.5510			0.03,0.18	4.50					-0.1145	0.1971	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	978604	978605	CT	-	wt	het	wt	off-target	QUAL=1443;DP=59,185,167;AF=0.00,0.45,0.00;MQM=60;SAP=130;ABP=6	AGRN	intron	AGRN:ENST00000379370.2:intron_variant:MODIFIER:intron7/35:c.1385-15_1385-14del::	AGRN:NM_001305275.2:intron_variant:MODIFIER:intron7/38:c.1385-15_1385-14del::,AGRN:NM_001364727.2:intron_variant:MODIFIER:intron6/35:c.1070-15_1070-14del::,AGRN:NM_198576.4:intron_variant:MODIFIER:intron7/35:c.1385-15_1385-14del::		103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];	263160 [benign DISEASE=not specified];			rs35881187	0.4792	0.5514	3578,.	0.0943,0.6972,0.7858,0.5385,0.5463	0.0350				8.99					-0.717	0.8161	0.11	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	981087	981087	A	G	hom	hom	hom	off-target	QUAL=5690;DP=66,64,51;AF=1.00,1.00,1.00;MQM=60;SAP=3;ABP=0	AGRN	intron	AGRN:ENST00000379370.2:intron_variant:MODIFIER:intron14/35:c.2537-26A>G::	AGRN:NM_001305275.2:intron_variant:MODIFIER:intron14/38:c.2537-26A>G::,AGRN:NM_001364727.2:intron_variant:MODIFIER:intron13/35:c.2222-26A>G::,AGRN:NM_198576.4:intron_variant:MODIFIER:intron14/35:c.2537-26A>G::		103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];	263172 [benign DISEASE=not specified,not provided];			rs3128098	0.8694	0.9206	11837,.	0.6365,0.9462,0.9999,0.9247,0.9552	-0.5730			0.04,0.15	4.78					-0.4987	0.31	0.11	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	981931	981931	A	G	hom	hom	hom		QUAL=6180;DP=51,93,69;AF=1.00,1.00,1.00;MQM=60;SAP=5;ABP=0	AGRN	synonymous	AGRN:ENST00000379370.2:synonymous_variant:LOW:exon18/36:c.3066A>G:p.Ser1022=:	AGRN:NM_001305275.2:synonymous_variant:LOW:exon18/39:c.3066A>G:p.Ser1022=:,AGRN:NM_001364727.2:synonymous_variant:LOW:exon17/36:c.2751A>G:p.Ser917=:,AGRN:NM_198576.4:synonymous_variant:LOW:exon18/36:c.3066A>G:p.Ser1022=:		103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];	128297 [benign DISEASE=not specified];			rs2465128		0.8865	10697,.	0.4974,0.9296,0.9677,0.9059,0.8885	-1.7540			0.02,0.07	0.05					0.0149	0.3183	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	982941	982941	T	C	hom	hom	hom	off-target	QUAL=9176;DP=47,149,105;AF=1.00,1.00,1.00;MQM=60;SAP=58;ABP=0	AGRN	intron	AGRN:ENST00000379370.2:intron_variant:MODIFIER:intron20/35:c.3517-12T>C::	AGRN:NM_001305275.2:intron_variant:MODIFIER:intron20/38:c.3517-12T>C::,AGRN:NM_001364727.2:intron_variant:MODIFIER:intron19/35:c.3202-12T>C::,AGRN:NM_198576.4:intron_variant:MODIFIER:intron20/35:c.3517-12T>C::		103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];	263181 [benign DISEASE=not specified];			rs3128102		0.8963	10707,.	0.4469,0.9319,0.9726,0.9133,0.9443	0.1090			0.03,0.17	4.37		6.84>6.29	0.000/0.014		-0.2095	0.6926	0.04	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	982994	982994	T	C	hom	hom	hom		QUAL=15297;DP=133,208,142;AF=0.98,1.00,1.00;MQM=60;SAP=13;ABP=0	AGRN	synonymous	AGRN:ENST00000379370.2:synonymous_variant:LOW:exon21/36:c.3558T>C:p.Phe1186=:PF01390 [SEA domain]	AGRN:NM_001305275.2:synonymous_variant:LOW:exon21/39:c.3558T>C:p.Phe1186=:,AGRN:NM_001364727.2:synonymous_variant:LOW:exon20/36:c.3243T>C:p.Phe1081=:,AGRN:NM_198576.4:synonymous_variant:LOW:exon21/36:c.3558T>C:p.Phe1186=:		103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];	128302 [benign DISEASE=not specified];			rs10267	0.8359	0.9083	11210,.	0.5251,0.9388,0.9995,0.9167,0.9527	0.5010			0.09,0.93	4.35					0.1695	0.7005	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	984302	984302	T	C	het	hom	wt		QUAL=588;DP=9,19,17;AF=0.67,1.00,0.00;MQM=60;SAP=7;ABP=5	AGRN	synonymous	AGRN:ENST00000379370.2:synonymous_variant:LOW:exon24/36:c.4161T>C:p.Thr1387=:	AGRN:NM_001305275.2:synonymous_variant:LOW:exon24/39:c.4161T>C:p.Thr1387=:,AGRN:NM_001364727.2:synonymous_variant:LOW:exon23/36:c.3846T>C:p.Thr1282=:,AGRN:NM_198576.4:synonymous_variant:LOW:exon24/36:c.4161T>C:p.Thr1387=:		103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];	128307 [benign DISEASE=not specified];			rs9442391	0.5457	0.5883	4023,.	0.2729,0.7050,0.8196,0.5652,0.5594	-1.1240			0.01,0.16	0.07					-0.0494	0.3047	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	985266	985266	C	T	het	hom	wt	off-target	QUAL=584;DP=8,20,11;AF=0.50,1.00,0.00;MQM=60;SAP=3;ABP=3	AGRN	intron	AGRN:ENST00000379370.2:intron_variant:MODIFIER:intron26/35:c.4745-17C>T::	AGRN:NM_001305275.2:intron_variant:MODIFIER:intron26/38:c.4745-17C>T::,AGRN:NM_001364727.2:intron_variant:MODIFIER:intron25/35:c.4430-17C>T::,AGRN:NM_198576.4:intron_variant:MODIFIER:intron26/35:c.4745-17C>T::		103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];	263188 [benign DISEASE=not specified];			rs2275813	0.4952	0.5575	3542,.	0.1480,0.7111,0.8103,0.5353,0.5454	1.9730			0.19,0.18	1.68		11.49>11.28			0.4455	0.1498	0.14	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	985444	985444	G	-	hom	wt	hom	off-target;low_conf_region	QUAL=303;DP=4,6,8;AF=0.75,0.00,1.00;MQM=60;SAP=13;ABP=0	AGRN	intron	AGRN:ENST00000379370.2:intron_variant:MODIFIER:intron27/35:c.4879+41del::	AGRN:NM_001305275.2:intron_variant:MODIFIER:intron27/38:c.4879+41del::,AGRN:NM_001364727.2:intron_variant:MODIFIER:intron26/35:c.4564+41del::,AGRN:NM_198576.4:intron_variant:MODIFIER:intron27/35:c.4879+41del::		103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];				rs71576592		0.5598	3743,.	0.7422,0.5306,0.6485,0.4549,0.4871	0.1170				6.06					-0.0041	0.3803	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	985446	985446	G	T	wt	het	wt	off-target;low_conf_region	QUAL=303;DP=4,6,8;AF=0.75,0.00,1.00;MQM=60;SAP=10;ABP=3	AGRN	intron	AGRN:ENST00000379370.2:intron_variant:MODIFIER:intron27/35:c.4879+29G>T::	AGRN:NM_001305275.2:intron_variant:MODIFIER:intron27/38:c.4879+29G>T::,AGRN:NM_001364727.2:intron_variant:MODIFIER:intron26/35:c.4564+29G>T::,AGRN:NM_198576.4:intron_variant:MODIFIER:intron27/35:c.4879+29G>T::		103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];	263191 [benign DISEASE=not specified];			rs2275812	0.3355	0.4151	1553,.	0.1015,0.4381,0.1553,0.4588,0.4611	-0.8900			0.08,0.12	1.53					-0.1413	0.3817	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	985449	985449	G	A	wt	hom	wt	off-target;low_conf_region	QUAL=303;DP=4,6,8;AF=0.75,0.00,1.00;MQM=60;SAP=4;ABP=3	AGRN	intron	AGRN:ENST00000379370.2:intron_variant:MODIFIER:intron27/35:c.4879+32G>A::	AGRN:NM_001305275.2:intron_variant:MODIFIER:intron27/38:c.4879+32G>A::,AGRN:NM_001364727.2:intron_variant:MODIFIER:intron26/35:c.4564+32G>A::,AGRN:NM_198576.4:intron_variant:MODIFIER:intron27/35:c.4879+32G>A::		103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];	263192 [benign DISEASE=not specified];			rs2799067	0.5256	0.5832	2268,.	0.2618,0.5481,0.5050,0.6172,0.6162	0.1530			0.03,0.07	0.11					-0.084	0.3811	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	985450	985450	G	A	hom	wt	hom	off-target;low_conf_region	QUAL=303;DP=4,6,8;AF=0.75,0.00,1.00;MQM=60;SAP=13;ABP=0	AGRN	intron	AGRN:ENST00000379370.2:intron_variant:MODIFIER:intron27/35:c.4879+33G>A::	AGRN:NM_001305275.2:intron_variant:MODIFIER:intron27/38:c.4879+33G>A::,AGRN:NM_001364727.2:intron_variant:MODIFIER:intron26/35:c.4564+33G>A::,AGRN:NM_198576.4:intron_variant:MODIFIER:intron27/35:c.4879+33G>A::		103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];				rs397834473	0.4465	0.5096	3832,.	0.6971,0.4836,0.6056,0.4288,0.4499	-0.4470			0.15,0.26	8.05				COSV65068887	-0.048	0.3808	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	987200	987200	C	T	hom	hom	hom		QUAL=10522;DP=63,150,134;AF=0.97,0.99,1.00;MQM=60;SAP=113;ABP=0	AGRN	splice_region&intron	AGRN:ENST00000379370.2:splice_region_variant&intron_variant:LOW:intron33/35:c.5651+5C>T::	AGRN:NM_001305275.2:splice_region_variant&intron_variant:LOW:intron34/38:c.5663+5C>T::,AGRN:NM_001364727.2:splice_region_variant&intron_variant:LOW:intron33/35:c.5348+5C>T::,AGRN:NM_198576.4:splice_region_variant&intron_variant:LOW:intron33/35:c.5651+5C>T::		103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];	128317 [benign DISEASE=not specified];			rs9803031		0.8871	10698,.	0.4387,0.9320,0.9957,0.9082,0.8828	-0.9360			0.02,0.14	0.10		9.65>8.73	0.000/0.016		-0.3907	0.4172	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	990280	990280	C	T	wt	het	het		QUAL=4766;DP=100,207,174;AF=0.00,0.59,0.51;MQM=60;SAP=309;ABP=12	AGRN	synonymous	AGRN:ENST00000379370.2:synonymous_variant:LOW:exon36/36:c.6057C>T:p.Asp2019=:PF00054 [Laminin G domain]	AGRN:NM_001305275.2:synonymous_variant:LOW:exon39/39:c.6126C>T:p.Asp2042=:,AGRN:NM_001364727.2:synonymous_variant:LOW:exon36/36:c.5754C>T:p.Asp1918=:,AGRN:NM_198576.4:synonymous_variant:LOW:exon36/36:c.6057C>T:p.Asp2019=:	regulatory_region_variant:promoter_flanking_region	103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];	128319 [benign DISEASE=not specified];			rs4275402		0.6764	5782,.	0.3114,0.7722,0.8138,0.6980,0.6133	-0.7110			0.35,0.88	1.43					-0.0151	0.9416	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	990380	990380	C	T	hom	het	het		QUAL=12321;DP=158,428,329;AF=0.98,0.49,0.44;MQM=60;SAP=122;ABP=10	AGRN	3'UTR	AGRN:ENST00000379370.2:3_prime_UTR_variant:MODIFIER:exon36/36:c.*19C>T::	AGRN:NM_001305275.2:3_prime_UTR_variant:MODIFIER:exon39/39:c.*19C>T::,AGRN:NM_001364727.2:3_prime_UTR_variant:MODIFIER:exon36/36:c.*19C>T::,AGRN:NM_198576.4:3_prime_UTR_variant:MODIFIER:exon36/36:c.*19C>T::	regulatory_region_variant:promoter_flanking_region	103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];	263157 [benign DISEASE=not specified];			rs3121561	0.3434	0.3621	2197,.	0.5233,0.2137,0.1794,0.2920,0.3087	-0.1240			0.05,0.09	0.06					-0.0075	0.9417	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	990417	990417	T	C	hom	het	het		QUAL=16538;DP=186,502,389;AF=0.99,0.49,0.46;MQM=60;SAP=15;ABP=8	AGRN,RP11-54O7.14	3'UTR,non_coding_transcript_exon	AGRN:ENST00000379370.2:3_prime_UTR_variant:MODIFIER:exon36/36:c.*56T>C::,RP11-54O7.14:ENST00000418300.1:non_coding_transcript_exon_variant:MODIFIER:exon1/2:n.5T>C::	AGRN:NM_001305275.2:3_prime_UTR_variant:MODIFIER:exon39/39:c.*56T>C::,AGRN:NM_001364727.2:3_prime_UTR_variant:MODIFIER:exon36/36:c.*56T>C::,AGRN:NM_198576.4:3_prime_UTR_variant:MODIFIER:exon36/36:c.*56T>C::		103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];				rs2465136	0.3840	0.3941	2699,.		0.3020			0.78,0.96	9.78					0.1272	0.942	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	990517	990517	C	T	hom	hom	het		QUAL=18345;DP=119,371,285;AF=0.99,1.00,0.48;MQM=60;SAP=198;ABP=4	AGRN,RP11-54O7.14	3'UTR,non_coding_transcript_exon	AGRN:ENST00000379370.2:3_prime_UTR_variant:MODIFIER:exon36/36:c.*156C>T::,RP11-54O7.14:ENST00000418300.1:non_coding_transcript_exon_variant:MODIFIER:exon1/2:n.105C>T::	AGRN:NM_001305275.2:3_prime_UTR_variant:MODIFIER:exon39/39:c.*156C>T::,AGRN:NM_001364727.2:3_prime_UTR_variant:MODIFIER:exon36/36:c.*156C>T::,AGRN:NM_198576.4:3_prime_UTR_variant:MODIFIER:exon36/36:c.*156C>T::		103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];				rs2710872	0.9179	0.8773	12103,.		-0.4100			0.04,0.14	3.47					-0.092	0.9416	0.05	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	990773	990773	C	T	hom	hom	het		QUAL=22307;DP=178,404,296;AF=1.00,1.00,0.54;MQM=60;SAP=89;ABP=7	AGRN,RP11-54O7.14	3'UTR,intron&non_coding_transcript	AGRN:ENST00000379370.2:3_prime_UTR_variant:MODIFIER:exon36/36:c.*412C>T::,RP11-54O7.14:ENST00000418300.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.183+178C>T::	AGRN:NM_001305275.2:3_prime_UTR_variant:MODIFIER:exon39/39:c.*412C>T::,AGRN:NM_001364727.2:3_prime_UTR_variant:MODIFIER:exon36/36:c.*412C>T::,AGRN:NM_198576.4:3_prime_UTR_variant:MODIFIER:exon36/36:c.*412C>T::		103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];				rs2799072	0.8460	0.8187	10690,.		-0.5960			0.05,0.13	2.15					-0.0044	0.9417	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	990806	990806	G	A	hom	hom	het		QUAL=24451;DP=209,448,311;AF=1.00,1.00,0.54;MQM=60;SAP=61;ABP=7	AGRN,RP11-54O7.14	3'UTR,intron&non_coding_transcript	AGRN:ENST00000379370.2:3_prime_UTR_variant:MODIFIER:exon36/36:c.*445G>A::,RP11-54O7.14:ENST00000418300.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.183+211G>A::	AGRN:NM_001305275.2:3_prime_UTR_variant:MODIFIER:exon39/39:c.*445G>A::,AGRN:NM_001364727.2:3_prime_UTR_variant:MODIFIER:exon36/36:c.*445G>A::,AGRN:NM_198576.4:3_prime_UTR_variant:MODIFIER:exon36/36:c.*445G>A::		103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];				rs2799073		0.8188	10688,.		-0.1840			0.06,0.14	5.96					0.0275	0.9421	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	990984	990984	G	A	hom	hom	het		QUAL=15848;DP=145,272,190;AF=1.00,1.00,0.59;MQM=60;SAP=270;ABP=16	AGRN,RP11-54O7.14	3'UTR,intron&non_coding_transcript	AGRN:ENST00000379370.2:3_prime_UTR_variant:MODIFIER:exon36/36:c.*623G>A::,RP11-54O7.14:ENST00000418300.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.184-294G>A::	AGRN:NM_001305275.2:3_prime_UTR_variant:MODIFIER:exon39/39:c.*623G>A::,AGRN:NM_001364727.2:3_prime_UTR_variant:MODIFIER:exon36/36:c.*623G>A::,AGRN:NM_198576.4:3_prime_UTR_variant:MODIFIER:exon36/36:c.*623G>A::		103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];				rs8014		0.8811	12210,.		-2.5600			0.00,0.06	0.95					-0.0137	0.9416	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1956362	1956362	G	A	hom	het	het	off-target	QUAL=6555;DP=80,170,172;AF=1.00,0.48,0.49;MQM=60;SAP=84;ABP=4	GABRD	intron	GABRD:ENST00000378585.4:intron_variant:MODIFIER:intron1/8:c.69-19G>A::	GABRD:NM_000815.5:intron_variant:MODIFIER:intron1/8:c.69-19G>A::		137163 [GENE=GABRD PHENOS=Epilepsy,juvenile myoclonic,susceptibility to,613060,Autosomal dominant/Epilepsy,idiopathic generalized,10,613060,Autosomal dominant/Epilepsy,generalized,with febrile seizures plus,type 5,susceptibility to,613060,Autosomal dominant];	256824 [benign DISEASE=not specified];			rs2376805	0.7756	0.8119	10356,.	0.7935,0.7394,0.7174,0.8311,0.7722	-0.2280			0.00,0.15	2.42		7.68>6.22			-0.5397	0.5014	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GABRD (inh=AD oe_syn=1.24 oe_mis=0.64 oe_lof=0.05)
chr1	1957037	1957037	T	C	het	het	wt		QUAL=6704;DP=154,399,340;AF=0.53,0.49,0.00;MQM=60;SAP=77;ABP=3	GABRD	synonymous	GABRD:ENST00000378585.4:synonymous_variant:LOW:exon4/9:c.330T>C:p.Gly110=:PF02931 [Neurotransmitter-gated ion-channel ligand binding domain]	GABRD:NM_000815.5:synonymous_variant:LOW:exon4/9:c.330T>C:p.Gly110=:	regulatory_region_variant:promoter_flanking_region	137163 [GENE=GABRD PHENOS=Epilepsy,juvenile myoclonic,susceptibility to,613060,Autosomal dominant/Epilepsy,idiopathic generalized,10,613060,Autosomal dominant/Epilepsy,generalized,with febrile seizures plus,type 5,susceptibility to,613060,Autosomal dominant];	256823 [benign DISEASE=not specified,not provided];			rs2229110	0.5613	0.6469	6668,.	0.7305,0.4736,0.3137,0.6572,0.4740	-1.3800			0.07,0.88	12.50					0.0631	0.0833	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GABRD (inh=AD oe_syn=1.24 oe_mis=0.64 oe_lof=0.05)
chr1	1957220	1957220	G	-	het	het	wt	off-target	QUAL=1267;DP=52,75,54;AF=0.44,0.51,0.00;MQM=60;SAP=135;ABP=3	GABRD	intron	GABRD:ENST00000378585.4:intron_variant:MODIFIER:intron4/8:c.470+45del::	GABRD:NM_000815.5:intron_variant:MODIFIER:intron4/8:c.470+45del::	regulatory_region_variant:promoter_flanking_region	137163 [GENE=GABRD PHENOS=Epilepsy,juvenile myoclonic,susceptibility to,613060,Autosomal dominant/Epilepsy,idiopathic generalized,10,613060,Autosomal dominant/Epilepsy,generalized,with febrile seizures plus,type 5,susceptibility to,613060,Autosomal dominant];				rs3831907		0.1196	281,.	0.2114,0.0549,0.0248,0.1141,0.0777	-4.7340				0.21					-0.2245	0.083	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GABRD (inh=AD oe_syn=1.24 oe_mis=0.64 oe_lof=0.05)
chr1	1960674	1960674	C	T	het	wt	het		QUAL=4894;DP=115,385,265;AF=0.49,0.01,0.56;MQM=60;SAP=15;ABP=7	GABRD	synonymous	GABRD:ENST00000378585.4:synonymous_variant:LOW:exon7/9:c.816C>T:p.Ser272=:PF02932 [Neurotransmitter-gated ion-channel transmembrane region]	GABRD:NM_000815.5:synonymous_variant:LOW:exon7/9:c.816C>T:p.Ser272=:		137163 [GENE=GABRD PHENOS=Epilepsy,juvenile myoclonic,susceptibility to,613060,Autosomal dominant/Epilepsy,idiopathic generalized,10,613060,Autosomal dominant/Epilepsy,generalized,with febrile seizures plus,type 5,susceptibility to,613060,Autosomal dominant];	256825 [benign DISEASE=not specified];			rs28408173	0.1983	0.1918	416,.	0.0319,0.2378,0.4717,0.1428,0.2543	-0.7780			0.10,0.96	6.47					-0.1811	0.1519	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GABRD (inh=AD oe_syn=1.24 oe_mis=0.64 oe_lof=0.05)
chr1	1961408	1961408	C	T	het	wt	het	off-target	QUAL=1581;DP=67,73,64;AF=0.55,0.01,0.50;MQM=60;SAP=43;ABP=4	GABRD	intron	GABRD:ENST00000378585.4:intron_variant:MODIFIER:intron8/8:c.1060-14C>T::	GABRD:NM_000815.5:intron_variant:MODIFIER:intron8/8:c.1060-14C>T::		137163 [GENE=GABRD PHENOS=Epilepsy,juvenile myoclonic,susceptibility to,613060,Autosomal dominant/Epilepsy,idiopathic generalized,10,613060,Autosomal dominant/Epilepsy,generalized,with febrile seizures plus,type 5,susceptibility to,613060,Autosomal dominant];	256822 [benign DISEASE=not specified];			rs28431879	0.1999	0.1856	434,.	0.0295,0.2369,0.4852,0.1366,0.2428	-1.4010			0.00,0.11	0.13		7.61>6.94			0.2732	0.6827	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GABRD (inh=AD oe_syn=1.24 oe_mis=0.64 oe_lof=0.05)
chr1	2337277	2337277	C	T	het	n/a	n/a		QUAL=108;DP=20,1,1;AF=0.40,0.00,0.00;MQM=60;SAP=20;ABP=5	PEX10	splice_region&intron,intron	PEX10:ENST00000288774.3:splice_region_variant&intron_variant:LOW:intron5/5:c.973-4G>A::,PEX10:ENST00000447513.2:splice_region_variant&intron_variant:LOW:intron5/5:c.913-4G>A::,PEX10:ENST00000507596.1:intron_variant:MODIFIER:intron5/5:c.913-10G>A::	PEX10:NM_002617.3:splice_region_variant&intron_variant:LOW:intron5/5:c.913-4G>A::,PEX10:NM_153818.1:splice_region_variant&intron_variant:LOW:intron5/5:c.973-4G>A::	regulatory_region_variant:enhancer	602859 [GENE=PEX10 PHENOS=Peroxisome biogenesis disorder 6B,614871,Autosomal recessive/Peroxisome biogenesis disorder 6A (Zellweger),614870,Autosomal recessive];	262791 [benign DISEASE=Peroxisome biogenesis disorder 6A,not specified,not provided];			rs11586985	0.0809	0.1050	168,.	0.0217,0.0584,0.1222,0.1219,0.1099	-1.9740			0.08,0.13	0.33		13.68>13.46,-18.79>-18.77	0.000/0.002		0.0348	0.9875	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RER1 (inh=n/a oe_syn=1.20 oe_mis=0.46 oe_lof=0.22), PEX10 (inh=AR oe_syn=1.00 oe_mis=1.06 oe_lof=0.48)
chr1	2338126	2338126	C	A	wt	het	het	off-target	QUAL=1037;DP=46,55,44;AF=0.00,0.49,0.48;MQM=60;SAP=34;ABP=3	PEX10	intron	PEX10:ENST00000288774.3:intron_variant:MODIFIER:intron4/5:c.836+33G>T::,PEX10:ENST00000447513.2:intron_variant:MODIFIER:intron4/5:c.776+33G>T::,PEX10:ENST00000507596.1:intron_variant:MODIFIER:intron4/5:c.776+33G>T::	PEX10:NM_002617.3:intron_variant:MODIFIER:intron4/5:c.776+33G>T::,PEX10:NM_153818.1:intron_variant:MODIFIER:intron4/5:c.836+33G>T::		602859 [GENE=PEX10 PHENOS=Peroxisome biogenesis disorder 6B,614871,Autosomal recessive/Peroxisome biogenesis disorder 6A (Zellweger),614870,Autosomal recessive];				rs3795269	0.3391	0.4016	2574,.	0.2892,0.4078,0.2649,0.4329,0.3642	0.5730			0.20,0.15	5.04					0.0371	0.8775	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RER1 (inh=n/a oe_syn=1.20 oe_mis=0.46 oe_lof=0.22), PEX10 (inh=AR oe_syn=1.00 oe_mis=1.06 oe_lof=0.48)
chr1	2340200	2340200	T	C	wt	het	het		QUAL=985;DP=41,48,39;AF=0.02,0.54,0.44;MQM=60;SAP=47;ABP=3	PEX10	synonymous	PEX10:ENST00000288774.3:synonymous_variant:LOW:exon3/6:c.291A>G:p.Thr97=:PF04757 [Pex2 / Pex12 amino terminal region],PEX10:ENST00000447513.2:synonymous_variant:LOW:exon3/6:c.291A>G:p.Thr97=:PF04757 [Pex2 / Pex12 amino terminal region],PEX10:ENST00000507596.1:synonymous_variant:LOW:exon3/6:c.291A>G:p.Thr97=:PF04757 [Pex2 / Pex12 amino terminal region]	PEX10:NM_002617.3:synonymous_variant:LOW:exon3/6:c.291A>G:p.Thr97=:,PEX10:NM_153818.1:synonymous_variant:LOW:exon3/6:c.291A>G:p.Thr97=:		602859 [GENE=PEX10 PHENOS=Peroxisome biogenesis disorder 6B,614871,Autosomal recessive/Peroxisome biogenesis disorder 6A (Zellweger),614870,Autosomal recessive];	129884 [benign DISEASE=Peroxisome biogenesis disorder 6A,Zellweger syndrome,not specified,not provided];			rs2494598		0.7735	8639,.	0.5917,0.7710,0.7184,0.8112,0.7245	-6.5230			0.03,0.05	0.02					0.1139	0.9118	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RER1 (inh=n/a oe_syn=1.20 oe_mis=0.46 oe_lof=0.22), PEX10 (inh=AR oe_syn=1.00 oe_mis=1.06 oe_lof=0.48)
chr1	5922834	5922834	C	A	het	hom	wt	off-target	QUAL=1544;DP=54,42,26;AF=0.37,1.00,0.00;MQM=60;SAP=129;ABP=11	NPHP4,MIR4689	downstream_gene,upstream_gene	NPHP4:ENST00000378156.4:downstream_gene_variant:MODIFIER::::,MIR4689:ENST00000582517.1:upstream_gene_variant:MODIFIER::::							rs12133533	0.0966	0.1249	305,.	0.0152,0.0833,0.0529,0.1640,0.1101	-0.3700			0.06,0.16	0.93								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR4689 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5926507	5926507	T	C	het	hom	wt		QUAL=8883;DP=271,183,153;AF=0.50,0.99,0.00;MQM=60;SAP=31;ABP=3	NPHP4	synonymous	NPHP4:ENST00000378156.4:synonymous_variant:LOW:exon26/30:c.3570A>G:p.Glu1190=:	NPHP4:NM_001291593.2:synonymous_variant:LOW:exon23/27:c.2031A>G:p.Glu677=:,NPHP4:NM_001291594.2:synonymous_variant:LOW:exon22/26:c.2034A>G:p.Glu678=:,NPHP4:NM_015102.5:synonymous_variant:LOW:exon26/30:c.3570A>G:p.Glu1190=:,NPHP4:NR_111987.2:non_coding_transcript_exon_variant:MODIFIER:exon29/33:n.4337A>G::		607215 [GENE=NPHP4 PHENOS=Nephronophthisis 4,606966,Autosomal recessive/Senior-Loken syndrome 4,606996,Autosomal recessive];	95683 [benign DISEASE=Nephronophthisis,Nephronophthisis 4,Senior-Loken syndrome 4,not specified];			rs555164	0.3197	0.3926	2149,.	0.2002,0.3706,0.2558,0.4222,0.4302	0.2880			0.02,0.92	4.49					0.0946	0.9445	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR4689 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5927031	5927031	A	G	het	hom	wt	off-target	QUAL=3719;DP=80,96,65;AF=0.48,1.00,0.00;MQM=60;SAP=152;ABP=3	NPHP4	intron	NPHP4:ENST00000378156.4:intron_variant:MODIFIER:intron25/29:c.3558+59T>C::	NPHP4:NM_001291593.2:intron_variant:MODIFIER:intron22/26:c.2019+59T>C::,NPHP4:NM_001291594.2:intron_variant:MODIFIER:intron21/25:c.2022+59T>C::,NPHP4:NM_015102.5:intron_variant:MODIFIER:intron25/29:c.3558+59T>C::,NPHP4:NR_111987.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron28/32:n.4325+59T>C::		607215 [GENE=NPHP4 PHENOS=Nephronophthisis 4,606966,Autosomal recessive/Senior-Loken syndrome 4,606996,Autosomal recessive];				rs12122135	0.1028	0.1260	296,.		-0.2430			0.02,0.10	0.53					-0.1239	0.4255	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR4689 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5927943	5927943	G	A	wt	het	wt		QUAL=3623;DP=131,358,269;AF=0.00,0.48,0.00;MQM=60;SAP=44;ABP=5	NPHP4	missense	NPHP4:ENST00000378156.4:missense_variant:MODERATE:exon24/30:c.3329C>T:p.Ala1110Val:	NPHP4:NM_001291593.2:missense_variant:MODERATE:exon21/27:c.1790C>T:p.Ala597Val:,NPHP4:NM_001291594.2:missense_variant:MODERATE:exon20/26:c.1793C>T:p.Ala598Val:,NPHP4:NM_015102.5:missense_variant:MODERATE:exon24/30:c.3329C>T:p.Ala1110Val:,NPHP4:NR_111987.2:non_coding_transcript_exon_variant:MODIFIER:exon27/33:n.4096C>T::		607215 [GENE=NPHP4 PHENOS=Nephronophthisis 4,606966,Autosomal recessive/Senior-Loken syndrome 4,606996,Autosomal recessive];	95682 [likely benign(replaced by megSAP based on classifications:1x1,3x2,1x3) DISEASE=Nephronophthisis,Nephronophthisis 4,Senior-Loken syndrome 4,not specified];	CM125782 [CLASS=DM MUT=ALT PHEN="Cardiovascular malformations" GENE=NPHP4];		rs139767853	0.0014	0.0037	0,.	0.0012,0.0030,0.0000,0.0060,0.0008	0.0280	T(0.55)	B(0.01)	0.08,0.26	6.34	0.32			COSV65394401	-0.1263	0.2169	0.01	2	176	0 / 0					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5934490	5934490	A	G	hom	hom	het	off-target	QUAL=5948;DP=73,112,68;AF=0.99,1.00,0.49;MQM=60;SAP=474;ABP=3	NPHP4	intron	NPHP4:ENST00000378156.4:intron_variant:MODIFIER:intron22/29:c.3231+41T>C::	NPHP4:NM_001291593.2:intron_variant:MODIFIER:intron19/26:c.1692+41T>C::,NPHP4:NM_001291594.2:intron_variant:MODIFIER:intron18/25:c.1695+41T>C::,NPHP4:NM_015102.5:intron_variant:MODIFIER:intron22/29:c.3231+41T>C::,NPHP4:NR_111987.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron25/32:n.3998+41T>C::		607215 [GENE=NPHP4 PHENOS=Nephronophthisis 4,606966,Autosomal recessive/Senior-Loken syndrome 4,606996,Autosomal recessive];	260554 [benign DISEASE=not specified];			rs868163	0.5693	0.6453	6624,.	0.7125,0.4989,0.2688,0.6436,0.6148	-3.6260			0.01,0.09	0.35					-0.0888	0.3108	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5935162	5935162	A	T	het	het	hom		QUAL=4959;DP=86,128,87;AF=0.38,0.52,1.00;MQM=60;SAP=289;ABP=5	NPHP4	splice_acceptor	NPHP4:ENST00000378156.4:splice_acceptor_variant:HIGH:intron20/29:c.2818-2T>A::	NPHP4:NM_001291593.2:splice_acceptor_variant:HIGH:intron17/26:c.1279-2T>A::,NPHP4:NM_001291594.2:splice_acceptor_variant:HIGH:intron16/25:c.1282-2T>A::,NPHP4:NM_015102.5:splice_acceptor_variant:HIGH:intron20/29:c.2818-2T>A::,NPHP4:NR_111987.2:splice_acceptor_variant&non_coding_transcript_variant:HIGH:intron23/32:n.3585-2T>A::		607215 [GENE=NPHP4 PHENOS=Nephronophthisis 4,606966,Autosomal recessive/Senior-Loken syndrome 4,606996,Autosomal recessive];	167375 [benign DISEASE=Nephronophthisis,Nephronophthisis 4,not specified];			rs1217117155,rs1287637		0.8606	11601,.	0.8938,0.7936,0.8101,0.8244,0.8282	0.4530			0.00,0.85	21.90		0.90>9.27					1	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5937391	5937391	C	T	n/a	hom	n/a	off-target	QUAL=158;DP=1,4,0;AF=1.00,1.00,;MQM=60;SAP=7;ABP=0	NPHP4	intron	NPHP4:ENST00000378156.4:intron_variant:MODIFIER:intron19/29:c.2612-33G>A::	NPHP4:NM_001291593.2:intron_variant:MODIFIER:intron16/26:c.1073-33G>A::,NPHP4:NM_001291594.2:intron_variant:MODIFIER:intron15/25:c.1076-33G>A::,NPHP4:NM_015102.5:intron_variant:MODIFIER:intron19/29:c.2612-33G>A::,NPHP4:NR_111987.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron20/32:n.3116-33G>A::		607215 [GENE=NPHP4 PHENOS=Nephronophthisis 4,606966,Autosomal recessive/Senior-Loken syndrome 4,606996,Autosomal recessive];	260547 [benign DISEASE=not specified];			rs3747989		0.8299	10876,.	0.9382,0.7305,0.8517,0.8010,0.7363	-2.2310			0.00,0.05	0.38					-0.166	0.8785	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5947308	5947308	G	A	wt	het	wt	off-target	QUAL=1781;DP=128,187,146;AF=0.00,0.42,0.01;MQM=60;SAP=88;ABP=13	NPHP4	intron	NPHP4:ENST00000378156.4:intron_variant:MODIFIER:intron18/29:c.2485+38C>T::	NPHP4:NM_001291593.2:intron_variant:MODIFIER:intron15/26:c.946+38C>T::,NPHP4:NM_001291594.2:intron_variant:MODIFIER:intron14/25:c.949+38C>T::,NPHP4:NM_015102.5:intron_variant:MODIFIER:intron18/29:c.2485+38C>T::,NPHP4:NR_111987.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron18/32:n.2702+38C>T::		607215 [GENE=NPHP4 PHENOS=Nephronophthisis 4,606966,Autosomal recessive/Senior-Loken syndrome 4,606996,Autosomal recessive];	260546 [benign DISEASE=not specified];			rs41280814	0.0863	0.1342	259,.	0.0275,0.0789,0.0795,0.1716,0.1155	-1.8090			0.05,0.17	1.87					0.1271	0.1386	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5965381	5965381	C	T	wt	het	wt		QUAL=2693;DP=207,262,206;AF=0.00,0.43,0.00;MQM=60;SAP=34;ABP=15	NPHP4	synonymous	NPHP4:ENST00000378156.4:synonymous_variant:LOW:exon15/30:c.1926G>A:p.Glu642=:	NPHP4:NM_001291593.2:synonymous_variant:LOW:exon12/27:c.387G>A:p.Glu129=:,NPHP4:NM_001291594.2:synonymous_variant:LOW:exon11/26:c.390G>A:p.Glu130=:,NPHP4:NM_015102.5:synonymous_variant:LOW:exon15/30:c.1926G>A:p.Glu642=:,NPHP4:NR_111987.2:non_coding_transcript_exon_variant:MODIFIER:exon15/33:n.2143G>A::		607215 [GENE=NPHP4 PHENOS=Nephronophthisis 4,606966,Autosomal recessive/Senior-Loken syndrome 4,606996,Autosomal recessive];	95673 [benign DISEASE=Nephronophthisis,Nephronophthisis 4,Senior-Loken syndrome 4,not specified];			rs12120967	0.0841	0.1317	259,.	0.0271,0.0767,0.0768,0.1672,0.1125	-0.7650			0.03,0.33	2.39					-0.2821	0.2799	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5987696	5987696	T	C	wt	het	wt	off-target	QUAL=2421;DP=133,184,150;AF=0.00,0.54,0.02;MQM=60;SAP=34;ABP=5	NPHP4	intron	NPHP4:ENST00000378156.4:intron_variant:MODIFIER:intron11/29:c.1441+13A>G::	NPHP4:NM_001291593.2:intron_variant:MODIFIER:intron10/26:c.75+13A>G::,NPHP4:NM_001291594.2:intron_variant:MODIFIER:intron9/25:c.75+13A>G::,NPHP4:NM_015102.5:intron_variant:MODIFIER:intron11/29:c.1441+13A>G::,NPHP4:NR_111987.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron11/32:n.1661+13A>G::		607215 [GENE=NPHP4 PHENOS=Nephronophthisis 4,606966,Autosomal recessive/Senior-Loken syndrome 4,606996,Autosomal recessive];	95671 [benign DISEASE=Nephronophthisis 4,Senior-Loken syndrome 4,not specified];			rs7520105	0.1412	0.1688	428,.	0.2101,0.0876,0.0770,0.1681,0.1150	0.8260			0.31,0.17	8.44					0.312	0.0098	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	6046432	6046432	C	G	wt	het	wt	off-target	QUAL=789;DP=52,52,46;AF=0.00,0.63,0.02;MQM=60;SAP=40;ABP=11	NPHP4	intron	NPHP4:ENST00000378156.4:intron_variant:MODIFIER:intron1/29:c.-38-45G>C::	NPHP4:NM_001291593.2:intron_variant:MODIFIER:intron1/26:c.-1267-45G>C::,NPHP4:NM_001291594.2:intron_variant:MODIFIER:intron1/25:c.-1088+5872G>C::,NPHP4:NM_015102.5:intron_variant:MODIFIER:intron1/29:c.-38-45G>C::,NPHP4:NR_111987.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/32:n.183-45G>C::		607215 [GENE=NPHP4 PHENOS=Nephronophthisis 4,606966,Autosomal recessive/Senior-Loken syndrome 4,606996,Autosomal recessive];				rs1295111	0.3878	0.4104	2658,.		-0.1940			0.09,0.19	2.10					-0.0722	0.4147	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	6052571	6052571	G	A	wt	het	wt	off-target	QUAL=398;DP=3,39,29;AF=0.00,0.51,0.00;MQM=60;SAP=46;ABP=3	KCNAB2	5'UTR,intron	KCNAB2:ENST00000378097.1:5_prime_UTR_variant:MODIFIER:exon1/16:c.-330G>A::,KCNAB2:ENST00000378111.1:intron_variant:MODIFIER:intron1/7:c.-53+955G>A::		regulatory_region_variant:promoter					rs61760765	0.0218	0.0351	27,.		-0.2790			0.16,0.33	10.44					-0.0227	0.0249	0	1	24	0 / 0					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78), KCNAB2 (inh=AD oe_syn=0.95 oe_mis=0.55 oe_lof=0.18)
chr1	6052581	6052581	G	A	n/a	hom	het	off-target	QUAL=1335;DP=1,33,28;AF=1.00,1.00,0.68;MQM=60;SAP=118;ABP=11	KCNAB2	5'UTR,intron	KCNAB2:ENST00000378097.1:5_prime_UTR_variant:MODIFIER:exon1/16:c.-320G>A::,KCNAB2:ENST00000378111.1:intron_variant:MODIFIER:intron1/7:c.-53+965G>A::		regulatory_region_variant:promoter,TF_binding_site_variant					rs806109		0.8310	10906,.		0.0500			0.10,0.21	8.98					0.0137	0.0251	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78), KCNAB2 (inh=AD oe_syn=0.95 oe_mis=0.55 oe_lof=0.18)
chr1	6526183	6526183	G	A	het	het	wt		QUAL=380;DP=12,20,5;AF=0.50,0.70,0.00;MQM=60;SAP=7;ABP=7	PLEKHG5,TNFRSF25	3'UTR,5'UTR	PLEKHG5:ENST00000340850.5:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1440C>T::,TNFRSF25:ENST00000351959.5:5_prime_UTR_variant:MODIFIER:exon1/9:c.-16C>T::,TNFRSF25:ENST00000356876.3:5_prime_UTR_variant:MODIFIER:exon1/10:c.-16C>T::,PLEKHG5:ENST00000377748.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*1440C>T::,TNFRSF25:ENST00000377782.3:5_prime_UTR_variant:MODIFIER:exon1/10:c.-16C>T::,PLEKHG5:ENST00000400913.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1440C>T::	TNFRSF25:NM_001039664.1:5_prime_UTR_variant:MODIFIER:exon1/5:c.-16C>T::,PLEKHG5:NM_001042663.2:3_prime_UTR_variant:MODIFIER:exon22/22:c.*1440C>T::,PLEKHG5:NM_001042664.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1440C>T::,PLEKHG5:NM_001042665.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1440C>T::,PLEKHG5:NM_001265592.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*1440C>T::,PLEKHG5:NM_001265593.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1440C>T::,PLEKHG5:NM_001265594.2:3_prime_UTR_variant:MODIFIER:exon22/22:c.*1468C>T::,TNFRSF25:NM_003790.2:5_prime_UTR_variant:MODIFIER:exon1/10:c.-16C>T::,PLEKHG5:NM_020631.5:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1440C>T::,TNFRSF25:NM_148965.1:5_prime_UTR_variant:MODIFIER:exon1/10:c.-16C>T::,TNFRSF25:NM_148966.1:5_prime_UTR_variant:MODIFIER:exon1/9:c.-16C>T::,TNFRSF25:NM_148967.1:5_prime_UTR_variant:MODIFIER:exon1/9:c.-16C>T::,TNFRSF25:NM_148970.1:5_prime_UTR_variant:MODIFIER:exon1/5:c.-16C>T::,PLEKHG5:NM_198681.3:3_prime_UTR_variant:MODIFIER:exon22/22:c.*1440C>T::	regulatory_region_variant:promoter	611101 [GENE=PLEKHG5 PHENOS=Spinal muscular atrophy,distal,autosomal recessive,4,611067,Autosomal recessive/Charcot-Marie-Tooth disease,recessive intermediate C,615376,Autosomal recessive];	297904 [benign DISEASE=Distal spinal muscular atrophy, autosomal recessive 4];			rs3007417	0.2023	0.1843	1065,.	0.5020,0.0510,0.0004,0.0703,0.0791	-0.6580			0.06,0.14	9.16					-0.1011	0.9103	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6526203	6526210	CGTGCTCT	-	het	het	wt		QUAL=349;DP=11,20,6;AF=0.55,0.65,0.00;MQM=60;SAP=6;ABP=6	PLEKHG5,TNFRSF25	3'UTR,5'UTR	PLEKHG5:ENST00000340850.5:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1413_*1420del::,TNFRSF25:ENST00000351959.5:5_prime_UTR_variant:MODIFIER:exon1/9:c.-43_-36del::,TNFRSF25:ENST00000356876.3:5_prime_UTR_variant:MODIFIER:exon1/10:c.-43_-36del::,PLEKHG5:ENST00000377748.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*1413_*1420del::,TNFRSF25:ENST00000377782.3:5_prime_UTR_variant:MODIFIER:exon1/10:c.-43_-36del::,PLEKHG5:ENST00000400913.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1413_*1420del::	TNFRSF25:NM_001039664.1:5_prime_UTR_variant:MODIFIER:exon1/5:c.-43_-36del::,PLEKHG5:NM_001042663.2:3_prime_UTR_variant:MODIFIER:exon22/22:c.*1413_*1420del::,PLEKHG5:NM_001042664.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1413_*1420del::,PLEKHG5:NM_001042665.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1413_*1420del::,PLEKHG5:NM_001265592.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*1413_*1420del::,PLEKHG5:NM_001265593.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1413_*1420del::,PLEKHG5:NM_001265594.2:3_prime_UTR_variant:MODIFIER:exon22/22:c.*1441_*1448del::,TNFRSF25:NM_003790.2:5_prime_UTR_variant:MODIFIER:exon1/10:c.-43_-36del::,PLEKHG5:NM_020631.5:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1413_*1420del::,TNFRSF25:NM_148965.1:5_prime_UTR_variant:MODIFIER:exon1/10:c.-43_-36del::,TNFRSF25:NM_148966.1:5_prime_UTR_variant:MODIFIER:exon1/9:c.-43_-36del::,TNFRSF25:NM_148967.1:5_prime_UTR_variant:MODIFIER:exon1/9:c.-43_-36del::,TNFRSF25:NM_148970.1:5_prime_UTR_variant:MODIFIER:exon1/5:c.-43_-36del::,PLEKHG5:NM_198681.3:3_prime_UTR_variant:MODIFIER:exon22/22:c.*1413_*1420del::	regulatory_region_variant:promoter	611101 [GENE=PLEKHG5 PHENOS=Spinal muscular atrophy,distal,autosomal recessive,4,611067,Autosomal recessive/Charcot-Marie-Tooth disease,recessive intermediate C,615376,Autosomal recessive];	297905 [benign DISEASE=Distal spinal muscular atrophy];			rs45616733		0.1839	1053,.	0.4251,0.0464,0.0006,0.0579,0.0691	0.8620				9.75					-0.1649	0.91	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6526241	6526244	CGCC	-	hom	het	wt		QUAL=317;DP=4,15,3;AF=1.00,0.73,0.00;MQM=60;SAP=4;ABP=10	PLEKHG5,TNFRSF25	3'UTR,5'UTR	PLEKHG5:ENST00000340850.5:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1379_*1382del::,TNFRSF25:ENST00000356876.3:5_prime_UTR_variant:MODIFIER:exon1/10:c.-77_-74del::,PLEKHG5:ENST00000377748.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*1379_*1382del::,PLEKHG5:ENST00000400913.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1379_*1382del::	TNFRSF25:NM_001039664.1:5_prime_UTR_variant:MODIFIER:exon1/5:c.-77_-74del::,PLEKHG5:NM_001042663.2:3_prime_UTR_variant:MODIFIER:exon22/22:c.*1379_*1382del::,PLEKHG5:NM_001042664.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1379_*1382del::,PLEKHG5:NM_001042665.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1379_*1382del::,PLEKHG5:NM_001265592.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*1379_*1382del::,PLEKHG5:NM_001265593.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1379_*1382del::,PLEKHG5:NM_001265594.2:3_prime_UTR_variant:MODIFIER:exon22/22:c.*1407_*1410del::,TNFRSF25:NM_003790.2:5_prime_UTR_variant:MODIFIER:exon1/10:c.-77_-74del::,PLEKHG5:NM_020631.5:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1379_*1382del::,TNFRSF25:NM_148965.1:5_prime_UTR_variant:MODIFIER:exon1/10:c.-77_-74del::,TNFRSF25:NM_148966.1:5_prime_UTR_variant:MODIFIER:exon1/9:c.-77_-74del::,TNFRSF25:NM_148967.1:5_prime_UTR_variant:MODIFIER:exon1/9:c.-77_-74del::,TNFRSF25:NM_148970.1:5_prime_UTR_variant:MODIFIER:exon1/5:c.-77_-74del::,PLEKHG5:NM_198681.3:3_prime_UTR_variant:MODIFIER:exon22/22:c.*1379_*1382del::	regulatory_region_variant:promoter	611101 [GENE=PLEKHG5 PHENOS=Spinal muscular atrophy,distal,autosomal recessive,4,611067,Autosomal recessive/Charcot-Marie-Tooth disease,recessive intermediate C,615376,Autosomal recessive];	297906 [benign DISEASE=Distal spinal muscular atrophy];			rs45542640		0.1838	1069,.		1.0930				6.68					0.227	0.9107	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6526319	6526319	C	T	het	het	wt		QUAL=296;DP=30,32,30;AF=0.37,0.38,0.00;MQM=60;SAP=53;ABP=12	PLEKHG5	3'UTR	PLEKHG5:ENST00000340850.5:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1304G>A::,PLEKHG5:ENST00000377748.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*1304G>A::,PLEKHG5:ENST00000400913.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1304G>A::	PLEKHG5:NM_001042663.2:3_prime_UTR_variant:MODIFIER:exon22/22:c.*1304G>A::,PLEKHG5:NM_001042664.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1304G>A::,PLEKHG5:NM_001042665.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1304G>A::,PLEKHG5:NM_001265592.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*1304G>A::,PLEKHG5:NM_001265593.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1304G>A::,PLEKHG5:NM_001265594.2:3_prime_UTR_variant:MODIFIER:exon22/22:c.*1332G>A::,PLEKHG5:NM_020631.5:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1304G>A::,PLEKHG5:NM_198681.3:3_prime_UTR_variant:MODIFIER:exon22/22:c.*1304G>A::	regulatory_region_variant:promoter	611101 [GENE=PLEKHG5 PHENOS=Spinal muscular atrophy,distal,autosomal recessive,4,611067,Autosomal recessive/Charcot-Marie-Tooth disease,recessive intermediate C,615376,Autosomal recessive];	297910 [benign DISEASE=Distal spinal muscular atrophy, autosomal recessive 4];			rs45604837	0.0863	0.0841	157,.		-0.5600			0.05,0.16	5.22					-0.0007	0.9104	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6526465	6526465	C	G	het	het	wt		QUAL=3432;DP=81,199,150;AF=0.48,0.54,0.00;MQM=60;SAP=113;ABP=4	PLEKHG5	3'UTR	PLEKHG5:ENST00000340850.5:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1158G>C::,PLEKHG5:ENST00000377748.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*1158G>C::,PLEKHG5:ENST00000400913.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1158G>C::	PLEKHG5:NM_001042663.2:3_prime_UTR_variant:MODIFIER:exon22/22:c.*1158G>C::,PLEKHG5:NM_001042664.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1158G>C::,PLEKHG5:NM_001042665.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1158G>C::,PLEKHG5:NM_001265592.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*1158G>C::,PLEKHG5:NM_001265593.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1158G>C::,PLEKHG5:NM_001265594.2:3_prime_UTR_variant:MODIFIER:exon22/22:c.*1186G>C::,PLEKHG5:NM_020631.5:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1158G>C::,PLEKHG5:NM_198681.3:3_prime_UTR_variant:MODIFIER:exon22/22:c.*1158G>C::		611101 [GENE=PLEKHG5 PHENOS=Spinal muscular atrophy,distal,autosomal recessive,4,611067,Autosomal recessive/Charcot-Marie-Tooth disease,recessive intermediate C,615376,Autosomal recessive];	297912 [benign DISEASE=Distal spinal muscular atrophy, autosomal recessive 4];		MIR3 (SINE/MIR)	rs2986754	0.2043	0.1816	1155,.		-0.5720			0.01,0.10	1.36					0.0015	0.9105	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6526858	6526858	A	-	het	het	het	low_conf_region	QUAL=268;DP=44,6,6;AF=0.25,0.17,0.50;MQM=60;SAP=7;ABP=29	PLEKHG5	3'UTR	PLEKHG5:ENST00000340850.5:3_prime_UTR_variant:MODIFIER:exon21/21:c.*765del::,PLEKHG5:ENST00000377748.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*765del::,PLEKHG5:ENST00000400913.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*765del::	PLEKHG5:NM_001042663.2:3_prime_UTR_variant:MODIFIER:exon22/22:c.*765del::,PLEKHG5:NM_001042664.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*765del::,PLEKHG5:NM_001042665.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*765del::,PLEKHG5:NM_001265592.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*765del::,PLEKHG5:NM_001265593.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*765del::,PLEKHG5:NM_001265594.2:3_prime_UTR_variant:MODIFIER:exon22/22:c.*793del::,PLEKHG5:NM_020631.5:3_prime_UTR_variant:MODIFIER:exon21/21:c.*765del::,PLEKHG5:NM_198681.3:3_prime_UTR_variant:MODIFIER:exon22/22:c.*765del::		611101 [GENE=PLEKHG5 PHENOS=Spinal muscular atrophy,distal,autosomal recessive,4,611067,Autosomal recessive/Charcot-Marie-Tooth disease,recessive intermediate C,615376,Autosomal recessive];	297922 [uncertain significance DISEASE=Distal spinal muscular atrophy];		AluSz (SINE/Alu)	rs372197062		0.0962	182,.		-2.9090				0.12					0.0105	0.9106	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6527333	6527333	A	G	het	het	wt		QUAL=1590;DP=75,59,53;AF=0.51,0.47,0.00;MQM=60;SAP=3;ABP=3	PLEKHG5	3'UTR	PLEKHG5:ENST00000340850.5:3_prime_UTR_variant:MODIFIER:exon21/21:c.*290T>C::,PLEKHG5:ENST00000377725.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*318T>C::,PLEKHG5:ENST00000377728.3:3_prime_UTR_variant:MODIFIER:exon21/21:c.*290T>C::,PLEKHG5:ENST00000377732.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*290T>C::,PLEKHG5:ENST00000377737.2:3_prime_UTR_variant:MODIFIER:exon22/22:c.*290T>C::,PLEKHG5:ENST00000377740.3:3_prime_UTR_variant:MODIFIER:exon22/22:c.*290T>C::,PLEKHG5:ENST00000377748.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*290T>C::,PLEKHG5:ENST00000400913.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*290T>C::,PLEKHG5:ENST00000400915.3:3_prime_UTR_variant:MODIFIER:exon22/22:c.*290T>C::,PLEKHG5:ENST00000535355.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*290T>C::	PLEKHG5:NM_001042663.2:3_prime_UTR_variant:MODIFIER:exon22/22:c.*290T>C::,PLEKHG5:NM_001042664.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*290T>C::,PLEKHG5:NM_001042665.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*290T>C::,PLEKHG5:NM_001265592.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*290T>C::,PLEKHG5:NM_001265593.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*290T>C::,PLEKHG5:NM_001265594.2:3_prime_UTR_variant:MODIFIER:exon22/22:c.*318T>C::,PLEKHG5:NM_020631.5:3_prime_UTR_variant:MODIFIER:exon21/21:c.*290T>C::,PLEKHG5:NM_198681.3:3_prime_UTR_variant:MODIFIER:exon22/22:c.*290T>C::	regulatory_region_variant:enhancer	611101 [GENE=PLEKHG5 PHENOS=Spinal muscular atrophy,distal,autosomal recessive,4,611067,Autosomal recessive/Charcot-Marie-Tooth disease,recessive intermediate C,615376,Autosomal recessive];	297928 [benign DISEASE=Distal spinal muscular atrophy, autosomal recessive 4];			rs14708	0.2670	0.2632	1682,.		2.0370			0.00,0.11	11.00					-0.0241	0.9356	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6529183	6529185	TCC	-	het	het	wt		QUAL=1322;DP=47,106,63;AF=0.38,0.45,0.05;MQM=60;SAP=37;ABP=9	PLEKHG5	inframe_deletion	PLEKHG5:ENST00000340850.5:inframe_deletion:MODERATE:exon19/21:c.2166_2168del:p.Glu723del:,PLEKHG5:ENST00000377725.1:inframe_deletion:MODERATE:exon19/22:c.2166_2168del:p.Glu723del:,PLEKHG5:ENST00000377728.3:inframe_deletion:MODERATE:exon19/21:c.2166_2168del:p.Glu723del:,PLEKHG5:ENST00000377732.1:inframe_deletion:MODERATE:exon19/21:c.2277_2279del:p.Glu760del:,PLEKHG5:ENST00000377737.2:inframe_deletion:MODERATE:exon20/22:c.2166_2168del:p.Glu723del:,PLEKHG5:ENST00000377740.3:inframe_deletion:MODERATE:exon20/22:c.2397_2399del:p.Glu800del:,PLEKHG5:ENST00000377748.1:inframe_deletion:MODERATE:exon20/22:c.2397_2399del:p.Glu800del:,PLEKHG5:ENST00000400913.1:inframe_deletion:MODERATE:exon19/21:c.2166_2168del:p.Glu723del:,PLEKHG5:ENST00000400915.3:inframe_deletion:MODERATE:exon20/22:c.2334_2336del:p.Glu779del:,PLEKHG5:ENST00000535355.1:inframe_deletion:MODERATE:exon19/21:c.2373_2375del:p.Glu792del:,PLEKHG5:ENST00000537245.1:inframe_deletion:MODERATE:exon20/22:c.2403_2405del:p.Glu802del:,PLEKHG5:ENST00000544978.1:inframe_deletion:MODERATE:exon20/22:c.2166_2168del:p.Glu723del:	PLEKHG5:NM_001042663.2:inframe_deletion:MODERATE:exon20/22:c.2334_2336del:p.Glu779del:,PLEKHG5:NM_001042664.1:inframe_deletion:MODERATE:exon19/21:c.2166_2168del:p.Glu723del:,PLEKHG5:NM_001042665.1:inframe_deletion:MODERATE:exon19/21:c.2166_2168del:p.Glu723del:,PLEKHG5:NM_001265592.1:inframe_deletion:MODERATE:exon20/22:c.2403_2405del:p.Glu802del:,PLEKHG5:NM_001265593.1:inframe_deletion:MODERATE:exon19/21:c.2373_2375del:p.Glu792del:,PLEKHG5:NM_001265594.2:inframe_deletion:MODERATE:exon19/22:c.2166_2168del:p.Glu723del:,PLEKHG5:NM_020631.5:inframe_deletion:MODERATE:exon19/21:c.2166_2168del:p.Glu723del:,PLEKHG5:NM_198681.3:inframe_deletion:MODERATE:exon20/22:c.2397_2399del:p.Glu800del:		611101 [GENE=PLEKHG5 PHENOS=Spinal muscular atrophy,distal,autosomal recessive,4,611067,Autosomal recessive/Charcot-Marie-Tooth disease,recessive intermediate C,615376,Autosomal recessive];	194979 [benign/likely benign DISEASE=Distal spinal muscular atrophy,not specified];		(TCC)n (Simple_repeat)	rs113541584		0.0848	125,.	0.1890,0.0573,0.0085,0.0753,0.0956	0.1060				11.98					-0.0217	0.1619	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6529443	6529443	A	G	het	het	wt		QUAL=9615;DP=312,486,391;AF=0.48,0.48,0.00;MQM=60;SAP=16;ABP=6	PLEKHG5	synonymous	PLEKHG5:ENST00000340850.5:synonymous_variant:LOW:exon18/21:c.2001T>C:p.Ser667=:,PLEKHG5:ENST00000377725.1:synonymous_variant:LOW:exon18/22:c.2001T>C:p.Ser667=:,PLEKHG5:ENST00000377728.3:synonymous_variant:LOW:exon18/21:c.2001T>C:p.Ser667=:,PLEKHG5:ENST00000377732.1:synonymous_variant:LOW:exon18/21:c.2112T>C:p.Ser704=:,PLEKHG5:ENST00000377737.2:synonymous_variant:LOW:exon19/22:c.2001T>C:p.Ser667=:,PLEKHG5:ENST00000377740.3:synonymous_variant:LOW:exon19/22:c.2232T>C:p.Ser744=:,PLEKHG5:ENST00000377748.1:synonymous_variant:LOW:exon19/22:c.2232T>C:p.Ser744=:,PLEKHG5:ENST00000400913.1:synonymous_variant:LOW:exon18/21:c.2001T>C:p.Ser667=:,PLEKHG5:ENST00000400915.3:synonymous_variant:LOW:exon19/22:c.2169T>C:p.Ser723=:,PLEKHG5:ENST00000535355.1:synonymous_variant:LOW:exon18/21:c.2208T>C:p.Ser736=:,PLEKHG5:ENST00000537245.1:synonymous_variant:LOW:exon19/22:c.2238T>C:p.Ser746=:,PLEKHG5:ENST00000544978.1:synonymous_variant:LOW:exon19/22:c.2001T>C:p.Ser667=:	PLEKHG5:NM_001042663.2:synonymous_variant:LOW:exon19/22:c.2169T>C:p.Ser723=:,PLEKHG5:NM_001042664.1:synonymous_variant:LOW:exon18/21:c.2001T>C:p.Ser667=:,PLEKHG5:NM_001042665.1:synonymous_variant:LOW:exon18/21:c.2001T>C:p.Ser667=:,PLEKHG5:NM_001265592.1:synonymous_variant:LOW:exon19/22:c.2238T>C:p.Ser746=:,PLEKHG5:NM_001265593.1:synonymous_variant:LOW:exon18/21:c.2208T>C:p.Ser736=:,PLEKHG5:NM_001265594.2:synonymous_variant:LOW:exon18/22:c.2001T>C:p.Ser667=:,PLEKHG5:NM_020631.5:synonymous_variant:LOW:exon18/21:c.2001T>C:p.Ser667=:,PLEKHG5:NM_198681.3:synonymous_variant:LOW:exon19/22:c.2232T>C:p.Ser744=:		611101 [GENE=PLEKHG5 PHENOS=Spinal muscular atrophy,distal,autosomal recessive,4,611067,Autosomal recessive/Charcot-Marie-Tooth disease,recessive intermediate C,615376,Autosomal recessive];	194881 [benign DISEASE=Distal spinal muscular atrophy, autosomal recessive 4,not specified];			rs730600	0.2696	0.2647	1701,.	0.5922,0.0937,0.0041,0.1423,0.1761	-0.2200			0.08,0.79	8.92					0.1586	0.0825	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6530435	6530435	A	G	het	het	wt	off-target	QUAL=1088;DP=39,55,49;AF=0.46,0.53,0.00;MQM=60;SAP=3;ABP=3	PLEKHG5	intron	PLEKHG5:ENST00000340850.5:intron_variant:MODIFIER:intron15/20:c.1681-20T>C::,PLEKHG5:ENST00000377725.1:intron_variant:MODIFIER:intron15/21:c.1681-20T>C::,PLEKHG5:ENST00000377728.3:intron_variant:MODIFIER:intron15/20:c.1681-20T>C::,PLEKHG5:ENST00000377732.1:intron_variant:MODIFIER:intron15/20:c.1792-20T>C::,PLEKHG5:ENST00000377737.2:intron_variant:MODIFIER:intron16/21:c.1681-20T>C::,PLEKHG5:ENST00000377740.3:intron_variant:MODIFIER:intron16/21:c.1912-20T>C::,PLEKHG5:ENST00000377748.1:intron_variant:MODIFIER:intron16/21:c.1912-20T>C::,PLEKHG5:ENST00000400913.1:intron_variant:MODIFIER:intron15/20:c.1681-20T>C::,PLEKHG5:ENST00000400915.3:intron_variant:MODIFIER:intron16/21:c.1849-20T>C::,PLEKHG5:ENST00000535355.1:intron_variant:MODIFIER:intron15/20:c.1888-20T>C::,PLEKHG5:ENST00000537245.1:intron_variant:MODIFIER:intron16/21:c.1918-20T>C::,PLEKHG5:ENST00000544978.1:intron_variant:MODIFIER:intron16/21:c.1681-20T>C::	PLEKHG5:NM_001042663.2:intron_variant:MODIFIER:intron16/21:c.1849-20T>C::,PLEKHG5:NM_001042664.1:intron_variant:MODIFIER:intron15/20:c.1681-20T>C::,PLEKHG5:NM_001042665.1:intron_variant:MODIFIER:intron15/20:c.1681-20T>C::,PLEKHG5:NM_001265592.1:intron_variant:MODIFIER:intron16/21:c.1918-20T>C::,PLEKHG5:NM_001265593.1:intron_variant:MODIFIER:intron15/20:c.1888-20T>C::,PLEKHG5:NM_001265594.2:intron_variant:MODIFIER:intron15/21:c.1681-20T>C::,PLEKHG5:NM_020631.5:intron_variant:MODIFIER:intron15/20:c.1681-20T>C::,PLEKHG5:NM_198681.3:intron_variant:MODIFIER:intron16/21:c.1912-20T>C::		611101 [GENE=PLEKHG5 PHENOS=Spinal muscular atrophy,distal,autosomal recessive,4,611067,Autosomal recessive/Charcot-Marie-Tooth disease,recessive intermediate C,615376,Autosomal recessive];				rs2986753	0.1717	0.1803	622,.	0.3429,0.0779,0.0039,0.1301,0.1509	-0.4640			0.01,0.12	6.39		7.80>7.76			0.1951	0.1275	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6530965	6530965	-	G	hom	hom	hom	off-target;low_conf_region	QUAL=5960;DP=40,117,84;AF=0.98,1.00,0.99;MQM=60;SAP=17;ABP=0	PLEKHG5	intron	PLEKHG5:ENST00000340850.5:intron_variant:MODIFIER:intron13/20:c.1393-22dup::,PLEKHG5:ENST00000377725.1:intron_variant:MODIFIER:intron13/21:c.1393-22dup::,PLEKHG5:ENST00000377728.3:intron_variant:MODIFIER:intron13/20:c.1393-22dup::,PLEKHG5:ENST00000377732.1:intron_variant:MODIFIER:intron13/20:c.1504-22dup::,PLEKHG5:ENST00000377737.2:intron_variant:MODIFIER:intron14/21:c.1393-22dup::,PLEKHG5:ENST00000377740.3:intron_variant:MODIFIER:intron14/21:c.1624-22dup::,PLEKHG5:ENST00000377748.1:intron_variant:MODIFIER:intron14/21:c.1624-22dup::,PLEKHG5:ENST00000400913.1:intron_variant:MODIFIER:intron13/20:c.1393-22dup::,PLEKHG5:ENST00000400915.3:intron_variant:MODIFIER:intron14/21:c.1561-22dup::,PLEKHG5:ENST00000535355.1:intron_variant:MODIFIER:intron13/20:c.1600-22dup::,PLEKHG5:ENST00000537245.1:intron_variant:MODIFIER:intron14/21:c.1630-22dup::,PLEKHG5:ENST00000544978.1:intron_variant:MODIFIER:intron14/21:c.1393-22dup::	PLEKHG5:NM_001042663.2:intron_variant:MODIFIER:intron14/21:c.1561-22dup::,PLEKHG5:NM_001042664.1:intron_variant:MODIFIER:intron13/20:c.1393-22dup::,PLEKHG5:NM_001042665.1:intron_variant:MODIFIER:intron13/20:c.1393-22dup::,PLEKHG5:NM_001265592.1:intron_variant:MODIFIER:intron14/21:c.1630-22dup::,PLEKHG5:NM_001265593.1:intron_variant:MODIFIER:intron13/20:c.1600-22dup::,PLEKHG5:NM_001265594.2:intron_variant:MODIFIER:intron13/21:c.1393-22dup::,PLEKHG5:NM_020631.5:intron_variant:MODIFIER:intron13/20:c.1393-22dup::,PLEKHG5:NM_198681.3:intron_variant:MODIFIER:intron14/21:c.1624-22dup::		611101 [GENE=PLEKHG5 PHENOS=Spinal muscular atrophy,distal,autosomal recessive,4,611067,Autosomal recessive/Charcot-Marie-Tooth disease,recessive intermediate C,615376,Autosomal recessive];	670557 [benign DISEASE=not provided];			rs111312565		1.0000	15524,.	1.0000,1.0000,0.9999,1.0000,1.0000					3.67					0.1757	0.1532	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6531589	6531589	C	T	het	het	wt		QUAL=1642;DP=35,114,115;AF=0.66,0.45,0.00;MQM=60;SAP=50;ABP=3	PLEKHG5	missense	PLEKHG5:ENST00000340850.5:missense_variant:MODERATE:exon12/21:c.1240G>A:p.Ala414Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000377725.1:missense_variant:MODERATE:exon12/22:c.1240G>A:p.Ala414Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000377728.3:missense_variant:MODERATE:exon12/21:c.1240G>A:p.Ala414Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000377732.1:missense_variant:MODERATE:exon12/21:c.1351G>A:p.Ala451Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000377737.2:missense_variant:MODERATE:exon13/22:c.1240G>A:p.Ala414Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000377740.3:missense_variant:MODERATE:exon13/22:c.1471G>A:p.Ala491Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000377748.1:missense_variant:MODERATE:exon13/22:c.1471G>A:p.Ala491Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000400913.1:missense_variant:MODERATE:exon12/21:c.1240G>A:p.Ala414Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000400915.3:missense_variant:MODERATE:exon13/22:c.1408G>A:p.Ala470Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000535355.1:missense_variant:MODERATE:exon12/21:c.1447G>A:p.Ala483Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000537245.1:missense_variant:MODERATE:exon13/22:c.1477G>A:p.Ala493Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000544978.1:missense_variant:MODERATE:exon13/22:c.1240G>A:p.Ala414Thr:PF00621 [RhoGEF domain]	PLEKHG5:NM_001042663.2:missense_variant:MODERATE:exon13/22:c.1408G>A:p.Ala470Thr:,PLEKHG5:NM_001042664.1:missense_variant:MODERATE:exon12/21:c.1240G>A:p.Ala414Thr:,PLEKHG5:NM_001042665.1:missense_variant:MODERATE:exon12/21:c.1240G>A:p.Ala414Thr:,PLEKHG5:NM_001265592.1:missense_variant:MODERATE:exon13/22:c.1477G>A:p.Ala493Thr:,PLEKHG5:NM_001265593.1:missense_variant:MODERATE:exon12/21:c.1447G>A:p.Ala483Thr:,PLEKHG5:NM_001265594.2:missense_variant:MODERATE:exon12/22:c.1240G>A:p.Ala414Thr:,PLEKHG5:NM_020631.5:missense_variant:MODERATE:exon12/21:c.1240G>A:p.Ala414Thr:,PLEKHG5:NM_198681.3:missense_variant:MODERATE:exon13/22:c.1471G>A:p.Ala491Thr:	regulatory_region_variant:promoter	611101 [GENE=PLEKHG5 PHENOS=Spinal muscular atrophy,distal,autosomal recessive,4,611067,Autosomal recessive/Charcot-Marie-Tooth disease,recessive intermediate C,615376,Autosomal recessive];	297959 [benign DISEASE=Distal spinal muscular atrophy, autosomal recessive 4];			rs74809741	0.0553	0.0579	62,.	0.0889,0.0369,0.0002,0.0593,0.0518	0.6400	T(0.45),T(0.44),T(0.45),T(0.43),T(0.45),T(0.44),T(0.43),T(0.45),T(0.43),T(0.41),T(0.42),T(0.44)	B(0.01),B(0.00),B(0.01),B(0.01),B(0.01),B(0.00),B(0.01),B(0.01),B(0.01),B(0.01),B(0.01),B(0.00)	0.73,0.93	15.78	0.04				0.0571	0.1504	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6533393	6533393	G	C	het	het	wt		QUAL=479;DP=25,25,19;AF=0.44,0.56,0.00;MQM=60;SAP=57;ABP=3	PLEKHG5	missense	PLEKHG5:ENST00000340850.5:missense_variant:MODERATE:exon8/21:c.713C>G:p.Thr238Ser:,PLEKHG5:ENST00000377725.1:missense_variant:MODERATE:exon8/22:c.713C>G:p.Thr238Ser:,PLEKHG5:ENST00000377728.3:missense_variant:MODERATE:exon8/21:c.713C>G:p.Thr238Ser:,PLEKHG5:ENST00000377732.1:missense_variant:MODERATE:exon8/21:c.824C>G:p.Thr275Ser:,PLEKHG5:ENST00000377737.2:missense_variant:MODERATE:exon9/22:c.713C>G:p.Thr238Ser:,PLEKHG5:ENST00000377740.3:missense_variant:MODERATE:exon9/22:c.944C>G:p.Thr315Ser:,PLEKHG5:ENST00000377748.1:missense_variant:MODERATE:exon9/22:c.944C>G:p.Thr315Ser:,PLEKHG5:ENST00000400913.1:missense_variant:MODERATE:exon8/21:c.713C>G:p.Thr238Ser:,PLEKHG5:ENST00000400915.3:missense_variant:MODERATE:exon9/22:c.881C>G:p.Thr294Ser:,PLEKHG5:ENST00000535355.1:missense_variant:MODERATE:exon8/21:c.920C>G:p.Thr307Ser:,PLEKHG5:ENST00000537245.1:missense_variant:MODERATE:exon9/22:c.950C>G:p.Thr317Ser:,PLEKHG5:ENST00000544978.1:missense_variant:MODERATE:exon9/22:c.713C>G:p.Thr238Ser:	PLEKHG5:NM_001042663.2:missense_variant:MODERATE:exon9/22:c.881C>G:p.Thr294Ser:,PLEKHG5:NM_001042664.1:missense_variant:MODERATE:exon8/21:c.713C>G:p.Thr238Ser:,PLEKHG5:NM_001042665.1:missense_variant:MODERATE:exon8/21:c.713C>G:p.Thr238Ser:,PLEKHG5:NM_001265592.1:missense_variant:MODERATE:exon9/22:c.950C>G:p.Thr317Ser:,PLEKHG5:NM_001265593.1:missense_variant:MODERATE:exon8/21:c.920C>G:p.Thr307Ser:,PLEKHG5:NM_001265594.2:missense_variant:MODERATE:exon8/22:c.713C>G:p.Thr238Ser:,PLEKHG5:NM_020631.5:missense_variant:MODERATE:exon8/21:c.713C>G:p.Thr238Ser:,PLEKHG5:NM_198681.3:missense_variant:MODERATE:exon9/22:c.944C>G:p.Thr315Ser:		611101 [GENE=PLEKHG5 PHENOS=Spinal muscular atrophy,distal,autosomal recessive,4,611067,Autosomal recessive/Charcot-Marie-Tooth disease,recessive intermediate C,615376,Autosomal recessive];	198895 [benign DISEASE=Distal spinal muscular atrophy, autosomal recessive 4,not specified];			rs61741379	0.2857	0.2786	1993,.	0.6445,0.0990,0.0072,0.1406,0.1621	0.8480	T(0.68),T(0.69),T(0.68),T(0.70),T(0.68),T(0.71),T(0.73),T(0.68),T(0.65),T(0.78),T(0.72),T(0.69)	B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00)	0.00,0.17	0.44	0.07				-0.0185	0.1635	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6579521	6579521	G	C	het	het	het		QUAL=3406;DP=120,91,76;AF=0.53,0.52,0.46;MQM=60;SAP=320;ABP=3	PLEKHG5	5'UTR,missense	PLEKHG5:ENST00000377737.2:5_prime_UTR_variant:MODIFIER:exon1/22:c.-181C>G::,PLEKHG5:ENST00000377740.3:missense_variant:MODERATE:exon1/22:c.51C>G:p.Ser17Arg:,PLEKHG5:ENST00000377748.1:missense_variant:MODERATE:exon1/22:c.51C>G:p.Ser17Arg:	PLEKHG5:NM_198681.3:missense_variant:MODERATE:exon1/22:c.51C>G:p.Ser17Arg:	regulatory_region_variant:promoter_flanking_region	611101 [GENE=PLEKHG5 PHENOS=Spinal muscular atrophy,distal,autosomal recessive,4,611067,Autosomal recessive/Charcot-Marie-Tooth disease,recessive intermediate C,615376,Autosomal recessive];	670484 [likely benign DISEASE=not provided];			rs17438786	0.0136	0.0242	10,.	0.0050,0.0165,0.0000,0.0326,0.0176	0.0870	 ,T(0.13),T(0.17)	 ,B(0.01),B(0.07)	0.13,0.49	9.18	0.09				-0.0149	0.0772		28	1105	0 / 0					PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38), NOL9 (inh=n/a oe_syn=1.08 oe_mis=0.77 oe_lof=0.31)
chr1	6579607	6579607	C	T	hom	hom	hom		QUAL=19979;DP=175,269,204;AF=1.00,1.00,1.00;MQM=60;SAP=737;ABP=0	PLEKHG5	5'UTR	PLEKHG5:ENST00000377737.2:5_prime_UTR_variant:MODIFIER:exon1/22:c.-267G>A::,PLEKHG5:ENST00000377740.3:5_prime_UTR_variant:MODIFIER:exon1/22:c.-36G>A::,PLEKHG5:ENST00000377748.1:5_prime_UTR_variant:MODIFIER:exon1/22:c.-36G>A::	PLEKHG5:NM_198681.3:5_prime_UTR_variant:MODIFIER:exon1/22:c.-36G>A::	regulatory_region_variant:promoter_flanking_region	611101 [GENE=PLEKHG5 PHENOS=Spinal muscular atrophy,distal,autosomal recessive,4,611067,Autosomal recessive/Charcot-Marie-Tooth disease,recessive intermediate C,615376,Autosomal recessive];	380860 [benign DISEASE=not specified];			rs1556035	0.7460	0.8595	9987,.	0.5189,0.9267,0.7933,0.8816,0.8645	0.2500			0.07,0.20	5.89					0.0189	0.0777		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38), NOL9 (inh=n/a oe_syn=1.08 oe_mis=0.77 oe_lof=0.31)
chr1	6579843	6579843	C	T	hom	hom	hom		QUAL=41832;DP=289,585,454;AF=0.99,1.00,1.00;MQM=60;SAP=142;ABP=0	PLEKHG5	5'UTR	PLEKHG5:ENST00000377737.2:5_prime_UTR_variant:MODIFIER:exon1/22:c.-503G>A::,PLEKHG5:ENST00000377740.3:5_prime_UTR_variant:MODIFIER:exon1/22:c.-272G>A::,PLEKHG5:ENST00000377748.1:5_prime_UTR_variant:MODIFIER:exon1/22:c.-272G>A::	PLEKHG5:NM_198681.3:5_prime_UTR_variant:MODIFIER:exon1/22:c.-272G>A::	regulatory_region_variant:promoter_flanking_region,regulatory_region_variant:CTCF_binding_site	611101 [GENE=PLEKHG5 PHENOS=Spinal muscular atrophy,distal,autosomal recessive,4,611067,Autosomal recessive/Charcot-Marie-Tooth disease,recessive intermediate C,615376,Autosomal recessive];	667919 [benign DISEASE=not provided];			rs1010584	0.7354	0.7734	9752,.		-0.5650			0.03,0.20	5.24					-0.0079	0.0773		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38), NOL9 (inh=n/a oe_syn=1.08 oe_mis=0.77 oe_lof=0.31)
chr1	10318652	10318652	C	G	wt	wt	het		QUAL=2875;DP=314,250,229;AF=0.00,0.00,0.50;MQM=60;SAP=5;ABP=3	KIF1B	synonymous	KIF1B:ENST00000263934.6:synonymous_variant:LOW:exon4/47:c.285C>G:p.Ala95=:PF00225 [Kinesin motor domain],KIF1B:ENST00000377081.1:synonymous_variant:LOW:exon3/48:c.285C>G:p.Ala95=:PF00225 [Kinesin motor domain],KIF1B:ENST00000377083.1:synonymous_variant:LOW:exon4/21:c.285C>G:p.Ala95=:PF00225 [Kinesin motor domain],KIF1B:ENST00000377086.1:synonymous_variant:LOW:exon4/49:c.285C>G:p.Ala95=:PF00225 [Kinesin motor domain],KIF1B:ENST00000377093.4:synonymous_variant:LOW:exon4/21:c.285C>G:p.Ala95=:PF00225 [Kinesin motor domain]	KIF1B:NM_001365951.2:synonymous_variant:LOW:exon4/49:c.285C>G:p.Ala95=:,KIF1B:NM_001365952.1:synonymous_variant:LOW:exon4/49:c.285C>G:p.Ala95=:,KIF1B:NM_001365953.1:synonymous_variant:LOW:exon4/21:c.285C>G:p.Ala95=:,KIF1B:NM_015074.3:synonymous_variant:LOW:exon4/47:c.285C>G:p.Ala95=:,KIF1B:NM_183416.4:synonymous_variant:LOW:exon4/21:c.285C>G:p.Ala95=:		605995 [GENE=KIF1B PHENOS=Pheochromocytoma,171300,Autosomal dominant/Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Somatic mutation,Autosomal dominant];	129399 [benign DISEASE=Neuroblastoma,Charcot-Marie-Tooth disease,Charcot-Marie-Tooth disease, type 2,not specified];			rs12402052	0.2300	0.2766	1045,.	0.0864,0.3446,0.2917,0.2914,0.2293	0.0540			0.81,0.97	11.90					-0.0803	0.3903	0.04	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10322054	10322054	G	A	wt	wt	het	off-target	QUAL=2024;DP=314,272,179;AF=0.00,0.00,0.46;MQM=60;SAP=10;ABP=5	KIF1B	intron	KIF1B:ENST00000263934.6:intron_variant:MODIFIER:intron5/46:c.429+26G>A::,KIF1B:ENST00000377081.1:intron_variant:MODIFIER:intron4/47:c.429+26G>A::,KIF1B:ENST00000377083.1:intron_variant:MODIFIER:intron5/20:c.429+26G>A::,KIF1B:ENST00000377086.1:intron_variant:MODIFIER:intron5/48:c.429+26G>A::,KIF1B:ENST00000377093.4:intron_variant:MODIFIER:intron5/20:c.429+26G>A::	KIF1B:NM_001365951.2:intron_variant:MODIFIER:intron5/48:c.429+26G>A::,KIF1B:NM_001365952.1:intron_variant:MODIFIER:intron5/48:c.429+26G>A::,KIF1B:NM_001365953.1:intron_variant:MODIFIER:intron5/20:c.429+26G>A::,KIF1B:NM_015074.3:intron_variant:MODIFIER:intron5/46:c.429+26G>A::,KIF1B:NM_183416.4:intron_variant:MODIFIER:intron5/20:c.429+26G>A::		605995 [GENE=KIF1B PHENOS=Pheochromocytoma,171300,Autosomal dominant/Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Somatic mutation,Autosomal dominant];				rs4846209	0.3399	0.3512	1943,.	0.3418,0.3938,0.3671,0.3431,0.2578	0.0780			0.00,0.08	3.60					0.096	0.091	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10327407	10327407	A	T	wt	wt	het	off-target	QUAL=1116;DP=256,130,100;AF=0.00,0.00,0.50;MQM=60;SAP=55;ABP=3	KIF1B	intron	KIF1B:ENST00000263934.6:intron_variant:MODIFIER:intron5/46:c.430-31A>T::,KIF1B:ENST00000377081.1:intron_variant:MODIFIER:intron4/47:c.430-31A>T::,KIF1B:ENST00000377083.1:intron_variant:MODIFIER:intron5/20:c.430-31A>T::,KIF1B:ENST00000377086.1:intron_variant:MODIFIER:intron5/48:c.430-31A>T::,KIF1B:ENST00000377093.4:intron_variant:MODIFIER:intron5/20:c.430-31A>T::	KIF1B:NM_001365951.2:intron_variant:MODIFIER:intron5/48:c.430-31A>T::,KIF1B:NM_001365952.1:intron_variant:MODIFIER:intron5/48:c.430-31A>T::,KIF1B:NM_001365953.1:intron_variant:MODIFIER:intron5/20:c.430-31A>T::,KIF1B:NM_015074.3:intron_variant:MODIFIER:intron5/46:c.430-31A>T::,KIF1B:NM_183416.4:intron_variant:MODIFIER:intron5/20:c.430-31A>T::		605995 [GENE=KIF1B PHENOS=Pheochromocytoma,171300,Autosomal dominant/Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Somatic mutation,Autosomal dominant];				rs12141246	0.3806	0.3770	2249,.	0.4133,0.3974,0.4087,0.3425,0.2575	-1.8450			0.00,0.07	2.05					0.2456	0.0636	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10328338	10328338	C	T	wt	wt	het	off-target	QUAL=2383;DP=239,187,186;AF=0.00,0.00,0.52;MQM=60;SAP=46;ABP=4	KIF1B	intron	KIF1B:ENST00000263934.6:intron_variant:MODIFIER:intron7/46:c.720+17C>T::,KIF1B:ENST00000377081.1:intron_variant:MODIFIER:intron6/47:c.720+17C>T::,KIF1B:ENST00000377083.1:intron_variant:MODIFIER:intron7/20:c.720+17C>T::,KIF1B:ENST00000377086.1:intron_variant:MODIFIER:intron7/48:c.720+17C>T::,KIF1B:ENST00000377093.4:intron_variant:MODIFIER:intron7/20:c.720+17C>T::	KIF1B:NM_001365951.2:intron_variant:MODIFIER:intron7/48:c.720+17C>T::,KIF1B:NM_001365952.1:intron_variant:MODIFIER:intron7/48:c.720+17C>T::,KIF1B:NM_001365953.1:intron_variant:MODIFIER:intron7/20:c.720+17C>T::,KIF1B:NM_015074.3:intron_variant:MODIFIER:intron7/46:c.720+17C>T::,KIF1B:NM_183416.4:intron_variant:MODIFIER:intron7/20:c.720+17C>T::		605995 [GENE=KIF1B PHENOS=Pheochromocytoma,171300,Autosomal dominant/Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Somatic mutation,Autosomal dominant];	260542 [benign DISEASE=Charcot-Marie-Tooth disease,not specified];			rs1339458	0.2540	0.2817	1113,.	0.1535,0.3485,0.2906,0.2919,0.2301	-1.1960			0.06,0.15	5.35					0.0266	0.2967	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10342629	10342629	G	A	wt	het	het	off-target	QUAL=5605;DP=180,224,219;AF=0.01,0.50,0.49;MQM=60;SAP=99;ABP=3	KIF1B	intron	KIF1B:ENST00000263934.6:intron_variant:MODIFIER:intron13/46:c.1296+38G>A::,KIF1B:ENST00000377081.1:intron_variant:MODIFIER:intron14/47:c.1434+38G>A::,KIF1B:ENST00000377083.1:intron_variant:MODIFIER:intron13/20:c.1296+38G>A::,KIF1B:ENST00000377086.1:intron_variant:MODIFIER:intron15/48:c.1434+38G>A::,KIF1B:ENST00000377093.4:intron_variant:MODIFIER:intron13/20:c.1296+38G>A::	KIF1B:NM_001365951.2:intron_variant:MODIFIER:intron15/48:c.1434+38G>A::,KIF1B:NM_001365952.1:intron_variant:MODIFIER:intron15/48:c.1434+38G>A::,KIF1B:NM_001365953.1:intron_variant:MODIFIER:intron13/20:c.1296+38G>A::,KIF1B:NM_015074.3:intron_variant:MODIFIER:intron13/46:c.1296+38G>A::,KIF1B:NM_183416.4:intron_variant:MODIFIER:intron13/20:c.1296+38G>A::		605995 [GENE=KIF1B PHENOS=Pheochromocytoma,171300,Autosomal dominant/Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Somatic mutation,Autosomal dominant];			L3 (LINE/CR1)	rs3748576	0.7127	0.7067	8153,.	0.9335,0.7352,0.5293,0.5971,0.6222	-0.7550			0.01,0.13	2.74					0.0723	0.0794	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10355834	10355834	C	T	wt	wt	het		QUAL=1539;DP=134,157,128;AF=0.01,0.00,0.48;MQM=60;SAP=11;ABP=3	KIF1B	intron	KIF1B:ENST00000263934.6:intron_variant:MODIFIER:intron17/46:c.1639+10C>T::,KIF1B:ENST00000377081.1:intron_variant:MODIFIER:intron18/47:c.1777+10C>T::,KIF1B:ENST00000377083.1:intron_variant:MODIFIER:intron17/20:c.1639+10C>T::,KIF1B:ENST00000377086.1:intron_variant:MODIFIER:intron19/48:c.1777+10C>T::,KIF1B:ENST00000377093.4:intron_variant:MODIFIER:intron17/20:c.1639+10C>T::	KIF1B:NM_001365951.2:intron_variant:MODIFIER:intron19/48:c.1777+10C>T::,KIF1B:NM_001365952.1:intron_variant:MODIFIER:intron19/48:c.1777+10C>T::,KIF1B:NM_001365953.1:intron_variant:MODIFIER:intron17/20:c.1639+10C>T::,KIF1B:NM_015074.3:intron_variant:MODIFIER:intron17/46:c.1639+10C>T::,KIF1B:NM_183416.4:intron_variant:MODIFIER:intron17/20:c.1639+10C>T::		605995 [GENE=KIF1B PHENOS=Pheochromocytoma,171300,Autosomal dominant/Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Somatic mutation,Autosomal dominant];	177960 [benign DISEASE=Neuroblastoma,Charcot-Marie-Tooth disease,Charcot-Marie-Tooth disease, type 2,not specified];			rs3753037	0.2640	0.2844	1165,.	0.1871,0.3503,0.2912,0.2920,0.2295	1.0480			0.09,0.20	3.93					-0.0837	0.1355	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10), RNU6-37P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	10357207	10357207	T	-	het	het	het	off-target;low_conf_region	QUAL=3686;DP=166,233,164;AF=0.34,0.31,0.29;MQM=60;SAP=4;ABP=171	KIF1B	intron	KIF1B:ENST00000263934.6:intron_variant:MODIFIER:intron19/46:c.1905-9del::,KIF1B:ENST00000377081.1:intron_variant:MODIFIER:intron20/47:c.2043-9del::,KIF1B:ENST00000377083.1:intron_variant:MODIFIER:intron19/20:c.1905-9del::,KIF1B:ENST00000377086.1:intron_variant:MODIFIER:intron21/48:c.2043-9del::,KIF1B:ENST00000377093.4:intron_variant:MODIFIER:intron19/20:c.1905-9del::	KIF1B:NM_001365951.2:intron_variant:MODIFIER:intron21/48:c.2043-9del::,KIF1B:NM_001365952.1:intron_variant:MODIFIER:intron21/48:c.2043-9del::,KIF1B:NM_001365953.1:intron_variant:MODIFIER:intron19/20:c.1905-9del::,KIF1B:NM_015074.3:intron_variant:MODIFIER:intron19/46:c.1905-9del::,KIF1B:NM_183416.4:intron_variant:MODIFIER:intron19/20:c.1905-9del::		605995 [GENE=KIF1B PHENOS=Pheochromocytoma,171300,Autosomal dominant/Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Somatic mutation,Autosomal dominant];	917114 [benign DISEASE=Charcot-Marie-Tooth disease];		(T)n (Simple_repeat)	rs58344165		0.4250	0,.	0.4308,0.4320,0.4215,0.4277,0.4367	-0.0240				0.03					0.1526	0.1651	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10), RNU6-37P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	10366487	10366487	T	G	wt	wt	het		QUAL=2586;DP=247,227,230;AF=0.00,0.00,0.45;MQM=60;SAP=4;ABP=8	KIF1B	intron,3'UTR	KIF1B:ENST00000263934.6:intron_variant:MODIFIER:intron20/46:c.1977+9183T>G::,KIF1B:ENST00000377081.1:intron_variant:MODIFIER:intron21/47:c.2115+9183T>G::,KIF1B:ENST00000377083.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1782T>G::,KIF1B:ENST00000377086.1:intron_variant:MODIFIER:intron22/48:c.2115+9183T>G::,KIF1B:ENST00000377093.4:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1782T>G::	KIF1B:NM_001365951.2:intron_variant:MODIFIER:intron22/48:c.2115+9183T>G::,KIF1B:NM_001365952.1:intron_variant:MODIFIER:intron22/48:c.2115+9183T>G::,KIF1B:NM_001365953.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1782T>G::,KIF1B:NM_015074.3:intron_variant:MODIFIER:intron20/46:c.1977+9183T>G::,KIF1B:NM_183416.4:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1782T>G::		605995 [GENE=KIF1B PHENOS=Pheochromocytoma,171300,Autosomal dominant/Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Somatic mutation,Autosomal dominant];				rs8019	0.3838	0.3972	2475,.		0.6540			0.00,0.09	2.13					0.0055	0.9466	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10), RN7SL731P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	10366692	10366692	C	G	wt	wt	het		QUAL=2901;DP=286,279,253;AF=0.00,0.00,0.47;MQM=60;SAP=84;ABP=4	KIF1B,RN7SL731P	intron,3'UTR,non_coding_transcript_exon	KIF1B:ENST00000263934.6:intron_variant:MODIFIER:intron20/46:c.1977+9388C>G::,KIF1B:ENST00000377081.1:intron_variant:MODIFIER:intron21/47:c.2115+9388C>G::,KIF1B:ENST00000377083.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1987C>G::,KIF1B:ENST00000377086.1:intron_variant:MODIFIER:intron22/48:c.2115+9388C>G::,KIF1B:ENST00000377093.4:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1987C>G::,RN7SL731P:ENST00000584329.1:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.170C>G::	KIF1B:NM_001365951.2:intron_variant:MODIFIER:intron22/48:c.2115+9388C>G::,KIF1B:NM_001365952.1:intron_variant:MODIFIER:intron22/48:c.2115+9388C>G::,KIF1B:NM_001365953.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1987C>G::,KIF1B:NM_015074.3:intron_variant:MODIFIER:intron20/46:c.1977+9388C>G::,KIF1B:NM_183416.4:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1987C>G::	regulatory_region_variant:promoter_flanking_region	605995 [GENE=KIF1B PHENOS=Pheochromocytoma,171300,Autosomal dominant/Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Somatic mutation,Autosomal dominant];			7SLRNA (srpRNA)	rs4623	0.3343	0.3429	1850,.		-0.5090			0.00,0.03	4.80					-0.0814	0.9562	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10), RN7SL731P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	10367424	10367424	G	A	wt	wt	het		QUAL=344;DP=114,45,43;AF=0.01,0.00,0.42;MQM=60;SAP=29;ABP=5	KIF1B	intron,3'UTR	KIF1B:ENST00000263934.6:intron_variant:MODIFIER:intron20/46:c.1977+10120G>A::,KIF1B:ENST00000377081.1:intron_variant:MODIFIER:intron21/47:c.2115+10120G>A::,KIF1B:ENST00000377086.1:intron_variant:MODIFIER:intron22/48:c.2115+10120G>A::,KIF1B:ENST00000377093.4:3_prime_UTR_variant:MODIFIER:exon21/21:c.*2719G>A::	KIF1B:NM_001365951.2:intron_variant:MODIFIER:intron22/48:c.2115+10120G>A::,KIF1B:NM_001365952.1:intron_variant:MODIFIER:intron22/48:c.2115+10120G>A::,KIF1B:NM_001365953.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*2719G>A::,KIF1B:NM_015074.3:intron_variant:MODIFIER:intron20/46:c.1977+10120G>A::,KIF1B:NM_183416.4:3_prime_UTR_variant:MODIFIER:exon21/21:c.*2719G>A::	regulatory_region_variant:promoter_flanking_region	605995 [GENE=KIF1B PHENOS=Pheochromocytoma,171300,Autosomal dominant/Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Somatic mutation,Autosomal dominant];			AluSx (SINE/Alu)	rs2004034	0.2316	0.2406	1052,.		-0.1060			0.00,0.11	3.44					0.001	0.9466	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10), RN7SL731P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	10367591	10367591	T	C	wt	wt	het		QUAL=1132;DP=189,99,86;AF=0.00,0.01,0.58;MQM=60;SAP=114;ABP=8	KIF1B	intron,3'UTR	KIF1B:ENST00000263934.6:intron_variant:MODIFIER:intron20/46:c.1977+10287T>C::,KIF1B:ENST00000377081.1:intron_variant:MODIFIER:intron21/47:c.2115+10287T>C::,KIF1B:ENST00000377086.1:intron_variant:MODIFIER:intron22/48:c.2115+10287T>C::,KIF1B:ENST00000377093.4:3_prime_UTR_variant:MODIFIER:exon21/21:c.*2886T>C::	KIF1B:NM_001365951.2:intron_variant:MODIFIER:intron22/48:c.2115+10287T>C::,KIF1B:NM_001365952.1:intron_variant:MODIFIER:intron22/48:c.2115+10287T>C::,KIF1B:NM_001365953.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*2886T>C::,KIF1B:NM_015074.3:intron_variant:MODIFIER:intron20/46:c.1977+10287T>C::,KIF1B:NM_183416.4:3_prime_UTR_variant:MODIFIER:exon21/21:c.*2886T>C::	regulatory_region_variant:promoter_flanking_region	605995 [GENE=KIF1B PHENOS=Pheochromocytoma,171300,Autosomal dominant/Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Somatic mutation,Autosomal dominant];			AluSx (SINE/Alu)	rs1065828	0.3341	0.3429	1865,.		-0.8920			0.00,0.03	3.77					0.0033	0.9466	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10), RN7SL731P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	10384176	10384176	-	TTGAAA	het	het	het	off-target;low_conf_region	QUAL=4665;DP=226,185,136;AF=0.45,0.38,0.42;MQM=60;SAP=450;ABP=34	KIF1B	intron	KIF1B:ENST00000263934.6:intron_variant:MODIFIER:intron23/46:c.2399+57_2399+58insTGAAAT::,KIF1B:ENST00000377081.1:intron_variant:MODIFIER:intron24/47:c.2537+57_2537+58insTGAAAT::,KIF1B:ENST00000377086.1:intron_variant:MODIFIER:intron25/48:c.2537+57_2537+58insTGAAAT::	KIF1B:NM_001365951.2:intron_variant:MODIFIER:intron25/48:c.2537+57_2537+58insTGAAAT::,KIF1B:NM_001365952.1:intron_variant:MODIFIER:intron25/48:c.2537+57_2537+58insTGAAAT::,KIF1B:NM_015074.3:intron_variant:MODIFIER:intron23/46:c.2399+57_2399+58insTGAAAT::		605995 [GENE=KIF1B PHENOS=Pheochromocytoma,171300,Autosomal dominant/Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Somatic mutation,Autosomal dominant];				rs3831405		0.2390	973,.						5.95					0.106	0.5623	0.1	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10394536	10394536	C	G	het	het	het	off-target	QUAL=8196;DP=247,219,151;AF=0.53,0.53,0.48;MQM=60;SAP=434;ABP=5	KIF1B	intron	KIF1B:ENST00000263934.6:intron_variant:MODIFIER:intron25/46:c.2787-42C>G::,KIF1B:ENST00000377081.1:intron_variant:MODIFIER:intron26/47:c.2925-42C>G::,KIF1B:ENST00000377086.1:intron_variant:MODIFIER:intron27/48:c.2925-42C>G::	KIF1B:NM_001365951.2:intron_variant:MODIFIER:intron27/48:c.2925-42C>G::,KIF1B:NM_001365952.1:intron_variant:MODIFIER:intron27/48:c.2925-42C>G::,KIF1B:NM_015074.3:intron_variant:MODIFIER:intron25/46:c.2787-42C>G::		605995 [GENE=KIF1B PHENOS=Pheochromocytoma,171300,Autosomal dominant/Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Somatic mutation,Autosomal dominant];				rs2276100	0.3339	0.3308	1727,.	0.3230,0.3842,0.3667,0.3197,0.2621	-0.0570			0.09,0.23	7.67					-0.1891	0.0642	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10397080	10397080	A	G	wt	het	wt	off-target	QUAL=1132;DP=202,101,79;AF=0.00,0.47,0.00;MQM=60;SAP=47;ABP=4	KIF1B	intron	KIF1B:ENST00000263934.6:intron_variant:MODIFIER:intron27/46:c.2992-52A>G::,KIF1B:ENST00000377081.1:intron_variant:MODIFIER:intron28/47:c.3130-52A>G::,KIF1B:ENST00000377086.1:intron_variant:MODIFIER:intron29/48:c.3130-52A>G::	KIF1B:NM_001365951.2:intron_variant:MODIFIER:intron29/48:c.3130-52A>G::,KIF1B:NM_001365952.1:intron_variant:MODIFIER:intron29/48:c.3130-52A>G::,KIF1B:NM_015074.3:intron_variant:MODIFIER:intron27/46:c.2992-52A>G::		605995 [GENE=KIF1B PHENOS=Pheochromocytoma,171300,Autosomal dominant/Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Somatic mutation,Autosomal dominant];				rs71643087	0.0112	0.0281	17,.		0.0100			0.01,0.20	3.93					-0.0034	0.3606	0	11	855	0 / 0					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10408838	10408838	T	-	het	het	het	off-target;low_conf_region	QUAL=155;DP=128,143,134;AF=0.16,0.10,0.17;MQM=60;SAP=50;ABP=457	KIF1B	intron	KIF1B:ENST00000263934.6:intron_variant:MODIFIER:intron35/46:c.3811+60del::,KIF1B:ENST00000377081.1:intron_variant:MODIFIER:intron36/47:c.3949+60del::,KIF1B:ENST00000377086.1:intron_variant:MODIFIER:intron37/48:c.3949+60del::	KIF1B:NM_001365951.2:intron_variant:MODIFIER:intron37/48:c.3949+60del::,KIF1B:NM_001365952.1:intron_variant:MODIFIER:intron37/48:c.3949+60del::,KIF1B:NM_015074.3:intron_variant:MODIFIER:intron35/46:c.3811+60del::		605995 [GENE=KIF1B PHENOS=Pheochromocytoma,171300,Autosomal dominant/Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Somatic mutation,Autosomal dominant];			FRAM (SINE/Alu)	rs35253111		0.2842	3,.	0.2232,0.3608,0.4320,0.2693,0.2557	1.6680				1.11					-0.0119	0.2342	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10420937	10420937	C	T	het	het	het	off-target	QUAL=11887;DP=258,372,298;AF=0.52,0.49,0.51;MQM=60;SAP=367;ABP=3	KIF1B	intron	KIF1B:ENST00000263934.6:intron_variant:MODIFIER:intron36/46:c.3918-50C>T::,KIF1B:ENST00000377081.1:intron_variant:MODIFIER:intron37/47:c.4056-50C>T::,KIF1B:ENST00000377086.1:intron_variant:MODIFIER:intron38/48:c.4056-50C>T::	KIF1B:NM_001365951.2:intron_variant:MODIFIER:intron38/48:c.4056-50C>T::,KIF1B:NM_001365952.1:intron_variant:MODIFIER:intron38/48:c.4056-50C>T::,KIF1B:NM_015074.3:intron_variant:MODIFIER:intron36/46:c.3918-50C>T::		605995 [GENE=KIF1B PHENOS=Pheochromocytoma,171300,Autosomal dominant/Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Somatic mutation,Autosomal dominant];				rs3748579	0.3341	0.3302	1713,.	0.3225,0.3839,0.3664,0.3196,0.2625	-0.4610			0.01,0.18	2.69					-0.0444	0.1022	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10425118	10425118	T	-	het	het	het	off-target	QUAL=3212;DP=98,111,87;AF=0.46,0.52,0.46;MQM=60;SAP=152;ABP=4	KIF1B	intron	KIF1B:ENST00000263934.6:intron_variant:MODIFIER:intron39/46:c.4229-33del::,KIF1B:ENST00000377081.1:intron_variant:MODIFIER:intron40/47:c.4367-33del::,KIF1B:ENST00000377086.1:intron_variant:MODIFIER:intron41/48:c.4367-33del::	KIF1B:NM_001365951.2:intron_variant:MODIFIER:intron41/48:c.4367-33del::,KIF1B:NM_001365952.1:intron_variant:MODIFIER:intron41/48:c.4367-33del::,KIF1B:NM_015074.3:intron_variant:MODIFIER:intron39/46:c.4229-33del::		605995 [GENE=KIF1B PHENOS=Pheochromocytoma,171300,Autosomal dominant/Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Somatic mutation,Autosomal dominant];				rs34161257		0.5252	4371,.	0.6622,0.4695,0.3722,0.4743,0.4639	0.5110				4.94					-0.1055	0.1667	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10431158	10431158	T	C	het	het	het	off-target	QUAL=7042;DP=217,224,156;AF=0.45,0.53,0.47;MQM=60;SAP=383;ABP=4	KIF1B	intron	KIF1B:ENST00000263934.6:intron_variant:MODIFIER:intron42/46:c.4687-41T>C::,KIF1B:ENST00000377081.1:intron_variant:MODIFIER:intron43/47:c.4825-41T>C::,KIF1B:ENST00000377086.1:intron_variant:MODIFIER:intron44/48:c.4825-41T>C::	KIF1B:NM_001365951.2:intron_variant:MODIFIER:intron44/48:c.4825-41T>C::,KIF1B:NM_001365952.1:intron_variant:MODIFIER:intron44/48:c.4825-41T>C::,KIF1B:NM_015074.3:intron_variant:MODIFIER:intron42/46:c.4687-41T>C::		605995 [GENE=KIF1B PHENOS=Pheochromocytoma,171300,Autosomal dominant/Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Somatic mutation,Autosomal dominant];				rs17411502	0.2490	0.2841	1126,.	0.1495,0.3490,0.2841,0.2958,0.2375	-0.7390			0.03,0.17	12.00					-0.0309	0.0985	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10435324	10435324	C	A	het	het	het		QUAL=7218;DP=295,148,115;AF=0.45,0.52,0.57;MQM=60;SAP=4;ABP=3	KIF1B	synonymous	KIF1B:ENST00000263934.6:synonymous_variant:LOW:exon46/47:c.5163C>A:p.Thr1721=:PF00169 [PH domain],KIF1B:ENST00000377081.1:synonymous_variant:LOW:exon47/48:c.5301C>A:p.Thr1767=:PF00169 [PH domain],KIF1B:ENST00000377086.1:synonymous_variant:LOW:exon48/49:c.5301C>A:p.Thr1767=:PF00169 [PH domain]	KIF1B:NM_001365951.2:synonymous_variant:LOW:exon48/49:c.5301C>A:p.Thr1767=:,KIF1B:NM_001365952.1:synonymous_variant:LOW:exon48/49:c.5301C>A:p.Thr1767=:,KIF1B:NM_015074.3:synonymous_variant:LOW:exon46/47:c.5163C>A:p.Thr1721=:		605995 [GENE=KIF1B PHENOS=Pheochromocytoma,171300,Autosomal dominant/Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Somatic mutation,Autosomal dominant];	129401 [benign DISEASE=Neuroblastoma,Charcot-Marie-Tooth disease,Charcot-Marie-Tooth disease, type 2,not specified];			rs11121552	0.2316	0.2795	1058,.	0.0874,0.3464,0.2848,0.2956,0.2374	-0.4200			0.27,0.97	8.67					-0.1605	0.0888	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10436892	10436892	-	AC	het	wt	het		QUAL=4727;DP=120,127,108;AF=0.40,0.01,0.31;MQM=60;SAP=28;ABP=222	KIF1B	3'UTR,intron	KIF1B:ENST00000263934.6:3_prime_UTR_variant:MODIFIER:exon47/47:c.*279_*280dup::,KIF1B:ENST00000377081.1:intron_variant:MODIFIER:intron47/47:c.5409-1473_5409-1472dup::,KIF1B:ENST00000377086.1:3_prime_UTR_variant:MODIFIER:exon49/49:c.*279_*280dup::	KIF1B:NM_001365951.2:3_prime_UTR_variant:MODIFIER:exon49/49:c.*279_*280dup::,KIF1B:NM_001365952.1:3_prime_UTR_variant:MODIFIER:exon49/49:c.*279_*280dup::,KIF1B:NM_015074.3:3_prime_UTR_variant:MODIFIER:exon47/47:c.*279_*280dup::		605995 [GENE=KIF1B PHENOS=Pheochromocytoma,171300,Autosomal dominant/Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Somatic mutation,Autosomal dominant];	291586 [uncertain significance DISEASE=Pheochromocytoma,Neuroblastoma,Charcot-Marie-Tooth disease, type 2];		(AC)n (Simple_repeat)	rs111663673		0.0594	37,.						3.46					-0.0038	0.8571	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10436924	10436924	C	T	het	het	wt	low_conf_region	QUAL=4727;DP=120,127,108;AF=0.40,0.01,0.31;MQM=60;SAP=15;ABP=6	KIF1B	3'UTR,intron	KIF1B:ENST00000263934.6:3_prime_UTR_variant:MODIFIER:exon47/47:c.*279C>T::,KIF1B:ENST00000377081.1:intron_variant:MODIFIER:intron47/47:c.5409-1473C>T::,KIF1B:ENST00000377086.1:3_prime_UTR_variant:MODIFIER:exon49/49:c.*279C>T::	KIF1B:NM_001365951.2:3_prime_UTR_variant:MODIFIER:exon49/49:c.*279C>T::,KIF1B:NM_001365952.1:3_prime_UTR_variant:MODIFIER:exon49/49:c.*279C>T::,KIF1B:NM_015074.3:3_prime_UTR_variant:MODIFIER:exon47/47:c.*279C>T::		605995 [GENE=KIF1B PHENOS=Pheochromocytoma,171300,Autosomal dominant/Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Somatic mutation,Autosomal dominant];	291594 [benign DISEASE=Neuroblastoma];		(AC)n (Simple_repeat)	rs78490707	0.0403	0.0080	11,.		-3.5950			0.04,0.22	2.40					-0.0033	0.8571	0	0	5	0 / 0					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10438006	10438006	A	T	het	wt	het		QUAL=1158;DP=76,72,54;AF=0.41,0.00,0.48;MQM=60;SAP=80;ABP=7	KIF1B	intron,3'UTR	KIF1B:ENST00000377081.1:intron_variant:MODIFIER:intron47/47:c.5409-391A>T::,KIF1B:ENST00000377086.1:3_prime_UTR_variant:MODIFIER:exon49/49:c.*1361A>T::	KIF1B:NM_001365951.2:3_prime_UTR_variant:MODIFIER:exon49/49:c.*1361A>T::,KIF1B:NM_001365952.1:3_prime_UTR_variant:MODIFIER:exon49/49:c.*1361A>T::,KIF1B:NM_015074.3:3_prime_UTR_variant:MODIFIER:exon47/47:c.*1361A>T::	regulatory_region_variant:promoter_flanking_region	605995 [GENE=KIF1B PHENOS=Pheochromocytoma,171300,Autosomal dominant/Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Somatic mutation,Autosomal dominant];	291610 [benign DISEASE=Neuroblastoma];		AluSg (SINE/Alu)	rs2847347	0.0182	0.0370	20,.		0.2110			0.16,0.23	2.63					-0.0032	0.857		1	26	0 / 0					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10438687	10438687	C	T	het	het	het		QUAL=12129;DP=252,354,281;AF=0.56,0.51,0.51;MQM=60;SAP=4;ABP=7	KIF1B	3'UTR	KIF1B:ENST00000377081.1:3_prime_UTR_variant:MODIFIER:exon48/48:c.*227C>T::,KIF1B:ENST00000377086.1:3_prime_UTR_variant:MODIFIER:exon49/49:c.*2042C>T::	KIF1B:NM_001365951.2:3_prime_UTR_variant:MODIFIER:exon49/49:c.*2042C>T::,KIF1B:NM_001365952.1:3_prime_UTR_variant:MODIFIER:exon49/49:c.*2042C>T::,KIF1B:NM_015074.3:3_prime_UTR_variant:MODIFIER:exon47/47:c.*2042C>T::	regulatory_region_variant:promoter_flanking_region	605995 [GENE=KIF1B PHENOS=Pheochromocytoma,171300,Autosomal dominant/Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Somatic mutation,Autosomal dominant];	291618 [benign DISEASE=Neuroblastoma];			rs1536262	0.5465	0.5500	4954,.		-1.2450			0.03,0.16	1.06					0.0005	0.9367		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10438892	10438892	G	A	het	het	het		QUAL=8827;DP=281,190,160;AF=0.53,0.52,0.57;MQM=60;SAP=75;ABP=11	KIF1B	3'UTR	KIF1B:ENST00000377081.1:3_prime_UTR_variant:MODIFIER:exon48/48:c.*432G>A::,KIF1B:ENST00000377086.1:3_prime_UTR_variant:MODIFIER:exon49/49:c.*2247G>A::	KIF1B:NM_001365951.2:3_prime_UTR_variant:MODIFIER:exon49/49:c.*2247G>A::,KIF1B:NM_001365952.1:3_prime_UTR_variant:MODIFIER:exon49/49:c.*2247G>A::,KIF1B:NM_015074.3:3_prime_UTR_variant:MODIFIER:exon47/47:c.*2247G>A::	regulatory_region_variant:promoter_flanking_region	605995 [GENE=KIF1B PHENOS=Pheochromocytoma,171300,Autosomal dominant/Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Somatic mutation,Autosomal dominant];	291619 [benign DISEASE=Neuroblastoma];			rs1002076	0.3337	0.3304	1723,.		0.4730			0.09,0.20	1.41					0.0002	0.9367		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10440556	10440556	A	G	het	het	het		QUAL=8931;DP=323,224,182;AF=0.50,0.48,0.49;MQM=51;SAP=13;ABP=4	KIF1B	3'UTR	KIF1B:ENST00000377081.1:3_prime_UTR_variant:MODIFIER:exon48/48:c.*2096A>G::,KIF1B:ENST00000377086.1:3_prime_UTR_variant:MODIFIER:exon49/49:c.*3911A>G::	KIF1B:NM_001365951.2:3_prime_UTR_variant:MODIFIER:exon49/49:c.*3911A>G::,KIF1B:NM_001365952.1:3_prime_UTR_variant:MODIFIER:exon49/49:c.*3911A>G::,KIF1B:NM_015074.3:3_prime_UTR_variant:MODIFIER:exon47/47:c.*3911A>G::	regulatory_region_variant:promoter_flanking_region	605995 [GENE=KIF1B PHENOS=Pheochromocytoma,171300,Autosomal dominant/Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Somatic mutation,Autosomal dominant];	291652 [benign DISEASE=Neuroblastoma];		AluSx (SINE/Alu)	rs1138791	0.3488	0.3605	2039,.		-1.5600			0.00,0.08	8.72					-0.0029	0.9366		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10441664	10441664	T	C	het	het	het		QUAL=13557;DP=452,349,272;AF=0.52,0.50,0.44;MQM=60;SAP=308;ABP=3	KIF1B	downstream_gene	KIF1B:ENST00000263934.6:downstream_gene_variant:MODIFIER::::,KIF1B:ENST00000377081.1:downstream_gene_variant:MODIFIER::::,KIF1B:ENST00000377086.1:downstream_gene_variant:MODIFIER::::			605995 [GENE=KIF1B PHENOS=Pheochromocytoma,171300,Autosomal dominant/Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Somatic mutation,Autosomal dominant];	368794 [benign DISEASE=Pheochromocytoma,Neuroblastoma,Charcot-Marie-Tooth disease, type 2];			rs3748581		0.5293	4497,.		0.2790			0.31,0.74	12.60								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	11085004	11085004	-	TGTTT	het	hom	het		QUAL=16295;DP=372,267,256;AF=0.49,1.00,0.50;MQM=60;SAP=35;ABP=3	TARDBP,MASP2,RP4-635E18.8	downstream_gene,upstream_gene	TARDBP:ENST00000240185.3:downstream_gene_variant:MODIFIER::::,TARDBP:ENST00000315091.3:downstream_gene_variant:MODIFIER::::,MASP2:ENST00000400897.3:downstream_gene_variant:MODIFIER::::,TARDBP:ENST00000439080.2:downstream_gene_variant:MODIFIER::::,RP4-635E18.8:ENST00000607145.1:upstream_gene_variant:MODIFIER::::	TARDBP:NM_007375.3:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2294_*2295insGTTTT::			291763 [benign DISEASE=Frontotemporal dementia,MASP2 deficiency,Amyotrophic Lateral Sclerosis, Dominant];			rs3059695		0.8767	12057,.						10.83					-0.0192	0.9159	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TARDBP (inh=AD oe_syn=1.10 oe_mis=0.32 oe_lof=0.06), MASP2 (inh=AR+AD oe_syn=1.07 oe_mis=0.99 oe_lof=0.81)
chr1	11846092	11846092	-	T	het	het	hom		QUAL=4319;DP=115,50,37;AF=0.75,0.90,0.89;MQM=60;SAP=248;ABP=127	MTHFR,C1orf167	3'UTR,intron	MTHFR:ENST00000376583.3:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4644dup::,MTHFR:ENST00000376592.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*4644dup::,C1orf167:ENST00000433342.1:intron_variant:MODIFIER:intron16/20:c.3639+757dup::	C1orf167:NM_001010881.2:intron_variant:MODIFIER:intron16/20:c.3567+757dup::,MTHFR:NM_001330358.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4644dup::,MTHFR:NM_005957.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4644dup::		607093 [GENE=MTHFR PHENOS=Vascular disease,susceptibility to/Schizophrenia,susceptibility to,181500,Autosomal dominant/Homocystinuria due to MTHFR deficiency,236250,Autosomal recessive/Neural tube defects,susceptibility to,601634,Autosomal recessive/Thromboembolism,susceptibility to,188050,Autosomal dominant];	292153 [benign DISEASE=Neural tube defects, folate-sensitive];			rs55740775		0.9797	13625,.						0.50					-0.0002	0.9618	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11846252	11846252	G	A	hom	het	het		QUAL=14963;DP=328,181,159;AF=1.00,0.54,0.50;MQM=60;SAP=46;ABP=5	MTHFR,C1orf167	3'UTR,intron	MTHFR:ENST00000376583.3:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4485C>T::,MTHFR:ENST00000376592.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*4485C>T::,C1orf167:ENST00000433342.1:intron_variant:MODIFIER:intron16/20:c.3639+906G>A::	C1orf167:NM_001010881.2:intron_variant:MODIFIER:intron16/20:c.3567+906G>A::,MTHFR:NM_001330358.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4485C>T::,MTHFR:NM_005957.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4485C>T::		607093 [GENE=MTHFR PHENOS=Vascular disease,susceptibility to/Schizophrenia,susceptibility to,181500,Autosomal dominant/Homocystinuria due to MTHFR deficiency,236250,Autosomal recessive/Neural tube defects,susceptibility to,601634,Autosomal recessive/Thromboembolism,susceptibility to,188050,Autosomal dominant];			Tigger15a (DNA/TcMar-Tigger)	rs4846048	0.7065	0.6858	7531,.		0.4870			0.00,0.12	6.07					-0.0018	0.9618	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11846447	11846447	G	A	hom	hom	hom		QUAL=25215;DP=379,214,181;AF=1.00,1.00,1.00;MQM=60;SAP=29;ABP=0	MTHFR,C1orf167	3'UTR,intron	MTHFR:ENST00000376583.3:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4290C>T::,MTHFR:ENST00000376592.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*4290C>T::,C1orf167:ENST00000433342.1:intron_variant:MODIFIER:intron16/20:c.3640-998G>A::	C1orf167:NM_001010881.2:intron_variant:MODIFIER:intron16/20:c.3568-998G>A::,MTHFR:NM_001330358.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4290C>T::,MTHFR:NM_005957.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4290C>T::		607093 [GENE=MTHFR PHENOS=Vascular disease,susceptibility to/Schizophrenia,susceptibility to,181500,Autosomal dominant/Homocystinuria due to MTHFR deficiency,236250,Autosomal recessive/Neural tube defects,susceptibility to,601634,Autosomal recessive/Thromboembolism,susceptibility to,188050,Autosomal dominant];				rs4845884		0.9393	13972,.		-0.7990			0.00,0.10	3.75					-0.0045	0.9618	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11846660	11846663	TTTT	-	het	het	het	low_conf_region	QUAL=1976;DP=66,28,21;AF=0.62,0.61,0.48;MQM=58;SAP=25;ABP=11	MTHFR,C1orf167	3'UTR,intron	MTHFR:ENST00000376583.3:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4074_*4077del::,MTHFR:ENST00000376590.3:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4074_*4077del::,MTHFR:ENST00000376592.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*4074_*4077del::,C1orf167:ENST00000433342.1:intron_variant:MODIFIER:intron16/20:c.3640-770_3640-767del::	C1orf167:NM_001010881.2:intron_variant:MODIFIER:intron16/20:c.3568-770_3568-767del::,MTHFR:NM_001330358.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4074_*4077del::,MTHFR:NM_005957.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4074_*4077del::	regulatory_region_variant:CTCF_binding_site	607093 [GENE=MTHFR PHENOS=Vascular disease,susceptibility to/Schizophrenia,susceptibility to,181500,Autosomal dominant/Homocystinuria due to MTHFR deficiency,236250,Autosomal recessive/Neural tube defects,susceptibility to,601634,Autosomal recessive/Thromboembolism,susceptibility to,188050,Autosomal dominant];	292164 [likely benign DISEASE=Neural tube defects, folate-sensitive];		AluJr (SINE/Alu)	rs55780505		0.5146	3151,.		0.3100				1.07					0.0048	0.9618	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11846660	11846664	TTTTT	-	het	het	het	low_conf_region	QUAL=1976;DP=66,28,21;AF=0.24,0.11,0.38;MQM=58;SAP=3;ABP=73	MTHFR,C1orf167	3'UTR,intron	MTHFR:ENST00000376583.3:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4073_*4077del::,MTHFR:ENST00000376590.3:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4073_*4077del::,MTHFR:ENST00000376592.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*4073_*4077del::,C1orf167:ENST00000433342.1:intron_variant:MODIFIER:intron16/20:c.3640-771_3640-767del::	C1orf167:NM_001010881.2:intron_variant:MODIFIER:intron16/20:c.3568-771_3568-767del::,MTHFR:NM_001330358.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4073_*4077del::,MTHFR:NM_005957.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4073_*4077del::	regulatory_region_variant:CTCF_binding_site	607093 [GENE=MTHFR PHENOS=Vascular disease,susceptibility to/Schizophrenia,susceptibility to,181500,Autosomal dominant/Homocystinuria due to MTHFR deficiency,236250,Autosomal recessive/Neural tube defects,susceptibility to,601634,Autosomal recessive/Thromboembolism,susceptibility to,188050,Autosomal dominant];			AluJr (SINE/Alu)	rs55780505		0.0078	0,.		0.3100				1.04					0.0058	0.9618	0.02	1	4	0 / 0					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11847334	11847334	-	GAA	hom	het	het		QUAL=9460;DP=224,220,132;AF=0.96,0.40,0.58;MQM=60;SAP=73;ABP=5	MTHFR,C1orf167	3'UTR,intron	MTHFR:ENST00000376583.3:3_prime_UTR_variant:MODIFIER:exon12/12:c.*3400_*3402dup::,MTHFR:ENST00000376590.3:3_prime_UTR_variant:MODIFIER:exon12/12:c.*3400_*3402dup::,MTHFR:ENST00000376592.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*3400_*3402dup::,C1orf167:ENST00000433342.1:intron_variant:MODIFIER:intron16/20:c.3640-108_3640-106dup::	C1orf167:NM_001010881.2:intron_variant:MODIFIER:intron16/20:c.3568-108_3568-106dup::,MTHFR:NM_001330358.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*3400_*3402dup::,MTHFR:NM_005957.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*3400_*3402dup::	TF_binding_site_variant	607093 [GENE=MTHFR PHENOS=Vascular disease,susceptibility to/Schizophrenia,susceptibility to,181500,Autosomal dominant/Homocystinuria due to MTHFR deficiency,236250,Autosomal recessive/Neural tube defects,susceptibility to,601634,Autosomal recessive/Thromboembolism,susceptibility to,188050,Autosomal dominant];				rs35134728		0.5694	5257,.						3.75					0.0018	0.9618	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11847759	11847759	C	T	hom	het	het		QUAL=11911;DP=188,289,242;AF=0.99,0.52,0.50;MQM=60;SAP=41;ABP=4	MTHFR,C1orf167	3'UTR,intron	MTHFR:ENST00000376583.3:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2978G>A::,MTHFR:ENST00000376590.3:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2978G>A::,MTHFR:ENST00000376592.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*2978G>A::,C1orf167:ENST00000433342.1:intron_variant:MODIFIER:intron17/20:c.3746-171C>T::	C1orf167:NM_001010881.2:intron_variant:MODIFIER:intron17/20:c.3674-171C>T::,MTHFR:NM_001330358.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2978G>A::,MTHFR:NM_005957.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2978G>A::	TF_binding_site_variant	607093 [GENE=MTHFR PHENOS=Vascular disease,susceptibility to/Schizophrenia,susceptibility to,181500,Autosomal dominant/Homocystinuria due to MTHFR deficiency,236250,Autosomal recessive/Neural tube defects,susceptibility to,601634,Autosomal recessive/Thromboembolism,susceptibility to,188050,Autosomal dominant];				rs3737966	0.5585	0.5604	5155,.		0.6900			0.30,0.29	7.60					-0.0611	0.9618	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11848139	11848139	G	A	wt	het	het		QUAL=2664;DP=120,122,84;AF=0.01,0.48,0.55;MQM=60;SAP=4;ABP=3	MTHFR,C1orf167	3'UTR,intron	MTHFR:ENST00000376583.3:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2598C>T::,MTHFR:ENST00000376590.3:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2598C>T::,MTHFR:ENST00000376592.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*2598C>T::,C1orf167:ENST00000433342.1:intron_variant:MODIFIER:intron18/20:c.3920+35G>A::	C1orf167:NM_001010881.2:intron_variant:MODIFIER:intron18/20:c.3848+35G>A::,MTHFR:NM_001330358.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2598C>T::,MTHFR:NM_005957.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2598C>T::	regulatory_region_variant:CTCF_binding_site	607093 [GENE=MTHFR PHENOS=Vascular disease,susceptibility to/Schizophrenia,susceptibility to,181500,Autosomal dominant/Homocystinuria due to MTHFR deficiency,236250,Autosomal recessive/Neural tube defects,susceptibility to,601634,Autosomal recessive/Thromboembolism,susceptibility to,188050,Autosomal dominant];				rs11559040	0.1268	0.1685	357,.	0.0352,0.0850,0.1026,0.1856,0.2669	-0.6770			0.09,0.19	5.09					-0.0188	0.9618	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11848879	11848879	A	G	hom	hom	hom		QUAL=18951;DP=240,217,151;AF=1.00,1.00,1.00;MQM=60;SAP=10;ABP=0	MTHFR,C1orf167	3'UTR,intron	MTHFR:ENST00000376583.3:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1858T>C::,MTHFR:ENST00000376585.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*1858T>C::,MTHFR:ENST00000376590.3:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1858T>C::,MTHFR:ENST00000376592.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*1858T>C::,C1orf167:ENST00000433342.1:intron_variant:MODIFIER:intron20/20:c.4245+76A>G::	C1orf167:NM_001010881.2:intron_variant:MODIFIER:intron20/20:c.4173+76A>G::,MTHFR:NM_001330358.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1858T>C::,MTHFR:NM_005957.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1858T>C::		607093 [GENE=MTHFR PHENOS=Vascular disease,susceptibility to/Schizophrenia,susceptibility to,181500,Autosomal dominant/Homocystinuria due to MTHFR deficiency,236250,Autosomal recessive/Neural tube defects,susceptibility to,601634,Autosomal recessive/Thromboembolism,susceptibility to,188050,Autosomal dominant];				rs2077360	0.9305	0.9366	13907,.		-0.5590			0.01,0.11	3.17					-0.0721	0.9618	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11849447	11849447	A	G	hom	hom	hom		QUAL=17680;DP=147,226,188;AF=1.00,1.00,1.00;MQM=60;SAP=9;ABP=0	MTHFR,C1orf167	3'UTR,missense	MTHFR:ENST00000376583.3:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1290T>C::,MTHFR:ENST00000376585.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*1290T>C::,MTHFR:ENST00000376590.3:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1290T>C::,MTHFR:ENST00000376592.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*1290T>C::,C1orf167:ENST00000433342.1:missense_variant:MODERATE:exon21/21:c.4366A>G:p.Arg1456Gly:	C1orf167:NM_001010881.2:missense_variant:MODERATE:exon21/21:c.4294A>G:p.Arg1432Gly:,MTHFR:NM_001330358.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1290T>C::,MTHFR:NM_005957.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1290T>C::		607093 [GENE=MTHFR PHENOS=Vascular disease,susceptibility to/Schizophrenia,susceptibility to,181500,Autosomal dominant/Homocystinuria due to MTHFR deficiency,236250,Autosomal recessive/Neural tube defects,susceptibility to,601634,Autosomal recessive/Thromboembolism,susceptibility to,188050,Autosomal dominant];				rs868014	0.9329	0.9874	13971,.	0.7812,0.9875,1.0000,0.9990,0.9997	-4.9500	 , , , ,T(0.24)	 , , , ,B(0.00)	0.02,0.21	3.28	0.03				0.1078	0.9618	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11850365	11850365	T	G	hom	het	het		QUAL=18953;DP=313,383,346;AF=1.00,0.49,0.49;MQM=60;SAP=224;ABP=4	MTHFR	3'UTR	MTHFR:ENST00000376583.3:3_prime_UTR_variant:MODIFIER:exon12/12:c.*372A>C::,MTHFR:ENST00000376585.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*372A>C::,MTHFR:ENST00000376590.3:3_prime_UTR_variant:MODIFIER:exon12/12:c.*372A>C::,MTHFR:ENST00000376592.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*372A>C::	MTHFR:NM_001330358.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*372A>C::,MTHFR:NM_005957.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*372A>C::		607093 [GENE=MTHFR PHENOS=Vascular disease,susceptibility to/Schizophrenia,susceptibility to,181500,Autosomal dominant/Homocystinuria due to MTHFR deficiency,236250,Autosomal recessive/Neural tube defects,susceptibility to,601634,Autosomal recessive/Thromboembolism,susceptibility to,188050,Autosomal dominant];				rs4846049		0.6369	6490,.		-0.6840			0.05,0.19	1.70					-0.0011	0.9618	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11851003	11851003	G	C	wt	het	het	off-target	QUAL=3882;DP=206,179,168;AF=0.00,0.43,0.48;MQM=60;SAP=43;ABP=9	MTHFR	intron	MTHFR:ENST00000376583.3:intron_variant:MODIFIER:intron11/11:c.1876-48C>G::,MTHFR:ENST00000376585.1:intron_variant:MODIFIER:intron12/12:c.1876-48C>G::,MTHFR:ENST00000376590.3:intron_variant:MODIFIER:intron11/11:c.1753-48C>G::,MTHFR:ENST00000376592.1:intron_variant:MODIFIER:intron10/10:c.1753-48C>G::	MTHFR:NM_001330358.1:intron_variant:MODIFIER:intron11/11:c.1876-48C>G::,MTHFR:NM_005957.5:intron_variant:MODIFIER:intron11/11:c.1753-48C>G::	TF_binding_site_variant	607093 [GENE=MTHFR PHENOS=Vascular disease,susceptibility to/Schizophrenia,susceptibility to,181500,Autosomal dominant/Homocystinuria due to MTHFR deficiency,236250,Autosomal recessive/Neural tube defects,susceptibility to,601634,Autosomal recessive/Thromboembolism,susceptibility to,188050,Autosomal dominant];				rs3818762		0.2600	880,.	0.1340,0.1420,0.2153,0.2748,0.4137	-1.1340			0.00,0.02	2.32					-0.1107	0.9177	0.04	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11852300	11852300	C	T	wt	het	het	off-target	QUAL=4639;DP=170,207,197;AF=0.01,0.48,0.47;MQM=60;SAP=13;ABP=5	MTHFR	intron	MTHFR:ENST00000376583.3:intron_variant:MODIFIER:intron10/11:c.1755+35G>A::,MTHFR:ENST00000376585.1:intron_variant:MODIFIER:intron11/12:c.1755+35G>A::,MTHFR:ENST00000376590.3:intron_variant:MODIFIER:intron10/11:c.1632+35G>A::,MTHFR:ENST00000376592.1:intron_variant:MODIFIER:intron9/10:c.1632+35G>A::	MTHFR:NM_001330358.1:intron_variant:MODIFIER:intron10/11:c.1755+35G>A::,MTHFR:NM_005957.5:intron_variant:MODIFIER:intron10/11:c.1632+35G>A::		607093 [GENE=MTHFR PHENOS=Vascular disease,susceptibility to/Schizophrenia,susceptibility to,181500,Autosomal dominant/Homocystinuria due to MTHFR deficiency,236250,Autosomal recessive/Neural tube defects,susceptibility to,601634,Autosomal recessive/Thromboembolism,susceptibility to,188050,Autosomal dominant];				rs1476413	0.2512	0.2614	890,.	0.1509,0.1389,0.2267,0.2731,0.4203	-1.1060			0.07,0.25	8.88					0.0255	0.0848	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11854457	11854457	G	A	hom	hom	hom		QUAL=18475;DP=119,264,202;AF=1.00,1.00,1.00;MQM=60;SAP=64;ABP=0	MTHFR	synonymous	MTHFR:ENST00000376583.3:synonymous_variant:LOW:exon8/12:c.1428C>T:p.Phe476=:,MTHFR:ENST00000376585.1:synonymous_variant:LOW:exon9/13:c.1428C>T:p.Phe476=:,MTHFR:ENST00000376590.3:synonymous_variant:LOW:exon8/12:c.1305C>T:p.Phe435=:,MTHFR:ENST00000376592.1:synonymous_variant:LOW:exon7/11:c.1305C>T:p.Phe435=:	MTHFR:NM_001330358.1:synonymous_variant:LOW:exon8/12:c.1428C>T:p.Phe476=:,MTHFR:NM_005957.5:synonymous_variant:LOW:exon8/12:c.1305C>T:p.Phe435=:		607093 [GENE=MTHFR PHENOS=Vascular disease,susceptibility to/Schizophrenia,susceptibility to,181500,Autosomal dominant/Homocystinuria due to MTHFR deficiency,236250,Autosomal recessive/Neural tube defects,susceptibility to,601634,Autosomal recessive/Thromboembolism,susceptibility to,188050,Autosomal dominant];	167306 [benign DISEASE=Homocystinuria due to MTHFR deficiency,not specified];			rs4846051	0.9029	0.9748	13266,.	0.6780,0.9819,0.9991,0.9983,0.9993	0.6310			0.47,0.83	6.45					-0.3366	0.2316	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11854476	11854476	T	G	wt	het	het		QUAL=7154;DP=165,287,227;AF=0.01,0.54,0.54;MQM=60;SAP=6;ABP=10	MTHFR	missense	MTHFR:ENST00000376583.3:missense_variant:MODERATE:exon8/12:c.1409A>C:p.Glu470Ala:,MTHFR:ENST00000376585.1:missense_variant:MODERATE:exon9/13:c.1409A>C:p.Glu470Ala:,MTHFR:ENST00000376590.3:missense_variant:MODERATE:exon8/12:c.1286A>C:p.Glu429Ala:,MTHFR:ENST00000376592.1:missense_variant:MODERATE:exon7/11:c.1286A>C:p.Glu429Ala:	MTHFR:NM_001330358.1:missense_variant:MODERATE:exon8/12:c.1409A>C:p.Glu470Ala:,MTHFR:NM_005957.5:missense_variant:MODERATE:exon8/12:c.1286A>C:p.Glu429Ala:	regulatory_region_variant:TF_binding_site	607093 [GENE=MTHFR PHENOS=Vascular disease,susceptibility to/Schizophrenia,susceptibility to,181500,Autosomal dominant/Homocystinuria due to MTHFR deficiency,236250,Autosomal recessive/Neural tube defects,susceptibility to,601634,Autosomal recessive/Thromboembolism,susceptibility to,188050,Autosomal dominant];	3521 [conflicting interpretations of pathogenicity, other DISEASE=Schizophrenia, susceptibility to,Gastrointestinal stromal tumor,Homocystinuria due to methylene tetrahydrofolate reductase deficiency,Neural tube defects, folate-sensitive,MTHFR deficiency, thermolabile type,Homocystinuria due to MTHFR deficiency,not specified,none provided,not provided];	CM981315 [CLASS=DFP MUT=ALT PHEN="Neural tube defect increased risk association with" GENE=MTHFR];		rs1801131	0.2494	0.2890	1116,.	0.1582,0.1594,0.2198,0.3186,0.4116	3.7910	T(0.15),T(0.15),T(0.14),T(0.14)	B(0.07),B(0.07),B(0.01),B(0.01)	0.96,0.96	22.10	0.20				-0.0943	0.2407	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11854755	11854755	G	A	hom	het	het	off-target	QUAL=3026;DP=70,54,57;AF=1.00,0.39,0.46;MQM=60;SAP=192;ABP=9	MTHFR	intron	MTHFR:ENST00000376583.3:intron_variant:MODIFIER:intron7/11:c.1289+31C>T::,MTHFR:ENST00000376585.1:intron_variant:MODIFIER:intron8/12:c.1289+31C>T::,MTHFR:ENST00000376590.3:intron_variant:MODIFIER:intron7/11:c.1166+31C>T::,MTHFR:ENST00000376592.1:intron_variant:MODIFIER:intron6/10:c.1166+31C>T::	MTHFR:NM_001330358.1:intron_variant:MODIFIER:intron7/11:c.1289+31C>T::,MTHFR:NM_005957.5:intron_variant:MODIFIER:intron7/11:c.1166+31C>T::	regulatory_region_variant:TF_binding_site	607093 [GENE=MTHFR PHENOS=Vascular disease,susceptibility to/Schizophrenia,susceptibility to,181500,Autosomal dominant/Homocystinuria due to MTHFR deficiency,236250,Autosomal recessive/Neural tube defects,susceptibility to,601634,Autosomal recessive/Thromboembolism,susceptibility to,188050,Autosomal dominant];				rs1994798	0.5793	0.6074	5239,.	0.4333,0.7727,0.7596,0.5879,0.4685	-3.8760			0.03,0.15	0.39					0.0638	0.212	0.04	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTHFR (inh=AR oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	12009955	12009955	C	T	het	het	het		QUAL=6861;DP=123,248,190;AF=0.46,0.49,0.53;MQM=60;SAP=59;ABP=3	PLOD1	synonymous	PLOD1:ENST00000196061.4:synonymous_variant:LOW:exon3/19:c.294C>T:p.Phe98=:,PLOD1:ENST00000376369.3:synonymous_variant:LOW:exon4/20:c.435C>T:p.Phe145=:	PLOD1:NM_000302.4:synonymous_variant:LOW:exon3/19:c.294C>T:p.Phe98=:,PLOD1:NM_001316320.2:synonymous_variant:LOW:exon4/20:c.435C>T:p.Phe145=:		153454 [GENE=PLOD1 PHENOS=Ehlers-Danlos syndrome,kyphoscoliotic type,1,225400,Autosomal recessive];	255803 [benign DISEASE=Ehlers-Danlos syndrome, hydroxylysine-deficient,not specified,Cardiovascular phenotype];			rs7529452	0.2678	0.3295	1533,.	0.0589,0.3522,0.3748,0.3160,0.4236	0.9490			0.69,0.83	11.79					-0.314	0.174	0.05	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	12009956	12009956	G	A	wt	wt	het		QUAL=1998;DP=146,243,186;AF=0.00,0.00,0.47;MQM=60;SAP=4;ABP=5	PLOD1	missense	PLOD1:ENST00000196061.4:missense_variant:MODERATE:exon3/19:c.295G>A:p.Ala99Thr:,PLOD1:ENST00000376369.3:missense_variant:MODERATE:exon4/20:c.436G>A:p.Ala146Thr:	PLOD1:NM_000302.4:missense_variant:MODERATE:exon3/19:c.295G>A:p.Ala99Thr:,PLOD1:NM_001316320.2:missense_variant:MODERATE:exon4/20:c.436G>A:p.Ala146Thr:		153454 [GENE=PLOD1 PHENOS=Ehlers-Danlos syndrome,kyphoscoliotic type,1,225400,Autosomal recessive];	196247 [benign DISEASE=Ehlers-Danlos syndrome, hydroxylysine-deficient,not specified,Cardiovascular phenotype];	CM068658 [CLASS=DP MUT=ALT PHEN="Bone mineral density association with" GENE=PLOD1];		rs7551175	0.2995	0.2590	1527,.	0.5503,0.0894,0.2527,0.1526,0.2126	1.4500	T(1.00),T(1.00)	B(0.00),B(0.00)	0.03,0.33	14.71	0.15				-0.1275	0.1796	0.05	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	12016957	12016957	T	G	wt	wt	het	off-target	QUAL=3761;DP=107,391,311;AF=0.00,0.00,0.50;MQM=60;SAP=70;ABP=3	PLOD1	intron	PLOD1:ENST00000196061.4:intron_variant:MODIFIER:intron6/18:c.644-17T>G::,PLOD1:ENST00000376369.3:intron_variant:MODIFIER:intron7/19:c.785-17T>G::	PLOD1:NM_000302.4:intron_variant:MODIFIER:intron6/18:c.644-17T>G::,PLOD1:NM_001316320.2:intron_variant:MODIFIER:intron7/19:c.785-17T>G::		153454 [GENE=PLOD1 PHENOS=Ehlers-Danlos syndrome,kyphoscoliotic type,1,225400,Autosomal recessive];	384719 [benign DISEASE=Ehlers-Danlos syndrome, hydroxylysine-deficient,not specified];			rs41307745	0.0769	0.0679	50,.	0.0104,0.0250,0.1423,0.0613,0.1356	3.2240			0.64,0.22	10.63		10.55>8.84			-0.7659	0.5216	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	12024235	12024235	C	T	het	het	het		QUAL=1166;DP=17,53,35;AF=0.59,0.53,0.40;MQM=60;SAP=3;ABP=3	PLOD1	synonymous	PLOD1:ENST00000196061.4:synonymous_variant:LOW:exon12/19:c.1206C>T:p.Asn402=:,PLOD1:ENST00000376369.3:synonymous_variant:LOW:exon13/20:c.1347C>T:p.Asn449=:	PLOD1:NM_000302.4:synonymous_variant:LOW:exon12/19:c.1206C>T:p.Asn402=:,PLOD1:NM_001316320.2:synonymous_variant:LOW:exon13/20:c.1347C>T:p.Asn449=:		153454 [GENE=PLOD1 PHENOS=Ehlers-Danlos syndrome,kyphoscoliotic type,1,225400,Autosomal recessive];	255799 [benign DISEASE=Ehlers-Danlos syndrome, hydroxylysine-deficient,not specified,Cardiovascular phenotype];			rs1130529	0.3484	0.3609	2053,.	0.2929,0.3668,0.3896,0.3275,0.4443	-1.0670			0.12,0.58	8.72					-0.2474	0.3036	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	12027204	12027204	C	T	het	het	hom	off-target	QUAL=9494;DP=39,211,205;AF=0.44,0.52,1.00;MQM=60;SAP=124;ABP=3	PLOD1	intron	PLOD1:ENST00000196061.4:intron_variant:MODIFIER:intron16/18:c.1755+56C>T::,PLOD1:ENST00000376369.3:intron_variant:MODIFIER:intron17/19:c.1896+56C>T::	PLOD1:NM_000302.4:intron_variant:MODIFIER:intron16/18:c.1755+56C>T::,PLOD1:NM_001316320.2:intron_variant:MODIFIER:intron17/19:c.1896+56C>T::	regulatory_region_variant:promoter_flanking_region,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	153454 [GENE=PLOD1 PHENOS=Ehlers-Danlos syndrome,kyphoscoliotic type,1,225400,Autosomal recessive];				rs2273293	0.5639	0.5222	4329,.		-3.7710			0.01,0.05	0.89					-0.0447	0.2984	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	12033113	12033113	A	G	het	het	hom	off-target	QUAL=11225;DP=132,263,209;AF=0.51,0.48,1.00;MQM=60;SAP=385;ABP=3	PLOD1	intron	PLOD1:ENST00000196061.4:intron_variant:MODIFIER:intron18/18:c.2028+59A>G::,PLOD1:ENST00000376369.3:intron_variant:MODIFIER:intron19/19:c.2169+59A>G::	PLOD1:NM_000302.4:intron_variant:MODIFIER:intron18/18:c.2028+59A>G::,PLOD1:NM_001316320.2:intron_variant:MODIFIER:intron19/19:c.2169+59A>G::		153454 [GENE=PLOD1 PHENOS=Ehlers-Danlos syndrome,kyphoscoliotic type,1,225400,Autosomal recessive];				rs3737961	0.6498	0.5826	5517,.		-0.4870			0.00,0.07	6.84					0.3297	0.1524	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	12040203	12040203	A	G	het	het	hom	off-target	QUAL=905;DP=24,24,20;AF=0.46,0.46,1.00;MQM=60;SAP=86;ABP=4	PLOD1,MFN2	downstream_gene,upstream_gene	PLOD1:ENST00000196061.4:downstream_gene_variant:MODIFIER::::,MFN2:ENST00000235329.5:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000444836.1:upstream_gene_variant:MODIFIER::::		regulatory_region_variant:promoter					rs2236053		0.5216	4305,.		-0.9190			0.00,0.13	3.32								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69), MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	12040324	12040324	A	G	het	het	hom		QUAL=4120;DP=30,123,101;AF=0.47,0.36,1.00;MQM=60;SAP=111;ABP=22	MFN2	5'UTR	MFN2:ENST00000444836.1:5_prime_UTR_variant:MODIFIER:exon1/18:c.-222A>G::	MFN2:NM_001127660.1:5_prime_UTR_variant:MODIFIER:exon1/18:c.-222A>G::	regulatory_region_variant:promoter	608507 [GENE=MFN2 PHENOS=Hereditary motor and sensory neuropathy VIA,601152,Autosomal dominant/Charcot-Marie-Tooth disease,axonal,type 2A2B,617087,Autosomal recessive/Charcot-Marie-Tooth disease,axonal,type 2A2A,609260,Autosomal dominant];	292362 [benign DISEASE=Hereditary motor and sensory neuropathy,Charcot-Marie-Tooth disease, type 2,Ehlers-Danlos syndrome, hydroxylysine-deficient,Hereditary motor and sensory neuropathy with optic atrophy];			rs2236054		0.5264	4410,.		-0.9110			0.00,0.09	8.23					-0.0633	0.173	0.04	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69), MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	12040479	12040479	T	C	het	het	hom		QUAL=5102;DP=51,128,113;AF=0.45,0.43,1.00;MQM=60;SAP=138;ABP=9	MFN2	5'UTR	MFN2:ENST00000235329.5:5_prime_UTR_variant:MODIFIER:exon1/19:c.-212T>C::,MFN2:ENST00000444836.1:5_prime_UTR_variant:MODIFIER:exon1/18:c.-67T>C::	MFN2:NM_001127660.1:5_prime_UTR_variant:MODIFIER:exon1/18:c.-67T>C::	regulatory_region_variant:promoter	608507 [GENE=MFN2 PHENOS=Hereditary motor and sensory neuropathy VIA,601152,Autosomal dominant/Charcot-Marie-Tooth disease,axonal,type 2A2B,617087,Autosomal recessive/Charcot-Marie-Tooth disease,axonal,type 2A2A,609260,Autosomal dominant];	292368 [benign DISEASE=Hereditary motor and sensory neuropathy,Charcot-Marie-Tooth disease, type 2,Ehlers-Danlos syndrome, hydroxylysine-deficient,Hereditary motor and sensory neuropathy with optic atrophy];			rs2180183		0.5520	4937,.		-0.2970			0.00,0.05	7.58					0.1335	0.2039	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69), MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	12041977	12041977	-	TTTTTT	het	wt	het	off-target	QUAL=264;DP=88,137,34;AF=0.06,0.11,0.24;MQM=59;SAP=51;ABP=362	MFN2	intron	MFN2:ENST00000235329.5:intron_variant:MODIFIER:intron1/18:c.-149-43_-149-38dup::,MFN2:ENST00000444836.1:intron_variant:MODIFIER:intron1/17:c.-5+1443_-5+1448dup::	MFN2:NM_001127660.1:intron_variant:MODIFIER:intron1/17:c.-5+1443_-5+1448dup::,MFN2:NM_014874.4:intron_variant:MODIFIER:intron1/18:c.-149-43_-149-38dup::		608507 [GENE=MFN2 PHENOS=Hereditary motor and sensory neuropathy VIA,601152,Autosomal dominant/Charcot-Marie-Tooth disease,axonal,type 2A2B,617087,Autosomal recessive/Charcot-Marie-Tooth disease,axonal,type 2A2A,609260,Autosomal dominant];				rs34602102		0.0308	54,.						6.09					0.209	0.3262	0.01	16	1	0 / 0					MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	12041977	12041977	-	TTTTTTT	wt	het	het	off-target	QUAL=264;DP=88,137,34;AF=0.08,0.08,0.24;MQM=58;SAP=55;ABP=349	MFN2	intron	MFN2:ENST00000235329.5:intron_variant:MODIFIER:intron1/18:c.-149-44_-149-38dup::,MFN2:ENST00000444836.1:intron_variant:MODIFIER:intron1/17:c.-5+1442_-5+1448dup::	MFN2:NM_001127660.1:intron_variant:MODIFIER:intron1/17:c.-5+1442_-5+1448dup::,MFN2:NM_014874.4:intron_variant:MODIFIER:intron1/18:c.-149-44_-149-38dup::		608507 [GENE=MFN2 PHENOS=Hereditary motor and sensory neuropathy VIA,601152,Autosomal dominant/Charcot-Marie-Tooth disease,axonal,type 2A2B,617087,Autosomal recessive/Charcot-Marie-Tooth disease,axonal,type 2A2A,609260,Autosomal dominant];				rs34602102		0.3083	1474,.						6.03					0.1216	0.3271	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	12062205	12062205	A	G	hom	hom	hom	off-target	QUAL=14555;DP=177,190,138;AF=0.99,0.99,0.99;MQM=60;SAP=1065;ABP=0	MFN2	intron	MFN2:ENST00000235329.5:intron_variant:MODIFIER:intron11/18:c.1160+45A>G::,MFN2:ENST00000444836.1:intron_variant:MODIFIER:intron10/17:c.1160+45A>G::	MFN2:NM_001127660.1:intron_variant:MODIFIER:intron10/17:c.1160+45A>G::,MFN2:NM_014874.4:intron_variant:MODIFIER:intron11/18:c.1160+45A>G::		608507 [GENE=MFN2 PHENOS=Hereditary motor and sensory neuropathy VIA,601152,Autosomal dominant/Charcot-Marie-Tooth disease,axonal,type 2A2B,617087,Autosomal recessive/Charcot-Marie-Tooth disease,axonal,type 2A2A,609260,Autosomal dominant];				rs2236057	0.6579	0.6615	6882,.	0.6479,0.5317,0.6765,0.6679,0.7034	-2.0590			0.01,0.11	3.53					-0.0379	0.4507	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	12071680	12071680	A	G	hom	hom	hom		QUAL=29234;DP=252,417,322;AF=0.99,1.00,0.99;MQM=60;SAP=132;ABP=0	MFN2	3'UTR	MFN2:ENST00000235329.5:3_prime_UTR_variant:MODIFIER:exon19/19:c.*58A>G::,MFN2:ENST00000444836.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*58A>G::	MFN2:NM_001127660.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*58A>G::,MFN2:NM_014874.4:3_prime_UTR_variant:MODIFIER:exon19/19:c.*58A>G::		608507 [GENE=MFN2 PHENOS=Hereditary motor and sensory neuropathy VIA,601152,Autosomal dominant/Charcot-Marie-Tooth disease,axonal,type 2A2B,617087,Autosomal recessive/Charcot-Marie-Tooth disease,axonal,type 2A2A,609260,Autosomal dominant];	292381 [benign DISEASE=Charcot-Marie-Tooth disease, type 2,Hereditary motor and sensory neuropathy with optic atrophy,not specified];			rs1042842	0.7324	0.7195	8238,.		-0.8580			0.04,0.13	0.76					0.0086	0.9418	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	12072518	12072518	G	C	hom	hom	hom		QUAL=12709;DP=104,172,142;AF=0.99,1.00,1.00;MQM=60;SAP=77;ABP=0	MFN2	3'UTR	MFN2:ENST00000235329.5:3_prime_UTR_variant:MODIFIER:exon19/19:c.*896G>C::,MFN2:ENST00000444836.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*896G>C::	MFN2:NM_001127660.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*896G>C::,MFN2:NM_014874.4:3_prime_UTR_variant:MODIFIER:exon19/19:c.*896G>C::		608507 [GENE=MFN2 PHENOS=Hereditary motor and sensory neuropathy VIA,601152,Autosomal dominant/Charcot-Marie-Tooth disease,axonal,type 2A2B,617087,Autosomal recessive/Charcot-Marie-Tooth disease,axonal,type 2A2A,609260,Autosomal dominant];	292393 [benign DISEASE=Charcot-Marie-Tooth disease, type 2,Hereditary motor and sensory neuropathy with optic atrophy];			rs3088064	0.5441	0.5709	5189,.		0.4850			0.22,0.22	3.06					0.0034	0.9417	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	12072534	12072534	C	T	wt	wt	het		QUAL=1661;DP=101,189,143;AF=0.00,0.00,0.50;MQM=60;SAP=4;ABP=3	MFN2	3'UTR	MFN2:ENST00000235329.5:3_prime_UTR_variant:MODIFIER:exon19/19:c.*912C>T::,MFN2:ENST00000444836.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*912C>T::	MFN2:NM_001127660.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*912C>T::,MFN2:NM_014874.4:3_prime_UTR_variant:MODIFIER:exon19/19:c.*912C>T::		608507 [GENE=MFN2 PHENOS=Hereditary motor and sensory neuropathy VIA,601152,Autosomal dominant/Charcot-Marie-Tooth disease,axonal,type 2A2B,617087,Autosomal recessive/Charcot-Marie-Tooth disease,axonal,type 2A2A,609260,Autosomal dominant];	292394 [benign DISEASE=Charcot-Marie-Tooth disease, type 2,Hereditary motor and sensory neuropathy with optic atrophy];			rs14305	0.0843	0.0541	51,.		0.1270			0.12,0.31	8.03					-0.0134	0.9415	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	16370428	16370432	GGGGG	-	n/a	hom	n/a	off-target;low_conf_region	QUAL=51;DP=0,3,0;AF=,1.00,;MQM=60;SAP=10;ABP=0	CLCNKB	intron	CLCNKB:ENST00000375679.4:intron_variant:MODIFIER:intron1/19:c.-8+61_-8+65del::	CLCNKB:NM_000085.5:intron_variant:MODIFIER:intron1/19:c.-8+61_-8+65del::		602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs140434107		0.5123	2076,.		1.3540				4.48					-0.1733	0.1524	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16371067	16371067	G	T	het	hom	n/a		QUAL=235;DP=4,5,1;AF=0.75,1.00,1.00;MQM=60;SAP=3;ABP=5	CLCNKB	missense	CLCNKB:ENST00000375679.4:missense_variant:MODERATE:exon2/20:c.80G>T:p.Arg27Leu:	CLCNKB:NM_000085.5:missense_variant:MODERATE:exon2/20:c.80G>T:p.Arg27Leu:		602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];	447107 [benign DISEASE=not specified,not provided];			rs2015352		0.6267	4826,.	0.2881,0.7293,0.6328,0.6333,0.6878	-0.4670	D(0.01)	B(0.16)	0.14,0.92	23.10	0.30				-0.1937	0.1463	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16372003	16372003	G	C	het	hom	het	off-target	QUAL=6433;DP=55,148,128;AF=0.42,1.00,0.48;MQM=60;SAP=355;ABP=6	CLCNKB	intron	CLCNKB:ENST00000375679.4:intron_variant:MODIFIER:intron2/19:c.101-50G>C::	CLCNKB:NM_000085.5:intron_variant:MODIFIER:intron2/19:c.101-50G>C::		602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs6604910	0.5665	0.6357	4863,.	0.2698,0.7354,0.6801,0.6380,0.7118	0.6820			0.01,0.14	5.62					0.0374	0.0427	0.04	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16372971	16372971	G	A	hom	hom	hom	off-target	QUAL=12409;DP=79,182,142;AF=1.00,1.00,1.00;MQM=60;SAP=441;ABP=0	CLCNKB	intron	CLCNKB:ENST00000375679.4:intron_variant:MODIFIER:intron3/19:c.230-59G>A::	CLCNKB:NM_000085.5:intron_variant:MODIFIER:intron3/19:c.230-59G>A::	regulatory_region_variant:CTCF_binding_site	602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs2014841		0.6933	8183,.		-0.2720			0.02,0.13	2.76					0.0129	0.1864	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16373124	16373124	A	G	hom	hom	hom		QUAL=23072;DP=177,312,247;AF=0.99,1.00,1.00;MQM=60;SAP=5;ABP=0	CLCNKB	synonymous	CLCNKB:ENST00000375679.4:synonymous_variant:LOW:exon4/20:c.324A>G:p.Ser108=:PF00654 [Voltage gated chloride channel]	CLCNKB:NM_000085.5:synonymous_variant:LOW:exon4/20:c.324A>G:p.Ser108=:	regulatory_region_variant:CTCF_binding_site	602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];	447104 [benign DISEASE=not specified,not provided];			rs5257	0.7404	0.8121	8159,.	0.3791,0.8994,0.9891,0.8093,0.8739	-4.7220			0.03,0.24	1.03					0.0177	0.191	0.88	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16373200	16373202	CTT	-	hom	hom	het	off-target;low_conf_region	QUAL=9234;DP=93,204,146;AF=1.00,1.00,0.49;MQM=60;SAP=317;ABP=3	CLCNKB	intron	CLCNKB:ENST00000375679.4:intron_variant:MODIFIER:intron4/19:c.358+44_358+46del::	CLCNKB:NM_000085.5:intron_variant:MODIFIER:intron4/19:c.358+44_358+46del::	regulatory_region_variant:CTCF_binding_site	602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs35820664		0.7861	7533,.	0.3540,0.8883,0.9891,0.7803,0.8442	0.5420				12.89					0.0277	0.1903	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16374533	16374533	G	C	hom	hom	hom		QUAL=383;DP=5,3,5;AF=1.00,1.00,1.00;MQM=60;SAP=23;ABP=0	CLCNKB	synonymous	CLCNKB:ENST00000375679.4:synonymous_variant:LOW:exon5/20:c.492G>C:p.Gly164=:PF00654 [Voltage gated chloride channel]	CLCNKB:NM_000085.5:synonymous_variant:LOW:exon5/20:c.492G>C:p.Gly164=:		602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];	447105 [benign DISEASE=not specified,not provided];			rs2014562		0.9317	12637,.	0.7589,0.9575,0.9997,0.9439,0.9278	-0.3820			0.06,0.95	7.14					0.081	0.6194	0.12	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16374994	16374994	C	T	hom	hom	hom		QUAL=17796;DP=152,244,202;AF=0.99,1.00,1.00;MQM=46;SAP=4;ABP=0	CLCNKB	splice_region&intron	CLCNKB:ENST00000375679.4:splice_region_variant&intron_variant:LOW:intron6/19:c.577-5C>T::	CLCNKB:NM_000085.5:splice_region_variant&intron_variant:LOW:intron6/19:c.577-5C>T::	regulatory_region_variant:promoter	602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];	381050 [benign/likely benign DISEASE=not specified,not provided];			rs1889788	0.7386	0.8104	8128,.	0.3760,0.8986,0.9890,0.8075,0.8732	-0.3170			0.02,0.22	0.92		4.28>4.16	0.000/0.000		-0.1753	0.4114	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16375063	16375063	C	G	hom	hom	hom		QUAL=16971;DP=185,215,174;AF=0.99,1.00,1.00;MQM=52;SAP=214;ABP=0	CLCNKB	missense	CLCNKB:ENST00000375679.4:missense_variant:MODERATE:exon7/20:c.641C>G:p.Ala214Gly:PF00654 [Voltage gated chloride channel]	CLCNKB:NM_000085.5:missense_variant:MODERATE:exon7/20:c.641C>G:p.Ala214Gly:	regulatory_region_variant:promoter	602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];	504916 [benign DISEASE=Bartter syndrome type 3,not specified];			rs1889789		0.9069	11137,.	0.5589,0.9388,0.9997,0.9259,0.9256	-0.0390	T(0.79)	B(0.00)	0.06,0.42	10.62	0.22				0.2562	0.2274	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16375064	16375064	A	C	hom	hom	hom		QUAL=16971;DP=185,215,174;AF=0.99,1.00,1.00;MQM=52;SAP=214;ABP=0	CLCNKB	synonymous	CLCNKB:ENST00000375679.4:synonymous_variant:LOW:exon7/20:c.642A>C:p.Ala214=:PF00654 [Voltage gated chloride channel]	CLCNKB:NM_000085.5:synonymous_variant:LOW:exon7/20:c.642A>C:p.Ala214=:	regulatory_region_variant:promoter	602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];	504915 [benign DISEASE=not specified];			rs1889790		0.9069	11137,.	0.5589,0.9388,0.9997,0.9258,0.9256	-2.2040			0.07,0.28	7.10					0.0237	0.219	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16375210	16375210	G	A	het	hom	wt	off-target	QUAL=4182;DP=96,100,103;AF=0.48,0.99,0.00;MQM=60;SAP=11;ABP=3	CLCNKB	intron	CLCNKB:ENST00000375679.4:intron_variant:MODIFIER:intron7/19:c.655+133G>A::	CLCNKB:NM_000085.5:intron_variant:MODIFIER:intron7/19:c.655+133G>A::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site	602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs9633514	0.3570	0.2951	1647,.		-0.2940			0.09,0.19	8.07							0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16375354	16375354	C	T	hom	hom	hom		QUAL=18576;DP=164,234,202;AF=1.00,1.00,1.00;MQM=60;SAP=30;ABP=0	CLCNKB	5'UTR,intron	CLCNKB:ENST00000375667.3:5_prime_UTR_variant:MODIFIER:exon1/13:c.-113C>T::,CLCNKB:ENST00000375679.4:intron_variant:MODIFIER:intron7/19:c.656-261C>T::	CLCNKB:NM_000085.5:intron_variant:MODIFIER:intron7/19:c.656-261C>T::,CLCNKB:NM_001165945.2:5_prime_UTR_variant:MODIFIER:exon1/13:c.-113C>T::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];			MIR (SINE/MIR)	rs9442227	0.7274	0.6835	7971,.		-0.1220			0.08,0.21	10.13					0.0024	0.2314	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16376191	16376191	C	T	hom	hom	hom		QUAL=25546;DP=179,402,312;AF=1.00,1.00,1.00;MQM=45;SAP=279;ABP=0	CLCNKB	missense	CLCNKB:ENST00000375667.3:missense_variant:MODERATE:exon2/13:c.353C>T:p.Ala118Val:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000375679.4:missense_variant:MODERATE:exon9/20:c.860C>T:p.Ala287Val:PF00654 [Voltage gated chloride channel]	CLCNKB:NM_000085.5:missense_variant:MODERATE:exon9/20:c.860C>T:p.Ala287Val:,CLCNKB:NM_001165945.2:missense_variant:MODERATE:exon2/13:c.353C>T:p.Ala118Val:		602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];	447108 [benign DISEASE=not specified,not provided];			rs7367494	0.8299	0.9249	11278,.	0.5573,0.9597,0.9988,0.9484,0.9335	-0.3350	T(1.00),T(1.00)	B(0.00),B(0.01)	0.02,0.12	0.13	0.22				-0.3397	0.1355	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16376230	16376230	-	T	hom	hom	hom	off-target;low_conf_region	QUAL=26415;DP=85,451,345;AF=0.99,1.00,1.00;MQM=51;SAP=35;ABP=0	CLCNKB	intron	CLCNKB:ENST00000375667.3:intron_variant:MODIFIER:intron2/12:c.359+33_359+34insT::,CLCNKB:ENST00000375679.4:intron_variant:MODIFIER:intron9/19:c.866+33_866+34insT::	CLCNKB:NM_000085.5:intron_variant:MODIFIER:intron9/19:c.866+33_866+34insT::,CLCNKB:NM_001165945.2:intron_variant:MODIFIER:intron2/12:c.359+33_359+34insT::		602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs59006537		0.9242	10761,.	0.4294,0.9451,0.9983,0.9544,0.9487					1.81					0.264	0.1427	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16376232	16376232	A	T	hom	hom	hom	off-target;low_conf_region	QUAL=26415;DP=85,451,345;AF=0.99,1.00,1.00;MQM=51;SAP=35;ABP=0	CLCNKB	intron	CLCNKB:ENST00000375667.3:intron_variant:MODIFIER:intron2/12:c.359+35A>T::,CLCNKB:ENST00000375679.4:intron_variant:MODIFIER:intron9/19:c.866+35A>T::	CLCNKB:NM_000085.5:intron_variant:MODIFIER:intron9/19:c.866+35A>T::,CLCNKB:NM_001165945.2:intron_variant:MODIFIER:intron2/12:c.359+35A>T::		602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs59924562		0.9253	10777,.	0.4491,0.9459,0.9984,0.9547,0.9477	-2.8490			0.01,0.08	1.02				COSV65161540	0.1004	0.1435	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16376239	16376239	C	-	hom	hom	hom	off-target	QUAL=24250;DP=80,440,335;AF=0.98,0.99,0.99;MQM=52;SAP=13;ABP=0	CLCNKB	intron	CLCNKB:ENST00000375667.3:intron_variant:MODIFIER:intron2/12:c.359+47del::,CLCNKB:ENST00000375679.4:intron_variant:MODIFIER:intron9/19:c.866+47del::	CLCNKB:NM_000085.5:intron_variant:MODIFIER:intron9/19:c.866+47del::,CLCNKB:NM_001165945.2:intron_variant:MODIFIER:intron2/12:c.359+47del::		602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs34589727		0.9148	10750,.	0.4231,0.9419,0.9988,0.9470,0.9354	-0.1430				1.91					-0.0581	0.1443	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16376278	16376278	G	A	hom	hom	hom	off-target	QUAL=30446;DP=134,499,364;AF=1.00,1.00,1.00;MQM=57;SAP=39;ABP=0	CLCNKB	intron	CLCNKB:ENST00000375667.3:intron_variant:MODIFIER:intron2/12:c.360-32G>A::,CLCNKB:ENST00000375679.4:intron_variant:MODIFIER:intron9/19:c.867-32G>A::	CLCNKB:NM_000085.5:intron_variant:MODIFIER:intron9/19:c.867-32G>A::,CLCNKB:NM_001165945.2:intron_variant:MODIFIER:intron2/12:c.360-32G>A::		602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs7365182	0.8279	0.9209	11342,.	0.5528,0.9546,0.9999,0.9463,0.9313	1.2090			0.08,0.18	3.89					-0.2906	0.1546	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16376319	16376319	T	C	hom	hom	hom		QUAL=32757;DP=181,483,361;AF=1.00,1.00,1.00;MQM=60;SAP=173;ABP=0	CLCNKB	synonymous	CLCNKB:ENST00000375667.3:synonymous_variant:LOW:exon3/13:c.369T>C:p.Cys123=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000375679.4:synonymous_variant:LOW:exon10/20:c.876T>C:p.Cys292=:PF00654 [Voltage gated chloride channel]	CLCNKB:NM_000085.5:synonymous_variant:LOW:exon10/20:c.876T>C:p.Cys292=:,CLCNKB:NM_001165945.2:synonymous_variant:LOW:exon3/13:c.369T>C:p.Cys123=:		602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];	377683 [benign DISEASE=not specified,not provided];			rs7368151	0.8301	0.9168	11434,.	0.5579,0.9485,0.9998,0.9431,0.9271	-4.5300			0.03,0.87	0.46					0.2721	0.0863	0.07	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16376458	16376458	T	C	hom	hom	hom	off-target	QUAL=16928;DP=125,259,183;AF=0.99,1.00,1.00;MQM=60;SAP=196;ABP=0	CLCNKB	intron	CLCNKB:ENST00000375667.3:intron_variant:MODIFIER:intron3/12:c.461+47T>C::,CLCNKB:ENST00000375679.4:intron_variant:MODIFIER:intron10/19:c.968+47T>C::	CLCNKB:NM_000085.5:intron_variant:MODIFIER:intron10/19:c.968+47T>C::,CLCNKB:NM_001165945.2:intron_variant:MODIFIER:intron3/12:c.461+47T>C::		602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs7368166		0.9131	11013,.	0.5505,0.9457,0.9985,0.9398,0.9198	-4.4690			0.00,0.06	6.61				COSV65161797	0.0986	0.0817	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16378649	16378649	C	G	het	wt	het	off-target	QUAL=482;DP=19,10,19;AF=0.58,0.00,0.68;MQM=60;SAP=39;ABP=9	CLCNKB	intron	CLCNKB:ENST00000375667.3:intron_variant:MODIFIER:intron7/12:c.902-44C>G::,CLCNKB:ENST00000375679.4:intron_variant:MODIFIER:intron14/19:c.1409-44C>G::	CLCNKB:NM_000085.5:intron_variant:MODIFIER:intron14/19:c.1409-44C>G::,CLCNKB:NM_001165945.2:intron_variant:MODIFIER:intron7/12:c.902-44C>G::		602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs2297726	0.1625	0.1727	421,.	0.0715,0.1591,0.2995,0.1706,0.1631	0.0970			0.05,0.21	8.36					-0.0054	0.0145	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16378739	16378739	G	A	wt	wt	het		QUAL=108;DP=27,16,22;AF=0.00,0.00,0.36;MQM=60;SAP=4;ABP=7	CLCNKB	synonymous	CLCNKB:ENST00000375667.3:synonymous_variant:LOW:exon8/13:c.948G>A:p.Ala316=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000375679.4:synonymous_variant:LOW:exon15/20:c.1455G>A:p.Ala485=:PF00654 [Voltage gated chloride channel]	CLCNKB:NM_000085.5:synonymous_variant:LOW:exon15/20:c.1455G>A:p.Ala485=:,CLCNKB:NM_001165945.2:synonymous_variant:LOW:exon8/13:c.948G>A:p.Ala316=:		602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];	585703 [benign DISEASE=not provided];			rs34652156	0.0301	0.0371	33,.	0.0580,0.0117,0.0000,0.0274,0.0299	-2.6720			0.05,0.21	0.12					-0.0414	0.0519	0.01	23	1073	0 / 0					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16380196	16380196	T	C	hom	hom	hom		QUAL=28211;DP=291,371,251;AF=1.00,1.00,1.00;MQM=51;SAP=165;ABP=0	CLCNKB	missense	CLCNKB:ENST00000375667.3:missense_variant:MODERATE:exon9/13:c.1178T>C:p.Met393Thr:PF00571 [CBS domain],CLCNKB:ENST00000375679.4:missense_variant:MODERATE:exon16/20:c.1685T>C:p.Met562Thr:PF00571 [CBS domain]	CLCNKB:NM_000085.5:missense_variant:MODERATE:exon16/20:c.1685T>C:p.Met562Thr:,CLCNKB:NM_001165945.2:missense_variant:MODERATE:exon9/13:c.1178T>C:p.Met393Thr:		602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];	447094 [benign DISEASE=not specified];			rs5253	0.8383	0.9347	12512,.	0.6863,0.9480,0.8076,0.9843,0.9317	-0.9230	T(0.49),T(0.46)	B(0.00),B(0.00)	0.00,0.10	0.06	0.28				0.0877	0.4846	0.04	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16380243	16380243	A	G	hom	hom	het		QUAL=15456;DP=134,312,232;AF=1.00,0.99,0.42;MQM=49;SAP=8;ABP=15	CLCNKB	missense	CLCNKB:ENST00000375667.3:missense_variant:MODERATE:exon9/13:c.1225A>G:p.Lys409Glu:PF00571 [CBS domain],CLCNKB:ENST00000375679.4:missense_variant:MODERATE:exon16/20:c.1732A>G:p.Lys578Glu:PF00571 [CBS domain]	CLCNKB:NM_000085.5:missense_variant:MODERATE:exon16/20:c.1732A>G:p.Lys578Glu:,CLCNKB:NM_001165945.2:missense_variant:MODERATE:exon9/13:c.1225A>G:p.Lys409Glu:		602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];	447096 [benign DISEASE=not specified,not provided];	CM1514575 [CLASS=DM? MUT=ALT PHEN="Migraine without aura" GENE=CLCNKB];		rs2275166	0.7017	0.7153	8082,.	0.7975,0.5184,0.7947,0.6591,0.5830	0.8530	T(1.00),T(1.00)	B(0.00),B(0.00)	0.01,0.19	11.82	0.16				0.1304	0.4868	0.16	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16380252	16380252	C	T	hom	hom	het		QUAL=14345;DP=116,302,217;AF=1.00,1.00,0.43;MQM=49;SAP=16;ABP=13	CLCNKB	synonymous	CLCNKB:ENST00000375667.3:synonymous_variant:LOW:exon9/13:c.1234C>T:p.Leu412=:PF00571 [CBS domain],CLCNKB:ENST00000375679.4:synonymous_variant:LOW:exon16/20:c.1741C>T:p.Leu581=:PF00571 [CBS domain]	CLCNKB:NM_000085.5:synonymous_variant:LOW:exon16/20:c.1741C>T:p.Leu581=:,CLCNKB:NM_001165945.2:synonymous_variant:LOW:exon9/13:c.1234C>T:p.Leu412=:		602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];	447097 [benign DISEASE=not specified,not provided];			rs2275167		0.6412	6486,.	0.5768,0.4929,0.7894,0.6443,0.5281	0.5590			0.14,0.85	9.50					-0.0697	0.4764	0.31	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16382877	16382877	A	G	hom	hom	hom	off-target	QUAL=11603;DP=50,203,147;AF=1.00,1.00,0.99;MQM=60;SAP=31;ABP=0	CLCNKB	intron	CLCNKB:ENST00000375667.3:intron_variant:MODIFIER:intron11/12:c.1420-40A>G::,CLCNKB:ENST00000375679.4:intron_variant:MODIFIER:intron18/19:c.1930-40A>G::	CLCNKB:NM_000085.5:intron_variant:MODIFIER:intron18/19:c.1930-40A>G::,CLCNKB:NM_001165945.2:intron_variant:MODIFIER:intron11/12:c.1420-40A>G::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region,TF_binding_site_variant	602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs7517792		0.7963	8798,.	0.7061,0.8840,0.8077,0.7871,0.8423	-2.5310			0.01,0.13	4.92					0.4037	0.0581	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16383329	16383329	-	C	hom	hom	het	off-target;low_conf_region	QUAL=45;DP=3,6,22;AF=0.00,0.67,0.18;MQM=45;SAP=7;ABP=22	CLCNKB	intron	CLCNKB:ENST00000375667.3:intron_variant:MODIFIER:intron12/12:c.1507-29dup::,CLCNKB:ENST00000375679.4:intron_variant:MODIFIER:intron19/19:c.2017-29dup::	CLCNKB:NM_000085.5:intron_variant:MODIFIER:intron19/19:c.2017-29dup::,CLCNKB:NM_001165945.2:intron_variant:MODIFIER:intron12/12:c.1507-29dup::		602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs138507185		0.6262	5321,.						3.06					-0.0738	0.719	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16383336	16383336	G	C	hom	hom	het	off-target;low_conf_region	QUAL=45;DP=3,6,22;AF=0.00,0.67,0.18;MQM=45;SAP=7;ABP=22	CLCNKB	intron	CLCNKB:ENST00000375667.3:intron_variant:MODIFIER:intron12/12:c.1507-28G>C::,CLCNKB:ENST00000375679.4:intron_variant:MODIFIER:intron19/19:c.2017-28G>C::	CLCNKB:NM_000085.5:intron_variant:MODIFIER:intron19/19:c.2017-28G>C::,CLCNKB:NM_001165945.2:intron_variant:MODIFIER:intron12/12:c.1507-28G>C::		602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs12746138		0.7085	6009,.	0.4283,0.8343,0.7670,0.6997,0.7947	-1.1840			0.00,0.06	0.04					0.0625	0.6768	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16383402	16383402	C	T	het	wt	wt		QUAL=651;DP=257,143,140;AF=0.26,0.07,0.00;MQM=34;SAP=168;ABP=135	CLCNKB	synonymous	CLCNKB:ENST00000375667.3:synonymous_variant:LOW:exon13/13:c.1545C>T:p.Ala515=:,CLCNKB:ENST00000375679.4:synonymous_variant:LOW:exon20/20:c.2055C>T:p.Ala685=:	CLCNKB:NM_000085.5:synonymous_variant:LOW:exon20/20:c.2055C>T:p.Ala685=:,CLCNKB:NM_001165945.2:synonymous_variant:LOW:exon13/13:c.1545C>T:p.Ala515=:		602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];	785932 [likely benign DISEASE=not provided];			rs6698427		0.0880	0,.	0.0128,0.0033,0.0132,0.0013,0.0025	0.3830			0.26,0.96	6.08					0.0486	0.8799	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16383448	16383448	A	C	het	hom	hom	low_conf_region	QUAL=15881;DP=219,287,241;AF=0.70,0.90,1.00;MQM=40;SAP=908;ABP=78	CLCNKB	3'UTR	CLCNKB:ENST00000375667.3:3_prime_UTR_variant:MODIFIER:exon13/13:c.*37A>C::,CLCNKB:ENST00000375679.4:3_prime_UTR_variant:MODIFIER:exon20/20:c.*37A>C::	CLCNKB:NM_000085.5:3_prime_UTR_variant:MODIFIER:exon20/20:c.*37A>C::,CLCNKB:NM_001165945.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*37A>C::		602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs10803415	0.9010	0.9041	5812,.	0.8429,0.9248,0.6951,0.9399,0.8839	-1.8510			0.00,0.05	7.77					-0.0392	0.8779	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16383547	16383547	T	C	wt	het	wt	low_conf_region	QUAL=540;DP=232,595,394;AF=0.05,0.19,0.00;MQM=31;SAP=272;ABP=511	CLCNKB	3'UTR	CLCNKB:ENST00000375667.3:3_prime_UTR_variant:MODIFIER:exon13/13:c.*136T>C::,CLCNKB:ENST00000375679.4:3_prime_UTR_variant:MODIFIER:exon20/20:c.*136T>C::	CLCNKB:NM_000085.5:3_prime_UTR_variant:MODIFIER:exon20/20:c.*136T>C::,CLCNKB:NM_001165945.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*136T>C::		602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs1057839		0.2174	4,.		0.0660			0.00,0.06	7.46					0.0125	0.8791	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16383574	16383574	A	T	het	het	wt		QUAL=888;DP=243,615,379;AF=0.13,0.20,0.00;MQM=33;SAP=342;ABP=757	CLCNKB	3'UTR	CLCNKB:ENST00000375667.3:3_prime_UTR_variant:MODIFIER:exon13/13:c.*163A>T::,CLCNKB:ENST00000375679.4:3_prime_UTR_variant:MODIFIER:exon20/20:c.*163A>T::	CLCNKB:NM_000085.5:3_prime_UTR_variant:MODIFIER:exon20/20:c.*163A>T::,CLCNKB:NM_001165945.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*163A>T::		602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs1057841		0.2479	0,.		0.4380			0.07,0.16	5.01					-0.0096	0.8786	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16383581	16383581	G	T	het	het	het		QUAL=19814;DP=244,614,378;AF=0.84,0.79,0.51;MQM=37;SAP=75;ABP=515	CLCNKB	3'UTR	CLCNKB:ENST00000375667.3:3_prime_UTR_variant:MODIFIER:exon13/13:c.*170G>T::,CLCNKB:ENST00000375679.4:3_prime_UTR_variant:MODIFIER:exon20/20:c.*170G>T::	CLCNKB:NM_000085.5:3_prime_UTR_variant:MODIFIER:exon20/20:c.*170G>T::,CLCNKB:NM_001165945.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*170G>T::		602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs1057844		0.4996	1874,.		-1.3730			0.03,0.14	1.89					0.0489	0.8799	0.05	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16383605	16383605	A	G	het	het	het		QUAL=19743;DP=195,647,401;AF=0.74,0.77,0.53;MQM=38;SAP=4;ABP=374	CLCNKB	3'UTR	CLCNKB:ENST00000375667.3:3_prime_UTR_variant:MODIFIER:exon13/13:c.*194A>G::,CLCNKB:ENST00000375679.4:3_prime_UTR_variant:MODIFIER:exon20/20:c.*194A>G::	CLCNKB:NM_000085.5:3_prime_UTR_variant:MODIFIER:exon20/20:c.*194A>G::,CLCNKB:NM_001165945.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*194A>G::		602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs1057845		0.4935	1687,.		-0.5960			0.01,0.17	7.73					-0.0093	0.8786	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16383668	16383668	T	G	hom	hom	hom		QUAL=32755;DP=170,660,360;AF=0.99,1.00,1.00;MQM=41;SAP=398;ABP=0	CLCNKB	3'UTR	CLCNKB:ENST00000375667.3:3_prime_UTR_variant:MODIFIER:exon13/13:c.*257T>G::,CLCNKB:ENST00000375679.4:3_prime_UTR_variant:MODIFIER:exon20/20:c.*257T>G::	CLCNKB:NM_000085.5:3_prime_UTR_variant:MODIFIER:exon20/20:c.*257T>G::,CLCNKB:NM_001165945.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*257T>G::		602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs6660218		1.0000	15695,.	1.0000,1.0000,0.9998,0.9999,1.0000	0.1210			0.00,0.08	5.39					-0.0444	0.9765	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16383682	16383682	G	C	het	het	wt		QUAL=4419;DP=218,649,321;AF=0.19,0.36,0.00;MQM=41;SAP=36;ABP=264	CLCNKB	3'UTR	CLCNKB:ENST00000375667.3:3_prime_UTR_variant:MODIFIER:exon13/13:c.*271G>C::,CLCNKB:ENST00000375679.4:3_prime_UTR_variant:MODIFIER:exon20/20:c.*271G>C::	CLCNKB:NM_000085.5:3_prime_UTR_variant:MODIFIER:exon20/20:c.*271G>C::,CLCNKB:NM_001165945.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*271G>C::		602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];	402540 [benign DISEASE=not specified];			rs1057854		0.3303	50,.	0.4019,0.2177,0.4238,0.3039,0.2888	-3.2740			0.01,0.12	0.52					-0.0312	0.9754	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16383742	16383742	C	G	het	het	hom		QUAL=18327;DP=339,515,224;AF=0.54,0.53,1.00;MQM=57;SAP=735;ABP=12	CLCNKB	3'UTR	CLCNKB:ENST00000375667.3:3_prime_UTR_variant:MODIFIER:exon13/13:c.*331C>G::,CLCNKB:ENST00000375679.4:3_prime_UTR_variant:MODIFIER:exon20/20:c.*331C>G::	CLCNKB:NM_000085.5:3_prime_UTR_variant:MODIFIER:exon20/20:c.*331C>G::,CLCNKB:NM_001165945.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*331C>G::		602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs1057857		0.6415	4036,.	0.5897,0.6972,0.4932,0.6536,0.6177	-0.3020			0.04,0.20	7.30					-0.0689	0.9738	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16383854	16383854	A	G	het	het	wt	off-target	QUAL=624;DP=102,110,56;AF=0.36,0.17,0.00;MQM=38;SAP=125;ABP=105	FAM131C,CLCNKB	downstream_gene	FAM131C:ENST00000375662.4:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000375667.3:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000375679.4:downstream_gene_variant:MODIFIER::::							rs749928769		0.0230	1,.		-0.5780			0.00,0.11	3.94								1	19	0 / 0					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	17312743	17312743	C	T	het	het	hom		QUAL=711;DP=16,25,19;AF=0.44,0.44,0.95;MQM=60;SAP=12;ABP=4	ATP13A2,RP1-37C10.3	synonymous,missense,intron&non_coding_transcript	ATP13A2:ENST00000326735.8:synonymous_variant:LOW:exon29/29:c.3516G>A:p.Pro1172=:,ATP13A2:ENST00000341676.5:missense_variant:MODERATE:exon27/27:c.3214G>A:p.Ala1072Thr:,RP1-37C10.3:ENST00000446261.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.187+7136C>T::,ATP13A2:ENST00000452699.1:synonymous_variant:LOW:exon29/29:c.3501G>A:p.Pro1167=:	ATP13A2:NM_001141973.3:synonymous_variant:LOW:exon29/29:c.3501G>A:p.Pro1167=:,ATP13A2:NM_001141974.3:missense_variant:MODERATE:exon27/27:c.3214G>A:p.Ala1072Thr:,ATP13A2:NM_022089.4:synonymous_variant:LOW:exon29/29:c.3516G>A:p.Pro1172=:		610513 [GENE=ATP13A2 PHENOS=Kufor-Rakeb syndrome,606693,Autosomal recessive/Spastic paraplegia 78,autosomal recessive,617225,Autosomal recessive];	128475 [benign DISEASE=Kufor-Rakeb syndrome,History of neurodevelopmental disorder,not specified,not provided];			rs3170740	0.3313	0.4703	3029,.	0.2020,0.4851,0.2946,0.5286,0.4630	-2.5490	 ,T(0.32), , 	 ,B(0.00), , 	0.02,0.13	0.10	0.24				-0.0394	0.8746	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	17313157	17313157	G	A	het	het	hom	off-target	QUAL=9621;DP=83,292,215;AF=0.39,0.50,1.00;MQM=60;SAP=37;ABP=5	ATP13A2,RP1-37C10.3	intron,intron&non_coding_transcript	ATP13A2:ENST00000326735.8:intron_variant:MODIFIER:intron27/28:c.3236-30C>T::,ATP13A2:ENST00000341676.5:intron_variant:MODIFIER:intron26/26:c.3103+143C>T::,RP1-37C10.3:ENST00000446261.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.187+7550G>A::,ATP13A2:ENST00000452699.1:intron_variant:MODIFIER:intron27/28:c.3221-30C>T::	ATP13A2:NM_001141973.3:intron_variant:MODIFIER:intron27/28:c.3221-30C>T::,ATP13A2:NM_001141974.3:intron_variant:MODIFIER:intron26/26:c.3103+143C>T::,ATP13A2:NM_022089.4:intron_variant:MODIFIER:intron27/28:c.3236-30C>T::	regulatory_region_variant:promoter_flanking_region	610513 [GENE=ATP13A2 PHENOS=Kufor-Rakeb syndrome,606693,Autosomal recessive/Spastic paraplegia 78,autosomal recessive,617225,Autosomal recessive];	559000 [benign DISEASE=not provided];			rs2076605	0.3468	0.4706	3051,.	0.2188,0.4839,0.2956,0.5242,0.4771	1.8880			0.04,0.13	5.20					-0.4763	0.6238	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	17313245	17313256	CCCAGGGCTCCT	-	het	het	wt	off-target	QUAL=2067;DP=44,208,167;AF=0.27,0.50,0.00;MQM=60;SAP=12;ABP=6	ATP13A2,RP1-37C10.3	intron,intron&non_coding_transcript	ATP13A2:ENST00000326735.8:intron_variant:MODIFIER:intron27/28:c.3235+44_3235+55del::,ATP13A2:ENST00000341676.5:intron_variant:MODIFIER:intron26/26:c.3103+44_3103+55del::,RP1-37C10.3:ENST00000446261.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.187+7641_187+7652del::,ATP13A2:ENST00000452699.1:intron_variant:MODIFIER:intron27/28:c.3220+44_3220+55del::	ATP13A2:NM_001141973.3:intron_variant:MODIFIER:intron27/28:c.3220+44_3220+55del::,ATP13A2:NM_001141974.3:intron_variant:MODIFIER:intron26/26:c.3103+44_3103+55del::,ATP13A2:NM_022089.4:intron_variant:MODIFIER:intron27/28:c.3235+44_3235+55del::	regulatory_region_variant:promoter_flanking_region	610513 [GENE=ATP13A2 PHENOS=Kufor-Rakeb syndrome,606693,Autosomal recessive/Spastic paraplegia 78,autosomal recessive,617225,Autosomal recessive];				rs143483351		0.2349	921,.		1.0320				7.60					-0.1427	0.7637	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	17313343	17313343	G	A	het	het	hom		QUAL=10641;DP=90,282,199;AF=0.47,0.49,1.00;MQM=60;SAP=18;ABP=4	ATP13A2,RP1-37C10.3	synonymous,intron&non_coding_transcript	ATP13A2:ENST00000326735.8:synonymous_variant:LOW:exon27/29:c.3192C>T:p.Ala1064=:,ATP13A2:ENST00000341676.5:synonymous_variant:LOW:exon26/27:c.3060C>T:p.Ala1020=:,RP1-37C10.3:ENST00000446261.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.187+7736G>A::,ATP13A2:ENST00000452699.1:synonymous_variant:LOW:exon27/29:c.3177C>T:p.Ala1059=:	ATP13A2:NM_001141973.3:synonymous_variant:LOW:exon27/29:c.3177C>T:p.Ala1059=:,ATP13A2:NM_001141974.3:synonymous_variant:LOW:exon26/27:c.3060C>T:p.Ala1020=:,ATP13A2:NM_022089.4:synonymous_variant:LOW:exon27/29:c.3192C>T:p.Ala1064=:	regulatory_region_variant:promoter_flanking_region	610513 [GENE=ATP13A2 PHENOS=Kufor-Rakeb syndrome,606693,Autosomal recessive/Spastic paraplegia 78,autosomal recessive,617225,Autosomal recessive];	128473 [benign DISEASE=Kufor-Rakeb syndrome,History of neurodevelopmental disorder,not specified,not provided];			rs9435659	0.3385	0.4652	3048,.	0.1875,0.4783,0.2891,0.5225,0.4729	-0.5550			0.07,0.19	0.32					-0.003	0.7625	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	17313454	17313454	G	A	het	het	wt		QUAL=2307;DP=59,177,138;AF=0.47,0.44,0.00;MQM=60;SAP=33;ABP=8	ATP13A2,RP1-37C10.3	splice_region&intron,intron&non_coding_transcript	ATP13A2:ENST00000326735.8:splice_region_variant&intron_variant:LOW:intron26/28:c.3084-3C>T::,ATP13A2:ENST00000341676.5:splice_region_variant&intron_variant:LOW:intron25/26:c.2952-3C>T::,RP1-37C10.3:ENST00000446261.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.187+7847G>A::,ATP13A2:ENST00000452699.1:splice_region_variant&intron_variant:LOW:intron26/28:c.3069-3C>T::	ATP13A2:NM_001141973.3:splice_region_variant&intron_variant:LOW:intron26/28:c.3069-3C>T::,ATP13A2:NM_001141974.3:splice_region_variant&intron_variant:LOW:intron25/26:c.2952-3C>T::,ATP13A2:NM_022089.4:splice_region_variant&intron_variant:LOW:intron26/28:c.3084-3C>T::	regulatory_region_variant:promoter_flanking_region	610513 [GENE=ATP13A2 PHENOS=Kufor-Rakeb syndrome,606693,Autosomal recessive/Spastic paraplegia 78,autosomal recessive,617225,Autosomal recessive];	128471 [benign DISEASE=Kufor-Rakeb syndrome,History of neurodevelopmental disorder,not specified,not provided];			rs7531163	0.3065	0.2819	997,.	0.1706,0.3596,0.5506,0.2392,0.2307	0.9070			0.66,0.95	10.88		9.29>9.90	0.001/0.100		-0.4271	0.9624	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	17313654	17313654	C	T	het	het	hom		QUAL=10630;DP=65,279,245;AF=0.51,0.47,1.00;MQM=60;SAP=149;ABP=4	ATP13A2,RP1-37C10.3	synonymous,intron&non_coding_transcript	ATP13A2:ENST00000326735.8:synonymous_variant:LOW:exon26/29:c.2970G>A:p.Val990=:,ATP13A2:ENST00000341676.5:synonymous_variant:LOW:exon25/27:c.2838G>A:p.Val946=:,RP1-37C10.3:ENST00000446261.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.187+8047C>T::,ATP13A2:ENST00000452699.1:synonymous_variant:LOW:exon26/29:c.2955G>A:p.Val985=:	ATP13A2:NM_001141973.3:synonymous_variant:LOW:exon26/29:c.2955G>A:p.Val985=:,ATP13A2:NM_001141974.3:synonymous_variant:LOW:exon25/27:c.2838G>A:p.Val946=:,ATP13A2:NM_022089.4:synonymous_variant:LOW:exon26/29:c.2970G>A:p.Val990=:	regulatory_region_variant:promoter_flanking_region	610513 [GENE=ATP13A2 PHENOS=Kufor-Rakeb syndrome,606693,Autosomal recessive/Spastic paraplegia 78,autosomal recessive,617225,Autosomal recessive];	128470 [benign DISEASE=Kufor-Rakeb syndrome,History of neurodevelopmental disorder,not specified,not provided];			rs761421	0.3462	0.4654	3067,.	0.2158,0.4792,0.2830,0.5203,0.4730	-0.9690			0.25,0.72	5.74					0.0079	0.0753	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	17314702	17314702	C	T	het	het	wt		QUAL=11043;DP=279,583,493;AF=0.48,0.51,0.01;MQM=60;SAP=31;ABP=3	ATP13A2,RP1-37C10.3	synonymous,intron&non_coding_transcript	ATP13A2:ENST00000326735.8:synonymous_variant:LOW:exon25/29:c.2790G>A:p.Ser930=:,ATP13A2:ENST00000341676.5:synonymous_variant:LOW:exon24/27:c.2658G>A:p.Ser886=:,RP1-37C10.3:ENST00000446261.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.187+9095C>T::,ATP13A2:ENST00000452699.1:synonymous_variant:LOW:exon25/29:c.2775G>A:p.Ser925=:	ATP13A2:NM_001141973.3:synonymous_variant:LOW:exon25/29:c.2775G>A:p.Ser925=:,ATP13A2:NM_001141974.3:synonymous_variant:LOW:exon24/27:c.2658G>A:p.Ser886=:,ATP13A2:NM_022089.4:synonymous_variant:LOW:exon25/29:c.2790G>A:p.Ser930=:	regulatory_region_variant:promoter_flanking_region	610513 [GENE=ATP13A2 PHENOS=Kufor-Rakeb syndrome,606693,Autosomal recessive/Spastic paraplegia 78,autosomal recessive,617225,Autosomal recessive];	128468 [benign DISEASE=Kufor-Rakeb syndrome,History of neurodevelopmental disorder,not specified,not provided];			rs3738815	0.2909	0.2494	847,.	0.1518,0.3342,0.5507,0.1933,0.2217	-2.3320			0.06,0.15	1.71					-0.1285	0.0728	0.05	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	17314942	17314942	G	A	het	het	hom		QUAL=14012;DP=294,321,260;AF=0.50,0.45,0.99;MQM=60;SAP=401;ABP=6	ATP13A2,RP1-37C10.3	synonymous,intron&non_coding_transcript	ATP13A2:ENST00000326735.8:synonymous_variant:LOW:exon24/29:c.2637C>T:p.Gly879=:PF12710 [haloacid dehalogenase-like hydrolase],ATP13A2:ENST00000341676.5:synonymous_variant:LOW:exon23/27:c.2505C>T:p.Gly835=:PF12710 [haloacid dehalogenase-like hydrolase],RP1-37C10.3:ENST00000446261.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.187+9335G>A::,ATP13A2:ENST00000452699.1:synonymous_variant:LOW:exon24/29:c.2622C>T:p.Gly874=:PF12710 [haloacid dehalogenase-like hydrolase]	ATP13A2:NM_001141973.3:synonymous_variant:LOW:exon24/29:c.2622C>T:p.Gly874=:,ATP13A2:NM_001141974.3:synonymous_variant:LOW:exon23/27:c.2505C>T:p.Gly835=:,ATP13A2:NM_022089.4:synonymous_variant:LOW:exon24/29:c.2637C>T:p.Gly879=:		610513 [GENE=ATP13A2 PHENOS=Kufor-Rakeb syndrome,606693,Autosomal recessive/Spastic paraplegia 78,autosomal recessive,617225,Autosomal recessive];	128466 [benign DISEASE=Kufor-Rakeb syndrome,History of neurodevelopmental disorder,not specified,not provided];			rs9435662	0.3387	0.4633	3017,.	0.1867,0.4771,0.2888,0.5193,0.4726	-4.7600			0.06,0.67	8.61					-0.169	0.0968	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	17319011	17319011	G	A	het	het	hom		QUAL=6570;DP=78,151,128;AF=0.47,0.48,1.00;MQM=60;SAP=55;ABP=4	ATP13A2,RP1-37C10.3	synonymous,intron&non_coding_transcript	ATP13A2:ENST00000326735.8:synonymous_variant:LOW:exon17/29:c.1815C>T:p.Pro605=:PF12710 [haloacid dehalogenase-like hydrolase],ATP13A2:ENST00000341676.5:synonymous_variant:LOW:exon17/27:c.1800C>T:p.Pro600=:PF12710 [haloacid dehalogenase-like hydrolase],RP1-37C10.3:ENST00000446261.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.188-12127G>A::,ATP13A2:ENST00000452699.1:synonymous_variant:LOW:exon17/29:c.1800C>T:p.Pro600=:PF12710 [haloacid dehalogenase-like hydrolase]	ATP13A2:NM_001141973.3:synonymous_variant:LOW:exon17/29:c.1800C>T:p.Pro600=:,ATP13A2:NM_001141974.3:synonymous_variant:LOW:exon17/27:c.1800C>T:p.Pro600=:,ATP13A2:NM_022089.4:synonymous_variant:LOW:exon17/29:c.1815C>T:p.Pro605=:		610513 [GENE=ATP13A2 PHENOS=Kufor-Rakeb syndrome,606693,Autosomal recessive/Spastic paraplegia 78,autosomal recessive,617225,Autosomal recessive];	128465 [benign DISEASE=Kufor-Rakeb syndrome,History of neurodevelopmental disorder,not specified,not provided];			rs2076603	0.4485	0.5563	4804,.	0.4404,0.5455,0.2863,0.6263,0.5184	0.1640			0.51,0.95	8.96					0.3326	0.3094	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	17331268	17331268	C	T	wt	wt	het		QUAL=643;DP=134,121,74;AF=0.00,0.00,0.41;MQM=60;SAP=3;ABP=9	ATP13A2,RP1-37C10.3	synonymous,non_coding_transcript_exon	ATP13A2:ENST00000326735.8:synonymous_variant:LOW:exon5/29:c.396G>A:p.Ala132=:PF12409 [P5-type ATPase cation transporter],ATP13A2:ENST00000341676.5:synonymous_variant:LOW:exon5/27:c.396G>A:p.Ala132=:PF12409 [P5-type ATPase cation transporter],RP1-37C10.3:ENST00000446261.1:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.318C>T::,ATP13A2:ENST00000452699.1:synonymous_variant:LOW:exon5/29:c.396G>A:p.Ala132=:PF12409 [P5-type ATPase cation transporter]	ATP13A2:NM_001141973.3:synonymous_variant:LOW:exon5/29:c.396G>A:p.Ala132=:,ATP13A2:NM_001141974.3:synonymous_variant:LOW:exon5/27:c.396G>A:p.Ala132=:,ATP13A2:NM_022089.4:synonymous_variant:LOW:exon5/29:c.396G>A:p.Ala132=:	regulatory_region_variant:CTCF_binding_site	610513 [GENE=ATP13A2 PHENOS=Kufor-Rakeb syndrome,606693,Autosomal recessive/Spastic paraplegia 78,autosomal recessive,617225,Autosomal recessive];	293803 [uncertain significance(replaced by megSAP based on classifications:1x2,1x3) DISEASE=Kufor-Rakeb syndrome,Spastic paraplegia 78, autosomal recessive];			rs140631323		0.0001	0,.	0.0000,0.0001,0.0000,0.0001,0.0002	-4.6690			0.02,0.09	4.74				COSV58702839	0.0245	0.946	0	1	10	0 / 0					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	19198064	19198064	T	G	het	het	wt		QUAL=3439;DP=95,185,148;AF=0.53,0.47,0.00;MQM=60;SAP=8;ABP=3	ALDH4A1,RP13-279N23.2	3'UTR,intron&NMD_transcript	ALDH4A1:ENST00000290597.5:3_prime_UTR_variant:MODIFIER:exon16/16:c.*262A>C::,ALDH4A1:ENST00000375341.3:3_prime_UTR_variant:MODIFIER:exon15/15:c.*1275A>C::,RP13-279N23.2:ENST00000494072.3:intron_variant&NMD_transcript_variant:MODIFIER:intron22/26:c.*1742+2893A>C::,ALDH4A1:ENST00000538309.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*1275A>C::,ALDH4A1:ENST00000538839.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*1275A>C::	ALDH4A1:NM_001161504.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*1275A>C::,ALDH4A1:NM_001319218.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*1275A>C::,ALDH4A1:NM_003748.4:3_prime_UTR_variant:MODIFIER:exon15/15:c.*1275A>C::,ALDH4A1:NM_170726.3:3_prime_UTR_variant:MODIFIER:exon16/16:c.*262A>C::	regulatory_region_variant:promoter_flanking_region	606811 [GENE=ALDH4A1 PHENOS=Hyperprolinemia,type II,239510,Autosomal recessive];	294333 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs1138333	0.1793	0.2342	888,.		1.6090			0.00,0.14	7.76					0.0424	0.9349	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	19198100	19198100	C	G	het	het	wt		QUAL=3397;DP=95,166,144;AF=0.55,0.49,0.00;MQM=60;SAP=7;ABP=3	ALDH4A1,RP13-279N23.2	3'UTR,intron&NMD_transcript	ALDH4A1:ENST00000290597.5:3_prime_UTR_variant:MODIFIER:exon16/16:c.*226G>C::,ALDH4A1:ENST00000375341.3:3_prime_UTR_variant:MODIFIER:exon15/15:c.*1239G>C::,RP13-279N23.2:ENST00000494072.3:intron_variant&NMD_transcript_variant:MODIFIER:intron22/26:c.*1742+2857G>C::,ALDH4A1:ENST00000538309.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*1239G>C::,ALDH4A1:ENST00000538839.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*1239G>C::	ALDH4A1:NM_001161504.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*1239G>C::,ALDH4A1:NM_001319218.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*1239G>C::,ALDH4A1:NM_003748.4:3_prime_UTR_variant:MODIFIER:exon15/15:c.*1239G>C::,ALDH4A1:NM_170726.3:3_prime_UTR_variant:MODIFIER:exon16/16:c.*226G>C::	regulatory_region_variant:promoter_flanking_region	606811 [GENE=ALDH4A1 PHENOS=Hyperprolinemia,type II,239510,Autosomal recessive];	294334 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs1138328	0.1651	0.2278	857,.		0.1130			0.00,0.11	3.60					0.0112	0.9349	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	19198141	19198141	T	C	het	het	wt		QUAL=3392;DP=120,146,139;AF=0.53,0.48,0.00;MQM=60;SAP=4;ABP=3	ALDH4A1,RP13-279N23.2	3'UTR,intron&NMD_transcript	ALDH4A1:ENST00000290597.5:3_prime_UTR_variant:MODIFIER:exon16/16:c.*185A>G::,ALDH4A1:ENST00000375341.3:3_prime_UTR_variant:MODIFIER:exon15/15:c.*1198A>G::,RP13-279N23.2:ENST00000494072.3:intron_variant&NMD_transcript_variant:MODIFIER:intron22/26:c.*1742+2816A>G::,ALDH4A1:ENST00000538309.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*1198A>G::,ALDH4A1:ENST00000538839.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*1198A>G::	ALDH4A1:NM_001161504.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*1198A>G::,ALDH4A1:NM_001319218.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*1198A>G::,ALDH4A1:NM_003748.4:3_prime_UTR_variant:MODIFIER:exon15/15:c.*1198A>G::,ALDH4A1:NM_170726.3:3_prime_UTR_variant:MODIFIER:exon16/16:c.*185A>G::	regulatory_region_variant:promoter_flanking_region	606811 [GENE=ALDH4A1 PHENOS=Hyperprolinemia,type II,239510,Autosomal recessive];	294336 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs7366541	0.1799	0.2344	896,.		-1.2020			0.06,0.15	4.38					0.0381	0.9349	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	19198414	19198414	G	A	het	het	wt		QUAL=4315;DP=168,196,168;AF=0.48,0.49,0.00;MQM=60;SAP=27;ABP=4	ALDH4A1,RP13-279N23.2	intron,3'UTR,intron&NMD_transcript	ALDH4A1:ENST00000290597.5:intron_variant:MODIFIER:intron15/15:c.*42-130C>T::,ALDH4A1:ENST00000375341.3:3_prime_UTR_variant:MODIFIER:exon15/15:c.*925C>T::,RP13-279N23.2:ENST00000494072.3:intron_variant&NMD_transcript_variant:MODIFIER:intron22/26:c.*1742+2543C>T::,ALDH4A1:ENST00000538309.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*925C>T::,ALDH4A1:ENST00000538839.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*925C>T::	ALDH4A1:NM_001161504.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*925C>T::,ALDH4A1:NM_001319218.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*925C>T::,ALDH4A1:NM_003748.4:3_prime_UTR_variant:MODIFIER:exon15/15:c.*925C>T::,ALDH4A1:NM_170726.3:intron_variant:MODIFIER:intron15/15:c.*42-130C>T::		606811 [GENE=ALDH4A1 PHENOS=Hyperprolinemia,type II,239510,Autosomal recessive];	294341 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs1140477	0.1935	0.2424	908,.		0.5800			0.12,0.17	4.58					-0.025	0.9345	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	19198418	19198418	C	T	het	het	wt		QUAL=4315;DP=168,196,168;AF=0.48,0.49,0.00;MQM=60;SAP=27;ABP=4	ALDH4A1,RP13-279N23.2	intron,3'UTR,intron&NMD_transcript	ALDH4A1:ENST00000290597.5:intron_variant:MODIFIER:intron15/15:c.*42-134G>A::,ALDH4A1:ENST00000375341.3:3_prime_UTR_variant:MODIFIER:exon15/15:c.*921G>A::,RP13-279N23.2:ENST00000494072.3:intron_variant&NMD_transcript_variant:MODIFIER:intron22/26:c.*1742+2539G>A::,ALDH4A1:ENST00000538309.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*921G>A::,ALDH4A1:ENST00000538839.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*921G>A::	ALDH4A1:NM_001161504.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*921G>A::,ALDH4A1:NM_001319218.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*921G>A::,ALDH4A1:NM_003748.4:3_prime_UTR_variant:MODIFIER:exon15/15:c.*921G>A::,ALDH4A1:NM_170726.3:intron_variant:MODIFIER:intron15/15:c.*42-134G>A::		606811 [GENE=ALDH4A1 PHENOS=Hyperprolinemia,type II,239510,Autosomal recessive];	294342 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs1138269	0.1933	0.2425	908,.		0.1330			0.06,0.16	4.89					0.0159	0.935	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	19198576	19198576	A	G	hom	hom	hom		QUAL=29673;DP=367,311,238;AF=1.00,0.99,1.00;MQM=60;SAP=10;ABP=0	ALDH4A1,RP13-279N23.2	intron,3'UTR,intron&NMD_transcript	ALDH4A1:ENST00000290597.5:intron_variant:MODIFIER:intron15/15:c.*42-292T>C::,ALDH4A1:ENST00000375341.3:3_prime_UTR_variant:MODIFIER:exon15/15:c.*763T>C::,RP13-279N23.2:ENST00000494072.3:intron_variant&NMD_transcript_variant:MODIFIER:intron22/26:c.*1742+2381T>C::,ALDH4A1:ENST00000538309.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*763T>C::,ALDH4A1:ENST00000538839.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*763T>C::	ALDH4A1:NM_001161504.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*763T>C::,ALDH4A1:NM_001319218.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*763T>C::,ALDH4A1:NM_003748.4:3_prime_UTR_variant:MODIFIER:exon15/15:c.*763T>C::,ALDH4A1:NM_170726.3:intron_variant:MODIFIER:intron15/15:c.*42-292T>C::		606811 [GENE=ALDH4A1 PHENOS=Hyperprolinemia,type II,239510,Autosomal recessive];	294344 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs1138267		0.6404	6551,.		-5.8090			0.01,0.12	1.11					0.0084	0.9349	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	19198627	19198627	G	A	het	het	wt		QUAL=6360;DP=288,262,203;AF=0.49,0.45,0.00;MQM=60;SAP=18;ABP=7	ALDH4A1,RP13-279N23.2	intron,3'UTR,intron&NMD_transcript	ALDH4A1:ENST00000290597.5:intron_variant:MODIFIER:intron15/15:c.*42-343C>T::,ALDH4A1:ENST00000375341.3:3_prime_UTR_variant:MODIFIER:exon15/15:c.*712C>T::,RP13-279N23.2:ENST00000494072.3:intron_variant&NMD_transcript_variant:MODIFIER:intron22/26:c.*1742+2330C>T::,ALDH4A1:ENST00000538309.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*712C>T::,ALDH4A1:ENST00000538839.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*712C>T::	ALDH4A1:NM_001161504.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*712C>T::,ALDH4A1:NM_001319218.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*712C>T::,ALDH4A1:NM_003748.4:3_prime_UTR_variant:MODIFIER:exon15/15:c.*712C>T::,ALDH4A1:NM_170726.3:intron_variant:MODIFIER:intron15/15:c.*42-343C>T::		606811 [GENE=ALDH4A1 PHENOS=Hyperprolinemia,type II,239510,Autosomal recessive];	294346 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs14311	0.1935	0.2427	934,.		-0.0360			0.00,0.08	4.21					-0.0112	0.9347	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	19198637	19198637	G	A	het	het	hom		QUAL=12426;DP=235,258,205;AF=0.48,0.53,1.00;MQM=60;SAP=6;ABP=3	ALDH4A1,RP13-279N23.2	intron,3'UTR,intron&NMD_transcript	ALDH4A1:ENST00000290597.5:intron_variant:MODIFIER:intron15/15:c.*42-353C>T::,ALDH4A1:ENST00000375341.3:3_prime_UTR_variant:MODIFIER:exon15/15:c.*702C>T::,RP13-279N23.2:ENST00000494072.3:intron_variant&NMD_transcript_variant:MODIFIER:intron22/26:c.*1742+2320C>T::,ALDH4A1:ENST00000538309.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*702C>T::,ALDH4A1:ENST00000538839.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*702C>T::	ALDH4A1:NM_001161504.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*702C>T::,ALDH4A1:NM_001319218.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*702C>T::,ALDH4A1:NM_003748.4:3_prime_UTR_variant:MODIFIER:exon15/15:c.*702C>T::,ALDH4A1:NM_170726.3:intron_variant:MODIFIER:intron15/15:c.*42-353C>T::		606811 [GENE=ALDH4A1 PHENOS=Hyperprolinemia,type II,239510,Autosomal recessive];	294347 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs3202002	0.4744	0.3877	2537,.		-0.3560			0.09,0.20	6.97					-0.0043	0.9348	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	19198682	19198682	C	-	het	het	hom		QUAL=7743;DP=101,182,165;AF=0.49,0.53,0.99;MQM=60;SAP=6;ABP=3	ALDH4A1,RP13-279N23.2	intron,3'UTR,intron&NMD_transcript	ALDH4A1:ENST00000290597.5:intron_variant:MODIFIER:intron15/15:c.*42-398del::,ALDH4A1:ENST00000375341.3:3_prime_UTR_variant:MODIFIER:exon15/15:c.*657del::,RP13-279N23.2:ENST00000494072.3:intron_variant&NMD_transcript_variant:MODIFIER:intron22/26:c.*1742+2275del::,ALDH4A1:ENST00000538309.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*657del::,ALDH4A1:ENST00000538839.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*657del::	ALDH4A1:NM_001161504.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*657del::,ALDH4A1:NM_001319218.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*657del::,ALDH4A1:NM_003748.4:3_prime_UTR_variant:MODIFIER:exon15/15:c.*657del::,ALDH4A1:NM_170726.3:intron_variant:MODIFIER:intron15/15:c.*42-398del::		606811 [GENE=ALDH4A1 PHENOS=Hyperprolinemia,type II,239510,Autosomal recessive];	294349 [likely benign DISEASE=Hyperprolinemia];			rs11311839		0.3952	2646,.		-3.2880				0.69					0.0265	0.9351	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	19198895	19198895	A	G	het	het	wt		QUAL=5011;DP=189,247,194;AF=0.48,0.45,0.00;MQM=60;SAP=10;ABP=8	ALDH4A1,RP13-279N23.2	intron,3'UTR,intron&NMD_transcript	ALDH4A1:ENST00000290597.5:intron_variant:MODIFIER:intron15/15:c.*41+403T>C::,ALDH4A1:ENST00000375341.3:3_prime_UTR_variant:MODIFIER:exon15/15:c.*444T>C::,RP13-279N23.2:ENST00000494072.3:intron_variant&NMD_transcript_variant:MODIFIER:intron22/26:c.*1742+2062T>C::,ALDH4A1:ENST00000538309.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*444T>C::,ALDH4A1:ENST00000538839.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*444T>C::	ALDH4A1:NM_001161504.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*444T>C::,ALDH4A1:NM_001319218.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*444T>C::,ALDH4A1:NM_003748.4:3_prime_UTR_variant:MODIFIER:exon15/15:c.*444T>C::,ALDH4A1:NM_170726.3:intron_variant:MODIFIER:intron15/15:c.*41+403T>C::		606811 [GENE=ALDH4A1 PHENOS=Hyperprolinemia,type II,239510,Autosomal recessive];	294353 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs9117	0.1102	0.1797	607,.		0.2380			0.17,0.18	6.75					0.0106	0.9349	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	19199221	19199221	C	T	het	het	hom		QUAL=20913;DP=213,487,404;AF=0.45,0.47,1.00;MQM=60;SAP=58;ABP=13	ALDH4A1,RP13-279N23.2	intron,3'UTR,intron&NMD_transcript	ALDH4A1:ENST00000290597.5:intron_variant:MODIFIER:intron15/15:c.*41+77G>A::,ALDH4A1:ENST00000375341.3:3_prime_UTR_variant:MODIFIER:exon15/15:c.*118G>A::,RP13-279N23.2:ENST00000494072.3:intron_variant&NMD_transcript_variant:MODIFIER:intron22/26:c.*1742+1736G>A::,ALDH4A1:ENST00000538309.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*118G>A::,ALDH4A1:ENST00000538839.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*118G>A::	ALDH4A1:NM_001161504.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*118G>A::,ALDH4A1:NM_001319218.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*118G>A::,ALDH4A1:NM_003748.4:3_prime_UTR_variant:MODIFIER:exon15/15:c.*118G>A::,ALDH4A1:NM_170726.3:intron_variant:MODIFIER:intron15/15:c.*41+77G>A::		606811 [GENE=ALDH4A1 PHENOS=Hyperprolinemia,type II,239510,Autosomal recessive];	294359 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs11740	0.4714	0.3878	2531,.		-1.0870			0.01,0.12	0.97					-0.0348	0.9348	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	19199473	19199473	T	A	het	het	hom	off-target	QUAL=12618;DP=147,285,227;AF=0.48,0.53,0.99;MQM=60;SAP=125;ABP=3	ALDH4A1,RP13-279N23.2	intron,intron&NMD_transcript	ALDH4A1:ENST00000290597.5:intron_variant:MODIFIER:intron14/15:c.1580-22A>T::,ALDH4A1:ENST00000375341.3:intron_variant:MODIFIER:intron14/14:c.1580-22A>T::,RP13-279N23.2:ENST00000494072.3:intron_variant&NMD_transcript_variant:MODIFIER:intron22/26:c.*1742+1484A>T::,ALDH4A1:ENST00000538309.1:intron_variant:MODIFIER:intron14/14:c.1400-22A>T::,ALDH4A1:ENST00000538839.1:intron_variant:MODIFIER:intron13/13:c.1427-22A>T::	ALDH4A1:NM_001161504.1:intron_variant:MODIFIER:intron14/14:c.1400-22A>T::,ALDH4A1:NM_001319218.1:intron_variant:MODIFIER:intron13/13:c.1427-22A>T::,ALDH4A1:NM_003748.4:intron_variant:MODIFIER:intron14/14:c.1580-22A>T::,ALDH4A1:NM_170726.3:intron_variant:MODIFIER:intron14/15:c.1580-22A>T::		606811 [GENE=ALDH4A1 PHENOS=Hyperprolinemia,type II,239510,Autosomal recessive];				rs28700162	0.4714	0.4724	2557,.	0.2427,0.5821,0.6726,0.4245,0.5857	0.1100			0.12,0.19	5.86					-0.0203	0.9079	0.05	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	19199487	19199487	A	G	het	het	wt	off-target	QUAL=4554;DP=101,254,201;AF=0.62,0.47,0.00;MQM=60;SAP=107;ABP=4	ALDH4A1,RP13-279N23.2	intron,intron&NMD_transcript	ALDH4A1:ENST00000290597.5:intron_variant:MODIFIER:intron14/15:c.1580-36T>C::,ALDH4A1:ENST00000375341.3:intron_variant:MODIFIER:intron14/14:c.1580-36T>C::,RP13-279N23.2:ENST00000494072.3:intron_variant&NMD_transcript_variant:MODIFIER:intron22/26:c.*1742+1470T>C::,ALDH4A1:ENST00000538309.1:intron_variant:MODIFIER:intron14/14:c.1400-36T>C::,ALDH4A1:ENST00000538839.1:intron_variant:MODIFIER:intron13/13:c.1427-36T>C::	ALDH4A1:NM_001161504.1:intron_variant:MODIFIER:intron14/14:c.1400-36T>C::,ALDH4A1:NM_001319218.1:intron_variant:MODIFIER:intron13/13:c.1427-36T>C::,ALDH4A1:NM_003748.4:intron_variant:MODIFIER:intron14/14:c.1580-36T>C::,ALDH4A1:NM_170726.3:intron_variant:MODIFIER:intron14/15:c.1580-36T>C::		606811 [GENE=ALDH4A1 PHENOS=Hyperprolinemia,type II,239510,Autosomal recessive];				rs35255325	0.1148	0.1962	614,.	0.0962,0.1974,0.0007,0.2520,0.1205	0.5300			0.05,0.16	6.19					0.1271	0.7519	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	19200908	19200908	G	C	het	het	hom	off-target	QUAL=6940;DP=103,165,121;AF=0.55,0.47,1.00;MQM=60;SAP=368;ABP=3	ALDH4A1,RP13-279N23.2	intron,intron&NMD_transcript	ALDH4A1:ENST00000290597.5:intron_variant:MODIFIER:intron14/15:c.1579+49C>G::,ALDH4A1:ENST00000375341.3:intron_variant:MODIFIER:intron14/14:c.1579+49C>G::,RP13-279N23.2:ENST00000494072.3:intron_variant&NMD_transcript_variant:MODIFIER:intron22/26:c.*1742+49C>G::,ALDH4A1:ENST00000538309.1:intron_variant:MODIFIER:intron14/14:c.1399+49C>G::,ALDH4A1:ENST00000538839.1:intron_variant:MODIFIER:intron13/13:c.1426+49C>G::	ALDH4A1:NM_001161504.1:intron_variant:MODIFIER:intron14/14:c.1399+49C>G::,ALDH4A1:NM_001319218.1:intron_variant:MODIFIER:intron13/13:c.1426+49C>G::,ALDH4A1:NM_003748.4:intron_variant:MODIFIER:intron14/14:c.1579+49C>G::,ALDH4A1:NM_170726.3:intron_variant:MODIFIER:intron14/15:c.1579+49C>G::		606811 [GENE=ALDH4A1 PHENOS=Hyperprolinemia,type II,239510,Autosomal recessive];				rs28529092		0.5001	3159,.	0.4323,0.5988,0.6738,0.4409,0.6074	3.0650			0.64,0.60	11.13					-0.0795	0.0875	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	19201956	19201956	A	G	hom	hom	hom		QUAL=18236;DP=311,136,131;AF=1.00,1.00,1.00;MQM=60;SAP=207;ABP=0	ALDH4A1,RP13-279N23.2	synonymous,3'UTR&NMD_transcript	ALDH4A1:ENST00000290597.5:synonymous_variant:LOW:exon13/16:c.1380T>C:p.Asp460=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000375341.3:synonymous_variant:LOW:exon13/15:c.1380T>C:p.Asp460=:PF00171 [Aldehyde dehydrogenase family],RP13-279N23.2:ENST00000494072.3:3_prime_UTR_variant&NMD_transcript_variant:MODIFIER:exon21/27:c.*1543T>C::,ALDH4A1:ENST00000538309.1:synonymous_variant:LOW:exon13/15:c.1200T>C:p.Asp400=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000538839.1:synonymous_variant:LOW:exon12/14:c.1227T>C:p.Asp409=:	ALDH4A1:NM_001161504.1:synonymous_variant:LOW:exon13/15:c.1200T>C:p.Asp400=:,ALDH4A1:NM_001319218.1:synonymous_variant:LOW:exon12/14:c.1227T>C:p.Asp409=:,ALDH4A1:NM_003748.4:synonymous_variant:LOW:exon13/15:c.1380T>C:p.Asp460=:,ALDH4A1:NM_170726.3:synonymous_variant:LOW:exon13/16:c.1380T>C:p.Asp460=:	regulatory_region_variant:promoter_flanking_region,TF_binding_site_variant	606811 [GENE=ALDH4A1 PHENOS=Hyperprolinemia,type II,239510,Autosomal recessive];	294369 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs2230708		0.7321	7602,.	0.6880,0.8178,0.7106,0.7190,0.7577	-1.4010			0.01,0.14	0.20					0.1678	0.2468	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	19202770	19202770	T	C	hom	hom	hom	off-target	QUAL=4001;DP=47,54,30;AF=1.00,1.00,1.00;MQM=60;SAP=146;ABP=0	ALDH4A1,RP13-279N23.2	intron,intron&NMD_transcript	ALDH4A1:ENST00000290597.5:intron_variant:MODIFIER:intron12/15:c.1338+39A>G::,ALDH4A1:ENST00000375341.3:intron_variant:MODIFIER:intron12/14:c.1338+39A>G::,RP13-279N23.2:ENST00000494072.3:intron_variant&NMD_transcript_variant:MODIFIER:intron20/26:c.*1501+39A>G::,ALDH4A1:ENST00000538309.1:intron_variant:MODIFIER:intron12/14:c.1158+39A>G::,ALDH4A1:ENST00000538839.1:intron_variant:MODIFIER:intron11/13:c.1186-773A>G::	ALDH4A1:NM_001161504.1:intron_variant:MODIFIER:intron12/14:c.1158+39A>G::,ALDH4A1:NM_001319218.1:intron_variant:MODIFIER:intron11/13:c.1186-773A>G::,ALDH4A1:NM_003748.4:intron_variant:MODIFIER:intron12/14:c.1338+39A>G::,ALDH4A1:NM_170726.3:intron_variant:MODIFIER:intron12/15:c.1338+39A>G::		606811 [GENE=ALDH4A1 PHENOS=Hyperprolinemia,type II,239510,Autosomal recessive];				rs7550822		0.9653	13484,.	0.7709,0.9760,0.9999,0.9775,0.9836	-0.2020			0.00,0.06	7.66					0.0369	0.3752	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	19202896	19202896	G	A	hom	hom	het		QUAL=7387;DP=131,96,72;AF=0.99,0.99,0.33;MQM=60;SAP=28;ABP=20	ALDH4A1,RP13-279N23.2	synonymous,3'UTR&NMD_transcript,intron	ALDH4A1:ENST00000290597.5:synonymous_variant:LOW:exon12/16:c.1251C>T:p.Ala417=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000375341.3:synonymous_variant:LOW:exon12/15:c.1251C>T:p.Ala417=:PF00171 [Aldehyde dehydrogenase family],RP13-279N23.2:ENST00000494072.3:3_prime_UTR_variant&NMD_transcript_variant:MODIFIER:exon20/27:c.*1414C>T::,ALDH4A1:ENST00000538309.1:synonymous_variant:LOW:exon12/15:c.1071C>T:p.Ala357=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000538839.1:intron_variant:MODIFIER:intron11/13:c.1185+806C>T::	ALDH4A1:NM_001161504.1:synonymous_variant:LOW:exon12/15:c.1071C>T:p.Ala357=:,ALDH4A1:NM_001319218.1:intron_variant:MODIFIER:intron11/13:c.1185+806C>T::,ALDH4A1:NM_003748.4:synonymous_variant:LOW:exon12/15:c.1251C>T:p.Ala417=:,ALDH4A1:NM_170726.3:synonymous_variant:LOW:exon12/16:c.1251C>T:p.Ala417=:		606811 [GENE=ALDH4A1 PHENOS=Hyperprolinemia,type II,239510,Autosomal recessive];	294374 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs2230707	0.5160	0.5117	3347,.	0.4402,0.6932,0.6078,0.4697,0.4989	-9.2540			0.02,0.29	8.41					-0.1124	0.3701	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	19202917	19202917	T	C	hom	hom	hom		QUAL=7613;DP=96,87,74;AF=1.00,0.99,0.97;MQM=60;SAP=4;ABP=0	ALDH4A1,RP13-279N23.2	synonymous,3'UTR&NMD_transcript,intron	ALDH4A1:ENST00000290597.5:synonymous_variant:LOW:exon12/16:c.1230A>G:p.Ser410=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000375341.3:synonymous_variant:LOW:exon12/15:c.1230A>G:p.Ser410=:PF00171 [Aldehyde dehydrogenase family],RP13-279N23.2:ENST00000494072.3:3_prime_UTR_variant&NMD_transcript_variant:MODIFIER:exon20/27:c.*1393A>G::,ALDH4A1:ENST00000538309.1:synonymous_variant:LOW:exon12/15:c.1050A>G:p.Ser350=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000538839.1:intron_variant:MODIFIER:intron11/13:c.1185+785A>G::	ALDH4A1:NM_001161504.1:synonymous_variant:LOW:exon12/15:c.1050A>G:p.Ser350=:,ALDH4A1:NM_001319218.1:intron_variant:MODIFIER:intron11/13:c.1185+785A>G::,ALDH4A1:NM_003748.4:synonymous_variant:LOW:exon12/15:c.1230A>G:p.Ser410=:,ALDH4A1:NM_170726.3:synonymous_variant:LOW:exon12/16:c.1230A>G:p.Ser410=:		606811 [GENE=ALDH4A1 PHENOS=Hyperprolinemia,type II,239510,Autosomal recessive];	294375 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs7550938	0.6609	0.6986	6220,.	0.4836,0.7945,0.7121,0.6946,0.7419	-5.5180			0.02,0.60	9.31					0.0601	0.3785	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	19202926	19202926	T	C	hom	hom	hom		QUAL=6315;DP=65,87,73;AF=1.00,0.99,0.96;MQM=60;SAP=5;ABP=0	ALDH4A1,RP13-279N23.2	synonymous,3'UTR&NMD_transcript,intron	ALDH4A1:ENST00000290597.5:synonymous_variant:LOW:exon12/16:c.1221A>G:p.Ala407=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000375341.3:synonymous_variant:LOW:exon12/15:c.1221A>G:p.Ala407=:PF00171 [Aldehyde dehydrogenase family],RP13-279N23.2:ENST00000494072.3:3_prime_UTR_variant&NMD_transcript_variant:MODIFIER:exon20/27:c.*1384A>G::,ALDH4A1:ENST00000538309.1:synonymous_variant:LOW:exon12/15:c.1041A>G:p.Ala347=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000538839.1:intron_variant:MODIFIER:intron11/13:c.1185+776A>G::	ALDH4A1:NM_001161504.1:synonymous_variant:LOW:exon12/15:c.1041A>G:p.Ala347=:,ALDH4A1:NM_001319218.1:intron_variant:MODIFIER:intron11/13:c.1185+776A>G::,ALDH4A1:NM_003748.4:synonymous_variant:LOW:exon12/15:c.1221A>G:p.Ala407=:,ALDH4A1:NM_170726.3:synonymous_variant:LOW:exon12/16:c.1221A>G:p.Ala407=:		606811 [GENE=ALDH4A1 PHENOS=Hyperprolinemia,type II,239510,Autosomal recessive];	294376 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs2230706		0.6978	6208,.	0.4828,0.7939,0.7102,0.6929,0.7422	0.2410			0.67,0.96	9.76					-0.0537	0.3729	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	19203997	19203997	C	G	hom	hom	hom		QUAL=7521;DP=83,107,56;AF=0.98,1.00,1.00;MQM=60;SAP=131;ABP=0	ALDH4A1,RP13-279N23.2	synonymous,3'UTR&NMD_transcript	ALDH4A1:ENST00000290597.5:synonymous_variant:LOW:exon10/16:c.1050G>C:p.Ala350=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000375341.3:synonymous_variant:LOW:exon10/15:c.1050G>C:p.Ala350=:PF00171 [Aldehyde dehydrogenase family],RP13-279N23.2:ENST00000494072.3:3_prime_UTR_variant&NMD_transcript_variant:MODIFIER:exon18/27:c.*1213G>C::,ALDH4A1:ENST00000538309.1:synonymous_variant:LOW:exon10/15:c.870G>C:p.Ala290=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000538839.1:synonymous_variant:LOW:exon10/14:c.1050G>C:p.Ala350=:PF00171 [Aldehyde dehydrogenase family]	ALDH4A1:NM_001161504.1:synonymous_variant:LOW:exon10/15:c.870G>C:p.Ala290=:,ALDH4A1:NM_001319218.1:synonymous_variant:LOW:exon10/14:c.1050G>C:p.Ala350=:,ALDH4A1:NM_003748.4:synonymous_variant:LOW:exon10/15:c.1050G>C:p.Ala350=:,ALDH4A1:NM_170726.3:synonymous_variant:LOW:exon10/16:c.1050G>C:p.Ala350=:		606811 [GENE=ALDH4A1 PHENOS=Hyperprolinemia,type II,239510,Autosomal recessive];	294382 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs2230705		0.7199	8148,.	0.7234,0.7459,0.4494,0.7190,0.5900	1.5080			0.18,0.93	5.85					0.0871	0.1537	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	19204154	19204154	G	A	het	wt	hom	off-target	QUAL=269;DP=14,20,8;AF=0.43,0.00,1.00;MQM=60;SAP=33;ABP=4	ALDH4A1,RP13-279N23.2	intron,intron&NMD_transcript	ALDH4A1:ENST00000290597.5:intron_variant:MODIFIER:intron9/15:c.941-48C>T::,ALDH4A1:ENST00000375341.3:intron_variant:MODIFIER:intron9/14:c.941-48C>T::,RP13-279N23.2:ENST00000494072.3:intron_variant&NMD_transcript_variant:MODIFIER:intron17/26:c.*1104-48C>T::,ALDH4A1:ENST00000538309.1:intron_variant:MODIFIER:intron9/14:c.761-48C>T::,ALDH4A1:ENST00000538839.1:intron_variant:MODIFIER:intron9/13:c.941-48C>T::	ALDH4A1:NM_001161504.1:intron_variant:MODIFIER:intron9/14:c.761-48C>T::,ALDH4A1:NM_001319218.1:intron_variant:MODIFIER:intron9/13:c.941-48C>T::,ALDH4A1:NM_003748.4:intron_variant:MODIFIER:intron9/14:c.941-48C>T::,ALDH4A1:NM_170726.3:intron_variant:MODIFIER:intron9/15:c.941-48C>T::		606811 [GENE=ALDH4A1 PHENOS=Hyperprolinemia,type II,239510,Autosomal recessive];				rs6426813		0.7698	7939,.	0.6963,0.8857,0.9544,0.7067,0.8413	-0.3830			0.03,0.09	2.18					-0.2303	0.1458	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	19208145	19208145	-	GGTTGCCT	hom	hom	hom	off-target	QUAL=672;DP=7,14,7;AF=1.00,1.00,1.00;MQM=60;SAP=64;ABP=0	ALDH4A1,RP13-279N23.2	intron,intron&NMD_transcript	ALDH4A1:ENST00000290597.5:intron_variant:MODIFIER:intron8/15:c.866+48_866+49insAGGCAACC::,ALDH4A1:ENST00000375341.3:intron_variant:MODIFIER:intron8/14:c.866+48_866+49insAGGCAACC::,RP13-279N23.2:ENST00000494072.3:intron_variant&NMD_transcript_variant:MODIFIER:intron16/26:c.*1029+48_*1029+49insAGGCAACC::,ALDH4A1:ENST00000538309.1:intron_variant:MODIFIER:intron8/14:c.686+48_686+49insAGGCAACC::,ALDH4A1:ENST00000538839.1:intron_variant:MODIFIER:intron8/13:c.866+48_866+49insAGGCAACC::	ALDH4A1:NM_001161504.1:intron_variant:MODIFIER:intron8/14:c.686+48_686+49insAGGCAACC::,ALDH4A1:NM_001319218.1:intron_variant:MODIFIER:intron8/13:c.866+48_866+49insAGGCAACC::,ALDH4A1:NM_003748.4:intron_variant:MODIFIER:intron8/14:c.866+48_866+49insAGGCAACC::,ALDH4A1:NM_170726.3:intron_variant:MODIFIER:intron8/15:c.866+48_866+49insAGGCAACC::		606811 [GENE=ALDH4A1 PHENOS=Hyperprolinemia,type II,239510,Autosomal recessive];				rs112548638		0.9957	15127,.	0.9437,0.9967,0.9999,0.9998,0.9995					2.57					0.0943	0.2172	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45), MIR4695 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	19211930	19211930	A	C	wt	wt	hom	off-target;low_conf_region	QUAL=55;DP=4,5,7;AF=0.00,0.00,0.86;MQM=60;SAP=9;ABP=0	ALDH4A1,RP13-279N23.2	intron,intron&NMD_transcript	ALDH4A1:ENST00000290597.5:intron_variant:MODIFIER:intron5/15:c.453+37T>G::,ALDH4A1:ENST00000375341.3:intron_variant:MODIFIER:intron5/14:c.453+37T>G::,RP13-279N23.2:ENST00000494072.3:intron_variant&NMD_transcript_variant:MODIFIER:intron12/26:c.*501+37T>G::,ALDH4A1:ENST00000538309.1:intron_variant:MODIFIER:intron5/14:c.273+37T>G::,ALDH4A1:ENST00000538839.1:intron_variant:MODIFIER:intron5/13:c.453+37T>G::	ALDH4A1:NM_001161504.1:intron_variant:MODIFIER:intron5/14:c.273+37T>G::,ALDH4A1:NM_001319218.1:intron_variant:MODIFIER:intron5/13:c.453+37T>G::,ALDH4A1:NM_003748.4:intron_variant:MODIFIER:intron5/14:c.453+37T>G::,ALDH4A1:NM_170726.3:intron_variant:MODIFIER:intron5/15:c.453+37T>G::		606811 [GENE=ALDH4A1 PHENOS=Hyperprolinemia,type II,239510,Autosomal recessive];			(CACCC)n (Simple_repeat)	rs752213358		0.2907	0,.	0.3541,0.4488,0.4416,0.2331,0.2196	-3.0270			0.00,0.06	0.05				COSV51892118	0.262	0.7877	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45), MIR4695 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	19211935	19211935	G	C	n/a	wt	het	off-target;low_conf_region	QUAL=27;DP=2,6,9;AF=0.00,0.00,0.56;MQM=60;SAP=14;ABP=3	ALDH4A1,RP13-279N23.2	intron,intron&NMD_transcript	ALDH4A1:ENST00000290597.5:intron_variant:MODIFIER:intron5/15:c.453+32C>G::,ALDH4A1:ENST00000375341.3:intron_variant:MODIFIER:intron5/14:c.453+32C>G::,RP13-279N23.2:ENST00000494072.3:intron_variant&NMD_transcript_variant:MODIFIER:intron12/26:c.*501+32C>G::,ALDH4A1:ENST00000538309.1:intron_variant:MODIFIER:intron5/14:c.273+32C>G::,ALDH4A1:ENST00000538839.1:intron_variant:MODIFIER:intron5/13:c.453+32C>G::	ALDH4A1:NM_001161504.1:intron_variant:MODIFIER:intron5/14:c.273+32C>G::,ALDH4A1:NM_001319218.1:intron_variant:MODIFIER:intron5/13:c.453+32C>G::,ALDH4A1:NM_003748.4:intron_variant:MODIFIER:intron5/14:c.453+32C>G::,ALDH4A1:NM_170726.3:intron_variant:MODIFIER:intron5/15:c.453+32C>G::		606811 [GENE=ALDH4A1 PHENOS=Hyperprolinemia,type II,239510,Autosomal recessive];			(CACCC)n (Simple_repeat)	rs188233802		0.3275	0,.	0.4060,0.4609,0.4566,0.2761,0.2668	-0.6220			0.06,0.16	3.38					-0.1774	0.9179	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45), MIR4695 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	19215834	19215834	T	C	hom	hom	hom	off-target	QUAL=11084;DP=120,143,95;AF=1.00,1.00,1.00;MQM=60;SAP=178;ABP=0	ALDH4A1,RP13-279N23.2	intron,intron&NMD_transcript	ALDH4A1:ENST00000290597.5:intron_variant:MODIFIER:intron3/15:c.249+22A>G::,ALDH4A1:ENST00000375341.3:intron_variant:MODIFIER:intron3/14:c.249+22A>G::,RP13-279N23.2:ENST00000494072.3:intron_variant&NMD_transcript_variant:MODIFIER:intron10/26:c.*297+22A>G::,ALDH4A1:ENST00000538309.1:intron_variant:MODIFIER:intron3/14:c.69+22A>G::,ALDH4A1:ENST00000538839.1:intron_variant:MODIFIER:intron3/13:c.249+22A>G::	ALDH4A1:NM_001161504.1:intron_variant:MODIFIER:intron3/14:c.69+22A>G::,ALDH4A1:NM_001319218.1:intron_variant:MODIFIER:intron3/13:c.249+22A>G::,ALDH4A1:NM_003748.4:intron_variant:MODIFIER:intron3/14:c.249+22A>G::,ALDH4A1:NM_170726.3:intron_variant:MODIFIER:intron3/15:c.249+22A>G::		606811 [GENE=ALDH4A1 PHENOS=Hyperprolinemia,type II,239510,Autosomal recessive];				rs941495	0.9844	0.9677	14684,.	0.9926,0.9727,0.9999,0.9571,0.9863	-0.2240			0.00,0.06	5.42					0.1203	0.1379	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	21889635	21889635	T	C	hom	het	hom		QUAL=4758;DP=28,125,90;AF=0.96,0.52,1.00;MQM=60;SAP=30;ABP=3	ALPL	synonymous	ALPL:ENST00000374832.1:synonymous_variant:LOW:exon5/12:c.330T>C:p.Ser110=:PF00245 [Alkaline phosphatase],ALPL:ENST00000374840.3:synonymous_variant:LOW:exon5/12:c.330T>C:p.Ser110=:PF00245 [Alkaline phosphatase],ALPL:ENST00000425315.2:synonymous_variant:LOW:exon4/11:c.330T>C:p.Ser110=:PF00245 [Alkaline phosphatase],ALPL:ENST00000539907.1:synonymous_variant:LOW:exon3/10:c.99T>C:p.Ser33=:PF00245 [Alkaline phosphatase],ALPL:ENST00000540617.1:synonymous_variant:LOW:exon4/11:c.165T>C:p.Ser55=:PF00245 [Alkaline phosphatase]	ALPL:NM_000478.6:synonymous_variant:LOW:exon5/12:c.330T>C:p.Ser110=:,ALPL:NM_001127501.4:synonymous_variant:LOW:exon4/11:c.165T>C:p.Ser55=:,ALPL:NM_001177520.3:synonymous_variant:LOW:exon3/10:c.99T>C:p.Ser33=:,ALPL:NM_001369803.2:synonymous_variant:LOW:exon5/12:c.330T>C:p.Ser110=:,ALPL:NM_001369804.2:synonymous_variant:LOW:exon5/12:c.330T>C:p.Ser110=:,ALPL:NM_001369805.2:synonymous_variant:LOW:exon5/12:c.330T>C:p.Ser110=:		171760 [GENE=ALPL PHENOS=Hypophosphatasia,adult,146300,Autosomal recessive,Autosomal dominant/Odontohypophosphatasia,146300,Autosomal recessive,Autosomal dominant/Hypophosphatasia,childhood,241510,Autosomal recessive/Hypophosphatasia,infantile,241500,Autosomal recessive];	197678 [benign DISEASE=not specified];			rs1780316	0.9295	0.9472	13471,.	0.8650,0.9679,0.9864,0.9435,0.9535	-0.9200			0.01,0.95	7.05					0.121	0.0705	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALPL (inh=AR+AD oe_syn=1.07 oe_mis=0.80 oe_lof=0.41)
chr1	21896925	21896925	C	T	het	het	wt	off-target	QUAL=6278;DP=187,304,243;AF=0.49,0.55,0.00;MQM=60;SAP=187;ABP=6	ALPL	intron	ALPL:ENST00000374830.1:intron_variant:MODIFIER:intron1/3:c.-66+58C>T::,ALPL:ENST00000374832.1:intron_variant:MODIFIER:intron8/11:c.862+58C>T::,ALPL:ENST00000374840.3:intron_variant:MODIFIER:intron8/11:c.862+58C>T::,ALPL:ENST00000425315.2:intron_variant:MODIFIER:intron7/10:c.862+58C>T::,ALPL:ENST00000539907.1:intron_variant:MODIFIER:intron6/9:c.631+58C>T::,ALPL:ENST00000540617.1:intron_variant:MODIFIER:intron7/10:c.697+58C>T::	ALPL:NM_000478.6:intron_variant:MODIFIER:intron8/11:c.862+58C>T::,ALPL:NM_001127501.4:intron_variant:MODIFIER:intron7/10:c.697+58C>T::,ALPL:NM_001177520.3:intron_variant:MODIFIER:intron6/9:c.631+58C>T::,ALPL:NM_001369803.2:intron_variant:MODIFIER:intron8/11:c.862+58C>T::,ALPL:NM_001369804.2:intron_variant:MODIFIER:intron8/11:c.862+58C>T::,ALPL:NM_001369805.2:intron_variant:MODIFIER:intron8/11:c.862+58C>T::		171760 [GENE=ALPL PHENOS=Hypophosphatasia,adult,146300,Autosomal recessive,Autosomal dominant/Odontohypophosphatasia,146300,Autosomal recessive,Autosomal dominant/Hypophosphatasia,childhood,241510,Autosomal recessive/Hypophosphatasia,infantile,241500,Autosomal recessive];				rs2275375	0.3231	0.2600	1110,.		-1.6000			0.01,0.13	0.17					0.2961	0.1494	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALPL (inh=AR+AD oe_syn=1.07 oe_mis=0.80 oe_lof=0.41)
chr1	21904206	21904206	C	T	wt	wt	het		QUAL=1739;DP=59,234,173;AF=0.00,0.00,0.46;MQM=60;SAP=12;ABP=6	ALPL	3'UTR	ALPL:ENST00000374829.1:3_prime_UTR_variant:MODIFIER:exon4/4:c.*65C>T::,ALPL:ENST00000374830.1:3_prime_UTR_variant:MODIFIER:exon4/4:c.*65C>T::,ALPL:ENST00000374832.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*65C>T::,ALPL:ENST00000374840.3:3_prime_UTR_variant:MODIFIER:exon12/12:c.*65C>T::,ALPL:ENST00000425315.2:3_prime_UTR_variant:MODIFIER:exon11/11:c.*65C>T::,ALPL:ENST00000539907.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*65C>T::,ALPL:ENST00000540617.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*65C>T::	ALPL:NM_000478.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*65C>T::,ALPL:NM_001127501.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*65C>T::,ALPL:NM_001177520.3:3_prime_UTR_variant:MODIFIER:exon10/10:c.*65C>T::,ALPL:NM_001369803.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*65C>T::,ALPL:NM_001369804.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*65C>T::,ALPL:NM_001369805.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*65C>T::		171760 [GENE=ALPL PHENOS=Hypophosphatasia,adult,146300,Autosomal recessive,Autosomal dominant/Odontohypophosphatasia,146300,Autosomal recessive,Autosomal dominant/Hypophosphatasia,childhood,241510,Autosomal recessive/Hypophosphatasia,infantile,241500,Autosomal recessive];	295558 [benign DISEASE=Hypophosphatasia];			rs1697405	0.3367	0.3519	2014,.		4.1560			0.71,0.96	12.53					0.0108	0.9335	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALPL (inh=AR+AD oe_syn=1.07 oe_mis=0.80 oe_lof=0.41)
chr1	21904263	21904263	C	-	het	wt	het		QUAL=20463;DP=179,280,240;AF=0.53,1.00,0.45;MQM=60;SAP=14;ABP=3	ALPL	3'UTR	ALPL:ENST00000374829.1:3_prime_UTR_variant:MODIFIER:exon4/4:c.*124del::,ALPL:ENST00000374832.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*124del::,ALPL:ENST00000374840.3:3_prime_UTR_variant:MODIFIER:exon12/12:c.*124del::,ALPL:ENST00000425315.2:3_prime_UTR_variant:MODIFIER:exon11/11:c.*124del::,ALPL:ENST00000539907.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*124del::,ALPL:ENST00000540617.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*124del::	ALPL:NM_000478.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*124del::,ALPL:NM_001127501.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*124del::,ALPL:NM_001177520.3:3_prime_UTR_variant:MODIFIER:exon10/10:c.*124del::,ALPL:NM_001369803.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*124del::,ALPL:NM_001369804.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*124del::,ALPL:NM_001369805.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*124del::		171760 [GENE=ALPL PHENOS=Hypophosphatasia,adult,146300,Autosomal recessive,Autosomal dominant/Odontohypophosphatasia,146300,Autosomal recessive,Autosomal dominant/Hypophosphatasia,childhood,241510,Autosomal recessive/Hypophosphatasia,infantile,241500,Autosomal recessive];	295560 [likely benign DISEASE=Hypophosphatasia];			rs140511985		0.0450	46,.		1.4120				15.30					0.0119	0.924	0	1	29	0 / 0					ALPL (inh=AR+AD oe_syn=1.07 oe_mis=0.80 oe_lof=0.41)
chr1	21904267	21904267	A	G	hom	hom	hom		QUAL=20463;DP=179,280,240;AF=0.53,1.00,0.45;MQM=60;SAP=14;ABP=3	ALPL	3'UTR	ALPL:ENST00000374829.1:3_prime_UTR_variant:MODIFIER:exon4/4:c.*126A>G::,ALPL:ENST00000374832.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*126A>G::,ALPL:ENST00000374840.3:3_prime_UTR_variant:MODIFIER:exon12/12:c.*126A>G::,ALPL:ENST00000425315.2:3_prime_UTR_variant:MODIFIER:exon11/11:c.*126A>G::,ALPL:ENST00000539907.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*126A>G::,ALPL:ENST00000540617.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*126A>G::	ALPL:NM_000478.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*126A>G::,ALPL:NM_001127501.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*126A>G::,ALPL:NM_001177520.3:3_prime_UTR_variant:MODIFIER:exon10/10:c.*126A>G::,ALPL:NM_001369803.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*126A>G::,ALPL:NM_001369804.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*126A>G::,ALPL:NM_001369805.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*126A>G::		171760 [GENE=ALPL PHENOS=Hypophosphatasia,adult,146300,Autosomal recessive,Autosomal dominant/Odontohypophosphatasia,146300,Autosomal recessive,Autosomal dominant/Hypophosphatasia,childhood,241510,Autosomal recessive/Hypophosphatasia,infantile,241500,Autosomal recessive];	295561 [benign DISEASE=Hypophosphatasia];			rs1697406	0.8682	0.8703	11867,.		0.7810			0.00,0.89	16.61					0.0076	0.924	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALPL (inh=AR+AD oe_syn=1.07 oe_mis=0.80 oe_lof=0.41)
chr1	21904374	21904374	A	C	wt	het	wt		QUAL=2236;DP=124,197,190;AF=0.00,0.46,0.00;MQM=60;SAP=18;ABP=5	ALPL	3'UTR	ALPL:ENST00000374829.1:3_prime_UTR_variant:MODIFIER:exon4/4:c.*233A>C::,ALPL:ENST00000374832.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*233A>C::,ALPL:ENST00000374840.3:3_prime_UTR_variant:MODIFIER:exon12/12:c.*233A>C::,ALPL:ENST00000425315.2:3_prime_UTR_variant:MODIFIER:exon11/11:c.*233A>C::,ALPL:ENST00000539907.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*233A>C::,ALPL:ENST00000540617.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*233A>C::	ALPL:NM_000478.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*233A>C::,ALPL:NM_001127501.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*233A>C::,ALPL:NM_001177520.3:3_prime_UTR_variant:MODIFIER:exon10/10:c.*233A>C::,ALPL:NM_001369803.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*233A>C::,ALPL:NM_001369804.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*233A>C::,ALPL:NM_001369805.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*233A>C::		171760 [GENE=ALPL PHENOS=Hypophosphatasia,adult,146300,Autosomal recessive,Autosomal dominant/Odontohypophosphatasia,146300,Autosomal recessive,Autosomal dominant/Hypophosphatasia,childhood,241510,Autosomal recessive/Hypophosphatasia,infantile,241500,Autosomal recessive];	295563 [benign DISEASE=Hypophosphatasia];			rs1772719	0.1645	0.1840	533,.		0.5040			0.48,0.95	15.01					0.0124	0.924	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALPL (inh=AR+AD oe_syn=1.07 oe_mis=0.80 oe_lof=0.41)
chr1	22149183	22149183	G	C	het	hom	wt		QUAL=1352;DP=22,42,27;AF=0.45,1.00,0.00;MQM=60;SAP=91;ABP=3	LDLRAD2,HSPG2	3'UTR,intron	LDLRAD2:ENST00000344642.2:3_prime_UTR_variant:MODIFIER:exon5/5:c.*475G>C::,HSPG2:ENST00000374695.3:3_prime_UTR_variant:MODIFIER:exon97/97:c.*626C>G::,LDLRAD2:ENST00000543870.1:intron_variant:MODIFIER:intron5/5:c.*218+257G>C::	LDLRAD2:NM_001013693.3:3_prime_UTR_variant:MODIFIER:exon5/5:c.*475G>C::,HSPG2:NM_001291860.2:3_prime_UTR_variant:MODIFIER:exon97/97:c.*626C>G::,HSPG2:NM_005529.7:3_prime_UTR_variant:MODIFIER:exon97/97:c.*626C>G::		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];	295685 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome];			rs1049644	0.3199	0.2993	1529,.		2.2390			0.26,0.18	6.22					0.0264	0.9143	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LDLRAD2 (inh=n/a oe_syn=1.10 oe_mis=1.04 oe_lof=0.66), HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22149935	22149935	T	C	hom	hom	hom		QUAL=15066;DP=110,232,143;AF=1.00,1.00,1.00;MQM=60;SAP=244;ABP=0	LDLRAD2,HSPG2	3'UTR,synonymous,intron	LDLRAD2:ENST00000344642.2:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1227T>C::,HSPG2:ENST00000374695.3:synonymous_variant:LOW:exon97/97:c.13050A>G:p.Ser4350=:PF00054 [Laminin G domain],LDLRAD2:ENST00000543870.1:intron_variant:MODIFIER:intron5/5:c.*219-468T>C::	LDLRAD2:NM_001013693.3:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1227T>C::,HSPG2:NM_001291860.2:synonymous_variant:LOW:exon97/97:c.13053A>G:p.Ser4351=:,HSPG2:NM_005529.7:synonymous_variant:LOW:exon97/97:c.13050A>G:p.Ser4350=:	regulatory_region_variant:promoter_flanking_region	142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];	295695 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,none provided,not provided];			rs897467		0.8075	9865,.	0.7083,0.7501,0.8158,0.8242,0.8256	-3.5700			0.04,0.86	10.96					0.0203	0.9139	0.23	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LDLRAD2 (inh=n/a oe_syn=1.10 oe_mis=1.04 oe_lof=0.66), HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22150118	22150118	C	T	wt	het	wt		QUAL=3342;DP=143,313,206;AF=0.00,0.44,0.00;MQM=60;SAP=11;ABP=12	LDLRAD2,HSPG2	3'UTR,missense,intron	LDLRAD2:ENST00000344642.2:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1410C>T::,HSPG2:ENST00000374695.3:missense_variant:MODERATE:exon96/97:c.12994G>A:p.Val4332Ile:PF00054 [Laminin G domain],LDLRAD2:ENST00000543870.1:intron_variant:MODIFIER:intron5/5:c.*219-285C>T::	LDLRAD2:NM_001013693.3:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1410C>T::,HSPG2:NM_001291860.2:missense_variant:MODERATE:exon96/97:c.12997G>A:p.Val4333Ile:,HSPG2:NM_005529.7:missense_variant:MODERATE:exon96/97:c.12994G>A:p.Val4332Ile:	regulatory_region_variant:promoter_flanking_region	142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];	295699 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,none provided];			rs1138469	0.0453	0.0571	44,.	0.0286,0.0272,0.0002,0.0622,0.1027	-1.4120	 ,T(1.00), 	 ,B(0.00), 	0.03,0.58	0.09	0.21				0.0067	0.9139	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LDLRAD2 (inh=n/a oe_syn=1.10 oe_mis=1.04 oe_lof=0.66), HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22150120	22150120	C	T	het	het	wt		QUAL=5782;DP=149,317,208;AF=0.45,0.55,0.01;MQM=60;SAP=7;ABP=4	LDLRAD2,HSPG2	3'UTR,missense,intron	LDLRAD2:ENST00000344642.2:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1412C>T::,HSPG2:ENST00000374695.3:missense_variant:MODERATE:exon96/97:c.12992G>A:p.Ser4331Asn:PF00054 [Laminin G domain],LDLRAD2:ENST00000543870.1:intron_variant:MODIFIER:intron5/5:c.*219-283C>T::	LDLRAD2:NM_001013693.3:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1412C>T::,HSPG2:NM_001291860.2:missense_variant:MODERATE:exon96/97:c.12995G>A:p.Ser4332Asn:,HSPG2:NM_005529.7:missense_variant:MODERATE:exon96/97:c.12992G>A:p.Ser4331Asn:	regulatory_region_variant:promoter_flanking_region	142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];	295700 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome];			rs3736360	0.1761	0.1814	422,.	0.0825,0.1274,0.1596,0.1792,0.2850	0.0960	 ,T(0.39), 	 ,B(0.00), 	0.21,0.89	17.87	0.12				0.1302	0.9138	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LDLRAD2 (inh=n/a oe_syn=1.10 oe_mis=1.04 oe_lof=0.66), HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22150160	22150160	G	T	het	het	wt		QUAL=7974;DP=288,324,205;AF=0.49,0.55,0.01;MQM=60;SAP=4;ABP=5	LDLRAD2,HSPG2	3'UTR,synonymous,intron	LDLRAD2:ENST00000344642.2:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1452G>T::,HSPG2:ENST00000374695.3:synonymous_variant:LOW:exon96/97:c.12952C>A:p.Arg4318=:PF00054 [Laminin G domain],LDLRAD2:ENST00000543870.1:intron_variant:MODIFIER:intron5/5:c.*219-243G>T::	LDLRAD2:NM_001013693.3:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1452G>T::,HSPG2:NM_001291860.2:synonymous_variant:LOW:exon96/97:c.12955C>A:p.Arg4319=:,HSPG2:NM_005529.7:synonymous_variant:LOW:exon96/97:c.12952C>A:p.Arg4318=:	regulatory_region_variant:promoter_flanking_region	142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];	295701 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,none provided];			rs3736358		0.1781	398,.	0.0345,0.1263,0.1596,0.1793,0.2850	3.5060			0.92,0.96	12.68				COSV60829904	-0.2194	0.9139	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LDLRAD2 (inh=n/a oe_syn=1.10 oe_mis=1.04 oe_lof=0.66), HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22150257	22150257	C	T	het	wt	hom	off-target	QUAL=3610;DP=71,202,108;AF=0.51,0.00,0.99;MQM=60;SAP=113;ABP=3	LDLRAD2,HSPG2	3'UTR,intron	LDLRAD2:ENST00000344642.2:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1549C>T::,HSPG2:ENST00000374695.3:intron_variant:MODIFIER:intron95/96:c.12900-45G>A::,LDLRAD2:ENST00000543870.1:intron_variant:MODIFIER:intron5/5:c.*219-146C>T::	LDLRAD2:NM_001013693.3:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1549C>T::,HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron95/96:c.12903-45G>A::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron95/96:c.12900-45G>A::	regulatory_region_variant:promoter_flanking_region	142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];				rs3736357	0.3752	0.4680	2888,.	0.1381,0.5328,0.6492,0.4898,0.3376	1.4950			0.09,0.16	4.59					-0.1702	0.9139	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LDLRAD2 (inh=n/a oe_syn=1.10 oe_mis=1.04 oe_lof=0.66), HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22154845	22154845	A	G	het	hom	wt		QUAL=1276;DP=42,32,37;AF=0.36,0.97,0.00;MQM=60;SAP=6;ABP=10	HSPG2	synonymous	HSPG2:ENST00000374695.3:synonymous_variant:LOW:exon89/97:c.12312T>C:p.Asp4104=:	HSPG2:NM_001291860.2:synonymous_variant:LOW:exon89/97:c.12315T>C:p.Asp4105=:,HSPG2:NM_005529.7:synonymous_variant:LOW:exon89/97:c.12312T>C:p.Asp4104=:		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];	295707 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome];			rs2228347	0.2572	0.2911	1099,.	0.1341,0.1842,0.1585,0.3076,0.4730	1.3460			0.11,0.83	9.13					0.1809	0.238	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LDLRAD2 (inh=n/a oe_syn=1.10 oe_mis=1.04 oe_lof=0.66), HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22155841	22155841	T	C	het	het	wt	off-target	QUAL=1223;DP=38,75,65;AF=0.53,0.52,0.00;MQM=60;SAP=106;ABP=3	HSPG2	intron	HSPG2:ENST00000374695.3:intron_variant:MODIFIER:intron87/96:c.11992+35A>G::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron87/96:c.11995+35A>G::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron87/96:c.11992+35A>G::		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];	618168 [benign DISEASE=not specified];			rs12042189	0.1564	0.1787	401,.	0.0343,0.1268,0.1582,0.1789,0.2840	-1.8010			0.03,0.13	0.30					-0.0627	0.086	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LDLRAD2 (inh=n/a oe_syn=1.10 oe_mis=1.04 oe_lof=0.66), HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22155853	22155853	C	T	het	het	wt	off-target	QUAL=1399;DP=58,83,71;AF=0.36,0.54,0.00;MQM=60;SAP=129;ABP=4	HSPG2	intron	HSPG2:ENST00000374695.3:intron_variant:MODIFIER:intron87/96:c.11992+23G>A::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron87/96:c.11995+23G>A::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron87/96:c.11992+23G>A::		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];	618169 [benign DISEASE=not specified];			rs12023794	0.1715	0.1804	433,.	0.0844,0.1273,0.1652,0.1786,0.2752	-0.8760			0.03,0.15	1.63					-0.0794	0.0861	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LDLRAD2 (inh=n/a oe_syn=1.10 oe_mis=1.04 oe_lof=0.66), HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22157689	22157689	G	A	hom	hom	hom	off-target	QUAL=16180;DP=93,254,201;AF=1.00,1.00,1.00;MQM=60;SAP=25;ABP=0	HSPG2	intron	HSPG2:ENST00000374695.3:intron_variant:MODIFIER:intron84/96:c.11562+19C>T::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron84/96:c.11565+19C>T::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron84/96:c.11562+19C>T::		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];				rs3736355	0.7592	0.7910	9378,.	0.6961,0.7415,0.8055,0.8006,0.8091	-2.8310			0.03,0.16	0.83					0.0757	0.2982	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22158120	22158120	G	T	het	het	wt	off-target	QUAL=2880;DP=81,142,101;AF=0.52,0.54,0.00;MQM=60;SAP=100;ABP=5	HSPG2	intron	HSPG2:ENST00000374695.3:intron_variant:MODIFIER:intron82/96:c.11352+25C>A::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron82/96:c.11355+25C>A::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron82/96:c.11352+25C>A::		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];				rs2270701	0.1651	0.1812	401,.	0.0590,0.1278,0.1579,0.1796,0.2864	-2.9900			0.06,0.11	0.49					0.1407	0.2196	0.1	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22159774	22159774	G	A	het	het	wt		QUAL=4173;DP=133,237,207;AF=0.44,0.50,0.00;MQM=60;SAP=103;ABP=5	HSPG2	synonymous	HSPG2:ENST00000374695.3:synonymous_variant:LOW:exon80/97:c.11082C>T:p.Pro3694=:PF02210 [Laminin G domain]	HSPG2:NM_001291860.2:synonymous_variant:LOW:exon80/97:c.11085C>T:p.Pro3695=:,HSPG2:NM_005529.7:synonymous_variant:LOW:exon80/97:c.11082C>T:p.Pro3694=:		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];	295724 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome];			rs2229486	0.0859	0.0965	181,.	0.1725,0.0410,0.0003,0.0796,0.1105	-3.3550			0.09,0.43	8.64					0.0302	0.9214	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22160043	22160043	C	T	het	het	wt		QUAL=5245;DP=178,284,221;AF=0.43,0.49,0.00;MQM=60;SAP=161;ABP=8	HSPG2	missense	HSPG2:ENST00000374695.3:missense_variant:MODERATE:exon79/97:c.10895G>A:p.Arg3632Gln:PF07679 [Immunoglobulin I-set domain]	HSPG2:NM_001291860.2:missense_variant:MODERATE:exon79/97:c.10898G>A:p.Arg3633Gln:,HSPG2:NM_005529.7:missense_variant:MODERATE:exon79/97:c.10895G>A:p.Arg3632Gln:		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];	295727 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome];			rs2229493	0.0859	0.0967	180,.	0.1735,0.0410,0.0002,0.0796,0.1106	-0.0650	T(0.54)	B(0.03)	0.19,0.21	2.96	0.05				-0.2217	0.9262	0.05	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22160148	22160148	C	T	het	wt	hom	off-target	QUAL=5246;DP=98,183,131;AF=0.59,0.00,1.00;MQM=60;SAP=279;ABP=10	HSPG2	intron	HSPG2:ENST00000374695.3:intron_variant:MODIFIER:intron78/96:c.10831-41G>A::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron78/96:c.10834-41G>A::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron78/96:c.10831-41G>A::		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];				rs7547731	0.3750	0.4643	2905,.	0.1375,0.5314,0.6473,0.4863,0.3319	-2.7290			0.06,0.14	2.31					-0.3656	0.9688	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22163390	22163390	G	A	het	het	wt		QUAL=5479;DP=177,353,226;AF=0.50,0.40,0.00;MQM=60;SAP=3;ABP=24	HSPG2	synonymous	HSPG2:ENST00000374695.3:synonymous_variant:LOW:exon75/97:c.10260C>T:p.His3420=:PF07679 [Immunoglobulin I-set domain]	HSPG2:NM_001291860.2:synonymous_variant:LOW:exon75/97:c.10263C>T:p.His3421=:,HSPG2:NM_005529.7:synonymous_variant:LOW:exon75/97:c.10260C>T:p.His3420=:		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];	295741 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome];			rs35444472	0.0861	0.0959	176,.	0.1701,0.0426,0.0004,0.0797,0.1119	2.3820			0.80,0.90	9.83					-0.1617	0.0624	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22163402	22163402	G	A	wt	het	wt		QUAL=5287;DP=176,347,223;AF=0.00,0.60,0.00;MQM=60;SAP=3;ABP=35	HSPG2	synonymous	HSPG2:ENST00000374695.3:synonymous_variant:LOW:exon75/97:c.10248C>T:p.Ser3416=:PF07679 [Immunoglobulin I-set domain]	HSPG2:NM_001291860.2:synonymous_variant:LOW:exon75/97:c.10251C>T:p.Ser3417=:,HSPG2:NM_005529.7:synonymous_variant:LOW:exon75/97:c.10248C>T:p.Ser3416=:		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];	295743 [benign/likely benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,none provided];	CS011537 [CLASS=DM? MUT=ALT PHEN="Dyssegmental dysplasia Silverman-Handmaker type" GENE=HSPG2];		rs41310390	0.0437	0.0586	44,.	0.0290,0.0287,0.0001,0.0642,0.0964	-2.4040			0.11,0.76	9.15					-0.2284	0.062	0.06	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22165901	22165901	A	G	het	het	wt		QUAL=2713;DP=82,87,39;AF=0.65,0.67,0.00;MQM=60;SAP=46;ABP=39	HSPG2	synonymous	HSPG2:ENST00000374695.3:synonymous_variant:LOW:exon73/97:c.9852T>C:p.Ala3284=:PF07679 [Immunoglobulin I-set domain]	HSPG2:NM_001291860.2:synonymous_variant:LOW:exon73/97:c.9855T>C:p.Ala3285=:,HSPG2:NM_005529.7:synonymous_variant:LOW:exon73/97:c.9852T>C:p.Ala3284=:		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];	295750 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,none provided,not provided];			rs2291826	0.3460	0.3320	1983,.	0.5383,0.1851,0.1598,0.2599,0.3809	-3.4070			0.02,0.12	0.29					0.0482	0.4546	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22167605	22167605	C	T	het	het	wt		QUAL=2048;DP=47,183,164;AF=0.45,0.42,0.00;MQM=60;SAP=92;ABP=15	HSPG2	missense	HSPG2:ENST00000374695.3:missense_variant:MODERATE:exon71/97:c.9502G>A:p.Ala3168Thr:PF07679 [Immunoglobulin I-set domain]	HSPG2:NM_001291860.2:missense_variant:MODERATE:exon71/97:c.9505G>A:p.Ala3169Thr:,HSPG2:NM_005529.7:missense_variant:MODERATE:exon71/97:c.9502G>A:p.Ala3168Thr:	regulatory_region_variant:promoter_flanking_region	142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];	295758 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome];			rs2228349	0.0837	0.0936	168,.	0.1609,0.0403,0.0002,0.0788,0.1103	0.9110	T(0.71)	B(0.01)	0.31,0.27	6.11	0.12				-0.0264	0.2183	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22168216	22168216	C	T	het	wt	hom	off-target	QUAL=6288;DP=75,231,181;AF=0.47,0.00,1.00;MQM=60;SAP=58;ABP=4	HSPG2	intron	HSPG2:ENST00000374695.3:intron_variant:MODIFIER:intron69/96:c.9194-50G>A::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron69/96:c.9197-50G>A::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron69/96:c.9194-50G>A::		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];				rs7556412		0.6519	6292,.	0.5013,0.6175,0.8146,0.6580,0.6022	-0.8510			0.08,0.23	7.09					-0.035	0.1881	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22168801	22168801	T	C	het	het	wt		QUAL=1437;DP=61,87,76;AF=0.46,0.43,0.00;MQM=60;SAP=35;ABP=8	HSPG2	missense	HSPG2:ENST00000374695.3:missense_variant:MODERATE:exon68/97:c.8983A>G:p.Ser2995Gly:PF13895 [Immunoglobulin domain]	HSPG2:NM_001291860.2:missense_variant:MODERATE:exon68/97:c.8986A>G:p.Ser2996Gly:,HSPG2:NM_005529.7:missense_variant:MODERATE:exon68/97:c.8983A>G:p.Ser2995Gly:		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];	295764 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,none provided];			rs2229491	0.0887	0.0982	189,.	0.1818,0.0411,0.0002,0.0794,0.1100	-0.0660	T(1.00)	B(0.00)	0.01,0.13	1.11	0.04				0.1154	0.1547	0.04	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22168845	22168845	A	T	het	het	wt		QUAL=924;DP=42,56,44;AF=0.52,0.38,0.00;MQM=60;SAP=58;ABP=6	HSPG2	missense	HSPG2:ENST00000374695.3:missense_variant:MODERATE:exon68/97:c.8939T>A:p.Leu2980His:PF13895 [Immunoglobulin domain]	HSPG2:NM_001291860.2:missense_variant:MODERATE:exon68/97:c.8942T>A:p.Leu2981His:,HSPG2:NM_005529.7:missense_variant:MODERATE:exon68/97:c.8939T>A:p.Leu2980His:		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];	295765 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,none provided];			rs2229489	0.0343	0.0490	31,.	0.0084,0.0237,0.0002,0.0568,0.1047	1.8860	T(1.00)	B(0.00)	0.18,0.31	13.61	0.07				0.0384	0.1526	0.03	59	2099	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22173144	22173144	C	T	het	het	wt	off-target	QUAL=8075;DP=101,508,376;AF=0.52,0.54,0.00;MQM=60;SAP=216;ABP=12	HSPG2	intron	HSPG2:ENST00000374695.3:intron_variant:MODIFIER:intron62/96:c.8165-52G>A::,HSPG2:ENST00000430507.1:intron_variant:MODIFIER:intron17/18:c.*1514-52G>A::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron62/96:c.8168-52G>A::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron62/96:c.8165-52G>A::		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];				rs34792235	0.0347	0.0493	31,.	0.0081,0.0237,0.0002,0.0568,0.1058	-1.2250			0.03,0.15	7.47					-0.0015	0.1776	0	49	1740	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22173990	22173990	A	G	het	het	wt		QUAL=7175;DP=155,424,324;AF=0.55,0.49,0.00;MQM=60;SAP=36;ABP=3	HSPG2	splice_region&intron	HSPG2:ENST00000374695.3:splice_region_variant&intron_variant:LOW:intron61/96:c.8026-5T>C::,HSPG2:ENST00000430507.1:splice_region_variant&intron_variant:LOW:intron16/18:c.*1375-5T>C::	HSPG2:NM_001291860.2:splice_region_variant&intron_variant:LOW:intron61/96:c.8029-5T>C::,HSPG2:NM_005529.7:splice_region_variant&intron_variant:LOW:intron61/96:c.8026-5T>C::		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];	295781 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome];			rs35917892	0.0347	0.0492	31,.	0.0083,0.0237,0.0002,0.0569,0.1058	-1.2120			0.01,0.10	0.55		4.39>3.72			0.1458	0.0448	0	61	2091	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22174426	22174426	T	G	het	hom	wt	off-target	QUAL=11558;DP=183,323,310;AF=0.45,0.99,0.01;MQM=60;SAP=3;ABP=7	HSPG2	intron	HSPG2:ENST00000374695.3:intron_variant:MODIFIER:intron60/96:c.7873+25A>C::,HSPG2:ENST00000430507.1:intron_variant:MODIFIER:intron15/18:c.*1222+25A>C::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron60/96:c.7876+25A>C::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron60/96:c.7873+25A>C::		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];				rs2290501	0.3748	0.3671	2283,.	0.5255,0.2081,0.1694,0.3145,0.4753	-0.0010			0.01,0.13	7.99					0.1015	0.3059	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22174518	22174518	G	T	het	het	wt		QUAL=7405;DP=270,363,358;AF=0.43,0.51,0.00;MQM=60;SAP=4;ABP=7	HSPG2	synonymous,3'UTR	HSPG2:ENST00000374695.3:synonymous_variant:LOW:exon60/97:c.7806C>A:p.Val2602=:PF07679 [Immunoglobulin I-set domain],HSPG2:ENST00000430507.1:3_prime_UTR_variant:MODIFIER:exon15/19:c.*1155C>A::	HSPG2:NM_001291860.2:synonymous_variant:LOW:exon60/97:c.7809C>A:p.Val2603=:,HSPG2:NM_005529.7:synonymous_variant:LOW:exon60/97:c.7806C>A:p.Val2602=:		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];	295785 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome];			rs12737091	0.0347	0.0491	29,.	0.0083,0.0237,0.0002,0.0567,0.1058	1.2660			0.69,0.85	13.94					-0.2782	0.196	0.98	60	2092	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22174600	22174600	A	G	hom	hom	hom	off-target	QUAL=17426;DP=85,247,234;AF=1.00,1.00,1.00;MQM=60;SAP=161;ABP=0	HSPG2	intron	HSPG2:ENST00000374695.3:intron_variant:MODIFIER:intron59/96:c.7738-14T>C::,HSPG2:ENST00000430507.1:intron_variant:MODIFIER:intron14/18:c.*1087-14T>C::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron59/96:c.7741-14T>C::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron59/96:c.7738-14T>C::		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];	295787 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome];			rs3767138	0.7620	0.7946	9614,.	0.7018,0.6937,0.8172,0.8169,0.8136	0.4330			0.01,0.16	12.19		10.37>10.27			-0.3981	0.44	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22175096	22175096	T	C	het	het	wt	off-target	QUAL=1844;DP=60,86,56;AF=0.50,0.58,0.00;MQM=60;SAP=144;ABP=6	HSPG2	intron	HSPG2:ENST00000374695.3:intron_variant:MODIFIER:intron59/96:c.7737+40A>G::,HSPG2:ENST00000430507.1:intron_variant:MODIFIER:intron14/18:c.*1086+40A>G::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron59/96:c.7740+40A>G::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron59/96:c.7737+40A>G::		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];				rs34726153	0.0349	0.0494	31,.	0.0085,0.0240,0.0002,0.0573,0.1059	-1.9520			0.04,0.14	2.10					-0.0786	0.219	0	49	1756	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22178469	22178469	A	G	het	het	wt	off-target	QUAL=2482;DP=66,121,84;AF=0.61,0.53,0.02;MQM=60;SAP=7;ABP=8	HSPG2	intron	HSPG2:ENST00000374695.3:intron_variant:MODIFIER:intron53/96:c.6871-50T>C::,HSPG2:ENST00000430507.1:intron_variant:MODIFIER:intron8/18:c.*220-50T>C::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron53/96:c.6874-50T>C::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron53/96:c.6871-50T>C::		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];				rs34346159	0.0347	0.0491	31,.	0.0080,0.0238,0.0002,0.0567,0.1058	-0.3870			0.00,0.08	8.02					0.0991	0.0464	0.05	49	1747	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22179244	22179244	C	T	het	het	wt		QUAL=3493;DP=86,203,152;AF=0.43,0.51,0.00;MQM=60;SAP=20;ABP=3	HSPG2	missense,3'UTR	HSPG2:ENST00000374695.3:missense_variant:MODERATE:exon52/97:c.6673G>A:p.Gly2225Ser:PF07679 [Immunoglobulin I-set domain],HSPG2:ENST00000430507.1:3_prime_UTR_variant:MODIFIER:exon7/19:c.*22G>A::	HSPG2:NM_001291860.2:missense_variant:MODERATE:exon52/97:c.6676G>A:p.Gly2226Ser:,HSPG2:NM_005529.7:missense_variant:MODERATE:exon52/97:c.6673G>A:p.Gly2225Ser:	regulatory_region_variant:promoter_flanking_region,TF_binding_site_variant	142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];	295807 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome];			rs35669711	0.0347	0.0492	30,.	0.0084,0.0238,0.0002,0.0569,0.1059	-0.1820	T(0.09), 	B(0.07), 	0.13,0.20	12.84	0.23				-0.0699	0.1042	0.02	60	2087	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22179451	22179451	C	T	het	het	wt		QUAL=5791;DP=77,434,272;AF=0.48,0.46,0.00;MQM=60;SAP=69;ABP=9	HSPG2	synonymous	HSPG2:ENST00000374695.3:synonymous_variant:LOW:exon51/97:c.6552G>A:p.Thr2184=:PF07679 [Immunoglobulin I-set domain],HSPG2:ENST00000430507.1:synonymous_variant:LOW:exon6/19:c.390G>A:p.Thr130=:PF00047 [Immunoglobulin domain]	HSPG2:NM_001291860.2:synonymous_variant:LOW:exon51/97:c.6555G>A:p.Thr2185=:,HSPG2:NM_005529.7:synonymous_variant:LOW:exon51/97:c.6552G>A:p.Thr2184=:	regulatory_region_variant:promoter_flanking_region,TF_binding_site_variant	142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];	295810 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome];			rs34443576	0.0345	0.0493	31,.	0.0085,0.0240,0.0004,0.0568,0.1060	-10.2480			0.02,0.10	1.10					-0.4532	0.9458	0.02	59	2084	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22180723	22180723	C	T	het	het	wt		QUAL=3031;DP=81,196,143;AF=0.46,0.51,0.00;MQM=60;SAP=38;ABP=3	HSPG2	synonymous,splice_region&intron	HSPG2:ENST00000374695.3:synonymous_variant:LOW:exon50/97:c.6402G>A:p.Val2134=:PF07679 [Immunoglobulin I-set domain],HSPG2:ENST00000430507.1:splice_region_variant&intron_variant:LOW:intron4/18:c.249+3G>A::	HSPG2:NM_001291860.2:synonymous_variant:LOW:exon50/97:c.6405G>A:p.Val2135=:,HSPG2:NM_005529.7:synonymous_variant:LOW:exon50/97:c.6402G>A:p.Val2134=:		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];	285614 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not specified];			rs12742444	0.0345	0.0472	30,.	0.0076,0.0233,0.0002,0.0540,0.1044	0.5220			0.53,0.86	8.12		-13.40>-9.18			0.99	0.5417	0	58	2078	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22181322	22181322	A	G	het	het	wt	off-target	QUAL=1240;DP=44,74,63;AF=0.57,0.43,0.00;MQM=60;SAP=110;ABP=3	HSPG2	intron	HSPG2:ENST00000374695.3:intron_variant:MODIFIER:intron48/96:c.6133+19T>C::,HSPG2:ENST00000430507.1:intron_variant:MODIFIER:intron2/18:c.-18+19T>C::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron48/96:c.6136+19T>C::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron48/96:c.6133+19T>C::		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];				rs36080251	0.0345	0.0491	30,.	0.0083,0.0239,0.0002,0.0567,0.1061	-0.7900			0.04,0.15	3.78					-0.0539	0.1588	0	48	1753	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22181895	22181895	C	T	het	het	wt		QUAL=5704;DP=151,311,257;AF=0.50,0.53,0.00;MQM=60;SAP=122;ABP=5	HSPG2	missense	HSPG2:ENST00000374695.3:missense_variant:MODERATE:exon47/97:c.5899G>A:p.Val1967Ile:PF07679 [Immunoglobulin I-set domain]	HSPG2:NM_001291860.2:missense_variant:MODERATE:exon47/97:c.5902G>A:p.Val1968Ile:,HSPG2:NM_005529.7:missense_variant:MODERATE:exon47/97:c.5899G>A:p.Val1967Ile:	regulatory_region_variant:CTCF_binding_site	142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];	295823 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome];			rs2229475	0.0347	0.0487	31,.	0.0082,0.0236,0.0002,0.0562,0.1053	1.8270	T(0.17)	D(1.00)	0.81,0.94	23.10	0.24				0.118	0.1492	0.01	58	2084	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22183471	22183471	A	C	hom	hom	hom	off-target	QUAL=1078;DP=19,13,7;AF=1.00,1.00,1.00;MQM=60;SAP=79;ABP=0	HSPG2	intron	HSPG2:ENST00000374695.3:intron_variant:MODIFIER:intron44/96:c.5575+37T>G::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron44/96:c.5578+37T>G::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron44/96:c.5575+37T>G::	regulatory_region_variant:promoter_flanking_region	142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];				rs12024579	0.7490	0.7884	9307,.	0.6607,0.7038,0.8137,0.8107,0.7977	-1.1730			0.01,0.11	5.35					-0.2979	0.5324	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22183476	22183476	A	G	het	het	wt	off-target	QUAL=103;DP=19,13,8;AF=0.16,0.54,0.00;MQM=60;SAP=25;ABP=13	HSPG2	intron	HSPG2:ENST00000374695.3:intron_variant:MODIFIER:intron44/96:c.5575+32T>C::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron44/96:c.5578+32T>C::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron44/96:c.5575+32T>C::	regulatory_region_variant:promoter_flanking_region	142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];				rs200354565	0.0461	0.0525	32,.	0.0409,0.0256,0.0003,0.0585,0.1067	-1.9140			0.01,0.11	4.50					0.2173	0.5271	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22183477	22183477	G	T	het	het	wt	off-target	QUAL=103;DP=19,13,8;AF=0.16,0.54,0.00;MQM=60;SAP=25;ABP=13	HSPG2	intron	HSPG2:ENST00000374695.3:intron_variant:MODIFIER:intron44/96:c.5575+31C>A::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron44/96:c.5578+31C>A::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron44/96:c.5575+31C>A::	regulatory_region_variant:promoter_flanking_region	142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];				rs12757277	0.0461	0.0525	32,.	0.0409,0.0256,0.0003,0.0584,0.1067	-3.3630			0.04,0.12	0.26					0.0481	0.5288	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22183739	22183739	A	G	hom	het	hom	off-target	QUAL=7811;DP=96,114,119;AF=1.00,0.48,1.00;MQM=60;SAP=68;ABP=3	HSPG2	intron	HSPG2:ENST00000374695.3:intron_variant:MODIFIER:intron43/96:c.5394+39T>C::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron43/96:c.5397+39T>C::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron43/96:c.5394+39T>C::	regulatory_region_variant:promoter_flanking_region	142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];				rs2305562	0.4469	0.5109	4079,.	0.4198,0.4836,0.4471,0.5460,0.3863	1.6230			0.13,0.23	9.63					-0.0323	0.535	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22191454	22191454	G	A	het	wt	hom		QUAL=7091;DP=119,347,208;AF=0.39,0.00,1.00;MQM=60;SAP=4;ABP=16	HSPG2	missense	HSPG2:ENST00000374695.3:missense_variant:MODERATE:exon36/97:c.4508C>T:p.Ala1503Val:PF00052 [Laminin B (Domain IV)]	HSPG2:NM_001291860.2:missense_variant:MODERATE:exon36/97:c.4511C>T:p.Ala1504Val:,HSPG2:NM_005529.7:missense_variant:MODERATE:exon36/97:c.4508C>T:p.Ala1503Val:		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];	291236 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not specified,none provided,not provided];			rs897471		0.7321	7924,.	0.6122,0.8067,0.8922,0.7350,0.5771	2.2610	T(0.06)	D(1.00)	0.46,0.70	22.10	0.15				-0.0496	0.0774	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22199081	22199081	A	T	hom	hom	hom	off-target	QUAL=5877;DP=51,80,80;AF=0.98,1.00,1.00;MQM=60;SAP=3;ABP=0	HSPG2	intron	HSPG2:ENST00000374695.3:intron_variant:MODIFIER:intron32/96:c.4029+32T>A::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron32/96:c.4032+32T>A::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron32/96:c.4029+32T>A::	regulatory_region_variant:CTCF_binding_site	142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];				rs2501266	0.9798	0.9958	15175,.	0.9402,0.9969,1.0000,0.9997,0.9999	-0.4800			0.03,0.08	0.05					-0.2063	0.2683	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22199245	22199245	C	T	het	wt	hom		QUAL=3063;DP=44,76,79;AF=0.64,0.01,1.00;MQM=60;SAP=21;ABP=10	HSPG2	synonymous	HSPG2:ENST00000374695.3:synonymous_variant:LOW:exon32/97:c.3897G>A:p.Val1299=:PF00053 [Laminin EGF domain]	HSPG2:NM_001291860.2:synonymous_variant:LOW:exon32/97:c.3900G>A:p.Val1300=:,HSPG2:NM_005529.7:synonymous_variant:LOW:exon32/97:c.3897G>A:p.Val1299=:		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];	285755 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not specified,not provided];			rs2229482	0.4249	0.5558	4528,.	0.2867,0.4025,0.4363,0.6384,0.5035	0.1280			0.73,0.88	10.27					-0.2178	0.2578	0.04	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22199821	22199821	G	A	het	wt	hom	off-target	QUAL=1475;DP=44,39,32;AF=0.48,0.00,1.00;MQM=60;SAP=6;ABP=3	HSPG2	intron	HSPG2:ENST00000374695.3:intron_variant:MODIFIER:intron30/96:c.3793+47C>T::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron30/96:c.3796+47C>T::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron30/96:c.3793+47C>T::		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];				rs2454290	0.7420	0.8308	9418,.	0.4849,0.9126,0.9771,0.8489,0.7345	0.0910			0.05,0.18	4.88					0.013	0.2693	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22202109	22202109	C	T	hom	hom	hom	off-target	QUAL=26126;DP=195,399,282;AF=0.98,1.00,1.00;MQM=60;SAP=459;ABP=0	HSPG2	intron	HSPG2:ENST00000374695.3:intron_variant:MODIFIER:intron25/96:c.3302+13G>A::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron25/96:c.3305+13G>A::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron25/96:c.3302+13G>A::		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];	295864 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,none provided];		MIRb (SINE/MIR)	rs2501265	0.9423	0.9858	14299,.	0.8166,0.9903,1.0000,0.9993,0.9996	-6.5090			0.01,0.15	3.54					-0.5234	0.7418	0.14	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22205466	22205466	T	C	hom	hom	hom	off-target;low_conf_region	QUAL=3619;DP=35,36,49;AF=0.97,1.00,1.00;MQM=60;SAP=28;ABP=0	HSPG2	intron	HSPG2:ENST00000374695.3:intron_variant:MODIFIER:intron18/96:c.2471+21A>G::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron18/96:c.2474+21A>G::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron18/96:c.2471+21A>G::		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];				rs2454293		0.9890	14709,.	0.8732,0.9919,0.9977,0.9977,0.9976	-0.9090			0.02,0.13	2.95				COSV65975893	0.132	0.3016	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22206649	22206649	T	C	hom	hom	hom		QUAL=21906;DP=191,255,236;AF=1.00,1.00,1.00;MQM=60;SAP=44;ABP=0	HSPG2	missense	HSPG2:ENST00000374695.3:missense_variant:MODERATE:exon17/97:c.2294A>G:p.Asn765Ser:PF00053 [Laminin EGF domain]	HSPG2:NM_001291860.2:missense_variant:MODERATE:exon17/97:c.2297A>G:p.Asn766Ser:,HSPG2:NM_005529.7:missense_variant:MODERATE:exon17/97:c.2294A>G:p.Asn765Ser:		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];	295881 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs989994		0.9845	14054,.	0.7872,0.9901,1.0000,0.9996,0.9996	0.8040	T(0.19)	B(0.02)	0.82,0.96	22.10	0.14				0.0615	0.0918	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22206942	22206942	G	A	hom	hom	hom		QUAL=7763;DP=117,73,61;AF=1.00,1.00,1.00;MQM=60;SAP=113;ABP=0	HSPG2	synonymous	HSPG2:ENST00000374695.3:synonymous_variant:LOW:exon16/97:c.2109C>T:p.Ala703=:PF00052 [Laminin B (Domain IV)]	HSPG2:NM_001291860.2:synonymous_variant:LOW:exon16/97:c.2112C>T:p.Ala704=:,HSPG2:NM_005529.7:synonymous_variant:LOW:exon16/97:c.2109C>T:p.Ala703=:		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];	295882 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs1874793		0.9845	14032,.	0.7876,0.9901,1.0000,0.9996,0.9997	1.4460			0.85,0.95	13.42					-0.2378	0.3612	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22207065	22207065	G	A	het	het	wt	off-target	QUAL=807;DP=36,52,41;AF=0.33,0.48,0.00;MQM=60;SAP=8;ABP=8	HSPG2	intron	HSPG2:ENST00000374695.3:intron_variant:MODIFIER:intron15/96:c.1999-13C>T::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron15/96:c.2002-13C>T::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron15/96:c.1999-13C>T::		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];	295886 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,none provided];			rs77828146	0.0082	0.0126	8,.	0.0028,0.0051,0.0000,0.0151,0.0198	-1.5230			0.08,0.19	0.88		5.42>5.43			0.3453	0.2408	0.01	7	528	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22207235	22207235	T	C	hom	hom	hom		QUAL=10961;DP=155,132,73;AF=1.00,1.00,1.00;MQM=60;SAP=22;ABP=0	HSPG2	missense	HSPG2:ENST00000374695.3:missense_variant:MODERATE:exon15/97:c.1912A>G:p.Met638Val:PF00052 [Laminin B (Domain IV)]	HSPG2:NM_001291860.2:missense_variant:MODERATE:exon15/97:c.1915A>G:p.Met639Val:,HSPG2:NM_005529.7:missense_variant:MODERATE:exon15/97:c.1912A>G:p.Met638Val:		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];	295887 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs1874792	0.9736	0.9944	15029,.	0.9191,0.9964,1.0000,0.9996,1.0000	1.5570	T(1.00)	B(0.00)	0.17,0.79	10.16	0.07				0.0353	0.2432	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22207805	22207817	CCCAGGGTGGCAG	-	hom	hom	hom	off-target;low_conf_region	QUAL=6257;DP=48,113,70;AF=1.00,1.00,1.00;MQM=60;SAP=155;ABP=0	HSPG2	intron	HSPG2:ENST00000374695.3:intron_variant:MODIFIER:intron14/96:c.1818+15_1818+27del::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron14/96:c.1821+15_1821+27del::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron14/96:c.1818+15_1818+27del::		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];				rs60267433		0.9908	14629,.	0.8763,0.9931,0.9998,0.9996,0.9998	3.6790				4.45					0.9727	0.054	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22208030	22208030	C	T	het	het	hom	off-target	QUAL=4597;DP=67,122,93;AF=0.46,0.43,1.00;MQM=60;SAP=225;ABP=9	HSPG2	intron	HSPG2:ENST00000374695.3:intron_variant:MODIFIER:intron13/96:c.1655-35G>A::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron13/96:c.1658-35G>A::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron13/96:c.1655-35G>A::		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];	439797 [benign DISEASE=not specified];			rs921847		0.9723	13742,.	0.7947,0.9850,1.0000,0.9843,0.9800	-0.4860			0.06,0.24	8.82					-0.094	0.0777	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22211222	22211222	T	C	het	het	het	off-target	QUAL=6859;DP=79,301,244;AF=0.56,0.48,0.43;MQM=60;SAP=65;ABP=9	HSPG2	intron	HSPG2:ENST00000374695.3:intron_variant:MODIFIER:intron12/96:c.1507+38A>G::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron12/96:c.1507+38A>G::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron12/96:c.1507+38A>G::		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];				rs4654994	0.8964	0.9135	12824,.	0.8502,0.8797,0.9665,0.9312,0.8939	-0.9900			0.01,0.10	1.97					-0.0774	0.2962	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22214127	22214127	A	G	hom	hom	het		QUAL=12535;DP=116,213,181;AF=1.00,1.00,0.50;MQM=60;SAP=229;ABP=3	HSPG2	synonymous	HSPG2:ENST00000374695.3:synonymous_variant:LOW:exon8/97:c.744T>C:p.Leu248=:	HSPG2:NM_001291860.2:synonymous_variant:LOW:exon8/97:c.744T>C:p.Leu248=:,HSPG2:NM_005529.7:synonymous_variant:LOW:exon8/97:c.744T>C:p.Leu248=:		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];	295909 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,none provided,not provided];			rs2229478		0.4490	3466,.	0.6401,0.5793,0.6276,0.3342,0.4043	-0.2610			0.06,0.22	1.41					0.1172	0.628	0.12	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22217108	22217108	G	A	hom	hom	hom		QUAL=25821;DP=218,332,276;AF=1.00,1.00,1.00;MQM=60;SAP=246;ABP=0	HSPG2	synonymous	HSPG2:ENST00000374695.3:synonymous_variant:LOW:exon4/97:c.324C>T:p.Phe108=:	HSPG2:NM_001291860.2:synonymous_variant:LOW:exon4/97:c.324C>T:p.Phe108=:,HSPG2:NM_005529.7:synonymous_variant:LOW:exon4/97:c.324C>T:p.Phe108=:		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];	295913 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs2501260	0.9481	0.9887	14430,.	0.8450,0.9934,1.0000,0.9996,0.9998	2.4590			0.81,0.94	13.58					-0.0357	0.2807	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22779159	22779159	T	C	hom	hom	hom		QUAL=28797;DP=267,395,256;AF=1.00,1.00,1.00;MQM=60;SAP=597;ABP=0	ZBTB40	intron,5'UTR	ZBTB40:ENST00000374651.4:intron_variant:MODIFIER:intron1/15:c.-70+662T>C::,ZBTB40:ENST00000375647.4:intron_variant:MODIFIER:intron1/17:c.-70+662T>C::,ZBTB40:ENST00000404138.1:5_prime_UTR_variant:MODIFIER:exon2/19:c.-350T>C::	ZBTB40:NM_001083621.1:5_prime_UTR_variant:MODIFIER:exon2/19:c.-350T>C::,ZBTB40:NM_001330398.1:intron_variant:MODIFIER:intron1/15:c.-70+662T>C::,ZBTB40:NM_014870.4:intron_variant:MODIFIER:intron1/17:c.-70+662T>C::	regulatory_region_variant:promoter				MER58B (DNA/hAT-Charlie)	rs10737466	0.9699	0.9779	15035,.		-1.6200			0.00,0.08	5.10					0.096	0.35	0.05	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22832743	22832743	A	T	hom	hom	het		QUAL=15558;DP=213,209,167;AF=1.00,0.99,0.56;MQM=60;SAP=484;ABP=8	ZBTB40	intron	ZBTB40:ENST00000374651.4:intron_variant:MODIFIER:intron4/15:c.1024+9A>T::,ZBTB40:ENST00000375647.4:intron_variant:MODIFIER:intron6/17:c.1360+9A>T::,ZBTB40:ENST00000404138.1:intron_variant:MODIFIER:intron7/18:c.1360+9A>T::	ZBTB40:NM_001083621.1:intron_variant:MODIFIER:intron7/18:c.1360+9A>T::,ZBTB40:NM_001330398.1:intron_variant:MODIFIER:intron4/15:c.1024+9A>T::,ZBTB40:NM_014870.4:intron_variant:MODIFIER:intron6/17:c.1360+9A>T::						rs209732	0.7991	0.7092	8169,.	0.8973,0.8436,0.8953,0.6147,0.7058	0.8940			0.02,0.92	15.79					0.0264	0.1756	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22835677	22835677	A	G	hom	hom	het		QUAL=24823;DP=339,306,273;AF=1.00,1.00,0.53;MQM=60;SAP=4;ABP=5	ZBTB40	missense	ZBTB40:ENST00000374651.4:missense_variant:MODERATE:exon7/16:c.1448A>G:p.Tyr483Cys:,ZBTB40:ENST00000375647.4:missense_variant:MODERATE:exon9/18:c.1784A>G:p.Tyr595Cys:,ZBTB40:ENST00000404138.1:missense_variant:MODERATE:exon10/19:c.1784A>G:p.Tyr595Cys:	ZBTB40:NM_001083621.1:missense_variant:MODERATE:exon10/19:c.1784A>G:p.Tyr595Cys:,ZBTB40:NM_001330398.1:missense_variant:MODERATE:exon7/16:c.1448A>G:p.Tyr483Cys:,ZBTB40:NM_014870.4:missense_variant:MODERATE:exon9/18:c.1784A>G:p.Tyr595Cys:						rs209729		0.7796	9652,.	0.9128,0.8838,0.8964,0.7168,0.7161	0.2230	T(0.10),D(0.03),D(0.03)	B(0.00),B(0.00),B(0.00)	0.03,0.18	12.32	0.02				0.1026	0.5368	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22846709	22846709	G	A	hom	hom	hom		QUAL=12141;DP=168,135,93;AF=1.00,1.00,1.00;MQM=60;SAP=114;ABP=0	ZBTB40	missense	ZBTB40:ENST00000374651.4:missense_variant:MODERATE:exon12/16:c.2653G>A:p.Val885Met:PF00096 [Zinc finger C2H2 type],ZBTB40:ENST00000375647.4:missense_variant:MODERATE:exon14/18:c.2989G>A:p.Val997Met:PF00096 [Zinc finger C2H2 type],ZBTB40:ENST00000404138.1:missense_variant:MODERATE:exon15/19:c.2989G>A:p.Val997Met:PF00096 [Zinc finger C2H2 type]	ZBTB40:NM_001083621.1:missense_variant:MODERATE:exon15/19:c.2989G>A:p.Val997Met:,ZBTB40:NM_001330398.1:missense_variant:MODERATE:exon12/16:c.2653G>A:p.Val885Met:,ZBTB40:NM_014870.4:missense_variant:MODERATE:exon14/18:c.2989G>A:p.Val997Met:						rs209720	0.9984	0.9973	15609,.	0.9991,0.9974,1.0000,0.9948,0.9993	2.3020	T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00)	0.39,0.96	18.81	0.17				-0.0295	0.4602	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50), ZBTB40-IT1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	22849003	22849003	A	C	hom	hom	het	off-target	QUAL=15028;DP=171,253,196;AF=0.99,0.99,0.48;MQM=60;SAP=339;ABP=4	ZBTB40	intron	ZBTB40:ENST00000374651.4:intron_variant:MODIFIER:intron14/15:c.2962+47A>C::,ZBTB40:ENST00000375647.4:intron_variant:MODIFIER:intron16/17:c.3298+47A>C::,ZBTB40:ENST00000404138.1:intron_variant:MODIFIER:intron17/18:c.3298+47A>C::	ZBTB40:NM_001083621.1:intron_variant:MODIFIER:intron17/18:c.3298+47A>C::,ZBTB40:NM_001330398.1:intron_variant:MODIFIER:intron14/15:c.2962+47A>C::,ZBTB40:NM_014870.4:intron_variant:MODIFIER:intron16/17:c.3298+47A>C::					MIR (SINE/MIR)	rs998978	0.3181	0.3392	1508,.	0.1520,0.1757,0.4593,0.3725,0.4202	-6.2890			0.00,0.08	0.10					0.0498	0.1575	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50), ZBTB40-IT1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	22852715	22852715	G	C	hom	hom	het		QUAL=10749;DP=165,140,108;AF=0.99,0.99,0.46;MQM=60;SAP=169;ABP=4	ZBTB40	synonymous	ZBTB40:ENST00000374651.4:synonymous_variant:LOW:exon16/16:c.3210G>C:p.Pro1070=:,ZBTB40:ENST00000375647.4:synonymous_variant:LOW:exon18/18:c.3546G>C:p.Pro1182=:,ZBTB40:ENST00000404138.1:synonymous_variant:LOW:exon19/19:c.3546G>C:p.Pro1182=:	ZBTB40:NM_001083621.1:synonymous_variant:LOW:exon19/19:c.3546G>C:p.Pro1182=:,ZBTB40:NM_001330398.1:synonymous_variant:LOW:exon16/16:c.3210G>C:p.Pro1070=:,ZBTB40:NM_014870.4:synonymous_variant:LOW:exon18/18:c.3546G>C:p.Pro1182=:						rs881646	0.3181	0.3388	1506,.	0.1520,0.1749,0.4593,0.3724,0.4203	-1.1410			0.09,0.18	0.20					-0.0184	0.8874	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22853141	22853141	G	A	hom	hom	het		QUAL=17221;DP=138,316,234;AF=1.00,1.00,0.50;MQM=60;SAP=18;ABP=3	ZBTB40	3'UTR	ZBTB40:ENST00000374651.4:3_prime_UTR_variant:MODIFIER:exon16/16:c.*252G>A::,ZBTB40:ENST00000375647.4:3_prime_UTR_variant:MODIFIER:exon18/18:c.*252G>A::,ZBTB40:ENST00000404138.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*252G>A::	ZBTB40:NM_001083621.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*252G>A::,ZBTB40:NM_001330398.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*252G>A::,ZBTB40:NM_014870.4:3_prime_UTR_variant:MODIFIER:exon18/18:c.*252G>A::						rs2281354	0.2378	0.2497	1184,.		0.1290			0.03,0.16	1.32					-0.002	0.8878	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22855194	22855194	-	T	het	het	het		QUAL=984;DP=34,39,32;AF=0.44,0.56,0.25;MQM=60;SAP=84;ABP=8	ZBTB40	3'UTR	ZBTB40:ENST00000375647.4:3_prime_UTR_variant:MODIFIER:exon18/18:c.*2320dup::,ZBTB40:ENST00000404138.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*2320dup::	ZBTB40:NM_001083621.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*2320dup::,ZBTB40:NM_001330398.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*2320dup::,ZBTB40:NM_014870.4:3_prime_UTR_variant:MODIFIER:exon18/18:c.*2320dup::					AluJo (SINE/Alu)	rs35637563		0.3286	1341,.						0.49					-0.0022	0.8826	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22855194	22855194	-	TT	wt	het	wt		QUAL=984;DP=34,39,32;AF=0.06,0.18,0.00;MQM=59;SAP=23;ABP=93	ZBTB40	3'UTR	ZBTB40:ENST00000375647.4:3_prime_UTR_variant:MODIFIER:exon18/18:c.*2319_*2320dup::,ZBTB40:ENST00000404138.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*2319_*2320dup::	ZBTB40:NM_001083621.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*2319_*2320dup::,ZBTB40:NM_001330398.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*2319_*2320dup::,ZBTB40:NM_014870.4:3_prime_UTR_variant:MODIFIER:exon18/18:c.*2319_*2320dup::					AluJo (SINE/Alu)	rs35637563		0.0027	1,.						0.47					-0.0051	0.8826	0.01	0	9	0 / 0					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22856601	22856601	T	C	hom	hom	het		QUAL=18834;DP=221,281,216;AF=0.99,1.00,0.49;MQM=60;SAP=83;ABP=3	ZBTB40	3'UTR	ZBTB40:ENST00000375647.4:3_prime_UTR_variant:MODIFIER:exon18/18:c.*3712T>C::,ZBTB40:ENST00000404138.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*3712T>C::	ZBTB40:NM_001083621.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*3712T>C::,ZBTB40:NM_001330398.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*3712T>C::,ZBTB40:NM_014870.4:3_prime_UTR_variant:MODIFIER:exon18/18:c.*3712T>C::	regulatory_region_variant:promoter_flanking_region					rs1062663	0.3295	0.3077	1570,.		-2.6560			0.01,0.08	0.17					0.0059	0.8828	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22965438	22965438	A	G	het	het	n/a		QUAL=331;DP=14,5,2;AF=0.64,0.60,1.00;MQM=60;SAP=13;ABP=6	C1QA	synonymous	C1QA:ENST00000374642.3:synonymous_variant:LOW:exon3/3:c.276A>G:p.Gly92=:PF01391 [Collagen triple helix repeat (20 copies)],C1QA:ENST00000402322.1:synonymous_variant:LOW:exon2/2:c.276A>G:p.Gly92=:PF01391 [Collagen triple helix repeat (20 copies)]	C1QA:NM_001347465.2:synonymous_variant:LOW:exon3/3:c.276A>G:p.Gly92=:,C1QA:NM_001347466.1:synonymous_variant:LOW:exon3/3:c.276A>G:p.Gly92=:,C1QA:NM_015991.4:synonymous_variant:LOW:exon3/3:c.276A>G:p.Gly92=:		120550 [GENE=C1QA PHENOS=C1q deficiency,613652,Autosomal recessive];				rs172378	0.6164	0.5055	4346,.	0.7372,0.6240,0.5917,0.3861,0.5848	-0.2950			0.03,0.22	1.55					-0.0987	0.8733	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1QA (inh=AR oe_syn=0.91 oe_mis=0.70 oe_lof=0.55), C1QC (inh=AR oe_syn=1.15 oe_mis=0.90 oe_lof=0.42)
chr1	22966227	22966227	T	G	het	het	het	off-target	QUAL=7781;DP=141,257,222;AF=0.52,0.47,0.54;MQM=60;SAP=188;ABP=4	C1QC,C1QA	upstream_gene,downstream_gene	C1QC:ENST00000374637.1:upstream_gene_variant:MODIFIER::::,C1QC:ENST00000374639.3:upstream_gene_variant:MODIFIER::::,C1QC:ENST00000374640.4:upstream_gene_variant:MODIFIER::::,C1QA:ENST00000374642.3:downstream_gene_variant:MODIFIER::::,C1QA:ENST00000402322.1:downstream_gene_variant:MODIFIER::::						AluSq2 (SINE/Alu)	rs10917274	0.4309	0.3525	2045,.		-2.9170			0.00,0.03	0.46								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1QA (inh=AR oe_syn=0.91 oe_mis=0.70 oe_lof=0.55), C1QC (inh=AR oe_syn=1.15 oe_mis=0.90 oe_lof=0.42)
chr1	22974297	22974297	C	A	wt	wt	het		QUAL=578;DP=123,94,66;AF=0.01,0.00,0.50;MQM=60;SAP=77;ABP=3	C1QC	3'UTR	C1QC:ENST00000374637.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*21C>A::,C1QC:ENST00000374639.3:3_prime_UTR_variant:MODIFIER:exon3/3:c.*21C>A::,C1QC:ENST00000374640.4:3_prime_UTR_variant:MODIFIER:exon3/3:c.*21C>A::	C1QC:NM_001114101.3:3_prime_UTR_variant:MODIFIER:exon3/3:c.*21C>A::,C1QC:NM_001347619.2:3_prime_UTR_variant:MODIFIER:exon3/3:c.*21C>A::,C1QC:NM_001347620.2:3_prime_UTR_variant:MODIFIER:exon2/2:c.*21C>A::,C1QC:NM_172369.5:3_prime_UTR_variant:MODIFIER:exon3/3:c.*21C>A::		120575 [GENE=C1QC PHENOS=C1q deficiency,613652,Autosomal recessive];				rs9434		0.5051	4565,.	0.8162,0.5080,0.5875,0.3688,0.4165	0.4040			0.26,0.93	8.73					0.0122	0.8795	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1QC (inh=AR oe_syn=1.15 oe_mis=0.90 oe_lof=0.42)
chr1	22974380	22974396	CCACCAGATGGACTTCT	-	wt	wt	het		QUAL=68;DP=25,16,18;AF=0.00,0.00,0.50;MQM=60;SAP=23;ABP=3	C1QC	3'UTR	C1QC:ENST00000374637.1:3_prime_UTR_variant:MODIFIER:exon3/3:::,C1QC:ENST00000374639.3:3_prime_UTR_variant:MODIFIER:exon3/3:c.*106_*122del::,C1QC:ENST00000374640.4:3_prime_UTR_variant:MODIFIER:exon3/3:c.*106_*122del::	C1QC:NM_001114101.3:3_prime_UTR_variant:MODIFIER:exon3/3:c.*106_*122del::,C1QC:NM_001347619.2:3_prime_UTR_variant:MODIFIER:exon3/3:c.*106_*122del::,C1QC:NM_001347620.2:3_prime_UTR_variant:MODIFIER:exon2/2:c.*106_*122del::,C1QC:NM_172369.5:3_prime_UTR_variant:MODIFIER:exon3/3:c.*106_*122del::		120575 [GENE=C1QC PHENOS=C1q deficiency,613652,Autosomal recessive];			L2d2 (LINE/L2)	rs60255495		0.3421	1792,.		1.9050				9.88					-0.4955	0.9772	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1QC (inh=AR oe_syn=1.15 oe_mis=0.90 oe_lof=0.42)
chr1	22974534	22974534	T	-	het	het	wt	low_conf_region	QUAL=1465;DP=47,69,39;AF=0.43,0.49,0.21;MQM=60;SAP=98;ABP=16	C1QC	3'UTR	C1QC:ENST00000374639.3:3_prime_UTR_variant:MODIFIER:exon3/3:c.*273del::,C1QC:ENST00000374640.4:3_prime_UTR_variant:MODIFIER:exon3/3:c.*273del::	C1QC:NM_001114101.3:3_prime_UTR_variant:MODIFIER:exon3/3:c.*273del::,C1QC:NM_001347619.2:3_prime_UTR_variant:MODIFIER:exon3/3:c.*273del::,C1QC:NM_001347620.2:3_prime_UTR_variant:MODIFIER:exon2/2:c.*273del::,C1QC:NM_172369.5:3_prime_UTR_variant:MODIFIER:exon3/3:c.*273del::		120575 [GENE=C1QC PHENOS=C1q deficiency,613652,Autosomal recessive];			L2d2 (LINE/L2)	rs10601144		0.0880	81,.		0.1990				0.13					0.0173	0.8797	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1QC (inh=AR oe_syn=1.15 oe_mis=0.90 oe_lof=0.42), C1QB (inh=AR oe_syn=1.09 oe_mis=0.71 oe_lof=0.33)
chr1	22974534	22974535	TT	-	wt	wt	het	low_conf_region	QUAL=1465;DP=47,69,39;AF=0.13,0.10,0.26;MQM=60;SAP=45;ABP=169	C1QC	3'UTR	C1QC:ENST00000374639.3:3_prime_UTR_variant:MODIFIER:exon3/3:c.*272_*273del::,C1QC:ENST00000374640.4:3_prime_UTR_variant:MODIFIER:exon3/3:c.*272_*273del::	C1QC:NM_001114101.3:3_prime_UTR_variant:MODIFIER:exon3/3:c.*272_*273del::,C1QC:NM_001347619.2:3_prime_UTR_variant:MODIFIER:exon3/3:c.*272_*273del::,C1QC:NM_001347620.2:3_prime_UTR_variant:MODIFIER:exon2/2:c.*272_*273del::,C1QC:NM_172369.5:3_prime_UTR_variant:MODIFIER:exon3/3:c.*272_*273del::		120575 [GENE=C1QC PHENOS=C1q deficiency,613652,Autosomal recessive];			L2d2 (LINE/L2)	rs10601144		0.5155	3518,.		0.1990				0.68					0.034	0.88	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1QC (inh=AR oe_syn=1.15 oe_mis=0.90 oe_lof=0.42), C1QB (inh=AR oe_syn=1.09 oe_mis=0.71 oe_lof=0.33)
chr1	22974566	22974566	T	G	het	wt	wt		QUAL=58;DP=46,61,46;AF=0.35,0.07,0.04;MQM=58;SAP=51;ABP=12	C1QC	3'UTR	C1QC:ENST00000374639.3:3_prime_UTR_variant:MODIFIER:exon3/3:c.*290T>G::,C1QC:ENST00000374640.4:3_prime_UTR_variant:MODIFIER:exon3/3:c.*290T>G::	C1QC:NM_001114101.3:3_prime_UTR_variant:MODIFIER:exon3/3:c.*290T>G::,C1QC:NM_001347619.2:3_prime_UTR_variant:MODIFIER:exon3/3:c.*290T>G::,C1QC:NM_001347620.2:3_prime_UTR_variant:MODIFIER:exon2/2:c.*290T>G::,C1QC:NM_172369.5:3_prime_UTR_variant:MODIFIER:exon3/3:c.*290T>G::		120575 [GENE=C1QC PHENOS=C1q deficiency,613652,Autosomal recessive];				rs1003478565		0.0017	0,.		-0.6170			0.02,0.14	5.80					-0.0633	0.8779	0	0	18	0 / 0					C1QC (inh=AR oe_syn=1.15 oe_mis=0.90 oe_lof=0.42), C1QB (inh=AR oe_syn=1.09 oe_mis=0.71 oe_lof=0.33)
chr1	22979655	22979655	T	G	het	het	het	off-target	QUAL=528;DP=26,16,22;AF=0.62,0.31,0.41;MQM=60;SAP=68;ABP=4	C1QB	5'UTR	C1QB:ENST00000509305.1:5_prime_UTR_variant:MODIFIER:exon1/3:c.-165T>G::			120570 [GENE=C1QB PHENOS=C1q deficiency,613652,Autosomal recessive];				rs291990		0.5803	5685,.		-0.0560			0.01,0.17	5.29					-0.0428	0.0785		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1QB (inh=AR oe_syn=1.09 oe_mis=0.71 oe_lof=0.33)
chr1	22987958	22987958	A	G	hom	hom	hom		QUAL=37896;DP=405,456,346;AF=1.00,1.00,1.00;MQM=60;SAP=3;ABP=0	C1QB	3'UTR	C1QB:ENST00000314933.6:3_prime_UTR_variant:MODIFIER:exon3/3:c.*79A>G::,C1QB:ENST00000509305.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*79A>G::	C1QB:NM_000491.5:3_prime_UTR_variant:MODIFIER:exon3/3:c.*79A>G::,C1QB:NM_001371184.1:3_prime_UTR_variant:MODIFIER:exon4/4:c.*79A>G::		120570 [GENE=C1QB PHENOS=C1q deficiency,613652,Autosomal recessive];				rs10580		0.9835	15171,.		-0.5240			0.00,0.09	5.28					0.0255	0.8686	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1QB (inh=AR oe_syn=1.09 oe_mis=0.71 oe_lof=0.33)
chr1	24122986	24122986	C	T	het	wt	het	off-target;low_conf_region	QUAL=943;DP=82,54,48;AF=0.56,0.02,0.44;MQM=60;SAP=142;ABP=3	GALE	intron	GALE:ENST00000374497.3:intron_variant:MODIFIER:intron10/11:c.873+13G>A::	GALE:NM_000403.4:intron_variant:MODIFIER:intron10/11:c.873+13G>A::,GALE:NM_001008216.2:intron_variant:MODIFIER:intron10/11:c.873+13G>A::,GALE:NM_001127621.2:intron_variant:MODIFIER:intron9/10:c.873+13G>A::		606953 [GENE=GALE PHENOS=Galactose epimerase deficiency,230350,Autosomal recessive];	92889 [benign DISEASE=UDPglucose-4-epimerase deficiency,not specified];		G-rich (Low_complexity)	rs760941		0.6596	3705,.	0.5444,0.7020,0.6319,0.6194,0.7364	-0.8630			0.05,0.15	5.49				COSV65720422	0.0509	0.9	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYPLA2 (inh=n/a oe_syn=1.05 oe_mis=0.60 oe_lof=0.07), GALE (inh=AR oe_syn=1.00 oe_mis=1.06 oe_lof=0.91)
chr1	24128467	24128467	C	T	hom	hom	het		QUAL=29953;DP=359,431,347;AF=1.00,1.00,0.50;MQM=60;SAP=40;ABP=3	HMGCL	3'UTR	HMGCL:ENST00000374483.4:3_prime_UTR_variant:MODIFIER:exon10/10:c.*486G>A::,HMGCL:ENST00000374490.3:3_prime_UTR_variant:MODIFIER:exon9/9:c.*486G>A::,HMGCL:ENST00000436439.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*486G>A::	HMGCL:NM_000191.3:3_prime_UTR_variant:MODIFIER:exon9/9:c.*486G>A::,HMGCL:NM_001166059.1:3_prime_UTR_variant:MODIFIER:exon7/7:c.*486G>A::	regulatory_region_variant:promoter	613898 [GENE=HMGCL PHENOS=HMG-CoA lyase deficiency,246450,Autosomal recessive];	296841 [benign DISEASE=UDPglucose-4-epimerase deficiency,Deficiency of hydroxymethylglutaryl-CoA lyase];			rs11714	0.8834	0.9202	13296,.		-0.8980			0.00,0.11	7.88					-0.0207	0.9578	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GALE (inh=AR oe_syn=1.00 oe_mis=1.06 oe_lof=0.91), HMGCL (inh=AR oe_syn=1.02 oe_mis=0.90 oe_lof=0.67)
chr1	24134721	24134721	T	C	hom	hom	het		QUAL=21710;DP=289,287,224;AF=1.00,1.00,0.53;MQM=60;SAP=17;ABP=4	HMGCL	synonymous	HMGCL:ENST00000374483.4:synonymous_variant:LOW:exon8/10:c.579A>G:p.Leu193=:PF00682 [HMGL-like],HMGCL:ENST00000374490.3:synonymous_variant:LOW:exon7/9:c.654A>G:p.Leu218=:PF00682 [HMGL-like],HMGCL:ENST00000436439.2:synonymous_variant:LOW:exon5/7:c.441A>G:p.Leu147=:PF00682 [HMGL-like]	HMGCL:NM_000191.3:synonymous_variant:LOW:exon7/9:c.654A>G:p.Leu218=:,HMGCL:NM_001166059.1:synonymous_variant:LOW:exon5/7:c.441A>G:p.Leu147=:	regulatory_region_variant:promoter_flanking_region	613898 [GENE=HMGCL PHENOS=HMG-CoA lyase deficiency,246450,Autosomal recessive];	92602 [benign DISEASE=Deficiency of hydroxymethylglutaryl-CoA lyase,not specified];			rs719400	0.8874	0.9305	13596,.	0.9678,0.8940,0.7880,0.9126,0.8738	0.8740			0.06,0.97	11.62					0.1876	0.3304	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HMGCL (inh=AR oe_syn=1.02 oe_mis=0.90 oe_lof=0.67)
chr1	24143932	24143932	A	G	hom	hom	het	off-target	QUAL=12964;DP=186,181,116;AF=0.99,1.00,0.50;MQM=60;SAP=388;ABP=3	HMGCL	intron	HMGCL:ENST00000374483.4:intron_variant:MODIFIER:intron4/9:c.177+34T>C::,HMGCL:ENST00000374490.3:intron_variant:MODIFIER:intron3/8:c.252+34T>C::,HMGCL:ENST00000436439.2:intron_variant:MODIFIER:intron3/6:c.252+34T>C::	HMGCL:NM_000191.3:intron_variant:MODIFIER:intron3/8:c.252+34T>C::,HMGCL:NM_001166059.1:intron_variant:MODIFIER:intron3/6:c.252+34T>C::		613898 [GENE=HMGCL PHENOS=HMG-CoA lyase deficiency,246450,Autosomal recessive];	255488 [benign DISEASE=not specified];			rs2076344	0.8878	0.9306	13619,.	0.9678,0.8946,0.7893,0.9132,0.8739	-1.2250			0.00,0.11	0.97					-0.1997	0.1349	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HMGCL (inh=AR oe_syn=1.02 oe_mis=0.90 oe_lof=0.67)
chr1	24151996	24151996	C	A	het	hom	het	off-target	QUAL=1438;DP=24,34,34;AF=0.29,1.00,0.47;MQM=60;SAP=102;ABP=8	HMGCL	intron	HMGCL:ENST00000374483.4:intron_variant:MODIFIER:intron2/9:c.-16+578G>T::		regulatory_region_variant:promoter	613898 [GENE=HMGCL PHENOS=HMG-CoA lyase deficiency,246450,Autosomal recessive];				rs6697805	0.3928	0.4051	2502,.		-2.8420			0.04,0.16	0.57								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HMGCL (inh=AR oe_syn=1.02 oe_mis=0.90 oe_lof=0.67)
chr1	24171543	24171543	C	G	het	hom	het	off-target	QUAL=2969;DP=103,45,47;AF=0.50,0.98,0.60;MQM=60;SAP=272;ABP=4	FUCA1	downstream_gene	FUCA1:ENST00000374479.3:downstream_gene_variant:MODIFIER::::							rs4649119	0.3425	0.3710	2272,.		-0.2630			0.08,0.16	1.46								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FUCA1 (inh=AR oe_syn=0.97 oe_mis=0.85 oe_lof=0.62)
chr1	24180807	24180807	A	-	het	het	het	off-target	QUAL=648;DP=108,48,33;AF=0.14,0.15,0.61;MQM=59;SAP=70;ABP=130	FUCA1	intron	FUCA1:ENST00000374479.3:intron_variant:MODIFIER:intron5/7:c.969+43del::	FUCA1:NM_000147.4:intron_variant:MODIFIER:intron5/7:c.969+43del::		612280 [GENE=FUCA1 PHENOS=Fucosidosis,230000,Autosomal recessive];			(A)n (Simple_repeat)	rs55699941		0.3054	101,.	0.2476,0.3209,0.3769,0.3017,0.3165	2.8690				1.06					-0.039	0.1504	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FUCA1 (inh=AR oe_syn=0.97 oe_mis=0.85 oe_lof=0.62)
chr1	24180962	24180962	T	C	het	hom	wt		QUAL=9715;DP=254,202,208;AF=0.50,1.00,0.00;MQM=60;SAP=12;ABP=3	FUCA1	missense	FUCA1:ENST00000374479.3:missense_variant:MODERATE:exon5/8:c.857A>G:p.Gln286Arg:PF01120 [Alpha-L-fucosidase]	FUCA1:NM_000147.4:missense_variant:MODERATE:exon5/8:c.857A>G:p.Gln286Arg:		612280 [GENE=FUCA1 PHENOS=Fucosidosis,230000,Autosomal recessive];	691 [benign DISEASE=FU1/FU2 POLYMORPHISM,Fucosidosis,not provided];			rs13551	0.2113	0.2807	1388,.	0.1406,0.2037,0.2647,0.3358,0.1516	0.6520	D(0.02)	B(0.00)	0.09,0.29	15.62	0.06				0.1293	0.1537	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FUCA1 (inh=AR oe_syn=0.97 oe_mis=0.85 oe_lof=0.62)
chr1	24194748	24194748	G	C	wt	wt	het		QUAL=1393;DP=154,122,112;AF=0.00,0.01,0.54;MQM=60;SAP=48;ABP=5	FUCA1	missense	FUCA1:ENST00000374479.3:missense_variant:MODERATE:exon1/8:c.29C>G:p.Pro10Arg:	FUCA1:NM_000147.4:missense_variant:MODERATE:exon1/8:c.29C>G:p.Pro10Arg:	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site	612280 [GENE=FUCA1 PHENOS=Fucosidosis,230000,Autosomal recessive];	193053 [benign DISEASE=Fucosidosis,not specified,not provided];			rs2070956	0.1430	0.1078	190,.	0.1111,0.1145,0.1998,0.0910,0.1267	-0.0120	T(0.16)	B(0.02)	0.06,0.08	9.31	0.09				-0.1281	0.1905	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FUCA1 (inh=AR oe_syn=0.97 oe_mis=0.85 oe_lof=0.62), CNR2 (inh=n/a oe_syn=1.04 oe_mis=0.86 oe_lof=0.97)
chr1	24194770	24194770	C	G	het	wt	het		QUAL=2452;DP=141,112,107;AF=0.46,0.00,0.45;MQM=60;SAP=155;ABP=7	FUCA1	missense	FUCA1:ENST00000374479.3:missense_variant:MODERATE:exon1/8:c.7G>C:p.Ala3Pro:	FUCA1:NM_000147.4:missense_variant:MODERATE:exon1/8:c.7G>C:p.Ala3Pro:	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	612280 [GENE=FUCA1 PHENOS=Fucosidosis,230000,Autosomal recessive];	296895 [benign/likely benign DISEASE=Fucosidosis,not provided];			rs61996282	0.0134	0.0153	3,.	0.0025,0.0506,0.0000,0.0080,0.0166	-2.4990	D(0.02)	B(0.00)	0.04,0.08	14.44	0.07				0.0945	0.1978	0	3	217	0 / 0					FUCA1 (inh=AR oe_syn=0.97 oe_mis=0.85 oe_lof=0.62), CNR2 (inh=n/a oe_syn=1.04 oe_mis=0.86 oe_lof=0.97)
chr1	24194773	24194773	G	A	wt	wt	het		QUAL=1196;DP=119,113,103;AF=0.00,0.01,0.52;MQM=60;SAP=63;ABP=4	FUCA1	missense	FUCA1:ENST00000374479.3:missense_variant:MODERATE:exon1/8:c.4C>T:p.Arg2Trp:	FUCA1:NM_000147.4:missense_variant:MODERATE:exon1/8:c.4C>T:p.Arg2Trp:	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	612280 [GENE=FUCA1 PHENOS=Fucosidosis,230000,Autosomal recessive];	193052 [benign DISEASE=Fucosidosis,not specified,not provided];			rs2070955	0.1430	0.1119	190,.	0.1141,0.1164,0.2051,0.0948,0.1271	-1.0160	D(0.00)	B(0.00)	0.02,0.08	17.87	0.08				-0.0349	0.1936	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FUCA1 (inh=AR oe_syn=0.97 oe_mis=0.85 oe_lof=0.62), CNR2 (inh=n/a oe_syn=1.04 oe_mis=0.86 oe_lof=0.97)
chr1	24194788	24194788	A	G	wt	wt	het		QUAL=1137;DP=74,100,96;AF=0.00,0.01,0.52;MQM=60;SAP=55;ABP=3	CNR2,FUCA1	downstream_gene,upstream_gene	CNR2:ENST00000374472.4:downstream_gene_variant:MODIFIER::::,FUCA1:ENST00000374479.3:upstream_gene_variant:MODIFIER::::,CNR2:ENST00000536471.1:downstream_gene_variant:MODIFIER::::	FUCA1:NM_000147.4:5_prime_UTR_variant:MODIFIER:exon1/8:c.-12T>C::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	612280 [GENE=FUCA1 PHENOS=Fucosidosis,230000,Autosomal recessive];	193051 [benign DISEASE=Fucosidosis,not specified,not provided];			rs2070954	0.1428	0.1140	187,.	0.1164,0.1167,0.2068,0.0965,0.1275	0.1910			0.00,0.04	11.86								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FUCA1 (inh=AR oe_syn=0.97 oe_mis=0.85 oe_lof=0.62), CNR2 (inh=n/a oe_syn=1.04 oe_mis=0.86 oe_lof=0.97)
chr1	24194862	24194862	A	C	wt	wt	het		QUAL=417;DP=25,33,49;AF=0.00,0.03,0.43;MQM=60;SAP=51;ABP=5	CNR2,FUCA1	downstream_gene,upstream_gene	CNR2:ENST00000374472.4:downstream_gene_variant:MODIFIER::::,FUCA1:ENST00000374479.3:upstream_gene_variant:MODIFIER::::,CNR2:ENST00000536471.1:downstream_gene_variant:MODIFIER::::		regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant		368872 [benign/likely benign DISEASE=Fucosidosis,not provided];			rs2070953	0.1428	0.1005	196,.		-0.0750			0.09,0.08	11.58								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FUCA1 (inh=AR oe_syn=0.97 oe_mis=0.85 oe_lof=0.62), CNR2 (inh=n/a oe_syn=1.04 oe_mis=0.86 oe_lof=0.97)
chr1	24194898	24194898	C	A	wt	wt	het	off-target	QUAL=322;DP=19,20,36;AF=0.00,0.00,0.47;MQM=60;SAP=40;ABP=3	CNR2,FUCA1	downstream_gene,upstream_gene	CNR2:ENST00000374472.4:downstream_gene_variant:MODIFIER::::,FUCA1:ENST00000374479.3:upstream_gene_variant:MODIFIER::::,CNR2:ENST00000536471.1:downstream_gene_variant:MODIFIER::::		regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant		683915 [benign DISEASE=not provided];			rs2070952	0.1428	0.1001	193,.		-0.8080			0.04,0.07	9.57								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FUCA1 (inh=AR oe_syn=0.97 oe_mis=0.85 oe_lof=0.62), CNR2 (inh=n/a oe_syn=1.04 oe_mis=0.86 oe_lof=0.97)
chr1	26131654	26131654	G	A	hom	het	hom		QUAL=15724;DP=155,332,220;AF=1.00,0.52,1.00;MQM=60;SAP=272;ABP=4	SELENON	missense	SELENON:ENST00000354177.4:missense_variant:MODERATE:exon3/13:c.323G>A:p.Cys108Tyr:,SELENON:ENST00000361547.2:missense_variant:MODERATE:exon4/13:c.425G>A:p.Cys142Tyr:,SELENON:ENST00000374315.1:missense_variant:MODERATE:exon3/12:c.323G>A:p.Cys108Tyr:	SELENON:NM_020451.3:missense_variant:MODERATE:exon4/13:c.425G>A:p.Cys142Tyr:,SELENON:NM_206926.2:missense_variant:MODERATE:exon3/12:c.323G>A:p.Cys108Tyr:		606210 [GENE=SELENON PHENOS=Muscular dystrophy,rigid spine,1,602771,Autosomal recessive/Myopathy,congenital,with fiber-type disproportion,255310,Autosomal recessive,Autosomal dominant];	95963 [benign DISEASE=Eichsfeld type congenital muscular dystrophy,not specified,SEPN1-Related Disorders,not provided];			rs7349185	0.8419	0.8183	9610,.	0.7779,0.9062,0.9425,0.7826,0.8772	0.9630	T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00)	0.01,0.11	7.99	0.04				0.0122	0.2732	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69)
chr1	26138136	26138136	C	A	hom	het	hom	off-target	QUAL=18620;DP=147,381,278;AF=1.00,0.52,1.00;MQM=60;SAP=41;ABP=5	SELENON	intron	SELENON:ENST00000354177.4:intron_variant:MODIFIER:intron7/12:c.991-46C>A::,SELENON:ENST00000361547.2:intron_variant:MODIFIER:intron8/12:c.1093-46C>A::,SELENON:ENST00000374315.1:intron_variant:MODIFIER:intron7/11:c.991-46C>A::	SELENON:NM_020451.3:intron_variant:MODIFIER:intron8/12:c.1093-46C>A::,SELENON:NM_206926.2:intron_variant:MODIFIER:intron7/11:c.991-46C>A::	regulatory_region_variant:promoter_flanking_region	606210 [GENE=SELENON PHENOS=Muscular dystrophy,rigid spine,1,602771,Autosomal recessive/Myopathy,congenital,with fiber-type disproportion,255310,Autosomal recessive,Autosomal dominant];	261271 [benign DISEASE=not specified,not provided];			rs760598	0.7470	0.7903	7814,.	0.4605,0.8803,0.9652,0.7681,0.8741	0.9050			0.25,0.26	9.32					-0.1709	0.2515	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69)
chr1	26138262	26138262	T	C	hom	het	hom		QUAL=24587;DP=211,488,351;AF=1.00,0.51,1.00;MQM=60;SAP=3;ABP=4	SELENON	synonymous	SELENON:ENST00000354177.4:synonymous_variant:LOW:exon8/13:c.1071T>C:p.Pro357=:,SELENON:ENST00000361547.2:synonymous_variant:LOW:exon9/13:c.1173T>C:p.Pro391=:,SELENON:ENST00000374315.1:synonymous_variant:LOW:exon8/12:c.1071T>C:p.Pro357=:	SELENON:NM_020451.3:synonymous_variant:LOW:exon9/13:c.1173T>C:p.Pro391=:,SELENON:NM_206926.2:synonymous_variant:LOW:exon8/12:c.1071T>C:p.Pro357=:		606210 [GENE=SELENON PHENOS=Muscular dystrophy,rigid spine,1,602771,Autosomal recessive/Myopathy,congenital,with fiber-type disproportion,255310,Autosomal recessive,Autosomal dominant];	95956 [benign DISEASE=Eichsfeld type congenital muscular dystrophy,not specified,SEPN1-Related Disorders,not provided];			rs760597		0.8099	8722,.	0.6070,0.8907,0.9651,0.7838,0.8768	0.2830			0.29,0.86	12.20					-0.1334	0.1659	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69)
chr1	26139137	26139137	C	T	hom	het	hom	off-target	QUAL=2973;DP=18,70,54;AF=1.00,0.54,1.00;MQM=60;SAP=79;ABP=4	SELENON	intron	SELENON:ENST00000354177.4:intron_variant:MODIFIER:intron8/12:c.1180-41C>T::,SELENON:ENST00000361547.2:intron_variant:MODIFIER:intron9/12:c.1282-41C>T::,SELENON:ENST00000374315.1:intron_variant:MODIFIER:intron8/11:c.1180-41C>T::	SELENON:NM_020451.3:intron_variant:MODIFIER:intron9/12:c.1282-41C>T::,SELENON:NM_206926.2:intron_variant:MODIFIER:intron8/11:c.1180-41C>T::		606210 [GENE=SELENON PHENOS=Muscular dystrophy,rigid spine,1,602771,Autosomal recessive/Myopathy,congenital,with fiber-type disproportion,255310,Autosomal recessive,Autosomal dominant];	261274 [benign DISEASE=not specified,not provided];			rs10902685	0.6977	0.7930	7303,.	0.2898,0.8793,0.9662,0.7870,0.8780	-0.4720			0.02,0.16	5.06					-0.2933	0.9593	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69)
chr1	26140573	26140573	C	A	hom	het	hom		QUAL=21794;DP=211,438,321;AF=1.00,0.50,1.00;MQM=60;SAP=120;ABP=3	SELENON,RP1-317E23.6	missense,missense&NMD_transcript	SELENON:ENST00000354177.4:missense_variant:MODERATE:exon12/13:c.1404C>A:p.Asn468Lys:,SELENON:ENST00000361547.2:missense_variant:MODERATE:exon12/13:c.1506C>A:p.Asn502Lys:,SELENON:ENST00000374315.1:missense_variant:MODERATE:exon11/12:c.1404C>A:p.Asn468Lys:,RP1-317E23.6:ENST00000527604.1:missense_variant&NMD_transcript_variant:MODERATE:exon2/4:c.27C>A:p.Asn9Lys:	SELENON:NM_020451.3:missense_variant:MODERATE:exon12/13:c.1506C>A:p.Asn502Lys:,SELENON:NM_206926.2:missense_variant:MODERATE:exon11/12:c.1404C>A:p.Asn468Lys:		606210 [GENE=SELENON PHENOS=Muscular dystrophy,rigid spine,1,602771,Autosomal recessive/Myopathy,congenital,with fiber-type disproportion,255310,Autosomal recessive,Autosomal dominant];	95959 [benign DISEASE=Eichsfeld type congenital muscular dystrophy,not specified,SEPN1-Related Disorders,not provided];			rs2294228	0.6975	0.7864	7403,.	0.2906,0.8791,0.9655,0.7822,0.8768	0.1590	T(0.10),T(0.12),T(0.14),T(0.17)	B(0.01),B(0.00),B(0.00),B(0.00)	0.37,0.52	14.91	0.09				-0.1415	0.3451	0.33	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69)
chr1	26143704	26143704	-	TTTTG	hom	het	hom		QUAL=11769;DP=147,232,190;AF=0.97,0.44,1.00;MQM=59;SAP=215;ABP=11	SELENON,RP1-317E23.3,RP1-317E23.6	3'UTR,intron&non_coding_transcript,intron&NMD_transcript	SELENON:ENST00000354177.4:3_prime_UTR_variant:MODIFIER:exon13/13:c.*1511_*1515dup::,SELENON:ENST00000361547.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*1511_*1515dup::,SELENON:ENST00000374315.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1511_*1515dup::,RP1-317E23.3:ENST00000442055.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/3:n.304-338_304-334dup::,RP1-317E23.6:ENST00000527604.1:intron_variant&NMD_transcript_variant:MODIFIER:intron2/3:c.123+3051_123+3055dup::	SELENON:NM_020451.3:3_prime_UTR_variant:MODIFIER:exon13/13:c.*1511_*1515dup::,SELENON:NM_206926.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1511_*1515dup::		606210 [GENE=SELENON PHENOS=Muscular dystrophy,rigid spine,1,602771,Autosomal recessive/Myopathy,congenital,with fiber-type disproportion,255310,Autosomal recessive,Autosomal dominant];			AluSx (SINE/Alu)	rs3033477		0.7102	8052,.						1.75					-0.0157	0.8975	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69), MTFR1L (inh=n/a oe_syn=1.16 oe_mis=0.77 oe_lof=0.24)
chr1	26143821	26143821	T	C	hom	het	hom		QUAL=16532;DP=245,268,179;AF=1.00,0.46,0.98;MQM=55;SAP=20;ABP=7	SELENON,RP1-317E23.3,RP1-317E23.6	3'UTR,intron&non_coding_transcript,intron&NMD_transcript	SELENON:ENST00000354177.4:3_prime_UTR_variant:MODIFIER:exon13/13:c.*1612T>C::,SELENON:ENST00000361547.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*1612T>C::,SELENON:ENST00000374315.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1612T>C::,RP1-317E23.3:ENST00000442055.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/3:n.303+232A>G::,RP1-317E23.6:ENST00000527604.1:intron_variant&NMD_transcript_variant:MODIFIER:intron2/3:c.123+3152T>C::	SELENON:NM_020451.3:3_prime_UTR_variant:MODIFIER:exon13/13:c.*1612T>C::,SELENON:NM_206926.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1612T>C::		606210 [GENE=SELENON PHENOS=Muscular dystrophy,rigid spine,1,602771,Autosomal recessive/Myopathy,congenital,with fiber-type disproportion,255310,Autosomal recessive,Autosomal dominant];	297050 [benign DISEASE=SEPN1-Related Disorders];		AluSx (SINE/Alu)	rs3203750	0.7630	0.7113	8215,.		-0.0630			0.00,0.13	5.15					-0.0043	0.8978	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69), MTFR1L (inh=n/a oe_syn=1.16 oe_mis=0.77 oe_lof=0.24)
chr1	26143931	26143931	T	C	hom	het	hom		QUAL=22116;DP=337,349,228;AF=1.00,0.45,1.00;MQM=54;SAP=102;ABP=11	SELENON,RP1-317E23.3,RP1-317E23.6	3'UTR,intron&non_coding_transcript,intron&NMD_transcript	SELENON:ENST00000354177.4:3_prime_UTR_variant:MODIFIER:exon13/13:c.*1722T>C::,SELENON:ENST00000361547.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*1722T>C::,SELENON:ENST00000374315.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1722T>C::,RP1-317E23.3:ENST00000442055.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/3:n.303+122A>G::,RP1-317E23.6:ENST00000527604.1:intron_variant&NMD_transcript_variant:MODIFIER:intron2/3:c.123+3262T>C::	SELENON:NM_020451.3:3_prime_UTR_variant:MODIFIER:exon13/13:c.*1722T>C::,SELENON:NM_206926.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1722T>C::		606210 [GENE=SELENON PHENOS=Muscular dystrophy,rigid spine,1,602771,Autosomal recessive/Myopathy,congenital,with fiber-type disproportion,255310,Autosomal recessive,Autosomal dominant];	297053 [benign DISEASE=SEPN1-Related Disorders];		AluSx (SINE/Alu)	rs4659383	0.8622	0.8010	10109,.		-1.2050			0.00,0.05	0.99					0.0044	0.8979	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69), MTFR1L (inh=n/a oe_syn=1.16 oe_mis=0.77 oe_lof=0.24)
chr1	26144438	26144438	C	-	hom	het	hom		QUAL=4306;DP=68,105,77;AF=0.99,0.61,1.00;MQM=60;SAP=251;ABP=14	SELENON,RP1-317E23.3,RP1-317E23.6	3'UTR,intron&non_coding_transcript,intron&NMD_transcript	SELENON:ENST00000354177.4:3_prime_UTR_variant:MODIFIER:exon13/13:c.*2236del::,SELENON:ENST00000361547.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*2236del::,SELENON:ENST00000374315.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2236del::,RP1-317E23.3:ENST00000442055.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.152-234del::,RP1-317E23.6:ENST00000527604.1:intron_variant&NMD_transcript_variant:MODIFIER:intron2/3:c.123+3776del::	SELENON:NM_020451.3:3_prime_UTR_variant:MODIFIER:exon13/13:c.*2236del::,SELENON:NM_206926.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2236del::	regulatory_region_variant:CTCF_binding_site	606210 [GENE=SELENON PHENOS=Muscular dystrophy,rigid spine,1,602771,Autosomal recessive/Myopathy,congenital,with fiber-type disproportion,255310,Autosomal recessive,Autosomal dominant];	297061 [uncertain significance DISEASE=SEPN1-Related Disorders];			rs371383269		0.7146	8260,.		-0.8160				1.70					0.0025	0.8979	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69), MTFR1L (inh=n/a oe_syn=1.16 oe_mis=0.77 oe_lof=0.24)
chr1	26508293	26508293	G	A	het	wt	het	off-target	QUAL=4915;DP=207,281,206;AF=0.48,0.00,0.51;MQM=60;SAP=287;ABP=3	CNKSR1	intron	CNKSR1:ENST00000361530.6:intron_variant:MODIFIER:intron3/20:c.393-55G>A::,CNKSR1:ENST00000374253.5:intron_variant:MODIFIER:intron3/20:c.393-55G>A::,CNKSR1:ENST00000531191.1:intron_variant:MODIFIER:intron2/19:c.-382-55G>A::	CNKSR1:NM_001297647.2:intron_variant:MODIFIER:intron3/20:c.393-55G>A::,CNKSR1:NM_001297648.2:intron_variant:MODIFIER:intron3/20:c.-377-55G>A::,CNKSR1:NM_006314.3:intron_variant:MODIFIER:intron3/20:c.393-55G>A::	regulatory_region_variant:open_chromatin_region				MIRb (SINE/MIR)	rs3819033	0.2859	0.1069	443,.		0.6040			0.15,0.25	7.02					0.0611	0.4407	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNKSR1 (inh=n/a oe_syn=1.00 oe_mis=0.92 oe_lof=1.00)
chr1	26508480	26508480	T	C	het	wt	het	off-target	QUAL=5552;DP=211,317,243;AF=0.46,0.00,0.52;MQM=60;SAP=247;ABP=3	CNKSR1	intron	CNKSR1:ENST00000361530.6:intron_variant:MODIFIER:intron4/20:c.477+48T>C::,CNKSR1:ENST00000374253.5:intron_variant:MODIFIER:intron4/20:c.477+48T>C::,CNKSR1:ENST00000531191.1:intron_variant:MODIFIER:intron3/19:c.-298+48T>C::	CNKSR1:NM_001297647.2:intron_variant:MODIFIER:intron4/20:c.477+48T>C::,CNKSR1:NM_001297648.2:intron_variant:MODIFIER:intron4/20:c.-293+48T>C::,CNKSR1:NM_006314.3:intron_variant:MODIFIER:intron4/20:c.477+48T>C::	regulatory_region_variant:open_chromatin_region					rs2275945	0.3365	0.2282	602,.	0.1604,0.4817,0.6399,0.0981,0.3757	0.2070			0.01,0.18	7.42					-0.0569	0.4411	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNKSR1 (inh=n/a oe_syn=1.00 oe_mis=0.92 oe_lof=1.00)
chr1	26511700	26511700	A	G	hom	hom	hom	off-target	QUAL=20226;DP=159,265,212;AF=1.00,1.00,1.00;MQM=60;SAP=10;ABP=0	CNKSR1	intron	CNKSR1:ENST00000361530.6:intron_variant:MODIFIER:intron14/20:c.1308+23A>G::,CNKSR1:ENST00000374253.5:intron_variant:MODIFIER:intron14/20:c.1329+23A>G::,CNKSR1:ENST00000531191.1:intron_variant:MODIFIER:intron13/19:c.534+23A>G::	CNKSR1:NM_001297647.2:intron_variant:MODIFIER:intron14/20:c.1329+23A>G::,CNKSR1:NM_001297648.2:intron_variant:MODIFIER:intron14/20:c.534+23A>G::,CNKSR1:NM_006314.3:intron_variant:MODIFIER:intron14/20:c.1308+23A>G::						rs2783680		0.6818	5621,.	0.4561,0.8001,0.9695,0.5905,0.7834	-0.9530			0.05,0.15	0.33					0.8355	0.0709	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNKSR1 (inh=n/a oe_syn=1.00 oe_mis=0.92 oe_lof=1.00)
chr1	27106975	27106975	C	T	wt	het	wt		QUAL=3132;DP=156,236,189;AF=0.00,0.52,0.00;MQM=60;SAP=11;ABP=4	ARID1A	synonymous	ARID1A:ENST00000324856.7:synonymous_variant:LOW:exon20/20:c.6586C>T:p.Leu2196=:PF12031 [SWI/SNF-like complex subunit BAF250/Osa],ARID1A:ENST00000374152.2:synonymous_variant:LOW:exon19/19:c.5437C>T:p.Leu1813=:PF12031 [SWI/SNF-like complex subunit BAF250/Osa],ARID1A:ENST00000457599.2:synonymous_variant:LOW:exon20/20:c.5935C>T:p.Leu1979=:PF12031 [SWI/SNF-like complex subunit BAF250/Osa],ARID1A:ENST00000540690.1:synonymous_variant:LOW:exon6/6:c.1570C>T:p.Leu524=:PF12031 [SWI/SNF-like complex subunit BAF250/Osa]	ARID1A:NM_006015.6:synonymous_variant:LOW:exon20/20:c.6586C>T:p.Leu2196=:,ARID1A:NM_139135.4:synonymous_variant:LOW:exon20/20:c.5935C>T:p.Leu1979=:		603024 [GENE=ARID1A PHENOS=Coffin-Siris syndrome 2,614607,Autosomal dominant];	210262 [benign DISEASE=not specified,not provided];			rs149633292	0.0016	0.0075	3,.	0.0005,0.0008,0.0000,0.0050,0.0007	0.8780			0.77,0.93	10.27				COSV61385556	-0.0141	0.9203	0	1	167	0 / 0	2	"Prima Vista kein Anhalt für Splice-Defekt; 160727%0A[2] ahwalds1 28.07.2016"			ARID1A (inh=AD oe_syn=1.08 oe_mis=0.70 oe_lof=0.02)
chr1	27107651	27107651	A	-	het	het	het		QUAL=649;DP=83,24,16;AF=0.27,0.29,0.25;MQM=60;SAP=4;ABP=60	ARID1A	3'UTR	ARID1A:ENST00000324856.7:3_prime_UTR_variant:MODIFIER:exon20/20:c.*421del::	ARID1A:NM_006015.6:3_prime_UTR_variant:MODIFIER:exon20/20:c.*421del::,ARID1A:NM_139135.4:3_prime_UTR_variant:MODIFIER:exon20/20:c.*421del::		603024 [GENE=ARID1A PHENOS=Coffin-Siris syndrome 2,614607,Autosomal dominant];			(A)n (Simple_repeat)	rs71007893		0.0451	4,.		0.0190				0.42					0.0029	0.9204	0	0	0	0 / 0					ARID1A (inh=AD oe_syn=1.08 oe_mis=0.70 oe_lof=0.02)
chr1	27696011	27696011	C	T	hom	hom	hom	off-target	QUAL=25914;DP=308,311,256;AF=1.00,1.00,1.00;MQM=60;SAP=1903;ABP=0	FCN3	intron	FCN3:ENST00000270879.4:intron_variant:MODIFIER:intron7/7:c.659-43G>A::,FCN3:ENST00000354982.2:intron_variant:MODIFIER:intron6/6:c.626-43G>A::	FCN3:NM_003665.3:intron_variant:MODIFIER:intron7/7:c.659-43G>A::,FCN3:NM_173452.2:intron_variant:MODIFIER:intron6/6:c.626-43G>A::		604973 [GENE=FCN3 PHENOS=Immunodeficiency due to ficolin 3 deficiency,613860,Autosomal recessive];			MIRb (SINE/MIR)	rs10218730	0.9924	0.9981	15445,.	0.9740,0.9990,1.0000,0.9999,0.9999	-0.2710			0.00,0.13	7.46					-0.463	0.977	0.06	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MAP3K6 (inh=n/a oe_syn=0.86 oe_mis=0.87 oe_lof=0.58), FCN3 (inh=AR oe_syn=0.74 oe_mis=0.91 oe_lof=0.45)
chr1	33245802	33245802	C	G	het	het	het		QUAL=9438;DP=256,253,186;AF=0.53,0.46,0.61;MQM=60;SAP=65;ABP=7	YARS1	synonymous	YARS1:ENST00000373477.4:synonymous_variant:LOW:exon11/13:c.1218G>C:p.Leu406=:PF01588 [Putative tRNA binding domain]	YARS:NM_003680.3:synonymous_variant:LOW:exon11/13:c.1218G>C:p.Leu406=:		603623 [GENE=YARS1 PHENOS=Charcot-Marie-Tooth disease,dominant intermediate C,608323,Autosomal dominant];	297151 [benign DISEASE=Charcot-Marie-Tooth disease, dominant intermediate C,not specified];			rs699005	0.0875	0.1079	218,.	0.1027,0.2180,0.0003,0.0970,0.0607	3.1640			0.95,0.94	10.92					-0.0208	0.4613	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					YARS1 (inh=AD oe_syn=1.10 oe_mis=0.81 oe_lof=0.37)
chr1	33252100	33252122	CACATGCATGACTATTCCTAGCC	-	het	wt	het	off-target	QUAL=3603;DP=114,316,226;AF=0.48,0.00,0.50;MQM=60;SAP=148;ABP=3	YARS1	intron	YARS1:ENST00000373477.4:intron_variant:MODIFIER:intron7/12:c.821-74_821-52del::	YARS:NM_003680.3:intron_variant:MODIFIER:intron7/12:c.821-74_821-52del::		603623 [GENE=YARS1 PHENOS=Charcot-Marie-Tooth disease,dominant intermediate C,608323,Autosomal dominant];				rs149745059		0.1469	378,.	0.0236,0.0903,0.1858,0.1445,0.2117	1.7820				6.07					0.1437	0.9306	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					YARS1 (inh=AD oe_syn=1.10 oe_mis=0.81 oe_lof=0.37)
chr1	33256884	33256884	C	A	hom	het	hom	off-target	QUAL=16303;DP=242,263,164;AF=0.99,0.52,0.99;MQM=60;SAP=276;ABP=4	YARS1	intron	YARS1:ENST00000373477.4:intron_variant:MODIFIER:intron5/12:c.592-29G>T::	YARS:NM_003680.3:intron_variant:MODIFIER:intron5/12:c.592-29G>T::		603623 [GENE=YARS1 PHENOS=Charcot-Marie-Tooth disease,dominant intermediate C,608323,Autosomal dominant];	670888 [benign DISEASE=not provided];			rs1765223	0.2911	0.3278	1734,.	0.3001,0.3504,0.2128,0.3120,0.3043	1.2300			0.00,0.09	4.05					0.4392	0.6044	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					YARS1 (inh=AD oe_syn=1.10 oe_mis=0.81 oe_lof=0.37)
chr1	33276424	33276424	G	A	hom	hom	hom	off-target	QUAL=21280;DP=290,212,158;AF=1.00,1.00,1.00;MQM=60;SAP=67;ABP=0	YARS1	intron	YARS1:ENST00000373477.4:intron_variant:MODIFIER:intron2/12:c.205-57C>T::	YARS:NM_003680.3:intron_variant:MODIFIER:intron2/12:c.205-57C>T::		603623 [GENE=YARS1 PHENOS=Charcot-Marie-Tooth disease,dominant intermediate C,608323,Autosomal dominant];	670335 [benign DISEASE=not provided];			rs4951787		0.9867	15282,.		-0.3090			0.00,0.11	0.79					0.0339	0.908	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					YARS1 (inh=AD oe_syn=1.10 oe_mis=0.81 oe_lof=0.37)
chr1	33282775	33282775	C	A	het	het	het	off-target	QUAL=3019;DP=118,103,71;AF=0.46,0.44,0.51;MQM=60;SAP=48;ABP=7	YARS1	intron	YARS1:ENST00000373477.4:intron_variant:MODIFIER:intron1/12:c.57+14G>T::	YARS:NM_003680.3:intron_variant:MODIFIER:intron1/12:c.57+14G>T::	regulatory_region_variant:promoter,TF_binding_site_variant	603623 [GENE=YARS1 PHENOS=Charcot-Marie-Tooth disease,dominant intermediate C,608323,Autosomal dominant];	297163 [benign DISEASE=Charcot-Marie-Tooth disease, dominant intermediate C,not specified];			rs72654020	0.0857	0.1062	217,.	0.0965,0.2176,0.0003,0.0969,0.0607	-0.0880			0.03,0.82	8.43					0.0596	0.2867	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					YARS1 (inh=AD oe_syn=1.10 oe_mis=0.81 oe_lof=0.37), S100PBP (inh=n/a oe_syn=1.12 oe_mis=0.99 oe_lof=0.11)
chr1	33283528	33283528	G	A	het	n/a	n/a		QUAL=41;DP=7,1,0;AF=0.57,0.00,;MQM=60;SAP=12;ABP=3	S100PBP,YARS1	intron,5'UTR	S100PBP:ENST00000373475.5:intron_variant:MODIFIER:intron1/6:c.-120+238G>A::,S100PBP:ENST00000373476.1:intron_variant:MODIFIER:intron1/6:c.-120+328G>A::,YARS1:ENST00000373477.4:5_prime_UTR_variant:MODIFIER:exon1/13:c.-683C>T::,S100PBP:ENST00000398243.3:intron_variant:MODIFIER:intron1/6:c.-120+238G>A::	S100PBP:NM_001256121.1:intron_variant:MODIFIER:intron1/6:c.-120+328G>A::,YARS:NM_003680.3:5_prime_UTR_variant:MODIFIER:exon1/13:c.-683C>T::,S100PBP:NM_022753.4:intron_variant:MODIFIER:intron1/6:c.-120+238G>A::	regulatory_region_variant:promoter,TF_binding_site_variant	603623 [GENE=YARS1 PHENOS=Charcot-Marie-Tooth disease,dominant intermediate C,608323,Autosomal dominant];	297175 [benign DISEASE=Charcot-Marie-Tooth disease, dominant intermediate C,not provided];			rs72654022	0.0603	0.0842	170,.		1.4860			0.02,0.44	10.68					-0.0851	0.4857	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					YARS1 (inh=AD oe_syn=1.10 oe_mis=0.81 oe_lof=0.37), S100PBP (inh=n/a oe_syn=1.12 oe_mis=0.99 oe_lof=0.11)
chr1	33475639	33475639	G	A	het	het	het		QUAL=1208;DP=709,540,551;AF=0.14,0.12,0.23;MQM=34;SAP=628;ABP=1810	AK2,RP1-117O3.2	3'UTR,intron&non_coding_transcript	AK2:ENST00000373449.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*791C>T::,RP1-117O3.2:ENST00000427524.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.246-20997G>A::	AK2:NM_001199199.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*791C>T::,AK2:NM_001319139.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*791C>T::,AK2:NM_001319141.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*840C>T::,AK2:NM_001319142.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*791C>T::,AK2:NM_001625.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*3143C>T::,AK2:NM_013411.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*791C>T::,AK2:NR_134976.2:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.1450C>T::	regulatory_region_variant:promoter_flanking_region	103020 [GENE=AK2 PHENOS=Reticular dysgenesis,267500,Autosomal recessive];				rs138902451		0.4659	0,.	0.0012,0.0297,0.0227,0.0304,0.0103	2.0200			0.61,0.91	21.70					-0.0072	0.8585		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33475650	33475650	T	C	het	het	het		QUAL=1322;DP=666,556,545;AF=0.13,0.13,0.24;MQM=34;SAP=622;ABP=1764	AK2,RP1-117O3.2	3'UTR,intron&non_coding_transcript	AK2:ENST00000373449.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*780A>G::,RP1-117O3.2:ENST00000427524.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.246-20986T>C::	AK2:NM_001199199.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*780A>G::,AK2:NM_001319139.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*780A>G::,AK2:NM_001319141.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*829A>G::,AK2:NM_001319142.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*780A>G::,AK2:NM_001625.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*3132A>G::,AK2:NM_013411.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*780A>G::,AK2:NR_134976.2:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.1439A>G::	regulatory_region_variant:promoter_flanking_region	103020 [GENE=AK2 PHENOS=Reticular dysgenesis,267500,Autosomal recessive];				rs141799861		0.4685	0,.	0.0021,0.0187,0.0246,0.0298,0.0073	0.0510			0.20,0.21	12.47					0.0089	0.8589		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33475687	33475687	C	G	het	het	het		QUAL=2555;DP=382,580,603;AF=0.11,0.16,0.29;MQM=33;SAP=268;ABP=1253	AK2,RP1-117O3.2	3'UTR,intron&non_coding_transcript	AK2:ENST00000373449.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*743G>C::,RP1-117O3.2:ENST00000427524.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.246-20949C>G::	AK2:NM_001199199.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*743G>C::,AK2:NM_001319139.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*743G>C::,AK2:NM_001319141.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*792G>C::,AK2:NM_001319142.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*743G>C::,AK2:NM_001625.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*3095G>C::,AK2:NM_013411.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*743G>C::,AK2:NR_134976.2:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.1402G>C::	regulatory_region_variant:promoter_flanking_region	103020 [GENE=AK2 PHENOS=Reticular dysgenesis,267500,Autosomal recessive];				rs201444233		0.4072	0,.	0.0016,0.0361,0.0370,0.0319,0.0107	0.3710			0.61,0.88	17.58					0.0064	0.8589		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33475721	33475721	G	C	het	het	het		QUAL=4060;DP=331,549,606;AF=0.11,0.20,0.31;MQM=35;SAP=70;ABP=971	AK2,RP1-117O3.2	3'UTR,intron&non_coding_transcript	AK2:ENST00000373449.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*709C>G::,RP1-117O3.2:ENST00000427524.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.246-20915G>C::	AK2:NM_001199199.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*709C>G::,AK2:NM_001319139.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*709C>G::,AK2:NM_001319141.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*758C>G::,AK2:NM_001319142.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*709C>G::,AK2:NM_001625.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*3061C>G::,AK2:NM_013411.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*709C>G::,AK2:NR_134976.2:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.1368C>G::	regulatory_region_variant:promoter_flanking_region	103020 [GENE=AK2 PHENOS=Reticular dysgenesis,267500,Autosomal recessive];				rs139591926		0.4686	0,.	0.0181,0.0565,0.0592,0.0824,0.0132	-0.4810			0.01,0.11	5.00				COSV61468964	0.0022	0.8588		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33475750	33475750	A	G	het	het	het		QUAL=4692;DP=430,530,576;AF=0.13,0.22,0.32;MQM=39;SAP=9;ABP=972	AK2,RP1-117O3.2	3'UTR,intron&non_coding_transcript	AK2:ENST00000373449.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*680T>C::,RP1-117O3.2:ENST00000427524.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.246-20886A>G::	AK2:NM_001199199.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*680T>C::,AK2:NM_001319139.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*680T>C::,AK2:NM_001319141.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*729T>C::,AK2:NM_001319142.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*680T>C::,AK2:NM_001625.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*3032T>C::,AK2:NM_013411.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*680T>C::,AK2:NR_134976.2:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.1339T>C::	regulatory_region_variant:promoter_flanking_region	103020 [GENE=AK2 PHENOS=Reticular dysgenesis,267500,Autosomal recessive];				rs142975905		0.4956	0,.	0.3438,0.4870,0.4964,0.4368,0.4782	1.2420			0.35,0.22	8.66					-0.0035	0.8586		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33475767	33475767	G	A	het	het	het		QUAL=4559;DP=516,514,544;AF=0.14,0.24,0.33;MQM=41;SAP=10;ABP=926	AK2,RP1-117O3.2	3'UTR,intron&non_coding_transcript	AK2:ENST00000373449.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*663C>T::,RP1-117O3.2:ENST00000427524.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.246-20869G>A::	AK2:NM_001199199.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*663C>T::,AK2:NM_001319139.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*663C>T::,AK2:NM_001319141.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*712C>T::,AK2:NM_001319142.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*663C>T::,AK2:NM_001625.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*3015C>T::,AK2:NM_013411.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*663C>T::,AK2:NR_134976.2:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.1322C>T::	regulatory_region_variant:promoter_flanking_region	103020 [GENE=AK2 PHENOS=Reticular dysgenesis,267500,Autosomal recessive];				rs74066436		0.4979	0,.	0.4825,0.4986,0.4998,0.4885,0.4985	0.6460			0.07,0.20	6.14					0.0025	0.8588		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33475791	33475791	A	G	het	het	het		QUAL=7327;DP=531,528,611;AF=0.20,0.27,0.37;MQM=43;SAP=24;ABP=673	AK2,RP1-117O3.2	3'UTR,intron&non_coding_transcript	AK2:ENST00000373449.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*639T>C::,RP1-117O3.2:ENST00000427524.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.246-20845A>G::	AK2:NM_001199199.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*639T>C::,AK2:NM_001319139.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*639T>C::,AK2:NM_001319141.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*688T>C::,AK2:NM_001319142.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*639T>C::,AK2:NM_001625.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2991T>C::,AK2:NM_013411.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*639T>C::,AK2:NR_134976.2:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.1298T>C::	regulatory_region_variant:promoter_flanking_region	103020 [GENE=AK2 PHENOS=Reticular dysgenesis,267500,Autosomal recessive];				rs6884		0.5608	1870,.	0.5995,0.6143,0.5706,0.5402,0.5566	0.9860			0.00,0.11	7.35					0.0002	0.8587		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33475879	33475879	C	T	het	het	het		QUAL=9261;DP=576,345,397;AF=0.28,0.31,0.41;MQM=54;SAP=176;ABP=337	AK2,RP1-117O3.2	3'UTR,intron&non_coding_transcript	AK2:ENST00000373449.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*551G>A::,RP1-117O3.2:ENST00000427524.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.246-20757C>T::	AK2:NM_001199199.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*551G>A::,AK2:NM_001319139.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*551G>A::,AK2:NM_001319141.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*600G>A::,AK2:NM_001319142.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*551G>A::,AK2:NM_001625.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2903G>A::,AK2:NM_013411.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*551G>A::,AK2:NR_134976.2:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.1210G>A::	regulatory_region_variant:promoter_flanking_region	103020 [GENE=AK2 PHENOS=Reticular dysgenesis,267500,Autosomal recessive];				rs61800917		0.4999	0,.	0.4993,0.5000,0.5000,0.4999,0.5000	0.3020			0.13,0.18	6.27					-0.0041	0.8586		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33475967	33475967	G	A	het	het	het		QUAL=2789;DP=415,189,172;AF=0.23,0.23,0.30;MQM=49;SAP=92;ABP=442	AK2,RP1-117O3.2	3'UTR,intron&non_coding_transcript	AK2:ENST00000373449.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*463C>T::,RP1-117O3.2:ENST00000427524.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.246-20669G>A::	AK2:NM_001199199.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*463C>T::,AK2:NM_001319139.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*463C>T::,AK2:NM_001319141.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*512C>T::,AK2:NM_001319142.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*463C>T::,AK2:NM_001625.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2815C>T::,AK2:NM_013411.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*463C>T::,AK2:NR_134976.2:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.1122C>T::	regulatory_region_variant:promoter_flanking_region	103020 [GENE=AK2 PHENOS=Reticular dysgenesis,267500,Autosomal recessive];				rs74066437		0.4965	0,.	0.4014,0.4864,0.4884,0.4679,0.4674	-0.5360			0.02,0.16	2.94					-0.0029	0.8586		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33475977	33475977	G	A	het	het	het		QUAL=946;DP=342,155,151;AF=0.15,0.16,0.26;MQM=44;SAP=69;ABP=572	AK2,RP1-117O3.2	3'UTR,intron&non_coding_transcript	AK2:ENST00000373449.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*453C>T::,RP1-117O3.2:ENST00000427524.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.246-20659G>A::	AK2:NM_001199199.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*453C>T::,AK2:NM_001319139.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*453C>T::,AK2:NM_001319141.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*502C>T::,AK2:NM_001319142.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*453C>T::,AK2:NM_001625.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2805C>T::,AK2:NM_013411.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*453C>T::,AK2:NR_134976.2:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.1112C>T::	regulatory_region_variant:promoter_flanking_region	103020 [GENE=AK2 PHENOS=Reticular dysgenesis,267500,Autosomal recessive];				rs115408325		0.4939	0,.	0.1392,0.3326,0.3322,0.1201,0.1676	0.9610			0.00,0.06	4.25				COSV61467261	-0.011	0.8584		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33475979	33475979	A	G	het	het	het		QUAL=946;DP=342,155,151;AF=0.15,0.16,0.26;MQM=44;SAP=69;ABP=572	AK2,RP1-117O3.2	3'UTR,intron&non_coding_transcript	AK2:ENST00000373449.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*451T>C::,RP1-117O3.2:ENST00000427524.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.246-20657A>G::	AK2:NM_001199199.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*451T>C::,AK2:NM_001319139.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*451T>C::,AK2:NM_001319141.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*500T>C::,AK2:NM_001319142.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*451T>C::,AK2:NM_001625.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2803T>C::,AK2:NM_013411.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*451T>C::,AK2:NR_134976.2:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.1110T>C::	regulatory_region_variant:promoter_flanking_region	103020 [GENE=AK2 PHENOS=Reticular dysgenesis,267500,Autosomal recessive];				rs4045165		0.4924	0,.	0.1117,0.2470,0.2219,0.0652,0.1106	-0.1460			0.00,0.07	2.79					-0.0108	0.8584		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33475982	33475982	C	A	het	het	het		QUAL=946;DP=342,155,151;AF=0.15,0.16,0.26;MQM=44;SAP=69;ABP=572	AK2,RP1-117O3.2	3'UTR,intron&non_coding_transcript	AK2:ENST00000373449.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*448G>T::,RP1-117O3.2:ENST00000427524.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.246-20654C>A::	AK2:NM_001199199.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*448G>T::,AK2:NM_001319139.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*448G>T::,AK2:NM_001319141.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*497G>T::,AK2:NM_001319142.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*448G>T::,AK2:NM_001625.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2800G>T::,AK2:NM_013411.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*448G>T::,AK2:NR_134976.2:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.1107G>T::	regulatory_region_variant:promoter_flanking_region	103020 [GENE=AK2 PHENOS=Reticular dysgenesis,267500,Autosomal recessive];				rs114902220		0.4913	0,.	0.0825,0.1746,0.1583,0.0358,0.0684	-0.1050			0.07,0.19	5.01					-0.0106	0.8584		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33475993	33475993	-	C	wt	het	het		QUAL=416;DP=305,155,151;AF=0.03,0.18,0.25;MQM=40;SAP=73;ABP=223	AK2,RP1-117O3.2	3'UTR,intron&non_coding_transcript	AK2:ENST00000373449.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*436dup::,RP1-117O3.2:ENST00000427524.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.246-20642dup::	AK2:NM_001199199.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*436dup::,AK2:NM_001319139.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*436dup::,AK2:NM_001319141.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*485dup::,AK2:NM_001319142.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*436dup::,AK2:NM_001625.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2788dup::,AK2:NM_013411.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*436dup::,AK2:NR_134976.2:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.1095dup::	regulatory_region_variant:promoter_flanking_region	103020 [GENE=AK2 PHENOS=Reticular dysgenesis,267500,Autosomal recessive];				rs67040956		0.4852	0,.	0.0162,0.0451,0.0327,0.0037,0.0149					9.42					-0.0054	0.8586		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33476032	33476032	T	C	het	het	het		QUAL=261;DP=231,153,129;AF=0.11,0.16,0.22;MQM=36;SAP=28;ABP=542	AK2,RP1-117O3.2	3'UTR,intron&non_coding_transcript	AK2:ENST00000373449.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*398A>G::,RP1-117O3.2:ENST00000427524.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.246-20604T>C::	AK2:NM_001199199.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*398A>G::,AK2:NM_001319139.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*398A>G::,AK2:NM_001319141.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*447A>G::,AK2:NM_001319142.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*398A>G::,AK2:NM_001625.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2750A>G::,AK2:NM_013411.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*398A>G::,AK2:NR_134976.2:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.1057A>G::	regulatory_region_variant:promoter_flanking_region	103020 [GENE=AK2 PHENOS=Reticular dysgenesis,267500,Autosomal recessive];				rs77170021		0.4904	0,.	0.0111,0.1004,0.0453,0.0318,0.0306	-0.8450			0.02,0.16	11.48					0.0119	0.859		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33476065	33476065	G	A	het	het	het		QUAL=1085;DP=324,148,114;AF=0.23,0.12,0.20;MQM=35;SAP=18;ABP=478	AK2,RP1-117O3.2	3'UTR,intron&non_coding_transcript	AK2:ENST00000373449.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*365C>T::,RP1-117O3.2:ENST00000427524.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.246-20571G>A::	AK2:NM_001199199.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*365C>T::,AK2:NM_001319139.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*365C>T::,AK2:NM_001319141.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*414C>T::,AK2:NM_001319142.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*365C>T::,AK2:NM_001625.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2717C>T::,AK2:NM_013411.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*365C>T::,AK2:NR_134976.2:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.1024C>T::	regulatory_region_variant:promoter_flanking_region	103020 [GENE=AK2 PHENOS=Reticular dysgenesis,267500,Autosomal recessive];				rs143947377		0.4971	0,.	0.1568,0.4139,0.3199,0.3716,0.3520	1.5880			0.76,0.97	16.98					0.0069	0.8589		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33476074	33476074	A	T	het	het	het		QUAL=1139;DP=343,154,118;AF=0.23,0.10,0.19;MQM=34;SAP=21;ABP=516	AK2,RP1-117O3.2	3'UTR,intron&non_coding_transcript	AK2:ENST00000373449.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*356T>A::,RP1-117O3.2:ENST00000427524.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.246-20562A>T::	AK2:NM_001199199.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*356T>A::,AK2:NM_001319139.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*356T>A::,AK2:NM_001319141.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*405T>A::,AK2:NM_001319142.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*356T>A::,AK2:NM_001625.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2708T>A::,AK2:NM_013411.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*356T>A::,AK2:NR_134976.2:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.1015T>A::	regulatory_region_variant:promoter_flanking_region	103020 [GENE=AK2 PHENOS=Reticular dysgenesis,267500,Autosomal recessive];				rs199780633		0.4969	0,.	0.1455,0.4073,0.2964,0.3645,0.3485	1.1940			0.49,0.95	15.36					-0.0002	0.8587		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33476090	33476090	T	C	het	het	het		QUAL=1447;DP=393,153,119;AF=0.25,0.12,0.16;MQM=34;SAP=22;ABP=518	AK2,RP1-117O3.2	3'UTR,intron&non_coding_transcript	AK2:ENST00000373449.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*340A>G::,RP1-117O3.2:ENST00000427524.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.246-20546T>C::,AK2:ENST00000548033.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*340A>G::	AK2:NM_001199199.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*340A>G::,AK2:NM_001319139.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*340A>G::,AK2:NM_001319141.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*389A>G::,AK2:NM_001319142.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*340A>G::,AK2:NM_001625.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2692A>G::,AK2:NM_013411.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*340A>G::,AK2:NR_134976.2:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.999A>G::	regulatory_region_variant:promoter_flanking_region	103020 [GENE=AK2 PHENOS=Reticular dysgenesis,267500,Autosomal recessive];				rs140167370		0.4965	0,.	0.1035,0.3746,0.2373,0.3256,0.3048	-2.1700			0.01,0.14	5.19					0.0542	0.8946		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33476143	33476143	G	A	het	het	het		QUAL=126;DP=256,111,86;AF=0.15,0.14,0.14;MQM=37;SAP=12;ABP=491	AK2,RP1-117O3.2	3'UTR,intron&non_coding_transcript	AK2:ENST00000373449.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*287C>T::,RP1-117O3.2:ENST00000427524.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.246-20493G>A::,AK2:ENST00000548033.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*287C>T::	AK2:NM_001199199.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*287C>T::,AK2:NM_001319139.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*287C>T::,AK2:NM_001319141.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*336C>T::,AK2:NM_001319142.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*287C>T::,AK2:NM_001625.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2639C>T::,AK2:NM_013411.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*287C>T::,AK2:NR_134976.2:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.946C>T::	regulatory_region_variant:promoter_flanking_region	103020 [GENE=AK2 PHENOS=Reticular dysgenesis,267500,Autosomal recessive];				rs201412582		0.4917	0,.	0.0026,0.0257,0.0074,0.0132,0.0111	0.5190			0.04,0.16	3.25					-0.0893	0.892		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33476224	33476225	AC	-	het	het	het		QUAL=1631;DP=219,73,71;AF=0.27,0.34,0.27;MQM=46;SAP=4;ABP=150	AK2,RP1-117O3.2	3'UTR,intron&non_coding_transcript	AK2:ENST00000373449.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*205_*206del::,RP1-117O3.2:ENST00000427524.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.246-20410_246-20409del::,AK2:ENST00000548033.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*205_*206del::	AK2:NM_001199199.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*205_*206del::,AK2:NM_001319139.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*205_*206del::,AK2:NM_001319141.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*254_*255del::,AK2:NM_001319142.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*205_*206del::,AK2:NM_001625.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2557_*2558del::,AK2:NM_013411.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*205_*206del::,AK2:NR_134976.2:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.864_865del::	regulatory_region_variant:promoter_flanking_region	103020 [GENE=AK2 PHENOS=Reticular dysgenesis,267500,Autosomal recessive];				rs67829320		0.4991	0,.	0.2745,0.4509,0.3832,0.4501,0.4693	-0.1330				6.63					-0.0075	0.8934		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33476239	33476239	T	C	het	het	het		QUAL=2631;DP=269,79,72;AF=0.30,0.37,0.32;MQM=47;SAP=9;ABP=122	AK2,RP1-117O3.2	3'UTR,intron&non_coding_transcript	AK2:ENST00000373449.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*191A>G::,RP1-117O3.2:ENST00000427524.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.246-20397T>C::,AK2:ENST00000548033.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*191A>G::	AK2:NM_001199199.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*191A>G::,AK2:NM_001319139.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*191A>G::,AK2:NM_001319141.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*240A>G::,AK2:NM_001319142.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*191A>G::,AK2:NM_001625.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2543A>G::,AK2:NM_013411.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*191A>G::,AK2:NR_134976.2:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.850A>G::	regulatory_region_variant:promoter_flanking_region	103020 [GENE=AK2 PHENOS=Reticular dysgenesis,267500,Autosomal recessive];				rs74066438		0.4993	0,.	0.3834,0.4825,0.4540,0.4748,0.4879	-0.0310			0.00,0.13	4.64					0.0401	0.9319		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33476292	33476292	A	G	het	het	het		QUAL=4622;DP=270,117,136;AF=0.30,0.45,0.49;MQM=50;SAP=131;ABP=64	AK2,RP1-117O3.2	3'UTR,intron&non_coding_transcript	AK2:ENST00000373449.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*138T>C::,RP1-117O3.2:ENST00000427524.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.246-20344A>G::,AK2:ENST00000548033.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*138T>C::	AK2:NM_001199199.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*138T>C::,AK2:NM_001319139.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*138T>C::,AK2:NM_001319141.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*187T>C::,AK2:NM_001319142.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*138T>C::,AK2:NM_001625.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2490T>C::,AK2:NM_013411.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*138T>C::,AK2:NR_134976.2:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.797T>C::	regulatory_region_variant:promoter_flanking_region	103020 [GENE=AK2 PHENOS=Reticular dysgenesis,267500,Autosomal recessive];				rs74066439		0.4993	0,.	0.4701,0.4886,0.4898,0.4828,0.4891	0.1450			0.03,0.16	6.84					0.0872	0.9325		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33476353	33476353	C	T	het	het	het		QUAL=2482;DP=231,143,155;AF=0.17,0.33,0.41;MQM=47;SAP=29;ABP=218	AK2,RP1-117O3.2	3'UTR,intron&non_coding_transcript	AK2:ENST00000373449.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*77G>A::,RP1-117O3.2:ENST00000427524.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.246-20283C>T::,AK2:ENST00000548033.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*77G>A::	AK2:NM_001199199.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*77G>A::,AK2:NM_001319139.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*77G>A::,AK2:NM_001319141.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*126G>A::,AK2:NM_001319142.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*77G>A::,AK2:NM_001625.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2429G>A::,AK2:NM_013411.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*77G>A::,AK2:NR_134976.2:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.736G>A::	regulatory_region_variant:promoter_flanking_region	103020 [GENE=AK2 PHENOS=Reticular dysgenesis,267500,Autosomal recessive];				rs66599471		0.4992	1,.	0.2505,0.1430,0.1915,0.2371,0.1579	-0.0210			0.49,0.95	15.65					0.1628	0.9335		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33476385	33476385	C	G	het	het	het	low_conf_region	QUAL=1763;DP=228,136,141;AF=0.20,0.26,0.37;MQM=48;SAP=9;ABP=249	AK2,RP1-117O3.2	3'UTR,intron&non_coding_transcript	AK2:ENST00000373449.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*45G>C::,RP1-117O3.2:ENST00000427524.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.246-20251C>G::,AK2:ENST00000467905.1:3_prime_UTR_variant:MODIFIER:exon8/8:c.*94G>C::,AK2:ENST00000548033.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*45G>C::	AK2:NM_001199199.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*45G>C::,AK2:NM_001319139.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*45G>C::,AK2:NM_001319141.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*94G>C::,AK2:NM_001319142.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*45G>C::,AK2:NM_001625.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2397G>C::,AK2:NM_013411.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*45G>C::,AK2:NR_134976.2:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.704G>C::	regulatory_region_variant:promoter_flanking_region	103020 [GENE=AK2 PHENOS=Reticular dysgenesis,267500,Autosomal recessive];				rs76881767		0.4957	0,.	0.0649,0.0106,0.0261,0.0577,0.0143	0.0630			0.25,0.95	20.80					-0.2755	0.9299		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33476387	33476387	C	T	het	het	het	low_conf_region	QUAL=1763;DP=228,136,141;AF=0.20,0.26,0.37;MQM=48;SAP=9;ABP=249	AK2,RP1-117O3.2	3'UTR,intron&non_coding_transcript	AK2:ENST00000373449.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*43G>A::,RP1-117O3.2:ENST00000427524.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.246-20249C>T::,AK2:ENST00000467905.1:3_prime_UTR_variant:MODIFIER:exon8/8:c.*92G>A::,AK2:ENST00000548033.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*43G>A::	AK2:NM_001199199.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*43G>A::,AK2:NM_001319139.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*43G>A::,AK2:NM_001319141.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*92G>A::,AK2:NM_001319142.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*43G>A::,AK2:NM_001625.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2395G>A::,AK2:NM_013411.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*43G>A::,AK2:NR_134976.2:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.702G>A::	regulatory_region_variant:promoter_flanking_region	103020 [GENE=AK2 PHENOS=Reticular dysgenesis,267500,Autosomal recessive];				rs201842558		0.4952	0,.	0.0529,0.0087,0.0213,0.0484,0.0123	-0.0090			0.07,0.90	18.43					-0.0223	0.9312		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33476396	33476396	G	A	het	het	het	low_conf_region	QUAL=1690;DP=229,136,132;AF=0.20,0.23,0.35;MQM=48;SAP=5;ABP=283	AK2,RP1-117O3.2	3'UTR,intron&non_coding_transcript	AK2:ENST00000373449.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*34C>T::,RP1-117O3.2:ENST00000427524.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.246-20240G>A::,AK2:ENST00000467905.1:3_prime_UTR_variant:MODIFIER:exon8/8:c.*83C>T::,AK2:ENST00000548033.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*34C>T::	AK2:NM_001199199.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*34C>T::,AK2:NM_001319139.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*34C>T::,AK2:NM_001319141.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*83C>T::,AK2:NM_001319142.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*34C>T::,AK2:NM_001625.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2386C>T::,AK2:NM_013411.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*34C>T::,AK2:NR_134976.2:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.693C>T::	regulatory_region_variant:promoter_flanking_region	103020 [GENE=AK2 PHENOS=Reticular dysgenesis,267500,Autosomal recessive];				rs79824855		0.4891	0,.	0.0220,0.0029,0.0075,0.0218,0.0043	2.0110			0.68,0.97	22.50					-0.2765	0.9299		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33476404	33476404	T	G	het	het	het	low_conf_region	QUAL=1367;DP=218,132,128;AF=0.20,0.23,0.32;MQM=48;SAP=5;ABP=282	AK2,RP1-117O3.2	3'UTR,intron&non_coding_transcript	AK2:ENST00000373449.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*26A>C::,RP1-117O3.2:ENST00000427524.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.246-20232T>G::,AK2:ENST00000467905.1:3_prime_UTR_variant:MODIFIER:exon8/8:c.*75A>C::,AK2:ENST00000548033.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*26A>C::	AK2:NM_001199199.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*26A>C::,AK2:NM_001319139.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*26A>C::,AK2:NM_001319141.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*75A>C::,AK2:NM_001319142.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*26A>C::,AK2:NM_001625.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2378A>C::,AK2:NM_013411.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*26A>C::,AK2:NR_134976.2:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.685A>C::		103020 [GENE=AK2 PHENOS=Reticular dysgenesis,267500,Autosomal recessive];				rs76230073		0.4784	0,.	0.0150,0.0019,0.0038,0.0149,0.0025	1.6190			0.03,0.92	19.41					-0.0217	0.9312		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33478931	33478931	G	C	het	wt	wt	low_conf_region	QUAL=524;DP=658,594,475;AF=0.17,0.02,0.04;MQM=36;SAP=22;ABP=608	AK2,RP1-117O3.2	missense,intron&non_coding_transcript,3'UTR	AK2:ENST00000354858.6:missense_variant:MODERATE:exon6/6:c.571C>G:p.His191Asp:PF00406 [Adenylate kinase],AK2:ENST00000373449.2:missense_variant:MODERATE:exon6/7:c.571C>G:p.His191Asp:PF00406 [Adenylate kinase],RP1-117O3.2:ENST00000427524.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.246-17705G>C::,AK2:ENST00000467905.1:missense_variant:MODERATE:exon6/8:c.571C>G:p.His191Asp:PF00406 [Adenylate kinase],AK2:ENST00000480134.1:3_prime_UTR_variant:MODIFIER:exon5/5:c.*74C>G::,AK2:ENST00000548033.1:missense_variant:MODERATE:exon5/6:c.445C>G:p.His149Asp:PF00406 [Adenylate kinase]	AK2:NM_001199199.2:missense_variant:MODERATE:exon6/7:c.547C>G:p.His183Asp:,AK2:NM_001319139.2:missense_variant:MODERATE:exon7/8:c.427C>G:p.His143Asp:,AK2:NM_001319140.1:missense_variant:MODERATE:exon7/7:c.427C>G:p.His143Asp:,AK2:NM_001319141.2:missense_variant:MODERATE:exon6/8:c.571C>G:p.His191Asp:,AK2:NM_001319142.2:missense_variant:MODERATE:exon5/6:c.445C>G:p.His149Asp:,AK2:NM_001319143.1:3_prime_UTR_variant:MODIFIER:exon5/5:c.*74C>G::,AK2:NM_001625.4:missense_variant:MODERATE:exon6/6:c.571C>G:p.His191Asp:,AK2:NM_013411.5:missense_variant:MODERATE:exon6/7:c.571C>G:p.His191Asp:,AK2:NR_134976.2:non_coding_transcript_exon_variant:MODIFIER:exon5/6:n.531C>G::		103020 [GENE=AK2 PHENOS=Reticular dysgenesis,267500,Autosomal recessive];	529737 [benign DISEASE=Reticular dysgenesis];			rs80324279		0.0346	0,.	0.0514,0.0241,0.0262,0.0454,0.0179	9.8310	D(0.01),D(0.01), ,D(0.01), ,D(0.01)	B(0.44),B(0.31), ,B(0.44), ,P(0.88)	1.00,1.00	23.50	0.78				0.1595	0.935	0	0	932	0 / 0					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33478959	33478959	C	G	het	wt	wt	low_conf_region	QUAL=661;DP=632,555,421;AF=0.17,0.02,0.03;MQM=36;SAP=18;ABP=592	AK2,RP1-117O3.2	missense,intron&non_coding_transcript,3'UTR	AK2:ENST00000354858.6:missense_variant:MODERATE:exon6/6:c.543G>C:p.Lys181Asn:PF00406 [Adenylate kinase],AK2:ENST00000373449.2:missense_variant:MODERATE:exon6/7:c.543G>C:p.Lys181Asn:PF00406 [Adenylate kinase],RP1-117O3.2:ENST00000427524.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.246-17677C>G::,AK2:ENST00000467905.1:missense_variant:MODERATE:exon6/8:c.543G>C:p.Lys181Asn:PF00406 [Adenylate kinase],AK2:ENST00000480134.1:3_prime_UTR_variant:MODIFIER:exon5/5:c.*46G>C::,AK2:ENST00000548033.1:missense_variant:MODERATE:exon5/6:c.417G>C:p.Lys139Asn:PF00406 [Adenylate kinase]	AK2:NM_001199199.2:missense_variant:MODERATE:exon6/7:c.519G>C:p.Lys173Asn:,AK2:NM_001319139.2:missense_variant:MODERATE:exon7/8:c.399G>C:p.Lys133Asn:,AK2:NM_001319140.1:missense_variant:MODERATE:exon7/7:c.399G>C:p.Lys133Asn:,AK2:NM_001319141.2:missense_variant:MODERATE:exon6/8:c.543G>C:p.Lys181Asn:,AK2:NM_001319142.2:missense_variant:MODERATE:exon5/6:c.417G>C:p.Lys139Asn:,AK2:NM_001319143.1:3_prime_UTR_variant:MODIFIER:exon5/5:c.*46G>C::,AK2:NM_001625.4:missense_variant:MODERATE:exon6/6:c.543G>C:p.Lys181Asn:,AK2:NM_013411.5:missense_variant:MODERATE:exon6/7:c.543G>C:p.Lys181Asn:,AK2:NR_134976.2:non_coding_transcript_exon_variant:MODIFIER:exon5/6:n.503G>C::		103020 [GENE=AK2 PHENOS=Reticular dysgenesis,267500,Autosomal recessive];				rs72884305		0.1114	0,.	0.1538,0.0784,0.0983,0.1469,0.0605	-0.4040	D(0.03),D(0.03), ,D(0.03), ,D(0.03)	B(0.09),B(0.03), ,B(0.09), ,B(0.05)	0.39,0.96	22.50	0.19				0.1058	0.9346	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	35246848	35246848	-	C	wt	het	wt		QUAL=151;DP=8,14,10;AF=0.00,0.57,0.00;MQM=60;SAP=20;ABP=4	GJB3,RP1-34M23.5	5'UTR,intron&non_coding_transcript	GJB3:ENST00000373366.2:5_prime_UTR_variant:MODIFIER:exon1/2:c.-551dup::,RP1-34M23.5:ENST00000542839.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.110+6740dup::	GJB3:NM_024009.3:5_prime_UTR_variant:MODIFIER:exon1/2:c.-551dup::	regulatory_region_variant:promoter,TF_binding_site_variant	603324 [GENE=GJB3 PHENOS=Deafness,autosomal dominant 2B,612644,Autosomal dominant/Deafness,autosomal recessive/Deafness,autosomal dominant,with peripheral neuropathy/Deafness,digenic,GJB2/GJB3,220290,Digenic dominant,Autosomal recessive/Erythrokeratodermia variabilis et progressiva 1,133200,Autosomal recessive,Autosomal dominant];				rs3831969		0.2675	1266,.						10.55					-0.0078	0.0506	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJB3 (inh=AR+AD oe_syn=0.87 oe_mis=1.11 oe_lof=0.63)
chr1	35251229	35251229	G	A	wt	het	het		QUAL=9699;DP=257,376,357;AF=0.00,0.50,0.54;MQM=60;SAP=7;ABP=5	GJB3,RP1-34M23.5	3'UTR,intron&non_coding_transcript	GJB3:ENST00000373362.3:3_prime_UTR_variant:MODIFIER:exon2/2:c.*53G>A::,GJB3:ENST00000373366.2:3_prime_UTR_variant:MODIFIER:exon2/2:c.*53G>A::,RP1-34M23.5:ENST00000542839.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.110+2360C>T::	GJB3:NM_001005752.2:3_prime_UTR_variant:MODIFIER:exon2/2:c.*53G>A::,GJB3:NM_024009.3:3_prime_UTR_variant:MODIFIER:exon2/2:c.*53G>A::		603324 [GENE=GJB3 PHENOS=Deafness,autosomal dominant 2B,612644,Autosomal dominant/Deafness,autosomal recessive/Deafness,autosomal dominant,with peripheral neuropathy/Deafness,digenic,GJB2/GJB3,220290,Digenic dominant,Autosomal recessive/Erythrokeratodermia variabilis et progressiva 1,133200,Autosomal recessive,Autosomal dominant];	297196 [benign DISEASE=Erythrokeratodermia variabilis et progressiva 1];			rs476220	0.4040	0.4918	3958,.		0.0710			0.11,0.23	5.30					0.0007	0.9421	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJB3 (inh=AR+AD oe_syn=0.87 oe_mis=1.11 oe_lof=0.63)
chr1	39491927	39491927	G	C	het	het	hom	off-target	QUAL=4597;DP=72,102,84;AF=0.47,0.50,1.00;MQM=60;SAP=167;ABP=3	NDUFS5	upstream_gene	NDUFS5:ENST00000372967.3:upstream_gene_variant:MODIFIER::::,NDUFS5:ENST00000372969.3:upstream_gene_variant:MODIFIER::::		regulatory_region_variant:promoter					rs1984600	0.5395	0.7164	8465,.		-0.2810			0.00,0.64	10.28								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NDUFS5 (inh=n/a oe_syn=0.73 oe_mis=1.00 oe_lof=0.53)
chr1	39492080	39492080	G	T	het	het	hom		QUAL=4638;DP=91,111,91;AF=0.51,0.47,1.00;MQM=60;SAP=55;ABP=3	NDUFS5	intron,splice_region&intron	NDUFS5:ENST00000372967.3:intron_variant:MODIFIER:intron1/2:c.-3+10G>T::,NDUFS5:ENST00000372969.3:splice_region_variant&intron_variant:LOW:intron1/2:c.-3+6G>T::	NDUFS5:NM_001184979.1:intron_variant:MODIFIER:intron1/2:c.-3+10G>T::,NDUFS5:NM_004552.3:splice_region_variant&intron_variant:LOW:intron1/2:c.-3+6G>T::	regulatory_region_variant:promoter					rs1122472	0.5377	0.7143	8426,.		-1.2950			0.01,0.69	12.28		6.53>7.92	0.000/0.028		-0.9318	0.3924	0.74	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NDUFS5 (inh=n/a oe_syn=0.73 oe_mis=1.00 oe_lof=0.53)
chr1	39494666	39494666	-	T	het	wt	wt	off-target;low_conf_region	QUAL=377;DP=107,66,46;AF=0.11,0.23,0.37;MQM=58;SAP=94;ABP=184	NDUFS5	intron	NDUFS5:ENST00000372967.3:intron_variant:MODIFIER:intron2/2:c.216+69dup::,NDUFS5:ENST00000372969.3:intron_variant:MODIFIER:intron2/2:c.216+69dup::	NDUFS5:NM_001184979.1:intron_variant:MODIFIER:intron2/2:c.216+69dup::,NDUFS5:NM_004552.3:intron_variant:MODIFIER:intron2/2:c.216+69dup::					AluSq10 (SINE/Alu)	rs35464164		0.6769	5655,.						2.30					0.0912	0.1455	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NDUFS5 (inh=n/a oe_syn=0.73 oe_mis=1.00 oe_lof=0.53)
chr1	39494666	39494666	C	T	wt	het	het	off-target;low_conf_region	QUAL=377;DP=107,66,46;AF=0.21,0.14,0.22;MQM=54;SAP=99;ABP=173	NDUFS5	intron	NDUFS5:ENST00000372967.3:intron_variant:MODIFIER:intron2/2:c.216+54C>T::,NDUFS5:ENST00000372969.3:intron_variant:MODIFIER:intron2/2:c.216+54C>T::	NDUFS5:NM_001184979.1:intron_variant:MODIFIER:intron2/2:c.216+54C>T::,NDUFS5:NM_004552.3:intron_variant:MODIFIER:intron2/2:c.216+54C>T::						rs372159643					-0.5700			0.01,0.15	0.28					-0.0064	0.146	0	17	109	0 / 0					NDUFS5 (inh=n/a oe_syn=0.73 oe_mis=1.00 oe_lof=0.53)
chr1	40539076	40539076	C	T	hom	het	het		QUAL=18414;DP=389,252,206;AF=1.00,0.50,0.39;MQM=60;SAP=59;ABP=12	PPT1	3'UTR	PPT1:ENST00000433473.3:3_prime_UTR_variant:MODIFIER:exon9/9:c.*657G>A::	PPT1:NM_000310.3:3_prime_UTR_variant:MODIFIER:exon9/9:c.*657G>A::,PPT1:NM_001142604.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*657G>A::,PPT1:NM_001363695.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*657G>A::		600722 [GENE=PPT1 PHENOS=Ceroid lipofuscinosis,neuronal,1,256730,Autosomal recessive];	297230 [benign DISEASE=Neuronal ceroid lipofuscinosis 1];			rs1126973	0.6673	0.7070	7874,.		0.4520			0.11,0.66	8.79					-0.0029	0.9225	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CAP1 (inh=n/a oe_syn=0.93 oe_mis=0.78 oe_lof=0.30), PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40539203	40539203	-	TGAT	hom	het	het		QUAL=19322;DP=340,457,360;AF=0.99,0.47,0.44;MQM=60;SAP=60;ABP=15	PPT1	3'UTR	PPT1:ENST00000433473.3:3_prime_UTR_variant:MODIFIER:exon9/9:c.*526_*529dup::	PPT1:NM_000310.3:3_prime_UTR_variant:MODIFIER:exon9/9:c.*526_*529dup::,PPT1:NM_001142604.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*526_*529dup::,PPT1:NM_001363695.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*526_*529dup::		600722 [GENE=PPT1 PHENOS=Ceroid lipofuscinosis,neuronal,1,256730,Autosomal recessive];	297233 [benign DISEASE=Neuronal Ceroid-Lipofuscinosis, Recessive];			rs397730033		0.6646	7053,.						2.20					0.0603	0.9127	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CAP1 (inh=n/a oe_syn=0.93 oe_mis=0.78 oe_lof=0.30), PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40539228	40539228	G	C	hom	het	het		QUAL=29567;DP=530,540,423;AF=1.00,0.48,0.46;MQM=60;SAP=160;ABP=9	PPT1	3'UTR	PPT1:ENST00000433473.3:3_prime_UTR_variant:MODIFIER:exon9/9:c.*505C>G::	PPT1:NM_000310.3:3_prime_UTR_variant:MODIFIER:exon9/9:c.*505C>G::,PPT1:NM_001142604.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*505C>G::,PPT1:NM_001363695.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*505C>G::		600722 [GENE=PPT1 PHENOS=Ceroid lipofuscinosis,neuronal,1,256730,Autosomal recessive];	297234 [benign DISEASE=Neuronal ceroid lipofuscinosis 1];			rs1126972		0.7024	7787,.		-0.6320			0.02,0.13	0.35					0.0123	0.9207	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CAP1 (inh=n/a oe_syn=0.93 oe_mis=0.78 oe_lof=0.30), PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40539448	40539448	A	C	hom	het	het		QUAL=39099;DP=853,464,415;AF=1.00,0.45,0.53;MQM=60;SAP=61;ABP=4	PPT1	3'UTR	PPT1:ENST00000433473.3:3_prime_UTR_variant:MODIFIER:exon9/9:c.*285T>G::	PPT1:NM_000310.3:3_prime_UTR_variant:MODIFIER:exon9/9:c.*285T>G::,PPT1:NM_001142604.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*285T>G::,PPT1:NM_001363695.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*285T>G::		600722 [GENE=PPT1 PHENOS=Ceroid lipofuscinosis,neuronal,1,256730,Autosomal recessive];	297240 [benign DISEASE=Neuronal ceroid lipofuscinosis 1];			rs1126970	0.6611	0.7028	7812,.		1.4180			0.33,0.40	7.64					-0.0229	0.8665	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CAP1 (inh=n/a oe_syn=0.93 oe_mis=0.78 oe_lof=0.30), PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40539572	40539572	A	G	het	het	wt		QUAL=7498;DP=342,267,237;AF=0.46,0.48,0.00;MQM=60;SAP=86;ABP=9	PPT1	3'UTR	PPT1:ENST00000433473.3:3_prime_UTR_variant:MODIFIER:exon9/9:c.*161T>C::,PPT1:ENST00000449045.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*161T>C::	PPT1:NM_000310.3:3_prime_UTR_variant:MODIFIER:exon9/9:c.*161T>C::,PPT1:NM_001142604.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*161T>C::,PPT1:NM_001363695.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*161T>C::		600722 [GENE=PPT1 PHENOS=Ceroid lipofuscinosis,neuronal,1,256730,Autosomal recessive];	297242 [benign DISEASE=Neuronal ceroid lipofuscinosis 1];			rs11552578	0.1514	0.1179	231,.		2.4320			0.75,0.92	12.66					0.0935	0.8937	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CAP1 (inh=n/a oe_syn=0.93 oe_mis=0.78 oe_lof=0.30), PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40546209	40546209	C	T	het	het	wt	off-target	QUAL=6236;DP=233,288,222;AF=0.49,0.49,0.00;MQM=60;SAP=190;ABP=4	PPT1	intron	PPT1:ENST00000433473.3:intron_variant:MODIFIER:intron5/8:c.537-50G>A::,PPT1:ENST00000449045.2:intron_variant:MODIFIER:intron2/5:c.228-50G>A::,PPT1:ENST00000530076.1:intron_variant:MODIFIER:intron1/4:c.-121-50G>A::	PPT1:NM_000310.3:intron_variant:MODIFIER:intron5/8:c.537-50G>A::,PPT1:NM_001142604.2:intron_variant:MODIFIER:intron2/5:c.228-50G>A::,PPT1:NM_001363695.2:intron_variant:MODIFIER:intron5/7:c.537-50G>A::	regulatory_region_variant:promoter_flanking_region	600722 [GENE=PPT1 PHENOS=Ceroid lipofuscinosis,neuronal,1,256730,Autosomal recessive];				rs77623018	0.0881	0.0862	97,.	0.0162,0.1045,0.1396,0.0569,0.1362	-1.7000			0.02,0.12	0.39					-0.1095	0.073	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40556942	40556942	A	T	wt	wt	het	off-target	QUAL=2667;DP=152,216,207;AF=0.00,0.00,0.51;MQM=60;SAP=39;ABP=3	PPT1	intron	PPT1:ENST00000433473.3:intron_variant:MODIFIER:intron4/8:c.433+59T>A::,PPT1:ENST00000449045.2:intron_variant:MODIFIER:intron1/5:c.125-1758T>A::	PPT1:NM_000310.3:intron_variant:MODIFIER:intron4/8:c.433+59T>A::,PPT1:NM_001142604.2:intron_variant:MODIFIER:intron1/5:c.125-1758T>A::,PPT1:NM_001363695.2:intron_variant:MODIFIER:intron4/7:c.433+59T>A::		600722 [GENE=PPT1 PHENOS=Ceroid lipofuscinosis,neuronal,1,256730,Autosomal recessive];	670785 [benign DISEASE=not provided];			rs56654546	0.1154	0.0898	133,.		0.8540			0.00,0.11	4.30					-0.0722	0.1515	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40557033	40557033	A	G	het	het	wt		QUAL=9319;DP=431,349,344;AF=0.44,0.48,0.00;MQM=60;SAP=3;ABP=14	PPT1	missense,intron	PPT1:ENST00000433473.3:missense_variant:MODERATE:exon4/9:c.401T>C:p.Ile134Thr:PF02089 [Palmitoyl protein thioesterase],PPT1:ENST00000449045.2:intron_variant:MODIFIER:intron1/5:c.125-1849T>C::	PPT1:NM_000310.3:missense_variant:MODERATE:exon4/9:c.401T>C:p.Ile134Thr:,PPT1:NM_001142604.2:intron_variant:MODIFIER:intron1/5:c.125-1849T>C::,PPT1:NM_001363695.2:missense_variant:MODERATE:exon4/8:c.401T>C:p.Ile134Thr:		600722 [GENE=PPT1 PHENOS=Ceroid lipofuscinosis,neuronal,1,256730,Autosomal recessive];	130022 [benign DISEASE=Neuronal ceroid lipofuscinosis 1,History of neurodevelopmental disorder,not specified,not provided];			rs1800205	0.0739	0.0659	72,.	0.0097,0.0357,0.1235,0.0483,0.1213	0.5750	T(0.37), 	B(0.04), 	0.86,0.97	17.51	0.20				0.0152	0.1515	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40562993	40562993	T	C	hom	hom	hom		QUAL=5693;DP=36,97,56;AF=1.00,1.00,1.00;MQM=60;SAP=24;ABP=0	PPT1	5'UTR	PPT1:ENST00000433473.3:5_prime_UTR_variant:MODIFIER:exon1/9:c.-83A>G::	PPT1:NM_000310.3:5_prime_UTR_variant:MODIFIER:exon1/9:c.-83A>G::	regulatory_region_variant:promoter	600722 [GENE=PPT1 PHENOS=Ceroid lipofuscinosis,neuronal,1,256730,Autosomal recessive];	297250 [benign DISEASE=Neuronal ceroid lipofuscinosis 1];			rs6600313	0.8327	0.8462	11305,.		-0.7110			0.01,0.11	9.62					0.0018	0.3367	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40563019	40563019	G	T	het	het	wt		QUAL=1551;DP=30,82,46;AF=0.60,0.54,0.02;MQM=60;SAP=7;ABP=6	PPT1	5'UTR	PPT1:ENST00000433473.3:5_prime_UTR_variant:MODIFIER:exon1/9:c.-109C>A::	PPT1:NM_000310.3:5_prime_UTR_variant:MODIFIER:exon1/9:c.-109C>A::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	600722 [GENE=PPT1 PHENOS=Ceroid lipofuscinosis,neuronal,1,256730,Autosomal recessive];	297251 [benign DISEASE=Neuronal ceroid lipofuscinosis 1];			rs41301070	0.1138	0.0926	180,.		-0.6360			0.04,0.12	4.13					0.0205	0.3376	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40735817	40735817	T	G	wt	wt	het	off-target	QUAL=327;DP=99,62,43;AF=0.00,0.00,0.40;MQM=60;SAP=4;ABP=7	ZMPSTE24	intron	ZMPSTE24:ENST00000372759.3:intron_variant:MODIFIER:intron5/9:c.627+18T>G::	ZMPSTE24:NM_005857.5:intron_variant:MODIFIER:intron5/9:c.627+18T>G::	regulatory_region_variant:open_chromatin_region	606480 [GENE=ZMPSTE24 PHENOS=Restrictive dermopathy,lethal,275210,Autosomal recessive/Mandibuloacral dysplasia with type B lipodystrophy,608612,Autosomal recessive];	140531 [benign DISEASE=not specified,not provided];			rs16827109	0.1154	0.1068	116,.	0.0627,0.1451,0.1617,0.0893,0.1472	0.1420			0.25,0.24	9.07					-0.1728	0.1247	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZMPSTE24 (inh=AR oe_syn=0.88 oe_mis=0.93 oe_lof=0.94)
chr1	40737516	40737516	T	G	hom	hom	hom	off-target	QUAL=11360;DP=124,126,105;AF=1.00,1.00,1.00;MQM=60;SAP=395;ABP=0	ZMPSTE24	intron	ZMPSTE24:ENST00000372759.3:intron_variant:MODIFIER:intron5/9:c.628-50T>G::	ZMPSTE24:NM_005857.5:intron_variant:MODIFIER:intron5/9:c.628-50T>G::		606480 [GENE=ZMPSTE24 PHENOS=Restrictive dermopathy,lethal,275210,Autosomal recessive/Mandibuloacral dysplasia with type B lipodystrophy,608612,Autosomal recessive];	140535 [benign DISEASE=not specified,not provided];			rs6677717		0.9851	15190,.	0.9983,0.9974,0.9999,0.9870,0.9859	-0.4140			0.00,0.07	4.45					-0.0694	0.0358	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZMPSTE24 (inh=AR oe_syn=0.88 oe_mis=0.93 oe_lof=0.94)
chr1	43198722	43198722	C	T	het	n/a	n/a	off-target	QUAL=171;DP=14,1,0;AF=0.64,1.00,;MQM=58;SAP=25;ABP=5	CLDN19	downstream_gene	CLDN19:ENST00000296387.1:downstream_gene_variant:MODIFIER::::,CLDN19:ENST00000372539.3:downstream_gene_variant:MODIFIER::::,CLDN19:ENST00000539749.1:downstream_gene_variant:MODIFIER::::						AluSg (SINE/Alu)	rs11210707		0.6374	6185,.		-0.2940			0.00,0.09	2.53								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLDN19 (inh=AR oe_syn=0.77 oe_mis=0.81 oe_lof=0.51)
chr1	43198748	43198748	-	TC	het	het	n/a	off-target	QUAL=231;DP=25,3,1;AF=0.60,0.33,0.00;MQM=53;SAP=38;ABP=4	CLDN19	downstream_gene	CLDN19:ENST00000296387.1:downstream_gene_variant:MODIFIER::::,CLDN19:ENST00000372539.3:downstream_gene_variant:MODIFIER::::,CLDN19:ENST00000539749.1:downstream_gene_variant:MODIFIER::::			610036 [GENE=CLDN19 PHENOS=Hypomagnesemia 5,renal,with ocular involvement,248190,Autosomal recessive];			AluSx1 (SINE/Alu)	rs200763067		0.0770	51,.						0.60								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLDN19 (inh=AR oe_syn=0.77 oe_mis=0.81 oe_lof=0.51)
chr1	43199024	43199024	C	T	het	het	wt		QUAL=6593;DP=211,332,253;AF=0.51,0.51,0.00;MQM=59;SAP=150;ABP=3	CLDN19	3'UTR	CLDN19:ENST00000296387.1:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1733G>A::,CLDN19:ENST00000539749.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*2409G>A::	CLDN19:NM_001123395.2:3_prime_UTR_variant:MODIFIER:exon4/4:c.*2515G>A::,CLDN19:NM_001185117.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*2409G>A::,CLDN19:NM_148960.3:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1733G>A::		610036 [GENE=CLDN19 PHENOS=Hypomagnesemia 5,renal,with ocular involvement,248190,Autosomal recessive];	297316 [benign DISEASE=Hypomagnesemia 5, renal, with ocular involvement];		AluSx1 (SINE/Alu)	rs112310775	0.1254	0.1267	247,.		-0.6940			0.00,0.06	0.69					-0.0057	0.8671		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLDN19 (inh=AR oe_syn=0.77 oe_mis=0.81 oe_lof=0.51)
chr1	43199115	43199115	A	G	het	het	wt		QUAL=10822;DP=399,441,353;AF=0.49,0.50,0.00;MQM=60;SAP=14;ABP=3	CLDN19	3'UTR	CLDN19:ENST00000296387.1:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1642T>C::,CLDN19:ENST00000539749.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*2318T>C::	CLDN19:NM_001123395.2:3_prime_UTR_variant:MODIFIER:exon4/4:c.*2424T>C::,CLDN19:NM_001185117.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*2318T>C::,CLDN19:NM_148960.3:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1642T>C::		610036 [GENE=CLDN19 PHENOS=Hypomagnesemia 5,renal,with ocular involvement,248190,Autosomal recessive];	297318 [benign DISEASE=Hypomagnesemia 5, renal, with ocular involvement];			rs56345167	0.1907	0.1884	614,.		0.4220			0.04,0.36	5.55					0.0117	0.8674		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLDN19 (inh=AR oe_syn=0.77 oe_mis=0.81 oe_lof=0.51)
chr1	43200526	43200526	T	C	het	het	het		QUAL=4984;DP=133,142,127;AF=0.49,0.51,0.43;MQM=60;SAP=4;ABP=5	CLDN19	3'UTR	CLDN19:ENST00000296387.1:3_prime_UTR_variant:MODIFIER:exon5/5:c.*231A>G::,CLDN19:ENST00000539749.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*907A>G::	CLDN19:NM_001123395.2:3_prime_UTR_variant:MODIFIER:exon4/4:c.*1013A>G::,CLDN19:NM_001185117.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*907A>G::,CLDN19:NM_148960.3:3_prime_UTR_variant:MODIFIER:exon5/5:c.*231A>G::	regulatory_region_variant:enhancer,regulatory_region_variant:CTCF_binding_site	610036 [GENE=CLDN19 PHENOS=Hypomagnesemia 5,renal,with ocular involvement,248190,Autosomal recessive];	297335 [benign DISEASE=Hypomagnesemia 5, renal, with ocular involvement];			rs912075	0.6068	0.5875	5473,.		-1.2490			0.00,0.06	5.44					0.0167	0.8675		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLDN19 (inh=AR oe_syn=0.77 oe_mis=0.81 oe_lof=0.51)
chr1	43200855	43200855	G	A	het	het	het		QUAL=7192;DP=115,253,210;AF=0.53,0.47,0.55;MQM=60;SAP=152;ABP=3	CLDN19	intron,3'UTR	CLDN19:ENST00000296387.1:intron_variant:MODIFIER:intron4/4:c.627-50C>T::,CLDN19:ENST00000372539.3:3_prime_UTR_variant:MODIFIER:exon4/4:c.*684C>T::,CLDN19:ENST00000539749.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*578C>T::	CLDN19:NM_001123395.2:3_prime_UTR_variant:MODIFIER:exon4/4:c.*684C>T::,CLDN19:NM_001185117.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*578C>T::,CLDN19:NM_148960.3:intron_variant:MODIFIER:intron4/4:c.627-50C>T::		610036 [GENE=CLDN19 PHENOS=Hypomagnesemia 5,renal,with ocular involvement,248190,Autosomal recessive];				rs74885359	0.0387	0.1031	227,.	0.0235,0.0526,0.0003,0.1380,0.0400	-0.7360			0.06,0.18	2.36					0.1422	0.8671	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLDN19 (inh=AR oe_syn=0.77 oe_mis=0.81 oe_lof=0.51)
chr1	43201216	43201216	A	C	het	het	het		QUAL=10360;DP=184,353,284;AF=0.45,0.49,0.49;MQM=60;SAP=4;ABP=5	CLDN19	intron,3'UTR	CLDN19:ENST00000296387.1:intron_variant:MODIFIER:intron4/4:c.626+333T>G::,CLDN19:ENST00000372539.3:3_prime_UTR_variant:MODIFIER:exon4/4:c.*323T>G::,CLDN19:ENST00000539749.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*217T>G::	CLDN19:NM_001123395.2:3_prime_UTR_variant:MODIFIER:exon4/4:c.*323T>G::,CLDN19:NM_001185117.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*217T>G::,CLDN19:NM_148960.3:intron_variant:MODIFIER:intron4/4:c.626+333T>G::	regulatory_region_variant:promoter_flanking_region,TF_binding_site_variant	610036 [GENE=CLDN19 PHENOS=Hypomagnesemia 5,renal,with ocular involvement,248190,Autosomal recessive];			L2b (LINE/L2)	rs12141833		0.5415	4773,.		-0.6380			0.00,0.11	3.20					0.004	0.8672	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLDN19 (inh=AR oe_syn=0.77 oe_mis=0.81 oe_lof=0.51)
chr1	43201534	43201534	G	A	het	het	wt		QUAL=4022;DP=85,242,175;AF=0.44,0.56,0.01;MQM=60;SAP=253;ABP=5	CLDN19	intron,3'UTR,missense	CLDN19:ENST00000296387.1:intron_variant:MODIFIER:intron4/4:c.626+15C>T::,CLDN19:ENST00000372539.3:3_prime_UTR_variant:MODIFIER:exon4/4:c.*5C>T::,CLDN19:ENST00000539749.1:missense_variant:MODERATE:exon3/3:c.556C>T:p.Arg186Cys:	CLDN19:NM_001123395.2:3_prime_UTR_variant:MODIFIER:exon4/4:c.*5C>T::,CLDN19:NM_001185117.1:missense_variant:MODERATE:exon3/3:c.556C>T:p.Arg186Cys:,CLDN19:NM_148960.3:intron_variant:MODIFIER:intron4/4:c.626+15C>T::	regulatory_region_variant:promoter_flanking_region	610036 [GENE=CLDN19 PHENOS=Hypomagnesemia 5,renal,with ocular involvement,248190,Autosomal recessive];	297339 [benign DISEASE=Hypomagnesemia 5, renal, with ocular involvement];			rs4660658	0.1905	0.1803	533,.	0.2412,0.2467,0.2450,0.1585,0.1289	-1.1640	 , ,T(0.07)	 , ,B(0.00)	0.02,0.20	2.11	0.12				0.1316	0.8671	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLDN19 (inh=AR oe_syn=0.77 oe_mis=0.81 oe_lof=0.51)
chr1	43212111	43212111	C	T	het	het	het		QUAL=9084;DP=295,206,180;AF=0.49,0.48,0.54;MQM=60;SAP=27;ABP=3	P3H1	3'UTR	P3H1:ENST00000236040.4:3_prime_UTR_variant:MODIFIER:exon14/14:c.*472G>A::,P3H1:ENST00000296388.5:3_prime_UTR_variant:MODIFIER:exon15/15:c.*257G>A::,P3H1:ENST00000397054.3:3_prime_UTR_variant:MODIFIER:exon15/15:c.*393G>A::	P3H1:NM_001146289.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*393G>A::,P3H1:NM_001243246.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*472G>A::,P3H1:NM_022356.4:3_prime_UTR_variant:MODIFIER:exon15/15:c.*257G>A::		610339 [GENE=P3H1 PHENOS=Osteogenesis imperfecta,type VIII,610915,Autosomal recessive];	873598 [benign DISEASE=Osteogenesis imperfecta type 8,Osteogenesis Imperfecta, Recessive];			rs6882	0.6625	0.6421	6503,.		0.1860			0.07,0.19	8.44					-0.0346	0.9398	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					P3H1 (inh=AR oe_syn=0.95 oe_mis=0.90 oe_lof=0.91)
chr1	43212431	43212431	A	G	hom	hom	hom		QUAL=21925;DP=215,344,210;AF=0.86,0.97,1.00;MQM=60;SAP=54;ABP=0	P3H1	3'UTR,synonymous	P3H1:ENST00000236040.4:3_prime_UTR_variant:MODIFIER:exon14/14:c.*152T>C::,P3H1:ENST00000296388.5:synonymous_variant:LOW:exon15/15:c.2148T>C:p.Gly716=:,P3H1:ENST00000397054.3:3_prime_UTR_variant:MODIFIER:exon15/15:c.*73T>C::	P3H1:NM_001146289.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*73T>C::,P3H1:NM_001243246.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*152T>C::,P3H1:NM_022356.4:synonymous_variant:LOW:exon15/15:c.2148T>C:p.Gly716=:		610339 [GENE=P3H1 PHENOS=Osteogenesis imperfecta,type VIII,610915,Autosomal recessive];	194558 [likely benign DISEASE=not specified];			rs4660662,rs752671524		1.0000	15690,.	0.9999,1.0000,1.0000,0.9998,1.0000	-0.1550			0.00,0.10	6.57				COSV52532087	0.0206	0.9404	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					P3H1 (inh=AR oe_syn=0.95 oe_mis=0.90 oe_lof=0.91)
chr1	43212869	43212869	A	T	het	het	wt		QUAL=2970;DP=110,126,74;AF=0.48,0.50,0.00;MQM=60;SAP=3;ABP=3	P3H1	missense,intron	P3H1:ENST00000236040.4:missense_variant:MODERATE:exon14/14:c.2129T>A:p.Phe710Tyr:,P3H1:ENST00000296388.5:intron_variant:MODIFIER:intron14/14:c.2055+74T>A::,P3H1:ENST00000397054.3:intron_variant:MODIFIER:intron14/14:c.2074+55T>A::	P3H1:NM_001146289.1:intron_variant:MODIFIER:intron14/14:c.2074+55T>A::,P3H1:NM_001243246.1:missense_variant:MODERATE:exon14/14:c.2129T>A:p.Phe710Tyr:,P3H1:NM_022356.4:intron_variant:MODIFIER:intron14/14:c.2055+74T>A::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	610339 [GENE=P3H1 PHENOS=Osteogenesis imperfecta,type VIII,610915,Autosomal recessive];	674902 [benign DISEASE=not provided];			rs3738496	0.1210	0.1309	213,.	0.0737,0.2078,0.2524,0.1144,0.0733	-0.0100	T(0.73), , 	B(0.03), , 	0.03,0.15	0.24	0.02				-0.1029	0.9239	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					P3H1 (inh=AR oe_syn=0.95 oe_mis=0.90 oe_lof=0.91)
chr1	43213499	43213499	C	T	het	het	het	off-target	QUAL=5991;DP=175,218,135;AF=0.47,0.48,0.49;MQM=60;SAP=137;ABP=5	P3H1	intron	P3H1:ENST00000236040.4:intron_variant:MODIFIER:intron12/13:c.1839-30G>A::,P3H1:ENST00000296388.5:intron_variant:MODIFIER:intron12/14:c.1839-30G>A::,P3H1:ENST00000397054.3:intron_variant:MODIFIER:intron12/14:c.1839-30G>A::	P3H1:NM_001146289.1:intron_variant:MODIFIER:intron12/14:c.1839-30G>A::,P3H1:NM_001243246.1:intron_variant:MODIFIER:intron12/13:c.1839-30G>A::,P3H1:NM_022356.4:intron_variant:MODIFIER:intron12/14:c.1839-30G>A::		610339 [GENE=P3H1 PHENOS=Osteogenesis imperfecta,type VIII,610915,Autosomal recessive];	674901 [benign DISEASE=not provided];			rs3738499	0.5541	0.6021	4705,.	0.3579,0.6219,0.6767,0.5938,0.6960	-0.8330			0.12,0.23	5.70					-0.0485	0.908	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					P3H1 (inh=AR oe_syn=0.95 oe_mis=0.90 oe_lof=0.91)
chr1	43228189	43228189	T	A	hom	hom	hom	off-target	QUAL=19123;DP=190,255,212;AF=0.99,1.00,1.00;MQM=60;SAP=533;ABP=0	P3H1	intron	P3H1:ENST00000236040.4:intron_variant:MODIFIER:intron1/13:c.466-43A>T::,P3H1:ENST00000296388.5:intron_variant:MODIFIER:intron1/14:c.466-43A>T::,P3H1:ENST00000397054.3:intron_variant:MODIFIER:intron1/14:c.466-43A>T::	P3H1:NM_001146289.1:intron_variant:MODIFIER:intron1/14:c.466-43A>T::,P3H1:NM_001243246.1:intron_variant:MODIFIER:intron1/13:c.466-43A>T::,P3H1:NM_022356.4:intron_variant:MODIFIER:intron1/14:c.466-43A>T::		610339 [GENE=P3H1 PHENOS=Osteogenesis imperfecta,type VIII,610915,Autosomal recessive];	674899 [benign DISEASE=not provided];			rs2816593		0.9866	15260,.	0.9973,0.9974,1.0000,0.9816,0.9927	-0.1870			0.00,0.08	4.37					0.0402	0.8283	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					P3H1 (inh=AR oe_syn=0.95 oe_mis=0.90 oe_lof=0.91), C1ORF50 (inh=n/a oe_syn=0.92 oe_mis=1.08 oe_lof=0.41)
chr1	43232798	43232798	G	T	wt	wt	het	off-target	QUAL=350;DP=8,19,27;AF=0.00,0.00,0.67;MQM=60;SAP=42;ABP=10	P3H1,C1orf50	upstream_gene	P3H1:ENST00000236040.4:upstream_gene_variant:MODIFIER::::,P3H1:ENST00000296388.5:upstream_gene_variant:MODIFIER::::,C1orf50:ENST00000372525.5:upstream_gene_variant:MODIFIER::::,P3H1:ENST00000397054.3:upstream_gene_variant:MODIFIER::::,C1orf50:ENST00000536543.1:upstream_gene_variant:MODIFIER::::		regulatory_region_variant:promoter					rs11210712	0.1384	0.2142	888,.		-0.0780			0.05,0.67	4.22								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					P3H1 (inh=AR oe_syn=0.95 oe_mis=0.90 oe_lof=0.91), C1ORF50 (inh=n/a oe_syn=0.92 oe_mis=1.08 oe_lof=0.41)
chr1	43232807	43232807	C	G	het	het	het	off-target	QUAL=606;DP=11,17,22;AF=0.73,0.59,0.64;MQM=60;SAP=72;ABP=12	P3H1,C1orf50	upstream_gene	P3H1:ENST00000236040.4:upstream_gene_variant:MODIFIER::::,P3H1:ENST00000296388.5:upstream_gene_variant:MODIFIER::::,C1orf50:ENST00000372525.5:upstream_gene_variant:MODIFIER::::,P3H1:ENST00000397054.3:upstream_gene_variant:MODIFIER::::,C1orf50:ENST00000536543.1:upstream_gene_variant:MODIFIER::::		regulatory_region_variant:promoter		674898 [benign DISEASE=not provided];			rs3738504	0.6496	0.5958	5582,.		0.9360			0.10,0.71	8.27								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					P3H1 (inh=AR oe_syn=0.95 oe_mis=0.90 oe_lof=0.91), C1ORF50 (inh=n/a oe_syn=0.92 oe_mis=1.08 oe_lof=0.41)
chr1	43392250	43392250	C	G	wt	wt	het		QUAL=2155;DP=289,266,227;AF=0.00,0.00,0.41;MQM=60;SAP=3;ABP=19	SLC2A1	3'UTR	SLC2A1:ENST00000426263.3:3_prime_UTR_variant:MODIFIER:exon10/10:c.*462G>C::	SLC2A1:NM_006516.3:3_prime_UTR_variant:MODIFIER:exon10/10:c.*462G>C::		138140 [GENE=SLC2A1 PHENOS=Dystonia 9,601042,Autosomal dominant/GLUT1 deficiency syndrome 1,infantile onset,severe,606777,Autosomal recessive,Autosomal dominant/Stomatin-deficient cryohydrocytosis with neurologic defects,608885,Autosomal dominant/GLUT1 deficiency syndrome 2,childhood onset,612126,Autosomal dominant/Epilepsy,idiopathic generalized,susceptibility to,12,614847,Autosomal dominant];	297374 [benign DISEASE=Dystonia 9,GLUT1 deficiency syndrome 1];			rs4658	0.3834	0.3369	2160,.		-0.3280			0.01,0.08	0.40					-0.0045	0.9205	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC2A1 (inh=AR+AD oe_syn=0.99 oe_mis=0.53 oe_lof=0.05)
chr1	43393245	43393245	-	GGTGAGAAAT	wt	het	het	off-target	QUAL=726;DP=177,77,99;AF=0.00,0.32,0.35;MQM=60;SAP=61;ABP=42	SLC2A1	intron	SLC2A1:ENST00000426263.3:intron_variant:MODIFIER:intron9/9:c.1278+30_1278+31insATTTCTCACC::	SLC2A1:NM_006516.3:intron_variant:MODIFIER:intron9/9:c.1278+30_1278+31insATTTCTCACC::		138140 [GENE=SLC2A1 PHENOS=Dystonia 9,601042,Autosomal dominant/GLUT1 deficiency syndrome 1,infantile onset,severe,606777,Autosomal recessive,Autosomal dominant/Stomatin-deficient cryohydrocytosis with neurologic defects,608885,Autosomal dominant/GLUT1 deficiency syndrome 2,childhood onset,612126,Autosomal dominant/Epilepsy,idiopathic generalized,susceptibility to,12,614847,Autosomal dominant];				rs3831326		0.5517	4915,.						2.73					0.1492	0.1156	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC2A1 (inh=AR+AD oe_syn=0.99 oe_mis=0.53 oe_lof=0.05)
chr1	43395635	43395635	C	T	wt	wt	het		QUAL=1558;DP=115,232,160;AF=0.00,0.00,0.43;MQM=60;SAP=71;ABP=11	SLC2A1	intron,synonymous	SLC2A1:ENST00000415851.2:intron_variant:MODIFIER:intron4/4:c.352-441G>A::,SLC2A1:ENST00000426263.3:synonymous_variant:LOW:exon5/10:c.588G>A:p.Pro196=:PF00083 [Sugar (and other) transporter]	SLC2A1:NM_006516.3:synonymous_variant:LOW:exon5/10:c.588G>A:p.Pro196=:		138140 [GENE=SLC2A1 PHENOS=Dystonia 9,601042,Autosomal dominant/GLUT1 deficiency syndrome 1,infantile onset,severe,606777,Autosomal recessive,Autosomal dominant/Stomatin-deficient cryohydrocytosis with neurologic defects,608885,Autosomal dominant/GLUT1 deficiency syndrome 2,childhood onset,612126,Autosomal dominant/Epilepsy,idiopathic generalized,susceptibility to,12,614847,Autosomal dominant];	95414 [benign DISEASE=Dystonia 9,GLUT1 deficiency syndrome 1,History of neurodevelopmental disorder,not specified];			rs2229682	0.1196	0.1845	470,.	0.0418,0.1995,0.0761,0.2078,0.1880	-4.4130			0.10,0.48	8.43					-0.0886	0.3805	0.13	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC2A1 (inh=AR+AD oe_syn=0.99 oe_mis=0.53 oe_lof=0.05)
chr1	43396414	43396414	G	A	wt	wt	het		QUAL=2460;DP=252,166,154;AF=0.00,0.01,0.62;MQM=60;SAP=5;ABP=21	SLC2A1	synonymous,intron	SLC2A1:ENST00000372500.3:synonymous_variant:LOW:exon4/4:c.399C>T:p.Cys133=:PF00083 [Sugar (and other) transporter],SLC2A1:ENST00000415851.2:intron_variant:MODIFIER:intron4/4:c.351+48C>T::,SLC2A1:ENST00000426263.3:synonymous_variant:LOW:exon4/10:c.399C>T:p.Cys133=:PF00083 [Sugar (and other) transporter]	SLC2A1:NM_006516.3:synonymous_variant:LOW:exon4/10:c.399C>T:p.Cys133=:		138140 [GENE=SLC2A1 PHENOS=Dystonia 9,601042,Autosomal dominant/GLUT1 deficiency syndrome 1,infantile onset,severe,606777,Autosomal recessive,Autosomal dominant/Stomatin-deficient cryohydrocytosis with neurologic defects,608885,Autosomal dominant/GLUT1 deficiency syndrome 2,childhood onset,612126,Autosomal dominant/Epilepsy,idiopathic generalized,susceptibility to,12,614847,Autosomal dominant];	95411 [benign DISEASE=Dystonia 9,GLUT1 deficiency syndrome 1,History of neurodevelopmental disorder,not specified,not provided];			rs11537641	0.1414	0.1897	499,.	0.0925,0.2031,0.0999,0.2048,0.1983	-1.1810			0.20,0.77	9.71					0.3148	0.9504	0.05	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC2A1 (inh=AR+AD oe_syn=0.99 oe_mis=0.53 oe_lof=0.05)
chr1	43408966	43408966	G	A	het	wt	het		QUAL=7402;DP=289,487,349;AF=0.44,0.00,0.52;MQM=60;SAP=68;ABP=4	SLC2A1	synonymous	SLC2A1:ENST00000372500.3:synonymous_variant:LOW:exon2/4:c.45C>T:p.Ala15=:,SLC2A1:ENST00000415851.2:synonymous_variant:LOW:exon2/5:c.45C>T:p.Ala15=:,SLC2A1:ENST00000426263.3:synonymous_variant:LOW:exon2/10:c.45C>T:p.Ala15=:	SLC2A1:NM_006516.3:synonymous_variant:LOW:exon2/10:c.45C>T:p.Ala15=:		138140 [GENE=SLC2A1 PHENOS=Dystonia 9,601042,Autosomal dominant/GLUT1 deficiency syndrome 1,infantile onset,severe,606777,Autosomal recessive,Autosomal dominant/Stomatin-deficient cryohydrocytosis with neurologic defects,608885,Autosomal dominant/GLUT1 deficiency syndrome 2,childhood onset,612126,Autosomal dominant/Epilepsy,idiopathic generalized,susceptibility to,12,614847,Autosomal dominant];	95413 [benign DISEASE=Dystonia 9,GLUT1 deficiency syndrome 1,History of neurodevelopmental disorder,not specified];			rs1385129	0.2404	0.2416	757,.	0.1769,0.3054,0.2876,0.2187,0.2675	-2.2290			0.12,0.61	11.78					-0.1985	0.0427	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC2A1 (inh=AR+AD oe_syn=0.99 oe_mis=0.53 oe_lof=0.05)
chr1	43812075	43812075	G	A	het	het	wt	off-target	QUAL=3880;DP=138,148,111;AF=0.58,0.53,0.01;MQM=60;SAP=225;ABP=11	MPL	intron	MPL:ENST00000372470.3:intron_variant:MODIFIER:intron6/11:c.981-41G>A::,MPL:ENST00000413998.2:intron_variant:MODIFIER:intron6/9:c.981-41G>A::	MPL:NM_005373.3:intron_variant:MODIFIER:intron6/11:c.981-41G>A::	regulatory_region_variant:promoter_flanking_region	159530 [GENE=MPL PHENOS=Myelofibrosis with myeloid metaplasia,somatic,254450/Thrombocytopenia,congenital amegakaryocytic,604498,Autosomal recessive/Thrombocythemia 2,601977,Somatic mutation,Autosomal dominant];	259760 [benign DISEASE=not specified];			rs1760670	0.2097	0.3034	1540,.	0.2200,0.3028,0.0676,0.3792,0.1450	0.6670			0.02,0.18	4.83					-0.0045	0.3486	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MPL (inh=AR+AD oe_syn=0.74 oe_mis=0.94 oe_lof=0.53)
chr1	43820193	43820193	G	A	wt	wt	het	off-target	QUAL=1537;DP=182,119,121;AF=0.00,0.01,0.51;MQM=60;SAP=55;ABP=3	CDC20,MPL,RP1-92O14.3	upstream_gene,downstream_gene	CDC20:ENST00000310955.6:upstream_gene_variant:MODIFIER::::,CDC20:ENST00000372462.1:upstream_gene_variant:MODIFIER::::,MPL:ENST00000372470.3:downstream_gene_variant:MODIFIER::::,MPL:ENST00000413998.2:downstream_gene_variant:MODIFIER::::,RP1-92O14.3:ENST00000424948.1:downstream_gene_variant:MODIFIER::::							rs79064184	0.0295	0.0403	43,.		0.0230			0.00,0.07	0.49								1	18	0 / 0					MPL (inh=AR+AD oe_syn=0.74 oe_mis=0.94 oe_lof=0.53), CDC20 (inh=n/a oe_syn=0.86 oe_mis=0.70 oe_lof=0.54)
chr1	44290530	44290530	A	G	het	hom	het		QUAL=7874;DP=265,112,116;AF=0.46,0.98,0.41;MQM=60;SAP=26;ABP=13	ST3GAL3	missense,intron	ST3GAL3:ENST00000262915.3:missense_variant:MODERATE:exon5/13:c.382A>G:p.Thr128Ala:,ST3GAL3:ENST00000330208.2:intron_variant:MODIFIER:intron4/6:c.209+9925A>G::,ST3GAL3:ENST00000332628.6:intron_variant:MODIFIER:intron3/9:c.209+9925A>G::,ST3GAL3:ENST00000335430.6:intron_variant:MODIFIER:intron3/9:c.161+9925A>G::,ST3GAL3:ENST00000347631.2:intron_variant:MODIFIER:intron4/11:c.254+9925A>G::,ST3GAL3:ENST00000351035.3:missense_variant:MODERATE:exon4/12:c.289A>G:p.Thr97Ala:,ST3GAL3:ENST00000353126.3:intron_variant:MODIFIER:intron4/9:c.209+9925A>G::,ST3GAL3:ENST00000361392.4:intron_variant:MODIFIER:intron4/11:c.209+9925A>G::,ST3GAL3:ENST00000361400.4:intron_variant:MODIFIER:intron3/10:c.161+9925A>G::,ST3GAL3:ENST00000361746.4:missense_variant:MODERATE:exon4/12:c.382A>G:p.Thr128Ala:,ST3GAL3:ENST00000361812.4:intron_variant:MODIFIER:intron3/5:c.254+9925A>G::,ST3GAL3:ENST00000372362.2:intron_variant:MODIFIER:intron3/5:c.209+9925A>G::,ST3GAL3:ENST00000372365.1:intron_variant:MODIFIER:intron3/7:c.209+9925A>G::,ST3GAL3:ENST00000372366.1:intron_variant:MODIFIER:intron2/6:c.206+9925A>G::,ST3GAL3:ENST00000372367.1:intron_variant:MODIFIER:intron2/6:c.206+9925A>G::,ST3GAL3:ENST00000372368.2:missense_variant:MODERATE:exon4/12:c.337A>G:p.Thr113Ala:,ST3GAL3:ENST00000372369.1:intron_variant:MODIFIER:intron3/10:c.209+9925A>G::,ST3GAL3:ENST00000372372.2:missense_variant:MODERATE:exon3/11:c.289A>G:p.Thr97Ala:,ST3GAL3:ENST00000372374.2:intron_variant:MODIFIER:intron4/10:c.209+9925A>G::,ST3GAL3:ENST00000372375.2:missense_variant:MODERATE:exon5/13:c.337A>G:p.Thr113Ala:,ST3GAL3:ENST00000372377.4:intron_variant:MODIFIER:intron4/8:c.209+9925A>G::,ST3GAL3:ENST00000528371.1:intron_variant:MODIFIER:intron2/6:c.161+9925A>G::,ST3GAL3:ENST00000531451.1:intron_variant:MODIFIER:intron2/4:c.161+9925A>G::,ST3GAL3:ENST00000531816.1:intron_variant:MODIFIER:intron2/3:c.161+9925A>G::,ST3GAL3:ENST00000531993.1:intron_variant:MODIFIER:intron2/7:c.161+9925A>G::,ST3GAL3:ENST00000533933.1:intron_variant:MODIFIER:intron3/8:c.209+9925A>G::,ST3GAL3:ENST00000545417.1:intron_variant:MODIFIER:intron4/6:c.254+9925A>G::	ST3GAL3:NM_001270459.2:intron_variant:MODIFIER:intron4/11:c.209+9925A>G::,ST3GAL3:NM_001270460.2:intron_variant:MODIFIER:intron4/10:c.209+9925A>G::,ST3GAL3:NM_001270461.3:intron_variant:MODIFIER:intron3/8:c.161+9925A>G::,ST3GAL3:NM_001270462.3:intron_variant:MODIFIER:intron3/7:c.161+9925A>G::,ST3GAL3:NM_001270463.3:intron_variant:MODIFIER:intron3/7:c.206+9925A>G::,ST3GAL3:NM_001270464.3:intron_variant:MODIFIER:intron3/7:c.161+9925A>G::,ST3GAL3:NM_001270465.2:intron_variant:MODIFIER:intron3/7:c.206+9925A>G::,ST3GAL3:NM_001270466.2:intron_variant:MODIFIER:intron3/4:c.161+9925A>G::,ST3GAL3:NM_001350619.2:intron_variant:MODIFIER:intron4/12:c.254+9925A>G::,ST3GAL3:NM_001350620.2:intron_variant:MODIFIER:intron4/12:c.209+9925A>G::,ST3GAL3:NM_001350621.2:intron_variant:MODIFIER:intron4/13:c.-245+9925A>G::,ST3GAL3:NM_001363573.2:missense_variant:MODERATE:exon5/11:c.337A>G:p.Thr113Ala:,ST3GAL3:NM_006279.5:intron_variant:MODIFIER:intron4/11:c.209+9925A>G::,ST3GAL3:NM_174963.5:missense_variant:MODERATE:exon5/13:c.382A>G:p.Thr128Ala:,ST3GAL3:NM_174964.4:intron_variant:MODIFIER:intron4/11:c.254+9925A>G::,ST3GAL3:NM_174965.3:intron_variant:MODIFIER:intron4/6:c.254+9925A>G::,ST3GAL3:NM_174966.4:intron_variant:MODIFIER:intron4/9:c.209+9925A>G::,ST3GAL3:NM_174967.4:intron_variant:MODIFIER:intron4/6:c.209+9925A>G::,ST3GAL3:NM_174968.5:missense_variant:MODERATE:exon5/13:c.337A>G:p.Thr113Ala:,ST3GAL3:NM_174969.4:intron_variant:MODIFIER:intron3/10:c.161+9925A>G::,ST3GAL3:NM_174970.4:intron_variant:MODIFIER:intron3/5:c.161+9925A>G::,ST3GAL3:NM_174971.5:missense_variant:MODERATE:exon4/12:c.289A>G:p.Thr97Ala:,ST3GAL3:NR_073016.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/11:n.397+9925A>G::,ST3GAL3:NR_073017.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/9:n.307-13361A>G::,ST3GAL3:NR_073018.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/10:n.397+9925A>G::,ST3GAL3:NR_073019.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/8:n.307-69525A>G::,ST3GAL3:NR_073020.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/9:n.349+9925A>G::,ST3GAL3:NR_073021.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/9:n.397+9925A>G::,ST3GAL3:NR_073023.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.397+9925A>G::,ST3GAL3:NR_146867.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/12:n.397+9925A>G::	regulatory_region_variant:promoter_flanking_region	606494 [GENE=ST3GAL3 PHENOS=Mental retardation,autosomal recessive 12,611090,Autosomal recessive/Developmental and epileptic encephalopathy 15,615006,Autosomal recessive];	130378 [benign DISEASE=not specified,not provided];		MER5B (DNA/hAT-Charlie)	rs37458	0.2364	0.3200	1653,.	0.3232,0.2169,0.1363,0.3575,0.1441	-0.1510	T(0.74), , , , ,T(0.74), , , ,T(0.74), , , , , ,T(0.70), ,T(0.74), ,T(0.70), , , , , , , 	B(0.00), , , , ,B(0.00), , , ,B(0.00), , , , , ,B(0.00), ,B(0.00), ,B(0.00), , , , , , , 	0.00,0.06	0.11	0.01				0.2694	0.2477	0.13	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ST3GAL3 (inh=AR oe_syn=0.97 oe_mis=0.74 oe_lof=0.36)
chr1	44365457	44365457	A	G	het	het	wt	off-target	QUAL=3652;DP=139,157,106;AF=0.48,0.56,0.00;MQM=60;SAP=215;ABP=4	ST3GAL3	intron	ST3GAL3:ENST00000262915.3:intron_variant:MODIFIER:intron10/12:c.951+58A>G::,ST3GAL3:ENST00000330208.2:intron_variant:MODIFIER:intron6/6:c.397+5308A>G::,ST3GAL3:ENST00000332628.6:intron_variant:MODIFIER:intron7/9:c.651+58A>G::,ST3GAL3:ENST00000335430.6:intron_variant:MODIFIER:intron7/9:c.509+522A>G::,ST3GAL3:ENST00000347631.2:intron_variant:MODIFIER:intron9/11:c.789+58A>G::,ST3GAL3:ENST00000351035.3:intron_variant:MODIFIER:intron9/11:c.858+58A>G::,ST3GAL3:ENST00000353126.3:intron_variant:MODIFIER:intron9/9:c.744+58A>G::,ST3GAL3:ENST00000361392.4:intron_variant:MODIFIER:intron9/11:c.744+58A>G::,ST3GAL3:ENST00000361400.4:intron_variant:MODIFIER:intron8/10:c.696+58A>G::,ST3GAL3:ENST00000361746.4:intron_variant:MODIFIER:intron9/11:c.951+58A>G::,ST3GAL3:ENST00000361812.4:intron_variant:MODIFIER:intron5/5:c.442+5308A>G::,ST3GAL3:ENST00000372362.2:intron_variant:MODIFIER:intron5/5:c.397+5308A>G::,ST3GAL3:ENST00000372365.1:intron_variant:MODIFIER:intron7/7:c.*22+496A>G::,ST3GAL3:ENST00000372366.1:intron_variant:MODIFIER:intron6/6:c.*22+496A>G::,ST3GAL3:ENST00000372367.1:intron_variant:MODIFIER:intron6/6:c.554+522A>G::,ST3GAL3:ENST00000372368.2:intron_variant:MODIFIER:intron9/11:c.906+58A>G::,ST3GAL3:ENST00000372369.1:intron_variant:MODIFIER:intron8/10:c.744+58A>G::,ST3GAL3:ENST00000372372.2:intron_variant:MODIFIER:intron8/10:c.858+58A>G::,ST3GAL3:ENST00000372374.2:intron_variant:MODIFIER:intron8/10:c.651+58A>G::,ST3GAL3:ENST00000372375.2:intron_variant:MODIFIER:intron10/12:c.906+58A>G::,ST3GAL3:ENST00000372377.4:intron_variant:MODIFIER:intron6/8:c.397+5308A>G::,ST3GAL3:ENST00000528371.1:intron_variant:MODIFIER:intron6/6:c.509+522A>G::,ST3GAL3:ENST00000531451.1:intron_variant:MODIFIER:intron4/4:c.349+5308A>G::,ST3GAL3:ENST00000531816.1:intron_variant:MODIFIER:intron3/3:c.255-30347A>G::,ST3GAL3:ENST00000531993.1:intron_variant:MODIFIER:intron7/7:c.696+58A>G::,ST3GAL3:ENST00000533933.1:intron_variant:MODIFIER:intron8/8:c.744+58A>G::,ST3GAL3:ENST00000545417.1:intron_variant:MODIFIER:intron6/6:c.442+5308A>G::	ST3GAL3:NM_001270459.2:intron_variant:MODIFIER:intron9/11:c.744+58A>G::,ST3GAL3:NM_001270460.2:intron_variant:MODIFIER:intron8/10:c.651+58A>G::,ST3GAL3:NM_001270461.3:intron_variant:MODIFIER:intron8/8:c.696+58A>G::,ST3GAL3:NM_001270462.3:intron_variant:MODIFIER:intron7/7:c.603+58A>G::,ST3GAL3:NM_001270463.3:intron_variant:MODIFIER:intron7/7:c.554+522A>G::,ST3GAL3:NM_001270464.3:intron_variant:MODIFIER:intron7/7:c.509+522A>G::,ST3GAL3:NM_001270465.2:intron_variant:MODIFIER:intron7/7:c.*22+496A>G::,ST3GAL3:NM_001270466.2:intron_variant:MODIFIER:intron4/4:c.255-30347A>G::,ST3GAL3:NM_001350619.2:intron_variant:MODIFIER:intron9/12:c.789+58A>G::,ST3GAL3:NM_001350620.2:intron_variant:MODIFIER:intron9/12:c.744+58A>G::,ST3GAL3:NM_001350621.2:intron_variant:MODIFIER:intron10/13:c.465+58A>G::,ST3GAL3:NM_001363573.2:intron_variant:MODIFIER:intron10/10:c.906+58A>G::,ST3GAL3:NM_006279.5:intron_variant:MODIFIER:intron9/11:c.744+58A>G::,ST3GAL3:NM_174963.5:intron_variant:MODIFIER:intron10/12:c.951+58A>G::,ST3GAL3:NM_174964.4:intron_variant:MODIFIER:intron9/11:c.789+58A>G::,ST3GAL3:NM_174965.3:intron_variant:MODIFIER:intron6/6:c.442+5308A>G::,ST3GAL3:NM_174966.4:intron_variant:MODIFIER:intron9/9:c.744+58A>G::,ST3GAL3:NM_174967.4:intron_variant:MODIFIER:intron6/6:c.397+5308A>G::,ST3GAL3:NM_174968.5:intron_variant:MODIFIER:intron10/12:c.906+58A>G::,ST3GAL3:NM_174969.4:intron_variant:MODIFIER:intron8/10:c.696+58A>G::,ST3GAL3:NM_174970.4:intron_variant:MODIFIER:intron5/5:c.349+5308A>G::,ST3GAL3:NM_174971.5:intron_variant:MODIFIER:intron9/11:c.858+58A>G::,ST3GAL3:NR_073016.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron9/11:n.964+58A>G::,ST3GAL3:NR_073017.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/9:n.841+58A>G::,ST3GAL3:NR_073018.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron10/10:n.1105+58A>G::,ST3GAL3:NR_073019.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/8:n.780+58A>G::,ST3GAL3:NR_073020.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/9:n.697+522A>G::,ST3GAL3:NR_073021.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron9/9:n.919+522A>G::,ST3GAL3:NR_073023.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/8:n.585+5308A>G::,ST3GAL3:NR_146867.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron9/12:n.964+58A>G::		606494 [GENE=ST3GAL3 PHENOS=Mental retardation,autosomal recessive 12,611090,Autosomal recessive/Developmental and epileptic encephalopathy 15,615006,Autosomal recessive];				rs783304	0.2804	0.2240	1009,.		-0.1060			0.01,0.09	5.85					-0.1373	0.4244	0.04	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ST3GAL3 (inh=AR oe_syn=0.97 oe_mis=0.74 oe_lof=0.36)
chr1	44386615	44386615	A	G	hom	hom	hom	off-target	QUAL=11934;DP=76,210,127;AF=0.99,1.00,0.98;MQM=60;SAP=228;ABP=0	ST3GAL3	intron	ST3GAL3:ENST00000262915.3:intron_variant:MODIFIER:intron12/12:c.1245+15A>G::,ST3GAL3:ENST00000330208.2:intron_variant:MODIFIER:intron6/6:c.398-9189A>G::,ST3GAL3:ENST00000332628.6:intron_variant:MODIFIER:intron9/9:c.945+15A>G::,ST3GAL3:ENST00000335430.6:intron_variant:MODIFIER:intron9/9:c.*116+15A>G::,ST3GAL3:ENST00000347631.2:intron_variant:MODIFIER:intron11/11:c.1083+15A>G::,ST3GAL3:ENST00000351035.3:intron_variant:MODIFIER:intron11/11:c.1152+15A>G::,ST3GAL3:ENST00000353126.3:intron_variant:MODIFIER:intron9/9:c.745-9189A>G::,ST3GAL3:ENST00000361392.4:intron_variant:MODIFIER:intron11/11:c.1038+15A>G::,ST3GAL3:ENST00000361400.4:intron_variant:MODIFIER:intron10/10:c.990+15A>G::,ST3GAL3:ENST00000361746.4:intron_variant:MODIFIER:intron11/11:c.1245+15A>G::,ST3GAL3:ENST00000361812.4:intron_variant:MODIFIER:intron5/5:c.443-9189A>G::,ST3GAL3:ENST00000372362.2:intron_variant:MODIFIER:intron5/5:c.398-9189A>G::,ST3GAL3:ENST00000372365.1:intron_variant:MODIFIER:intron7/7:c.*23-9189A>G::,ST3GAL3:ENST00000372366.1:intron_variant:MODIFIER:intron6/6:c.*23-9189A>G::,ST3GAL3:ENST00000372367.1:intron_variant:MODIFIER:intron6/6:c.555-9189A>G::,ST3GAL3:ENST00000372368.2:intron_variant:MODIFIER:intron11/11:c.1200+15A>G::,ST3GAL3:ENST00000372369.1:intron_variant:MODIFIER:intron10/10:c.948+15A>G::,ST3GAL3:ENST00000372372.2:intron_variant:MODIFIER:intron10/10:c.1152+15A>G::,ST3GAL3:ENST00000372374.2:intron_variant:MODIFIER:intron10/10:c.945+15A>G::,ST3GAL3:ENST00000372375.2:intron_variant:MODIFIER:intron12/12:c.1200+15A>G::,ST3GAL3:ENST00000372377.4:intron_variant:MODIFIER:intron8/8:c.*235+15A>G::,ST3GAL3:ENST00000528371.1:intron_variant:MODIFIER:intron6/6:c.510-9189A>G::,ST3GAL3:ENST00000531451.1:intron_variant:MODIFIER:intron4/4:c.350-9189A>G::,ST3GAL3:ENST00000531816.1:intron_variant:MODIFIER:intron3/3:c.255-9189A>G::,ST3GAL3:ENST00000531993.1:intron_variant:MODIFIER:intron7/7:c.697-9189A>G::,ST3GAL3:ENST00000533933.1:intron_variant:MODIFIER:intron8/8:c.745-9189A>G::,ST3GAL3:ENST00000545417.1:intron_variant:MODIFIER:intron6/6:c.443-9189A>G::	ST3GAL3:NM_001270459.2:intron_variant:MODIFIER:intron11/11:c.948+15A>G::,ST3GAL3:NM_001270460.2:intron_variant:MODIFIER:intron10/10:c.945+15A>G::,ST3GAL3:NM_001270461.3:intron_variant:MODIFIER:intron8/8:c.697-9189A>G::,ST3GAL3:NM_001270462.3:intron_variant:MODIFIER:intron7/7:c.604-9189A>G::,ST3GAL3:NM_001270463.3:intron_variant:MODIFIER:intron7/7:c.555-9189A>G::,ST3GAL3:NM_001270464.3:intron_variant:MODIFIER:intron7/7:c.510-9189A>G::,ST3GAL3:NM_001270465.2:intron_variant:MODIFIER:intron7/7:c.*23-9189A>G::,ST3GAL3:NM_001270466.2:intron_variant:MODIFIER:intron4/4:c.255-9189A>G::,ST3GAL3:NM_001350619.2:intron_variant:MODIFIER:intron11/12:c.1083+15A>G::,ST3GAL3:NM_001350620.2:intron_variant:MODIFIER:intron11/12:c.1038+15A>G::,ST3GAL3:NM_001350621.2:intron_variant:MODIFIER:intron12/13:c.759+15A>G::,ST3GAL3:NM_001363573.2:intron_variant:MODIFIER:intron10/10:c.907-9189A>G::,ST3GAL3:NM_006279.5:intron_variant:MODIFIER:intron11/11:c.1038+15A>G::,ST3GAL3:NM_174963.5:intron_variant:MODIFIER:intron12/12:c.1245+15A>G::,ST3GAL3:NM_174964.4:intron_variant:MODIFIER:intron11/11:c.1083+15A>G::,ST3GAL3:NM_174965.3:intron_variant:MODIFIER:intron6/6:c.443-9189A>G::,ST3GAL3:NM_174966.4:intron_variant:MODIFIER:intron9/9:c.745-9189A>G::,ST3GAL3:NM_174967.4:intron_variant:MODIFIER:intron6/6:c.398-9189A>G::,ST3GAL3:NM_174968.5:intron_variant:MODIFIER:intron12/12:c.1200+15A>G::,ST3GAL3:NM_174969.4:intron_variant:MODIFIER:intron10/10:c.990+15A>G::,ST3GAL3:NM_174970.4:intron_variant:MODIFIER:intron5/5:c.350-9189A>G::,ST3GAL3:NM_174971.5:intron_variant:MODIFIER:intron11/11:c.1152+15A>G::,ST3GAL3:NR_073016.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron11/11:n.1258+15A>G::,ST3GAL3:NR_073017.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron9/9:n.1135+15A>G::,ST3GAL3:NR_073018.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron10/10:n.1106-9189A>G::,ST3GAL3:NR_073019.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron8/8:n.1074+15A>G::,ST3GAL3:NR_073020.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron9/9:n.991+15A>G::,ST3GAL3:NR_073021.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron9/9:n.920-9189A>G::,ST3GAL3:NR_073023.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron8/8:n.879+15A>G::,ST3GAL3:NR_146867.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron11/12:n.1258+15A>G::		606494 [GENE=ST3GAL3 PHENOS=Mental retardation,autosomal recessive 12,611090,Autosomal recessive/Developmental and epileptic encephalopathy 15,615006,Autosomal recessive];	262909 [benign DISEASE=not specified];			rs3120803		0.8813	11468,.	0.6951,0.8484,0.8544,0.9213,0.8667	-1.1910			0.00,0.06	1.00					-0.0874	0.3622	0.29	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ST3GAL3 (inh=AR oe_syn=0.97 oe_mis=0.74 oe_lof=0.36)
chr1	44386642	44386642	G	C	het	het	wt	off-target	QUAL=3455;DP=84,157,94;AF=0.52,0.64,0.00;MQM=60;SAP=125;ABP=23	ST3GAL3	intron	ST3GAL3:ENST00000262915.3:intron_variant:MODIFIER:intron12/12:c.1245+42G>C::,ST3GAL3:ENST00000330208.2:intron_variant:MODIFIER:intron6/6:c.398-9162G>C::,ST3GAL3:ENST00000332628.6:intron_variant:MODIFIER:intron9/9:c.945+42G>C::,ST3GAL3:ENST00000335430.6:intron_variant:MODIFIER:intron9/9:c.*116+42G>C::,ST3GAL3:ENST00000347631.2:intron_variant:MODIFIER:intron11/11:c.1083+42G>C::,ST3GAL3:ENST00000351035.3:intron_variant:MODIFIER:intron11/11:c.1152+42G>C::,ST3GAL3:ENST00000353126.3:intron_variant:MODIFIER:intron9/9:c.745-9162G>C::,ST3GAL3:ENST00000361392.4:intron_variant:MODIFIER:intron11/11:c.1038+42G>C::,ST3GAL3:ENST00000361400.4:intron_variant:MODIFIER:intron10/10:c.990+42G>C::,ST3GAL3:ENST00000361746.4:intron_variant:MODIFIER:intron11/11:c.1245+42G>C::,ST3GAL3:ENST00000361812.4:intron_variant:MODIFIER:intron5/5:c.443-9162G>C::,ST3GAL3:ENST00000372362.2:intron_variant:MODIFIER:intron5/5:c.398-9162G>C::,ST3GAL3:ENST00000372365.1:intron_variant:MODIFIER:intron7/7:c.*23-9162G>C::,ST3GAL3:ENST00000372366.1:intron_variant:MODIFIER:intron6/6:c.*23-9162G>C::,ST3GAL3:ENST00000372367.1:intron_variant:MODIFIER:intron6/6:c.555-9162G>C::,ST3GAL3:ENST00000372368.2:intron_variant:MODIFIER:intron11/11:c.1200+42G>C::,ST3GAL3:ENST00000372369.1:intron_variant:MODIFIER:intron10/10:c.948+42G>C::,ST3GAL3:ENST00000372372.2:intron_variant:MODIFIER:intron10/10:c.1152+42G>C::,ST3GAL3:ENST00000372374.2:intron_variant:MODIFIER:intron10/10:c.945+42G>C::,ST3GAL3:ENST00000372375.2:intron_variant:MODIFIER:intron12/12:c.1200+42G>C::,ST3GAL3:ENST00000372377.4:intron_variant:MODIFIER:intron8/8:c.*235+42G>C::,ST3GAL3:ENST00000528371.1:intron_variant:MODIFIER:intron6/6:c.510-9162G>C::,ST3GAL3:ENST00000531451.1:intron_variant:MODIFIER:intron4/4:c.350-9162G>C::,ST3GAL3:ENST00000531816.1:intron_variant:MODIFIER:intron3/3:c.255-9162G>C::,ST3GAL3:ENST00000531993.1:intron_variant:MODIFIER:intron7/7:c.697-9162G>C::,ST3GAL3:ENST00000533933.1:intron_variant:MODIFIER:intron8/8:c.745-9162G>C::,ST3GAL3:ENST00000545417.1:intron_variant:MODIFIER:intron6/6:c.443-9162G>C::	ST3GAL3:NM_001270459.2:intron_variant:MODIFIER:intron11/11:c.948+42G>C::,ST3GAL3:NM_001270460.2:intron_variant:MODIFIER:intron10/10:c.945+42G>C::,ST3GAL3:NM_001270461.3:intron_variant:MODIFIER:intron8/8:c.697-9162G>C::,ST3GAL3:NM_001270462.3:intron_variant:MODIFIER:intron7/7:c.604-9162G>C::,ST3GAL3:NM_001270463.3:intron_variant:MODIFIER:intron7/7:c.555-9162G>C::,ST3GAL3:NM_001270464.3:intron_variant:MODIFIER:intron7/7:c.510-9162G>C::,ST3GAL3:NM_001270465.2:intron_variant:MODIFIER:intron7/7:c.*23-9162G>C::,ST3GAL3:NM_001270466.2:intron_variant:MODIFIER:intron4/4:c.255-9162G>C::,ST3GAL3:NM_001350619.2:intron_variant:MODIFIER:intron11/12:c.1083+42G>C::,ST3GAL3:NM_001350620.2:intron_variant:MODIFIER:intron11/12:c.1038+42G>C::,ST3GAL3:NM_001350621.2:intron_variant:MODIFIER:intron12/13:c.759+42G>C::,ST3GAL3:NM_001363573.2:intron_variant:MODIFIER:intron10/10:c.907-9162G>C::,ST3GAL3:NM_006279.5:intron_variant:MODIFIER:intron11/11:c.1038+42G>C::,ST3GAL3:NM_174963.5:intron_variant:MODIFIER:intron12/12:c.1245+42G>C::,ST3GAL3:NM_174964.4:intron_variant:MODIFIER:intron11/11:c.1083+42G>C::,ST3GAL3:NM_174965.3:intron_variant:MODIFIER:intron6/6:c.443-9162G>C::,ST3GAL3:NM_174966.4:intron_variant:MODIFIER:intron9/9:c.745-9162G>C::,ST3GAL3:NM_174967.4:intron_variant:MODIFIER:intron6/6:c.398-9162G>C::,ST3GAL3:NM_174968.5:intron_variant:MODIFIER:intron12/12:c.1200+42G>C::,ST3GAL3:NM_174969.4:intron_variant:MODIFIER:intron10/10:c.990+42G>C::,ST3GAL3:NM_174970.4:intron_variant:MODIFIER:intron5/5:c.350-9162G>C::,ST3GAL3:NM_174971.5:intron_variant:MODIFIER:intron11/11:c.1152+42G>C::,ST3GAL3:NR_073016.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron11/11:n.1258+42G>C::,ST3GAL3:NR_073017.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron9/9:n.1135+42G>C::,ST3GAL3:NR_073018.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron10/10:n.1106-9162G>C::,ST3GAL3:NR_073019.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron8/8:n.1074+42G>C::,ST3GAL3:NR_073020.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron9/9:n.991+42G>C::,ST3GAL3:NR_073021.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron9/9:n.920-9162G>C::,ST3GAL3:NR_073023.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron8/8:n.879+42G>C::,ST3GAL3:NR_146867.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron11/12:n.1258+42G>C::		606494 [GENE=ST3GAL3 PHENOS=Mental retardation,autosomal recessive 12,611090,Autosomal recessive/Developmental and epileptic encephalopathy 15,615006,Autosomal recessive];				rs3764833	0.0687	0.0556	61,.	0.0891,0.0490,0.1303,0.0398,0.0432	0.2340			0.03,0.16	7.47					0.002	0.3613	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ST3GAL3 (inh=AR oe_syn=0.97 oe_mis=0.74 oe_lof=0.36)
chr1	44395786	44395786	C	T	het	het	hom	off-target	QUAL=10360;DP=170,258,184;AF=0.44,0.47,1.00;MQM=60;SAP=100;ABP=11	ST3GAL3	intron	ST3GAL3:ENST00000262915.3:intron_variant:MODIFIER:intron12/12:c.1246-18C>T::,ST3GAL3:ENST00000330208.2:intron_variant:MODIFIER:intron6/6:c.398-18C>T::,ST3GAL3:ENST00000332628.6:intron_variant:MODIFIER:intron9/9:c.946-18C>T::,ST3GAL3:ENST00000335430.6:intron_variant:MODIFIER:intron9/9:c.*117-18C>T::,ST3GAL3:ENST00000347631.2:intron_variant:MODIFIER:intron11/11:c.1084-18C>T::,ST3GAL3:ENST00000351035.3:intron_variant:MODIFIER:intron11/11:c.1153-18C>T::,ST3GAL3:ENST00000353126.3:intron_variant:MODIFIER:intron9/9:c.745-18C>T::,ST3GAL3:ENST00000361392.4:intron_variant:MODIFIER:intron11/11:c.1039-18C>T::,ST3GAL3:ENST00000361400.4:intron_variant:MODIFIER:intron10/10:c.991-18C>T::,ST3GAL3:ENST00000361746.4:intron_variant:MODIFIER:intron11/11:c.1246-18C>T::,ST3GAL3:ENST00000361812.4:intron_variant:MODIFIER:intron5/5:c.443-18C>T::,ST3GAL3:ENST00000372362.2:intron_variant:MODIFIER:intron5/5:c.398-18C>T::,ST3GAL3:ENST00000372365.1:intron_variant:MODIFIER:intron7/7:c.*23-18C>T::,ST3GAL3:ENST00000372366.1:intron_variant:MODIFIER:intron6/6:c.*23-18C>T::,ST3GAL3:ENST00000372367.1:intron_variant:MODIFIER:intron6/6:c.555-18C>T::,ST3GAL3:ENST00000372368.2:intron_variant:MODIFIER:intron11/11:c.1201-18C>T::,ST3GAL3:ENST00000372369.1:intron_variant:MODIFIER:intron10/10:c.949-18C>T::,ST3GAL3:ENST00000372372.2:intron_variant:MODIFIER:intron10/10:c.1153-18C>T::,ST3GAL3:ENST00000372374.2:intron_variant:MODIFIER:intron10/10:c.946-18C>T::,ST3GAL3:ENST00000372375.2:intron_variant:MODIFIER:intron12/12:c.1201-18C>T::,ST3GAL3:ENST00000372377.4:intron_variant:MODIFIER:intron8/8:c.*236-18C>T::,ST3GAL3:ENST00000528371.1:intron_variant:MODIFIER:intron6/6:c.510-18C>T::,ST3GAL3:ENST00000531451.1:intron_variant:MODIFIER:intron4/4:c.350-18C>T::,ST3GAL3:ENST00000531816.1:intron_variant:MODIFIER:intron3/3:c.255-18C>T::,ST3GAL3:ENST00000531993.1:intron_variant:MODIFIER:intron7/7:c.697-18C>T::,ST3GAL3:ENST00000533933.1:intron_variant:MODIFIER:intron8/8:c.745-18C>T::,ST3GAL3:ENST00000545417.1:intron_variant:MODIFIER:intron6/6:c.443-18C>T::	ST3GAL3:NM_001270459.2:intron_variant:MODIFIER:intron11/11:c.949-18C>T::,ST3GAL3:NM_001270460.2:intron_variant:MODIFIER:intron10/10:c.946-18C>T::,ST3GAL3:NM_001270461.3:intron_variant:MODIFIER:intron8/8:c.697-18C>T::,ST3GAL3:NM_001270462.3:intron_variant:MODIFIER:intron7/7:c.604-18C>T::,ST3GAL3:NM_001270463.3:intron_variant:MODIFIER:intron7/7:c.555-18C>T::,ST3GAL3:NM_001270464.3:intron_variant:MODIFIER:intron7/7:c.510-18C>T::,ST3GAL3:NM_001270465.2:intron_variant:MODIFIER:intron7/7:c.*23-18C>T::,ST3GAL3:NM_001270466.2:intron_variant:MODIFIER:intron4/4:c.255-18C>T::,ST3GAL3:NM_001350619.2:intron_variant:MODIFIER:intron12/12:c.1280-18C>T::,ST3GAL3:NM_001350620.2:intron_variant:MODIFIER:intron12/12:c.1235-18C>T::,ST3GAL3:NM_001350621.2:intron_variant:MODIFIER:intron13/13:c.956-18C>T::,ST3GAL3:NM_001363573.2:intron_variant:MODIFIER:intron10/10:c.907-18C>T::,ST3GAL3:NM_006279.5:intron_variant:MODIFIER:intron11/11:c.1039-18C>T::,ST3GAL3:NM_174963.5:intron_variant:MODIFIER:intron12/12:c.1246-18C>T::,ST3GAL3:NM_174964.4:intron_variant:MODIFIER:intron11/11:c.1084-18C>T::,ST3GAL3:NM_174965.3:intron_variant:MODIFIER:intron6/6:c.443-18C>T::,ST3GAL3:NM_174966.4:intron_variant:MODIFIER:intron9/9:c.745-18C>T::,ST3GAL3:NM_174967.4:intron_variant:MODIFIER:intron6/6:c.398-18C>T::,ST3GAL3:NM_174968.5:intron_variant:MODIFIER:intron12/12:c.1201-18C>T::,ST3GAL3:NM_174969.4:intron_variant:MODIFIER:intron10/10:c.991-18C>T::,ST3GAL3:NM_174970.4:intron_variant:MODIFIER:intron5/5:c.350-18C>T::,ST3GAL3:NM_174971.5:intron_variant:MODIFIER:intron11/11:c.1153-18C>T::,ST3GAL3:NR_073016.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron11/11:n.1259-18C>T::,ST3GAL3:NR_073017.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron9/9:n.1136-18C>T::,ST3GAL3:NR_073018.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron10/10:n.1106-18C>T::,ST3GAL3:NR_073019.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron8/8:n.1075-18C>T::,ST3GAL3:NR_073020.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron9/9:n.992-18C>T::,ST3GAL3:NR_073021.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron9/9:n.920-18C>T::,ST3GAL3:NR_073023.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron8/8:n.880-18C>T::,ST3GAL3:NR_146867.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron12/12:n.1455-18C>T::	regulatory_region_variant:promoter_flanking_region	606494 [GENE=ST3GAL3 PHENOS=Mental retardation,autosomal recessive 12,611090,Autosomal recessive/Developmental and epileptic encephalopathy 15,615006,Autosomal recessive];	262910 [benign DISEASE=not specified];		L3 (LINE/CR1)	rs2108202	0.5188	0.6753	6777,.	0.2202,0.5744,0.6408,0.7772,0.6130	1.2100			0.03,0.21	12.57		9.65>10.17			0.1436	0.8463	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ST3GAL3 (inh=AR oe_syn=0.97 oe_mis=0.74 oe_lof=0.36), ARTN (inh=n/a oe_syn=0.91 oe_mis=0.63 oe_lof=0.22)
chr1	44396196	44396196	A	G	het	het	wt		QUAL=3125;DP=152,118,75;AF=0.43,0.49,0.00;MQM=60;SAP=3;ABP=8	ST3GAL3	3'UTR	ST3GAL3:ENST00000262915.3:3_prime_UTR_variant:MODIFIER:exon13/13:c.*303A>G::,ST3GAL3:ENST00000330208.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*322A>G::,ST3GAL3:ENST00000335430.6:3_prime_UTR_variant:MODIFIER:exon10/10:c.*509A>G::,ST3GAL3:ENST00000351035.3:3_prime_UTR_variant:MODIFIER:exon12/12:c.*303A>G::,ST3GAL3:ENST00000353126.3:3_prime_UTR_variant:MODIFIER:exon10/10:c.*303A>G::,ST3GAL3:ENST00000361392.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*303A>G::,ST3GAL3:ENST00000361400.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*303A>G::,ST3GAL3:ENST00000372374.2:3_prime_UTR_variant:MODIFIER:exon11/11:c.*303A>G::,ST3GAL3:ENST00000372375.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*303A>G::,ST3GAL3:ENST00000372377.4:3_prime_UTR_variant:MODIFIER:exon9/9:c.*628A>G::,ST3GAL3:ENST00000545417.1:3_prime_UTR_variant:MODIFIER:exon7/7:c.*322A>G::	ST3GAL3:NM_001270459.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*303A>G::,ST3GAL3:NM_001270460.2:3_prime_UTR_variant:MODIFIER:exon11/11:c.*303A>G::,ST3GAL3:NM_001270461.3:3_prime_UTR_variant:MODIFIER:exon9/9:c.*303A>G::,ST3GAL3:NM_001270462.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*303A>G::,ST3GAL3:NM_001270463.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*341A>G::,ST3GAL3:NM_001270464.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*341A>G::,ST3GAL3:NM_001270465.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*415A>G::,ST3GAL3:NM_001270466.2:3_prime_UTR_variant:MODIFIER:exon5/5:c.*341A>G::,ST3GAL3:NM_001350619.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*322A>G::,ST3GAL3:NM_001350620.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*322A>G::,ST3GAL3:NM_001350621.2:3_prime_UTR_variant:MODIFIER:exon14/14:c.*322A>G::,ST3GAL3:NM_001363573.2:3_prime_UTR_variant:MODIFIER:exon11/11:c.*303A>G::,ST3GAL3:NM_006279.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*303A>G::,ST3GAL3:NM_174963.5:3_prime_UTR_variant:MODIFIER:exon13/13:c.*303A>G::,ST3GAL3:NM_174964.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*303A>G::,ST3GAL3:NM_174965.3:3_prime_UTR_variant:MODIFIER:exon7/7:c.*322A>G::,ST3GAL3:NM_174966.4:3_prime_UTR_variant:MODIFIER:exon10/10:c.*303A>G::,ST3GAL3:NM_174967.4:3_prime_UTR_variant:MODIFIER:exon7/7:c.*322A>G::,ST3GAL3:NM_174968.5:3_prime_UTR_variant:MODIFIER:exon13/13:c.*303A>G::,ST3GAL3:NM_174969.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*303A>G::,ST3GAL3:NM_174970.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*322A>G::,ST3GAL3:NM_174971.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*303A>G::,ST3GAL3:NR_073016.3:non_coding_transcript_exon_variant:MODIFIER:exon12/12:n.1651A>G::,ST3GAL3:NR_073017.3:non_coding_transcript_exon_variant:MODIFIER:exon10/10:n.1528A>G::,ST3GAL3:NR_073018.3:non_coding_transcript_exon_variant:MODIFIER:exon11/11:n.1498A>G::,ST3GAL3:NR_073019.3:non_coding_transcript_exon_variant:MODIFIER:exon9/9:n.1467A>G::,ST3GAL3:NR_073020.3:non_coding_transcript_exon_variant:MODIFIER:exon10/10:n.1384A>G::,ST3GAL3:NR_073021.3:non_coding_transcript_exon_variant:MODIFIER:exon10/10:n.1312A>G::,ST3GAL3:NR_073023.3:non_coding_transcript_exon_variant:MODIFIER:exon9/9:n.1272A>G::,ST3GAL3:NR_146867.2:non_coding_transcript_exon_variant:MODIFIER:exon13/13:n.1847A>G::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	606494 [GENE=ST3GAL3 PHENOS=Mental retardation,autosomal recessive 12,611090,Autosomal recessive/Developmental and epileptic encephalopathy 15,615006,Autosomal recessive];				rs12561948	0.0507	0.0383	28,.		1.5480			0.70,0.94	16.71					0.0167	0.9298	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ST3GAL3 (inh=AR oe_syn=0.97 oe_mis=0.74 oe_lof=0.36), ARTN (inh=n/a oe_syn=0.91 oe_mis=0.63 oe_lof=0.22)
chr1	44396646	44396646	C	G	het	het	hom		QUAL=13486;DP=225,263,221;AF=0.49,0.54,1.00;MQM=60;SAP=10;ABP=4	ST3GAL3	3'UTR	ST3GAL3:ENST00000262915.3:3_prime_UTR_variant:MODIFIER:exon13/13:c.*753C>G::,ST3GAL3:ENST00000330208.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*772C>G::,ST3GAL3:ENST00000335430.6:3_prime_UTR_variant:MODIFIER:exon10/10:c.*959C>G::,ST3GAL3:ENST00000351035.3:3_prime_UTR_variant:MODIFIER:exon12/12:c.*753C>G::,ST3GAL3:ENST00000353126.3:3_prime_UTR_variant:MODIFIER:exon10/10:c.*753C>G::,ST3GAL3:ENST00000361392.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*753C>G::,ST3GAL3:ENST00000361400.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*753C>G::,ST3GAL3:ENST00000372374.2:3_prime_UTR_variant:MODIFIER:exon11/11:c.*753C>G::,ST3GAL3:ENST00000372375.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*753C>G::,ST3GAL3:ENST00000372377.4:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1078C>G::,ST3GAL3:ENST00000545417.1:3_prime_UTR_variant:MODIFIER:exon7/7:c.*772C>G::	ST3GAL3:NM_001270459.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*753C>G::,ST3GAL3:NM_001270460.2:3_prime_UTR_variant:MODIFIER:exon11/11:c.*753C>G::,ST3GAL3:NM_001270461.3:3_prime_UTR_variant:MODIFIER:exon9/9:c.*753C>G::,ST3GAL3:NM_001270462.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*753C>G::,ST3GAL3:NM_001270463.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*791C>G::,ST3GAL3:NM_001270464.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*791C>G::,ST3GAL3:NM_001270465.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*865C>G::,ST3GAL3:NM_001270466.2:3_prime_UTR_variant:MODIFIER:exon5/5:c.*791C>G::,ST3GAL3:NM_001350619.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*772C>G::,ST3GAL3:NM_001350620.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*772C>G::,ST3GAL3:NM_001350621.2:3_prime_UTR_variant:MODIFIER:exon14/14:c.*772C>G::,ST3GAL3:NM_001363573.2:3_prime_UTR_variant:MODIFIER:exon11/11:c.*753C>G::,ST3GAL3:NM_006279.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*753C>G::,ST3GAL3:NM_174963.5:3_prime_UTR_variant:MODIFIER:exon13/13:c.*753C>G::,ST3GAL3:NM_174964.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*753C>G::,ST3GAL3:NM_174965.3:3_prime_UTR_variant:MODIFIER:exon7/7:c.*772C>G::,ST3GAL3:NM_174966.4:3_prime_UTR_variant:MODIFIER:exon10/10:c.*753C>G::,ST3GAL3:NM_174967.4:3_prime_UTR_variant:MODIFIER:exon7/7:c.*772C>G::,ST3GAL3:NM_174968.5:3_prime_UTR_variant:MODIFIER:exon13/13:c.*753C>G::,ST3GAL3:NM_174969.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*753C>G::,ST3GAL3:NM_174970.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*772C>G::,ST3GAL3:NM_174971.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*753C>G::,ST3GAL3:NR_073016.3:non_coding_transcript_exon_variant:MODIFIER:exon12/12:n.2101C>G::,ST3GAL3:NR_073017.3:non_coding_transcript_exon_variant:MODIFIER:exon10/10:n.1978C>G::,ST3GAL3:NR_073018.3:non_coding_transcript_exon_variant:MODIFIER:exon11/11:n.1948C>G::,ST3GAL3:NR_073019.3:non_coding_transcript_exon_variant:MODIFIER:exon9/9:n.1917C>G::,ST3GAL3:NR_073020.3:non_coding_transcript_exon_variant:MODIFIER:exon10/10:n.1834C>G::,ST3GAL3:NR_073021.3:non_coding_transcript_exon_variant:MODIFIER:exon10/10:n.1762C>G::,ST3GAL3:NR_073023.3:non_coding_transcript_exon_variant:MODIFIER:exon9/9:n.1722C>G::,ST3GAL3:NR_146867.2:non_coding_transcript_exon_variant:MODIFIER:exon13/13:n.2297C>G::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	606494 [GENE=ST3GAL3 PHENOS=Mental retardation,autosomal recessive 12,611090,Autosomal recessive/Developmental and epileptic encephalopathy 15,615006,Autosomal recessive];				rs6801	0.5188	0.6104	6779,.		0.1600			0.06,0.22	7.02					-0.0049	0.9296	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ST3GAL3 (inh=AR oe_syn=0.97 oe_mis=0.74 oe_lof=0.36), ARTN (inh=n/a oe_syn=0.91 oe_mis=0.63 oe_lof=0.22)
chr1	45285534	45285534	A	C	wt	wt	het		QUAL=164;DP=127,28,26;AF=0.00,0.00,0.42;MQM=60;SAP=19;ABP=4	PTCH2	3'UTR	PTCH2:ENST00000447098.2:3_prime_UTR_variant:MODIFIER:exon23/23:c.*827T>G::	PTCH2:NM_001166292.1:3_prime_UTR_variant:MODIFIER:exon23/23:c.*827T>G::	regulatory_region_variant:promoter,TF_binding_site_variant	603673 [GENE=PTCH2 PHENOS=Basal cell carcinoma,somatic,605462/Basal cell nevus syndrome,109400,Autosomal dominant/Medulloblastoma,somatic,155255];				rs181782534	0.0104	0.0122	1,.		-0.4960			0.00,0.36	1.03					-0.0023	0.774		3	102	0 / 0					PTCH2 (inh=AR+AD oe_syn=1.00 oe_mis=0.92 oe_lof=0.64), RNU5E-6P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	45285648	45285648	C	T	hom	het	het		QUAL=19744;DP=507,176,167;AF=0.99,0.49,0.54;MQM=60;SAP=669;ABP=4	RNU5E-6P,PTCH2	non_coding_transcript_exon,3'UTR	RNU5E-6P:ENST00000365574.1:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.22G>A::,PTCH2:ENST00000447098.2:3_prime_UTR_variant:MODIFIER:exon23/23:c.*713G>A::	PTCH2:NM_001166292.1:3_prime_UTR_variant:MODIFIER:exon23/23:c.*713G>A::	regulatory_region_variant:promoter	603673 [GENE=PTCH2 PHENOS=Basal cell carcinoma,somatic,605462/Basal cell nevus syndrome,109400,Autosomal dominant/Medulloblastoma,somatic,155255];			U5 (snRNA)	rs41269085	0.2290	0.2273	918,.		-0.3180			0.00,0.39	0.38					-0.0073	0.9444		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTCH2 (inh=AR+AD oe_syn=1.00 oe_mis=0.92 oe_lof=0.64), RNU5E-6P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	45292866	45292866	G	A	hom	het	het		QUAL=8898;DP=158,208,147;AF=0.99,0.50,0.51;MQM=60;SAP=61;ABP=3	PTCH2	synonymous	PTCH2:ENST00000372192.3:synonymous_variant:LOW:exon16/22:c.2487C>T:p.Asp829=:,PTCH2:ENST00000447098.2:synonymous_variant:LOW:exon16/23:c.2487C>T:p.Asp829=:	PTCH2:NM_001166292.1:synonymous_variant:LOW:exon16/23:c.2487C>T:p.Asp829=:,PTCH2:NM_003738.5:synonymous_variant:LOW:exon16/22:c.2487C>T:p.Asp829=:		603673 [GENE=PTCH2 PHENOS=Basal cell carcinoma,somatic,605462/Basal cell nevus syndrome,109400,Autosomal dominant/Medulloblastoma,somatic,155255];				rs2295996	0.1478	0.1624	352,.	0.0810,0.1773,0.2106,0.1669,0.1589	0.7970			0.70,0.93	7.22					-0.1037	0.4121	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTCH2 (inh=AR+AD oe_syn=1.00 oe_mis=0.92 oe_lof=0.64)
chr1	45293518	45293518	A	G	hom	het	het		QUAL=12996;DP=194,323,269;AF=0.99,0.48,0.48;MQM=60;SAP=472;ABP=5	PTCH2	synonymous	PTCH2:ENST00000372192.3:synonymous_variant:LOW:exon14/22:c.2055T>C:p.Ala685=:,PTCH2:ENST00000447098.2:synonymous_variant:LOW:exon14/23:c.2055T>C:p.Ala685=:	PTCH2:NM_001166292.1:synonymous_variant:LOW:exon14/23:c.2055T>C:p.Ala685=:,PTCH2:NM_003738.5:synonymous_variant:LOW:exon14/22:c.2055T>C:p.Ala685=:		603673 [GENE=PTCH2 PHENOS=Basal cell carcinoma,somatic,605462/Basal cell nevus syndrome,109400,Autosomal dominant/Medulloblastoma,somatic,155255];				rs7525308	0.4455	0.4339	3094,.	0.5872,0.4169,0.4801,0.3461,0.3545	2.0950			0.06,0.81	9.66					0.3642	0.0781	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTCH2 (inh=AR+AD oe_syn=1.00 oe_mis=0.92 oe_lof=0.64)
chr1	45294156	45294156	T	C	hom	het	het	off-target	QUAL=21887;DP=234,682,518;AF=1.00,0.48,0.53;MQM=60;SAP=100;ABP=3	PTCH2	intron	PTCH2:ENST00000372192.3:intron_variant:MODIFIER:intron12/21:c.1590+22A>G::,PTCH2:ENST00000447098.2:intron_variant:MODIFIER:intron12/22:c.1590+22A>G::	PTCH2:NM_001166292.1:intron_variant:MODIFIER:intron12/22:c.1590+22A>G::,PTCH2:NM_003738.5:intron_variant:MODIFIER:intron12/21:c.1590+22A>G::		603673 [GENE=PTCH2 PHENOS=Basal cell carcinoma,somatic,605462/Basal cell nevus syndrome,109400,Autosomal dominant/Medulloblastoma,somatic,155255];				rs2273940	0.4433	0.4321	3050,.	0.5776,0.4168,0.4807,0.3456,0.3543	-1.9150			0.00,0.09	4.60					0.0566	0.153	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTCH2 (inh=AR+AD oe_syn=1.00 oe_mis=0.92 oe_lof=0.64)
chr1	45307506	45307506	G	A	hom	het	het	off-target	QUAL=7530;DP=81,212,183;AF=0.99,0.55,0.51;MQM=60;SAP=198;ABP=6	PTCH2	intron	PTCH2:ENST00000372192.3:intron_variant:MODIFIER:intron2/21:c.265+13C>T::,PTCH2:ENST00000447098.2:intron_variant:MODIFIER:intron2/22:c.265+13C>T::	PTCH2:NM_001166292.1:intron_variant:MODIFIER:intron2/22:c.265+13C>T::,PTCH2:NM_003738.5:intron_variant:MODIFIER:intron2/21:c.265+13C>T::		603673 [GENE=PTCH2 PHENOS=Basal cell carcinoma,somatic,605462/Basal cell nevus syndrome,109400,Autosomal dominant/Medulloblastoma,somatic,155255];				rs3795720	0.3720	0.3744	1961,.	0.3300,0.5242,0.4336,0.3463,0.3434	1.7090			0.03,0.33	9.12					0.2599	0.0154	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTCH2 (inh=AR+AD oe_syn=1.00 oe_mis=0.92 oe_lof=0.64)
chr1	45340282	45340282	C	T	hom	het	het		QUAL=20686;DP=402,314,252;AF=1.00,0.48,0.48;MQM=60;SAP=323;ABP=5	EIF2B3	intron,3'UTR	EIF2B3:ENST00000360403.2:intron_variant:MODIFIER:intron10/11:c.1202+68G>A::,EIF2B3:ENST00000372183.3:3_prime_UTR_variant:MODIFIER:exon10/10:c.*31G>A::	EIF2B3:NM_001166588.2:3_prime_UTR_variant:MODIFIER:exon10/10:c.*31G>A::,EIF2B3:NM_001261418.1:intron_variant:MODIFIER:intron10/10:c.1202+68G>A::,EIF2B3:NM_020365.5:intron_variant:MODIFIER:intron10/11:c.1202+68G>A::		606273 [GENE=EIF2B3 PHENOS=Leukoencephalopathy with vanishing white matter,603896,Autosomal recessive];			HAL1 (LINE/L1)	rs9988451	0.4517	0.4353	3074,.	0.5880,0.5364,0.4362,0.3537,0.3517	0.6900			0.00,0.04	6.23					-0.039	0.8817	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EIF2B3 (inh=AR oe_syn=0.80 oe_mis=0.81 oe_lof=0.21)
chr1	45345446	45345446	T	A	hom	het	het	off-target	QUAL=4385;DP=102,64,44;AF=1.00,0.48,0.57;MQM=60;SAP=296;ABP=3	EIF2B3	intron	EIF2B3:ENST00000360403.2:intron_variant:MODIFIER:intron8/11:c.975+44A>T::,EIF2B3:ENST00000372183.3:intron_variant:MODIFIER:intron8/9:c.975+44A>T::	EIF2B3:NM_001166588.2:intron_variant:MODIFIER:intron8/9:c.975+44A>T::,EIF2B3:NM_001261418.1:intron_variant:MODIFIER:intron8/10:c.975+44A>T::,EIF2B3:NM_020365.5:intron_variant:MODIFIER:intron8/11:c.975+44A>T::		606273 [GENE=EIF2B3 PHENOS=Leukoencephalopathy with vanishing white matter,603896,Autosomal recessive];	261223 [benign DISEASE=not specified];			rs3738248	0.1448	0.1619	364,.	0.1145,0.1545,0.1655,0.1739,0.1604	0.2890			0.19,0.27	8.76					0.1324	0.3198	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EIF2B3 (inh=AR oe_syn=0.80 oe_mis=0.81 oe_lof=0.21)
chr1	45362992	45362992	T	C	hom	het	het	off-target	QUAL=6665;DP=142,91,71;AF=1.00,0.57,0.52;MQM=60;SAP=241;ABP=6	EIF2B3	intron	EIF2B3:ENST00000360403.2:intron_variant:MODIFIER:intron6/11:c.656+35A>G::,EIF2B3:ENST00000372183.3:intron_variant:MODIFIER:intron6/9:c.656+35A>G::	EIF2B3:NM_001166588.2:intron_variant:MODIFIER:intron6/9:c.656+35A>G::,EIF2B3:NM_001261418.1:intron_variant:MODIFIER:intron6/10:c.656+35A>G::,EIF2B3:NM_020365.5:intron_variant:MODIFIER:intron6/11:c.656+35A>G::		606273 [GENE=EIF2B3 PHENOS=Leukoencephalopathy with vanishing white matter,603896,Autosomal recessive];	261222 [benign DISEASE=not specified];			rs263978	0.7911	0.6850	7788,.	0.9083,0.7886,0.9742,0.5467,0.6533	-0.9150			0.00,0.07	2.17					-0.1239	0.1747	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EIF2B3 (inh=AR oe_syn=0.80 oe_mis=0.81 oe_lof=0.21)
chr1	45452227	45452227	G	C	hom	het	het		QUAL=6870;DP=126,187,107;AF=1.00,0.43,0.43;MQM=60;SAP=3;ABP=16	EIF2B3	5'UTR	EIF2B3:ENST00000360403.2:5_prime_UTR_variant:MODIFIER:exon1/12:c.-72C>G::,EIF2B3:ENST00000372183.3:5_prime_UTR_variant:MODIFIER:exon1/10:c.-72C>G::	EIF2B3:NM_001166588.2:5_prime_UTR_variant:MODIFIER:exon1/10:c.-72C>G::,EIF2B3:NM_001261418.1:5_prime_UTR_variant:MODIFIER:exon1/11:c.-72C>G::,EIF2B3:NM_020365.5:5_prime_UTR_variant:MODIFIER:exon1/12:c.-72C>G::	regulatory_region_variant:promoter,TF_binding_site_variant	606273 [GENE=EIF2B3 PHENOS=Leukoencephalopathy with vanishing white matter,603896,Autosomal recessive];	297453 [benign DISEASE=Leukoencephalopathy with vanishing white matter];			rs489676	0.4806	0.4807	3725,.		-3.3680			0.00,0.12	6.44					-0.3141	0.1347	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EIF2B3 (inh=AR oe_syn=0.80 oe_mis=0.81 oe_lof=0.21), MRPS17P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	45975089	45975089	T	-	het	het	het	low_conf_region	QUAL=574;DP=66,115,109;AF=0.20,0.10,0.27;MQM=60;SAP=10;ABP=257	MMACHC	3'UTR	MMACHC:ENST00000401061.4:3_prime_UTR_variant:MODIFIER:exon4/4:c.*217del::	MMACHC:NM_001330540.2:3_prime_UTR_variant:MODIFIER:exon4/4:c.*217del::,MMACHC:NM_015506.3:3_prime_UTR_variant:MODIFIER:exon4/4:c.*217del::		609831 [GENE=MMACHC PHENOS=Methylmalonic aciduria and homocystinuria,cblC type,277400,Autosomal recessive];			AluSg7 (SINE/Alu)	rs56934185		0.0419	25,.		-2.0510				0.02					0.0069	0.9177	0	2	2	0 / 0					MMACHC (inh=AR oe_syn=1.26 oe_mis=1.23 oe_lof=1.21), PRDX1 (inh=AR oe_syn=1.03 oe_mis=0.95 oe_lof=1.40)
chr1	45975166	45975166	A	G	wt	het	wt		QUAL=1064;DP=195,142,122;AF=0.00,0.38,0.00;MQM=60;SAP=44;ABP=21	MMACHC	3'UTR	MMACHC:ENST00000401061.4:3_prime_UTR_variant:MODIFIER:exon4/4:c.*279A>G::	MMACHC:NM_001330540.2:3_prime_UTR_variant:MODIFIER:exon4/4:c.*279A>G::,MMACHC:NM_015506.3:3_prime_UTR_variant:MODIFIER:exon4/4:c.*279A>G::		609831 [GENE=MMACHC PHENOS=Methylmalonic aciduria and homocystinuria,cblC type,277400,Autosomal recessive];	297502 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];		AluSg7 (SINE/Alu)	rs9729395	0.2634	0.2156	729,.		0.6090			0.01,0.06	1.09					0.1154	0.9482	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MMACHC (inh=AR oe_syn=1.26 oe_mis=1.23 oe_lof=1.21), PRDX1 (inh=AR oe_syn=1.03 oe_mis=0.95 oe_lof=1.40)
chr1	45975300	45975300	G	A	wt	wt	het		QUAL=2026;DP=182,192,134;AF=0.01,0.01,0.59;MQM=60;SAP=40;ABP=12	MMACHC	3'UTR	MMACHC:ENST00000401061.4:3_prime_UTR_variant:MODIFIER:exon4/4:c.*413G>A::	MMACHC:NM_001330540.2:3_prime_UTR_variant:MODIFIER:exon4/4:c.*413G>A::,MMACHC:NM_015506.3:3_prime_UTR_variant:MODIFIER:exon4/4:c.*413G>A::		609831 [GENE=MMACHC PHENOS=Methylmalonic aciduria and homocystinuria,cblC type,277400,Autosomal recessive];	297505 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];		AluSg7 (SINE/Alu)	rs12021717	0.1184	0.1908	600,.		0.1590			0.02,0.09	3.14					-0.0177	0.9173	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MMACHC (inh=AR oe_syn=1.26 oe_mis=1.23 oe_lof=1.21), PRDX1 (inh=AR oe_syn=1.03 oe_mis=0.95 oe_lof=1.40)
chr1	45975740	45975741	CT	-	wt	het	wt		QUAL=1771;DP=234,185,174;AF=0.00,0.49,0.01;MQM=58;SAP=22;ABP=3	MMACHC	3'UTR	MMACHC:ENST00000401061.4:3_prime_UTR_variant:MODIFIER:exon4/4:c.*855_*856del::	MMACHC:NM_001330540.2:3_prime_UTR_variant:MODIFIER:exon4/4:c.*855_*856del::,MMACHC:NM_015506.3:3_prime_UTR_variant:MODIFIER:exon4/4:c.*855_*856del::		609831 [GENE=MMACHC PHENOS=Methylmalonic aciduria and homocystinuria,cblC type,277400,Autosomal recessive];	297512 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];		AluSx4 (SINE/Alu)	rs398052965		0.6567	6035,.		0.2120				1.22					0.0216	0.9851	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MMACHC (inh=AR oe_syn=1.26 oe_mis=1.23 oe_lof=1.21), PRDX1 (inh=AR oe_syn=1.03 oe_mis=0.95 oe_lof=1.40)
chr1	45975749	45975749	A	-	het	het	het	low_conf_region	QUAL=969;DP=153,101,103;AF=0.20,0.17,0.24;MQM=58;SAP=3;ABP=279	MMACHC	3'UTR	MMACHC:ENST00000401061.4:3_prime_UTR_variant:MODIFIER:exon4/4:c.*877del::	MMACHC:NM_001330540.2:3_prime_UTR_variant:MODIFIER:exon4/4:c.*877del::,MMACHC:NM_015506.3:3_prime_UTR_variant:MODIFIER:exon4/4:c.*877del::		609831 [GENE=MMACHC PHENOS=Methylmalonic aciduria and homocystinuria,cblC type,277400,Autosomal recessive];			AluSx4 (SINE/Alu)	rs986671995		0.1046	106,.		0.0860				1.07					0.0081	0.985	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MMACHC (inh=AR oe_syn=1.26 oe_mis=1.23 oe_lof=1.21), PRDX1 (inh=AR oe_syn=1.03 oe_mis=0.95 oe_lof=1.40)
chr1	45976147	45976147	G	A	wt	het	wt		QUAL=4632;DP=342,402,281;AF=0.00,0.49,0.00;MQM=60;SAP=11;ABP=3	MMACHC	3'UTR	MMACHC:ENST00000401061.4:3_prime_UTR_variant:MODIFIER:exon4/4:c.*1260G>A::	MMACHC:NM_001330540.2:3_prime_UTR_variant:MODIFIER:exon4/4:c.*1260G>A::,MMACHC:NM_015506.3:3_prime_UTR_variant:MODIFIER:exon4/4:c.*1260G>A::		609831 [GENE=MMACHC PHENOS=Methylmalonic aciduria and homocystinuria,cblC type,277400,Autosomal recessive];	297522 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];		AluJr (SINE/Alu)	rs882803		0.6553	6779,.		-3.5650			0.00,0.05	1.65					-0.0119	0.985	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MMACHC (inh=AR oe_syn=1.26 oe_mis=1.23 oe_lof=1.21), PRDX1 (inh=AR oe_syn=1.03 oe_mis=0.95 oe_lof=1.40)
chr1	45976263	45976263	-	T	wt	het	wt		QUAL=3818;DP=313,316,259;AF=0.01,0.47,0.00;MQM=60;SAP=5;ABP=5	MMACHC	3'UTR	MMACHC:ENST00000401061.4:3_prime_UTR_variant:MODIFIER:exon4/4:c.*1376_*1377insT::	MMACHC:NM_001330540.2:3_prime_UTR_variant:MODIFIER:exon4/4:c.*1376_*1377insT::,MMACHC:NM_015506.3:3_prime_UTR_variant:MODIFIER:exon4/4:c.*1376_*1377insT::		609831 [GENE=MMACHC PHENOS=Methylmalonic aciduria and homocystinuria,cblC type,277400,Autosomal recessive];	297525 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];			rs5773883	0.7438	0.6549	6752,.						1.46					-0.0043	0.9175	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MMACHC (inh=AR oe_syn=1.26 oe_mis=1.23 oe_lof=1.21), PRDX1 (inh=AR oe_syn=1.03 oe_mis=0.95 oe_lof=1.40)
chr1	45976587	45976587	A	G	wt	het	wt		QUAL=2435;DP=264,170,153;AF=0.00,0.56,0.00;MQM=60;SAP=5;ABP=8	MMACHC	3'UTR	MMACHC:ENST00000401061.4:3_prime_UTR_variant:MODIFIER:exon4/4:c.*1700A>G::	MMACHC:NM_001330540.2:3_prime_UTR_variant:MODIFIER:exon4/4:c.*1700A>G::,MMACHC:NM_015506.3:3_prime_UTR_variant:MODIFIER:exon4/4:c.*1700A>G::		609831 [GENE=MMACHC PHENOS=Methylmalonic aciduria and homocystinuria,cblC type,277400,Autosomal recessive];	297529 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];			rs1044717	0.8255	0.7252	8336,.		-0.7830			0.00,0.14	3.95					0.0057	0.9177	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MMACHC (inh=AR oe_syn=1.26 oe_mis=1.23 oe_lof=1.21), PRDX1 (inh=AR oe_syn=1.03 oe_mis=0.95 oe_lof=1.40)
chr1	46164390	46164399	TTTTTTTTTT	-	hom	hom	n/a	low_conf_region	QUAL=738;DP=21,5,1;AF=1.00,1.00,1.00;MQM=60;SAP=62;ABP=0	IPP	3'UTR	IPP:ENST00000396478.3:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1239_*1248del::	IPP:NM_001145349.1:intron_variant:MODIFIER:intron9/9:c.1651+1343_1651+1352del::,IPP:NM_005897.3:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1239_*1248del::					AluJb (SINE/Alu)	rs78627575		0.3325	1113,.		0.6660				0.79					0.0214	0.8357	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM69 (inh=n/a oe_syn=0.73 oe_mis=0.95 oe_lof=0.86), IPP (inh=n/a oe_syn=1.07 oe_mis=0.92 oe_lof=0.43)
chr1	46164846	46164846	A	T	hom	hom	het		QUAL=21004;DP=305,299,179;AF=0.99,1.00,0.47;MQM=60;SAP=745;ABP=4	IPP	3'UTR	IPP:ENST00000396478.3:3_prime_UTR_variant:MODIFIER:exon9/9:c.*792T>A::	IPP:NM_001145349.1:intron_variant:MODIFIER:intron9/9:c.1651+896T>A::,IPP:NM_005897.3:3_prime_UTR_variant:MODIFIER:exon9/9:c.*792T>A::						rs10749856	0.3249	0.2851	1307,.		1.4050			0.25,0.25	7.15					-0.0161	0.8346	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM69 (inh=n/a oe_syn=0.73 oe_mis=0.95 oe_lof=0.86), IPP (inh=n/a oe_syn=1.07 oe_mis=0.92 oe_lof=0.43)
chr1	46165875	46165875	-	A	hom	hom	het	off-target;low_conf_region	QUAL=9613;DP=140,200,187;AF=0.86,0.89,0.41;MQM=60;SAP=189;ABP=16	IPP	intron	IPP:ENST00000396478.3:intron_variant:MODIFIER:intron8/8:c.1531-14dup::	IPP:NM_001145349.1:intron_variant:MODIFIER:intron8/9:c.1531-14dup::,IPP:NM_005897.3:intron_variant:MODIFIER:intron8/8:c.1531-14dup::						rs550999501		0.3258	1150,.	0.2497,0.3549,0.3603,0.3157,0.3748					15.75					0.1761	0.5212	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IPP (inh=n/a oe_syn=1.07 oe_mis=0.92 oe_lof=0.43)
chr1	46195375	46195375	T	C	hom	hom	het		QUAL=10558;DP=230,65,60;AF=1.00,0.97,0.57;MQM=60;SAP=139;ABP=5	IPP	missense	IPP:ENST00000396478.3:missense_variant:MODERATE:exon4/9:c.791A>G:p.Lys264Arg:	IPP:NM_001145349.1:missense_variant:MODERATE:exon4/10:c.791A>G:p.Lys264Arg:,IPP:NM_005897.3:missense_variant:MODERATE:exon4/9:c.791A>G:p.Lys264Arg:	regulatory_region_variant:promoter_flanking_region					rs28375469	0.3149	0.3037	1259,.	0.2374,0.3238,0.3392,0.2946,0.3608	7.6250	T(0.22)	B(0.00)	0.98,0.99	21.90	0.19				0.1936	0.294	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IPP (inh=n/a oe_syn=1.07 oe_mis=0.92 oe_lof=0.43)
chr1	46206540	46206540	A	G	hom	hom	het	off-target	QUAL=9701;DP=268,37,25;AF=1.00,1.00,0.68;MQM=60;SAP=700;ABP=10	IPP	intron	IPP:ENST00000396478.3:intron_variant:MODIFIER:intron3/8:c.724+33T>C::	IPP:NM_001145349.1:intron_variant:MODIFIER:intron3/9:c.724+33T>C::,IPP:NM_005897.3:intron_variant:MODIFIER:intron3/8:c.724+33T>C::						rs28507722	0.3149	0.2999	1256,.	0.2384,0.3223,0.3345,0.2944,0.3666	2.9420			0.24,0.19	7.63					-0.0298	0.2501	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IPP (inh=n/a oe_syn=1.07 oe_mis=0.92 oe_lof=0.43)
chr1	46655158	46655158	T	C	hom	hom	hom		QUAL=12726;DP=140,129,141;AF=0.99,1.00,1.00;MQM=60;SAP=158;ABP=0	POMGNT1	missense,missense&splice_region,3'UTR	POMGNT1:ENST00000371984.3:missense_variant:MODERATE:exon21/22:c.1867A>G:p.Met623Val:,POMGNT1:ENST00000371986.3:missense_variant&splice_region_variant:MODERATE:exon21/23:c.1867A>G:p.Met623Val:,POMGNT1:ENST00000371992.1:missense_variant&splice_region_variant:MODERATE:exon21/23:c.1867A>G:p.Met623Val:,POMGNT1:ENST00000396420.3:3_prime_UTR_variant:MODIFIER:exon18/19:c.*1536A>G::,POMGNT1:ENST00000535522.1:missense_variant:MODERATE:exon20/22:c.1801A>G:p.Met601Val:	POMGNT1:NM_001243766.1:splice_region_variant&synonymous_variant:LOW:exon21/23:c.1867A>G:p.Val623=:,POMGNT1:NM_001290129.1:synonymous_variant:LOW:exon20/22:c.1801A>G:p.Val601=:,POMGNT1:NM_001290130.1:synonymous_variant:LOW:exon20/22:c.1438A>G:p.Val480=:,POMGNT1:NM_017739.3:synonymous_variant:LOW:exon21/22:c.1867A>G:p.Val623=:		606822 [GENE=POMGNT1 PHENOS=Muscular dystrophy-dystroglycanopathy (congenital with mental retardation),type B,3,613151,Autosomal recessive/Muscular dystrophy-dystroglycanopathy (limb-girdle),type C,3,613157,Autosomal recessive/Retinitis pigmentosa 76,617123,Autosomal recessive/Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies),type A,3,253280,Autosomal recessive];	167524 [benign DISEASE=Muscle eye brain disease,not specified];			rs6659553	0.9425	0.9868	14228,.	0.8186,0.9914,1.0000,0.9996,0.9997	5.7560		B(0.00),B(0.00),B(0.00), ,B(0.00)	0.18,0.92	23.20	0.33	2.63>0.43			-1.1479	0.9915	0.19	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TSPAN1 (inh=n/a oe_syn=1.16 oe_mis=0.87 oe_lof=0.79), POMGNT1 (inh=AR oe_syn=1.02 oe_mis=0.88 oe_lof=0.79)
chr1	46659104	46659104	T	C	hom	het	hom	off-target	QUAL=40585;DP=345,796,624;AF=1.00,0.49,1.00;MQM=60;SAP=17;ABP=4	POMGNT1	intron,3'UTR	POMGNT1:ENST00000371984.3:intron_variant:MODIFIER:intron11/21:c.1027-44A>G::,POMGNT1:ENST00000371986.3:intron_variant:MODIFIER:intron11/22:c.1027-44A>G::,POMGNT1:ENST00000371992.1:intron_variant:MODIFIER:intron11/22:c.1027-44A>G::,POMGNT1:ENST00000396420.3:3_prime_UTR_variant:MODIFIER:exon9/19:c.*652A>G::,POMGNT1:ENST00000535522.1:intron_variant:MODIFIER:intron10/21:c.961-44A>G::	POMGNT1:NM_001243766.1:intron_variant:MODIFIER:intron11/22:c.1027-44A>G::,POMGNT1:NM_001290129.1:intron_variant:MODIFIER:intron10/21:c.961-44A>G::,POMGNT1:NM_001290130.1:intron_variant:MODIFIER:intron10/21:c.598-44A>G::,POMGNT1:NM_017739.3:intron_variant:MODIFIER:intron11/21:c.1027-44A>G::		606822 [GENE=POMGNT1 PHENOS=Muscular dystrophy-dystroglycanopathy (congenital with mental retardation),type B,3,613151,Autosomal recessive/Muscular dystrophy-dystroglycanopathy (limb-girdle),type C,3,613157,Autosomal recessive/Retinitis pigmentosa 76,617123,Autosomal recessive/Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies),type A,3,253280,Autosomal recessive];	260869 [benign DISEASE=not specified,not provided];			rs7527668	0.3670	0.3895	2479,.	0.4473,0.3957,0.1454,0.3563,0.4455	-1.4020			0.01,0.14	7.29					0.5017	0.9078	0.12	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					POMGNT1 (inh=AR oe_syn=1.02 oe_mis=0.88 oe_lof=0.79)
chr1	46659363	46659363	T	C	hom	het	hom	off-target	QUAL=23564;DP=294,329,318;AF=0.99,0.55,1.00;MQM=60;SAP=164;ABP=9	POMGNT1	intron,3'UTR	POMGNT1:ENST00000371984.3:intron_variant:MODIFIER:intron10/21:c.951-52A>G::,POMGNT1:ENST00000371986.3:intron_variant:MODIFIER:intron10/22:c.951-52A>G::,POMGNT1:ENST00000371992.1:intron_variant:MODIFIER:intron10/22:c.951-52A>G::,POMGNT1:ENST00000396420.3:3_prime_UTR_variant:MODIFIER:exon9/19:c.*393A>G::,POMGNT1:ENST00000535522.1:intron_variant:MODIFIER:intron9/21:c.885-52A>G::	POMGNT1:NM_001243766.1:intron_variant:MODIFIER:intron10/22:c.951-52A>G::,POMGNT1:NM_001290129.1:intron_variant:MODIFIER:intron9/21:c.885-52A>G::,POMGNT1:NM_001290130.1:intron_variant:MODIFIER:intron9/21:c.522-52A>G::,POMGNT1:NM_017739.3:intron_variant:MODIFIER:intron10/21:c.951-52A>G::		606822 [GENE=POMGNT1 PHENOS=Muscular dystrophy-dystroglycanopathy (congenital with mental retardation),type B,3,613151,Autosomal recessive/Muscular dystrophy-dystroglycanopathy (limb-girdle),type C,3,613157,Autosomal recessive/Retinitis pigmentosa 76,617123,Autosomal recessive/Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies),type A,3,253280,Autosomal recessive];	671035 [benign DISEASE=not provided];			rs7527935	0.3335	0.3605	2118,.	0.3463,0.3885,0.1456,0.3530,0.4452	-0.0920			0.07,0.18	7.57					0.013	0.9099	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					POMGNT1 (inh=AR oe_syn=1.02 oe_mis=0.88 oe_lof=0.79)
chr1	46660295	46660295	T	C	hom	het	hom		QUAL=17412;DP=254,303,198;AF=1.00,0.45,0.99;MQM=60;SAP=112;ABP=11	POMGNT1	synonymous,missense	POMGNT1:ENST00000371984.3:synonymous_variant:LOW:exon8/22:c.681A>G:p.Lys227=:,POMGNT1:ENST00000371986.3:synonymous_variant:LOW:exon8/23:c.681A>G:p.Lys227=:,POMGNT1:ENST00000371992.1:synonymous_variant:LOW:exon8/23:c.681A>G:p.Lys227=:,POMGNT1:ENST00000396420.3:missense_variant:MODERATE:exon7/19:c.563A>G:p.Asn188Ser:,POMGNT1:ENST00000535522.1:synonymous_variant:LOW:exon7/22:c.615A>G:p.Lys205=:	POMGNT1:NM_001243766.1:synonymous_variant:LOW:exon8/23:c.681A>G:p.Lys227=:,POMGNT1:NM_001290129.1:synonymous_variant:LOW:exon7/22:c.615A>G:p.Lys205=:,POMGNT1:NM_001290130.1:synonymous_variant:LOW:exon7/22:c.252A>G:p.Lys84=:,POMGNT1:NM_017739.3:synonymous_variant:LOW:exon8/22:c.681A>G:p.Lys227=:		606822 [GENE=POMGNT1 PHENOS=Muscular dystrophy-dystroglycanopathy (congenital with mental retardation),type B,3,613151,Autosomal recessive/Muscular dystrophy-dystroglycanopathy (limb-girdle),type C,3,613157,Autosomal recessive/Retinitis pigmentosa 76,617123,Autosomal recessive/Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies),type A,3,253280,Autosomal recessive];	95761 [benign DISEASE=Limb-girdle muscular dystrophy-dystroglycanopathy, type C3,Muscle eye brain disease,not specified,Congenital Muscular Dystrophy, alpha-dystroglycan related,not provided];			rs2292487	0.3335	0.3607	2127,.	0.3470,0.3886,0.1448,0.3532,0.4458	0.5750		 , , ,B(0.06), 	0.24,0.90	12.89	0.05				0.1211	0.911	0.04	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					POMGNT1 (inh=AR oe_syn=1.02 oe_mis=0.88 oe_lof=0.79)
chr1	47716041	47716042	AA	-	het	wt	het		QUAL=5473;DP=253,174,173;AF=0.51,0.00,0.52;MQM=56;SAP=3;ABP=4	STIL	3'UTR	STIL:ENST00000337817.5:3_prime_UTR_variant:MODIFIER:exon17/17:c.*766_*767del::,STIL:ENST00000360380.3:3_prime_UTR_variant:MODIFIER:exon18/18:c.*766_*767del::,STIL:ENST00000371877.3:3_prime_UTR_variant:MODIFIER:exon17/17:c.*766_*767del::	STIL:NM_001048166.1:3_prime_UTR_variant:MODIFIER:exon17/17:c.*766_*767del::,STIL:NM_001282936.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*766_*767del::,STIL:NM_001282937.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*766_*767del::,STIL:NM_001282938.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*766_*767del::,STIL:NM_001282939.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*766_*767del::,STIL:NM_003035.2:3_prime_UTR_variant:MODIFIER:exon17/17:c.*766_*767del::		181590 [GENE=STIL PHENOS=Microcephaly 7,primary,autosomal recessive,612703,Autosomal recessive];	297544 [benign DISEASE=Primary Microcephaly, Recessive];			rs75930208		0.4371	3477,.		1.6250				5.58					0.0102	0.9418	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					STIL (inh=AR oe_syn=0.87 oe_mis=0.88 oe_lof=0.24)
chr1	47717189	47717189	A	G	het	wt	het		QUAL=8417;DP=442,305,231;AF=0.50,0.01,0.40;MQM=60;SAP=35;ABP=10	STIL	synonymous	STIL:ENST00000243182.6:synonymous_variant:LOW:exon17/17:c.3483T>C:p.Pro1161=:,STIL:ENST00000337817.5:synonymous_variant:LOW:exon17/17:c.3483T>C:p.Pro1161=:,STIL:ENST00000360380.3:synonymous_variant:LOW:exon18/18:c.3483T>C:p.Pro1161=:,STIL:ENST00000371877.3:synonymous_variant:LOW:exon17/17:c.3486T>C:p.Pro1162=:,STIL:ENST00000396221.2:synonymous_variant:LOW:exon17/17:c.3432T>C:p.Pro1144=:	STIL:NM_001048166.1:synonymous_variant:LOW:exon17/17:c.3486T>C:p.Pro1162=:,STIL:NM_001282936.1:synonymous_variant:LOW:exon18/18:c.3483T>C:p.Pro1161=:,STIL:NM_001282937.1:synonymous_variant:LOW:exon18/18:c.3432T>C:p.Pro1144=:,STIL:NM_001282938.1:synonymous_variant:LOW:exon19/19:c.3345T>C:p.Pro1115=:,STIL:NM_001282939.1:synonymous_variant:LOW:exon19/19:c.3291T>C:p.Pro1097=:,STIL:NM_003035.2:synonymous_variant:LOW:exon17/17:c.3483T>C:p.Pro1161=:		181590 [GENE=STIL PHENOS=Microcephaly 7,primary,autosomal recessive,612703,Autosomal recessive];	94095 [benign DISEASE=Primary autosomal recessive microcephaly 7,not specified,not provided];			rs2758735	0.3934	0.5020	3526,.	0.1611,0.4426,0.4497,0.5248,0.5374	0.0230			0.08,0.22	2.41					-0.0061	0.9417	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					STIL (inh=AR oe_syn=0.87 oe_mis=0.88 oe_lof=0.24)
chr1	47726087	47726087	T	C	het	het	het		QUAL=6436;DP=210,176,117;AF=0.51,0.47,0.47;MQM=60;SAP=76;ABP=4	STIL	missense	STIL:ENST00000243182.6:missense_variant:MODERATE:exon16/17:c.2951A>G:p.His984Arg:,STIL:ENST00000337817.5:missense_variant:MODERATE:exon16/17:c.2951A>G:p.His984Arg:,STIL:ENST00000360380.3:missense_variant:MODERATE:exon17/18:c.2951A>G:p.His984Arg:,STIL:ENST00000371877.3:missense_variant:MODERATE:exon16/17:c.2954A>G:p.His985Arg:,STIL:ENST00000396221.2:missense_variant:MODERATE:exon16/17:c.2900A>G:p.His967Arg:	STIL:NM_001048166.1:missense_variant:MODERATE:exon16/17:c.2954A>G:p.His985Arg:,STIL:NM_001282936.1:missense_variant:MODERATE:exon17/18:c.2951A>G:p.His984Arg:,STIL:NM_001282937.1:missense_variant:MODERATE:exon17/18:c.2900A>G:p.His967Arg:,STIL:NM_001282938.1:missense_variant:MODERATE:exon18/19:c.2813A>G:p.His938Arg:,STIL:NM_001282939.1:missense_variant:MODERATE:exon18/19:c.2759A>G:p.His920Arg:,STIL:NM_003035.2:missense_variant:MODERATE:exon16/17:c.2951A>G:p.His984Arg:		181590 [GENE=STIL PHENOS=Microcephaly 7,primary,autosomal recessive,612703,Autosomal recessive];	94094 [benign DISEASE=Primary autosomal recessive microcephaly 7,not specified,not provided];			rs13376679	0.1783	0.2478	1070,.	0.2040,0.1450,0.0230,0.3086,0.2306	0.0410	T(0.53),T(0.53),T(0.53),T(0.53),T(0.58)	B(0.00),B(0.00),B(0.00),B(0.00),B(0.00)	0.09,0.25	2.20	0.03				0.0774	0.2274	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					STIL (inh=AR oe_syn=0.87 oe_mis=0.88 oe_lof=0.24)
chr1	47735280	47735280	T	C	het	n/a	n/a	off-target	QUAL=66;DP=5,0,0;AF=0.60,,;MQM=60;SAP=10;ABP=3	STIL	intron	STIL:ENST00000243182.6:intron_variant:MODIFIER:intron14/16:c.2615+27A>G::,STIL:ENST00000337817.5:intron_variant:MODIFIER:intron14/16:c.2615+27A>G::,STIL:ENST00000360380.3:intron_variant:MODIFIER:intron15/17:c.2615+27A>G::,STIL:ENST00000371877.3:intron_variant:MODIFIER:intron14/16:c.2615+27A>G::,STIL:ENST00000396221.2:intron_variant:MODIFIER:intron14/16:c.2615+27A>G::	STIL:NM_001048166.1:intron_variant:MODIFIER:intron14/16:c.2615+27A>G::,STIL:NM_001282936.1:intron_variant:MODIFIER:intron15/17:c.2615+27A>G::,STIL:NM_001282937.1:intron_variant:MODIFIER:intron15/17:c.2615+27A>G::,STIL:NM_001282938.1:intron_variant:MODIFIER:intron16/18:c.2474+27A>G::,STIL:NM_001282939.1:intron_variant:MODIFIER:intron16/18:c.2474+27A>G::,STIL:NM_003035.2:intron_variant:MODIFIER:intron14/16:c.2615+27A>G::		181590 [GENE=STIL PHENOS=Microcephaly 7,primary,autosomal recessive,612703,Autosomal recessive];	160057 [benign DISEASE=not specified,not provided];			rs2742104	0.3944	0.5026	3520,.	0.1611,0.4436,0.4519,0.5254,0.5374	-0.1350			0.02,0.11	0.49					-0.2039	0.2808	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					STIL (inh=AR oe_syn=0.87 oe_mis=0.88 oe_lof=0.24)
chr1	47767914	47767914	G	A	het	hom	het		QUAL=13750;DP=245,258,185;AF=0.51,0.99,0.54;MQM=60;SAP=33;ABP=5	STIL	missense	STIL:ENST00000243182.6:missense_variant:MODERATE:exon4/17:c.257C>T:p.Ala86Val:PF15253 [SCL-interrupting locus protein N-terminus],STIL:ENST00000337817.5:missense_variant:MODERATE:exon4/17:c.257C>T:p.Ala86Val:PF15253 [SCL-interrupting locus protein N-terminus],STIL:ENST00000360380.3:missense_variant:MODERATE:exon5/18:c.257C>T:p.Ala86Val:PF15253 [SCL-interrupting locus protein N-terminus],STIL:ENST00000371877.3:missense_variant:MODERATE:exon4/17:c.257C>T:p.Ala86Val:PF15253 [SCL-interrupting locus protein N-terminus],STIL:ENST00000396221.2:missense_variant:MODERATE:exon4/17:c.257C>T:p.Ala86Val:PF15253 [SCL-interrupting locus protein N-terminus]	STIL:NM_001048166.1:missense_variant:MODERATE:exon4/17:c.257C>T:p.Ala86Val:,STIL:NM_001282936.1:missense_variant:MODERATE:exon5/18:c.257C>T:p.Ala86Val:,STIL:NM_001282937.1:missense_variant:MODERATE:exon5/18:c.257C>T:p.Ala86Val:,STIL:NM_001282938.1:missense_variant:MODERATE:exon5/19:c.257C>T:p.Ala86Val:,STIL:NM_001282939.1:missense_variant:MODERATE:exon5/19:c.257C>T:p.Ala86Val:,STIL:NM_003035.2:missense_variant:MODERATE:exon4/17:c.257C>T:p.Ala86Val:		181590 [GENE=STIL PHENOS=Microcephaly 7,primary,autosomal recessive,612703,Autosomal recessive];	21354 [benign DISEASE=Primary autosomal recessive microcephaly 7,not specified,not provided];			rs3125630		0.5621	5451,.	0.8412,0.5552,0.5487,0.4763,0.4630	5.1810	T(1.00),T(1.00),T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00),B(0.00),B(0.00)	0.02,0.93	17.11	0.17				-0.3663	0.7648	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					STIL (inh=AR oe_syn=0.87 oe_mis=0.88 oe_lof=0.24)
chr1	51066088	51066088	T	C	het	wt	het		QUAL=3511;DP=166,172,136;AF=0.43,0.00,0.48;MQM=60;SAP=78;ABP=9	FAF1	intron	FAF1:ENST00000371778.4:intron_variant:MODIFIER:intron9/19:c.745-4200A>G::,FAF1:ENST00000396153.2:intron_variant:MODIFIER:intron8/18:c.745-4200A>G::,FAF1:ENST00000545823.1:intron_variant:MODIFIER:intron1/11:c.19-4200A>G::	FAF1:NM_007051.3:intron_variant:MODIFIER:intron8/18:c.745-4200A>G::					Charlie1a (DNA/hAT-Charlie)	rs6679854	0.1695	0.2093	738,.		0.3230			0.01,0.11	5.77							0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FAF1 (inh=n/a oe_syn=0.86 oe_mis=0.68 oe_lof=0.12)
chr1	53662823	53662823	C	A	het	het	wt	off-target	QUAL=1516;DP=12,106,61;AF=0.42,0.60,0.00;MQM=60;SAP=3;ABP=10	CPT2	intron	CPT2:ENST00000371486.3:intron_variant:MODIFIER:intron1/4:c.152+56C>A::	CPT2:NM_000098.3:intron_variant:MODIFIER:intron1/4:c.152+56C>A::,CPT2:NM_001330589.2:intron_variant:MODIFIER:intron1/4:c.152+56C>A::	regulatory_region_variant:promoter	600650 [GENE=CPT2 PHENOS=CPT II deficiency,myopathic,stress-induced,255110,Autosomal recessive,Autosomal dominant/CPT II deficiency,infantile,600649,Autosomal recessive/CPT II deficiency,lethal neonatal,608836,Autosomal recessive/Encephalopathy,acute,infection-induced,4,susceptibility to,614212,Autosomal recessive,Autosomal dominant];				rs72673121	0.0889	0.1372	382,.		0.0470			0.06,0.41	7.68					0.1741	0.1196	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CPT2 (inh=AR+AD oe_syn=1.12 oe_mis=0.94 oe_lof=0.78)
chr1	53676448	53676448	G	A	het	hom	wt		QUAL=11049;DP=284,230,215;AF=0.52,1.00,0.00;MQM=60;SAP=55;ABP=4	CPT2,RP5-1024G6.2	missense,intron&non_coding_transcript	CPT2:ENST00000371486.3:missense_variant:MODERATE:exon4/5:c.1102G>A:p.Val368Ile:PF00755 [Choline/Carnitine o-acyltransferase],RP5-1024G6.2:ENST00000452466.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.436-232C>T::	CPT2:NM_000098.3:missense_variant:MODERATE:exon4/5:c.1102G>A:p.Val368Ile:,CPT2:NM_001330589.2:missense_variant:MODERATE:exon4/5:c.1102G>A:p.Val368Ile:		600650 [GENE=CPT2 PHENOS=CPT II deficiency,myopathic,stress-induced,255110,Autosomal recessive,Autosomal dominant/CPT II deficiency,infantile,600649,Autosomal recessive/CPT II deficiency,lethal neonatal,608836,Autosomal recessive/Encephalopathy,acute,infection-induced,4,susceptibility to,614212,Autosomal recessive,Autosomal dominant];	92429 [benign DISEASE=Carnitine palmitoyltransferase II deficiency,not specified,none provided,not provided]; 30118 [risk factor DISEASE=Encephalopathy, acute, infection-induced, 4, susceptibility to];	CM139511 [CLASS=DP MUT=ALT PHEN="Infuenza infection-associated encephalopathy" GENE=CPT2];		rs1799821	0.4131	0.4877	3742,.	0.2816,0.4382,0.7280,0.5441,0.2629	-0.0530	T(1.00), 	B(0.00), 	0.11,0.33	0.16	0.23				-0.0101	0.2057	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CPT2 (inh=AR+AD oe_syn=1.12 oe_mis=0.94 oe_lof=0.78), CZIB (inh=n/a oe_syn=1.14 oe_mis=0.98 oe_lof=0.84)
chr1	53679229	53679229	A	G	het	het	wt		QUAL=6115;DP=265,238,177;AF=0.48,0.46,0.00;MQM=60;SAP=8;ABP=7	CPT2,RP5-1024G6.2	missense,non_coding_transcript_exon	CPT2:ENST00000371486.3:missense_variant:MODERATE:exon5/5:c.1939A>G:p.Met647Val:PF00755 [Choline/Carnitine o-acyltransferase],RP5-1024G6.2:ENST00000452466.1:non_coding_transcript_exon_variant:MODIFIER:exon1/2:n.219T>C::	CPT2:NM_000098.3:missense_variant:MODERATE:exon5/5:c.1939A>G:p.Met647Val:,CPT2:NM_001330589.2:missense_variant:MODERATE:exon5/5:c.1870A>G:p.Met624Val:		600650 [GENE=CPT2 PHENOS=CPT II deficiency,myopathic,stress-induced,255110,Autosomal recessive,Autosomal dominant/CPT II deficiency,infantile,600649,Autosomal recessive/CPT II deficiency,lethal neonatal,608836,Autosomal recessive/Encephalopathy,acute,infection-induced,4,susceptibility to,614212,Autosomal recessive,Autosomal dominant];	92433 [benign DISEASE=Carnitine palmitoyltransferase II deficiency, infantile,Carnitine palmitoyltransferase II deficiency, lethal neonatal,Carnitine palmitoyltransferase II deficiency,not specified];	CM1720321 [CLASS=DM? MUT=ALT PHEN="Carnitine palmitoyltransferase 2 deficiency" GENE=CPT2];		rs1799822	0.1004	0.1644	409,.	0.0460,0.1283,0.0839,0.2198,0.1010	7.4480	D(0.01), 	B(0.01), 	0.99,0.99	23.40	0.29				0.0607	0.8778	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CPT2 (inh=AR+AD oe_syn=1.12 oe_mis=0.94 oe_lof=0.78), CZIB (inh=n/a oe_syn=1.14 oe_mis=0.98 oe_lof=0.84)
chr1	53679878	53679878	T	C	wt	het	wt		QUAL=694;DP=104,47,48;AF=0.00,0.60,0.00;MQM=60;SAP=14;ABP=7	CZIB	3'UTR	CZIB:ENST00000294360.4:3_prime_UTR_variant:MODIFIER:exon8/8:c.*453A>G::	C1orf123:NM_001304759.1:3_prime_UTR_variant:MODIFIER:exon7/7:c.*453A>G::,C1orf123:NM_001304760.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*453A>G::,C1orf123:NM_017887.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*453A>G::		600650 [GENE=CPT2 PHENOS=CPT II deficiency,myopathic,stress-induced,255110,Autosomal recessive,Autosomal dominant/CPT II deficiency,infantile,600649,Autosomal recessive/CPT II deficiency,lethal neonatal,608836,Autosomal recessive/Encephalopathy,acute,infection-induced,4,susceptibility to,614212,Autosomal recessive,Autosomal dominant];	368876 [benign DISEASE=Carnitine palmitoyltransferase II deficiency];			rs1056438	0.2282	0.2730	1433,.		-0.2740			0.00,0.11	1.93					-0.0121	0.9058	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CPT2 (inh=AR+AD oe_syn=1.12 oe_mis=0.94 oe_lof=0.78), CZIB (inh=n/a oe_syn=1.14 oe_mis=0.98 oe_lof=0.84)
chr1	55315351	55315351	T	C	hom	hom	hom		QUAL=17039;DP=244,156,129;AF=1.00,1.00,1.00;MQM=60;SAP=9;ABP=0	DHCR24	3'UTR	DHCR24:ENST00000371269.3:3_prime_UTR_variant:MODIFIER:exon9/9:c.*2555A>G::	DHCR24:NM_014762.4:3_prime_UTR_variant:MODIFIER:exon9/9:c.*2555A>G::		606418 [GENE=DHCR24 PHENOS=Desmosterolosis,602398,Autosomal recessive];	297612 [benign DISEASE=Desmosterolosis];			rs657688	0.9998	0.9994	15674,.		-0.6960			0.01,0.12	4.23					0.0023	0.8721	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DHCR24 (inh=AR oe_syn=0.93 oe_mis=0.76 oe_lof=0.29)
chr1	55315941	55315941	G	T	het	het	wt		QUAL=10531;DP=445,385,318;AF=0.47,0.50,0.00;MQM=60;SAP=22;ABP=5	DHCR24	3'UTR	DHCR24:ENST00000371269.3:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1965C>A::	DHCR24:NM_014762.4:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1965C>A::	regulatory_region_variant:open_chromatin_region	606418 [GENE=DHCR24 PHENOS=Desmosterolosis,602398,Autosomal recessive];	297621 [benign DISEASE=Desmosterolosis];			rs11555500	0.0102	0.0239	15,.		0.8540			0.17,0.20	3.60					-0.0029	0.872	0	0	12	0 / 0					DHCR24 (inh=AR oe_syn=0.93 oe_mis=0.76 oe_lof=0.29)
chr1	55316082	55316082	A	C	hom	hom	hom		QUAL=25092;DP=317,256,190;AF=1.00,1.00,1.00;MQM=60;SAP=7;ABP=0	DHCR24	3'UTR	DHCR24:ENST00000371269.3:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1824T>G::	DHCR24:NM_014762.4:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1824T>G::	regulatory_region_variant:open_chromatin_region	606418 [GENE=DHCR24 PHENOS=Desmosterolosis,602398,Autosomal recessive];	297623 [benign DISEASE=Desmosterolosis];			rs654561		0.9906	15413,.		-0.2950			0.03,0.14	1.10					0.0138	0.8723	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DHCR24 (inh=AR oe_syn=0.93 oe_mis=0.76 oe_lof=0.29)
chr1	55319902	55319902	A	G	hom	hom	hom		QUAL=601;DP=7,9,3;AF=1.00,1.00,1.00;MQM=60;SAP=29;ABP=0	DHCR24	synonymous	DHCR24:ENST00000371269.3:synonymous_variant:LOW:exon7/9:c.1026T>C:p.Ile342=:,DHCR24:ENST00000535035.1:synonymous_variant:LOW:exon7/9:c.903T>C:p.Ile301=:,DHCR24:ENST00000537443.1:synonymous_variant:LOW:exon4/6:c.378T>C:p.Ile126=:	DHCR24:NM_014762.4:synonymous_variant:LOW:exon7/9:c.1026T>C:p.Ile342=:		606418 [GENE=DHCR24 PHENOS=Desmosterolosis,602398,Autosomal recessive];	297654 [benign DISEASE=Desmosterolosis];			rs718265	0.6276	0.6725	7164,.	0.6163,0.5374,0.3983,0.6914,0.8057	1.6080			0.28,0.87	11.24					0.1888	0.085	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DHCR24 (inh=AR oe_syn=0.93 oe_mis=0.76 oe_lof=0.29)
chr1	55464743	55464743	T	C	hom	het	hom		QUAL=35458;DP=338,647,531;AF=0.99,0.49,1.00;MQM=60;SAP=535;ABP=4	BSND	5'UTR	BSND:ENST00000371265.4:5_prime_UTR_variant:MODIFIER:exon1/4:c.-117T>C::	BSND:NM_057176.3:5_prime_UTR_variant:MODIFIER:exon1/4:c.-117T>C::		606412 [GENE=BSND PHENOS=Sensorineural deafness with mild renal dysfunction,602522,Autosomal recessive/Bartter syndrome,type 4a,602522,Autosomal recessive];	297673 [benign DISEASE=Bartter disease type 4a];			rs2500340	0.5941	0.6621	7170,.		-0.9270			0.00,0.09	1.08					0.044	0.2187	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BSND (inh=AR oe_syn=1.20 oe_mis=0.99 oe_lof=1.19)
chr1	55464790	55464790	C	G	hom	het	hom		QUAL=37533;DP=331,756,570;AF=0.99,0.49,1.00;MQM=60;SAP=208;ABP=4	BSND	5'UTR	BSND:ENST00000371265.4:5_prime_UTR_variant:MODIFIER:exon1/4:c.-70C>G::	BSND:NM_057176.3:5_prime_UTR_variant:MODIFIER:exon1/4:c.-70C>G::		606412 [GENE=BSND PHENOS=Sensorineural deafness with mild renal dysfunction,602522,Autosomal recessive/Bartter syndrome,type 4a,602522,Autosomal recessive];	297674 [benign DISEASE=Bartter disease type 4a];			rs2500341		0.6627	7169,.		-0.5640			0.00,0.09	3.25					-0.065	0.2148	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BSND (inh=AR oe_syn=1.20 oe_mis=0.99 oe_lof=1.19)
chr1	55474325	55474325	A	C	het	hom	wt		QUAL=18369;DP=293,451,321;AF=0.56,1.00,0.01;MQM=60;SAP=160;ABP=11	BSND	3'UTR	BSND:ENST00000371265.4:3_prime_UTR_variant:MODIFIER:exon4/4:c.*24A>C::	BSND:NM_057176.3:3_prime_UTR_variant:MODIFIER:exon4/4:c.*24A>C::		606412 [GENE=BSND PHENOS=Sensorineural deafness with mild renal dysfunction,602522,Autosomal recessive/Bartter syndrome,type 4a,602522,Autosomal recessive];	297681 [benign DISEASE=Bartter disease type 4a];			rs6682884	0.3624	0.4330	3004,.	0.4963,0.2002,0.3039,0.4267,0.2805	0.5630			0.06,0.17	2.78					0.0191	0.8939	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BSND (inh=AR oe_syn=1.20 oe_mis=0.99 oe_lof=1.19)
chr1	55474476	55474476	C	G	het	hom	wt	off-target	QUAL=5167;DP=167,124,81;AF=0.43,1.00,0.00;MQM=60;SAP=429;ABP=10	BSND	3'UTR	BSND:ENST00000371265.4:3_prime_UTR_variant:MODIFIER:exon4/4:c.*175C>G::	BSND:NM_057176.3:3_prime_UTR_variant:MODIFIER:exon4/4:c.*175C>G::		606412 [GENE=BSND PHENOS=Sensorineural deafness with mild renal dysfunction,602522,Autosomal recessive/Bartter syndrome,type 4a,602522,Autosomal recessive];	368877 [benign DISEASE=Bartter syndrome];			rs4339899	0.4299	0.4664	3545,.		-1.0850			0.02,0.09	0.17					0.003	0.8936	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BSND (inh=AR oe_syn=1.20 oe_mis=0.99 oe_lof=1.19)
chr1	57340727	57340727	C	A	het	wt	hom		QUAL=5778;DP=134,210,141;AF=0.43,0.00,0.99;MQM=60;SAP=7;ABP=8	C8A	missense	C8A:ENST00000361249.3:missense_variant:MODERATE:exon3/11:c.277C>A:p.Gln93Lys:	C8A:NM_000562.3:missense_variant:MODERATE:exon3/11:c.277C>A:p.Gln93Lys:		120950 [GENE=C8A PHENOS=C8 deficiency,type I,613790,Autosomal recessive];	17039 [benign DISEASE=COMPLEMENT COMPONENT 8, ALPHA SUBUNIT, A/B POLYMORPHISM,not specified];			rs652785	0.3437	0.3653	1749,.	0.2062,0.2106,0.4662,0.3818,0.4981	0.1090	T(0.67)	B(0.01)	0.05,0.25	7.86	0.10				0.1246	0.1445	0.04	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C8A (inh=AR oe_syn=1.13 oe_mis=1.17 oe_lof=0.85)
chr1	57383358	57383358	C	T	wt	het	wt		QUAL=6230;DP=364,465,376;AF=0.00,0.53,0.00;MQM=60;SAP=4;ABP=6	C8A	missense	C8A:ENST00000361249.3:missense_variant:MODERATE:exon11/11:c.1724C>T:p.Pro575Leu:PF00090 [Thrombospondin type 1 domain]	C8A:NM_000562.3:missense_variant:MODERATE:exon11/11:c.1724C>T:p.Pro575Leu:		120950 [GENE=C8A PHENOS=C8 deficiency,type I,613790,Autosomal recessive];				rs17300936	0.0613	0.0932	137,.	0.0305,0.0374,0.0763,0.1263,0.0758	0.7210	T(0.48)	B(0.00)	0.05,0.22	8.84	0.02				-0.0644	0.9251	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C8A (inh=AR oe_syn=1.13 oe_mis=1.17 oe_lof=0.85)
chr1	57395020	57395020	A	G	het	wt	het	low_conf_region	QUAL=14115;DP=534,781,529;AF=0.52,0.00,0.49;MQM=60;SAP=130;ABP=3	C8B	3'UTR	C8B:ENST00000371237.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*57T>C::,C8B:ENST00000543257.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*57T>C::	C8B:NM_000066.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*57T>C::,C8B:NM_001278543.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*57T>C::,C8B:NM_001278544.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*57T>C::		120960 [GENE=C8B PHENOS=C8 deficiency,type II,613789,Autosomal recessive];				rs2795	0.3672	0.3172	1662,.		0.0350			0.01,0.16	5.50					0.0204	0.9298	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C8B (inh=AR oe_syn=1.26 oe_mis=1.12 oe_lof=0.98)
chr1	57395251	57395251	T	C	hom	hom	hom	off-target	QUAL=25363;DP=271,294,249;AF=1.00,1.00,1.00;MQM=60;SAP=1168;ABP=0	C8B	intron	C8B:ENST00000371237.4:intron_variant:MODIFIER:intron11/11:c.1622-20A>G::,C8B:ENST00000535057.1:intron_variant:MODIFIER:intron12/12:c.1436-20A>G::,C8B:ENST00000543257.1:intron_variant:MODIFIER:intron12/12:c.1466-20A>G::	C8B:NM_000066.4:intron_variant:MODIFIER:intron11/11:c.1622-20A>G::,C8B:NM_001278543.1:intron_variant:MODIFIER:intron12/12:c.1466-20A>G::,C8B:NM_001278544.1:intron_variant:MODIFIER:intron12/12:c.1436-20A>G::		120960 [GENE=C8B PHENOS=C8 deficiency,type II,613789,Autosomal recessive];				rs605648		0.8858	11359,.	0.7906,0.9243,0.9403,0.8559,0.9700	-1.5990			0.01,0.13	4.05		8.84>8.35			-0.5359	0.9742	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C8B (inh=AR oe_syn=1.26 oe_mis=1.12 oe_lof=0.98)
chr1	57409329	57409329	A	G	wt	wt	het	off-target	QUAL=2748;DP=186,229,187;AF=0.00,0.00,0.58;MQM=60;SAP=52;ABP=14	C8B	intron	C8B:ENST00000371237.4:intron_variant:MODIFIER:intron8/11:c.1234+40T>C::,C8B:ENST00000535057.1:intron_variant:MODIFIER:intron9/12:c.1048+40T>C::,C8B:ENST00000543257.1:intron_variant:MODIFIER:intron9/12:c.1078+40T>C::	C8B:NM_000066.4:intron_variant:MODIFIER:intron8/11:c.1234+40T>C::,C8B:NM_001278543.1:intron_variant:MODIFIER:intron9/12:c.1078+40T>C::,C8B:NM_001278544.1:intron_variant:MODIFIER:intron9/12:c.1048+40T>C::		120960 [GENE=C8B PHENOS=C8 deficiency,type II,613789,Autosomal recessive];				rs72670361	0.0168	0.0306	19,.	0.0074,0.0201,0.0001,0.0475,0.0065	0.1490			0.00,0.11	1.07					-0.0551	0.0554	0	32	1221	0 / 0					C8B (inh=AR oe_syn=1.26 oe_mis=1.12 oe_lof=0.98)
chr1	57422484	57422484	C	T	hom	hom	hom		QUAL=26256;DP=294,267,249;AF=1.00,1.00,1.00;MQM=60;SAP=157;ABP=0	C8B	missense	C8B:ENST00000371237.4:missense_variant:MODERATE:exon3/12:c.349G>A:p.Gly117Arg:,C8B:ENST00000535057.1:missense_variant:MODERATE:exon4/13:c.163G>A:p.Gly55Arg:,C8B:ENST00000543257.1:missense_variant:MODERATE:exon4/13:c.193G>A:p.Gly65Arg:	C8B:NM_000066.4:missense_variant:MODERATE:exon3/12:c.349G>A:p.Gly117Arg:,C8B:NM_001278543.1:synonymous_variant:LOW:exon4/13:c.193G>A:p.Arg65=:,C8B:NM_001278544.1:synonymous_variant:LOW:exon4/13:c.163G>A:p.Arg55=:		120960 [GENE=C8B PHENOS=C8 deficiency,type II,613789,Autosomal recessive];				rs1013579	0.9864	0.9777	15018,.	0.9943,0.9755,0.9999,0.9684,0.9896	0.5340	T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00)	0.10,0.93	15.70	0.04				-0.112	0.4701	0.09	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C8B (inh=AR oe_syn=1.26 oe_mis=1.12 oe_lof=0.98)
chr1	63881552	63881552	C	T	het	hom	het		QUAL=7279;DP=245,87,64;AF=0.56,1.00,0.44;MQM=60;SAP=246;ABP=6	ALG6	missense	ALG6:ENST00000263440.4:missense_variant:MODERATE:exon10/14:c.917C>T:p.Ser306Phe:PF03155 [ALG6 ALG8 glycosyltransferase family],ALG6:ENST00000371108.4:missense_variant:MODERATE:exon11/15:c.911C>T:p.Ser304Phe:PF03155 [ALG6 ALG8 glycosyltransferase family]	ALG6:NM_013339.4:missense_variant:MODERATE:exon11/15:c.911C>T:p.Ser304Phe:		604566 [GENE=ALG6 PHENOS=Congenital disorder of glycosylation,type Ic,603147,Autosomal recessive];	95531 [benign/likely benign DISEASE=Congenital disorder of glycosylation type 1C,not specified];			rs4630153	0.8305	0.7535	8792,.	0.8699,0.8233,0.8607,0.6835,0.8564	0.9670	T(0.32),T(0.32)	B(0.00),B(0.00)	0.01,0.25	21.50	0.19				-0.7	0.1255	0.25	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALG6 (inh=AR oe_syn=0.92 oe_mis=0.73 oe_lof=0.39)
chr1	63903452	63903452	T	C	het	hom	het		QUAL=2122;DP=96,21,14;AF=0.53,1.00,0.57;MQM=60;SAP=82;ABP=4	ALG6	3'UTR	ALG6:ENST00000371108.4:3_prime_UTR_variant:MODIFIER:exon15/15:c.*761T>C::	ALG6:NM_013339.4:3_prime_UTR_variant:MODIFIER:exon15/15:c.*761T>C::		604566 [GENE=ALG6 PHENOS=Congenital disorder of glycosylation,type Ic,603147,Autosomal recessive];	297858 [benign DISEASE=Congenital disorder of glycosylation type 1C];			rs3009572	0.6847	0.5866	5763,.		-0.2370			0.02,0.15	3.60					-0.0007	0.9247	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALG6 (inh=AR oe_syn=0.92 oe_mis=0.73 oe_lof=0.39), ITGB3BP (inh=n/a oe_syn=1.01 oe_mis=0.85 oe_lof=0.85)
chr1	67465791	67465791	G	A	het	wt	wt	low_conf_region	QUAL=17;DP=109,44,25;AF=0.20,0.00,0.04;MQM=60;SAP=53;ABP=87	SLC35D1	3'UTR	SLC35D1:ENST00000235345.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4232C>T::	SLC35D1:NM_015139.3:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4232C>T::	regulatory_region_variant:promoter_flanking_region	610804 [GENE=SLC35D1 PHENOS=Schneckenbecken dysplasia,269250,Autosomal recessive];			AluJr (SINE/Alu)	rs901342235		0.0043	0,.		-0.2840			0.00,0.05	0.44					-0.0064	0.9122	0	3	13	0 / 0					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67465970	67465970	T	-	het	het	wt		QUAL=228;DP=28,8,7;AF=0.21,0.00,0.29;MQM=60;SAP=4;ABP=38	SLC35D1	3'UTR	SLC35D1:ENST00000235345.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4053del::	SLC35D1:NM_015139.3:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4053del::	regulatory_region_variant:promoter_flanking_region	610804 [GENE=SLC35D1 PHENOS=Schneckenbecken dysplasia,269250,Autosomal recessive];			(T)n (Simple_repeat)	rs377396719		0.0065	0,.		0.6960				0.73					0.0012	0.9124	0	4	30	0 / 0					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67465988	67465988	A	-	het	wt	het	low_conf_region	QUAL=228;DP=28,8,7;AF=0.21,0.00,0.29;MQM=60;SAP=4;ABP=25	SLC35D1	3'UTR	SLC35D1:ENST00000235345.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4035del::	SLC35D1:NM_015139.3:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4035del::	regulatory_region_variant:promoter_flanking_region	610804 [GENE=SLC35D1 PHENOS=Schneckenbecken dysplasia,269250,Autosomal recessive];				rs397861605		0.0253	30,.		-0.6180				0.65					0.0026	0.9124	0	5	25	0 / 0					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67465988	67465988	A	T	wt	wt	het	low_conf_region	QUAL=228;DP=28,8,7;AF=0.21,0.00,0.29;MQM=60;SAP=4;ABP=52	SLC35D1	3'UTR	SLC35D1:ENST00000235345.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4035T>A::	SLC35D1:NM_015139.3:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4035T>A::	regulatory_region_variant:promoter_flanking_region	610804 [GENE=SLC35D1 PHENOS=Schneckenbecken dysplasia,269250,Autosomal recessive];				rs7540819		0.6285	4314,.		-0.6180			0.00,0.09	1.24					0.0021	0.9124	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67512903	67512903	G	T	hom	hom	hom	off-target	QUAL=12449;DP=171,112,106;AF=1.00,1.00,1.00;MQM=60;SAP=502;ABP=0	SLC35D1	intron	SLC35D1:ENST00000235345.5:intron_variant:MODIFIER:intron7/11:c.636+45C>A::,SLC35D1:ENST00000506472.2:intron_variant:MODIFIER:intron6/10:c.399+45C>A::	SLC35D1:NM_015139.3:intron_variant:MODIFIER:intron7/11:c.636+45C>A::		610804 [GENE=SLC35D1 PHENOS=Schneckenbecken dysplasia,269250,Autosomal recessive];				rs1024229	0.7095	0.6800	7324,.	0.7697,0.6619,0.6296,0.6613,0.7501	-1.0460			0.01,0.12	0.51					-0.0272	0.1886	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67512920	67512920	A	C	hom	hom	hom	off-target	QUAL=13959;DP=180,139,121;AF=1.00,1.00,1.00;MQM=60;SAP=477;ABP=0	SLC35D1	intron	SLC35D1:ENST00000235345.5:intron_variant:MODIFIER:intron7/11:c.636+28T>G::,SLC35D1:ENST00000506472.2:intron_variant:MODIFIER:intron6/10:c.399+28T>G::	SLC35D1:NM_015139.3:intron_variant:MODIFIER:intron7/11:c.636+28T>G::		610804 [GENE=SLC35D1 PHENOS=Schneckenbecken dysplasia,269250,Autosomal recessive];				rs1024230		0.6799	7325,.	0.7700,0.6625,0.6304,0.6618,0.7505	-0.3190			0.03,0.20	7.47					-0.6958	0.1929	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67520060	67520061	CA	-	het	hom	het	low_conf_region	QUAL=474;DP=22,12,8;AF=0.41,1.00,0.50;MQM=60;SAP=57;ABP=4	SLC35D1	upstream_gene	SLC35D1:ENST00000235345.5:upstream_gene_variant:MODIFIER::::,SLC35D1:ENST00000506472.2:upstream_gene_variant:MODIFIER::::		regulatory_region_variant:promoter,TF_binding_site_variant					rs3840439		0.6043	5748,.		0.3240				8.69								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67520083	67520083	C	T	het	wt	het		QUAL=196;DP=11,7,6;AF=0.82,0.00,0.50;MQM=60;SAP=29;ABP=9	SLC35D1	upstream_gene	SLC35D1:ENST00000235345.5:upstream_gene_variant:MODIFIER::::,SLC35D1:ENST00000506472.2:upstream_gene_variant:MODIFIER::::		regulatory_region_variant:promoter,TF_binding_site_variant					rs3806321	0.1567	0.1575	458,.		-0.6850			0.03,0.68	5.51								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67520140	67520140	T	G	hom	hom	n/a	off-target	QUAL=245;DP=4,3,2;AF=1.00,1.00,1.00;MQM=60;SAP=23;ABP=0	SLC35D1	upstream_gene	SLC35D1:ENST00000235345.5:upstream_gene_variant:MODIFIER::::,SLC35D1:ENST00000506472.2:upstream_gene_variant:MODIFIER::::		regulatory_region_variant:promoter,TF_binding_site_variant					rs2025087	0.8001	0.7543	8937,.		-1.1290			0.00,0.60	7.08								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	76190216	76190216	G	A	hom	het	het		QUAL=2074;DP=15,99,70;AF=0.93,0.43,0.50;MQM=60;SAP=94;ABP=5	ACADM	5'UTR	ACADM:ENST00000370841.4:5_prime_UTR_variant:MODIFIER:exon1/12:c.-257G>A::	ACADM:NM_000016.5:5_prime_UTR_variant:MODIFIER:exon1/12:c.-257G>A::,ACADM:NM_001127328.2:5_prime_UTR_variant:MODIFIER:exon1/12:c.-257G>A::,ACADM:NM_001286042.1:5_prime_UTR_variant:MODIFIER:exon1/11:c.-277G>A::,ACADM:NM_001286043.1:5_prime_UTR_variant:MODIFIER:exon1/13:c.-257G>A::,ACADM:NM_001286044.1:5_prime_UTR_variant:MODIFIER:exon1/9:c.-554G>A::	regulatory_region_variant:promoter	607008 [GENE=ACADM PHENOS=Acyl-CoA dehydrogenase,medium chain,deficiency of,201450,Autosomal recessive];	298063 [likely benign DISEASE=Medium-chain acyl-coenzyme A dehydrogenase deficiency];			rs17848068	0.2043	0.2666	1167,.		-0.4080			0.03,0.12	5.13					0.0289	0.3766	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACADM (inh=AR oe_syn=0.98 oe_mis=0.90 oe_lof=0.80)
chr1	76194230	76194230	T	-	hom	hom	hom	off-target;low_conf_region	QUAL=16907;DP=177,206,157;AF=1.00,1.00,1.00;MQM=60;SAP=415;ABP=0	ACADM	intron	ACADM:ENST00000370834.5:intron_variant:MODIFIER:intron2/12:c.118+60del::,ACADM:ENST00000370841.4:intron_variant:MODIFIER:intron2/11:c.118+60del::,ACADM:ENST00000420607.2:intron_variant:MODIFIER:intron2/11:c.130+60del::,ACADM:ENST00000541113.1:intron_variant:MODIFIER:intron1/10:c.10+3731del::,ACADM:ENST00000543667.1:intron_variant:MODIFIER:intron1/8:c.-268+3731del::	ACADM:NM_000016.5:intron_variant:MODIFIER:intron2/11:c.118+60del::,ACADM:NM_001127328.2:intron_variant:MODIFIER:intron2/11:c.130+60del::,ACADM:NM_001286042.1:intron_variant:MODIFIER:intron1/10:c.10+3731del::,ACADM:NM_001286043.1:intron_variant:MODIFIER:intron2/12:c.118+60del::,ACADM:NM_001286044.1:intron_variant:MODIFIER:intron1/8:c.-268+3731del::		607008 [GENE=ACADM PHENOS=Acyl-CoA dehydrogenase,medium chain,deficiency of,201450,Autosomal recessive];	226050 [benign DISEASE=Medium-chain acyl-coenzyme A dehydrogenase deficiency];			rs796117827		1.0000	15704,.		0.0000				0.43					0.0347	0.908	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACADM (inh=AR oe_syn=0.98 oe_mis=0.90 oe_lof=0.80)
chr1	76229326	76229326	T	C	wt	het	het		QUAL=125;DP=31,10,6;AF=0.03,0.70,0.17;MQM=60;SAP=23;ABP=3	ACADM	3'UTR	ACADM:ENST00000370841.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*878T>C::	ACADM:NM_000016.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*878T>C::,ACADM:NM_001127328.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*878T>C::,ACADM:NM_001286042.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*878T>C::,ACADM:NM_001286043.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*878T>C::,ACADM:NM_001286044.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*878T>C::		607008 [GENE=ACADM PHENOS=Acyl-CoA dehydrogenase,medium chain,deficiency of,201450,Autosomal recessive];	298081 [benign DISEASE=Medium-chain acyl-coenzyme A dehydrogenase deficiency];			rs1146587	0.6917	0.6526	6704,.		-1.2010			0.00,0.09	7.45					-0.003	0.8901	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACADM (inh=AR oe_syn=0.98 oe_mis=0.90 oe_lof=0.80)
chr1	92940411	92940411	C	T	het	het	wt		QUAL=6135;DP=277,165,118;AF=0.55,0.49,0.00;MQM=60;SAP=89;ABP=5	GFI1	3'UTR	GFI1:ENST00000294702.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1175G>A::,GFI1:ENST00000370332.1:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1175G>A::,GFI1:ENST00000427103.1:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1175G>A::	GFI1:NM_001127215.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1175G>A::,GFI1:NM_001127216.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1175G>A::,GFI1:NM_005263.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1175G>A::	regulatory_region_variant:promoter_flanking_region	600871 [GENE=GFI1 PHENOS=Neutropenia,nonimmune chronic idiopathic,of adults,607847,Autosomal dominant/Neutropenia,severe congenital 2,autosomal dominant,613107,Autosomal dominant];				rs41313373	0.0673	0.0930	192,.		2.6380			0.62,0.93	14.87					-0.0319	0.8908	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GFI1 (inh=AD oe_syn=0.70 oe_mis=0.72 oe_lof=0.25)
chr1	92941357	92941357	A	G	wt	wt	het		QUAL=3081;DP=443,280,226;AF=0.00,0.00,0.52;MQM=60;SAP=3;ABP=4	GFI1	3'UTR	GFI1:ENST00000294702.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*229T>C::,GFI1:ENST00000370332.1:3_prime_UTR_variant:MODIFIER:exon7/7:c.*229T>C::,GFI1:ENST00000427103.1:3_prime_UTR_variant:MODIFIER:exon7/7:c.*229T>C::	GFI1:NM_001127215.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*229T>C::,GFI1:NM_001127216.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*229T>C::,GFI1:NM_005263.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*229T>C::		600871 [GENE=GFI1 PHENOS=Neutropenia,nonimmune chronic idiopathic,of adults,607847,Autosomal dominant/Neutropenia,severe congenital 2,autosomal dominant,613107,Autosomal dominant];				rs4970714	0.8083	0.7128	8099,.		-2.7500			0.04,0.14	0.05				COSV54042587	0.0109	0.8917	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GFI1 (inh=AD oe_syn=0.70 oe_mis=0.72 oe_lof=0.25)
chr1	92944314	92944314	-	AGAGAG	wt	wt	het	low_conf_region	QUAL=5365;DP=60,154,98;AF=0.70,0.41,0.46;MQM=60;SAP=21;ABP=58	GFI1	splice_region&intron	GFI1:ENST00000294702.5:splice_region_variant&intron_variant:LOW:intron5/6:c.925-10_925-5dup::,GFI1:ENST00000370332.1:splice_region_variant&intron_variant:LOW:intron5/6:c.925-10_925-5dup::,GFI1:ENST00000427103.1:splice_region_variant&intron_variant:LOW:intron5/6:c.925-10_925-5dup::	GFI1:NM_001127215.2:splice_region_variant&intron_variant:LOW:intron5/6:c.925-10_925-5dup::,GFI1:NM_001127216.2:splice_region_variant&intron_variant:LOW:intron5/6:c.925-10_925-5dup::,GFI1:NM_005263.5:splice_region_variant&intron_variant:LOW:intron5/6:c.925-10_925-5dup::	regulatory_region_variant:promoter_flanking_region	600871 [GENE=GFI1 PHENOS=Neutropenia,nonimmune chronic idiopathic,of adults,607847,Autosomal dominant/Neutropenia,severe congenital 2,autosomal dominant,613107,Autosomal dominant];			(AG)n (Simple_repeat)	rs35896485		0.3561	1613,.						7.38					0.3718	0.0301	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GFI1 (inh=AD oe_syn=0.70 oe_mis=0.72 oe_lof=0.25)
chr1	92944315	92944316	AG	-	wt	het	wt	low_conf_region	QUAL=5365;DP=60,154,98;AF=0.70,0.41,0.46;MQM=60;SAP=22;ABP=182	GFI1	splice_region&intron	GFI1:ENST00000294702.5:splice_region_variant&intron_variant:LOW:intron5/6:c.925-6_925-5del::,GFI1:ENST00000370332.1:splice_region_variant&intron_variant:LOW:intron5/6:c.925-6_925-5del::,GFI1:ENST00000427103.1:splice_region_variant&intron_variant:LOW:intron5/6:c.925-6_925-5del::	GFI1:NM_001127215.2:splice_region_variant&intron_variant:LOW:intron5/6:c.925-6_925-5del::,GFI1:NM_001127216.2:splice_region_variant&intron_variant:LOW:intron5/6:c.925-6_925-5del::,GFI1:NM_005263.5:splice_region_variant&intron_variant:LOW:intron5/6:c.925-6_925-5del::	regulatory_region_variant:promoter_flanking_region	600871 [GENE=GFI1 PHENOS=Neutropenia,nonimmune chronic idiopathic,of adults,607847,Autosomal dominant/Neutropenia,severe congenital 2,autosomal dominant,613107,Autosomal dominant];	298182 [likely benign(replaced by megSAP based on classifications:1x1,2x3) DISEASE=Severe congenital neutropenia];		(AG)n (Simple_repeat)	rs35896485		0.1425	301,.		3.1710				12.01					-0.2347	0.148	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GFI1 (inh=AD oe_syn=0.70 oe_mis=0.72 oe_lof=0.25)
chr1	92944315	92944320	AGAGAG	-	hom	het	het	low_conf_region	QUAL=5365;DP=60,154,98;AF=0.00,0.34,0.01;MQM=60;SAP=126;ABP=14	GFI1	splice_region&intron	GFI1:ENST00000294702.5:splice_region_variant&intron_variant:LOW:intron5/6:c.925-10_925-5del::,GFI1:ENST00000370332.1:splice_region_variant&intron_variant:LOW:intron5/6:c.925-10_925-5del::,GFI1:ENST00000427103.1:splice_region_variant&intron_variant:LOW:intron5/6:c.925-10_925-5del::	GFI1:NM_001127215.2:splice_region_variant&intron_variant:LOW:intron5/6:c.925-10_925-5del::,GFI1:NM_001127216.2:splice_region_variant&intron_variant:LOW:intron5/6:c.925-10_925-5del::,GFI1:NM_005263.5:splice_region_variant&intron_variant:LOW:intron5/6:c.925-10_925-5del::	regulatory_region_variant:promoter_flanking_region	600871 [GENE=GFI1 PHENOS=Neutropenia,nonimmune chronic idiopathic,of adults,607847,Autosomal dominant/Neutropenia,severe congenital 2,autosomal dominant,613107,Autosomal dominant];	298185 [benign DISEASE=Severe congenital neutropenia];		(AG)n (Simple_repeat)	rs35896485		0.1257	244,.		3.1710				11.46					-0.8635	0.6095	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GFI1 (inh=AD oe_syn=0.70 oe_mis=0.72 oe_lof=0.25)
chr1	92948938	92948938	C	T	het	wt	het		QUAL=3292;DP=92,322,265;AF=0.47,0.00,0.46;MQM=60;SAP=101;ABP=8	GFI1	missense	GFI1:ENST00000294702.5:missense_variant:MODERATE:exon2/7:c.107G>A:p.Ser36Asn:,GFI1:ENST00000370332.1:missense_variant:MODERATE:exon2/7:c.107G>A:p.Ser36Asn:,GFI1:ENST00000427103.1:missense_variant:MODERATE:exon2/7:c.107G>A:p.Ser36Asn:	GFI1:NM_001127215.2:missense_variant:MODERATE:exon2/7:c.107G>A:p.Ser36Asn:,GFI1:NM_001127216.2:missense_variant:MODERATE:exon2/7:c.107G>A:p.Ser36Asn:,GFI1:NM_005263.5:missense_variant:MODERATE:exon2/7:c.107G>A:p.Ser36Asn:	regulatory_region_variant:promoter	600871 [GENE=GFI1 PHENOS=Neutropenia,nonimmune chronic idiopathic,of adults,607847,Autosomal dominant/Neutropenia,severe congenital 2,autosomal dominant,613107,Autosomal dominant];	259699 [benign DISEASE=Severe congenital neutropenia 2, autosomal dominant,not specified];			rs34631763	0.0194	0.0426	45,.	0.0094,0.0282,0.0000,0.0564,0.0089	4.3850	T(0.53),T(0.53),T(0.53)	B(0.02),B(0.02),B(0.02)	0.90,0.96	21.00	0.06				0.0051	0.0847	0.01	46	1516	0 / 0					GFI1 (inh=AD oe_syn=0.70 oe_mis=0.72 oe_lof=0.25)
chr1	92951657	92951657	-	A	het	het	het	off-target	QUAL=2388;DP=85,107,67;AF=0.47,0.33,0.51;MQM=60;SAP=3;ABP=17	GFI1	intron	GFI1:ENST00000294702.5:intron_variant:MODIFIER:intron1/6:c.-100+625dup::	GFI1:NM_005263.5:intron_variant:MODIFIER:intron1/6:c.-100+625dup::	regulatory_region_variant:promoter	600871 [GENE=GFI1 PHENOS=Neutropenia,nonimmune chronic idiopathic,of adults,607847,Autosomal dominant/Neutropenia,severe congenital 2,autosomal dominant,613107,Autosomal dominant];				rs112925059		0.1272	180,.						15.62								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GFI1 (inh=AD oe_syn=0.70 oe_mis=0.72 oe_lof=0.25)
chr1	97543752	97543752	G	A	het	het	het		QUAL=15972;DP=469,438,323;AF=0.48,0.48,0.50;MQM=60;SAP=229;ABP=5	DPYD	3'UTR	DPYD:ENST00000370192.3:3_prime_UTR_variant:MODIFIER:exon23/23:c.*780C>T::	DPYD:NM_000110.4:3_prime_UTR_variant:MODIFIER:exon23/23:c.*780C>T::		612779 [GENE=DPYD PHENOS=Dihydropyrimidine dehydrogenase deficiency,274270,Autosomal recessive/5-fluorouracil toxicity,274270,Autosomal recessive];	100064 [benign DISEASE=Dihydropyrimidine dehydrogenase deficiency,not provided];			rs291593	0.3850	0.3011	1586,.		-0.6800			0.00,0.09	1.34					-0.0169	0.8943	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	97543764	97543764	C	T	het	het	het		QUAL=15430;DP=401,461,340;AF=0.49,0.47,0.50;MQM=60;SAP=142;ABP=5	DPYD	3'UTR	DPYD:ENST00000370192.3:3_prime_UTR_variant:MODIFIER:exon23/23:c.*768G>A::	DPYD:NM_000110.4:3_prime_UTR_variant:MODIFIER:exon23/23:c.*768G>A::		612779 [GENE=DPYD PHENOS=Dihydropyrimidine dehydrogenase deficiency,274270,Autosomal recessive/5-fluorouracil toxicity,274270,Autosomal recessive];	100065 [benign DISEASE=Dihydropyrimidine dehydrogenase deficiency,not provided];			rs291592	0.5775	0.4485	3485,.		0.1790			0.03,0.16	3.22					-0.0164	0.8943	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	97543959	97543959	C	T	het	wt	het		QUAL=7028;DP=325,285,212;AF=0.53,0.00,0.44;MQM=60;SAP=210;ABP=3	DPYD	3'UTR	DPYD:ENST00000370192.3:3_prime_UTR_variant:MODIFIER:exon23/23:c.*573G>A::	DPYD:NM_000110.4:3_prime_UTR_variant:MODIFIER:exon23/23:c.*573G>A::		612779 [GENE=DPYD PHENOS=Dihydropyrimidine dehydrogenase deficiency,274270,Autosomal recessive/5-fluorouracil toxicity,274270,Autosomal recessive];	100067 [benign DISEASE=Dihydropyrimidine dehydrogenase deficiency,not provided];			rs1042482	0.0895	0.0665	73,.		0.1710			0.04,0.17	4.05					-0.0082	0.8945	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	97547831	97547831	G	A	hom	hom	hom	off-target	QUAL=15063;DP=185,164,126;AF=1.00,1.00,1.00;MQM=60;SAP=702;ABP=0	DPYD	intron	DPYD:ENST00000370192.3:intron_variant:MODIFIER:intron22/22:c.2907+55C>T::	DPYD:NM_000110.4:intron_variant:MODIFIER:intron22/22:c.2907+55C>T::	regulatory_region_variant:open_chromatin_region	612779 [GENE=DPYD PHENOS=Dihydropyrimidine dehydrogenase deficiency,274270,Autosomal recessive/5-fluorouracil toxicity,274270,Autosomal recessive];				rs290854		1.0000	15699,.		0.2900			0.02,0.17	5.16					0.1268	0.0863	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	97915624	97915624	A	G	het	het	wt		QUAL=4777;DP=203,187,150;AF=0.45,0.52,0.00;MQM=60;SAP=177;ABP=4	DPYD	synonymous	DPYD:ENST00000370192.3:synonymous_variant:LOW:exon14/23:c.1896T>C:p.Phe632=:PF01180 [Dihydroorotate dehydrogenase]	DPYD:NM_000110.4:synonymous_variant:LOW:exon14/23:c.1896T>C:p.Phe632=:		612779 [GENE=DPYD PHENOS=Dihydropyrimidine dehydrogenase deficiency,274270,Autosomal recessive/5-fluorouracil toxicity,274270,Autosomal recessive];	100088 [benign DISEASE=Dihydropyrimidine dehydrogenase deficiency,not specified,not provided];			rs17376848	0.0521	0.0510	50,.	0.0218,0.0873,0.1256,0.0411,0.0347	0.2800			0.52,0.94	3.58					-0.0103	0.199	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	97981242	97981242	T	C	hom	hom	het	off-target;low_conf_region	QUAL=8036;DP=188,54,44;AF=1.00,1.00,0.45;MQM=60;SAP=546;ABP=4	DPYD	intron	DPYD:ENST00000370192.3:intron_variant:MODIFIER:intron13/22:c.1740+40A>G::	DPYD:NM_000110.4:intron_variant:MODIFIER:intron13/22:c.1740+40A>G::		612779 [GENE=DPYD PHENOS=Dihydropyrimidine dehydrogenase deficiency,274270,Autosomal recessive/5-fluorouracil toxicity,274270,Autosomal recessive];	100090 [not provided DISEASE=not provided];			rs2811178	0.6518	0.6357	5852,.	0.6347,0.7027,0.7442,0.5962,0.6264	-0.0290			0.12,0.17	2.49					-0.0766	0.2031	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	98144726	98144726	T	C	wt	het	wt		QUAL=586;DP=168,55,36;AF=0.01,0.47,0.00;MQM=60;SAP=4;ABP=3	DPYD	missense	DPYD:ENST00000370192.3:missense_variant:MODERATE:exon8/23:c.775A>G:p.Lys259Glu:	DPYD:NM_000110.4:missense_variant:MODERATE:exon8/23:c.775A>G:p.Lys259Glu:		612779 [GENE=DPYD PHENOS=Dihydropyrimidine dehydrogenase deficiency,274270,Autosomal recessive/5-fluorouracil toxicity,274270,Autosomal recessive];	235464 [likely benign(replaced by megSAP based on classifications:3x1,2x2,1x3) DISEASE=Dihydropyrimidine dehydrogenase deficiency,not specified,not provided];	CM033369 [CLASS=DM MUT=ALT PHEN="Dihydropyrimidine dehydrogenase deficiency" GENE=DPYD];		rs45589337	0.0044	0.0062	4,.	0.0015,0.0032,0.0000,0.0082,0.0050	4.4920	D(0.00)	B(0.29)	0.92,0.98	23.00	0.61				0.443	0.2481	0	2	313	0 / 0	1	"[3] Stephan Waldmüller 18.11.2015%0A[n/a] comment imported from detected variant: HGMD: DM für Dihydropyrimidine dehydrogenase deficiency, Literatur nicht überzeugend, VUS3, swal 151118%0A[1] ahbuchr1 26.09.2016 MAF>1%, homozygote in ExAC"			DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	98185527	98185527	A	G	hom	hom	hom		QUAL=15789;DP=206,150,123;AF=1.00,1.00,1.00;MQM=60;SAP=12;ABP=0	DPYD	3'UTR,intron	DPYD:ENST00000306031.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*917T>C::,DPYD:ENST00000370192.3:intron_variant:MODIFIER:intron5/22:c.483+1539T>C::,DPYD:ENST00000423006.2:intron_variant:MODIFIER:intron4/6:c.372+1539T>C::	DPYD:NM_000110.4:intron_variant:MODIFIER:intron5/22:c.483+1539T>C::,DPYD:NM_001160301.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*917T>C::		612779 [GENE=DPYD PHENOS=Dihydropyrimidine dehydrogenase deficiency,274270,Autosomal recessive/5-fluorouracil toxicity,274270,Autosomal recessive];				rs2151562		0.9952	15528,.		0.4030			0.00,0.07	1.18					0.0217	0.9502	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	98186077	98186077	T	C	hom	hom	hom		QUAL=20031;DP=281,192,136;AF=1.00,1.00,1.00;MQM=60;SAP=214;ABP=0	DPYD	3'UTR,intron	DPYD:ENST00000306031.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*367A>G::,DPYD:ENST00000370192.3:intron_variant:MODIFIER:intron5/22:c.483+989A>G::,DPYD:ENST00000423006.2:intron_variant:MODIFIER:intron4/6:c.372+989A>G::	DPYD:NM_000110.4:intron_variant:MODIFIER:intron5/22:c.483+989A>G::,DPYD:NM_001160301.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*367A>G::		612779 [GENE=DPYD PHENOS=Dihydropyrimidine dehydrogenase deficiency,274270,Autosomal recessive/5-fluorouracil toxicity,274270,Autosomal recessive];				rs1333718	0.9978	0.9952	15531,.		0.7060			0.01,0.92	17.95					0.0026	0.95	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	98348885	98348885	G	A	hom	het	hom		QUAL=15071;DP=217,215,162;AF=1.00,0.52,1.00;MQM=60;SAP=11;ABP=4	DPYD	missense,intron	DPYD:ENST00000306031.5:missense_variant:MODERATE:exon2/6:c.85C>T:p.Arg29Cys:,DPYD:ENST00000370192.3:missense_variant:MODERATE:exon2/23:c.85C>T:p.Arg29Cys:,DPYD:ENST00000423006.2:intron_variant:MODIFIER:intron1/6:c.39+37555C>T::	DPYD:NM_000110.4:synonymous_variant:LOW:exon2/23:c.85C>T:p.Cys29=:,DPYD:NM_001160301.1:synonymous_variant:LOW:exon2/6:c.85C>T:p.Cys29=:		612779 [GENE=DPYD PHENOS=Dihydropyrimidine dehydrogenase deficiency,274270,Autosomal recessive/5-fluorouracil toxicity,274270,Autosomal recessive];	100123 [benign DISEASE=Dihydropyrimidine dehydrogenase deficiency,not provided];			rs1801265	0.7398	0.7718	8229,.	0.5869,0.7887,0.9280,0.7774,0.7450	2.2360	T(0.18),T(0.18), 	P(0.66),B(0.01), 	0.52,0.96	23.50	0.31				-0.3046	0.2561	0.04	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	98454469	98454469	G	T	wt	het	wt		QUAL=707;DP=245,74,71;AF=0.00,0.42,0.00;MQM=60;SAP=9;ABP=7		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:non_coding_transcript_exon_variant:MODIFIER:exon5/5:n.1556C>A::						rs41285694	0.0962	0.1257	332,.		0.4890			0.03,0.27	6.13					0.0046	0.9529		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98455128	98455128	A	-	het	het	het		QUAL=951;DP=85,28,17;AF=0.39,0.25,0.24;MQM=60;SAP=16;ABP=32		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:splice_region_variant&intron_variant&non_coding_transcript_variant:LOW:intron4/4:n.900-3del::	regulatory_region_variant:open_chromatin_region				AluSp (SINE/Alu)	rs543197080		0.0487	26,.		-0.9110				1.49					0.1653	0.7365		0	0	0 / 0					
chr1	98455957	98455957	G	A	wt	het	wt		QUAL=1441;DP=173,145,115;AF=0.00,0.42,0.00;MQM=60;SAP=52;ABP=11		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/4:n.900-832C>T::					L1PA13 (LINE/L1)	rs61785886	0.0966	0.1259	334,.		-1.2470			0.00,0.04	0.57								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98456643	98456643	G	A	wt	het	wt		QUAL=661;DP=145,76,45;AF=0.00,0.39,0.00;MQM=59;SAP=6;ABP=10		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/4:n.900-1518C>T::					AluY (SINE/Alu)	rs61785887	0.0737	0.0918	158,.		-0.3260			0.00,0.04	1.08								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98456731	98456731	C	T	wt	het	wt		QUAL=965;DP=215,114,57;AF=0.00,0.39,0.00;MQM=59;SAP=4;ABP=14		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/4:n.900-1606G>A::					AluY (SINE/Alu)	rs61785888	0.0965	0.1264	331,.		0.3940			0.00,0.05	3.13								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98456907	98456907	C	A	wt	het	wt		QUAL=1314;DP=192,96,87;AF=0.00,0.53,0.00;MQM=60;SAP=18;ABP=4		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/4:n.900-1782G>T::						rs4573558	0.1060	0.1353	344,.		-1.1730			0.00,0.08	0.28								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98457303	98457303	C	G	wt	het	wt		QUAL=2097;DP=278,175,105;AF=0.00,0.47,0.00;MQM=60;SAP=4;ABP=4		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/4:n.900-2178G>C::						rs2893376	0.1492	0.1731	496,.		-1.0480			0.00,0.07	1.35								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98457523	98457523	A	T	wt	het	wt		QUAL=1562;DP=205,125,63;AF=0.00,0.49,0.00;MQM=60;SAP=29;ABP=3		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/4:n.900-2398T>A::						rs2391873	0.1378	0.1620	428,.		-0.1440			0.07,0.95	17.99								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98460060	98460060	A	C	het	het	wt		QUAL=2945;DP=159,88,63;AF=0.48,0.51,0.00;MQM=60;SAP=216;ABP=3		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/4:n.899+412T>G::					AluSx (SINE/Alu)						-0.3560			0.01,0.10	4.14								0	3	0 / 0					
chr1	98460106	98460106	G	A	hom	het	hom		QUAL=9106;DP=167,125,85;AF=1.00,0.53,1.00;MQM=60;SAP=609;ABP=4		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/4:n.899+366C>T::					AluSx (SINE/Alu)	rs9440288	0.8552	0.8328	10887,.		-1.3490			0.00,0.05	0.26								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98461132	98461132	G	C	hom	het	hom		QUAL=22295;DP=266,366,282;AF=1.00,0.47,1.00;MQM=60;SAP=85;ABP=6		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-576C>G::					L2a (LINE/L2)	rs9324380	0.9267	0.9083	12972,.		-4.7750			0.00,0.04	0.01								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98461257	98461257	-	TTGT	hom	het	hom		QUAL=16391;DP=233,270,209;AF=0.99,0.44,1.00;MQM=60;SAP=48;ABP=11		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-702_815-701insACAA::						rs10655213		0.8635	11706,.						1.22								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98461443	98461443	C	T	het	het	het		QUAL=4940;DP=163,103,96;AF=0.52,0.52,0.47;MQM=60;SAP=43;ABP=3		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-887G>A::						rs9662365	0.4657	0.4794	3583,.		-0.0300			0.29,0.95	16.98								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98461954	98461954	T	C	hom	het	hom		QUAL=5956;DP=150,33,26;AF=0.99,0.58,1.00;MQM=60;SAP=260;ABP=5		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-1398A>G::						rs1938570	0.8936	0.8559	11556,.		-0.4170			0.01,0.11	1.03								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98462921	98462921	C	A	het	het	wt		QUAL=5236;DP=252,183,155;AF=0.50,0.48,0.00;MQM=60;SAP=70;ABP=3		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-2365G>T::						rs146033831	0.0176	0.0063	11,.		-0.1570			0.14,0.84	10.38								1	28	0 / 0					
chr1	98465528	98465528	G	A	hom	het	hom		QUAL=22742;DP=309,336,252;AF=1.00,0.50,1.00;MQM=60;SAP=336;ABP=3		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-4972C>T::						rs2154403	0.9034	0.8736	12050,.		0.9340			0.00,0.07	3.72								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98465840	98465840	G	A	het	wt	het		QUAL=5670;DP=282,308,224;AF=0.48,0.00,0.42;MQM=60;SAP=18;ABP=14		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-5284C>T::					L2a (LINE/L2)	rs116319667	0.0046	0.0092	3,.		-0.3330			0.00,0.06	1.34								4	127	0 / 0					
chr1	98466786	98466786	T	C	wt	wt	het		QUAL=1949;DP=337,175,144;AF=0.01,0.00,0.51;MQM=60;SAP=3;ABP=3		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-6230A>G::						rs12138817	0.1697	0.2159	881,.		-0.8380			0.01,0.13	2.99								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98468539	98468540	TA	-	hom	het	hom		QUAL=17143;DP=328,205,144;AF=0.99,0.54,1.00;MQM=60;SAP=239;ABP=6		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-7984_815-7983del::						rs5776390		0.8633	11719,.		0.0920				0.75								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98469687	98469687	A	-	het	het	wt		QUAL=6975;DP=212,312,245;AF=0.50,0.51,0.00;MQM=60;SAP=10;ABP=3		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-9131del::						rs564190891		0.0016	3,.		1.9190				11.32								0	14	0 / 0					
chr1	98470051	98470051	-	AT	hom	het	hom		QUAL=23711;DP=514,229,128;AF=1.00,0.48,1.00;MQM=60;SAP=100;ABP=3		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-9496_815-9495insAT::						rs10655252		0.8387	11018,.						0.18								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98470605	98470605	A	G	hom	het	hom		QUAL=6776;DP=178,25,20;AF=1.00,0.44,1.00;MQM=60;SAP=228;ABP=4		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-10049T>C::						rs10747495	0.9022	0.8733	12044,.		0.6230			0.00,0.07	5.83								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98471787	98471787	C	A	wt	wt	het		QUAL=231;DP=278,89,55;AF=0.00,0.00,0.33;MQM=60;SAP=7;ABP=17		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-11231G>T::					L1ME4a (LINE/L1)	rs55635742	0.0106	0.0191	9,.		-0.4440			0.03,0.11	0.37								6	199	0 / 0					
chr1	98472208	98472208	A	G	het	het	wt		QUAL=2965;DP=167,97,75;AF=0.45,0.41,0.00;MQM=60;SAP=52;ABP=13		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-11652T>C::					(ATTAC)n (Simple_repeat)	rs78878051	0.0633	0.0172	35,.		0.8530			0.04,0.13	2.10								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98472879	98472879	C	T	hom	het	hom		QUAL=20982;DP=326,254,193;AF=1.00,0.56,1.00;MQM=60;SAP=16;ABP=11		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-12323G>A::						rs1938564	0.8137	0.7962	10003,.		-0.3770			0.02,0.14	2.05								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98472958	98472958	T	A	hom	het	hom		QUAL=15848;DP=223,183,170;AF=1.00,0.55,1.00;MQM=60;SAP=23;ABP=6		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-12402A>T::						rs1938563	0.9014	0.8724	11985,.		0.7930			0.00,0.06	7.44								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98473716	98473716	T	A	hom	het	hom		QUAL=18887;DP=396,129,116;AF=1.00,0.55,1.00;MQM=60;SAP=185;ABP=6		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-13160A>T::	regulatory_region_variant:promoter_flanking_region,regulatory_region_variant:CTCF_binding_site					rs1938562	0.9014	0.8724	11980,.		1.0500			0.00,0.06	4.38								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98474767	98474767	C	T	hom	het	hom		QUAL=15281;DP=289,162,116;AF=1.00,0.49,1.00;MQM=60;SAP=342;ABP=3		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-14211G>A::	regulatory_region_variant:promoter_flanking_region					rs2391902		0.8031	10138,.		0.3170			0.02,0.91	13.70								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98475522	98475522	T	C	hom	het	hom		QUAL=16397;DP=305,172,118;AF=1.00,0.52,1.00;MQM=60;SAP=174;ABP=4		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-14966A>G::						rs2154402	0.9255	0.9080	12952,.		0.0780			0.00,0.38	8.55								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98475913	98475913	G	A	hom	het	hom		QUAL=14298;DP=297,125,87;AF=1.00,0.55,1.00;MQM=60;SAP=8;ABP=6		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-15357C>T::						rs9324381		0.8381	11005,.		0.6210			0.27,0.19	3.09								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98476718	98476718	G	A	hom	het	hom		QUAL=26002;DP=417,278,218;AF=1.00,0.60,1.00;MQM=60;SAP=3;ABP=26		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-16162C>T::						rs1938561	0.9022	0.8733	12035,.		0.2940			0.00,0.10	3.46								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98476950	98476950	T	C	hom	het	hom		QUAL=25126;DP=338,328,267;AF=1.00,0.55,1.00;MQM=60;SAP=3;ABP=10		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-16394A>G::					L2c (LINE/L2)	rs9440293	0.9024	0.8697	11849,.		-1.1440			0.00,0.08	2.61								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98476958	98476958	C	T	hom	het	hom		QUAL=25419;DP=342,337,268;AF=1.00,0.55,1.00;MQM=60;SAP=6;ABP=9		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-16402G>A::					L2c (LINE/L2)	rs9727941	0.8614	0.8351	10865,.		-0.2260			0.01,0.12	4.37								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98476966	98476966	G	C	hom	het	hom		QUAL=25193;DP=342,340,264;AF=1.00,0.56,1.00;MQM=60;SAP=17;ABP=12		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-16410C>G::					L2c (LINE/L2)	rs9724773		0.8350	10859,.		0.3340			0.06,0.15	2.88								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98478159	98478159	-	AC	het	het	hom		QUAL=11041;DP=251,167,118;AF=0.85,0.49,0.92;MQM=60;SAP=62;ABP=157		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-17605_815-17604dup::					MIRb (SINE/MIR)&(AC)n (Simple_repeat)	rs112555829		0.7584	8397,.						1.92								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98478544	98478544	A	T	hom	het	hom		QUAL=29726;DP=408,452,332;AF=1.00,0.48,1.00;MQM=60;SAP=180;ABP=5		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-17988T>A::					L2c (LINE/L2)	rs1938565	0.9024	0.8733	12041,.		0.0650			0.00,0.05	8.09								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98478981	98478981	C	T	hom	het	hom		QUAL=5313;DP=127,28,22;AF=1.00,0.43,1.00;MQM=60;SAP=13;ABP=4		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-18425G>A::						rs1938566	0.8247	0.8032	10142,.		-1.0060			0.01,0.09	0.17								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98480128	98480128	T	C	hom	het	hom		QUAL=22015;DP=405,218,193;AF=1.00,0.49,1.00;MQM=60;SAP=87;ABP=3		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-19572A>G::					MER102b (DNA/hAT-Charlie)	rs1938567	0.8772	0.8531	11333,.		-0.9290			0.00,0.21	8.97								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98480212	98480212	C	T	het	wt	het		QUAL=7934;DP=427,199,146;AF=0.53,0.01,0.49;MQM=60;SAP=22;ABP=6		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-19656G>A::					MER102b (DNA/hAT-Charlie)	rs11165944	0.3331	0.2970	1537,.		-1.1520			0.01,0.14	3.12								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98480316	98480316	A	-	het	het	het		QUAL=729;DP=94,47,34;AF=0.17,0.34,0.18;MQM=60;SAP=5;ABP=125		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-19760del::					A-rich (Low_complexity)	rs756636800		0.0195	1,.		0.3210				0.73								6	61	0 / 0					
chr1	98481750	98481750	C	T	het	wt	het		QUAL=6517;DP=334,298,216;AF=0.45,0.01,0.47;MQM=60;SAP=21;ABP=11		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-21194G>A::						rs6683447	0.3187	0.2735	1392,.		-0.8880			0.03,0.13	1.07								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98482580	98482580	G	A	hom	het	hom		QUAL=14209;DP=266,171,104;AF=1.00,0.50,1.00;MQM=60;SAP=364;ABP=3		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-22024C>T::					L1MB1 (LINE/L1)	rs2391903	0.9259	0.9078	12956,.		0.1850			0.00,0.05	3.52								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98482693	98482693	A	G	hom	het	hom		QUAL=16860;DP=242,245,159;AF=1.00,0.54,1.00;MQM=60;SAP=3;ABP=6		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-22137T>C::					L1MB1 (LINE/L1)	rs1892549	0.8710	0.8475	11287,.		-0.1970			0.01,0.10	3.49								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98482828	98482828	A	G	hom	het	hom		QUAL=15797;DP=301,139,122;AF=1.00,0.44,1.00;MQM=60;SAP=53;ABP=8		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-22272T>C::					L1MB1 (LINE/L1)	rs1892550	0.8710	0.8475	11298,.		-1.2570			0.05,0.13	0.65								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98482961	98482961	C	T	hom	het	hom		QUAL=14104;DP=278,134,97;AF=1.00,0.45,0.99;MQM=60;SAP=90;ABP=6		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-22405G>A::					L1MB1 (LINE/L1)	rs1892551		0.8473	11262,.		0.8730			0.00,0.11	1.87								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98483035	98483035	G	A	hom	het	hom		QUAL=9832;DP=215,75,54;AF=1.00,0.48,1.00;MQM=60;SAP=268;ABP=3		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-22479C>T::						rs1892552	0.8710	0.8480	11291,.		-0.1400			0.00,0.12	3.19								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98483150	98483150	A	G	hom	het	hom		QUAL=6154;DP=147,34,19;AF=1.00,0.62,1.00;MQM=60;SAP=4;ABP=7		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-22594T>C::						rs2391904		0.8475	11289,.		-0.2660			0.00,0.07	3.94								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98483230	98483230	T	A	wt	wt	het		QUAL=148;DP=225,54,29;AF=0.00,0.00,0.41;MQM=60;SAP=6;ABP=5		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-22674A>T::						rs116414424	0.0152	0.0252	14,.		-1.0500			0.02,0.16	9.02								1	13	0 / 0					
chr1	98483322	98483322	T	C	hom	het	hom		QUAL=6597;DP=154,49,33;AF=1.00,0.31,1.00;MQM=60;SAP=10;ABP=19		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-22766A>G::						rs9324382	0.8692	0.8466	11256,.		0.6070			0.04,0.38	11.13								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98484152	98484152	T	C	hom	het	hom		QUAL=7912;DP=166,91,53;AF=1.00,0.35,1.00;MQM=60;SAP=3;ABP=20		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-23596A>G::						rs1938571		0.7961	10010,.		-0.2760			0.02,0.10	1.25								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98484291	98484291	G	A	hom	het	hom		QUAL=11134;DP=208,108,97;AF=1.00,0.36,1.00;MQM=60;SAP=10;ABP=21		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-23735C>T::						rs4447033		0.8476	11290,.		0.0630			0.00,0.05	2.17								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98484474	98484474	T	C	hom	het	hom		QUAL=3396;DP=58,39,40;AF=1.00,0.36,1.00;MQM=57;SAP=64;ABP=10		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-23918A>G::					AluSx1 (SINE/Alu)	rs1938572	0.8710	0.8474	11238,.		-2.8460			0.00,0.02	0.30								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98484617	98484617	C	T	hom	het	hom		QUAL=3205;DP=79,27,12;AF=1.00,0.41,1.00;MQM=60;SAP=4;ABP=5		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-24061G>A::					AluSx1 (SINE/Alu)	rs1938573		0.8504	11143,.		-0.0880			0.00,0.07	1.14								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98484954	98484954	G	T	hom	het	hom		QUAL=19082;DP=334,222,156;AF=1.00,0.47,1.00;MQM=60;SAP=8;ABP=5		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-24398C>A::						rs1938558	0.8708	0.8473	11292,.		1.1760			0.54,0.64	9.68								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98485102	98485102	G	A	hom	het	hom		QUAL=13924;DP=249,154,126;AF=1.00,0.43,1.00;MQM=60;SAP=5;ABP=10		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-24546C>T::					MIR (SINE/MIR)	rs1938559	0.8710	0.8474	11292,.		0.7790			0.03,0.15	3.81								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98485192	98485192	C	T	hom	het	hom		QUAL=22243;DP=509,138,106;AF=1.00,0.43,1.00;MQM=60;SAP=50;ABP=8		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-24636G>A::					MIR (SINE/MIR)	rs1938560	0.8710	0.8475	11294,.		0.0080			0.00,0.05	3.84								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98485573	98485573	C	T	hom	het	hom		QUAL=8877;DP=148,74,88;AF=1.00,0.64,1.00;MQM=60;SAP=378;ABP=15		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-25017G>A::						rs9324383	0.8710	0.8480	11294,.		0.5250			0.00,0.12	3.16								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98485698	98485698	-	TT	het	n/a	n/a		QUAL=245;DP=17,2,2;AF=0.53,0.00,1.00;MQM=58;SAP=3;ABP=9		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-25144_815-25143dup::					AluSx1 (SINE/Alu)	rs10637296		0.0502	111,.						0.97								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98485698	98485698	-	TTT	het	n/a	n/a		QUAL=245;DP=17,2,2;AF=0.29,0.00,0.00;MQM=58;SAP=13;ABP=3		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-25145_815-25143dup::					AluSx1 (SINE/Alu)	rs10637296		0.7857	8107,.						0.95								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98485927	98485927	T	C	hom	het	hom		QUAL=6991;DP=106,108,83;AF=1.00,0.44,0.99;MQM=58;SAP=356;ABP=6		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-25371A>G::					AluSx1 (SINE/Alu)	rs9725319	0.8710	0.8477	11265,.		-1.8120			0.00,0.03	3.27								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98485991	98485991	C	T	het	het	wt		QUAL=2529;DP=109,159,136;AF=0.38,0.45,0.00;MQM=60;SAP=55;ABP=19		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-25435G>A::					AluSx1 (SINE/Alu)	rs74829086	0.0527	0.0136	21,.		-1.7340			0.00,0.09	0.33								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98486162	98486162	T	C	hom	het	hom		QUAL=7539;DP=149,73,66;AF=1.00,0.36,1.00;MQM=60;SAP=219;ABP=16		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+25402A>G::						rs4477335		0.8475	11276,.		-0.2590			0.00,0.09	4.31								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98486242	98486242	-	A	hom	het	hom		QUAL=4523;DP=130,24,19;AF=0.95,0.42,0.95;MQM=60;SAP=47;ABP=4		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+25321dup::						rs61381274		0.8474	11224,.						0.66								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98486370	98486370	G	A	hom	het	hom		QUAL=4962;DP=101,41,32;AF=1.00,0.46,1.00;MQM=60;SAP=28;ABP=3		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+25194C>T::						rs4480407	0.8928	0.8647	11763,.		0.8280			0.00,0.05	3.20								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98486694	98486694	A	C	wt	wt	het		QUAL=1902;DP=497,183,160;AF=0.00,0.00,0.50;MQM=60;SAP=60;ABP=3		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+24870T>G::						rs79792869	0.0152	0.0251	14,.		0.1050			0.05,0.17	4.06								1	13	0 / 0					
chr1	98487080	98487080	A	G	wt	wt	het		QUAL=3008;DP=491,218,177;AF=0.00,0.00,0.62;MQM=60;SAP=26;ABP=26		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+24484T>C::						rs77482155	0.0222	0.0364	19,.		2.9440			0.37,0.59	13.07								1	17	0 / 0					
chr1	98487333	98487333	A	G	hom	het	hom		QUAL=20753;DP=273,282,220;AF=1.00,0.57,1.00;MQM=60;SAP=13;ABP=17		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+24231T>C::						rs9659624		0.8475	11283,.		0.7480			0.07,0.32	14.78								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98487510	98487510	C	A	hom	het	hom		QUAL=20777;DP=389,203,161;AF=1.00,0.55,1.00;MQM=60;SAP=13;ABP=8		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+24054G>T::						rs5005705		0.8465	11249,.		-1.3280			0.02,0.16	0.90								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98487566	98487566	C	T	hom	het	hom		QUAL=13839;DP=234,144,129;AF=1.00,0.53,0.99;MQM=60;SAP=48;ABP=5		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+23998G>A::						rs9324384		0.8476	11285,.		-0.7030			0.01,0.17	3.88								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98487763	98487763	G	A	hom	het	hom		QUAL=18166;DP=308,181,165;AF=1.00,0.50,0.99;MQM=60;SAP=42;ABP=3		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+23801C>T::						rs4634961		0.8478	11291,.		-0.3680			0.01,0.15	2.39								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98487899	98487899	C	A	hom	het	hom		QUAL=19909;DP=273,262,232;AF=1.00,0.52,1.00;MQM=60;SAP=76;ABP=4		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+23665G>T::						rs9324385		0.8477	11290,.		-0.0390			0.00,0.11	2.41								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98487959	98487959	G	A	hom	het	hom		QUAL=26112;DP=376,327,265;AF=1.00,0.51,1.00;MQM=60;SAP=11;ABP=3		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+23605C>T::						rs9324386	0.8710	0.8479	11293,.		-0.0420			0.00,0.08	6.61								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98488030	98488030	G	A	hom	het	hom		QUAL=22549;DP=330,330,214;AF=1.00,0.50,1.00;MQM=60;SAP=104;ABP=3		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+23534C>T::						rs9324387	0.8712	0.8474	11286,.		-0.1070			0.04,0.18	4.64								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98488155	98488155	G	A	hom	het	hom		QUAL=17805;DP=284,197,169;AF=1.00,0.46,1.00;MQM=60;SAP=3;ABP=5		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+23409C>T::						rs9324388	0.8710	0.8477	11290,.		0.2610			0.04,0.18	2.72								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98488863	98488863	A	G	hom	het	hom		QUAL=16756;DP=319,131,127;AF=1.00,0.64,1.00;MQM=60;SAP=433;ABP=26		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+22701T>C::						rs9659996		0.8474	11285,.		1.6450			0.13,0.18	5.90								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98488895	98488895	C	T	hom	het	hom		QUAL=10333;DP=169,92,101;AF=1.00,0.58,1.00;MQM=60;SAP=129;ABP=8		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+22669G>A::						rs9658841	0.8710	0.8476	11292,.		-0.3150			0.01,0.12	0.60								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98489080	98489080	G	A	hom	het	hom		QUAL=7307;DP=173,38,26;AF=1.00,0.61,1.00;MQM=60;SAP=22;ABP=7		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+22484C>T::						rs9661157		0.8477	11285,.		-0.5770			0.00,0.07	2.29								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98489277	98489277	-	TACTT	het	het	hom	low_conf_region	QUAL=5493;DP=140,90,56;AF=0.86,0.36,0.96;MQM=60;SAP=5;ABP=55		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+22286_814+22287insAAGTA::						rs71071680		0.8460	11156,.						11.56								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98489330	98489330	C	T	hom	het	hom		QUAL=9460;DP=219,81,52;AF=1.00,0.31,1.00;MQM=60;SAP=135;ABP=29		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+22234G>A::						rs10747496	0.8710	0.8478	11262,.		0.3090			0.00,0.07	1.50								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98489478	98489478	A	G	hom	het	hom		QUAL=19514;DP=400,163,125;AF=1.00,0.42,1.00;MQM=60;SAP=5;ABP=11		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+22086T>C::						rs4584446		0.8474	11276,.		-0.0160			0.01,0.13	4.16								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98489735	98489735	T	C	hom	het	hom		QUAL=14495;DP=325,130,57;AF=1.00,0.51,1.00;MQM=60;SAP=356;ABP=3		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+21829A>G::						rs2391905	0.8710	0.8475	11281,.		0.2230			0.04,0.13	2.81								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98490012	98490013	TT	-	hom	het	hom		QUAL=10759;DP=294,95,79;AF=0.91,0.54,0.92;MQM=60;SAP=129;ABP=4		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+21551_814+21552del::					L2a (LINE/L2)	rs55633609		0.8382	9529,.		0.4430				0.42								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98490165	98490165	C	T	hom	het	hom		QUAL=8594;DP=179,72,46;AF=1.00,0.44,1.00;MQM=60;SAP=9;ABP=5		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+21399G>A::						rs4950117	0.8940	0.8653	11768,.		0.2440			0.00,0.06	4.29								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98490358	98490358	G	T	hom	het	hom		QUAL=16021;DP=258,169,154;AF=1.00,0.51,0.99;MQM=60;SAP=21;ABP=3		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+21206C>A::						rs4950118		0.8470	11263,.		0.5330			0.65,0.96	17.69								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98490636	98490636	T	C	hom	het	hom		QUAL=18236;DP=372,172,121;AF=0.99,0.48,1.00;MQM=60;SAP=151;ABP=3		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+20928A>G::						rs10783082		0.8476	11275,.		0.1180			0.02,0.17	14.55								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98490770	98490770	-	TTAAGTAT	hom	het	hom		QUAL=13747;DP=233,151,153;AF=0.96,0.56,1.00;MQM=60;SAP=6;ABP=8		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+20786_814+20793dup::						rs5776392		0.8428	11022,.						1.69								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98491248	98491248	A	C	hom	het	hom		QUAL=18371;DP=338,192,140;AF=1.00,0.45,1.00;MQM=60;SAP=6;ABP=7		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+20316T>G::					MIR3 (SINE/MIR)	rs4950119	0.8682	0.8347	10978,.		-0.6670			0.00,0.06	2.27								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98491382	98491382	G	A	hom	het	hom		QUAL=14540;DP=269,175,105;AF=1.00,0.44,1.00;MQM=60;SAP=56;ABP=8		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+20182C>T::					MIRb (SINE/MIR)	rs4950120	0.8710	0.8476	11262,.		0.1710			0.00,0.04	7.70								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98491473	98491473	A	C	hom	het	hom		QUAL=17760;DP=354,173,116;AF=1.00,0.50,0.99;MQM=60;SAP=104;ABP=3		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+20091T>G::					MIRb (SINE/MIR)	rs4245673	0.8710	0.8472	11279,.		0.9410			0.09,0.16	5.05								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98491732	98491732	T	C	hom	het	hom		QUAL=18295;DP=252,284,193;AF=1.00,0.49,1.00;MQM=60;SAP=122;ABP=3		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+19832A>G::						rs1938568	0.8710	0.8474	11281,.		0.6250			0.47,0.94	11.64								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98492462	98492462	C	T	hom	het	hom		QUAL=22556;DP=420,198,185;AF=1.00,0.46,0.99;MQM=60;SAP=58;ABP=5		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+19102G>A::						rs9440393	0.8710	0.8476	11282,.		-0.7830			0.00,0.06	0.21								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98492580	98492580	A	G	het	het	het		QUAL=13338;DP=470,283,260;AF=0.49,0.50,0.48;MQM=60;SAP=38;ABP=4		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+18984T>C::						rs9440302	0.4575	0.4750	3497,.		0.5010			0.07,0.20	4.83								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98492854	98492854	T	C	hom	het	hom		QUAL=16861;DP=354,113,95;AF=1.00,0.50,1.00;MQM=60;SAP=27;ABP=3		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+18710A>G::						rs9324389	0.8710	0.8477	11274,.		-2.2810			0.03,0.17	5.58								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98492901	98492901	G	A	wt	wt	het		QUAL=1388;DP=320,90,92;AF=0.00,0.00,0.59;MQM=60;SAP=3;ABP=9		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+18663C>T::						rs74700717	0.0106	0.0192	9,.		-1.3510			0.03,0.19	4.87								6	200	0 / 0					
chr1	98493263	98493263	A	G	hom	het	hom		QUAL=13381;DP=216,187,123;AF=1.00,0.45,1.00;MQM=60;SAP=240;ABP=7		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+18301T>C::						rs1938569	0.8706	0.8474	11262,.		0.7980			0.11,0.31	6.28								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98493785	98493785	G	A	hom	het	hom		QUAL=2323;DP=63,14,11;AF=0.98,0.36,1.00;MQM=60;SAP=90;ABP=5		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+17779C>T::						rs2022864	0.8712	0.8484	10915,.		-0.8400			0.01,0.10	0.38								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98493789	98493789	A	G	hom	het	hom		QUAL=2323;DP=63,14,11;AF=0.98,0.36,1.00;MQM=60;SAP=90;ABP=5		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+17775T>C::						rs2022865	0.8712	0.8479	10917,.		0.3550			0.02,0.26	6.14								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98494185	98494185	G	A	hom	het	hom		QUAL=12902;DP=215,153,104;AF=1.00,0.55,0.99;MQM=60;SAP=60;ABP=6		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+17379C>T::						rs10875124	0.8710	0.8471	11177,.		0.8860			0.00,0.08	5.52								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98494200	98494200	A	C	hom	het	hom		QUAL=12380;DP=217,140,97;AF=1.00,0.53,0.99;MQM=60;SAP=77;ABP=4		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+17364T>G::						rs10875125		0.8470	11180,.		0.2010			0.04,0.19	4.95								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98494388	98494388	-	A	hom	het	hom		QUAL=7901;DP=174,82,48;AF=0.98,0.44,1.00;MQM=60;SAP=120;ABP=6		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+17175dup::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:open_chromatin_region					rs11404556		0.8475	11240,.						7.10								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98494606	98494606	A	G	hom	het	hom		QUAL=14527;DP=242,151,132;AF=1.00,0.44,1.00;MQM=60;SAP=17;ABP=8		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+16958T>C::	regulatory_region_variant:open_chromatin_region					rs1198574	0.8712	0.8474	11249,.		0.7390			0.72,0.96	18.84								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98495513	98495513	T	C	hom	het	hom		QUAL=10065;DP=153,129,96;AF=1.00,0.54,1.00;MQM=60;SAP=99;ABP=5		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+16051A>G::						rs1198573		0.8475	11228,.		3.3540			0.32,0.20	8.69								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98496512	98496512	T	-	het	wt	het		QUAL=4131;DP=218,144,105;AF=0.50,0.03,0.60;MQM=60;SAP=181;ABP=5		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+15052del::	regulatory_region_variant:promoter_flanking_region					rs377025796		0.0118	7,.		0.8290				0.31								0	91	0 / 0					
chr1	98497176	98497176	A	C	hom	het	hom		QUAL=6033;DP=157,15,15;AF=1.00,0.67,1.00;MQM=60;SAP=6;ABP=7		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+14388T>G::						rs1198572		0.8175	10496,.		-0.4370			0.01,0.11	10.31								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98497355	98497355	A	G	het	wt	het		QUAL=777;DP=53,9,13;AF=0.51,0.00,0.62;MQM=59;SAP=30;ABP=4		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+14209T>C::	regulatory_region_variant:promoter_flanking_region					rs188465986	0.0022	0.0078	2,.		0.0570			0.04,0.14	3.42								0	96	0 / 0					
chr1	98497364	98497367	ACAC	-	wt	wt	het	low_conf_region	QUAL=31;DP=21,6,9;AF=0.00,0.00,0.44;MQM=60;SAP=12;ABP=3		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+14197_814+14200del::	regulatory_region_variant:promoter_flanking_region				(AC)n (Simple_repeat)	rs34012276		0.0436	25,.		0.3450				3.37								7	1	0 / 0					
chr1	98497672	98497672	A	G	hom	het	hom		QUAL=4984;DP=120,35,21;AF=1.00,0.37,1.00;MQM=60;SAP=89;ABP=8		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+13892T>C::						rs1198571	0.8706	0.8475	11258,.		0.1410			0.00,0.07	3.71								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98498339	98498339	C	T	wt	wt	het		QUAL=2115;DP=592,248,195;AF=0.00,0.00,0.47;MQM=60;SAP=11;ABP=5		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+13225G>A::						rs17371457	0.1374	0.1686	568,.		-0.6140			0.02,0.18	4.39								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98498898	98498898	C	A	hom	het	hom		QUAL=23929;DP=421,268,189;AF=1.00,0.47,1.00;MQM=60;SAP=209;ABP=5		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+12666G>T::						rs1782815	0.8686	0.8467	11260,.		0.1660			0.02,0.22	1.67								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98499590	98499590	A	-	het	het	wt	low_conf_region	QUAL=1630;DP=86,36,30;AF=0.58,0.53,0.00;MQM=58;SAP=67;ABP=8		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+11974del::					(AGAA)n (Simple_repeat)	rs143336786		0.0299	11,.		-0.4760				0.38								0	8	0 / 0					
chr1	98499651	98499651	G	A	het	het	het	low_conf_region	QUAL=1393;DP=67,14,17;AF=0.52,0.50,0.65;MQM=54;SAP=6;ABP=4		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+11913C>T::					(AGAA)n (Simple_repeat)	rs1782814		0.2214	453,.		0.3370			0.00,0.06	3.02								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98499663	98499663	-	AAAG	hom	het	hom	low_conf_region	QUAL=1400;DP=41,7,10;AF=0.93,0.29,0.90;MQM=59;SAP=3;ABP=6		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+11897_814+11900dup::					(AGAA)n (Simple_repeat)	rs780129382		0.2583	886,.						0.61								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98499843	98499843	T	C	hom	het	hom		QUAL=10095;DP=169,158,94;AF=0.99,0.46,1.00;MQM=60;SAP=118;ABP=5		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+11721A>G::	regulatory_region_variant:promoter_flanking_region					rs1782813		0.8587	11586,.		-0.1880			0.01,0.18	3.05								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98500045	98500045	G	C	het	wt	het		QUAL=6853;DP=389,168,132;AF=0.50,0.01,0.45;MQM=60;SAP=20;ABP=4		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+11519C>G::					UCON1 (Unknown)	rs7554283	0.3195	0.2740	1395,.		1.4460			0.81,0.98	16.23								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98501011	98501011	T	C	het	wt	het		QUAL=7039;DP=315,249,202;AF=0.49,0.00,0.53;MQM=60;SAP=30;ABP=3		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+10553A>G::						rs4950101	0.2772	0.2414	1082,.		1.6260			0.78,0.97	13.09								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98501984	98501984	T	C	hom	het	hom		QUAL=13795;DP=275,106,84;AF=0.99,0.59,1.00;MQM=60;SAP=4;ABP=11		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+9580A>G::						rs1702294		0.8112	10358,.		-0.3760			0.01,0.10	0.13								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98502159	98502159	G	C	hom	het	hom		QUAL=29015;DP=320,438,361;AF=1.00,0.51,1.00;MQM=60;SAP=59;ABP=4		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+9405C>G::					Tigger3a (DNA/TcMar-Tigger)	rs1702293		0.9079	12952,.		-2.1860			0.00,0.03	0.12								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98502340	98502340	G	A	hom	het	hom		QUAL=18808;DP=240,243,231;AF=1.00,0.48,1.00;MQM=60;SAP=15;ABP=4		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+9224C>T::					Tigger3a (DNA/TcMar-Tigger)	rs1782810		0.7719	9397,.		0.6560			0.01,0.06	0.55								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98502410	98502410	A	C	hom	het	hom		QUAL=21495;DP=275,295,249;AF=1.00,0.51,1.00;MQM=60;SAP=63;ABP=3		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+9154T>G::					Tigger3a (DNA/TcMar-Tigger)	rs1782811	0.9026	0.8731	12032,.		-2.7760			0.00,0.04	0.62								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98502594	98502594	A	C	hom	het	hom		QUAL=18001;DP=241,270,208;AF=1.00,0.49,1.00;MQM=60;SAP=283;ABP=3		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+8970T>G::						rs1628294	0.9257	0.9079	12953,.		-0.4680			0.00,0.10	5.33								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98502934	98502934	G	T	hom	het	hom		QUAL=10741;DP=212,108,74;AF=1.00,0.38,1.00;MQM=60;SAP=25;ABP=17		intergenic	::intergenic_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+8630C>A::				CR159174 [CLASS=DP MUT=ALT PHEN="Schizophrenia increased risk" GENE=MIR137HG];		rs1625579	0.7969	0.7716	9378,.		-0.3210			0.00,0.06	0.15								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr1	98506110	98506110	A	-	het	het	het		QUAL=754;DP=188,132,100;AF=0.21,0.17,0.13;MQM=60;SAP=11;ABP=386	MIR137HG	downstream_gene	MIR137HG:ENST00000580305.1:downstream_gene_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+5454del::						rs528539462		0.0297	0,.		-1.7420				0.08								0	8	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98506616	98506616	-	TTCATTCA	het	het	wt		QUAL=2640;DP=82,37,19;AF=0.43,0.03,0.37;MQM=60;SAP=4;ABP=5	MIR137HG	downstream_gene	MIR137HG:ENST00000580305.1:downstream_gene_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+4940_814+4947dup::					(TTCA)n (Simple_repeat)	rs35835879		0.1491	422,.						0.08								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98506616	98506616	-	TTCATTCATTCA	het	wt	het		QUAL=2640;DP=82,37,19;AF=0.43,0.03,0.37;MQM=57;SAP=3;ABP=46	MIR137HG	downstream_gene	MIR137HG:ENST00000580305.1:downstream_gene_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+4936_814+4947dup::					(TTCA)n (Simple_repeat)	rs35835879		0.5487	4645,.						0.07								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98506616	98506616	-	TTCATTCATTCATTCA	wt	wt	het		QUAL=2640;DP=82,37,19;AF=0.43,0.03,0.37;MQM=60;SAP=6;ABP=6	MIR137HG	downstream_gene	MIR137HG:ENST00000580305.1:downstream_gene_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+4932_814+4947dup::					(TTCA)n (Simple_repeat)	rs35835879		0.1144	224,.						0.06								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98507696	98507696	A	G	hom	het	hom		QUAL=6051;DP=154,35,15;AF=0.99,0.43,1.00;MQM=60;SAP=3;ABP=5	MIR137HG	downstream_gene	MIR137HG:ENST00000385223.1:downstream_gene_variant:MODIFIER::::,MIR137HG:ENST00000580305.1:downstream_gene_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+3868T>C::						rs4292998	0.8129	0.7828	9644,.		-0.0470			0.06,0.20	10.60								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98507718	98507718	C	A	hom	het	hom		QUAL=7220;DP=183,38,18;AF=1.00,0.45,1.00;MQM=60;SAP=4;ABP=4	MIR137HG	downstream_gene	MIR137HG:ENST00000385223.1:downstream_gene_variant:MODIFIER::::,MIR137HG:ENST00000580305.1:downstream_gene_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+3846G>T::						rs4411173	0.8896	0.8585	11604,.		0.5560			0.00,0.07	4.18								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98508258	98508258	C	T	hom	het	hom		QUAL=39501;DP=575,500,411;AF=1.00,0.52,1.00;MQM=60;SAP=243;ABP=5	MIR137HG	downstream_gene	MIR137HG:ENST00000385223.1:downstream_gene_variant:MODIFIER::::,MIR137HG:ENST00000580305.1:downstream_gene_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+3306G>A::						rs2802535	0.8097	0.7814	9588,.		-0.6370			0.03,0.11	0.32								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98508488	98508488	G	A	het	het	wt		QUAL=8631;DP=418,196,173;AF=0.50,0.56,0.00;MQM=60;SAP=197;ABP=5	MIR137HG	downstream_gene	MIR137HG:ENST00000385223.1:downstream_gene_variant:MODIFIER::::,MIR137HG:ENST00000580305.1:downstream_gene_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+3076C>T::	regulatory_region_variant:CTCF_binding_site					rs78924727	0.0527	0.0135	21,.		-0.2230			0.01,0.20	1.27								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98512127	98512127	G	T	hom	het	hom		QUAL=32948;DP=408,496,411;AF=1.00,0.48,1.00;MQM=60;SAP=12;ABP=6	MIR137HG	upstream_gene	MIR137HG:ENST00000385223.1:upstream_gene_variant:MODIFIER::::,MIR137HG:ENST00000580305.1:upstream_gene_variant:MODIFIER::::	MIR137HG:NR_046105.1:non_coding_transcript_exon_variant:MODIFIER:exon2/5:n.373C>A::	regulatory_region_variant:promoter					rs2660304	0.8468	0.8165	10449,.		1.2090			0.55,0.64	15.34					-0.0264	0.2222		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98513144	98513144	T	A	hom	het	hom		QUAL=13166;DP=231,132,116;AF=1.00,0.53,1.00;MQM=60;SAP=11;ABP=4	MIR137HG	upstream_gene	MIR137HG:ENST00000385223.1:upstream_gene_variant:MODIFIER::::,MIR137HG:ENST00000580305.1:upstream_gene_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.317-961A>T::						rs2660303	0.9259	0.9069	12917,.		-0.2550			0.02,0.15	0.49								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98513676	98513676	-	CA	wt	het	wt	low_conf_region	QUAL=922;DP=19,77,17;AF=0.16,0.00,0.29;MQM=60;SAP=9;ABP=4	MIR137HG	upstream_gene	MIR137HG:ENST00000385223.1:upstream_gene_variant:MODIFIER::::,MIR137HG:ENST00000580305.1:upstream_gene_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.316+1256_316+1257dup::					(CA)n (Simple_repeat)	rs1553269771									1.15								15	30	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98513676	98513676	-	CGCA	het	wt	hom	low_conf_region	QUAL=922;DP=19,77,17;AF=0.16,0.00,0.29;MQM=53;SAP=7;ABP=22	MIR137HG	upstream_gene	MIR137HG:ENST00000385223.1:upstream_gene_variant:MODIFIER::::,MIR137HG:ENST00000580305.1:upstream_gene_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.316+1257_316+1258insTGCG::					(CA)n (Simple_repeat)	rs150117500									1.09								6	59	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98513712	98513712	-	CACACACACC	het	wt	hom	low_conf_region	QUAL=922;DP=19,77,17;AF=0.16,0.00,0.29;MQM=53;SAP=7;ABP=22	MIR137HG	upstream_gene	MIR137HG:ENST00000385223.1:upstream_gene_variant:MODIFIER::::,MIR137HG:ENST00000580305.1:upstream_gene_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.316+1221_316+1222insGGTGTGTGTG::					(CA)n (Simple_repeat)	rs750747213		0.0323	24,.						4.06								1	0	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98513845	98513845	G	A	hom	het	hom		QUAL=13233;DP=147,260,183;AF=1.00,0.47,0.99;MQM=60;SAP=46;ABP=5	MIR137HG	upstream_gene	MIR137HG:ENST00000385223.1:upstream_gene_variant:MODIFIER::::,MIR137HG:ENST00000580305.1:upstream_gene_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.316+1089C>T::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter,TF_binding_site_variant					rs61786696	0.9263	0.9079	12965,.		0.4930			0.00,0.19	7.43								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98513959	98513959	A	G	hom	het	hom		QUAL=18014;DP=246,275,207;AF=1.00,0.49,1.00;MQM=60;SAP=17;ABP=3	MIR137HG	upstream_gene	MIR137HG:ENST00000385223.1:upstream_gene_variant:MODIFIER::::,MIR137HG:ENST00000580305.1:upstream_gene_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.316+975T>C::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter,TF_binding_site_variant					rs61786697	0.9261	0.9078	12956,.		2.5710			0.00,0.84	14.17								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98514590	98514590	-	CT	wt	het	wt		QUAL=677;DP=158,105,97;AF=0.13,0.11,0.12;MQM=60;SAP=22;ABP=292	MIR137HG	upstream_gene	MIR137HG:ENST00000385223.1:upstream_gene_variant:MODIFIER::::,MIR137HG:ENST00000580305.1:upstream_gene_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.316+342_316+343dup::	regulatory_region_variant:promoter				(CT)n (Simple_repeat)	rs143725104		0.0143	4,.						9.46								2	83	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98514591	98514592	CT	-	het	wt	het		QUAL=677;DP=158,105,97;AF=0.02,0.33,0.00;MQM=60;SAP=9;ABP=443	MIR137HG	upstream_gene	MIR137HG:ENST00000385223.1:upstream_gene_variant:MODIFIER::::,MIR137HG:ENST00000580305.1:upstream_gene_variant:MODIFIER::::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.316+342_316+343del::	regulatory_region_variant:promoter				(CT)n (Simple_repeat)	rs143725104		0.0147	5,.		0.0030				9.73								0	9	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	100316589	100316589	A	G	wt	wt	het		QUAL=1881;DP=310,144,107;AF=0.00,0.01,0.66;MQM=60;SAP=3;ABP=28	AGL	5'UTR,splice_acceptor	AGL:ENST00000294724.4:5_prime_UTR_variant:MODIFIER:exon2/34:c.-10A>G::,AGL:ENST00000361302.3:5_prime_UTR_variant:MODIFIER:exon1/34:c.-201A>G::,AGL:ENST00000361915.3:5_prime_UTR_variant:MODIFIER:exon2/34:c.-10A>G::,AGL:ENST00000370163.3:5_prime_UTR_variant:MODIFIER:exon2/34:c.-10A>G::,AGL:ENST00000370165.3:splice_acceptor_variant:HIGH:intron1/33:c.-8-2A>G::	AGL:NM_000028.2:5_prime_UTR_variant:MODIFIER:exon2/34:c.-10A>G::,AGL:NM_000642.3:5_prime_UTR_variant:MODIFIER:exon2/34:c.-10A>G::,AGL:NM_000643.2:5_prime_UTR_variant:MODIFIER:exon2/34:c.-10A>G::,AGL:NM_000644.2:splice_acceptor_variant:HIGH:intron1/33:c.-8-2A>G::,AGL:NM_000646.2:5_prime_UTR_variant:MODIFIER:exon1/34:c.-201A>G::	regulatory_region_variant:promoter	610860 [GENE=AGL PHENOS=Glycogen storage disease IIIb,232400,Autosomal recessive/Glycogen storage disease IIIa,232400,Autosomal recessive];	195096 [benign DISEASE=Glycogen storage disease type III,not specified,not provided];			rs2307130	0.4271	0.4694	2843,.	0.2635,0.4393,0.5339,0.4925,0.5368	0.3640			0.07,0.39	16.06		3.27>-4.68	0.000/0.000		-1.6286	0.9995	0.24	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	100318093	100318093	T	-	het	het	het	off-target;low_conf_region	QUAL=263;DP=12,13,6;AF=0.42,0.54,0.17;MQM=58;SAP=31;ABP=5	AGL	intron	AGL:ENST00000294724.4:intron_variant:MODIFIER:intron2/33:c.82+1432del::,AGL:ENST00000361302.3:intron_variant:MODIFIER:intron1/33:c.-109-5del::,AGL:ENST00000361915.3:intron_variant:MODIFIER:intron2/33:c.82+1432del::,AGL:ENST00000370163.3:intron_variant:MODIFIER:intron2/33:c.82+1432del::,AGL:ENST00000370165.3:intron_variant:MODIFIER:intron2/33:c.82+1432del::	AGL:NM_000028.2:intron_variant:MODIFIER:intron2/33:c.82+1432del::,AGL:NM_000642.3:intron_variant:MODIFIER:intron2/33:c.82+1432del::,AGL:NM_000643.2:intron_variant:MODIFIER:intron2/33:c.82+1432del::,AGL:NM_000644.2:intron_variant:MODIFIER:intron2/33:c.82+1432del::,AGL:NM_000646.2:intron_variant:MODIFIER:intron1/33:c.-109-5del::		610860 [GENE=AGL PHENOS=Glycogen storage disease IIIb,232400,Autosomal recessive/Glycogen storage disease IIIa,232400,Autosomal recessive];			AluJo (SINE/Alu)	rs58176899		0.0021	0,.		-0.2470				3.54					-0.0472	0.3326	0.05	8	7	0 / 0					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	100327026	100327026	C	T	het	het	het		QUAL=12692;DP=435,300,201;AF=0.53,0.46,0.48;MQM=60;SAP=4;ABP=3	AGL	intron,5'UTR	AGL:ENST00000294724.4:intron_variant:MODIFIER:intron2/33:c.83-33C>T::,AGL:ENST00000361302.3:intron_variant:MODIFIER:intron2/33:c.35-33C>T::,AGL:ENST00000361522.4:5_prime_UTR_variant:MODIFIER:exon1/32:c.-2C>T::,AGL:ENST00000361915.3:intron_variant:MODIFIER:intron2/33:c.83-33C>T::,AGL:ENST00000370161.2:intron_variant:MODIFIER:intron1/32:c.35-33C>T::,AGL:ENST00000370163.3:intron_variant:MODIFIER:intron2/33:c.83-33C>T::,AGL:ENST00000370165.3:intron_variant:MODIFIER:intron2/33:c.83-33C>T::	AGL:NM_000028.2:intron_variant:MODIFIER:intron2/33:c.83-33C>T::,AGL:NM_000642.3:intron_variant:MODIFIER:intron2/33:c.83-33C>T::,AGL:NM_000643.2:intron_variant:MODIFIER:intron2/33:c.83-33C>T::,AGL:NM_000644.2:intron_variant:MODIFIER:intron2/33:c.83-33C>T::,AGL:NM_000646.2:intron_variant:MODIFIER:intron2/33:c.35-33C>T::		610860 [GENE=AGL PHENOS=Glycogen storage disease IIIb,232400,Autosomal recessive/Glycogen storage disease IIIa,232400,Autosomal recessive];	256750 [benign DISEASE=not specified];			rs2307129	0.2272	0.2331	1048,.	0.3863,0.1314,0.1224,0.1714,0.1899	-0.3770			0.05,0.14	2.52					0.2315	0.1478	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	100329889	100329889	G	C	het	het	hom	off-target	QUAL=2599;DP=96,50,33;AF=0.54,0.38,1.00;MQM=60;SAP=220;ABP=3	AGL	intron	AGL:ENST00000294724.4:intron_variant:MODIFIER:intron4/33:c.461-53G>C::,AGL:ENST00000361302.3:intron_variant:MODIFIER:intron4/33:c.413-53G>C::,AGL:ENST00000361522.4:intron_variant:MODIFIER:intron2/31:c.410-53G>C::,AGL:ENST00000361915.3:intron_variant:MODIFIER:intron4/33:c.461-53G>C::,AGL:ENST00000370161.2:intron_variant:MODIFIER:intron3/32:c.413-53G>C::,AGL:ENST00000370163.3:intron_variant:MODIFIER:intron4/33:c.461-53G>C::,AGL:ENST00000370165.3:intron_variant:MODIFIER:intron4/33:c.461-53G>C::	AGL:NM_000028.2:intron_variant:MODIFIER:intron4/33:c.461-53G>C::,AGL:NM_000642.3:intron_variant:MODIFIER:intron4/33:c.461-53G>C::,AGL:NM_000643.2:intron_variant:MODIFIER:intron4/33:c.461-53G>C::,AGL:NM_000644.2:intron_variant:MODIFIER:intron4/33:c.461-53G>C::,AGL:NM_000646.2:intron_variant:MODIFIER:intron4/33:c.413-53G>C::		610860 [GENE=AGL PHENOS=Glycogen storage disease IIIb,232400,Autosomal recessive/Glycogen storage disease IIIa,232400,Autosomal recessive];	676092 [benign DISEASE=not provided];			rs535461		0.7230	8277,.		-0.0930			0.09,0.16	0.29					0.0487	0.465	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	100336361	100336361	C	T	het	het	hom		QUAL=8617;DP=341,117,98;AF=0.43,0.51,1.00;MQM=60;SAP=23;ABP=14	AGL	synonymous	AGL:ENST00000294724.4:synonymous_variant:LOW:exon7/34:c.894C>T:p.Leu298=:PF14701 [Glycogen debranching enzyme glucanotransferase domain],AGL:ENST00000361302.3:synonymous_variant:LOW:exon7/34:c.846C>T:p.Leu282=:PF14701 [Glycogen debranching enzyme glucanotransferase domain],AGL:ENST00000361522.4:synonymous_variant:LOW:exon5/32:c.843C>T:p.Leu281=:PF14701 [Glycogen debranching enzyme glucanotransferase domain],AGL:ENST00000361915.3:synonymous_variant:LOW:exon7/34:c.894C>T:p.Leu298=:PF14701 [Glycogen debranching enzyme glucanotransferase domain],AGL:ENST00000370161.2:synonymous_variant:LOW:exon6/33:c.846C>T:p.Leu282=:PF14701 [Glycogen debranching enzyme glucanotransferase domain],AGL:ENST00000370163.3:synonymous_variant:LOW:exon7/34:c.894C>T:p.Leu298=:PF14701 [Glycogen debranching enzyme glucanotransferase domain],AGL:ENST00000370165.3:synonymous_variant:LOW:exon7/34:c.894C>T:p.Leu298=:PF14701 [Glycogen debranching enzyme glucanotransferase domain]	AGL:NM_000028.2:synonymous_variant:LOW:exon7/34:c.894C>T:p.Leu298=:,AGL:NM_000642.3:synonymous_variant:LOW:exon7/34:c.894C>T:p.Leu298=:,AGL:NM_000643.2:synonymous_variant:LOW:exon7/34:c.894C>T:p.Leu298=:,AGL:NM_000644.2:synonymous_variant:LOW:exon7/34:c.894C>T:p.Leu298=:,AGL:NM_000646.2:synonymous_variant:LOW:exon7/34:c.846C>T:p.Leu282=:		610860 [GENE=AGL PHENOS=Glycogen storage disease IIIb,232400,Autosomal recessive/Glycogen storage disease IIIa,232400,Autosomal recessive];	198432 [benign DISEASE=Glycogen storage disease type III,not specified,not provided];			rs2230306		0.7559	9100,.	0.9171,0.6906,0.6850,0.7028,0.7519	1.3620			0.80,0.95	13.07					-0.1865	0.2803	0.12	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	100340225	100340225	G	A	het	het	hom	off-target;low_conf_region	QUAL=11584;DP=218,229,169;AF=0.50,0.54,1.00;MQM=60;SAP=149;ABP=4	AGL	intron	AGL:ENST00000294724.4:intron_variant:MODIFIER:intron7/33:c.959-18G>A::,AGL:ENST00000361302.3:intron_variant:MODIFIER:intron7/33:c.911-18G>A::,AGL:ENST00000361522.4:intron_variant:MODIFIER:intron5/31:c.908-18G>A::,AGL:ENST00000361915.3:intron_variant:MODIFIER:intron7/33:c.959-18G>A::,AGL:ENST00000370161.2:intron_variant:MODIFIER:intron6/32:c.911-18G>A::,AGL:ENST00000370163.3:intron_variant:MODIFIER:intron7/33:c.959-18G>A::,AGL:ENST00000370165.3:intron_variant:MODIFIER:intron7/33:c.959-18G>A::	AGL:NM_000028.2:intron_variant:MODIFIER:intron7/33:c.959-18G>A::,AGL:NM_000642.3:intron_variant:MODIFIER:intron7/33:c.959-18G>A::,AGL:NM_000643.2:intron_variant:MODIFIER:intron7/33:c.959-18G>A::,AGL:NM_000644.2:intron_variant:MODIFIER:intron7/33:c.959-18G>A::,AGL:NM_000646.2:intron_variant:MODIFIER:intron7/33:c.911-18G>A::		610860 [GENE=AGL PHENOS=Glycogen storage disease IIIb,232400,Autosomal recessive/Glycogen storage disease IIIa,232400,Autosomal recessive];	256751 [benign DISEASE=not specified,not provided];			rs634880		0.7326	8461,.	0.8453,0.6822,0.7106,0.7096,0.7330	-1.0390			0.00,0.06	0.65		10.97>11.37			-0.1622	0.653	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	100343153	100343153	A	G	wt	wt	het	off-target	QUAL=302;DP=175,41,22;AF=0.00,0.00,0.68;MQM=60;SAP=21;ABP=9	AGL	intron	AGL:ENST00000294724.4:intron_variant:MODIFIER:intron11/33:c.1424-44A>G::,AGL:ENST00000361302.3:intron_variant:MODIFIER:intron11/33:c.1376-44A>G::,AGL:ENST00000361522.4:intron_variant:MODIFIER:intron9/31:c.1373-44A>G::,AGL:ENST00000361915.3:intron_variant:MODIFIER:intron11/33:c.1424-44A>G::,AGL:ENST00000370161.2:intron_variant:MODIFIER:intron10/32:c.1376-44A>G::,AGL:ENST00000370163.3:intron_variant:MODIFIER:intron11/33:c.1424-44A>G::,AGL:ENST00000370165.3:intron_variant:MODIFIER:intron11/33:c.1424-44A>G::	AGL:NM_000028.2:intron_variant:MODIFIER:intron11/33:c.1424-44A>G::,AGL:NM_000642.3:intron_variant:MODIFIER:intron11/33:c.1424-44A>G::,AGL:NM_000643.2:intron_variant:MODIFIER:intron11/33:c.1424-44A>G::,AGL:NM_000644.2:intron_variant:MODIFIER:intron11/33:c.1424-44A>G::,AGL:NM_000646.2:intron_variant:MODIFIER:intron11/33:c.1376-44A>G::		610860 [GENE=AGL PHENOS=Glycogen storage disease IIIb,232400,Autosomal recessive/Glycogen storage disease IIIa,232400,Autosomal recessive];	256722 [benign DISEASE=not specified];			rs2291638	0.2843	0.3515	1766,.	0.0899,0.3604,0.4446,0.3883,0.3040	-0.3690			0.13,0.25	11.51					0.0137	0.1467	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	100346741	100346741	T	C	wt	wt	het		QUAL=2697;DP=287,284,209;AF=0.00,0.00,0.51;MQM=60;SAP=4;ABP=3	AGL	splice_region&intron	AGL:ENST00000294724.4:splice_region_variant&intron_variant:LOW:intron15/33:c.2001+8T>C::,AGL:ENST00000361302.3:splice_region_variant&intron_variant:LOW:intron15/33:c.1953+8T>C::,AGL:ENST00000361522.4:splice_region_variant&intron_variant:LOW:intron13/31:c.1950+8T>C::,AGL:ENST00000361915.3:splice_region_variant&intron_variant:LOW:intron15/33:c.2001+8T>C::,AGL:ENST00000370161.2:splice_region_variant&intron_variant:LOW:intron14/32:c.1953+8T>C::,AGL:ENST00000370163.3:splice_region_variant&intron_variant:LOW:intron15/33:c.2001+8T>C::,AGL:ENST00000370165.3:splice_region_variant&intron_variant:LOW:intron15/33:c.2001+8T>C::	AGL:NM_000028.2:splice_region_variant&intron_variant:LOW:intron15/33:c.2001+8T>C::,AGL:NM_000642.3:splice_region_variant&intron_variant:LOW:intron15/33:c.2001+8T>C::,AGL:NM_000643.2:splice_region_variant&intron_variant:LOW:intron15/33:c.2001+8T>C::,AGL:NM_000644.2:splice_region_variant&intron_variant:LOW:intron15/33:c.2001+8T>C::,AGL:NM_000646.2:splice_region_variant&intron_variant:LOW:intron15/33:c.1953+8T>C::		610860 [GENE=AGL PHENOS=Glycogen storage disease IIIb,232400,Autosomal recessive/Glycogen storage disease IIIa,232400,Autosomal recessive];	256725 [benign DISEASE=Glycogen storage disease type III,not specified,not provided];			rs3736296	0.5585	0.5541	4328,.	0.4313,0.6220,0.6604,0.5444,0.5893	2.1680			0.60,0.41	4.66			0.000/0.002		0.166	0.1317	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	100353675	100353675	G	A	het	het	hom	off-target	QUAL=12231;DP=172,264,206;AF=0.53,0.47,1.00;MQM=60;SAP=104;ABP=3	AGL	intron	AGL:ENST00000294724.4:intron_variant:MODIFIER:intron21/33:c.2812+11G>A::,AGL:ENST00000361302.3:intron_variant:MODIFIER:intron21/33:c.2764+11G>A::,AGL:ENST00000361522.4:intron_variant:MODIFIER:intron19/31:c.2761+11G>A::,AGL:ENST00000361915.3:intron_variant:MODIFIER:intron21/33:c.2812+11G>A::,AGL:ENST00000370161.2:intron_variant:MODIFIER:intron20/32:c.2764+11G>A::,AGL:ENST00000370163.3:intron_variant:MODIFIER:intron21/33:c.2812+11G>A::,AGL:ENST00000370165.3:intron_variant:MODIFIER:intron21/33:c.2812+11G>A::	AGL:NM_000028.2:intron_variant:MODIFIER:intron21/33:c.2812+11G>A::,AGL:NM_000642.3:intron_variant:MODIFIER:intron21/33:c.2812+11G>A::,AGL:NM_000643.2:intron_variant:MODIFIER:intron21/33:c.2812+11G>A::,AGL:NM_000644.2:intron_variant:MODIFIER:intron21/33:c.2812+11G>A::,AGL:NM_000646.2:intron_variant:MODIFIER:intron21/33:c.2764+11G>A::	regulatory_region_variant:open_chromatin_region	610860 [GENE=AGL PHENOS=Glycogen storage disease IIIb,232400,Autosomal recessive/Glycogen storage disease IIIa,232400,Autosomal recessive];	256730 [benign DISEASE=Glycogen storage disease type III,not specified,not provided];			rs555929	0.6811	0.6904	7013,.	0.5852,0.7226,0.6885,0.6936,0.7307	-0.7550			0.00,0.17	1.45					0.3226	0.0661	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	100357141	100357141	T	A	wt	wt	het	off-target	QUAL=1409;DP=198,186,121;AF=0.00,0.00,0.47;MQM=60;SAP=35;ABP=4	AGL	intron	AGL:ENST00000294724.4:intron_variant:MODIFIER:intron22/33:c.2950-21T>A::,AGL:ENST00000361302.3:intron_variant:MODIFIER:intron22/33:c.2902-21T>A::,AGL:ENST00000361522.4:intron_variant:MODIFIER:intron20/31:c.2899-21T>A::,AGL:ENST00000361915.3:intron_variant:MODIFIER:intron22/33:c.2950-21T>A::,AGL:ENST00000370161.2:intron_variant:MODIFIER:intron21/32:c.2902-21T>A::,AGL:ENST00000370163.3:intron_variant:MODIFIER:intron22/33:c.2950-21T>A::,AGL:ENST00000370165.3:intron_variant:MODIFIER:intron22/33:c.2950-21T>A::	AGL:NM_000028.2:intron_variant:MODIFIER:intron22/33:c.2950-21T>A::,AGL:NM_000642.3:intron_variant:MODIFIER:intron22/33:c.2950-21T>A::,AGL:NM_000643.2:intron_variant:MODIFIER:intron22/33:c.2950-21T>A::,AGL:NM_000644.2:intron_variant:MODIFIER:intron22/33:c.2950-21T>A::,AGL:NM_000646.2:intron_variant:MODIFIER:intron22/33:c.2902-21T>A::		610860 [GENE=AGL PHENOS=Glycogen storage disease IIIb,232400,Autosomal recessive/Glycogen storage disease IIIa,232400,Autosomal recessive];	256733 [benign DISEASE=not specified];			rs2035961		0.5367	3795,.	0.3801,0.6127,0.6593,0.5275,0.5855	0.0470			0.07,0.25	6.68					0.0537	0.2956	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	100358103	100358103	C	T	het	het	het		QUAL=8363;DP=251,223,182;AF=0.49,0.51,0.47;MQM=60;SAP=8;ABP=4	AGL	missense	AGL:ENST00000294724.4:missense_variant:MODERATE:exon24/34:c.3199C>T:p.Pro1067Ser:,AGL:ENST00000361302.3:missense_variant:MODERATE:exon24/34:c.3151C>T:p.Pro1051Ser:,AGL:ENST00000361522.4:missense_variant:MODERATE:exon22/32:c.3148C>T:p.Pro1050Ser:,AGL:ENST00000361915.3:missense_variant:MODERATE:exon24/34:c.3199C>T:p.Pro1067Ser:,AGL:ENST00000370161.2:missense_variant:MODERATE:exon23/33:c.3151C>T:p.Pro1051Ser:,AGL:ENST00000370163.3:missense_variant:MODERATE:exon24/34:c.3199C>T:p.Pro1067Ser:,AGL:ENST00000370165.3:missense_variant:MODERATE:exon24/34:c.3199C>T:p.Pro1067Ser:	AGL:NM_000028.2:missense_variant:MODERATE:exon24/34:c.3199C>T:p.Pro1067Ser:,AGL:NM_000642.3:missense_variant:MODERATE:exon24/34:c.3199C>T:p.Pro1067Ser:,AGL:NM_000643.2:missense_variant:MODERATE:exon24/34:c.3199C>T:p.Pro1067Ser:,AGL:NM_000644.2:missense_variant:MODERATE:exon24/34:c.3199C>T:p.Pro1067Ser:,AGL:NM_000646.2:missense_variant:MODERATE:exon24/34:c.3151C>T:p.Pro1051Ser:		610860 [GENE=AGL PHENOS=Glycogen storage disease IIIb,232400,Autosomal recessive/Glycogen storage disease IIIa,232400,Autosomal recessive];	256734 [benign DISEASE=Glycogen storage disease type III,not specified,not provided];			rs3753494	0.1106	0.1366	347,.	0.1169,0.0998,0.0294,0.1496,0.1452	7.2300	D(0.04),D(0.03),D(0.03),D(0.04),D(0.03),D(0.04),D(0.04)	B(0.10),B(0.05),B(0.05),B(0.10),B(0.05),B(0.10),B(0.10)	0.98,0.99	22.30	0.30				-0.0803	0.1333	0.11	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	100358200	100358200	G	A	het	het	hom	off-target	QUAL=5718;DP=136,117,88;AF=0.46,0.49,1.00;MQM=60;SAP=296;ABP=5	AGL	intron	AGL:ENST00000294724.4:intron_variant:MODIFIER:intron24/33:c.3259+37G>A::,AGL:ENST00000361302.3:intron_variant:MODIFIER:intron24/33:c.3211+37G>A::,AGL:ENST00000361522.4:intron_variant:MODIFIER:intron22/31:c.3208+37G>A::,AGL:ENST00000361915.3:intron_variant:MODIFIER:intron24/33:c.3259+37G>A::,AGL:ENST00000370161.2:intron_variant:MODIFIER:intron23/32:c.3211+37G>A::,AGL:ENST00000370163.3:intron_variant:MODIFIER:intron24/33:c.3259+37G>A::,AGL:ENST00000370165.3:intron_variant:MODIFIER:intron24/33:c.3259+37G>A::	AGL:NM_000028.2:intron_variant:MODIFIER:intron24/33:c.3259+37G>A::,AGL:NM_000642.3:intron_variant:MODIFIER:intron24/33:c.3259+37G>A::,AGL:NM_000643.2:intron_variant:MODIFIER:intron24/33:c.3259+37G>A::,AGL:NM_000644.2:intron_variant:MODIFIER:intron24/33:c.3259+37G>A::,AGL:NM_000646.2:intron_variant:MODIFIER:intron24/33:c.3211+37G>A::		610860 [GENE=AGL PHENOS=Glycogen storage disease IIIb,232400,Autosomal recessive/Glycogen storage disease IIIa,232400,Autosomal recessive];	256735 [benign DISEASE=not specified,not provided];			rs594249	0.6815	0.6911	7026,.	0.5841,0.7229,0.6889,0.6939,0.7346	-1.3340			0.00,0.05	0.31					0.1133	0.1347	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	100366446	100366446	G	T	het	wt	wt	off-target;low_conf_region	QUAL=1465;DP=79,50,49;AF=0.28,0.42,0.78;MQM=57;SAP=64;ABP=108	AGL	intron	AGL:ENST00000294724.4:intron_variant:MODIFIER:intron26/33:c.3588+29G>T::,AGL:ENST00000361302.3:intron_variant:MODIFIER:intron26/33:c.3540+29G>T::,AGL:ENST00000361522.4:intron_variant:MODIFIER:intron24/31:c.3537+29G>T::,AGL:ENST00000361915.3:intron_variant:MODIFIER:intron26/33:c.3588+29G>T::,AGL:ENST00000370161.2:intron_variant:MODIFIER:intron25/32:c.3540+29G>T::,AGL:ENST00000370163.3:intron_variant:MODIFIER:intron26/33:c.3588+29G>T::,AGL:ENST00000370165.3:intron_variant:MODIFIER:intron26/33:c.3588+29G>T::	AGL:NM_000028.2:intron_variant:MODIFIER:intron26/33:c.3588+29G>T::,AGL:NM_000642.3:intron_variant:MODIFIER:intron26/33:c.3588+29G>T::,AGL:NM_000643.2:intron_variant:MODIFIER:intron26/33:c.3588+29G>T::,AGL:NM_000644.2:intron_variant:MODIFIER:intron26/33:c.3588+29G>T::,AGL:NM_000646.2:intron_variant:MODIFIER:intron26/33:c.3540+29G>T::		610860 [GENE=AGL PHENOS=Glycogen storage disease IIIb,232400,Autosomal recessive/Glycogen storage disease IIIa,232400,Autosomal recessive];			(T)n (Simple_repeat)	rs201885902		0.0169	0,.	0.0243,0.0180,0.0202,0.0153,0.0173	-0.1580			0.03,0.11	0.29					0.0634	0.3172	0.02	111	499	0 / 0	2	"[2] auto-classification 22.09.2017%0A%0A"			AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	100366447	100366448	TT	-	wt	het	hom	off-target;low_conf_region	QUAL=1465;DP=79,50,49;AF=0.27,0.08,0.06;MQM=60;SAP=179;ABP=34	AGL	intron	AGL:ENST00000294724.4:intron_variant:MODIFIER:intron26/33:c.3588+43_3588+44del::,AGL:ENST00000361302.3:intron_variant:MODIFIER:intron26/33:c.3540+43_3540+44del::,AGL:ENST00000361522.4:intron_variant:MODIFIER:intron24/31:c.3537+43_3537+44del::,AGL:ENST00000361915.3:intron_variant:MODIFIER:intron26/33:c.3588+43_3588+44del::,AGL:ENST00000370161.2:intron_variant:MODIFIER:intron25/32:c.3540+43_3540+44del::,AGL:ENST00000370163.3:intron_variant:MODIFIER:intron26/33:c.3588+43_3588+44del::,AGL:ENST00000370165.3:intron_variant:MODIFIER:intron26/33:c.3588+43_3588+44del::	AGL:NM_000028.2:intron_variant:MODIFIER:intron26/33:c.3588+43_3588+44del::,AGL:NM_000642.3:intron_variant:MODIFIER:intron26/33:c.3588+43_3588+44del::,AGL:NM_000643.2:intron_variant:MODIFIER:intron26/33:c.3588+43_3588+44del::,AGL:NM_000644.2:intron_variant:MODIFIER:intron26/33:c.3588+43_3588+44del::,AGL:NM_000646.2:intron_variant:MODIFIER:intron26/33:c.3540+43_3540+44del::		610860 [GENE=AGL PHENOS=Glycogen storage disease IIIb,232400,Autosomal recessive/Glycogen storage disease IIIa,232400,Autosomal recessive];			(T)n (Simple_repeat)	rs35956186		0.5178	3116,.	0.3430,0.3746,0.3694,0.4285,0.3509	2.7560				0.95					-0.0648	0.3184	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	100376448	100376448	G	A	wt	wt	het	off-target	QUAL=2103;DP=102,266,176;AF=0.00,0.00,0.49;MQM=60;SAP=9;ABP=3	AGL	intron	AGL:ENST00000294724.4:intron_variant:MODIFIER:intron28/33:c.3836+45G>A::,AGL:ENST00000361302.3:intron_variant:MODIFIER:intron28/33:c.3788+45G>A::,AGL:ENST00000361522.4:intron_variant:MODIFIER:intron26/31:c.3785+45G>A::,AGL:ENST00000361915.3:intron_variant:MODIFIER:intron28/33:c.3836+45G>A::,AGL:ENST00000370161.2:intron_variant:MODIFIER:intron27/32:c.3788+45G>A::,AGL:ENST00000370163.3:intron_variant:MODIFIER:intron28/33:c.3836+45G>A::,AGL:ENST00000370165.3:intron_variant:MODIFIER:intron28/33:c.3836+45G>A::	AGL:NM_000028.2:intron_variant:MODIFIER:intron28/33:c.3836+45G>A::,AGL:NM_000642.3:intron_variant:MODIFIER:intron28/33:c.3836+45G>A::,AGL:NM_000643.2:intron_variant:MODIFIER:intron28/33:c.3836+45G>A::,AGL:NM_000644.2:intron_variant:MODIFIER:intron28/33:c.3836+45G>A::,AGL:NM_000646.2:intron_variant:MODIFIER:intron28/33:c.3788+45G>A::		610860 [GENE=AGL PHENOS=Glycogen storage disease IIIb,232400,Autosomal recessive/Glycogen storage disease IIIa,232400,Autosomal recessive];	256744 [benign DISEASE=not specified];			rs2274570	0.4613	0.4822	3533,.	0.3712,0.5710,0.5425,0.5001,0.3654	-0.8020			0.00,0.07	2.18					0.0806	0.3448	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	100376456	100376456	T	A	wt	wt	het	off-target	QUAL=2114;DP=106,261,173;AF=0.00,0.00,0.50;MQM=60;SAP=14;ABP=3	AGL	intron	AGL:ENST00000294724.4:intron_variant:MODIFIER:intron28/33:c.3836+53T>A::,AGL:ENST00000361302.3:intron_variant:MODIFIER:intron28/33:c.3788+53T>A::,AGL:ENST00000361522.4:intron_variant:MODIFIER:intron26/31:c.3785+53T>A::,AGL:ENST00000361915.3:intron_variant:MODIFIER:intron28/33:c.3836+53T>A::,AGL:ENST00000370161.2:intron_variant:MODIFIER:intron27/32:c.3788+53T>A::,AGL:ENST00000370163.3:intron_variant:MODIFIER:intron28/33:c.3836+53T>A::,AGL:ENST00000370165.3:intron_variant:MODIFIER:intron28/33:c.3836+53T>A::	AGL:NM_000028.2:intron_variant:MODIFIER:intron28/33:c.3836+53T>A::,AGL:NM_000642.3:intron_variant:MODIFIER:intron28/33:c.3836+53T>A::,AGL:NM_000643.2:intron_variant:MODIFIER:intron28/33:c.3836+53T>A::,AGL:NM_000644.2:intron_variant:MODIFIER:intron28/33:c.3836+53T>A::,AGL:NM_000646.2:intron_variant:MODIFIER:intron28/33:c.3788+53T>A::		610860 [GENE=AGL PHENOS=Glycogen storage disease IIIb,232400,Autosomal recessive/Glycogen storage disease IIIa,232400,Autosomal recessive];				rs1541041	0.4599	0.4754	3532,.		0.4470			0.00,0.12	3.15					0.0073	0.3455	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	100387479	100387479	G	T	wt	wt	het		QUAL=1097;DP=305,95,85;AF=0.00,0.00,0.52;MQM=60;SAP=4;ABP=3	AGL	3'UTR	AGL:ENST00000294724.4:3_prime_UTR_variant:MODIFIER:exon34/34:c.*272G>T::,AGL:ENST00000361302.3:3_prime_UTR_variant:MODIFIER:exon34/34:c.*272G>T::,AGL:ENST00000361522.4:3_prime_UTR_variant:MODIFIER:exon32/32:c.*272G>T::,AGL:ENST00000361915.3:3_prime_UTR_variant:MODIFIER:exon34/34:c.*272G>T::,AGL:ENST00000370161.2:3_prime_UTR_variant:MODIFIER:exon33/33:c.*272G>T::,AGL:ENST00000370163.3:3_prime_UTR_variant:MODIFIER:exon34/34:c.*272G>T::,AGL:ENST00000370165.3:3_prime_UTR_variant:MODIFIER:exon34/34:c.*272G>T::	AGL:NM_000028.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*272G>T::,AGL:NM_000642.3:3_prime_UTR_variant:MODIFIER:exon34/34:c.*272G>T::,AGL:NM_000643.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*272G>T::,AGL:NM_000644.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*272G>T::,AGL:NM_000646.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*272G>T::		610860 [GENE=AGL PHENOS=Glycogen storage disease IIIb,232400,Autosomal recessive/Glycogen storage disease IIIa,232400,Autosomal recessive];	291351 [benign DISEASE=Glycogen storage disease type III];			rs1804808	0.3321	0.3328	1993,.		0.1010			0.02,0.18	2.35				COSV54053994	-0.02	0.9301	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	100387939	100387939	C	T	het	het	hom		QUAL=4302;DP=173,53,41;AF=0.49,0.45,1.00;MQM=60;SAP=14;ABP=4	AGL	3'UTR	AGL:ENST00000294724.4:3_prime_UTR_variant:MODIFIER:exon34/34:c.*732C>T::,AGL:ENST00000361302.3:3_prime_UTR_variant:MODIFIER:exon34/34:c.*732C>T::,AGL:ENST00000361522.4:3_prime_UTR_variant:MODIFIER:exon32/32:c.*732C>T::,AGL:ENST00000361915.3:3_prime_UTR_variant:MODIFIER:exon34/34:c.*732C>T::,AGL:ENST00000370161.2:3_prime_UTR_variant:MODIFIER:exon33/33:c.*732C>T::,AGL:ENST00000370163.3:3_prime_UTR_variant:MODIFIER:exon34/34:c.*732C>T::,AGL:ENST00000370165.3:3_prime_UTR_variant:MODIFIER:exon34/34:c.*732C>T::	AGL:NM_000028.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*732C>T::,AGL:NM_000642.3:3_prime_UTR_variant:MODIFIER:exon34/34:c.*732C>T::,AGL:NM_000643.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*732C>T::,AGL:NM_000644.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*732C>T::,AGL:NM_000646.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*732C>T::		610860 [GENE=AGL PHENOS=Glycogen storage disease IIIb,232400,Autosomal recessive/Glycogen storage disease IIIa,232400,Autosomal recessive];	291359 [benign DISEASE=Glycogen storage disease type III];			rs3766600	0.5905	0.6324	6251,.		1.0200			0.00,0.11	2.26					-0.0078	0.9303	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	100388235	100388235	C	T	wt	wt	het		QUAL=258;DP=191,61,42;AF=0.01,0.00,0.38;MQM=60;SAP=6;ABP=8	AGL	3'UTR	AGL:ENST00000294724.4:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1028C>T::,AGL:ENST00000361302.3:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1028C>T::,AGL:ENST00000361522.4:3_prime_UTR_variant:MODIFIER:exon32/32:c.*1028C>T::,AGL:ENST00000361915.3:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1028C>T::,AGL:ENST00000370161.2:3_prime_UTR_variant:MODIFIER:exon33/33:c.*1028C>T::,AGL:ENST00000370163.3:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1028C>T::,AGL:ENST00000370165.3:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1028C>T::	AGL:NM_000028.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1028C>T::,AGL:NM_000642.3:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1028C>T::,AGL:NM_000643.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1028C>T::,AGL:NM_000644.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1028C>T::,AGL:NM_000646.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1028C>T::		610860 [GENE=AGL PHENOS=Glycogen storage disease IIIb,232400,Autosomal recessive/Glycogen storage disease IIIa,232400,Autosomal recessive];	291363 [benign DISEASE=Glycogen storage disease type III];			rs3766601	0.4683	0.4869	3732,.		1.1110			0.00,0.06	2.90					-0.0053	0.9303	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	100388503	100388503	A	C	wt	wt	het		QUAL=895;DP=221,69,61;AF=0.00,0.00,0.57;MQM=60;SAP=3;ABP=6	AGL	3'UTR	AGL:ENST00000294724.4:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1296A>C::,AGL:ENST00000361302.3:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1296A>C::,AGL:ENST00000361522.4:3_prime_UTR_variant:MODIFIER:exon32/32:c.*1296A>C::,AGL:ENST00000361915.3:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1296A>C::,AGL:ENST00000370161.2:3_prime_UTR_variant:MODIFIER:exon33/33:c.*1296A>C::,AGL:ENST00000370163.3:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1296A>C::,AGL:ENST00000370165.3:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1296A>C::	AGL:NM_000028.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1296A>C::,AGL:NM_000642.3:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1296A>C::,AGL:NM_000643.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1296A>C::,AGL:NM_000644.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1296A>C::,AGL:NM_000646.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1296A>C::		610860 [GENE=AGL PHENOS=Glycogen storage disease IIIb,232400,Autosomal recessive/Glycogen storage disease IIIa,232400,Autosomal recessive];	291368 [benign DISEASE=Glycogen storage disease type III];			rs1804809	0.3758	0.3837	2457,.		0.3860			0.07,0.13	1.27					0.0028	0.9304	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	100388748	100388748	T	C	wt	wt	het		QUAL=1707;DP=266,168,123;AF=0.00,0.01,0.54;MQM=60;SAP=3;ABP=4	AGL	3'UTR	AGL:ENST00000294724.4:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1541T>C::,AGL:ENST00000361302.3:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1541T>C::,AGL:ENST00000361522.4:3_prime_UTR_variant:MODIFIER:exon32/32:c.*1541T>C::,AGL:ENST00000361915.3:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1541T>C::,AGL:ENST00000370161.2:3_prime_UTR_variant:MODIFIER:exon33/33:c.*1541T>C::,AGL:ENST00000370163.3:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1541T>C::,AGL:ENST00000370165.3:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1541T>C::	AGL:NM_000028.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1541T>C::,AGL:NM_000642.3:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1541T>C::,AGL:NM_000643.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1541T>C::,AGL:NM_000644.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1541T>C::,AGL:NM_000646.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1541T>C::		610860 [GENE=AGL PHENOS=Glycogen storage disease IIIb,232400,Autosomal recessive/Glycogen storage disease IIIa,232400,Autosomal recessive];	291369 [benign DISEASE=Glycogen storage disease type III];			rs3766603	0.4018	0.4073	2624,.		-1.4470			0.00,0.09	2.25					0.0084	0.9305	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	100652729	100652729	G	A	wt	wt	het		QUAL=325;DP=111,41,37;AF=0.00,0.02,0.43;MQM=60;SAP=32;ABP=4	DBT	3'UTR	DBT:ENST00000370132.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*9082C>T::	DBT:NM_001918.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*9082C>T::		248610 [GENE=DBT PHENOS=Maple syrup urine disease,type II,248600,Autosomal recessive];	291375 [benign DISEASE=Maple syrup urine disease];			rs72728160	0.0577	0.1192	285,.		0.3270			0.15,0.62	6.42					-0.0023	0.9102	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100653257	100653257	T	-	het	het	het	low_conf_region	QUAL=163;DP=17,10,6;AF=0.35,0.30,0.33;MQM=59;SAP=8;ABP=11	DBT	3'UTR	DBT:ENST00000370132.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*8554del::	DBT:NM_001918.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*8554del::		248610 [GENE=DBT PHENOS=Maple syrup urine disease,type II,248600,Autosomal recessive];			AluJb (SINE/Alu)	rs886044938		0.0183	0,.		-1.4320				0.80					0.0009	0.9103	0	5	70	0 / 0					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100654908	100654908	A	-	het	n/a	wt	low_conf_region	QUAL=1049;DP=42,1,8;AF=0.38,0.00,0.38;MQM=57;SAP=26;ABP=3	DBT	3'UTR	DBT:ENST00000370132.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*6903del::	DBT:NM_001918.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*6903del::	regulatory_region_variant:promoter_flanking_region	248610 [GENE=DBT PHENOS=Maple syrup urine disease,type II,248600,Autosomal recessive];	291391 [uncertain significance DISEASE=Maple syrup urine disease];		AluSz (SINE/Alu)	rs71709231		0.7932	8066,.		0.0000				0.54					0.002	0.9103	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100654908	100654909	AA	-	wt	n/a	het	low_conf_region	QUAL=1049;DP=42,1,8;AF=0.48,1.00,0.00;MQM=55;SAP=13;ABP=53	DBT	3'UTR	DBT:ENST00000370132.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*6902_*6903del::	DBT:NM_001918.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*6902_*6903del::	regulatory_region_variant:promoter_flanking_region	248610 [GENE=DBT PHENOS=Maple syrup urine disease,type II,248600,Autosomal recessive];			AluSz (SINE/Alu)	rs71709231		0.0298	7,.		0.0000				0.52					0.0034	0.9103	0	0	32	0 / 0					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100654908	100654908	A	T	het	n/a	het	low_conf_region	QUAL=1049;DP=42,1,8;AF=0.38,0.00,0.38;MQM=59;SAP=4;ABP=9	DBT	3'UTR	DBT:ENST00000370132.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*6903T>A::	DBT:NM_001918.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*6903T>A::	regulatory_region_variant:promoter_flanking_region	248610 [GENE=DBT PHENOS=Maple syrup urine disease,type II,248600,Autosomal recessive];	291392 [benign DISEASE=Maple syrup urine disease];		AluSz (SINE/Alu)	rs10783125	0.9339	0.1297	346,.		0.0000			0.01,0.09	1.76					0.0023	0.9103	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100654909	100654909	A	T	het	n/a	wt	low_conf_region	QUAL=1049;DP=42,1,8;AF=0.38,0.00,0.38;MQM=57;SAP=26;ABP=3	DBT	3'UTR	DBT:ENST00000370132.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*6902T>A::	DBT:NM_001918.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*6902T>A::	regulatory_region_variant:promoter_flanking_region	248610 [GENE=DBT PHENOS=Maple syrup urine disease,type II,248600,Autosomal recessive];	875221 [uncertain significance DISEASE=Maple syrup urine disease];		AluSz (SINE/Alu)	rs200943386		0.7589	7371,.		0.0000			0.01,0.09	1.73					0.0016	0.9103	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100654910	100654910	A	T	wt	n/a	het	low_conf_region	QUAL=1049;DP=42,1,8;AF=0.38,0.00,0.38;MQM=55;SAP=13;ABP=53	DBT	3'UTR	DBT:ENST00000370132.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*6901T>A::	DBT:NM_001918.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*6901T>A::	regulatory_region_variant:promoter_flanking_region	248610 [GENE=DBT PHENOS=Maple syrup urine disease,type II,248600,Autosomal recessive];	291393 [uncertain significance DISEASE=Maple syrup urine disease];		AluSz (SINE/Alu)	rs200062717		0.0312	7,.		0.0000			0.01,0.09	1.73					0.0018	0.9103	0	0	31	0 / 0					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100655583	100655583	T	A	hom	hom	hom		QUAL=4322;DP=104,13,15;AF=1.00,1.00,1.00;MQM=60;SAP=16;ABP=0	DBT	3'UTR	DBT:ENST00000370132.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*6228A>T::	DBT:NM_001918.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*6228A>T::		248610 [GENE=DBT PHENOS=Maple syrup urine disease,type II,248600,Autosomal recessive];	291395 [benign DISEASE=Maple syrup urine disease];		MER3 (DNA/hAT-Charlie)	rs4281338	0.7668	0.7572	9498,.		-0.7070			0.01,0.07	0.13					-0.0004	0.9103	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100655696	100655697	AA	-	het	het	wt		QUAL=3461;DP=180,89,57;AF=0.49,0.65,0.02;MQM=60;SAP=192;ABP=7	DBT	3'UTR	DBT:ENST00000370132.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*6114_*6115del::	DBT:NM_001918.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*6114_*6115del::		248610 [GENE=DBT PHENOS=Maple syrup urine disease,type II,248600,Autosomal recessive];	291396 [uncertain significance DISEASE=Maple syrup urine disease];		MLT1J2 (LTR/ERVL-MaLR)	rs3081711		0.1791	610,.		0.5040				2.54					0.0028	0.9103	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100656265	100656265	C	T	hom	hom	hom		QUAL=13984;DP=174,140,105;AF=0.99,1.00,1.00;MQM=60;SAP=30;ABP=0	DBT	3'UTR	DBT:ENST00000370132.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*5546G>A::	DBT:NM_001918.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*5546G>A::		248610 [GENE=DBT PHENOS=Maple syrup urine disease,type II,248600,Autosomal recessive];	291404 [benign DISEASE=Maple syrup urine disease];			rs11166412	0.8007	0.7963	10252,.		-0.8580			0.00,0.07	0.60					0.001	0.9103	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100656494	100656494	A	G	wt	wt	het		QUAL=1899;DP=403,261,187;AF=0.00,0.00,0.43;MQM=60;SAP=3;ABP=10	DBT	3'UTR	DBT:ENST00000370132.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*5317T>C::	DBT:NM_001918.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*5317T>C::		248610 [GENE=DBT PHENOS=Maple syrup urine disease,type II,248600,Autosomal recessive];	291406 [benign DISEASE=Maple syrup urine disease];			rs11166413	0.2638	0.3123	1890,.		0.7090			0.03,0.11	1.65					0.0012	0.9103	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100656661	100656661	T	C	hom	hom	hom		QUAL=24021;DP=361,207,156;AF=1.00,1.00,1.00;MQM=60;SAP=65;ABP=0	DBT	3'UTR	DBT:ENST00000370132.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*5150A>G::	DBT:NM_001918.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*5150A>G::		248610 [GENE=DBT PHENOS=Maple syrup urine disease,type II,248600,Autosomal recessive];	291407 [benign DISEASE=Maple syrup urine disease];			rs6701655	0.7696	0.7588	9531,.		0.1170			0.01,0.11	3.46					0.0055	0.9104	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100657304	100657329	ATACACACACACACACACACACACAC	-	het	het	wt		QUAL=1881;DP=27,49,26;AF=0.44,0.41,0.88;MQM=58;SAP=3;ABP=5	DBT	3'UTR	DBT:ENST00000370132.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*4482_*4507del::	DBT:NM_001918.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*4482_*4507del::		248610 [GENE=DBT PHENOS=Maple syrup urine disease,type II,248600,Autosomal recessive];			(AC)n (Simple_repeat)	rs1418854977		0.0482	92,.		0.6450				0.30					0.0116	0.9105	0	4	8	0 / 0					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100657304	100657331	ATACACACACACACACACACACACACAC	-	het	het	hom		QUAL=1881;DP=27,49,26;AF=0.33,0.51,0.00;MQM=59;SAP=4;ABP=7	DBT	3'UTR	DBT:ENST00000370132.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*4480_*4507del::	DBT:NM_001918.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*4480_*4507del::		248610 [GENE=DBT PHENOS=Maple syrup urine disease,type II,248600,Autosomal recessive];			(AC)n (Simple_repeat)	rs140341302		0.6543	6177,.		0.6450				0.28					0.0124	0.9105	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100658578	100658578	G	A	hom	hom	hom		QUAL=34734;DP=334,473,320;AF=0.99,1.00,1.00;MQM=60;SAP=4;ABP=0	DBT	3'UTR	DBT:ENST00000370132.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*3233C>T::	DBT:NM_001918.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*3233C>T::		248610 [GENE=DBT PHENOS=Maple syrup urine disease,type II,248600,Autosomal recessive];	291424 [benign DISEASE=Maple syrup urine disease];			rs2784174		0.7588	9526,.		0.1820			0.01,0.11	1.38					-0.0008	0.9103	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100671866	100671866	T	A	wt	wt	het	low_conf_region	QUAL=299;DP=237,112,77;AF=0.00,0.00,0.25;MQM=60;SAP=3;ABP=46	DBT	intron	DBT:ENST00000370132.4:intron_variant:MODIFIER:intron9/10:c.1210-9A>T::	DBT:NM_001918.4:intron_variant:MODIFIER:intron9/10:c.1210-9A>T::		248610 [GENE=DBT PHENOS=Maple syrup urine disease,type II,248600,Autosomal recessive];	93987 [benign DISEASE=Maple syrup urine disease,not specified];			rs34229137		0.4005	1550,.	0.1865,0.4504,0.3281,0.4141,0.3893	0.7540			0.00,0.16	3.51		6.05>7.40	0.000/0.000	COSV64494912	0.0811	0.1394	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100672060	100672060	T	C	hom	hom	hom		QUAL=28874;DP=341,301,245;AF=1.00,1.00,1.00;MQM=60;SAP=8;ABP=0	DBT	missense	DBT:ENST00000370132.4:missense_variant:MODERATE:exon9/11:c.1150A>G:p.Ser384Gly:PF00198 [2-oxoacid dehydrogenases acyltransferase (catalytic domain)]	DBT:NM_001918.4:synonymous_variant:LOW:exon9/11:c.1150A>G:p.Gly384=:		248610 [GENE=DBT PHENOS=Maple syrup urine disease,type II,248600,Autosomal recessive];	128885 [benign DISEASE=Maple syrup urine disease,not specified];			rs12021720		0.9174	12280,.	0.7628,0.9547,0.9692,0.9082,0.9519	1.9050	T(1.00)	B(0.00)	0.02,0.23	14.32	0.12				-0.1334	0.2956	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100680593	100680593	-	T	het	het	het	off-target;low_conf_region	QUAL=1280;DP=88,24,25;AF=0.59,0.42,0.48;MQM=60;SAP=123;ABP=5	DBT	intron	DBT:ENST00000370131.3:intron_variant:MODIFIER:intron6/7:c.773-55dup::,DBT:ENST00000370132.4:intron_variant:MODIFIER:intron6/10:c.773-55dup::	DBT:NM_001918.4:intron_variant:MODIFIER:intron6/10:c.773-55dup::		248610 [GENE=DBT PHENOS=Maple syrup urine disease,type II,248600,Autosomal recessive];				rs11431894		0.7411	6915,.						1.19					-0.0082	0.2209	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50), BRI3P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	100715454	100715454	G	A	hom	hom	hom	off-target	QUAL=12906;DP=44,276,190;AF=1.00,1.00,0.99;MQM=60;SAP=175;ABP=0	DBT,RP11-305E17.4	upstream_gene,downstream_gene	DBT:ENST00000370131.3:upstream_gene_variant:MODIFIER::::,DBT:ENST00000370132.4:upstream_gene_variant:MODIFIER::::,RP11-305E17.4:ENST00000435545.1:downstream_gene_variant:MODIFIER::::,RP11-305E17.4:ENST00000595511.1:downstream_gene_variant:MODIFIER::::		regulatory_region_variant:promoter					rs3806235		0.7289	9069,.		-1.2120			0.01,0.42	4.47								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	109771063	109771063	T	C	hom	hom	hom		QUAL=21702;DP=237,230,204;AF=1.00,1.00,1.00;MQM=60;SAP=24;ABP=0	SARS1	intron	SARS1:ENST00000234677.2:intron_variant:MODIFIER:intron3/10:c.288+9T>C::,SARS1:ENST00000369923.4:intron_variant:MODIFIER:intron3/11:c.288+9T>C::	SARS:NM_001330669.1:intron_variant:MODIFIER:intron3/11:c.288+9T>C::,SARS:NM_006513.4:intron_variant:MODIFIER:intron3/10:c.288+9T>C::		607529 [GENE=SARS1 PHENOS=Neurodevelopmental disorder with microcephaly,ataxia,and seizures,617709,Autosomal recessive];				rs683182	0.6799	0.7679	8188,.	0.4629,0.8116,0.8993,0.7960,0.6581	-0.8580			0.04,0.16	0.62					0.1138	0.1816	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SARS1 (inh=AR oe_syn=0.82 oe_mis=0.57 oe_lof=0.07)
chr1	109778577	109778577	T	C	hom	hom	hom	off-target	QUAL=18676;DP=176,262,160;AF=1.00,1.00,1.00;MQM=60;SAP=443;ABP=0	SARS1	intron	SARS1:ENST00000234677.2:intron_variant:MODIFIER:intron7/10:c.970-22T>C::,SARS1:ENST00000369923.4:intron_variant:MODIFIER:intron7/11:c.970-22T>C::	SARS:NM_001330669.1:intron_variant:MODIFIER:intron7/11:c.970-22T>C::,SARS:NM_006513.4:intron_variant:MODIFIER:intron7/10:c.970-22T>C::		607529 [GENE=SARS1 PHENOS=Neurodevelopmental disorder with microcephaly,ataxia,and seizures,617709,Autosomal recessive];				rs658092		0.7692	8276,.	0.4870,0.8138,0.8988,0.7962,0.6586	0.8080			0.02,0.33	10.75					-0.0099	0.0595	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SARS1 (inh=AR oe_syn=0.82 oe_mis=0.57 oe_lof=0.07)
chr1	110709719	110709719	T	C	het	hom	het		QUAL=19003;DP=262,391,330;AF=0.45,1.00,0.00;MQM=60;SAP=76;ABP=200	SLC6A17,RP5-1028L10.1	synonymous,non_coding_transcript_exon	SLC6A17:ENST00000331565.4:synonymous_variant:LOW:exon2/12:c.168T>C:p.Asp56=:,RP5-1028L10.1:ENST00000418579.1:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.168A>G::,RP5-1028L10.1:ENST00000430098.1:non_coding_transcript_exon_variant:MODIFIER:exon1/2:n.87A>G::,RP5-1028L10.1:ENST00000443008.1:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.507A>G::	SLC6A17:NM_001010898.4:synonymous_variant:LOW:exon2/12:c.168T>C:p.Asp56=:		610299 [GENE=SLC6A17 PHENOS=Mental retardation,autosomal recessive 48,616269,Autosomal recessive];				rs7527375	0.3930	0.5132	4049,.	0.5055,0.2634,0.2103,0.5324,0.3637	-5.4670			0.02,0.13	9.11					0.0237	0.9075	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110709720	110709720	G	A	het	hom	wt		QUAL=19003;DP=262,391,330;AF=0.45,1.00,0.00;MQM=60;SAP=227;ABP=9	SLC6A17,RP5-1028L10.1	missense,non_coding_transcript_exon	SLC6A17:ENST00000331565.4:missense_variant:MODERATE:exon2/12:c.169G>A:p.Ala57Thr:,RP5-1028L10.1:ENST00000418579.1:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.167C>T::,RP5-1028L10.1:ENST00000430098.1:non_coding_transcript_exon_variant:MODIFIER:exon1/2:n.86C>T::,RP5-1028L10.1:ENST00000443008.1:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.506C>T::	SLC6A17:NM_001010898.4:missense_variant:MODERATE:exon2/12:c.169G>A:p.Ala57Thr:		610299 [GENE=SLC6A17 PHENOS=Mental retardation,autosomal recessive 48,616269,Autosomal recessive];				rs12737742	0.2502	0.3725	2387,.	0.0887,0.2113,0.2096,0.4562,0.3459	0.5370	T(0.47), , , 	B(0.05), , , 	0.14,0.32	13.86	0.08				-0.2121	0.9033	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110709734	110709734	G	A	wt	wt	het		QUAL=4213;DP=250,374,312;AF=0.00,0.00,0.55;MQM=60;SAP=104;ABP=9	SLC6A17,RP5-1028L10.1	synonymous,non_coding_transcript_exon	SLC6A17:ENST00000331565.4:synonymous_variant:LOW:exon2/12:c.183G>A:p.Pro61=:PF00209 [Sodium neurotransmitter symporter family],RP5-1028L10.1:ENST00000418579.1:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.153C>T::,RP5-1028L10.1:ENST00000430098.1:non_coding_transcript_exon_variant:MODIFIER:exon1/2:n.72C>T::,RP5-1028L10.1:ENST00000443008.1:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.492C>T::	SLC6A17:NM_001010898.4:synonymous_variant:LOW:exon2/12:c.183G>A:p.Pro61=:		610299 [GENE=SLC6A17 PHENOS=Mental retardation,autosomal recessive 48,616269,Autosomal recessive];				rs41281364	0.0389	0.0561	58,.	0.0526,0.0342,0.0002,0.0745,0.0145	-3.2570			0.03,0.14	10.58					-0.0706	0.9058	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110738296	110738296	G	A	het	het	het		QUAL=16298;DP=294,543,382;AF=0.50,0.53,0.53;MQM=60;SAP=55;ABP=8	SLC6A17	synonymous	SLC6A17:ENST00000331565.4:synonymous_variant:LOW:exon10/12:c.1581G>A:p.Ser527=:PF00209 [Sodium neurotransmitter symporter family]	SLC6A17:NM_001010898.4:synonymous_variant:LOW:exon10/12:c.1581G>A:p.Ser527=:		610299 [GENE=SLC6A17 PHENOS=Mental retardation,autosomal recessive 48,616269,Autosomal recessive];				rs2784140	0.2897	0.4162	2765,.	0.0971,0.3307,0.2726,0.4960,0.3911	-1.7640			0.08,0.67	10.31				COSV58995492	-0.0872	0.5195	0.16	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110740273	110740273	G	T	het	het	het	off-target	QUAL=4589;DP=239,72,57;AF=0.54,0.58,0.40;MQM=60;SAP=364;ABP=5	SLC6A17	intron	SLC6A17:ENST00000331565.4:intron_variant:MODIFIER:intron11/11:c.1815+52G>T::	SLC6A17:NM_001010898.4:intron_variant:MODIFIER:intron11/11:c.1815+52G>T::	regulatory_region_variant:promoter_flanking_region	610299 [GENE=SLC6A17 PHENOS=Mental retardation,autosomal recessive 48,616269,Autosomal recessive];				rs2603581	0.3165	0.4147	2867,.	0.1791,0.3314,0.2731,0.4937,0.3907	-0.2040			0.00,0.06	4.53					0.215	0.1679	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110740688	110740688	C	T	het	het	het	off-target	QUAL=8831;DP=177,329,255;AF=0.46,0.47,0.50;MQM=60;SAP=135;ABP=6	SLC6A17	intron	SLC6A17:ENST00000331565.4:intron_variant:MODIFIER:intron11/11:c.1816-10C>T::	SLC6A17:NM_001010898.4:intron_variant:MODIFIER:intron11/11:c.1816-10C>T::		610299 [GENE=SLC6A17 PHENOS=Mental retardation,autosomal recessive 48,616269,Autosomal recessive];				rs2761445	0.3195	0.4263	2946,.	0.1831,0.3383,0.2739,0.5055,0.3988	-0.2780			0.01,0.14	4.86		0.77>0.84	0.000/		0.5984	0.8399	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110741081	110741081	C	G	het	wt	het		QUAL=2473;DP=137,157,119;AF=0.50,0.01,0.34;MQM=60;SAP=30;ABP=14	SLC6A17	3'UTR	SLC6A17:ENST00000331565.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*15C>G::	SLC6A17:NM_001010898.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*15C>G::		610299 [GENE=SLC6A17 PHENOS=Mental retardation,autosomal recessive 48,616269,Autosomal recessive];				rs2761446	0.0170	0.0371	25,.	0.0071,0.0140,0.0000,0.0516,0.0315	0.1420			0.22,0.37	7.25					0.0055	0.9451	0	64	1600	0 / 0					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110741086	110741086	C	T	wt	wt	het		QUAL=1787;DP=136,207,140;AF=0.00,0.00,0.54;MQM=60;SAP=4;ABP=5	SLC6A17	3'UTR	SLC6A17:ENST00000331565.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*20C>T::	SLC6A17:NM_001010898.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*20C>T::		610299 [GENE=SLC6A17 PHENOS=Mental retardation,autosomal recessive 48,616269,Autosomal recessive];				rs41306175	0.0497	0.0815	96,.	0.0844,0.0451,0.0045,0.1070,0.0165	-2.8590			0.03,0.27	5.96					0.0029	0.945	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110741349	110741349	G	T	het	het	hom		QUAL=17024;DP=355,331,269;AF=0.46,0.57,1.00;MQM=60;SAP=4;ABP=4	SLC6A17	3'UTR	SLC6A17:ENST00000331565.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*283G>T::	SLC6A17:NM_001010898.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*283G>T::		610299 [GENE=SLC6A17 PHENOS=Mental retardation,autosomal recessive 48,616269,Autosomal recessive];				rs2603580	0.5425	0.6458	6707,.		-0.1760			0.00,0.05	0.40					-0.0018	0.945	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110741583	110741583	C	G	het	het	hom		QUAL=10074;DP=169,215,176;AF=0.39,0.53,1.00;MQM=60;SAP=4;ABP=7	SLC6A17	3'UTR	SLC6A17:ENST00000331565.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*517C>G::	SLC6A17:NM_001010898.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*517C>G::		610299 [GENE=SLC6A17 PHENOS=Mental retardation,autosomal recessive 48,616269,Autosomal recessive];				rs2784141	0.5447	0.6455	6703,.		-1.4930			0.00,0.06	0.64					0.0033	0.9451	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110742085	110742085	T	C	het	het	hom		QUAL=27421;DP=284,680,502;AF=0.45,0.49,1.00;MQM=60;SAP=23;ABP=7	SLC6A17	3'UTR	SLC6A17:ENST00000331565.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1019T>C::	SLC6A17:NM_001010898.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1019T>C::		610299 [GENE=SLC6A17 PHENOS=Mental retardation,autosomal recessive 48,616269,Autosomal recessive];				rs2603579	0.5449	0.6465	6721,.		0.6680			0.35,0.79	9.33					0.0028	0.945	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110742502	110742502	A	G	het	het	het		QUAL=1510;DP=163,101,83;AF=0.31,0.26,0.25;MQM=58;SAP=152;ABP=146	SLC6A17	3'UTR	SLC6A17:ENST00000331565.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1436A>G::	SLC6A17:NM_001010898.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1436A>G::		610299 [GENE=SLC6A17 PHENOS=Mental retardation,autosomal recessive 48,616269,Autosomal recessive];			(GATG)n (Simple_repeat)	rs2361044	0.2883	0.3791	2112,.		-0.8410			0.00,0.06	0.05					-0.0242	0.9448	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110742615	110742615	A	G	het	het	het		QUAL=2486;DP=123,105,70;AF=0.42,0.43,0.34;MQM=60;SAP=208;ABP=26	SLC6A17	3'UTR	SLC6A17:ENST00000331565.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1549A>G::	SLC6A17:NM_001010898.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1549A>G::		610299 [GENE=SLC6A17 PHENOS=Mental retardation,autosomal recessive 48,616269,Autosomal recessive];			GA-rich (Low_complexity)	rs12133992	0.2867	0.3696	2551,.		0.2940			0.01,0.18	3.34					-0.0086	0.9449	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110742992	110742992	T	G	het	het	het		QUAL=7221;DP=171,266,180;AF=0.50,0.45,0.53;MQM=60;SAP=5;ABP=4	SLC6A17	3'UTR	SLC6A17:ENST00000331565.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1926T>G::	SLC6A17:NM_001010898.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1926T>G::		610299 [GENE=SLC6A17 PHENOS=Mental retardation,autosomal recessive 48,616269,Autosomal recessive];				rs2784142	0.3079	0.3968	2828,.		1.1030			0.00,0.08	2.70					0.0024	0.945	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110743588	110743588	G	C	het	het	wt		QUAL=8310;DP=162,474,387;AF=0.53,0.52,0.00;MQM=60;SAP=11;ABP=5	SLC6A17	3'UTR	SLC6A17:ENST00000331565.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2522G>C::	SLC6A17:NM_001010898.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2522G>C::	regulatory_region_variant:enhancer	610299 [GENE=SLC6A17 PHENOS=Mental retardation,autosomal recessive 48,616269,Autosomal recessive];				rs151008748	0.0132	0.0218	14,.		-0.6950			0.03,0.15	9.56					0.0083	0.9451	0	1	10	0 / 0					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110743835	110743835	G	A	wt	wt	het		QUAL=2275;DP=217,183,164;AF=0.00,0.00,0.54;MQM=60;SAP=6;ABP=6	SLC6A17	3'UTR	SLC6A17:ENST00000331565.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2769G>A::	SLC6A17:NM_001010898.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2769G>A::	regulatory_region_variant:enhancer	610299 [GENE=SLC6A17 PHENOS=Mental retardation,autosomal recessive 48,616269,Autosomal recessive];				rs12138403	0.0491	0.0812	100,.		0.1620			0.02,0.14	2.23					-0.0005	0.945	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110744181	110744181	C	T	wt	wt	het		QUAL=1083;DP=97,123,96;AF=0.01,0.00,0.46;MQM=60;SAP=3;ABP=4	SLC6A17	3'UTR	SLC6A17:ENST00000331565.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*3115C>T::	SLC6A17:NM_001010898.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*3115C>T::	regulatory_region_variant:enhancer	610299 [GENE=SLC6A17 PHENOS=Mental retardation,autosomal recessive 48,616269,Autosomal recessive];				rs62621393	0.0491	0.0813	100,.		-4.4330			0.00,0.10	0.28					0.0039	0.9451	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110744874	110744874	G	A	wt	het	wt	off-target	QUAL=1733;DP=60,162,110;AF=0.00,0.46,0.00;MQM=60;SAP=20;ABP=6	SLC6A17	downstream_gene	SLC6A17:ENST00000331565.4:downstream_gene_variant:MODIFIER::::							rs45445195	0.0138	0.0195	10,.		-0.8180			0.00,0.08	0.95								4	167	0 / 0					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	115247750	115247750	A	-	wt	wt	het		QUAL=1003;DP=204,121,77;AF=0.00,0.01,0.58;MQM=60;SAP=5;ABP=8	NRAS	3'UTR	NRAS:ENST00000369535.4:3_prime_UTR_variant:MODIFIER:exon7/7:c.*2965del::	NRAS:NM_002524.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*2965del::		164790 [GENE=NRAS PHENOS=Epidermal nevus,somatic,162900/Melanocytic nevus syndrome,congenital,somatic,137550/Schimmelpenning-Feuerstein-Mims syndrome,somatic mosaic,163200/Colorectal cancer,somatic,114500/RAS-associated autoimmune lymphoproliferative syndrome type IV,somatic,614470/Thyroid carcinoma,follicular,somatic,188470/Neurocutaneous melanosis,somatic,249400/Noonan syndrome 6,613224,Autosomal dominant];	291946 [likely benign DISEASE=Noonan syndrome];			rs61652108		0.2081	778,.		-0.3110				8.54					0.0033	0.9059	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NRAS (inh=AD oe_syn=1.00 oe_mis=0.53 oe_lof=0.19)
chr1	115249843	115249843	G	A	wt	wt	het		QUAL=1561;DP=407,196,125;AF=0.00,0.01,0.51;MQM=60;SAP=27;ABP=3	NRAS	3'UTR	NRAS:ENST00000369535.4:3_prime_UTR_variant:MODIFIER:exon7/7:c.*872C>T::	NRAS:NM_002524.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*872C>T::		164790 [GENE=NRAS PHENOS=Epidermal nevus,somatic,162900/Melanocytic nevus syndrome,congenital,somatic,137550/Schimmelpenning-Feuerstein-Mims syndrome,somatic mosaic,163200/Colorectal cancer,somatic,114500/RAS-associated autoimmune lymphoproliferative syndrome type IV,somatic,614470/Thyroid carcinoma,follicular,somatic,188470/Neurocutaneous melanosis,somatic,249400/Noonan syndrome 6,613224,Autosomal dominant];	291967 [benign DISEASE=Noonan syndrome 6];			rs14804	0.1510	0.2080	775,.		0.3800			0.00,0.06	3.64					-0.0036	0.9058	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NRAS (inh=AD oe_syn=1.00 oe_mis=0.53 oe_lof=0.19)
chr1	115259401	115259401	C	T	het	het	wt		QUAL=3644;DP=181,128,111;AF=0.60,0.38,0.00;MQM=60;SAP=182;ABP=3	NRAS	5'UTR	NRAS:ENST00000369535.4:5_prime_UTR_variant:MODIFIER:exon1/7:c.-140G>A::		regulatory_region_variant:promoter,TF_binding_site_variant	164790 [GENE=NRAS PHENOS=Epidermal nevus,somatic,162900/Melanocytic nevus syndrome,congenital,somatic,137550/Schimmelpenning-Feuerstein-Mims syndrome,somatic mosaic,163200/Colorectal cancer,somatic,114500/RAS-associated autoimmune lymphoproliferative syndrome type IV,somatic,614470/Thyroid carcinoma,follicular,somatic,188470/Neurocutaneous melanosis,somatic,249400/Noonan syndrome 6,613224,Autosomal dominant];									3.7740			0.91,0.81	21.80					-0.0429	0.1055	0	0	2	0 / 0					NRAS (inh=AD oe_syn=1.00 oe_mis=0.53 oe_lof=0.19), CSDE1 (inh=n/a oe_syn=0.96 oe_mis=0.55 oe_lof=0.05)
chr1	115572365	115572365	A	G	het	het	hom	off-target	QUAL=8225;DP=163,179,123;AF=0.48,0.48,1.00;MQM=60;SAP=185;ABP=4	TSHB	upstream_gene	TSHB:ENST00000256592.1:upstream_gene_variant:MODIFIER::::,TSHB:ENST00000369517.1:upstream_gene_variant:MODIFIER::::							rs1321108	0.3894	0.4260	2989,.		1.2590			0.72,0.96	17.31								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TSHB (inh=AR oe_syn=1.13 oe_mis=0.90 oe_lof=0.87)
chr1	115576023	115576023	A	G	hom	hom	hom		QUAL=17928;DP=259,149,135;AF=1.00,1.00,1.00;MQM=60;SAP=58;ABP=0	TSHB	missense	TSHB:ENST00000256592.1:missense_variant:MODERATE:exon2/3:c.40A>G:p.Thr14Ala:,TSHB:ENST00000369517.1:missense_variant:MODERATE:exon1/2:c.40A>G:p.Thr14Ala:	TSHB:NM_000549.5:missense_variant:MODERATE:exon2/3:c.40A>G:p.Thr14Ala:		188540 [GENE=TSHB PHENOS=Hypothyroidism,congenital,nongoitrous 4,275100,Autosomal recessive];	256640 [benign DISEASE=Congenital hypothyroidism,Secondary hypothyroidism,not specified];			rs10776792		0.9747	14915,.	0.9947,0.9916,0.9999,0.9634,0.9611	0.2250	T(0.63),T(0.63)	B(0.00),B(0.00)	0.01,0.15	0.01	0.05				0.0455	0.2977	0.04	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TSHB (inh=AR oe_syn=1.13 oe_mis=0.90 oe_lof=0.87)
chr1	115829313	115829313	G	A	hom	hom	het		QUAL=20236;DP=184,388,276;AF=0.99,0.99,0.51;MQM=60;SAP=138;ABP=3	NGF,RP4-663N10.1	missense,intron&non_coding_transcript	NGF:ENST00000369512.2:missense_variant:MODERATE:exon3/3:c.104C>T:p.Ala35Val:,RP4-663N10.1:ENST00000425449.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.207+3452G>A::	NGF:NM_002506.3:missense_variant:MODERATE:exon3/3:c.104C>T:p.Ala35Val:,NGF-AS1:NR_157569.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.207+3452G>A::		162030 [GENE=NGF PHENOS=Neuropathy,hereditary sensory and autonomic,type V,608654,Autosomal recessive];	291993 [benign DISEASE=Congenital sensory neuropathy with selective loss of small myelinated fibers];			rs6330	0.2474	0.3715	2407,.	0.1882,0.3459,0.1629,0.4483,0.2346	2.2990	D(0.04), 	B(0.00), 	0.90,0.98	22.70	0.10				0.0117	0.8455	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NGF-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), NGF (inh=AR oe_syn=1.17 oe_mis=0.80 oe_lof=0.00)
chr1	119965519	119965519	C	T	het	het	wt		QUAL=10711;DP=464,355,297;AF=0.54,0.41,0.00;MQM=60;SAP=11;ABP=5	HSD3B2	3'UTR	HSD3B2:ENST00000369416.3:3_prime_UTR_variant:MODIFIER:exon4/4:c.*276C>T::,HSD3B2:ENST00000543831.1:3_prime_UTR_variant:MODIFIER:exon4/4:c.*276C>T::	HSD3B2:NM_000198.4:3_prime_UTR_variant:MODIFIER:exon4/4:c.*276C>T::,HSD3B2:NM_001166120.1:3_prime_UTR_variant:MODIFIER:exon4/4:c.*276C>T::		613890 [GENE=HSD3B2 PHENOS=Adrenal hyperplasia,congenital,due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency,201810,Autosomal recessive];	292274 [benign DISEASE=3 beta-Hydroxysteroid dehydrogenase deficiency];			rs1819698	0.3101	0.2236	1237,.		0.8090			0.00,0.03	3.12					-0.0113	0.9297	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSD3B2 (inh=AR oe_syn=1.33 oe_mis=0.87 oe_lof=0.99)
chr1	119965564	119965564	C	G	het	het	wt		QUAL=10563;DP=434,354,291;AF=0.54,0.42,0.00;MQM=60;SAP=5;ABP=4	HSD3B2	3'UTR	HSD3B2:ENST00000369416.3:3_prime_UTR_variant:MODIFIER:exon4/4:c.*321C>G::,HSD3B2:ENST00000543831.1:3_prime_UTR_variant:MODIFIER:exon4/4:c.*321C>G::	HSD3B2:NM_000198.4:3_prime_UTR_variant:MODIFIER:exon4/4:c.*321C>G::,HSD3B2:NM_001166120.1:3_prime_UTR_variant:MODIFIER:exon4/4:c.*321C>G::		613890 [GENE=HSD3B2 PHENOS=Adrenal hyperplasia,congenital,due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency,201810,Autosomal recessive];	292275 [benign DISEASE=3 beta-Hydroxysteroid dehydrogenase deficiency];			rs1361530	0.2560	0.1749	646,.		-0.9650			0.01,0.09	3.87					-0.0021	0.9298	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSD3B2 (inh=AR oe_syn=1.33 oe_mis=0.87 oe_lof=0.99)
chr1	147228529	147228529	G	A	wt	wt	het		QUAL=1650;DP=347,217,145;AF=0.00,0.00,0.46;MQM=60;SAP=15;ABP=5	GJA5	3'UTR	GJA5:ENST00000271348.2:3_prime_UTR_variant:MODIFIER:exon2/2:c.*1741C>T::	GJA5:NM_005266.6:3_prime_UTR_variant:MODIFIER:exon2/2:c.*1766C>T::,GJA5:NM_181703.4:3_prime_UTR_variant:MODIFIER:exon2/2:c.*1766C>T::	regulatory_region_variant:CTCF_binding_site	121013 [GENE=GJA5 PHENOS=Atrial fibrillation,familial,11,614049,Autosomal dominant/Atrial standstill,digenic (GJA5/SCN5A),108770,Autosomal dominant];				rs1404290876		0.0001	0,.		0.4560			0.08,0.32	7.13					0.0019	0.8847	0	0	2	0 / 0					GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39)
chr1	147228874	147228874	C	T	het	wt	het		QUAL=6203;DP=264,300,193;AF=0.51,0.00,0.54;MQM=60;SAP=5;ABP=5	GJA5	3'UTR	GJA5:ENST00000271348.2:3_prime_UTR_variant:MODIFIER:exon2/2:c.*1396G>A::	GJA5:NM_005266.6:3_prime_UTR_variant:MODIFIER:exon2/2:c.*1421G>A::,GJA5:NM_181703.4:3_prime_UTR_variant:MODIFIER:exon2/2:c.*1421G>A::	regulatory_region_variant:promoter_flanking_region	121013 [GENE=GJA5 PHENOS=Atrial fibrillation,familial,11,614049,Autosomal dominant/Atrial standstill,digenic (GJA5/SCN5A),108770,Autosomal dominant];				rs11240121	0.4073	0.2990	1644,.		-0.2330			0.00,0.09	5.25					0.0007	0.8847	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39)
chr1	147229299	147229299	G	A	hom	het	hom		QUAL=12789;DP=214,161,133;AF=1.00,0.50,1.00;MQM=60;SAP=337;ABP=3	GJA5	3'UTR	GJA5:ENST00000271348.2:3_prime_UTR_variant:MODIFIER:exon2/2:c.*971C>T::	GJA5:NM_005266.6:3_prime_UTR_variant:MODIFIER:exon2/2:c.*996C>T::,GJA5:NM_181703.4:3_prime_UTR_variant:MODIFIER:exon2/2:c.*996C>T::	regulatory_region_variant:promoter_flanking_region	121013 [GENE=GJA5 PHENOS=Atrial fibrillation,familial,11,614049,Autosomal dominant/Atrial standstill,digenic (GJA5/SCN5A),108770,Autosomal dominant];				rs1043806,rs1553226571	0.8662	0.8006	10064,.		0.7320			0.00,0.38	9.69					-0.0001	0.8846	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39)
chr1	147229382	147229382	G	A	hom	hom	hom		QUAL=22608;DP=249,277,196;AF=1.00,1.00,1.00;MQM=60;SAP=54;ABP=0	GJA5	3'UTR	GJA5:ENST00000271348.2:3_prime_UTR_variant:MODIFIER:exon2/2:c.*888C>T::,GJA5:ENST00000369237.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*888C>T::	GJA5:NM_005266.6:3_prime_UTR_variant:MODIFIER:exon2/2:c.*913C>T::,GJA5:NM_181703.4:3_prime_UTR_variant:MODIFIER:exon2/2:c.*913C>T::	regulatory_region_variant:promoter_flanking_region	121013 [GENE=GJA5 PHENOS=Atrial fibrillation,familial,11,614049,Autosomal dominant/Atrial standstill,digenic (GJA5/SCN5A),108770,Autosomal dominant];				rs10900395	0.9886	0.9883	15335,.		1.1850			0.00,0.11	6.13					0.0064	0.8847	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39)
chr1	147229563	147229563	G	A	het	wt	het		QUAL=7562;DP=348,382,316;AF=0.43,0.00,0.48;MQM=60;SAP=40;ABP=15	GJA5,RP11-433J22.2	3'UTR,non_coding_transcript_exon	GJA5:ENST00000271348.2:3_prime_UTR_variant:MODIFIER:exon2/2:c.*707C>T::,GJA5:ENST00000369237.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*707C>T::,RP11-433J22.2:ENST00000428911.1:non_coding_transcript_exon_variant:MODIFIER:exon1/2:n.138G>A::	GJA5:NM_005266.6:3_prime_UTR_variant:MODIFIER:exon2/2:c.*732C>T::,GJA5:NM_181703.4:3_prime_UTR_variant:MODIFIER:exon2/2:c.*732C>T::	regulatory_region_variant:promoter_flanking_region	121013 [GENE=GJA5 PHENOS=Atrial fibrillation,familial,11,614049,Autosomal dominant/Atrial standstill,digenic (GJA5/SCN5A),108770,Autosomal dominant];				rs1043802	0.3191	0.2495	997,.		0.3440			0.01,0.20	7.39					0.0783	0.8847	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39)
chr1	147229628	147229628	-	GGGCATTTGCCAGAGGTACATACCA	het	het	het		QUAL=7593;DP=216,376,286;AF=0.27,0.49,0.44;MQM=60;SAP=14;ABP=54	GJA5,RP11-433J22.2	3'UTR,non_coding_transcript_exon	GJA5:ENST00000271348.2:3_prime_UTR_variant:MODIFIER:exon2/2:c.*617_*641dup::,GJA5:ENST00000369237.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*617_*641dup::,RP11-433J22.2:ENST00000428911.1:non_coding_transcript_exon_variant:MODIFIER:exon1/2:n.204_228dup::	GJA5:NM_005266.6:3_prime_UTR_variant:MODIFIER:exon2/2:c.*642_*666dup::,GJA5:NM_181703.4:3_prime_UTR_variant:MODIFIER:exon2/2:c.*642_*666dup::	regulatory_region_variant:promoter_flanking_region,TF_binding_site_variant	121013 [GENE=GJA5 PHENOS=Atrial fibrillation,familial,11,614049,Autosomal dominant/Atrial standstill,digenic (GJA5/SCN5A),108770,Autosomal dominant];													4.16					-0.0207	0.8845	0	474	404	0 / 0					GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39)
chr1	147229662	147229662	G	A	wt	het	wt		QUAL=5528;DP=438,504,384;AF=0.00,0.43,0.00;MQM=60;SAP=3;ABP=25	GJA5,RP11-433J22.2	3'UTR,non_coding_transcript_exon	GJA5:ENST00000271348.2:3_prime_UTR_variant:MODIFIER:exon2/2:c.*608C>T::,GJA5:ENST00000369237.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*608C>T::,RP11-433J22.2:ENST00000428911.1:non_coding_transcript_exon_variant:MODIFIER:exon1/2:n.237G>A::	GJA5:NM_005266.6:3_prime_UTR_variant:MODIFIER:exon2/2:c.*608C>T::,GJA5:NM_181703.4:3_prime_UTR_variant:MODIFIER:exon2/2:c.*608C>T::	regulatory_region_variant:promoter_flanking_region,TF_binding_site_variant	121013 [GENE=GJA5 PHENOS=Atrial fibrillation,familial,11,614049,Autosomal dominant/Atrial standstill,digenic (GJA5/SCN5A),108770,Autosomal dominant];	292441 [likely benign DISEASE=Familial atrial fibrillation];			rs36005900	0.0675	0.1515	482,.		0.4910			0.15,0.80	13.96					-0.0175	0.8845	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39)
chr1	147230217	147230217	T	C	hom	het	hom		QUAL=19575;DP=315,233,191;AF=1.00,0.54,0.99;MQM=60;SAP=96;ABP=6	GJA5,RP11-433J22.2	3'UTR,intron&non_coding_transcript	GJA5:ENST00000271348.2:3_prime_UTR_variant:MODIFIER:exon2/2:c.*53A>G::,GJA5:ENST00000369237.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*53A>G::,RP11-433J22.2:ENST00000428911.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.455-245T>C::	GJA5:NM_005266.6:3_prime_UTR_variant:MODIFIER:exon2/2:c.*53A>G::,GJA5:NM_181703.4:3_prime_UTR_variant:MODIFIER:exon2/2:c.*53A>G::	regulatory_region_variant:promoter_flanking_region	121013 [GENE=GJA5 PHENOS=Atrial fibrillation,familial,11,614049,Autosomal dominant/Atrial standstill,digenic (GJA5/SCN5A),108770,Autosomal dominant];				rs1692141	0.8804	0.8145	10432,.		-0.1160			0.01,0.24	5.30					-0.0119	0.8845	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39)
chr1	147232555	147232555	T	C	hom	hom	hom	off-target	QUAL=16890;DP=151,240,159;AF=1.00,1.00,1.00;MQM=60;SAP=382;ABP=0	GJA5	intron	GJA5:ENST00000271348.2:intron_variant:MODIFIER:intron1/1:c.-33-1176A>G::,GJA5:ENST00000369237.1:intron_variant:MODIFIER:intron1/1:c.-34+52A>G::	GJA5:NM_005266.6:intron_variant:MODIFIER:intron1/1:c.-33-1176A>G::,GJA5:NM_181703.4:intron_variant:MODIFIER:intron1/1:c.-34+52A>G::	regulatory_region_variant:promoter_flanking_region	121013 [GENE=GJA5 PHENOS=Atrial fibrillation,familial,11,614049,Autosomal dominant/Atrial standstill,digenic (GJA5/SCN5A),108770,Autosomal dominant];			L2c (LINE/L2)	rs791278	0.9852	0.9850	15237,.		-1.3250			0.00,0.11	1.39					0.0154	0.1058	0.11	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39)
chr1	147232646	147232646	G	A	wt	wt	het		QUAL=3088;DP=306,364,250;AF=0.00,0.00,0.52;MQM=60;SAP=5;ABP=4	GJA5	intron,5'UTR	GJA5:ENST00000271348.2:intron_variant:MODIFIER:intron1/1:c.-33-1267C>T::,GJA5:ENST00000369237.1:5_prime_UTR_variant:MODIFIER:exon1/2:c.-73C>T::	GJA5:NM_005266.6:intron_variant:MODIFIER:intron1/1:c.-33-1267C>T::,GJA5:NM_181703.4:5_prime_UTR_variant:MODIFIER:exon1/2:c.-73C>T::	regulatory_region_variant:promoter_flanking_region	121013 [GENE=GJA5 PHENOS=Atrial fibrillation,familial,11,614049,Autosomal dominant/Atrial standstill,digenic (GJA5/SCN5A),108770,Autosomal dominant];			L2c (LINE/L2)	rs191717313	0.0004	0.0017	0,.		-0.0120			0.03,0.19	15.49					-0.6517	0.0936	0.12	0	30	0 / 0					GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39)
chr1	147232740	147232740	C	T	het	het	het	off-target	QUAL=6566;DP=193,236,169;AF=0.50,0.42,0.44;MQM=60;SAP=217;ABP=16	GJA5	intron	GJA5:ENST00000271348.2:intron_variant:MODIFIER:intron1/1:c.-33-1361G>A::	GJA5:NM_005266.6:intron_variant:MODIFIER:intron1/1:c.-33-1361G>A::	regulatory_region_variant:promoter_flanking_region	121013 [GENE=GJA5 PHENOS=Atrial fibrillation,familial,11,614049,Autosomal dominant/Atrial standstill,digenic (GJA5/SCN5A),108770,Autosomal dominant];			L2c (LINE/L2)	rs10465885		0.5496	4755,.		-0.1700			0.02,0.18	1.91								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39)
chr1	147245324	147245324	T	C	hom	hom	hom	off-target	QUAL=15850;DP=196,169,140;AF=1.00,1.00,1.00;MQM=60;SAP=527;ABP=0	GJA5	intron	GJA5:ENST00000271348.2:intron_variant:MODIFIER:intron1/1:c.-34+32A>G::	GJA5:NM_005266.6:intron_variant:MODIFIER:intron1/1:c.-34+32A>G::	regulatory_region_variant:promoter_flanking_region	121013 [GENE=GJA5 PHENOS=Atrial fibrillation,familial,11,614049,Autosomal dominant/Atrial standstill,digenic (GJA5/SCN5A),108770,Autosomal dominant];				rs1692137	0.9748	0.9821	15139,.		1.3810			0.10,0.15	4.24					-0.0742	0.1235		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39)
chr1	147245474	147245474	G	C	hom	hom	hom		QUAL=20918;DP=216,279,183;AF=1.00,1.00,1.00;MQM=60;SAP=126;ABP=0	GJA5	5'UTR	GJA5:ENST00000271348.2:5_prime_UTR_variant:MODIFIER:exon1/2:c.-152C>G::		regulatory_region_variant:promoter_flanking_region	121013 [GENE=GJA5 PHENOS=Atrial fibrillation,familial,11,614049,Autosomal dominant/Atrial standstill,digenic (GJA5/SCN5A),108770,Autosomal dominant];	368828 [likely benign DISEASE=Familial atrial fibrillation];			rs1553229282,rs791286		0.9822	15139,.		0.7030			0.01,0.87	18.71					-0.5228	0.1119		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39)
chr1	150771703	150771703	T	C	hom	hom	hom		QUAL=34867;DP=351,363,341;AF=1.00,1.00,1.00;MQM=60;SAP=17;ABP=0	CTSK	synonymous	CTSK:ENST00000271651.3:synonymous_variant:LOW:exon7/8:c.831A>G:p.Ala277=:PF00112 [Papain family cysteine protease]	CTSK:NM_000396.4:synonymous_variant:LOW:exon7/8:c.831A>G:p.Ala277=:	regulatory_region_variant:promoter_flanking_region	601105 [GENE=CTSK PHENOS=Pycnodysostosis,265800,Autosomal recessive];				rs10788796	0.9633	0.9897	15064,.	0.9221,0.9930,0.9930,0.9987,0.9776	-6.7590			0.02,0.13	6.18					0.0429	0.3955	0.05	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CTSK (inh=AR oe_syn=0.89 oe_mis=0.79 oe_lof=0.55), UBE2D3P3 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	151313774	151313774	A	G	het	wt	hom		QUAL=6568;DP=284,137,90;AF=0.49,0.01,1.00;MQM=60;SAP=36;ABP=3	RFX5,RP11-126K1.8	3'UTR,intron&non_coding_transcript	RFX5:ENST00000290524.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*888T>C::,RP11-126K1.8:ENST00000422153.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.255+396A>G::	RFX5:NM_000449.3:3_prime_UTR_variant:MODIFIER:exon11/11:c.*888T>C::,RFX5:NM_001025603.2:3_prime_UTR_variant:MODIFIER:exon11/11:c.*888T>C::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region,TF_binding_site_variant	601863 [GENE=RFX5 PHENOS=Bare lymphocyte syndrome,type II,complementation group C,209920,Autosomal recessive/Bare lymphocyte syndrome,type II,complementation group E,209920,Autosomal recessive];	292600 [benign DISEASE=Bare lymphocyte syndrome 2];			rs7552906	0.6280	0.6236	6096,.		0.2260			0.07,0.13	6.20					0.0196	0.9248	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RFX5 (inh=AR+AD oe_syn=0.75 oe_mis=0.93 oe_lof=0.76)
chr1	151314379	151314379	T	C	het	het	hom		QUAL=8302;DP=199,157,113;AF=0.56,0.47,1.00;MQM=60;SAP=416;ABP=4	RFX5,RP11-126K1.8	3'UTR,non_coding_transcript_exon	RFX5:ENST00000290524.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*283A>G::,RFX5:ENST00000368870.2:3_prime_UTR_variant:MODIFIER:exon11/11:c.*283A>G::,RP11-126K1.8:ENST00000422153.1:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.295T>C::	RFX5:NM_000449.3:3_prime_UTR_variant:MODIFIER:exon11/11:c.*283A>G::,RFX5:NM_001025603.2:3_prime_UTR_variant:MODIFIER:exon11/11:c.*283A>G::	regulatory_region_variant:promoter_flanking_region	601863 [GENE=RFX5 PHENOS=Bare lymphocyte syndrome,type II,complementation group C,209920,Autosomal recessive/Bare lymphocyte syndrome,type II,complementation group E,209920,Autosomal recessive];	292605 [benign DISEASE=Bare lymphocyte syndrome 2];		MLT1K (LTR/ERVL-MaLR)	rs1752387	0.7644	0.7673	9246,.		-1.3700			0.00,0.16	6.90					0.0878	0.9819	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RFX5 (inh=AR+AD oe_syn=0.75 oe_mis=0.93 oe_lof=0.76)
chr1	151315287	151315287	G	C	het	wt	het		QUAL=3187;DP=117,186,137;AF=0.50,0.00,0.51;MQM=60;SAP=14;ABP=3	RFX5	missense	RFX5:ENST00000290524.4:missense_variant:MODERATE:exon11/11:c.1226C>G:p.Pro409Arg:PF14621 [RFX5 DNA-binding domain],RFX5:ENST00000368870.2:missense_variant:MODERATE:exon11/11:c.1226C>G:p.Pro409Arg:PF14621 [RFX5 DNA-binding domain],RFX5:ENST00000452513.2:missense_variant:MODERATE:exon10/10:c.1106C>G:p.Pro369Arg:PF14621 [RFX5 DNA-binding domain],RFX5:ENST00000452671.2:missense_variant:MODERATE:exon11/11:c.1226C>G:p.Pro409Arg:PF14621 [RFX5 DNA-binding domain]	RFX5:NM_000449.3:missense_variant:MODERATE:exon11/11:c.1226C>G:p.Pro409Arg:,RFX5:NM_001025603.2:missense_variant:MODERATE:exon11/11:c.1226C>G:p.Pro409Arg:		601863 [GENE=RFX5 PHENOS=Bare lymphocyte syndrome,type II,complementation group C,209920,Autosomal recessive/Bare lymphocyte syndrome,type II,complementation group E,209920,Autosomal recessive];	292612 [benign DISEASE=Bare lymphocyte syndrome 2,not specified];			rs2233854	0.0635	0.1172	299,.	0.0253,0.0720,0.0004,0.1665,0.0990	1.7470	D(0.00),D(0.00),D(0.00),D(0.00)	B(0.11),B(0.11),B(0.12),B(0.11)	0.59,0.64	18.22	0.03				0.0341	0.9423	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RFX5 (inh=AR+AD oe_syn=0.75 oe_mis=0.93 oe_lof=0.76)
chr1	151316161	151316161	G	A	hom	hom	hom		QUAL=13222;DP=186,132,94;AF=1.00,1.00,1.00;MQM=60;SAP=37;ABP=0	RFX5	synonymous	RFX5:ENST00000290524.4:synonymous_variant:LOW:exon9/11:c.753C>T:p.Leu251=:,RFX5:ENST00000368870.2:synonymous_variant:LOW:exon9/11:c.753C>T:p.Leu251=:,RFX5:ENST00000452513.2:synonymous_variant:LOW:exon8/10:c.633C>T:p.Leu211=:,RFX5:ENST00000452671.2:synonymous_variant:LOW:exon9/11:c.753C>T:p.Leu251=:	RFX5:NM_000449.3:synonymous_variant:LOW:exon9/11:c.753C>T:p.Leu251=:,RFX5:NM_001025603.2:synonymous_variant:LOW:exon9/11:c.753C>T:p.Leu251=:		601863 [GENE=RFX5 PHENOS=Bare lymphocyte syndrome,type II,complementation group C,209920,Autosomal recessive/Bare lymphocyte syndrome,type II,complementation group E,209920,Autosomal recessive];	403373 [benign DISEASE=not specified];			rs1752386		0.9945	15024,.	0.9251,0.9964,1.0000,0.9999,0.9998	0.2350			0.18,0.34	8.44					-0.8061	0.9629	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RFX5 (inh=AR+AD oe_syn=0.75 oe_mis=0.93 oe_lof=0.76)
chr1	152274685	152274685	T	A	hom	hom	hom		QUAL=8564;DP=95,107,63;AF=1.00,1.00,1.00;MQM=60;SAP=180;ABP=0	FLG,FLG-AS1	3'UTR,intron&non_coding_transcript	FLG:ENST00000368799.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*491A>T::,FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+376T>A::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.376+376T>A::	FLG:NM_002016.2:3_prime_UTR_variant:MODIFIER:exon3/3:c.*491A>T::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs1933061	0.9994	0.9981	15639,.		-2.2810			0.00,0.16	2.13					-0.0003	0.9302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152276149	152276149	C	T	het	het	het		QUAL=43428;DP=452,1869,1276;AF=0.48,0.51,0.50;MQM=60;SAP=53;ABP=3	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.1:missense_variant:MODERATE:exon3/3:c.11213G>A:p.Arg3738His:,FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+1840C>T::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.376+1840C>T::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.11213G>A:p.Arg3738His:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs77422831	0.2869	0.2423	479,.	0.0294,0.4284,0.5593,0.1422,0.3682	-2.2520	T(0.43), , 	B(0.07), , 	0.01,0.11	5.01	0.02				-0.0006	0.9302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152276377	152276377	C	G	wt	het	het	low_conf_region	QUAL=10016;DP=493,2040,1476;AF=0.05,0.31,0.19;MQM=28;SAP=450;ABP=1800	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.1:missense_variant:MODERATE:exon3/3:c.10985G>C:p.Ser3662Thr:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+2068C>G::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.376+2068C>G::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.10985G>C:p.Ser3662Thr:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs75235053		0.0173	0,.	0.0002,0.0292,0.0645,0.0041,0.0201	-0.7420	D(0.01), , 	P(0.76), , 	0.07,0.17	14.20	0.03				0.0032	0.9302	0	0	3874	0 / 0					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152276459	152276459	C	T	wt	het	het		QUAL=17382;DP=411,2202,1550;AF=0.10,0.38,0.22;MQM=31;SAP=491;ABP=1105	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.1:missense_variant:MODERATE:exon3/3:c.10903G>A:p.Asp3635Asn:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+2150C>T::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.376+2150C>T::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.10903G>A:p.Asp3635Asn:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs75448155		0.0941	0,.	0.0104,0.1571,0.2732,0.0600,0.1449	1.6290	D(0.00), , 	D(0.97), , 	0.16,0.38	22.80	0.10				-0.0006	0.9302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152276583	152276583	C	G	het	het	het	low_conf_region	QUAL=11129;DP=349,632,898;AF=0.15,0.69,0.19;MQM=33;SAP=47;ABP=364	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.1:missense_variant:MODERATE:exon3/3:c.10779G>C:p.Glu3593Asp:,FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+2274C>G::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.376+2274C>G::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.10779G>C:p.Glu3593Asp:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs12083389	0.3614	0.1541	369,.	0.4017,0.1810,0.2813,0.0226,0.1261	0.3080	T(1.00), , 	B(0.01), , 	0.00,0.06	3.78	0.04				0.0005	0.9302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152276598	152276598	G	A	wt	hom	het	low_conf_region	QUAL=11624;DP=371,428,807;AF=0.07,0.98,0.21;MQM=31;SAP=138;ABP=605	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.1:synonymous_variant:LOW:exon3/3:c.10764C>T:p.His3588=:,FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+2289G>A::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.376+2289G>A::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.10764C>T:p.His3588=:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs12742178	0.0887	0.0655	77,.	0.0246,0.1379,0.3089,0.0141,0.1036	-2.1460			0.00,0.05	0.00					-0.0007	0.9302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152276626	152276626	G	C	het	hom	het	low_conf_region	QUAL=6371;DP=432,313,753;AF=0.12,0.98,0.15;MQM=33;SAP=235;ABP=1330	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.1:missense_variant:MODERATE:exon3/3:c.10736C>G:p.Thr3579Arg:,FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+2317G>C::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.376+2317G>C::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.10736C>G:p.Thr3579Arg:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs3126075	0.4778	0.1863	938,.	0.4692,0.1227,0.3199,0.0121,0.0769	-5.4480	T(0.57), , 	B(0.00), , 	0.00,0.05	0.20	0.01				-0.0006	0.9302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152276671	152276671	C	T	wt	het	het	low_conf_region	QUAL=1748;DP=599,484,883;AF=0.10,0.26,0.13;MQM=45;SAP=277;ABP=1242	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.1:missense_variant:MODERATE:exon3/3:c.10691G>A:p.Arg3564His:,FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+2362C>T::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.376+2362C>T::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.10691G>A:p.Arg3564His:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs7518080	0.2564	0.0886	0,.	0.2098,0.2029,0.3318,0.0226,0.1590	-1.3060	T(1.00), , 	B(0.00), , 	0.00,0.04	0.00	0.01				0.0004	0.9302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152276699	152276699	A	G	het	het	het	low_conf_region	QUAL=7831;DP=509,547,893;AF=0.26,0.55,0.14;MQM=36;SAP=810;ABP=780	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.1:missense_variant:MODERATE:exon3/3:c.10663T>C:p.Trp3555Arg:,FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+2390A>G::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.376+2390A>G::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.10663T>C:p.Trp3555Arg:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs12728605		0.1233	4,.	0.2392,0.2063,0.3023,0.0353,0.1825	-1.1810	T(0.58), , 	B(0.12), , 	0.00,0.03	1.41	0.01				0.0025	0.9302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152276772	152276772	C	A	het	het	het	low_conf_region	QUAL=31914;DP=402,670,1141;AF=0.45,0.86,0.44;MQM=57;SAP=59;ABP=99	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.1:missense_variant:MODERATE:exon3/3:c.10590G>T:p.Arg3530Ser:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+2463C>A::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.376+2463C>A::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.10590G>T:p.Arg3530Ser:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs72697000	0.2905	0.2461	322,.	0.0291,0.4311,0.5574,0.1447,0.3866	-5.0060	T(0.73), , 	D(1.00), , 	0.00,0.09	8.42	0.06				-0.0009	0.9302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152276871	152276871	A	G	het	hom	het	low_conf_region	QUAL=38311;DP=523,642,1125;AF=0.41,0.99,0.47;MQM=59;SAP=8;ABP=37	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.1:synonymous_variant:LOW:exon3/3:c.10491T>C:p.Asp3497=:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+2562A>G::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.376+2562A>G::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.10491T>C:p.Asp3497=:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs3126066	0.4471	0.2836	1497,.	0.4821,0.4531,0.5950,0.1468,0.3918	-3.4900			0.00,0.05	0.01				COSV64251897	0.0019	0.9302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152276889	152276889	A	G	het	hom	het	low_conf_region	QUAL=37815;DP=525,633,1141;AF=0.41,0.99,0.46;MQM=59;SAP=13;ABP=46	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.1:synonymous_variant:LOW:exon3/3:c.10473T>C:p.Asn3491=:,FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+2580A>G::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.376+2580A>G::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.10473T>C:p.Asn3491=:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs3126067		0.3268	2653,.	0.7179,0.4684,0.5971,0.1488,0.3926	-4.3620			0.00,0.05	0.02					0.0028	0.9302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152277055	152277055	C	G	het	het	het	low_conf_region	QUAL=26580;DP=474,545,850;AF=0.38,0.89,0.46;MQM=54;SAP=33;ABP=66	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.1:missense_variant:MODERATE:exon3/3:c.10307G>C:p.Gly3436Ala:,FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+2746C>G::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.376+2746C>G::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.10307G>C:p.Gly3436Ala:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs2065955	0.5142	0.3179	2474,.	0.7135,0.4648,0.5895,0.1467,0.3798	-0.5970	T(0.08), , 	P(0.75), , 	0.02,0.14	9.11	0.03				-0.0019	0.9302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152277168	152277168	A	G	het	hom	het		QUAL=44988;DP=507,910,1061;AF=0.46,0.99,0.46;MQM=51;SAP=255;ABP=29	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.1:synonymous_variant:LOW:exon3/3:c.10194T>C:p.Ser3398=:,FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+2859A>G::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.376+2859A>G::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.10194T>C:p.Ser3398=:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs3091276	0.4736	0.2925	1639,.	0.5216,0.4581,0.6032,0.1510,0.4066	-2.0220			0.00,0.08	0.01					0.0006	0.9302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152277309	152277309	G	A	wt	het	wt		QUAL=25910;DP=618,2025,1358;AF=0.00,0.51,0.00;MQM=54;SAP=3;ABP=6	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.1:synonymous_variant:LOW:exon3/3:c.10053C>T:p.Asp3351=:,FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+3000G>A::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.376+3000G>A::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.10053C>T:p.Asp3351=:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs34687484	0.0028	0.0039	0,.	0.0006,0.0035,0.0001,0.0051,0.0057	-6.2540			0.00,0.06	0.00					-0.0009	0.9302	0	3	211	0 / 0					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152277345	152277345	C	T	het	het	het	low_conf_region	QUAL=46987;DP=549,1986,1335;AF=0.45,0.48,0.48;MQM=59;SAP=4;ABP=24	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.1:synonymous_variant:LOW:exon3/3:c.10017G>A:p.Gln3339=:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+3036C>T::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.376+3036C>T::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.10017G>A:p.Gln3339=:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs2065956	0.2875	0.2428	490,.	0.0290,0.4286,0.5598,0.1423,0.3712	-1.0760			0.01,0.11	0.02					0.0029	0.9302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152277396	152277396	T	C	het	hom	het	low_conf_region	QUAL=80656;DP=508,1869,1283;AF=0.45,0.99,0.49;MQM=59;SAP=45;ABP=9	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.1:synonymous_variant:LOW:exon3/3:c.9966A>G:p.Gln3322=:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+3087T>C::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.376+3087T>C::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.9966A>G:p.Gln3322=:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs6681433	0.3411	0.2728	644,.	0.1272,0.4468,0.5789,0.1653,0.4282	-1.7460			0.01,0.05	0.00					-0.0003	0.9302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152277554	152277554	G	A	wt	het	wt		QUAL=19238;DP=489,1540,1192;AF=0.00,0.49,0.00;MQM=60;SAP=27;ABP=5	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.1:missense_variant:MODERATE:exon3/3:c.9808C>T:p.Arg3270Cys:,FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+3245G>A::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.376+3245G>A::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.9808C>T:p.Arg3270Cys:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs35621145	0.0250	0.0228	6,.	0.0041,0.0137,0.0191,0.0225,0.0564	-0.5000	D(0.04), , 	P(0.84), , 	0.00,0.09	15.46	0.11				0.0011	0.9302	0	21	757	0 / 0					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152277717	152277717	C	A	het	hom	het	low_conf_region	QUAL=41422;DP=278,1121,895;AF=0.33,1.00,0.35;MQM=49;SAP=282;ABP=244	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.1:synonymous_variant:LOW:exon3/3:c.9645G>T:p.Val3215=:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+3408C>A::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.376+3408C>A::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.9645G>T:p.Val3215=:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs9436066	0.4696	0.3044	1518,.	0.4829,0.4618,0.6400,0.1669,0.4309	-6.2400			0.00,0.06	0.01					-0.0032	0.9302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152277822	152277822	T	C	het	hom	wt	low_conf_region	QUAL=7881;DP=323,337,656;AF=0.17,0.98,0.00;MQM=38;SAP=839;ABP=302	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.1:synonymous_variant:LOW:exon3/3:c.9540A>G:p.Ser3180=:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+3513T>C::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.376+3513T>C::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.9540A>G:p.Ser3180=:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs3126069	0.2238	0.1309	350,.	0.0331,0.2724,0.4288,0.0439,0.2553	-4.3740			0.00,0.03	0.00				COSV64251192	0.0006	0.9302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152277826	152277826	A	C	het	hom	wt	low_conf_region	QUAL=7881;DP=323,337,656;AF=0.17,0.98,0.00;MQM=38;SAP=839;ABP=302	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.1:missense_variant:MODERATE:exon3/3:c.9536T>G:p.Val3179Gly:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+3517A>C::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.376+3517A>C::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.9536T>G:p.Val3179Gly:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs2065957	0.3936	0.2372	1155,.	0.4397,0.3037,0.4669,0.0473,0.2644	-0.6040	T(1.00), , 	B(0.00), , 	0.00,0.04	2.08	0.03				-0.0005	0.9302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152278434	152278434	T	G	het	wt	het	low_conf_region	QUAL=2672;DP=446,551,489;AF=0.23,0.00,0.24;MQM=39;SAP=487;ABP=563	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.1:missense_variant:MODERATE:exon3/3:c.8928A>C:p.Glu2976Asp:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+4125T>G::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.376+4125T>G::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.8928A>C:p.Glu2976Asp:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs61816760	0.2873	0.3872	107,.	0.3544,0.3002,0.1149,0.3919,0.3118	-1.3040	T(0.54), , 	B(0.25), , 	0.03,0.15	2.43	0.02				0.0001	0.9302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152278484	152278484	C	T	wt	het	wt		QUAL=3339;DP=440,878,702;AF=0.00,0.25,0.00;MQM=39;SAP=485;ABP=469	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.1:missense_variant:MODERATE:exon3/3:c.8878G>A:p.Gly2960Ser:,FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+4175C>T::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.376+4175C>T::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.8878G>A:p.Gly2960Ser:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs61690342		0.0323	2,.	0.0988,0.0148,0.0170,0.0185,0.0459	-1.1860	T(0.29), , 	B(0.00), , 	0.01,0.12	0.06	0.04				-0.0021	0.9302	0	0	796	0 / 0					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152278555	152278555	T	C	het	het	het		QUAL=26928;DP=437,1611,1309;AF=0.26,0.50,0.25;MQM=46;SAP=838;ABP=474	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.1:missense_variant:MODERATE:exon3/3:c.8807A>G:p.Asp2936Gly:,FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+4246T>C::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.376+4246T>C::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.8807A>G:p.Asp2936Gly:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs80221306		0.2073	2,.	0.0902,0.3298,0.4025,0.1353,0.3092	-0.3860	T(0.38), , 	B(0.01), , 	0.01,0.15	9.25	0.02				-0.0013	0.9302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152278689	152278689	C	A	het	hom	het		QUAL=149422;DP=679,3377,2560;AF=0.56,1.00,0.56;MQM=50;SAP=69;ABP=89	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.1:synonymous_variant:LOW:exon3/3:c.8673G>T:p.Val2891=:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+4380C>A::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.376+4380C>A::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.8673G>T:p.Val2891=:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs57672167	0.3964	0.2792	993,.	0.2106,0.4529,0.5810,0.1651,0.4244	-5.7280			0.00,0.03	0.01					-0.0032	0.9302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152278814	152278814	C	T	wt	het	het	low_conf_region	QUAL=21783;DP=1091,4217,2992;AF=0.09,0.25,0.18;MQM=39;SAP=179;ABP=4835	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.1:missense_variant:MODERATE:exon3/3:c.8548G>A:p.Gly2850Ser:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+4505C>T::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.376+4505C>T::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.8548G>A:p.Gly2850Ser:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs2184952		0.0725	0,.	0.0452,0.1831,0.2761,0.0226,0.1603	-2.5340	T(0.85), , 	B(0.12), , 	0.00,0.05	0.24	0.02				-0.0011	0.9302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152278856	152278856	T	G	het	het	het		QUAL=16038;DP=832,3961,2688;AF=0.23,0.18,0.21;MQM=51;SAP=4;ABP=6132	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.1:missense_variant:MODERATE:exon3/3:c.8506A>C:p.Ser2836Arg:,FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+4547T>G::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.376+4547T>G::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.8506A>C:p.Ser2836Arg:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs11582087		0.1781	0,.	0.0255,0.3147,0.3953,0.1105,0.2619	-1.7590	D(0.04), , 	B(0.09), , 	0.00,0.09	12.25	0.03				-0.0	0.9302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152279019	152279019	G	A	het	het	het		QUAL=8465;DP=982,4110,2430;AF=0.15,0.17,0.19;MQM=35;SAP=10;ABP=7065	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.1:synonymous_variant:LOW:exon3/3:c.8343C>T:p.Asp2781=:,FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+4710G>A::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.376+4710G>A::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.8343C>T:p.Asp2781=:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs57670307		0.1244	0,.	0.0176,0.2495,0.3700,0.0663,0.1923	-5.5940			0.00,0.07	0.01				COSV64246502	-0.0002	0.9302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152279729	152279729	C	T	het	hom	het		QUAL=71009;DP=571,1542,1193;AF=0.47,0.99,0.53;MQM=59;SAP=3;ABP=4	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.1:missense_variant:MODERATE:exon3/3:c.7633G>A:p.Gly2545Arg:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+5420C>T::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.376+5420C>T::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.7633G>A:p.Gly2545Arg:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs3126072	0.4748	0.3025	1693,.	0.5242,0.4626,0.6041,0.1658,0.4260	-1.5600	T(0.45), , 	B(0.00), , 	0.00,0.05	6.82	0.02				-0.0028	0.9302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152279841	152279841	G	C	het	hom	het		QUAL=72352;DP=470,1574,1191;AF=0.48,1.00,0.52;MQM=59;SAP=30;ABP=4	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.1:missense_variant:MODERATE:exon3/3:c.7521C>G:p.His2507Gln:,FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+5532G>C::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.376+5532G>C::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.7521C>G:p.His2507Gln:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs3126074	0.4623	0.2999	1539,.	0.4833,0.4609,0.6037,0.1658,0.4261	-7.9550	T(1.00), , 	B(0.00), , 	0.00,0.04	0.00	0.02				0.0004	0.9302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152279920	152279920	A	G	het	hom	het		QUAL=75419;DP=453,1663,1211;AF=0.49,1.00,0.53;MQM=59;SAP=24;ABP=9	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.1:missense_variant:MODERATE:exon3/3:c.7442T>C:p.Leu2481Ser:,FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+5611A>G::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.376+5611A>G::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.7442T>C:p.Leu2481Ser:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs55650366	0.3425	0.2723	640,.	0.1323,0.4464,0.5791,0.1649,0.4241	-1.3450	T(1.00), , 	B(0.00), , 	0.00,0.05	0.00	0.01				0.0025	0.9302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152279964	152279964	C	T	wt	het	wt		QUAL=22743;DP=615,1675,1225;AF=0.00,0.52,0.00;MQM=60;SAP=23;ABP=10	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.1:synonymous_variant:LOW:exon3/3:c.7398G>A:p.Pro2466=:,FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+5655C>T::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.376+5655C>T::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.7398G>A:p.Pro2466=:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs71625199	0.0248	0.0227	5,.	0.0034,0.0137,0.0191,0.0225,0.0559	-8.7560			0.00,0.05	0.01					-0.0	0.9302	0	13	763	0 / 0					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152280032	152280032	T	C	het	hom	het		QUAL=82501;DP=547,1840,1326;AF=0.48,1.00,0.51;MQM=58;SAP=88;ABP=3	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.1:missense_variant:MODERATE:exon3/3:c.7330A>G:p.Lys2444Glu:,FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+5723T>C::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.376+5723T>C::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.7330A>G:p.Lys2444Glu:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs71625200	0.3431	0.2723	642,.	0.1324,0.4465,0.5790,0.1647,0.4240	-0.8890	T(1.00), , 	B(0.00), , 	0.00,0.08	5.35	0.03				0.0018	0.9302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152280170	152280170	C	G	het	hom	het		QUAL=56454;DP=452,1441,1160;AF=0.44,0.97,0.44;MQM=47;SAP=526;ABP=55	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.1:missense_variant:MODERATE:exon3/3:c.7192G>C:p.Glu2398Gln:,FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+5861C>G::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.376+5861C>G::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.7192G>C:p.Glu2398Gln:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs71625201	0.3305	0.2585	229,.	0.1263,0.4148,0.5201,0.1622,0.4039	-1.3100	T(0.37), , 	B(0.01), , 	0.01,0.12	0.17	0.02				0.0002	0.9302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152280265	152280265	C	G	het	het	het		QUAL=34894;DP=498,1085,1100;AF=0.38,0.86,0.31;MQM=38;SAP=541;ABP=54	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.1:missense_variant:MODERATE:exon3/3:c.7097G>C:p.Ser2366Thr:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+5956C>G::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.376+5956C>G::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.7097G>C:p.Ser2366Thr:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs71625202		0.2131	55,.	0.0305,0.3389,0.4093,0.1431,0.3311	0.0300	D(0.01), , 	D(0.97), , 	0.07,0.22	18.14	0.09				0.0032	0.9302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152280347	152280347	C	T	het	het	het	low_conf_region	QUAL=29864;DP=486,1015,1153;AF=0.34,0.79,0.29;MQM=37;SAP=269;ABP=5	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.1:missense_variant:MODERATE:exon3/3:c.7015G>A:p.Asp2339Asn:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+6038C>T::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.376+6038C>T::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.7015G>A:p.Asp2339Asn:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs139476473		0.1505	228,.	0.0218,0.2926,0.3790,0.0742,0.2640	1.6910	D(0.02), , 	D(0.94), , 	0.15,0.66	22.60	0.14				-0.0006	0.9302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152280372	152280372	G	A	het	hom	het		QUAL=41013;DP=507,1041,1117;AF=0.48,0.99,0.34;MQM=36;SAP=1200;ABP=184	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.1:synonymous_variant:LOW:exon3/3:c.6990C>T:p.His2330=:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+6063G>A::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.376+6063G>A::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.6990C>T:p.His2330=:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs6664985	0.4535	0.2725	1496,.	0.4379,0.4447,0.6132,0.1053,0.4062	-3.4130			0.01,0.14	0.01					-0.0003	0.9302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152280471	152280471	C	G	het	het	het	low_conf_region	QUAL=9710;DP=656,1873,1348;AF=0.23,0.29,0.14;MQM=37;SAP=139;ABP=2466	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.1:missense_variant:MODERATE:exon3/3:c.6891G>C:p.Glu2297Asp:,FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+6162C>G::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.376+6162C>G::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.6891G>C:p.Glu2297Asp:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs78179835		0.1955	16,.	0.0979,0.3197,0.3852,0.1256,0.3042	-1.8340	T(1.00), , 	B(0.00), , 	0.00,0.07	0.00	0.03				0.0005	0.9302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152280685	152280685	C	A	wt	het	wt	low_conf_region	QUAL=1927;DP=392,1784,1242;AF=0.03,0.15,0.06;MQM=55;SAP=127;ABP=1887	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.1:missense_variant:MODERATE:exon3/3:c.6677G>T:p.Gly2226Val:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+6376C>A::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.376+6376C>A::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.6677G>T:p.Gly2226Val:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs544807449	0.1833	0.0214	0,.	0.0573,0.0448,0.1537,0.0034,0.0303	0.1350	T(0.07), , 	B(0.37), , 	0.03,0.11	8.35	0.17			COSV64242592,COSV64251050				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152280687	152280687	C	T	wt	het	wt	low_conf_region	QUAL=1927;DP=392,1784,1242;AF=0.03,0.15,0.06;MQM=55;SAP=127;ABP=1887	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.1:synonymous_variant:LOW:exon3/3:c.6675G>A:p.Val2225=:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+6378C>T::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.376+6378C>T::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.6675G>A:p.Val2225=:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs564482396	0.1833	0.0235	0,.	0.0637,0.0529,0.1703,0.0039,0.0338	-1.6180			0.00,0.05	0.01				COSV64243287,COSV64244530				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152280688	152280688	A	G	wt	het	wt	low_conf_region	QUAL=1927;DP=392,1784,1242;AF=0.03,0.15,0.06;MQM=55;SAP=127;ABP=1887	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.1:missense_variant:MODERATE:exon3/3:c.6674T>C:p.Val2225Ala:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+6379A>G::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.376+6379A>G::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.6674T>C:p.Val2225Ala:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs116918835	0.1833	0.0334	0,.	0.0770,0.0904,0.2047,0.0070,0.0495	-0.5260	T(0.52), , 	B(0.00), , 	0.00,0.08	0.73	0.04			COSV64243288				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152280691	152280691	A	T	wt	het	wt	low_conf_region	QUAL=1927;DP=392,1784,1242;AF=0.03,0.15,0.06;MQM=55;SAP=127;ABP=1887	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.1:missense_variant:MODERATE:exon3/3:c.6671T>A:p.Leu2224Gln:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+6382A>T::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.376+6382A>T::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.6671T>A:p.Leu2224Gln:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs117945779	0.1915	0.0410	0,.	0.1132,0.1120,0.2285,0.0089,0.0603	-1.9610	T(0.99), , 	B(0.00), , 	0.00,0.05	1.46	0.03			COSV64235963	-0.0003	0.9302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152280736	152280736	T	C	het	het	het		QUAL=23801;DP=784,2384,1501;AF=0.32,0.33,0.18;MQM=55;SAP=74;ABP=1979	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.1:missense_variant:MODERATE:exon3/3:c.6626A>G:p.His2209Arg:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+6427T>C::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.376+6427T>C::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.6626A>G:p.His2209Arg:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs66977240		0.2191	0,.	0.3443,0.3420,0.4132,0.1283,0.3119	-5.2630	T(0.75), , 	B(0.00), , 	0.00,0.04	0.03	0.01				0.0007	0.9302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152280759	152280759	A	G	het	het	het		QUAL=36237;DP=856,2669,1554;AF=0.34,0.40,0.23;MQM=54;SAP=102;ABP=1146	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.1:synonymous_variant:LOW:exon3/3:c.6603T>C:p.Asp2201=:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+6450A>G::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.376+6450A>G::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.6603T>C:p.Asp2201=:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs2338554	0.3672	0.2427	519,.	0.4274,0.3505,0.4200,0.1478,0.3295	-2.2170			0.00,0.05	0.01					0.0025	0.9302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152280782	152280782	A	G	het	hom	het		QUAL=131514;DP=875,2788,1653;AF=0.66,1.00,0.63;MQM=57;SAP=54;ABP=429	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.1:missense_variant:MODERATE:exon3/3:c.6580T>C:p.Tyr2194His:,FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+6473A>G::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.376+6473A>G::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.6580T>C:p.Tyr2194His:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs2184953	0.5397	0.3395	2718,.	0.7165,0.4761,0.6055,0.1680,0.4295	-2.7490	T(0.34), , 	B(0.00), , 	0.00,0.04	0.01	0.01				0.0018	0.9302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152280788	152280788	T	G	het	het	het		QUAL=71525;DP=882,2825,1658;AF=0.32,0.73,0.27;MQM=55;SAP=116;ABP=19	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.1:missense_variant:MODERATE:exon3/3:c.6574A>C:p.Lys2192Gln:,FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+6479T>G::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.376+6479T>G::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.6574A>C:p.Lys2192Gln:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs66954353		0.2410	5,.	0.3644,0.3513,0.4198,0.1511,0.3321	0.4010	T(1.00), , 	B(0.00), , 	0.00,0.04	1.99	0.02				0.0	0.9302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152280864	152280864	A	G	het	hom	het		QUAL=111876;DP=509,2561,1512;AF=0.61,1.00,0.66;MQM=55;SAP=3;ABP=386	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.1:synonymous_variant:LOW:exon3/3:c.6498T>C:p.Ser2166=:,FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-6518A>G::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.377-6518A>G::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.6498T>C:p.Ser2166=:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs2184954	0.4637	0.3000	1566,.	0.4840,0.4611,0.6040,0.1658,0.4263	-4.5190			0.00,0.03	0.02					-0.0006	0.9302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152280900	152280900	T	G	het	het	het		QUAL=32612;DP=690,2391,1471;AF=0.32,0.36,0.31;MQM=51;SAP=8;ABP=1025	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.1:missense_variant:MODERATE:exon3/3:c.6462A>C:p.Gln2154His:,FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-6482T>G::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.377-6482T>G::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.6462A>C:p.Gln2154His:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs74129452	0.3438	0.2384	0,.	0.3643,0.3503,0.4198,0.1470,0.3280	-3.3330	T(1.00), , 	B(0.00), , 	0.00,0.02	0.00	0.11				0.0014	0.9302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152281007	152281007	A	G	het	het	het		QUAL=32704;DP=828,2396,1597;AF=0.30,0.32,0.31;MQM=59;SAP=54;ABP=1454	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.1:missense_variant:MODERATE:exon3/3:c.6355T>C:p.Tyr2119His:,FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-6375A>G::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.377-6375A>G::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.6355T>C:p.Tyr2119His:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs7512553	0.3277	0.2255	0,.	0.3638,0.3437,0.4134,0.1326,0.2979	-0.3240	T(1.00), , 	B(0.00), , 	0.00,0.04	0.11	0.04				0.0032	0.9302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152281008	152281008	A	G	het	het	het		QUAL=32704;DP=828,2396,1597;AF=0.30,0.32,0.31;MQM=59;SAP=54;ABP=1454	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.1:synonymous_variant:LOW:exon3/3:c.6354T>C:p.His2118=:,FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-6374A>G::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.377-6374A>G::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.6354T>C:p.His2118=:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs7512554	0.3277	0.2255	0,.	0.3638,0.3437,0.4134,0.1326,0.2979	-1.6980			0.00,0.07	0.03					0.0021	0.9302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152281039	152281039	G	A	het	het	het		QUAL=33358;DP=929,2392,1648;AF=0.30,0.32,0.32;MQM=60;SAP=26;ABP=1478	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.1:missense_variant:MODERATE:exon3/3:c.6323C>T:p.Ala2108Val:,FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-6343G>A::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.377-6343G>A::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.6323C>T:p.Ala2108Val:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs7522925		0.2256	0,.	0.3649,0.3438,0.4134,0.1327,0.2980	-3.7960	T(0.06), , 	B(0.02), , 	0.01,0.09	0.01	0.07				-0.0013	0.9302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152281228	152281228	C	G	het	het	het		QUAL=37985;DP=732,2612,1965;AF=0.25,0.33,0.35;MQM=53;SAP=24;ABP=1401	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.1:missense_variant:MODERATE:exon3/3:c.6134G>C:p.Ser2045Thr:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-6154C>G::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.377-6154C>G::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.6134G>C:p.Ser2045Thr:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs7546186		0.2182	0,.	0.3448,0.3391,0.4078,0.1243,0.2958	1.5140	T(0.09), , 	P(0.72), , 	0.12,0.22	13.39	0.09				0.0013	0.9302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152281290	152281290	A	G	het	het	het		QUAL=35209;DP=648,2594,1989;AF=0.22,0.33,0.34;MQM=51;SAP=14;ABP=1491	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.1:synonymous_variant:LOW:exon3/3:c.6072T>C:p.His2024=:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-6092A>G::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.377-6092A>G::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.6072T>C:p.His2024=:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs80353812	0.3281	0.2236	0,.	0.3573,0.3430,0.4129,0.1309,0.2980	-6.8960			0.00,0.08	0.00					0.0018	0.9302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152281304	152281304	A	C	het	het	het		QUAL=36698;DP=651,2606,1966;AF=0.26,0.34,0.34;MQM=51;SAP=31;ABP=1370	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.1:missense_variant:MODERATE:exon3/3:c.6058T>G:p.Ser2020Ala:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-6078A>C::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.377-6078A>C::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.6058T>G:p.Ser2020Ala:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs7512857		0.2234	0,.	0.3420,0.3425,0.4133,0.1323,0.2975	0.3910	T(0.18), , 	D(0.93), , 	0.01,0.16	14.32	0.03				0.002	0.9302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152281317	152281317	G	T	wt	het	wt		QUAL=21146;DP=785,2642,2029;AF=0.00,0.34,0.00;MQM=60;SAP=21;ABP=583	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.1:missense_variant:MODERATE:exon3/3:c.6045C>A:p.Asp2015Glu:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-6065G>T::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.377-6065G>T::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.6045C>A:p.Asp2015Glu:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs71626704	0.0248	0.0227	5,.	0.0034,0.0136,0.0190,0.0224,0.0559	0.0400	T(0.20), , 	B(0.23), , 	0.06,0.49	8.66	0.05				0.0009	0.9302	0	13	764	0 / 0					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152281479	152281479	G	T	het	hom	het		QUAL=105742;DP=875,1992,1621;AF=0.59,1.00,0.68;MQM=56;SAP=138;ABP=477	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.1:missense_variant:MODERATE:exon3/3:c.5883C>A:p.His1961Gln:,FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-5903G>T::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.377-5903G>T::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.5883C>A:p.His1961Gln:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs3126079		0.3389	2717,.	0.7162,0.4760,0.6056,0.1679,0.4270	-4.7170	T(0.81), , 	B(0.00), , 	0.00,0.04	0.00	0.02				0.0013	0.9302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152281523	152281523	A	C	het	het	het		QUAL=20146;DP=809,1834,1555;AF=0.19,0.30,0.30;MQM=49;SAP=183;ABP=1820	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.1:missense_variant:MODERATE:exon3/3:c.5839T>G:p.Trp1947Gly:,FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-5859A>C::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.377-5859A>C::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.5839T>G:p.Trp1947Gly:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs80059102		0.1979	0,.	0.3165,0.3198,0.4060,0.1120,0.2686	-0.5520	T(0.31), , 	B(0.00), , 	0.01,0.14	8.24	0.01				0.0008	0.9302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152281534	152281534	A	T	het	het	het		QUAL=17149;DP=754,1780,1514;AF=0.18,0.28,0.28;MQM=48;SAP=238;ABP=2034	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.1:missense_variant:MODERATE:exon3/3:c.5828T>A:p.Leu1943His:,FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-5848A>T::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.377-5848A>T::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.5828T>A:p.Leu1943His:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs113544881	0.3135	0.1808	0,.	0.2351,0.2815,0.3878,0.0756,0.2233	-2.7300	T(1.00), , 	B(0.00), , 	0.00,0.04	0.60	0.05				0.0018	0.9302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152281690	152281690	C	T	het	het	het		QUAL=41127;DP=535,1368,1169;AF=0.47,0.53,0.51;MQM=59;SAP=4;ABP=8	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.1:missense_variant:MODERATE:exon3/3:c.5672G>A:p.Arg1891Gln:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-5692C>T::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.377-5692C>T::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.5672G>A:p.Arg1891Gln:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs12407748	0.2875	0.2422	477,.	0.0292,0.4282,0.5601,0.1421,0.3676	-4.3630	T(0.46), , 	B(0.17), , 	0.00,0.06	0.04	0.05				-0.0002	0.9302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152281691	152281691	G	A	wt	het	wt		QUAL=16083;DP=553,1369,1171;AF=0.00,0.46,0.00;MQM=60;SAP=6;ABP=18	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.1:missense_variant:MODERATE:exon3/3:c.5671C>T:p.Arg1891Trp:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-5691G>A::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.377-5691G>A::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.5671C>T:p.Arg1891Trp:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs36006086	0.0250	0.0227	4,.	0.0041,0.0136,0.0190,0.0225,0.0559	-0.6350	D(0.01), , 	D(0.98), , 	0.00,0.10	18.06	0.04			COSV64241834	-0.0002	0.9302	0	15	763	0 / 0					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152281745	152281745	G	T	wt	het	wt		QUAL=16155;DP=626,1416,1185;AF=0.00,0.45,0.00;MQM=60;SAP=9;ABP=38	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.1:missense_variant:MODERATE:exon3/3:c.5617C>A:p.Gln1873Lys:,FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-5637G>T::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.377-5637G>T::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.5617C>A:p.Gln1873Lys:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs62623409	0.0250	0.0227	5,.	0.0041,0.0136,0.0189,0.0224,0.0557	-0.9500	T(0.09), , 	B(0.04), , 	0.01,0.10	6.79	0.04				0.0003	0.9302	0	15	762	0 / 0					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152281948	152281948	G	A	het	het	het		QUAL=37515;DP=454,1937,1117;AF=0.48,0.39,0.51;MQM=58;SAP=13;ABP=109	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.1:missense_variant:MODERATE:exon3/3:c.5414C>T:p.Ala1805Val:,FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-5434G>A::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.377-5434G>A::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.5414C>T:p.Ala1805Val:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs12405241	0.2875	0.2422	481,.	0.0290,0.4278,0.5603,0.1421,0.3679	-5.6240	T(0.20), , 	D(0.96), , 	0.00,0.11	5.45	0.10				-0.0013	0.9302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152282092	152282092	T	C	wt	het	wt		QUAL=2513;DP=509,1981,1241;AF=0.00,0.17,0.00;MQM=52;SAP=3;ABP=1922	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.1:missense_variant:MODERATE:exon3/3:c.5270A>G:p.Glu1757Gly:,FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-5290T>C::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.377-5290T>C::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.5270A>G:p.Glu1757Gly:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs778942937		0.0029	0,.	0.0000,0.0000,0.0000,0.0001,0.0001	0.7390	T(0.11), , 	B(0.08), , 	0.02,0.24	13.88	0.03			COSV64244851	-0.0015	0.9302	0	0	93	0 / 0					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152282267	152282267	G	A	het	het	het		QUAL=36047;DP=404,1515,1224;AF=0.47,0.48,0.47;MQM=60;SAP=9;ABP=17	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.1:missense_variant:MODERATE:exon3/3:c.5095C>T:p.Arg1699Cys:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-5115G>A::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.377-5115G>A::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.5095C>T:p.Arg1699Cys:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs12405278	0.2877	0.2422	481,.	0.0290,0.4279,0.5603,0.1421,0.3680	0.1370	D(0.02), , 	D(0.91), , 	0.03,0.15	18.95	0.05				-0.0012	0.9302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152282311	152282311	C	T	het	het	het		QUAL=39160;DP=506,1507,1234;AF=0.46,0.51,0.48;MQM=60;SAP=26;ABP=6	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.1:missense_variant:MODERATE:exon3/3:c.5051G>A:p.Arg1684His:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-5071C>T::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.377-5071C>T::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.5051G>A:p.Arg1684His:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs12407807	0.2967	0.2447	498,.	0.0644,0.4288,0.5603,0.1421,0.3681	-2.4830	T(0.55), , 	D(0.97), , 	0.00,0.08	10.76	0.07				-0.0008	0.9302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152282522	152282522	C	T	wt	wt	het		QUAL=11066;DP=550,1242,1009;AF=0.00,0.00,0.48;MQM=60;SAP=12;ABP=8	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.1:missense_variant:MODERATE:exon3/3:c.4840G>A:p.Ala1614Thr:,FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-4860C>T::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.377-4860C>T::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.4840G>A:p.Ala1614Thr:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];									-1.2150	T(0.20), , 	B(0.16), , 	0.00,0.08	5.13	0.03			COSV64246735	0.0014	0.9302	0	0	1	0 / 0					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152282794	152282794	G	A	wt	het	wt		QUAL=16935;DP=438,1463,1151;AF=0.00,0.48,0.00;MQM=60;SAP=3;ABP=7	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.1:missense_variant:MODERATE:exon3/3:c.4568C>T:p.Thr1523Ile:,FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-4588G>A::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.377-4588G>A::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.4568C>T:p.Thr1523Ile:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs12750081	0.0250	0.0227	4,.	0.0041,0.0136,0.0190,0.0225,0.0559	-0.3320	D(0.04), , 	B(0.04), , 	0.01,0.11	9.85	0.01				0.0002	0.9302	0	15	760	0 / 0					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152282910	152282910	G	C	wt	het	wt		QUAL=18554;DP=484,1491,1078;AF=0.00,0.49,0.00;MQM=60;SAP=11;ABP=4	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.1:missense_variant:MODERATE:exon3/3:c.4452C>G:p.Asp1484Glu:,FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-4472G>C::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.377-4472G>C::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.4452C>G:p.Asp1484Glu:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs71626706	0.0248	0.0227	5,.	0.0034,0.0136,0.0190,0.0225,0.0560	-5.4290	T(1.00), , 	B(0.00), , 	0.00,0.06	0.00	0.05				-0.002	0.9302	0	15	764	0 / 0					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152282917	152282917	G	T	het	het	het		QUAL=37973;DP=476,1520,1069;AF=0.50,0.50,0.49;MQM=59;SAP=14;ABP=3	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.1:missense_variant:MODERATE:exon3/3:c.4445C>A:p.Ser1482Tyr:,FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-4465G>T::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.377-4465G>T::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.4445C>A:p.Ser1482Tyr:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs11204978	0.2871	0.2422	480,.	0.0290,0.4279,0.5602,0.1420,0.3678	0.2480	D(0.00), , 	B(0.34), , 	0.02,0.13	12.81	0.06				0.0007	0.9302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152282952	152282952	A	G	wt	het	wt		QUAL=19660;DP=535,1568,1140;AF=0.00,0.49,0.00;MQM=60;SAP=15;ABP=5	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.1:synonymous_variant:LOW:exon3/3:c.4410T>C:p.His1470=:,FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-4430A>G::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.377-4430A>G::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.4410T>C:p.His1470=:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs12732920	0.0250	0.0227	4,.	0.0034,0.0136,0.0190,0.0225,0.0562	-8.9450			0.00,0.05	0.00					0.0016	0.9302	0	15	764	0 / 0					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152283053	152283053	G	A	wt	het	wt		QUAL=20686;DP=583,1685,1195;AF=0.00,0.49,0.00;MQM=60;SAP=3;ABP=5	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.1:missense_variant:MODERATE:exon3/3:c.4309C>T:p.Arg1437Cys:,FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-4329G>A::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.377-4329G>A::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.4309C>T:p.Arg1437Cys:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];	916211 [likely benign DISEASE=not provided];			rs12750571	0.0048	0.0050	0,.	0.0006,0.0049,0.0002,0.0067,0.0066	-0.2710	D(0.01), , 	P(0.64), , 	0.01,0.11	17.36	0.04				0.0001	0.9302	0	4	322	0 / 0					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152283236	152283236	T	C	het	hom	het		QUAL=75960;DP=523,1679,1305;AF=0.48,1.00,0.49;MQM=55;SAP=7;ABP=6	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.1:missense_variant:MODERATE:exon3/3:c.4126A>G:p.Arg1376Gly:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-4146T>C::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.377-4146T>C::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.4126A>G:p.Arg1376Gly:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs11581433	0.3431	0.2728	646,.	0.1321,0.4483,0.5792,0.1650,0.4241	-2.3740	T(1.00), , 	B(0.00), , 	0.00,0.09	0.09	0.01				0.0016	0.9302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152283283	152283283	C	T	het	het	het		QUAL=40020;DP=517,1651,1245;AF=0.49,0.49,0.50;MQM=54;SAP=15;ABP=5	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.1:missense_variant:MODERATE:exon3/3:c.4079G>A:p.Arg1360His:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-4099C>T::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.377-4099C>T::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.4079G>A:p.Arg1360His:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs11586631	0.2877	0.2423	482,.	0.0295,0.4279,0.5602,0.1420,0.3678	-6.3060	T(0.83), , 	B(0.05), , 	0.00,0.10	0.02	0.02				-0.0008	0.9302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152283862	152283862	G	C	het	hom	het		QUAL=64820;DP=534,1458,1103;AF=0.49,1.00,0.50;MQM=54;SAP=4;ABP=3	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.1:missense_variant:MODERATE:exon3/3:c.3500C>G:p.Ala1167Gly:,FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-3520G>C::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.377-3520G>C::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.3500C>G:p.Ala1167Gly:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs58001094	0.5341	0.3362	2665,.	0.6886,0.4595,0.5991,0.1656,0.4086	-3.6180	T(1.00), , 	B(0.01), , 	0.00,0.05	0.00	0.05				0.0032	0.9302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152283975	152283975	A	G	het	hom	het		QUAL=75250;DP=569,1699,1205;AF=0.50,1.00,0.50;MQM=52;SAP=17;ABP=3	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.1:synonymous_variant:LOW:exon3/3:c.3387T>C:p.Ser1129=:,FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-3407A>G::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.377-3407A>G::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.3387T>C:p.Ser1129=:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs66831674	0.4631	0.2998	1537,.	0.4836,0.4608,0.6036,0.1657,0.4260	-3.4180			0.00,0.05	0.01					0.0006	0.9302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152284377	152284377	G	A	het	het	wt		QUAL=29778;DP=574,1576,1314;AF=0.53,0.54,0.02;MQM=56;SAP=3;ABP=26	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.1:synonymous_variant:LOW:exon3/3:c.2985C>T:p.His995=:,FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-3005G>A::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.377-3005G>A::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.2985C>T:p.His995=:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs373872833		0.0001	0,.	0.0000,0.0004,0.0001,0.0001,0.0001	-0.6480			0.00,0.11	0.03				COSV64236179	-0.0007	0.9302	0	0	10	0 / 0					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152284424	152284424	G	C	wt	het	wt		QUAL=21845;DP=719,1650,1324;AF=0.02,0.51,0.04;MQM=55;SAP=85;ABP=5	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.1:missense_variant:MODERATE:exon3/3:c.2938C>G:p.His980Asp:,FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-2958G>C::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.377-2958G>C::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.2938C>G:p.His980Asp:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];	402869 [benign DISEASE=not specified];			rs12756586	0.0340	0.0236	5,.	0.0149,0.0140,0.0190,0.0225,0.0565	-1.1170	T(1.00), , 	B(0.00), , 	0.00,0.06	0.00	0.02				0.0015	0.9302	0	15	814	0 / 0					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152284478	152284478	A	G	wt	het	wt	low_conf_region	QUAL=745;DP=530,1786,1303;AF=0.02,0.13,0.07;MQM=39;SAP=111;ABP=2070	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.1:missense_variant:MODERATE:exon3/3:c.2884T>C:p.Trp962Arg:,FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-2904A>G::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.377-2904A>G::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.2884T>C:p.Trp962Arg:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs199888588		0.0265	0,.	0.0127,0.0002,0.0002,0.0001,0.0001	-0.8190	T(0.91), , 	B(0.00), , 	0.00,0.03	0.01	0.02				0.0025	0.9302	0	0	374	0 / 0					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152284497	152284497	A	G	wt	het	wt	low_conf_region	QUAL=2251;DP=509,1945,1342;AF=0.02,0.16,0.07;MQM=40;SAP=12;ABP=1987	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.1:synonymous_variant:LOW:exon3/3:c.2865T>C:p.His955=:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-2885A>G::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.377-2885A>G::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.2865T>C:p.His955=:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs144437056	0.0513	0.0376	0,.	0.0280,0.0002,0.0003,0.0001,0.0001	-5.3240			0.00,0.03	0.00					0.0012	0.9302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152284505	152284505	C	G	wt	het	wt		QUAL=2853;DP=539,2008,1372;AF=0.02,0.16,0.07;MQM=41;SAP=5;ABP=1968	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.1:missense_variant:MODERATE:exon3/3:c.2857G>C:p.Glu953Gln:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-2877C>G::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.377-2877C>G::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.2857G>C:p.Glu953Gln:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs201137357	0.1368	0.0502	11,.	0.1388,0.0031,0.0004,0.0005,0.0003	-0.3120	T(0.10), , 	P(0.89), , 	0.02,0.14	14.31	0.06				0.0005	0.9302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152284541	152284541	G	A	wt	het	wt		QUAL=120;DP=524,2143,1435;AF=0.00,0.13,0.00;MQM=45;SAP=6;ABP=2587	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.1:missense_variant:MODERATE:exon3/3:c.2821C>T:p.Arg941Cys:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-2841G>A::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.377-2841G>A::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.2821C>T:p.Arg941Cys:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs138002269		0.0011	0,.	0.0001,0.0003,0.0001,0.0004,0.0012	-0.6690	D(0.01), , 	D(0.96), , 	0.02,0.14	21.80	0.05			COSV64246254	-0.0012	0.9302	0	0	629	0 / 0					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152284576	152284576	C	A	wt	het	wt		QUAL=2034;DP=580,2113,1428;AF=0.03,0.15,0.05;MQM=43;SAP=109;ABP=2269	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.1:missense_variant:MODERATE:exon3/3:c.2786G>T:p.Gly929Val:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-2806C>A::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.377-2806C>A::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.2786G>T:p.Gly929Val:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs143382793		0.0189	0,.	0.0037,0.0001,0.0001,0.0001,0.0001	-0.1670	D(0.04), , 	P(0.85), , 	0.01,0.10	15.94	0.03				0.0023	0.9302	0	0	842	0 / 0					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152284597	152284597	A	C	wt	het	wt		QUAL=347;DP=513,2110,1421;AF=0.02,0.13,0.04;MQM=43;SAP=119;ABP=2559	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.1:missense_variant:MODERATE:exon3/3:c.2765T>G:p.Ile922Ser:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-2785A>C::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.377-2785A>C::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.2765T>G:p.Ile922Ser:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs201928359		0.0124	0,.	0.0000,0.0001,0.0000,0.0000,0.0000	-2.7080	T(1.00), , 	B(0.00), , 	0.00,0.04	2.56	0.02				0.0003	0.9302	0	0	324	0 / 0					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152284854	152284854	A	G	het	hom	het		QUAL=57123;DP=474,1244,874;AF=0.48,0.99,0.51;MQM=59;SAP=20;ABP=3	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.1:synonymous_variant:LOW:exon3/3:c.2508T>C:p.Asp836=:,FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-2528A>G::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.377-2528A>G::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.2508T>C:p.Asp836=:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs3120653	0.4732	0.3030	1584,.	0.5223,0.4630,0.6035,0.1663,0.4245	-0.0990			0.00,0.07	0.03				COSV64244277	0.0015	0.9302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152285099	152285099	C	T	het	hom	het		QUAL=86263;DP=490,1884,1419;AF=0.52,1.00,0.50;MQM=60;SAP=24;ABP=3	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.1:missense_variant:MODERATE:exon3/3:c.2263G>A:p.Glu755Lys:,FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-2283C>T::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.377-2283C>T::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.2263G>A:p.Glu755Lys:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];	377878 [benign DISEASE=not specified];			rs74129461	0.3277	0.2681	583,.	0.0746,0.4437,0.5790,0.1649,0.4238	-0.3090	D(0.03), , 	B(0.22), , 	0.01,0.14	14.58	0.03				-0.0022	0.9302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152285181	152285181	G	T	wt	het	wt		QUAL=22871;DP=468,1842,1375;AF=0.00,0.48,0.00;MQM=60;SAP=31;ABP=7	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.1:missense_variant:MODERATE:exon3/3:c.2181C>A:p.His727Gln:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-2201G>T::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.377-2201G>T::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.2181C>A:p.His727Gln:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs7512779	0.0250	0.0227	6,.	0.0041,0.0137,0.0190,0.0225,0.0558	-2.7370	T(0.07), , 	B(0.15), , 	0.00,0.09	0.00	0.01				0.0002	0.9302	0	16	761	0 / 0					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152285930	152285930	G	A	het	hom	het		QUAL=70157;DP=510,1569,1174;AF=0.51,0.99,0.49;MQM=60;SAP=11;ABP=3	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.1:missense_variant:MODERATE:exon3/3:c.1432C>T:p.Pro478Ser:,FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-1452G>A::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.377-1452G>A::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.1432C>T:p.Pro478Ser:		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];	666623 [benign DISEASE=not specified];	CM084968 [CLASS=DP MUT=ALT PHEN="Psoriasis increased risk association with" GENE=FLG];		rs11584340	0.3446	0.2726	649,.	0.1354,0.4467,0.5789,0.1649,0.4241	-1.8930	T(1.00), , 	B(0.03), , 	0.00,0.05	0.00	0.04				-0.0009	0.9302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152286002	152286002	T	C	het	hom	het		QUAL=68360;DP=447,1577,1149;AF=0.48,0.99,0.49;MQM=60;SAP=6;ABP=5	FLG,FLG-AS1	missense,non_coding_transcript_exon,intron&non_coding_transcript	FLG:ENST00000368799.1:missense_variant:MODERATE:exon3/3:c.1360A>G:p.Thr454Ala:,FLG-AS1:ENST00000392688.2:non_coding_transcript_exon_variant:MODIFIER:exon1/7:n.68T>C::,FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-1380T>C::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.377-1380T>C::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.1360A>G:p.Thr454Ala:,FLG-AS1:NR_103778.1:non_coding_transcript_exon_variant:MODIFIER:exon1/7:n.68T>C::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];	666624 [benign DISEASE=not specified];	CM1611993 [CLASS=R MUT=ALT PHEN="Ichthyosis vulgaris" GENE=FLG];		rs2011331	0.4641	0.3006	1560,.	0.4865,0.4623,0.6050,0.1660,0.4262	-2.8550	T(1.00), , , 	B(0.01), , , 	0.00,0.05	0.16	0.08				0.0259	0.9302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152286032	152286032	C	T	het	het	het		QUAL=40537;DP=561,1562,1210;AF=0.47,0.46,0.50;MQM=60;SAP=5;ABP=19	FLG,FLG-AS1	missense,non_coding_transcript_exon,intron&non_coding_transcript	FLG:ENST00000368799.1:missense_variant:MODERATE:exon3/3:c.1330G>A:p.Gly444Arg:,FLG-AS1:ENST00000392688.2:non_coding_transcript_exon_variant:MODIFIER:exon1/7:n.98C>T::,FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-1350C>T::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.377-1350C>T::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.1330G>A:p.Gly444Arg:,FLG-AS1:NR_103778.1:non_coding_transcript_exon_variant:MODIFIER:exon1/7:n.98C>T::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs11588170	0.2871	0.2421	472,.	0.0290,0.4281,0.5599,0.1419,0.3677	-0.6390	T(0.18), , , 	P(0.82), , , 	0.01,0.11	11.31	0.04				-0.0406	0.9302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152286126	152286126	A	G	het	wt	het		QUAL=20436;DP=457,1513,1204;AF=0.49,0.00,0.50;MQM=60;SAP=4;ABP=3	FLG,FLG-AS1	synonymous,non_coding_transcript_exon,intron&non_coding_transcript	FLG:ENST00000368799.1:synonymous_variant:LOW:exon3/3:c.1236T>C:p.Arg412=:PF03516 [Filaggrin],FLG-AS1:ENST00000392688.2:non_coding_transcript_exon_variant:MODIFIER:exon1/7:n.192A>G::,FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-1256A>G::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.377-1256A>G::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.1236T>C:p.Arg412=:,FLG-AS1:NR_103778.1:non_coding_transcript_exon_variant:MODIFIER:exon1/7:n.192A>G::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs11582620	0.0861	0.1159	177,.	0.0178,0.0931,0.1025,0.1188,0.2011	-1.9280			0.00,0.08	0.09					0.0106	0.9302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152286367	152286367	C	A	het	hom	het		QUAL=59319;DP=561,1279,911;AF=0.51,1.00,0.50;MQM=60;SAP=138;ABP=3	FLG,FLG-AS1	missense,non_coding_transcript_exon,intron&non_coding_transcript	FLG:ENST00000368799.1:missense_variant:MODERATE:exon3/3:c.995G>T:p.Gly332Val:,FLG-AS1:ENST00000392688.2:non_coding_transcript_exon_variant:MODIFIER:exon1/7:n.433C>A::,FLG-AS1:ENST00000420707.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-1015C>A::,FLG-AS1:ENST00000593011.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.377-1015C>A::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.995G>T:p.Gly332Val:,FLG-AS1:NR_103778.1:non_coding_transcript_exon_variant:MODIFIER:exon1/7:n.433C>A::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal recessive,Autosomal dominant];				rs41267154	0.3407	0.2719	634,.	0.1270,0.4463,0.5787,0.1648,0.4240	-1.0190	D(0.04), , , 	D(1.00), , , 	0.03,0.18	16.73	0.02				0.009	0.9302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	154128672	154128672	G	A	wt	wt	het		QUAL=797;DP=183,125,86;AF=0.01,0.00,0.45;MQM=60;SAP=7;ABP=5	TPM3	3'UTR	TPM3:ENST00000368533.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*1443C>T::	TPM3:NM_001043351.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*1443C>T::,TPM3:NM_001043352.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*2773C>T::,TPM3:NM_001043353.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*2773C>T::,TPM3:NM_001278188.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1443C>T::,TPM3:NM_001278189.2:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1522C>T::,TPM3:NM_001278190.1:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1443C>T::,TPM3:NM_001278191.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*1443C>T::,TPM3:NM_001349679.2:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1522C>T::,TPM3:NM_001364679.2:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1443C>T::,TPM3:NM_001364680.2:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1443C>T::,TPM3:NM_001364681.2:3_prime_UTR_variant:MODIFIER:exon9/9:c.*2773C>T::,TPM3:NM_153649.4:3_prime_UTR_variant:MODIFIER:exon8/8:c.*1443C>T::,TPM3:NR_103461.2:non_coding_transcript_exon_variant:MODIFIER:exon8/8:n.2285C>T::		191030 [GENE=TPM3 PHENOS=CAP myopathy 1,609284,Autosomal recessive,Autosomal dominant/Nemaline myopathy 1,autosomal dominant or recessive,609284,Autosomal recessive,Autosomal dominant/Myopathy,congenital,with fiber-type disproportion,255310,Autosomal recessive,Autosomal dominant];			AluSq2 (SINE/Alu)	rs4540651		0.6039	5968,.		-0.8210			0.00,0.04	1.02					-0.0067	0.947		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NUP210L (inh=n/a oe_syn=0.95 oe_mis=0.76 oe_lof=0.27), TPM3 (inh=AR+AD oe_syn=0.96 oe_mis=0.45 oe_lof=0.37)
chr1	154129265	154129265	A	G	wt	wt	het		QUAL=132;DP=105,19,11;AF=0.00,0.00,0.73;MQM=60;SAP=7;ABP=8	TPM3	3'UTR	TPM3:ENST00000328159.4:3_prime_UTR_variant:MODIFIER:exon9/9:c.*929T>C::,TPM3:ENST00000330188.9:3_prime_UTR_variant:MODIFIER:exon8/8:c.*850T>C::,TPM3:ENST00000341372.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*850T>C::,TPM3:ENST00000341485.5:3_prime_UTR_variant:MODIFIER:exon8/8:c.*850T>C::,TPM3:ENST00000368533.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*850T>C::	TPM3:NM_001043351.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*850T>C::,TPM3:NM_001043352.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*2180T>C::,TPM3:NM_001043353.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*2180T>C::,TPM3:NM_001278188.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*850T>C::,TPM3:NM_001278189.2:3_prime_UTR_variant:MODIFIER:exon9/9:c.*929T>C::,TPM3:NM_001278190.1:3_prime_UTR_variant:MODIFIER:exon7/7:c.*850T>C::,TPM3:NM_001278191.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*850T>C::,TPM3:NM_001349679.2:3_prime_UTR_variant:MODIFIER:exon9/9:c.*929T>C::,TPM3:NM_001364679.2:3_prime_UTR_variant:MODIFIER:exon9/9:c.*850T>C::,TPM3:NM_001364680.2:3_prime_UTR_variant:MODIFIER:exon9/9:c.*850T>C::,TPM3:NM_001364681.2:3_prime_UTR_variant:MODIFIER:exon9/9:c.*2180T>C::,TPM3:NM_153649.4:3_prime_UTR_variant:MODIFIER:exon8/8:c.*850T>C::,TPM3:NR_103461.2:non_coding_transcript_exon_variant:MODIFIER:exon8/8:n.1692T>C::		191030 [GENE=TPM3 PHENOS=CAP myopathy 1,609284,Autosomal recessive,Autosomal dominant/Nemaline myopathy 1,autosomal dominant or recessive,609284,Autosomal recessive,Autosomal dominant/Myopathy,congenital,with fiber-type disproportion,255310,Autosomal recessive,Autosomal dominant];				rs1051370	0.3229	0.3023	1550,.		-0.4070			0.02,0.38	12.35					0.0345	0.9638		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NUP210L (inh=n/a oe_syn=0.95 oe_mis=0.76 oe_lof=0.27), TPM3 (inh=AR+AD oe_syn=0.96 oe_mis=0.45 oe_lof=0.37)
chr1	154134557	154134557	A	C	wt	wt	het		QUAL=1952;DP=454,366,217;AF=0.00,0.00,0.44;MQM=60;SAP=22;ABP=10	TPM3	intron	TPM3:ENST00000271850.7:intron_variant:MODIFIER:intron8/8:c.776-4360T>G::,TPM3:ENST00000302206.5:intron_variant:MODIFIER:intron7/7:c.395-4360T>G::,TPM3:ENST00000323144.7:intron_variant:MODIFIER:intron7/7:c.665-3033T>G::,TPM3:ENST00000328159.4:intron_variant:MODIFIER:intron8/8:c.744-4360T>G::,TPM3:ENST00000330188.9:intron_variant:MODIFIER:intron7/7:c.665-4360T>G::,TPM3:ENST00000341372.3:intron_variant:MODIFIER:intron7/7:c.590-4360T>G::,TPM3:ENST00000341485.5:intron_variant:MODIFIER:intron7/7:c.617-4360T>G::,TPM3:ENST00000368531.2:intron_variant:MODIFIER:intron7/7:c.665-3033T>G::,TPM3:ENST00000368533.3:intron_variant:MODIFIER:intron7/7:c.665-4360T>G::	TPM3:NM_001043351.2:intron_variant:MODIFIER:intron7/7:c.665-4360T>G::,TPM3:NM_001043352.2:intron_variant:MODIFIER:intron7/7:c.665-3033T>G::,TPM3:NM_001043353.2:intron_variant:MODIFIER:intron7/7:c.665-3033T>G::,TPM3:NM_001278188.2:intron_variant:MODIFIER:intron6/6:c.467-4360T>G::,TPM3:NM_001278189.2:intron_variant:MODIFIER:intron8/8:c.744-4360T>G::,TPM3:NM_001278190.1:intron_variant:MODIFIER:intron6/6:c.602-4360T>G::,TPM3:NM_001278191.2:intron_variant:MODIFIER:intron7/7:c.395-4360T>G::,TPM3:NM_001349679.2:intron_variant:MODIFIER:intron8/8:c.744-4360T>G::,TPM3:NM_001364679.2:intron_variant:MODIFIER:intron8/8:c.776-4360T>G::,TPM3:NM_001364680.2:intron_variant:MODIFIER:intron8/8:c.776-4360T>G::,TPM3:NM_001364681.2:intron_variant:MODIFIER:intron8/8:c.776-3033T>G::,TPM3:NM_001364682.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*5856T>G::,TPM3:NM_001364683.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*5856T>G::,TPM3:NM_152263.4:3_prime_UTR_variant:MODIFIER:exon10/10:c.*5856T>G::,TPM3:NM_153649.4:intron_variant:MODIFIER:intron7/7:c.665-4360T>G::,TPM3:NR_103461.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/7:n.760-4360T>G::		191030 [GENE=TPM3 PHENOS=CAP myopathy 1,609284,Autosomal recessive,Autosomal dominant/Nemaline myopathy 1,autosomal dominant or recessive,609284,Autosomal recessive,Autosomal dominant/Myopathy,congenital,with fiber-type disproportion,255310,Autosomal recessive,Autosomal dominant];	292625 [benign DISEASE=Congenital fiber-type disproportion,Nemaline myopathy];			rs3196889	0.3215	0.2972	1476,.		0.4210			0.01,0.22	7.59								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TPM3 (inh=AR+AD oe_syn=0.96 oe_mis=0.45 oe_lof=0.37), RN7SL431P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	154138228	154138228	G	A	wt	wt	het		QUAL=640;DP=198,56,37;AF=0.01,0.00,0.76;MQM=60;SAP=36;ABP=24	TPM3	intron	TPM3:ENST00000271850.7:intron_variant:MODIFIER:intron8/8:c.775+4648C>T::,TPM3:ENST00000302206.5:intron_variant:MODIFIER:intron7/7:c.394+4648C>T::,TPM3:ENST00000323144.7:intron_variant:MODIFIER:intron7/7:c.664+4648C>T::,TPM3:ENST00000328159.4:intron_variant:MODIFIER:intron8/8:c.743+3553C>T::,TPM3:ENST00000330188.9:intron_variant:MODIFIER:intron7/7:c.664+4648C>T::,TPM3:ENST00000341372.3:intron_variant:MODIFIER:intron7/7:c.589+4648C>T::,TPM3:ENST00000341485.5:intron_variant:MODIFIER:intron7/7:c.616+4648C>T::,TPM3:ENST00000368531.2:intron_variant:MODIFIER:intron7/7:c.664+4648C>T::,TPM3:ENST00000368533.3:intron_variant:MODIFIER:intron7/7:c.664+4648C>T::	TPM3:NM_001043351.2:intron_variant:MODIFIER:intron7/7:c.664+4648C>T::,TPM3:NM_001043352.2:intron_variant:MODIFIER:intron7/7:c.664+4648C>T::,TPM3:NM_001043353.2:intron_variant:MODIFIER:intron7/7:c.664+4648C>T::,TPM3:NM_001278188.2:intron_variant:MODIFIER:intron6/6:c.466+4648C>T::,TPM3:NM_001278189.2:intron_variant:MODIFIER:intron8/8:c.743+3553C>T::,TPM3:NM_001278190.1:intron_variant:MODIFIER:intron6/6:c.601+4648C>T::,TPM3:NM_001278191.2:intron_variant:MODIFIER:intron7/7:c.394+4648C>T::,TPM3:NM_001349679.2:intron_variant:MODIFIER:intron8/8:c.743+3553C>T::,TPM3:NM_001364679.2:intron_variant:MODIFIER:intron8/8:c.775+4648C>T::,TPM3:NM_001364680.2:intron_variant:MODIFIER:intron8/8:c.775+4648C>T::,TPM3:NM_001364681.2:intron_variant:MODIFIER:intron8/8:c.775+4648C>T::,TPM3:NM_001364682.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*2185C>T::,TPM3:NM_001364683.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*2185C>T::,TPM3:NM_152263.4:3_prime_UTR_variant:MODIFIER:exon10/10:c.*2185C>T::,TPM3:NM_153649.4:intron_variant:MODIFIER:intron7/7:c.664+4648C>T::,TPM3:NR_103461.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/7:n.759+4648C>T::		191030 [GENE=TPM3 PHENOS=CAP myopathy 1,609284,Autosomal recessive,Autosomal dominant/Nemaline myopathy 1,autosomal dominant or recessive,609284,Autosomal recessive,Autosomal dominant/Myopathy,congenital,with fiber-type disproportion,255310,Autosomal recessive,Autosomal dominant];	292666 [benign DISEASE=Congenital fiber-type disproportion,Nemaline myopathy];		AluSq2 (SINE/Alu)	rs10908723	0.3201	0.2995	1381,.		-0.0270			0.01,0.08	2.40								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TPM3 (inh=AR+AD oe_syn=0.96 oe_mis=0.45 oe_lof=0.37), RN7SL431P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	154138266	154138266	A	-	het	het	het		QUAL=971;DP=145,41,27;AF=0.20,0.29,0.22;MQM=59;SAP=66;ABP=147	TPM3	intron	TPM3:ENST00000271850.7:intron_variant:MODIFIER:intron8/8:c.775+4610del::,TPM3:ENST00000302206.5:intron_variant:MODIFIER:intron7/7:c.394+4610del::,TPM3:ENST00000323144.7:intron_variant:MODIFIER:intron7/7:c.664+4610del::,TPM3:ENST00000328159.4:intron_variant:MODIFIER:intron8/8:c.743+3515del::,TPM3:ENST00000330188.9:intron_variant:MODIFIER:intron7/7:c.664+4610del::,TPM3:ENST00000341372.3:intron_variant:MODIFIER:intron7/7:c.589+4610del::,TPM3:ENST00000341485.5:intron_variant:MODIFIER:intron7/7:c.616+4610del::,TPM3:ENST00000368531.2:intron_variant:MODIFIER:intron7/7:c.664+4610del::,TPM3:ENST00000368533.3:intron_variant:MODIFIER:intron7/7:c.664+4610del::	TPM3:NM_001043351.2:intron_variant:MODIFIER:intron7/7:c.664+4610del::,TPM3:NM_001043352.2:intron_variant:MODIFIER:intron7/7:c.664+4610del::,TPM3:NM_001043353.2:intron_variant:MODIFIER:intron7/7:c.664+4610del::,TPM3:NM_001278188.2:intron_variant:MODIFIER:intron6/6:c.466+4610del::,TPM3:NM_001278189.2:intron_variant:MODIFIER:intron8/8:c.743+3515del::,TPM3:NM_001278190.1:intron_variant:MODIFIER:intron6/6:c.601+4610del::,TPM3:NM_001278191.2:intron_variant:MODIFIER:intron7/7:c.394+4610del::,TPM3:NM_001349679.2:intron_variant:MODIFIER:intron8/8:c.743+3515del::,TPM3:NM_001364679.2:intron_variant:MODIFIER:intron8/8:c.775+4610del::,TPM3:NM_001364680.2:intron_variant:MODIFIER:intron8/8:c.775+4610del::,TPM3:NM_001364681.2:intron_variant:MODIFIER:intron8/8:c.775+4610del::,TPM3:NM_001364682.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*2147del::,TPM3:NM_001364683.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*2147del::,TPM3:NM_152263.4:3_prime_UTR_variant:MODIFIER:exon10/10:c.*2147del::,TPM3:NM_153649.4:intron_variant:MODIFIER:intron7/7:c.664+4610del::,TPM3:NR_103461.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/7:n.759+4610del::		191030 [GENE=TPM3 PHENOS=CAP myopathy 1,609284,Autosomal recessive,Autosomal dominant/Nemaline myopathy 1,autosomal dominant or recessive,609284,Autosomal recessive,Autosomal dominant/Myopathy,congenital,with fiber-type disproportion,255310,Autosomal recessive,Autosomal dominant];	292667 [likely benign DISEASE=Congenital fiber-type disproportion,Nemaline myopathy];		AluSq2 (SINE/Alu)	rs68185418		0.2921	236,.		-1.6610				0.01								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TPM3 (inh=AR+AD oe_syn=0.96 oe_mis=0.45 oe_lof=0.37), RN7SL431P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	154139165	154139165	-	T	wt	wt	het	low_conf_region	QUAL=101;DP=175,37,36;AF=0.05,0.00,0.31;MQM=60;SAP=12;ABP=15	TPM3	intron	TPM3:ENST00000271850.7:intron_variant:MODIFIER:intron8/8:c.775+3710dup::,TPM3:ENST00000302206.5:intron_variant:MODIFIER:intron7/7:c.394+3710dup::,TPM3:ENST00000323144.7:intron_variant:MODIFIER:intron7/7:c.664+3710dup::,TPM3:ENST00000328159.4:intron_variant:MODIFIER:intron8/8:c.743+2615dup::,TPM3:ENST00000330188.9:intron_variant:MODIFIER:intron7/7:c.664+3710dup::,TPM3:ENST00000341372.3:intron_variant:MODIFIER:intron7/7:c.589+3710dup::,TPM3:ENST00000341485.5:intron_variant:MODIFIER:intron7/7:c.616+3710dup::,TPM3:ENST00000368531.2:intron_variant:MODIFIER:intron7/7:c.664+3710dup::,TPM3:ENST00000368533.3:intron_variant:MODIFIER:intron7/7:c.664+3710dup::	TPM3:NM_001043351.2:intron_variant:MODIFIER:intron7/7:c.664+3710dup::,TPM3:NM_001043352.2:intron_variant:MODIFIER:intron7/7:c.664+3710dup::,TPM3:NM_001043353.2:intron_variant:MODIFIER:intron7/7:c.664+3710dup::,TPM3:NM_001278188.2:intron_variant:MODIFIER:intron6/6:c.466+3710dup::,TPM3:NM_001278189.2:intron_variant:MODIFIER:intron8/8:c.743+2615dup::,TPM3:NM_001278190.1:intron_variant:MODIFIER:intron6/6:c.601+3710dup::,TPM3:NM_001278191.2:intron_variant:MODIFIER:intron7/7:c.394+3710dup::,TPM3:NM_001349679.2:intron_variant:MODIFIER:intron8/8:c.743+2615dup::,TPM3:NM_001364679.2:intron_variant:MODIFIER:intron8/8:c.775+3710dup::,TPM3:NM_001364680.2:intron_variant:MODIFIER:intron8/8:c.775+3710dup::,TPM3:NM_001364681.2:intron_variant:MODIFIER:intron8/8:c.775+3710dup::,TPM3:NM_001364682.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*1247dup::,TPM3:NM_001364683.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1247dup::,TPM3:NM_152263.4:3_prime_UTR_variant:MODIFIER:exon10/10:c.*1247dup::,TPM3:NM_153649.4:intron_variant:MODIFIER:intron7/7:c.664+3710dup::,TPM3:NR_103461.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/7:n.759+3710dup::		191030 [GENE=TPM3 PHENOS=CAP myopathy 1,609284,Autosomal recessive,Autosomal dominant/Nemaline myopathy 1,autosomal dominant or recessive,609284,Autosomal recessive,Autosomal dominant/Myopathy,congenital,with fiber-type disproportion,255310,Autosomal recessive,Autosomal dominant];	292677 [benign DISEASE=Congenital fiber-type disproportion,Nemaline myopathy];		AluSx1 (SINE/Alu)	rs72189266		0.4201	2332,.						3.21								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TPM3 (inh=AR+AD oe_syn=0.96 oe_mis=0.45 oe_lof=0.37), RN7SL431P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	154139381	154139381	A	C	wt	wt	het		QUAL=552;DP=146,71,61;AF=0.00,0.01,0.44;MQM=60;SAP=18;ABP=5	TPM3	intron	TPM3:ENST00000271850.7:intron_variant:MODIFIER:intron8/8:c.775+3495T>G::,TPM3:ENST00000302206.5:intron_variant:MODIFIER:intron7/7:c.394+3495T>G::,TPM3:ENST00000323144.7:intron_variant:MODIFIER:intron7/7:c.664+3495T>G::,TPM3:ENST00000328159.4:intron_variant:MODIFIER:intron8/8:c.743+2400T>G::,TPM3:ENST00000330188.9:intron_variant:MODIFIER:intron7/7:c.664+3495T>G::,TPM3:ENST00000341372.3:intron_variant:MODIFIER:intron7/7:c.589+3495T>G::,TPM3:ENST00000341485.5:intron_variant:MODIFIER:intron7/7:c.616+3495T>G::,TPM3:ENST00000368531.2:intron_variant:MODIFIER:intron7/7:c.664+3495T>G::,TPM3:ENST00000368533.3:intron_variant:MODIFIER:intron7/7:c.664+3495T>G::	TPM3:NM_001043351.2:intron_variant:MODIFIER:intron7/7:c.664+3495T>G::,TPM3:NM_001043352.2:intron_variant:MODIFIER:intron7/7:c.664+3495T>G::,TPM3:NM_001043353.2:intron_variant:MODIFIER:intron7/7:c.664+3495T>G::,TPM3:NM_001278188.2:intron_variant:MODIFIER:intron6/6:c.466+3495T>G::,TPM3:NM_001278189.2:intron_variant:MODIFIER:intron8/8:c.743+2400T>G::,TPM3:NM_001278190.1:intron_variant:MODIFIER:intron6/6:c.601+3495T>G::,TPM3:NM_001278191.2:intron_variant:MODIFIER:intron7/7:c.394+3495T>G::,TPM3:NM_001349679.2:intron_variant:MODIFIER:intron8/8:c.743+2400T>G::,TPM3:NM_001364679.2:intron_variant:MODIFIER:intron8/8:c.775+3495T>G::,TPM3:NM_001364680.2:intron_variant:MODIFIER:intron8/8:c.775+3495T>G::,TPM3:NM_001364681.2:intron_variant:MODIFIER:intron8/8:c.775+3495T>G::,TPM3:NM_001364682.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*1032T>G::,TPM3:NM_001364683.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1032T>G::,TPM3:NM_152263.4:3_prime_UTR_variant:MODIFIER:exon10/10:c.*1032T>G::,TPM3:NM_153649.4:intron_variant:MODIFIER:intron7/7:c.664+3495T>G::,TPM3:NR_103461.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/7:n.759+3495T>G::		191030 [GENE=TPM3 PHENOS=CAP myopathy 1,609284,Autosomal recessive,Autosomal dominant/Nemaline myopathy 1,autosomal dominant or recessive,609284,Autosomal recessive,Autosomal dominant/Myopathy,congenital,with fiber-type disproportion,255310,Autosomal recessive,Autosomal dominant];	292682 [benign DISEASE=Congenital fiber-type disproportion,Nemaline myopathy];		AluSx1 (SINE/Alu)	rs6673171	0.3229	0.2982	1481,.		0.7440			0.01,0.09	4.25								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TPM3 (inh=AR+AD oe_syn=0.96 oe_mis=0.45 oe_lof=0.37), RN7SL431P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	154141908	154141908	A	G	wt	wt	het	off-target	QUAL=3013;DP=183,303,249;AF=0.00,0.00,0.49;MQM=60;SAP=53;ABP=3	TPM3	intron	TPM3:ENST00000271850.7:intron_variant:MODIFIER:intron8/8:c.775+968T>C::,TPM3:ENST00000302206.5:intron_variant:MODIFIER:intron7/7:c.394+968T>C::,TPM3:ENST00000323144.7:intron_variant:MODIFIER:intron7/7:c.664+968T>C::,TPM3:ENST00000328159.4:intron_variant:MODIFIER:intron7/8:c.665-49T>C::,TPM3:ENST00000330188.9:intron_variant:MODIFIER:intron7/7:c.664+968T>C::,TPM3:ENST00000341372.3:intron_variant:MODIFIER:intron7/7:c.589+968T>C::,TPM3:ENST00000341485.5:intron_variant:MODIFIER:intron7/7:c.616+968T>C::,TPM3:ENST00000368530.2:intron_variant:MODIFIER:intron8/9:c.776-49T>C::,TPM3:ENST00000368531.2:intron_variant:MODIFIER:intron7/7:c.664+968T>C::,TPM3:ENST00000368533.3:intron_variant:MODIFIER:intron7/7:c.664+968T>C::	TPM3:NM_001043351.2:intron_variant:MODIFIER:intron7/7:c.664+968T>C::,TPM3:NM_001043352.2:intron_variant:MODIFIER:intron7/7:c.664+968T>C::,TPM3:NM_001043353.2:intron_variant:MODIFIER:intron7/7:c.664+968T>C::,TPM3:NM_001278188.2:intron_variant:MODIFIER:intron6/6:c.466+968T>C::,TPM3:NM_001278189.2:intron_variant:MODIFIER:intron7/8:c.665-49T>C::,TPM3:NM_001278190.1:intron_variant:MODIFIER:intron6/6:c.601+968T>C::,TPM3:NM_001278191.2:intron_variant:MODIFIER:intron7/7:c.394+968T>C::,TPM3:NM_001349679.2:intron_variant:MODIFIER:intron7/8:c.665-49T>C::,TPM3:NM_001364679.2:intron_variant:MODIFIER:intron8/8:c.775+968T>C::,TPM3:NM_001364680.2:intron_variant:MODIFIER:intron8/8:c.775+968T>C::,TPM3:NM_001364681.2:intron_variant:MODIFIER:intron8/8:c.775+968T>C::,TPM3:NM_001364682.1:intron_variant:MODIFIER:intron8/9:c.776-49T>C::,TPM3:NM_001364683.1:intron_variant:MODIFIER:intron7/8:c.665-49T>C::,TPM3:NM_152263.4:intron_variant:MODIFIER:intron8/9:c.776-49T>C::,TPM3:NM_153649.4:intron_variant:MODIFIER:intron7/7:c.664+968T>C::,TPM3:NR_103461.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/7:n.759+968T>C::		191030 [GENE=TPM3 PHENOS=CAP myopathy 1,609284,Autosomal recessive,Autosomal dominant/Nemaline myopathy 1,autosomal dominant or recessive,609284,Autosomal recessive,Autosomal dominant/Myopathy,congenital,with fiber-type disproportion,255310,Autosomal recessive,Autosomal dominant];	262627 [benign DISEASE=not specified,not provided];			rs4845364	0.7322	0.6193	6334,.	0.8127,0.7172,0.8686,0.5117,0.6475	1.4390			0.41,0.82	21.60					-0.074	0.6758	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TPM3 (inh=AR+AD oe_syn=0.96 oe_mis=0.45 oe_lof=0.37), RN7SL431P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	154245142	154245142	T	G	wt	het	wt		QUAL=2986;DP=377,244,166;AF=0.00,0.50,0.02;MQM=60;SAP=3;ABP=3	HAX1	5'UTR	HAX1:ENST00000328703.7:5_prime_UTR_variant:MODIFIER:exon1/7:c.-58T>G::,HAX1:ENST00000457918.2:5_prime_UTR_variant:MODIFIER:exon1/7:c.-58T>G::,HAX1:ENST00000483970.2:5_prime_UTR_variant:MODIFIER:exon1/7:c.-58T>G::	HAX1:NM_001018837.2:5_prime_UTR_variant:MODIFIER:exon1/7:c.-58T>G::,HAX1:NM_006118.4:5_prime_UTR_variant:MODIFIER:exon1/7:c.-58T>G::	regulatory_region_variant:promoter,TF_binding_site_variant	605998 [GENE=HAX1 PHENOS=Neutropenia,severe congenital 3,autosomal recessive,610738,Autosomal recessive];	292700 [benign DISEASE=Kostmann syndrome];			rs11265425		0.2338	1053,.		-2.2010			0.01,0.29	6.45					-0.0109	0.3843	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					UBAP2L (inh=n/a oe_syn=1.01 oe_mis=0.62 oe_lof=0.03), HAX1 (inh=AR oe_syn=0.87 oe_mis=0.97 oe_lof=0.85)
chr1	154548721	154548721	T	C	hom	het	hom		QUAL=8880;DP=112,108,126;AF=0.98,0.52,1.00;MQM=60;SAP=11;ABP=3	CHRNB2	3'UTR	CHRNB2:ENST00000368476.3:3_prime_UTR_variant:MODIFIER:exon6/6:c.*313T>C::	CHRNB2:NM_000748.3:3_prime_UTR_variant:MODIFIER:exon6/6:c.*313T>C::		118507 [GENE=CHRNB2 PHENOS=Epilepsy,nocturnal frontal lobe,3,605375];				rs2072660		0.7078	7965,.		-1.8830			0.04,0.11	1.19					0.0035	0.9268	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CHRNB2 (inh=AD oe_syn=1.02 oe_mis=0.67 oe_lof=0.46)
chr1	154548880	154548880	G	A	wt	het	wt		QUAL=1186;DP=76,106,62;AF=0.00,0.48,0.02;MQM=60;SAP=3;ABP=3	CHRNB2	3'UTR	CHRNB2:ENST00000368476.3:3_prime_UTR_variant:MODIFIER:exon6/6:c.*472G>A::	CHRNB2:NM_000748.3:3_prime_UTR_variant:MODIFIER:exon6/6:c.*472G>A::		118507 [GENE=CHRNB2 PHENOS=Epilepsy,nocturnal frontal lobe,3,605375];	375660 [drug response DISEASE=nicotine response - Efficacy, Toxicity/ADR];			rs2072661	0.2646	0.2513	974,.		0.6430			0.07,0.13	4.00					-0.0035	0.9267	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CHRNB2 (inh=AD oe_syn=1.02 oe_mis=0.67 oe_lof=0.46)
chr1	154549470	154549470	T	C	wt	het	wt		QUAL=3420;DP=301,299,241;AF=0.00,0.45,0.00;MQM=60;SAP=16;ABP=10	CHRNB2	3'UTR	CHRNB2:ENST00000368476.3:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1062T>C::	CHRNB2:NM_000748.3:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1062T>C::		118507 [GENE=CHRNB2 PHENOS=Epilepsy,nocturnal frontal lobe,3,605375];				rs12130403	0.2859	0.2945	1363,.		-0.0760			0.09,0.11	3.46					0.0108	0.9269	0.05	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CHRNB2 (inh=AD oe_syn=1.02 oe_mis=0.67 oe_lof=0.46)
chr1	154550944	154550945	AG	-	wt	het	wt		QUAL=3305;DP=271,267,211;AF=0.00,0.48,0.00;MQM=60;SAP=22;ABP=4	CHRNB2	3'UTR	CHRNB2:ENST00000368476.3:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2538_*2539del::	CHRNB2:NM_000748.3:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2538_*2539del::	regulatory_region_variant:promoter_flanking_region	118507 [GENE=CHRNB2 PHENOS=Epilepsy,nocturnal frontal lobe,3,605375];				rs3841062		0.2716	1152,.		0.4860				5.06					0.0015	0.9268	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CHRNB2 (inh=AD oe_syn=1.02 oe_mis=0.67 oe_lof=0.46), ADAR (inh=AR+AD oe_syn=1.13 oe_mis=0.75 oe_lof=0.26)
chr1	154552010	154552010	C	G	het	wt	het		QUAL=8355;DP=295,411,336;AF=0.56,0.00,0.48;MQM=60;SAP=3;ABP=4	CHRNB2,RP11-61L14.6	3'UTR,intron&non_coding_transcript	CHRNB2:ENST00000368476.3:3_prime_UTR_variant:MODIFIER:exon6/6:c.*3602C>G::,RP11-61L14.6:ENST00000421866.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.47+83G>C::	CHRNB2:NM_000748.3:3_prime_UTR_variant:MODIFIER:exon6/6:c.*3602C>G::		118507 [GENE=CHRNB2 PHENOS=Epilepsy,nocturnal frontal lobe,3,605375];				rs1049998302		0.0001	0,.		-0.4130			0.14,0.15	2.87					-0.3196	0.9269	0	0	2	0 / 0					CHRNB2 (inh=AD oe_syn=1.02 oe_mis=0.67 oe_lof=0.46), ADAR (inh=AR+AD oe_syn=1.13 oe_mis=0.75 oe_lof=0.26)
chr1	155205669	155205669	G	T	hom	hom	hom	off-target	QUAL=19892;DP=92,334,251;AF=1.00,1.00,1.00;MQM=52;SAP=650;ABP=0	GBA	intron	GBA:ENST00000327247.5:intron_variant:MODIFIER:intron9/11:c.1225-34C>A::,GBA:ENST00000368373.3:intron_variant:MODIFIER:intron8/10:c.1225-34C>A::,GBA:ENST00000427500.3:intron_variant:MODIFIER:intron7/9:c.1078-34C>A::,GBA:ENST00000428024.3:intron_variant:MODIFIER:intron7/9:c.964-34C>A::,GBA:ENST00000536770.1:intron_variant:MODIFIER:intron6/8:c.886-34C>A::	GBA:NM_000157.4:intron_variant:MODIFIER:intron8/10:c.1225-34C>A::,GBA:NM_001005741.3:intron_variant:MODIFIER:intron9/11:c.1225-34C>A::,GBA:NM_001005742.3:intron_variant:MODIFIER:intron9/11:c.1225-34C>A::,GBA:NM_001171811.2:intron_variant:MODIFIER:intron7/9:c.964-34C>A::,GBA:NM_001171812.2:intron_variant:MODIFIER:intron7/9:c.1078-34C>A::	regulatory_region_variant:promoter_flanking_region	606463 [GENE=GBA PHENOS=Gaucher disease,type III,231000,Autosomal recessive/Parkinson disease,late-onset,susceptibility to,168600,Multifactorial,Autosomal dominant/Gaucher disease,type IIIC,231005,Autosomal recessive/Gaucher disease,type I,230800,Autosomal recessive/Gaucher disease,perinatal lethal,608013,Autosomal recessive/Gaucher disease,type II,230900,Autosomal recessive/Lewy body dementia,susceptibility to,127750,Autosomal dominant];	256871 [benign DISEASE=Gaucher disease,not specified,not provided];			rs3115534		0.9866	14293,.	0.8399,0.9923,0.9996,0.9975,0.9983	0.6620			0.00,0.04	7.96					-0.1359	0.2207	0.04	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTX1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), GBA (inh=AR+AD oe_syn=1.05 oe_mis=0.81 oe_lof=0.51)
chr1	155207387	155207387	A	T	het	wt	het	off-target	QUAL=3984;DP=187,174,140;AF=0.51,0.00,0.54;MQM=53;SAP=326;ABP=5	GBA	intron	GBA:ENST00000327247.5:intron_variant:MODIFIER:intron7/11:c.762-18T>A::,GBA:ENST00000368373.3:intron_variant:MODIFIER:intron6/10:c.762-18T>A::,GBA:ENST00000427500.3:intron_variant:MODIFIER:intron5/9:c.615-18T>A::,GBA:ENST00000428024.3:intron_variant:MODIFIER:intron5/9:c.501-18T>A::,GBA:ENST00000536770.1:intron_variant:MODIFIER:intron4/8:c.423-18T>A::	GBA:NM_000157.4:intron_variant:MODIFIER:intron6/10:c.762-18T>A::,GBA:NM_001005741.3:intron_variant:MODIFIER:intron7/11:c.762-18T>A::,GBA:NM_001005742.3:intron_variant:MODIFIER:intron7/11:c.762-18T>A::,GBA:NM_001171811.2:intron_variant:MODIFIER:intron5/9:c.501-18T>A::,GBA:NM_001171812.2:intron_variant:MODIFIER:intron5/9:c.615-18T>A::		606463 [GENE=GBA PHENOS=Gaucher disease,type III,231000,Autosomal recessive/Parkinson disease,late-onset,susceptibility to,168600,Multifactorial,Autosomal dominant/Gaucher disease,type IIIC,231005,Autosomal recessive/Gaucher disease,type I,230800,Autosomal recessive/Gaucher disease,perinatal lethal,608013,Autosomal recessive/Gaucher disease,type II,230900,Autosomal recessive/Lewy body dementia,susceptibility to,127750,Autosomal dominant];	198756 [benign DISEASE=not specified,not provided];			rs140335079	0.0018	0.0090	2,.	0.0026,0.0034,0.0001,0.0130,0.0014	-0.0700			0.03,0.11	6.51		10.84>7.92			-1.0984	0.8734	0.03	2	517	0 / 0					MTX1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), GBA (inh=AR+AD oe_syn=1.05 oe_mis=0.81 oe_lof=0.51)
chr1	155214641	155214642	GA	-	wt	het	het	low_conf_region	QUAL=9;DP=115,119,86;AF=0.11,0.10,0.17;MQM=60;SAP=25;ABP=245	GBA,FAM189B	upstream_gene,downstream_gene	GBA:ENST00000327247.5:upstream_gene_variant:MODIFIER::::,FAM189B:ENST00000350210.2:downstream_gene_variant:MODIFIER::::,FAM189B:ENST00000361361.2:downstream_gene_variant:MODIFIER::::,FAM189B:ENST00000368368.3:downstream_gene_variant:MODIFIER::::,GBA:ENST00000368373.3:upstream_gene_variant:MODIFIER::::,GBA:ENST00000427500.3:upstream_gene_variant:MODIFIER::::,GBA:ENST00000428024.3:upstream_gene_variant:MODIFIER::::,GBA:ENST00000536770.1:upstream_gene_variant:MODIFIER::::		regulatory_region_variant:promoter				(GAGA)n (Simple_repeat)	rs3841430		0.3533	1827,.		-0.1570				7.78								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GBA (inh=AR+AD oe_syn=1.05 oe_mis=0.81 oe_lof=0.51), FAM189B (inh=n/a oe_syn=0.93 oe_mis=0.90 oe_lof=0.47)
chr1	155724315	155724315	G	T	het	wt	het	off-target;low_conf_region	QUAL=228;DP=58,81,47;AF=0.41,0.04,0.11;MQM=49;SAP=72;ABP=49	GON4L	intron	GON4L:ENST00000271883.5:intron_variant:MODIFIER:intron27/31:c.5518-36C>A::,GON4L:ENST00000368331.1:intron_variant:MODIFIER:intron27/31:c.5518-36C>A::,GON4L:ENST00000437809.1:intron_variant:MODIFIER:intron27/31:c.5518-36C>A::	GON4L:NM_001282856.1:intron_variant:MODIFIER:intron27/31:c.5518-36C>A::,GON4L:NM_001282858.2:intron_variant:MODIFIER:intron27/31:c.5518-36C>A::,GON4L:NM_001282860.1:intron_variant:MODIFIER:intron27/31:c.5518-36C>A::						rs200722936		0.0585		0.0370,0.0498,0.0430,0.0547,0.0982	0.1270			0.01,0.16	1.49				COSV55185833				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSTO2P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), GON4L (inh=n/a oe_syn=1.03 oe_mis=0.86 oe_lof=0.20)
chr1	155737385	155737385	C	T	hom	hom	hom	off-target	QUAL=8261;DP=37,156,118;AF=1.00,1.00,1.00;MQM=45;SAP=150;ABP=0	GON4L	intron	GON4L:ENST00000271883.5:intron_variant:MODIFIER:intron19/31:c.2647-53G>A::,GON4L:ENST00000361040.5:intron_variant:MODIFIER:intron19/20:c.2647-53G>A::,GON4L:ENST00000368331.1:intron_variant:MODIFIER:intron19/31:c.2647-53G>A::,GON4L:ENST00000437809.1:intron_variant:MODIFIER:intron19/31:c.2647-53G>A::	GON4L:NM_001282856.1:intron_variant:MODIFIER:intron19/31:c.2647-53G>A::,GON4L:NM_001282858.2:intron_variant:MODIFIER:intron19/31:c.2647-53G>A::,GON4L:NM_001282860.1:intron_variant:MODIFIER:intron19/31:c.2647-53G>A::,GON4L:NM_001282861.2:intron_variant:MODIFIER:intron19/20:c.2647-53G>A::,GON4L:NM_032292.6:intron_variant:MODIFIER:intron19/20:c.2647-53G>A::						rs849712	0.9279	0.9356	13897,.		0.2140			0.00,0.08	2.31					0.0066	0.9579	0.12	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GON4L (inh=n/a oe_syn=1.03 oe_mis=0.86 oe_lof=0.20)
chr1	155755097	155755097	G	A	hom	hom	hom	off-target	QUAL=25676;DP=234,305,248;AF=1.00,1.00,1.00;MQM=60;SAP=188;ABP=0	GON4L	intron	GON4L:ENST00000271883.5:intron_variant:MODIFIER:intron13/31:c.1788+28C>T::,GON4L:ENST00000361040.5:intron_variant:MODIFIER:intron13/20:c.1788+28C>T::,GON4L:ENST00000368331.1:intron_variant:MODIFIER:intron13/31:c.1788+28C>T::,GON4L:ENST00000437809.1:intron_variant:MODIFIER:intron13/31:c.1788+28C>T::	GON4L:NM_001282856.1:intron_variant:MODIFIER:intron13/31:c.1788+28C>T::,GON4L:NM_001282858.2:intron_variant:MODIFIER:intron13/31:c.1788+28C>T::,GON4L:NM_001282860.1:intron_variant:MODIFIER:intron13/31:c.1788+28C>T::,GON4L:NM_001282861.2:intron_variant:MODIFIER:intron13/20:c.1788+28C>T::,GON4L:NM_032292.6:intron_variant:MODIFIER:intron13/20:c.1788+28C>T::						rs822021		0.9836	13914,.	0.7734,0.9901,0.9999,0.9996,0.9996	-0.2560			0.01,0.12	6.47					0.0825	0.8674	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GON4L (inh=n/a oe_syn=1.03 oe_mis=0.86 oe_lof=0.20)
chr1	155785579	155785582	AACT	-	hom	hom	hom	off-target	QUAL=22100;DP=247,270,210;AF=1.00,1.00,1.00;MQM=60;SAP=213;ABP=0	GON4L	intron	GON4L:ENST00000271883.5:intron_variant:MODIFIER:intron8/31:c.1161+14_1161+17del::,GON4L:ENST00000361040.5:intron_variant:MODIFIER:intron8/20:c.1161+14_1161+17del::,GON4L:ENST00000368331.1:intron_variant:MODIFIER:intron8/31:c.1161+14_1161+17del::,GON4L:ENST00000437809.1:intron_variant:MODIFIER:intron8/31:c.1161+14_1161+17del::	GON4L:NM_001282856.1:intron_variant:MODIFIER:intron8/31:c.1161+14_1161+17del::,GON4L:NM_001282858.2:intron_variant:MODIFIER:intron8/31:c.1161+14_1161+17del::,GON4L:NM_001282860.1:intron_variant:MODIFIER:intron8/31:c.1161+14_1161+17del::,GON4L:NM_001282861.2:intron_variant:MODIFIER:intron8/20:c.1161+14_1161+17del::,GON4L:NM_032292.6:intron_variant:MODIFIER:intron8/20:c.1161+14_1161+17del::						rs148569012		0.9332	11938,.	0.6358,0.9666,0.9991,0.9504,0.9506	-0.3330				12.98					0.128	0.4399	0.19	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GON4L (inh=n/a oe_syn=1.03 oe_mis=0.86 oe_lof=0.20)
chr1	156025096	156025096	C	T	wt	wt	het		QUAL=1260;DP=86,167,108;AF=0.00,0.00,0.51;MQM=60;SAP=12;ABP=3	LAMTOR2	synonymous	LAMTOR2:ENST00000368302.3:synonymous_variant:LOW:exon2/4:c.111C>T:p.Tyr37=:PF03259 [Roadblock/LC7 domain],LAMTOR2:ENST00000368304.5:synonymous_variant:LOW:exon2/3:c.111C>T:p.Tyr37=:PF03259 [Roadblock/LC7 domain],LAMTOR2:ENST00000368305.4:synonymous_variant:LOW:exon2/4:c.111C>T:p.Tyr37=:PF03259 [Roadblock/LC7 domain]	LAMTOR2:NM_001145264.2:synonymous_variant:LOW:exon2/3:c.111C>T:p.Tyr37=:,LAMTOR2:NM_014017.4:synonymous_variant:LOW:exon2/4:c.111C>T:p.Tyr37=:	regulatory_region_variant:promoter	610389 [GENE=LAMTOR2 PHENOS=Immunodeficiency due to defect in MAPBP-interacting protein,610798,Autosomal recessive];				rs7541	0.0717	0.1214	220,.	0.0514,0.0910,0.0004,0.1614,0.0814	-0.9570			0.11,0.74	12.05					-0.0997	0.9375	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					UBQLN4 (inh=n/a oe_syn=0.86 oe_mis=0.56 oe_lof=0.12), LAMTOR2 (inh=AR oe_syn=1.11 oe_mis=0.57 oe_lof=0.30)
chr1	156105028	156105028	T	C	wt	wt	het		QUAL=341;DP=90,54,36;AF=0.01,0.00,0.47;MQM=60;SAP=20;ABP=3	LMNA	synonymous	LMNA:ENST00000347559.2:synonymous_variant:LOW:exon5/11:c.861T>C:p.Ala287=:PF00038 [Intermediate filament protein],LMNA:ENST00000361308.4:synonymous_variant:LOW:exon5/10:c.861T>C:p.Ala287=:PF00038 [Intermediate filament protein],LMNA:ENST00000368297.1:synonymous_variant:LOW:exon6/11:c.618T>C:p.Ala206=:PF00038 [Intermediate filament protein],LMNA:ENST00000368299.3:synonymous_variant:LOW:exon5/12:c.861T>C:p.Ala287=:PF00038 [Intermediate filament protein],LMNA:ENST00000368300.4:synonymous_variant:LOW:exon5/12:c.861T>C:p.Ala287=:PF00038 [Intermediate filament protein],LMNA:ENST00000368301.2:synonymous_variant:LOW:exon8/13:c.861T>C:p.Ala287=:PF00038 [Intermediate filament protein],LMNA:ENST00000392353.3:synonymous_variant:LOW:exon5/10:c.618T>C:p.Ala206=:PF00038 [Intermediate filament protein],LMNA:ENST00000448611.2:synonymous_variant:LOW:exon5/13:c.525T>C:p.Ala175=:PF00038 [Intermediate filament protein],LMNA:ENST00000473598.2:synonymous_variant:LOW:exon6/13:c.564T>C:p.Ala188=:PF00038 [Intermediate filament protein]	LMNA:NM_001257374.3:synonymous_variant:LOW:exon5/13:c.525T>C:p.Ala175=:,LMNA:NM_001282624.1:synonymous_variant:LOW:exon6/11:c.618T>C:p.Ala206=:,LMNA:NM_001282625.1:synonymous_variant:LOW:exon8/13:c.861T>C:p.Ala287=:,LMNA:NM_001282626.2:synonymous_variant:LOW:exon5/12:c.861T>C:p.Ala287=:,LMNA:NM_005572.3:synonymous_variant:LOW:exon5/10:c.861T>C:p.Ala287=:,LMNA:NM_170707.4:synonymous_variant:LOW:exon5/12:c.861T>C:p.Ala287=:,LMNA:NM_170708.3:synonymous_variant:LOW:exon5/11:c.861T>C:p.Ala287=:	regulatory_region_variant:promoter_flanking_region	150330 [GENE=LMNA PHENOS=Muscular dystrophy,congenital,613205,Autosomal dominant/Lipodystrophy,familial partial,type 2,151660,Autosomal dominant/Charcot-Marie-Tooth disease,type 2B1,605588,Autosomal recessive/Cardiomyopathy,dilated,1A,115200,Autosomal dominant/Heart-hand syndrome,Slovenian type,610140,Autosomal dominant/Hutchinson-Gilford progeria,176670,Autosomal recessive,Autosomal dominant/Restrictive dermopathy,lethal,275210,Autosomal recessive/Mandibuloacral dysplasia,248370,Autosomal recessive/Emery-Dreifuss muscular dystrophy 2,autosomal dominant,181350,Autosomal dominant/Emery-Dreifuss muscular dystrophy 3,autosomal recessive,616516,Autosomal recessive/Malouf syndrome,212112,Autosomal dominant];	48088 [benign DISEASE=Cardiomyopathy,Dilated cardiomyopathy 1A,Familial partial lipodystrophy 2,Hutchinson-Gilford syndrome,Mandibuloacral dysplasia with type A lipodystrophy,Lethal tight skin contracture syndrome,Charcot-Marie-Tooth disease type 2B1,Congenital muscular dystrophy, LMNA-related,Charcot-Marie-Tooth disease,Emery-Dreifuss muscular dystrophy,Charcot-Marie-Tooth disease, type 2,Emery-Dreifuss muscular dystrophy 2, autosomal dominant,not specified,Cardiovascular phenotype,Lipoatrophy with Diabetes, Hepatic Steatosis, Hypertrophic Cardiomyopathy, and Leukomelanodermic Papules,Limb-Girdle Muscular Dystrophy, Recessive,not provided];			rs538089	0.1931	0.1720	923,.	0.4582,0.0653,0.0191,0.0722,0.1383	-7.5170			0.04,0.13	9.54					0.0844	0.8512	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LMNA (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.07)
chr1	156105928	156105928	G	A	wt	wt	het	off-target	QUAL=3073;DP=90,311,261;AF=0.01,0.00,0.49;MQM=60;SAP=14;ABP=3	LMNA	intron	LMNA:ENST00000347559.2:intron_variant:MODIFIER:intron6/10:c.1157+16G>A::,LMNA:ENST00000361308.4:intron_variant:MODIFIER:intron6/9:c.1157+16G>A::,LMNA:ENST00000368297.1:intron_variant:MODIFIER:intron7/10:c.914+16G>A::,LMNA:ENST00000368299.3:intron_variant:MODIFIER:intron6/11:c.1157+16G>A::,LMNA:ENST00000368300.4:intron_variant:MODIFIER:intron6/11:c.1157+16G>A::,LMNA:ENST00000368301.2:intron_variant:MODIFIER:intron9/12:c.1157+16G>A::,LMNA:ENST00000392353.3:intron_variant:MODIFIER:intron6/9:c.914+16G>A::,LMNA:ENST00000448611.2:intron_variant:MODIFIER:intron6/12:c.821+16G>A::,LMNA:ENST00000473598.2:intron_variant:MODIFIER:intron7/12:c.860+16G>A::	LMNA:NM_001257374.3:intron_variant:MODIFIER:intron6/12:c.821+16G>A::,LMNA:NM_001282624.1:intron_variant:MODIFIER:intron7/10:c.914+16G>A::,LMNA:NM_001282625.1:intron_variant:MODIFIER:intron9/12:c.1157+16G>A::,LMNA:NM_001282626.2:intron_variant:MODIFIER:intron6/11:c.1157+16G>A::,LMNA:NM_005572.3:intron_variant:MODIFIER:intron6/9:c.1157+16G>A::,LMNA:NM_170707.4:intron_variant:MODIFIER:intron6/11:c.1157+16G>A::,LMNA:NM_170708.3:intron_variant:MODIFIER:intron6/10:c.1157+16G>A::	regulatory_region_variant:promoter_flanking_region	150330 [GENE=LMNA PHENOS=Muscular dystrophy,congenital,613205,Autosomal dominant/Lipodystrophy,familial partial,type 2,151660,Autosomal dominant/Charcot-Marie-Tooth disease,type 2B1,605588,Autosomal recessive/Cardiomyopathy,dilated,1A,115200,Autosomal dominant/Heart-hand syndrome,Slovenian type,610140,Autosomal dominant/Hutchinson-Gilford progeria,176670,Autosomal recessive,Autosomal dominant/Restrictive dermopathy,lethal,275210,Autosomal recessive/Mandibuloacral dysplasia,248370,Autosomal recessive/Emery-Dreifuss muscular dystrophy 2,autosomal dominant,181350,Autosomal dominant/Emery-Dreifuss muscular dystrophy 3,autosomal recessive,616516,Autosomal recessive/Malouf syndrome,212112,Autosomal dominant];	36474 [benign/likely benign DISEASE=Primary dilated cardiomyopathy,Charcot-Marie-Tooth disease,not specified,not provided];			rs534807	0.1923	0.1712	919,.	0.4589,0.0650,0.0191,0.0713,0.1322	-0.1280			0.23,0.23	1.73					0.0761	0.8489	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LMNA (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.07)
chr1	156106185	156106185	T	C	wt	wt	het		QUAL=1107;DP=44,140,108;AF=0.00,0.00,0.46;MQM=60;SAP=14;ABP=4	LMNA	synonymous	LMNA:ENST00000347559.2:synonymous_variant:LOW:exon7/11:c.1338T>C:p.Asp446=:PF00932 [Lamin Tail Domain],LMNA:ENST00000361308.4:synonymous_variant:LOW:exon7/10:c.1338T>C:p.Asp446=:PF00932 [Lamin Tail Domain],LMNA:ENST00000368297.1:synonymous_variant:LOW:exon8/11:c.1095T>C:p.Asp365=:PF00932 [Lamin Tail Domain],LMNA:ENST00000368299.3:synonymous_variant:LOW:exon7/12:c.1338T>C:p.Asp446=:PF00932 [Lamin Tail Domain],LMNA:ENST00000368300.4:synonymous_variant:LOW:exon7/12:c.1338T>C:p.Asp446=:PF00932 [Lamin Tail Domain],LMNA:ENST00000368301.2:synonymous_variant:LOW:exon10/13:c.1338T>C:p.Asp446=:PF00932 [Lamin Tail Domain],LMNA:ENST00000392353.3:synonymous_variant:LOW:exon7/10:c.1095T>C:p.Asp365=:PF00932 [Lamin Tail Domain],LMNA:ENST00000448611.2:synonymous_variant:LOW:exon7/13:c.1002T>C:p.Asp334=:PF00932 [Lamin Tail Domain],LMNA:ENST00000473598.2:synonymous_variant:LOW:exon8/13:c.1041T>C:p.Asp347=:PF00932 [Lamin Tail Domain]	LMNA:NM_001257374.3:synonymous_variant:LOW:exon7/13:c.1002T>C:p.Asp334=:,LMNA:NM_001282624.1:synonymous_variant:LOW:exon8/11:c.1095T>C:p.Asp365=:,LMNA:NM_001282625.1:synonymous_variant:LOW:exon10/13:c.1338T>C:p.Asp446=:,LMNA:NM_001282626.2:synonymous_variant:LOW:exon7/12:c.1338T>C:p.Asp446=:,LMNA:NM_005572.3:synonymous_variant:LOW:exon7/10:c.1338T>C:p.Asp446=:,LMNA:NM_170707.4:synonymous_variant:LOW:exon7/12:c.1338T>C:p.Asp446=:,LMNA:NM_170708.3:synonymous_variant:LOW:exon7/11:c.1338T>C:p.Asp446=:	regulatory_region_variant:promoter_flanking_region	150330 [GENE=LMNA PHENOS=Muscular dystrophy,congenital,613205,Autosomal dominant/Lipodystrophy,familial partial,type 2,151660,Autosomal dominant/Charcot-Marie-Tooth disease,type 2B1,605588,Autosomal recessive/Cardiomyopathy,dilated,1A,115200,Autosomal dominant/Heart-hand syndrome,Slovenian type,610140,Autosomal dominant/Hutchinson-Gilford progeria,176670,Autosomal recessive,Autosomal dominant/Restrictive dermopathy,lethal,275210,Autosomal recessive/Mandibuloacral dysplasia,248370,Autosomal recessive/Emery-Dreifuss muscular dystrophy 2,autosomal dominant,181350,Autosomal dominant/Emery-Dreifuss muscular dystrophy 3,autosomal recessive,616516,Autosomal recessive/Malouf syndrome,212112,Autosomal dominant];	48037 [benign DISEASE=Cardiomyopathy,Dilated cardiomyopathy 1A,Familial partial lipodystrophy 2,Hutchinson-Gilford syndrome,Mandibuloacral dysplasia with type A lipodystrophy,Lethal tight skin contracture syndrome,Charcot-Marie-Tooth disease type 2B1,Congenital muscular dystrophy, LMNA-related,Charcot-Marie-Tooth disease,Emery-Dreifuss muscular dystrophy,Charcot-Marie-Tooth disease, type 2,Emery-Dreifuss muscular dystrophy 2, autosomal dominant,not specified,Cardiovascular phenotype,Lipoatrophy with Diabetes, Hepatic Steatosis, Hypertrophic Cardiomyopathy, and Leukomelanodermic Papules,Limb-Girdle Muscular Dystrophy, Recessive,not provided];			rs505058	0.2492	0.2239	1805,.	0.6399,0.0747,0.0198,0.0734,0.1436	-0.3620			0.17,0.86	10.71					0.0736	0.8586	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LMNA (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.07)
chr1	156106863	156106863	C	T	wt	wt	het	off-target	QUAL=2835;DP=180,371,240;AF=0.00,0.00,0.53;MQM=60;SAP=31;ABP=5	LMNA	intron	LMNA:ENST00000347559.2:intron_variant:MODIFIER:intron8/10:c.1489-41C>T::,LMNA:ENST00000361308.4:intron_variant:MODIFIER:intron8/9:c.1489-41C>T::,LMNA:ENST00000368297.1:intron_variant:MODIFIER:intron9/10:c.1246-41C>T::,LMNA:ENST00000368299.3:intron_variant:MODIFIER:intron8/11:c.1489-41C>T::,LMNA:ENST00000368300.4:intron_variant:MODIFIER:intron8/11:c.1489-41C>T::,LMNA:ENST00000368301.2:intron_variant:MODIFIER:intron11/12:c.1489-41C>T::,LMNA:ENST00000392353.3:intron_variant:MODIFIER:intron8/9:c.1246-41C>T::,LMNA:ENST00000448611.2:intron_variant:MODIFIER:intron8/12:c.1153-41C>T::,LMNA:ENST00000473598.2:intron_variant:MODIFIER:intron9/12:c.1192-41C>T::	LMNA:NM_001257374.3:intron_variant:MODIFIER:intron8/12:c.1153-41C>T::,LMNA:NM_001282624.1:intron_variant:MODIFIER:intron9/10:c.1246-41C>T::,LMNA:NM_001282625.1:intron_variant:MODIFIER:intron11/12:c.1489-41C>T::,LMNA:NM_001282626.2:intron_variant:MODIFIER:intron8/11:c.1489-41C>T::,LMNA:NM_005572.3:intron_variant:MODIFIER:intron8/9:c.1489-41C>T::,LMNA:NM_170707.4:intron_variant:MODIFIER:intron8/11:c.1489-41C>T::,LMNA:NM_170708.3:intron_variant:MODIFIER:intron8/10:c.1489-41C>T::	regulatory_region_variant:promoter_flanking_region	150330 [GENE=LMNA PHENOS=Muscular dystrophy,congenital,613205,Autosomal dominant/Lipodystrophy,familial partial,type 2,151660,Autosomal dominant/Charcot-Marie-Tooth disease,type 2B1,605588,Autosomal recessive/Cardiomyopathy,dilated,1A,115200,Autosomal dominant/Heart-hand syndrome,Slovenian type,610140,Autosomal dominant/Hutchinson-Gilford progeria,176670,Autosomal recessive,Autosomal dominant/Restrictive dermopathy,lethal,275210,Autosomal recessive/Mandibuloacral dysplasia,248370,Autosomal recessive/Emery-Dreifuss muscular dystrophy 2,autosomal dominant,181350,Autosomal dominant/Emery-Dreifuss muscular dystrophy 3,autosomal recessive,616516,Autosomal recessive/Malouf syndrome,212112,Autosomal dominant];	66834 [benign DISEASE=not specified,not provided];			rs553016	0.1823	0.1637	809,.	0.4276,0.0634,0.0192,0.0716,0.1376	0.3060			0.22,0.27	3.03					0.2528	0.8579	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LMNA (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.07)
chr1	156107534	156107534	C	T	het	het	wt		QUAL=6847;DP=148,346,262;AF=0.61,0.54,0.00;MQM=60;SAP=29;ABP=20	LMNA	intron,synonymous,splice_region&synonymous	LMNA:ENST00000347559.2:intron_variant:MODIFIER:intron9/10:c.1608+511C>T::,LMNA:ENST00000361308.4:synonymous_variant:LOW:exon10/10:c.1698C>T:p.His566=:,LMNA:ENST00000368297.1:synonymous_variant:LOW:exon11/11:c.1455C>T:p.His485=:,LMNA:ENST00000368299.3:splice_region_variant&synonymous_variant:LOW:exon10/12:c.1698C>T:p.His566=:,LMNA:ENST00000368300.4:splice_region_variant&synonymous_variant:LOW:exon10/12:c.1698C>T:p.His566=:,LMNA:ENST00000368301.2:synonymous_variant:LOW:exon13/13:c.1698C>T:p.His566=:,LMNA:ENST00000392353.3:synonymous_variant:LOW:exon10/10:c.1455C>T:p.His485=:,LMNA:ENST00000448611.2:splice_region_variant&synonymous_variant:LOW:exon10/13:c.1362C>T:p.His454=:,LMNA:ENST00000473598.2:splice_region_variant&synonymous_variant:LOW:exon11/13:c.1401C>T:p.His467=:	LMNA:NM_001257374.3:splice_region_variant&synonymous_variant:LOW:exon10/13:c.1362C>T:p.His454=:,LMNA:NM_001282624.1:synonymous_variant:LOW:exon11/11:c.1455C>T:p.His485=:,LMNA:NM_001282625.1:synonymous_variant:LOW:exon13/13:c.1698C>T:p.His566=:,LMNA:NM_001282626.2:splice_region_variant&synonymous_variant:LOW:exon10/12:c.1698C>T:p.His566=:,LMNA:NM_005572.3:synonymous_variant:LOW:exon10/10:c.1698C>T:p.His566=:,LMNA:NM_170707.4:splice_region_variant&synonymous_variant:LOW:exon10/12:c.1698C>T:p.His566=:,LMNA:NM_170708.3:intron_variant:MODIFIER:intron9/10:c.1608+511C>T::	regulatory_region_variant:promoter_flanking_region,TF_binding_site_variant	150330 [GENE=LMNA PHENOS=Muscular dystrophy,congenital,613205,Autosomal dominant/Lipodystrophy,familial partial,type 2,151660,Autosomal dominant/Charcot-Marie-Tooth disease,type 2B1,605588,Autosomal recessive/Cardiomyopathy,dilated,1A,115200,Autosomal dominant/Heart-hand syndrome,Slovenian type,610140,Autosomal dominant/Hutchinson-Gilford progeria,176670,Autosomal recessive,Autosomal dominant/Restrictive dermopathy,lethal,275210,Autosomal recessive/Mandibuloacral dysplasia,248370,Autosomal recessive/Emery-Dreifuss muscular dystrophy 2,autosomal dominant,181350,Autosomal dominant/Emery-Dreifuss muscular dystrophy 3,autosomal recessive,616516,Autosomal recessive/Malouf syndrome,212112,Autosomal dominant];	48048 [benign DISEASE=Cardiomyopathy,Dilated cardiomyopathy 1A,Familial partial lipodystrophy 2,Hutchinson-Gilford syndrome,Mandibuloacral dysplasia with type A lipodystrophy,Lethal tight skin contracture syndrome,Charcot-Marie-Tooth disease type 2B1,Congenital muscular dystrophy, LMNA-related,Charcot-Marie-Tooth disease,Emery-Dreifuss muscular dystrophy,Charcot-Marie-Tooth disease, type 2,Emery-Dreifuss muscular dystrophy 2, autosomal dominant,not specified,Cardiovascular phenotype,Lipoatrophy with Diabetes, Hepatic Steatosis, Hypertrophic Cardiomyopathy, and Leukomelanodermic Papules,Limb-Girdle Muscular Dystrophy, Recessive,not provided];	CM003892 [CLASS=DP MUT=ALT PHEN="Metabolic syndrome association with" GENE=LMNA];		rs4641	0.2202	0.2627	710,.	0.0906,0.3237,0.2650,0.2651,0.2933	-1.2430			0.31,0.89	10.69		9.30>7.83			-0.8195	0.9214	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LMNA (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.07)
chr1	156108976	156108976	G	C	wt	wt	het		QUAL=36;DP=68,15,7;AF=0.00,0.00,0.57;MQM=60;SAP=5;ABP=3	LMNA	3'UTR,intron	LMNA:ENST00000347559.2:3_prime_UTR_variant:MODIFIER:exon11/11:c.*79G>C::,LMNA:ENST00000368299.3:3_prime_UTR_variant:MODIFIER:exon12/12:c.*79G>C::,LMNA:ENST00000368300.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*79G>C::,LMNA:ENST00000448611.2:intron_variant:MODIFIER:intron12/12:c.1655+83G>C::,LMNA:ENST00000473598.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*79G>C::	LMNA:NM_001257374.3:intron_variant:MODIFIER:intron12/12:c.1655+83G>C::,LMNA:NM_001282626.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*79G>C::,LMNA:NM_170707.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*79G>C::,LMNA:NM_170708.3:3_prime_UTR_variant:MODIFIER:exon11/11:c.*79G>C::	regulatory_region_variant:promoter_flanking_region	150330 [GENE=LMNA PHENOS=Muscular dystrophy,congenital,613205,Autosomal dominant/Lipodystrophy,familial partial,type 2,151660,Autosomal dominant/Charcot-Marie-Tooth disease,type 2B1,605588,Autosomal recessive/Cardiomyopathy,dilated,1A,115200,Autosomal dominant/Heart-hand syndrome,Slovenian type,610140,Autosomal dominant/Hutchinson-Gilford progeria,176670,Autosomal recessive,Autosomal dominant/Restrictive dermopathy,lethal,275210,Autosomal recessive/Mandibuloacral dysplasia,248370,Autosomal recessive/Emery-Dreifuss muscular dystrophy 2,autosomal dominant,181350,Autosomal dominant/Emery-Dreifuss muscular dystrophy 3,autosomal recessive,616516,Autosomal recessive/Malouf syndrome,212112,Autosomal dominant];	66756 [not provided DISEASE=not provided];			rs7339	0.1853	0.1661	831,.		-0.0730			0.01,0.12	8.63					-0.0457	0.871	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LMNA (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.07)
chr1	156109094	156109094	-	A	wt	wt	het		QUAL=46;DP=69,51,34;AF=0.00,0.04,0.24;MQM=60;SAP=6;ABP=24	LMNA	3'UTR,intron	LMNA:ENST00000347559.2:3_prime_UTR_variant:MODIFIER:exon11/11:c.*211dup::,LMNA:ENST00000368299.3:3_prime_UTR_variant:MODIFIER:exon12/12:c.*211dup::,LMNA:ENST00000368300.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*211dup::,LMNA:ENST00000448611.2:intron_variant:MODIFIER:intron12/12:c.1655+215dup::	LMNA:NM_001257374.3:intron_variant:MODIFIER:intron12/12:c.1655+215dup::,LMNA:NM_001282626.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*211dup::,LMNA:NM_170707.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*211dup::,LMNA:NM_170708.3:3_prime_UTR_variant:MODIFIER:exon11/11:c.*211dup::		150330 [GENE=LMNA PHENOS=Muscular dystrophy,congenital,613205,Autosomal dominant/Lipodystrophy,familial partial,type 2,151660,Autosomal dominant/Charcot-Marie-Tooth disease,type 2B1,605588,Autosomal recessive/Cardiomyopathy,dilated,1A,115200,Autosomal dominant/Heart-hand syndrome,Slovenian type,610140,Autosomal dominant/Hutchinson-Gilford progeria,176670,Autosomal recessive,Autosomal dominant/Restrictive dermopathy,lethal,275210,Autosomal recessive/Mandibuloacral dysplasia,248370,Autosomal recessive/Emery-Dreifuss muscular dystrophy 2,autosomal dominant,181350,Autosomal dominant/Emery-Dreifuss muscular dystrophy 3,autosomal recessive,616516,Autosomal recessive/Malouf syndrome,212112,Autosomal dominant];				rs200317083		0.1370	281,.						14.77					-0.1217	0.9358	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LMNA (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.07)
chr1	156785617	156785617	G	A	hom	hom	hom		QUAL=22354;DP=196,298,210;AF=1.00,1.00,1.00;MQM=60;SAP=54;ABP=0	SH2D2A,NTRK1	intron,5'UTR	SH2D2A:ENST00000368198.3:intron_variant:MODIFIER:intron2/8:c.69+181C>T::,SH2D2A:ENST00000368199.3:intron_variant:MODIFIER:intron2/8:c.123+181C>T::,NTRK1:ENST00000392302.2:5_prime_UTR_variant:MODIFIER:exon1/17:c.-5G>A::,SH2D2A:ENST00000392306.2:intron_variant:MODIFIER:intron2/8:c.123+181C>T::	NTRK1:NM_001007792.1:5_prime_UTR_variant:MODIFIER:exon1/17:c.-5G>A::,SH2D2A:NM_001161441.1:intron_variant:MODIFIER:intron2/8:c.123+181C>T::,SH2D2A:NM_001161442.2:intron_variant:MODIFIER:intron2/8:c.69+181C>T::,SH2D2A:NM_001161443.2:intron_variant:MODIFIER:intron1/7:c.39+181C>T::,SH2D2A:NM_001161444.2:intron_variant:MODIFIER:intron2/7:c.123+181C>T::,SH2D2A:NM_003975.4:intron_variant:MODIFIER:intron2/8:c.123+181C>T::	regulatory_region_variant:promoter	191315 [GENE=NTRK1 PHENOS=Insensitivity to pain,congenital,with anhidrosis,256800,Autosomal recessive];	380853 [benign DISEASE=not specified];			rs1800601		0.6740	6230,.	0.4989,0.6951,0.8177,0.6775,0.6549	-1.8140			0.00,0.07	1.98					-0.0897	0.4513	0.04	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SH2D2A (inh=n/a oe_syn=0.86 oe_mis=0.91 oe_lof=0.68), NTRK1 (inh=AR+AD oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	156845492	156845492	-	GT	wt	het	wt	off-target;low_conf_region	QUAL=932;DP=16,44,39;AF=0.06,0.00,0.56;MQM=60;SAP=15;ABP=82	NTRK1	intron	NTRK1:ENST00000358660.3:intron_variant:MODIFIER:intron11/15:c.1483+69_1483+70dup::,NTRK1:ENST00000368196.3:intron_variant:MODIFIER:intron11/15:c.1483+69_1483+70dup::,NTRK1:ENST00000392302.2:intron_variant:MODIFIER:intron12/16:c.1393+69_1393+70dup::,NTRK1:ENST00000524377.1:intron_variant:MODIFIER:intron12/16:c.1501+69_1501+70dup::	NTRK1:NM_001007792.1:intron_variant:MODIFIER:intron12/16:c.1393+69_1393+70dup::,NTRK1:NM_001012331.1:intron_variant:MODIFIER:intron11/15:c.1483+69_1483+70dup::,NTRK1:NM_002529.3:intron_variant:MODIFIER:intron12/16:c.1501+69_1501+70dup::		191315 [GENE=NTRK1 PHENOS=Insensitivity to pain,congenital,with anhidrosis,256800,Autosomal recessive];			(GT)n (Simple_repeat)	rs56185968		0.1037	304,.						4.90					0.0866	0.8415	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NTRK1 (inh=AR+AD oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	156845492	156845492	-	GTGT	wt	het	wt	off-target;low_conf_region	QUAL=932;DP=16,44,39;AF=0.06,0.00,0.56;MQM=60;SAP=24;ABP=3	NTRK1	intron	NTRK1:ENST00000358660.3:intron_variant:MODIFIER:intron11/15:c.1483+67_1483+70dup::,NTRK1:ENST00000368196.3:intron_variant:MODIFIER:intron11/15:c.1483+67_1483+70dup::,NTRK1:ENST00000392302.2:intron_variant:MODIFIER:intron12/16:c.1393+67_1393+70dup::,NTRK1:ENST00000524377.1:intron_variant:MODIFIER:intron12/16:c.1501+67_1501+70dup::	NTRK1:NM_001007792.1:intron_variant:MODIFIER:intron12/16:c.1393+67_1393+70dup::,NTRK1:NM_001012331.1:intron_variant:MODIFIER:intron11/15:c.1483+67_1483+70dup::,NTRK1:NM_002529.3:intron_variant:MODIFIER:intron12/16:c.1501+67_1501+70dup::		191315 [GENE=NTRK1 PHENOS=Insensitivity to pain,congenital,with anhidrosis,256800,Autosomal recessive];			(GT)n (Simple_repeat)	rs56185968		0.4936	3529,.						4.77					-0.0516	0.8423	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NTRK1 (inh=AR+AD oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	156845493	156845494	GT	-	wt	wt	het	off-target;low_conf_region	QUAL=932;DP=16,44,39;AF=0.06,0.30,0.03;MQM=60;SAP=24;ABP=4	NTRK1	intron	NTRK1:ENST00000358660.3:intron_variant:MODIFIER:intron11/15:c.1483+69_1483+70del::,NTRK1:ENST00000368196.3:intron_variant:MODIFIER:intron11/15:c.1483+69_1483+70del::,NTRK1:ENST00000392302.2:intron_variant:MODIFIER:intron12/16:c.1393+69_1393+70del::,NTRK1:ENST00000524377.1:intron_variant:MODIFIER:intron12/16:c.1501+69_1501+70del::	NTRK1:NM_001007792.1:intron_variant:MODIFIER:intron12/16:c.1393+69_1393+70del::,NTRK1:NM_001012331.1:intron_variant:MODIFIER:intron11/15:c.1483+69_1483+70del::,NTRK1:NM_002529.3:intron_variant:MODIFIER:intron12/16:c.1501+69_1501+70del::		191315 [GENE=NTRK1 PHENOS=Insensitivity to pain,congenital,with anhidrosis,256800,Autosomal recessive];			(GT)n (Simple_repeat)	rs56185968		0.1493	323,.		1.6560				5.20					-0.0953	0.8425	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NTRK1 (inh=AR+AD oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	156846233	156846233	G	A	het	wt	hom		QUAL=6451;DP=147,146,147;AF=0.51,0.00,1.00;MQM=60;SAP=51;ABP=3	NTRK1	synonymous	NTRK1:ENST00000358660.3:synonymous_variant:LOW:exon13/16:c.1665G>A:p.Gln555=:PF07714 [Protein tyrosine kinase],NTRK1:ENST00000368196.3:synonymous_variant:LOW:exon13/16:c.1656G>A:p.Gln552=:PF07714 [Protein tyrosine kinase],NTRK1:ENST00000392302.2:synonymous_variant:LOW:exon14/17:c.1566G>A:p.Gln522=:PF07714 [Protein tyrosine kinase],NTRK1:ENST00000524377.1:synonymous_variant:LOW:exon14/17:c.1674G>A:p.Gln558=:PF07714 [Protein tyrosine kinase]	NTRK1:NM_001007792.1:synonymous_variant:LOW:exon14/17:c.1566G>A:p.Gln522=:,NTRK1:NM_001012331.1:synonymous_variant:LOW:exon13/16:c.1656G>A:p.Gln552=:,NTRK1:NM_002529.3:synonymous_variant:LOW:exon14/17:c.1674G>A:p.Gln558=:	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	191315 [GENE=NTRK1 PHENOS=Insensitivity to pain,congenital,with anhidrosis,256800,Autosomal recessive];	292889 [benign DISEASE=Hereditary insensitivity to pain with anhidrosis,not specified];			rs6334	0.2129	0.2203	610,.	0.1314,0.2163,0.3494,0.2144,0.2352	0.2840			0.84,0.91	10.65					0.0241	0.3716	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NTRK1 (inh=AR+AD oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	156848995	156848995	C	T	het	hom	wt		QUAL=3877;DP=48,128,104;AF=0.33,0.97,0.01;MQM=60;SAP=11;ABP=15	NTRK1	synonymous	NTRK1:ENST00000358660.3:synonymous_variant:LOW:exon14/16:c.1878C>T:p.Ala626=:PF07714 [Protein tyrosine kinase],NTRK1:ENST00000368196.3:synonymous_variant:LOW:exon14/16:c.1869C>T:p.Ala623=:PF07714 [Protein tyrosine kinase],NTRK1:ENST00000392302.2:synonymous_variant:LOW:exon15/17:c.1779C>T:p.Ala593=:PF07714 [Protein tyrosine kinase],NTRK1:ENST00000524377.1:synonymous_variant:LOW:exon15/17:c.1887C>T:p.Ala629=:PF07714 [Protein tyrosine kinase]	NTRK1:NM_001007792.1:synonymous_variant:LOW:exon15/17:c.1779C>T:p.Ala593=:,NTRK1:NM_001012331.1:synonymous_variant:LOW:exon14/16:c.1869C>T:p.Ala623=:,NTRK1:NM_002529.3:synonymous_variant:LOW:exon15/17:c.1887C>T:p.Ala629=:		191315 [GENE=NTRK1 PHENOS=Insensitivity to pain,congenital,with anhidrosis,256800,Autosomal recessive];	138564 [benign DISEASE=Hereditary insensitivity to pain with anhidrosis,not specified];			rs6337	0.3341	0.5779	5628,.	0.1981,0.5752,0.0396,0.7242,0.3929	-4.5650			0.07,0.92	7.51					-0.0304	0.3695	0.04	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NTRK1 (inh=AR+AD oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	160009121	160009121	A	C	het	wt	het		QUAL=3010;DP=171,80,68;AF=0.50,0.00,0.46;MQM=60;SAP=7;ABP=3	KCNJ10	3'UTR	KCNJ10:ENST00000368089.3:3_prime_UTR_variant:MODIFIER:exon2/2:c.*2062T>G::	KCNJ10:NM_002241.5:3_prime_UTR_variant:MODIFIER:exon2/2:c.*2062T>G::		602208 [GENE=KCNJ10 PHENOS=Enlarged vestibular aqueduct,digenic,600791,Autosomal recessive/SESAME syndrome,612780,Autosomal recessive];	293090 [benign DISEASE=Deafness, autosomal recessive 4, with enlarged vestibular aqueduct,EAST syndrome];			rs1053074	0.4810	0.4435	3285,.		1.4870			0.77,0.94	8.05					0.006	0.9391	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCNJ10 (inh=AR oe_syn=1.02 oe_mis=0.72 oe_lof=0.29)
chr1	160009143	160009143	G	C	hom	hom	hom		QUAL=8475;DP=141,69,59;AF=1.00,1.00,0.97;MQM=60;SAP=24;ABP=0	KCNJ10	3'UTR	KCNJ10:ENST00000368089.3:3_prime_UTR_variant:MODIFIER:exon2/2:c.*2040C>G::	KCNJ10:NM_002241.5:3_prime_UTR_variant:MODIFIER:exon2/2:c.*2040C>G::		602208 [GENE=KCNJ10 PHENOS=Enlarged vestibular aqueduct,digenic,600791,Autosomal recessive/SESAME syndrome,612780,Autosomal recessive];	293091 [benign DISEASE=Deafness, autosomal recessive 4, with enlarged vestibular aqueduct,EAST syndrome];			rs2486254		0.9973	15459,.		0.2730			0.00,0.12	2.56					0.0013	0.939	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCNJ10 (inh=AR oe_syn=1.02 oe_mis=0.72 oe_lof=0.29)
chr1	160009164	160009165	AC	-	wt	het	wt		QUAL=983;DP=13,41,37;AF=0.23,0.07,0.46;MQM=60;SAP=6;ABP=13	KCNJ10	3'UTR	KCNJ10:ENST00000368089.3:3_prime_UTR_variant:MODIFIER:exon2/2:c.*2018_*2019del::	KCNJ10:NM_002241.5:3_prime_UTR_variant:MODIFIER:exon2/2:c.*2018_*2019del::		602208 [GENE=KCNJ10 PHENOS=Enlarged vestibular aqueduct,digenic,600791,Autosomal recessive/SESAME syndrome,612780,Autosomal recessive];	293094 [uncertain significance DISEASE=Pendred syndrome,Seizures, Sensorineural Deafness, Ataxia, Intellectual Disability, and Electrolyte Imbalance Syndrome,Nonsyndromic Hearing Loss, Mixed];		(AC)n (Simple_repeat)	rs56656397		0.1185	190,.		-0.0330				0.97					0.0026	0.9391	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCNJ10 (inh=AR oe_syn=1.02 oe_mis=0.72 oe_lof=0.29)
chr1	160009164	160009167	ACAC	-	wt	wt	het		QUAL=983;DP=13,41,37;AF=0.23,0.07,0.46;MQM=60;SAP=6;ABP=39	KCNJ10	3'UTR	KCNJ10:ENST00000368089.3:3_prime_UTR_variant:MODIFIER:exon2/2:c.*2016_*2019del::	KCNJ10:NM_002241.5:3_prime_UTR_variant:MODIFIER:exon2/2:c.*2016_*2019del::		602208 [GENE=KCNJ10 PHENOS=Enlarged vestibular aqueduct,digenic,600791,Autosomal recessive/SESAME syndrome,612780,Autosomal recessive];	293095 [likely benign DISEASE=Pendred syndrome,Seizures, Sensorineural Deafness, Ataxia, Intellectual Disability, and Electrolyte Imbalance Syndrome,Nonsyndromic Hearing Loss, Mixed];		(AC)n (Simple_repeat)	rs56656397		0.1638	381,.		-0.0330				0.95					0.0046	0.9391	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCNJ10 (inh=AR oe_syn=1.02 oe_mis=0.72 oe_lof=0.29)
chr1	160009164	160009169	ACACAC	-	het	wt	het		QUAL=983;DP=13,41,37;AF=0.23,0.07,0.46;MQM=60;SAP=4;ABP=51	KCNJ10	3'UTR	KCNJ10:ENST00000368089.3:3_prime_UTR_variant:MODIFIER:exon2/2:c.*2014_*2019del::	KCNJ10:NM_002241.5:3_prime_UTR_variant:MODIFIER:exon2/2:c.*2014_*2019del::		602208 [GENE=KCNJ10 PHENOS=Enlarged vestibular aqueduct,digenic,600791,Autosomal recessive/SESAME syndrome,612780,Autosomal recessive];	293097 [uncertain significance DISEASE=Pendred syndrome,Seizures, Sensorineural Deafness, Ataxia, Intellectual Disability, and Electrolyte Imbalance Syndrome,Nonsyndromic Hearing Loss, Mixed];		(AC)n (Simple_repeat)	rs56656397		0.0968	156,.		-0.0330				0.97					0.0066	0.9391	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCNJ10 (inh=AR oe_syn=1.02 oe_mis=0.72 oe_lof=0.29)
chr1	160009419	160009419	A	C	hom	hom	hom		QUAL=31885;DP=366,345,263;AF=1.00,1.00,1.00;MQM=60;SAP=37;ABP=0	KCNJ10	3'UTR	KCNJ10:ENST00000368089.3:3_prime_UTR_variant:MODIFIER:exon2/2:c.*1764T>G::	KCNJ10:NM_002241.5:3_prime_UTR_variant:MODIFIER:exon2/2:c.*1764T>G::		602208 [GENE=KCNJ10 PHENOS=Enlarged vestibular aqueduct,digenic,600791,Autosomal recessive/SESAME syndrome,612780,Autosomal recessive];	293102 [benign DISEASE=Deafness, autosomal recessive 4, with enlarged vestibular aqueduct,EAST syndrome];			rs2486253		0.8131	10378,.		0.4040			0.12,0.26	10.84					0.0096	0.9391	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCNJ10 (inh=AR oe_syn=1.02 oe_mis=0.72 oe_lof=0.29)
chr1	160010151	160010151	C	T	wt	wt	het		QUAL=2265;DP=333,282,195;AF=0.00,0.00,0.50;MQM=60;SAP=6;ABP=3	KCNJ10	3'UTR	KCNJ10:ENST00000368089.3:3_prime_UTR_variant:MODIFIER:exon2/2:c.*1032G>A::	KCNJ10:NM_002241.5:3_prime_UTR_variant:MODIFIER:exon2/2:c.*1032G>A::		602208 [GENE=KCNJ10 PHENOS=Enlarged vestibular aqueduct,digenic,600791,Autosomal recessive/SESAME syndrome,612780,Autosomal recessive];	874513 [benign/likely benign DISEASE=Deafness, autosomal recessive 4, with enlarged vestibular aqueduct,EAST syndrome];			rs17375748	0.0244	0.0431	31,.		0.1640			0.05,0.19	3.63					-0.0002	0.939	0	1	30	0 / 0					KCNJ10 (inh=AR oe_syn=1.02 oe_mis=0.72 oe_lof=0.29)
chr1	160246990	160246990	T	-	het	het	het		QUAL=1155;DP=291,191,136;AF=0.17,0.16,0.21;MQM=60;SAP=4;ABP=571	PEX19,DCAF8	3'UTR,intron	PEX19:ENST00000368072.5:3_prime_UTR_variant:MODIFIER:exon8/8:c.*2351del::,DCAF8:ENST00000556710.1:intron_variant:MODIFIER:intron6/17:c.436+931del::,DCAF8:ENST00000608310.1:intron_variant:MODIFIER:intron6/17:c.436+931del::	PEX19:NM_001193644.1:3_prime_UTR_variant:MODIFIER:exon8/8:c.*2359del::,PEX19:NM_002857.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*2351del::,PEX19:NR_036492.1:non_coding_transcript_exon_variant:MODIFIER:exon7/7:n.3168del::,PEX19:NR_036493.1:non_coding_transcript_exon_variant:MODIFIER:exon7/7:n.3192del::		615820 [GENE=DCAF8 PHENOS=Giant axonal neuropathy 2,autosomal dominant,610100,Autosomal dominant],600279 [GENE=PEX19 PHENOS=Peroxisome biogenesis disorder 12A (Zellweger),614886,Autosomal recessive];			Charlie10 (DNA/hAT-Charlie)	rs751979135		0.2519	0,.	0.2253,0.2326,0.2514,0.2578,0.2549	-0.2200				1.19					0.0018	0.9523	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DCAF8 (inh=AD oe_syn=0.91 oe_mis=0.63 oe_lof=0.14), PEX19 (inh=AR oe_syn=1.11 oe_mis=1.17 oe_lof=0.52)
chr1	160247185	160247185	G	C	het	hom	wt		QUAL=10234;DP=282,217,165;AF=0.44,1.00,0.01;MQM=60;SAP=11;ABP=11	PEX19,DCAF8	3'UTR,intron	PEX19:ENST00000368072.5:3_prime_UTR_variant:MODIFIER:exon8/8:c.*2156C>G::,DCAF8:ENST00000556710.1:intron_variant:MODIFIER:intron6/17:c.436+736C>G::,DCAF8:ENST00000608310.1:intron_variant:MODIFIER:intron6/17:c.436+736C>G::	PEX19:NM_001193644.1:3_prime_UTR_variant:MODIFIER:exon8/8:c.*2164C>G::,PEX19:NM_002857.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*2156C>G::,PEX19:NR_036492.1:non_coding_transcript_exon_variant:MODIFIER:exon7/7:n.2973C>G::,PEX19:NR_036493.1:non_coding_transcript_exon_variant:MODIFIER:exon7/7:n.2997C>G::		615820 [GENE=DCAF8 PHENOS=Giant axonal neuropathy 2,autosomal dominant,610100,Autosomal dominant],600279 [GENE=PEX19 PHENOS=Peroxisome biogenesis disorder 12A (Zellweger),614886,Autosomal recessive];	293196 [benign DISEASE=Peroxisome biogenesis disorder 12A];		Charlie10 (DNA/hAT-Charlie)	rs10594	0.4523	0.4950	3119,.	0.3382,0.4808,0.3476,0.5072,0.6152	0.4560			0.17,0.16	0.94					-0.1276	0.9524	0.18	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DCAF8 (inh=AD oe_syn=0.91 oe_mis=0.63 oe_lof=0.14), PEX19 (inh=AR oe_syn=1.11 oe_mis=1.17 oe_lof=0.52)
chr1	160251792	160251792	A	G	het	hom	wt	off-target	QUAL=6832;DP=209,148,91;AF=0.44,1.00,0.00;MQM=60;SAP=296;ABP=10	PEX19,DCAF8	intron	PEX19:ENST00000368072.5:intron_variant:MODIFIER:intron5/7:c.594+37T>C::,PEX19:ENST00000440949.3:intron_variant:MODIFIER:intron5/7:c.324+37T>C::,DCAF8:ENST00000556710.1:intron_variant:MODIFIER:intron3/17:c.153+37T>C::,DCAF8:ENST00000608310.1:intron_variant:MODIFIER:intron3/17:c.153+37T>C::	PEX19:NM_001193644.1:intron_variant:MODIFIER:intron5/7:c.594+37T>C::,PEX19:NM_002857.3:intron_variant:MODIFIER:intron5/7:c.594+37T>C::,PEX19:NR_036492.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/6:n.511+37T>C::,PEX19:NR_036493.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/6:n.535+37T>C::		615820 [GENE=DCAF8 PHENOS=Giant axonal neuropathy 2,autosomal dominant,610100,Autosomal dominant],600279 [GENE=PEX19 PHENOS=Peroxisome biogenesis disorder 12A (Zellweger),614886,Autosomal recessive];				rs2795067	0.6703	0.6290	6548,.	0.8687,0.5589,0.4645,0.5555,0.7045	-1.5860			0.01,0.10	2.39					-0.0453	0.3686	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DCAF8 (inh=AD oe_syn=0.91 oe_mis=0.63 oe_lof=0.14), PEX19 (inh=AR oe_syn=1.11 oe_mis=1.17 oe_lof=0.52)
chr1	161140278	161140278	A	-	het	het	wt		QUAL=6406;DP=227,376,326;AF=0.46,0.45,0.00;MQM=60;SAP=82;ABP=12	PPOX	frameshift,intron	PPOX:ENST00000352210.5:frameshift_variant:HIGH:exon10/13:c.1067del:p.Gln356ArgfsTer10:PF01593 [Flavin containing amine oxidoreductase],PPOX:ENST00000367999.4:frameshift_variant:HIGH:exon10/13:c.1067del:p.Gln356ArgfsTer10:PF01593 [Flavin containing amine oxidoreductase],PPOX:ENST00000432542.2:frameshift_variant:HIGH:exon4/6:c.302del:p.Gln101ArgfsTer10:PF01593 [Flavin containing amine oxidoreductase],PPOX:ENST00000535223.1:intron_variant:MODIFIER:intron2/3:c.88-132del::,PPOX:ENST00000544598.1:intron_variant:MODIFIER:intron3/5:c.223-132del::	PPOX:NM_000309.5:frameshift_variant:HIGH:exon10/13:c.1067del:p.Gln356ArgfsTer10:,PPOX:NM_001122764.3:frameshift_variant:HIGH:exon10/13:c.1067del:p.Gln356ArgfsTer10:,PPOX:NM_001350128.2:frameshift_variant:HIGH:exon9/12:c.968del:p.Gln323ArgfsTer10:,PPOX:NM_001350129.2:frameshift_variant:HIGH:exon10/13:c.659del:p.Gln220ArgfsTer10:,PPOX:NM_001350130.2:frameshift_variant:HIGH:exon10/13:c.581del:p.Gln194ArgfsTer10:,PPOX:NM_001350131.2:frameshift_variant:HIGH:exon9/12:c.581del:p.Gln194ArgfsTer10:,PPOX:NM_001365398.1:frameshift_variant:HIGH:exon10/13:c.1067del:p.Gln356ArgfsTer10:,PPOX:NM_001365399.1:intron_variant:MODIFIER:intron9/11:c.988-132del::,PPOX:NM_001365400.1:frameshift_variant:HIGH:exon9/12:c.659del:p.Gln220ArgfsTer10:,PPOX:NM_001365401.1:frameshift_variant:HIGH:exon9/12:c.581del:p.Gln194ArgfsTer10:		600923 [GENE=PPOX PHENOS=Porphyria variegata,176200,Autosomal dominant];									7.3390									0.1105	0.6871	0.12	0	3	0 / 0					USP21 (inh=n/a oe_syn=0.95 oe_mis=0.69 oe_lof=0.31), PPOX (inh=AD oe_syn=1.05 oe_mis=0.83 oe_lof=0.30), B4GALT3 (inh=n/a oe_syn=0.94 oe_mis=0.74 oe_lof=0.34)
chr1	161184059	161184059	-	TG	wt	het	wt	low_conf_region	QUAL=1610;DP=205,212,158;AF=0.02,0.27,0.08;MQM=60;SAP=67;ABP=313	NDUFS2	3'UTR	NDUFS2:ENST00000367993.3:3_prime_UTR_variant:MODIFIER:exon15/15:c.*106_*107dup::,NDUFS2:ENST00000392179.4:3_prime_UTR_variant:MODIFIER:exon13/13:c.*358_*359dup::	NDUFS2:NM_001166159.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*358_*359dup::,NDUFS2:NM_004550.4:3_prime_UTR_variant:MODIFIER:exon15/15:c.*106_*107dup::	regulatory_region_variant:promoter	602985 [GENE=NDUFS2 PHENOS=Mitochondrial complex I deficiency,nuclear type 6,618228,Autosomal recessive];	293284 [uncertain significance DISEASE=Mitochondrial complex I deficiency];		(TG)n (Simple_repeat)	rs10629771		0.2818	1160,.						11.73					-0.0324	0.9624	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NDUFS2 (inh=AR oe_syn=1.16 oe_mis=0.74 oe_lof=0.34), FCER1G (inh=n/a oe_syn=0.85 oe_mis=1.01 oe_lof=0.13)
chr1	161184059	161184059	-	TGTG	wt	wt	het	low_conf_region	QUAL=1610;DP=205,212,158;AF=0.02,0.27,0.08;MQM=60;SAP=42;ABP=450	NDUFS2	3'UTR	NDUFS2:ENST00000367993.3:3_prime_UTR_variant:MODIFIER:exon15/15:c.*104_*107dup::,NDUFS2:ENST00000392179.4:3_prime_UTR_variant:MODIFIER:exon13/13:c.*356_*359dup::	NDUFS2:NM_001166159.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*356_*359dup::,NDUFS2:NM_004550.4:3_prime_UTR_variant:MODIFIER:exon15/15:c.*104_*107dup::	regulatory_region_variant:promoter	602985 [GENE=NDUFS2 PHENOS=Mitochondrial complex I deficiency,nuclear type 6,618228,Autosomal recessive];			(TG)n (Simple_repeat)	rs10629771		0.1273	218,.						11.67					-0.065	0.9623	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NDUFS2 (inh=AR oe_syn=1.16 oe_mis=0.74 oe_lof=0.34), FCER1G (inh=n/a oe_syn=0.85 oe_mis=1.01 oe_lof=0.13)
chr1	161184097	161184097	A	G	wt	het	wt		QUAL=2164;DP=360,251,186;AF=0.00,0.39,0.00;MQM=60;SAP=112;ABP=29	NDUFS2	3'UTR	NDUFS2:ENST00000367993.3:3_prime_UTR_variant:MODIFIER:exon15/15:c.*114A>G::,NDUFS2:ENST00000392179.4:3_prime_UTR_variant:MODIFIER:exon13/13:c.*366A>G::	NDUFS2:NM_001166159.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*366A>G::,NDUFS2:NM_004550.4:3_prime_UTR_variant:MODIFIER:exon15/15:c.*114A>G::	regulatory_region_variant:promoter	602985 [GENE=NDUFS2 PHENOS=Mitochondrial complex I deficiency,nuclear type 6,618228,Autosomal recessive];	293289 [benign DISEASE=Mitochondrial complex I deficiency, nuclear type 1];			rs1136224	0.1821	0.1399	362,.		-0.2700			0.00,0.12	2.64					0.0414	0.9341	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NDUFS2 (inh=AR oe_syn=1.16 oe_mis=0.74 oe_lof=0.34), FCER1G (inh=n/a oe_syn=0.85 oe_mis=1.01 oe_lof=0.13)
chr1	161274648	161274648	G	C	wt	het	het	low_conf_region	QUAL=71;DP=35,33,28;AF=0.00,0.30,0.29;MQM=60;SAP=42;ABP=25	MPZ	3'UTR	MPZ:ENST00000360451.6:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1018C>G::,MPZ:ENST00000491222.2:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1018C>G::,MPZ:ENST00000533357.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1018C>G::	MPZ:NM_000530.8:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1018C>G::,MPZ:NM_001315491.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*826C>G::	regulatory_region_variant:promoter	159440 [GENE=MPZ PHENOS=Charcot-Marie-Tooth disease,type 2J,607736,Autosomal dominant/Charcot-Marie-Tooth disease,type 1B,118200,Autosomal dominant/Dejerine-Sottas disease,145900,Autosomal recessive,Autosomal dominant/Hypomyelinating neuropathy,congenital,2,618184,Autosomal dominant/Charcot-Marie-Tooth disease,dominant intermediate D,607791,Autosomal dominant/Roussy-Levy syndrome,180800,Autosomal dominant/Charcot-Marie-Tooth disease,type 2I,607677,Autosomal dominant];				rs185093979		0.2991	0,.		-0.6030			0.01,0.16	0.95					-0.1966	0.9574	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MPZ (inh=AR+AD oe_syn=0.82 oe_mis=0.77 oe_lof=0.25)
chr1	161274905	161274905	T	C	wt	wt	het		QUAL=172;DP=68,18,29;AF=0.00,0.00,0.38;MQM=60;SAP=3;ABP=7	MPZ	3'UTR	MPZ:ENST00000360451.6:3_prime_UTR_variant:MODIFIER:exon6/6:c.*761A>G::,MPZ:ENST00000491222.2:3_prime_UTR_variant:MODIFIER:exon5/5:c.*761A>G::,MPZ:ENST00000533357.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*761A>G::	MPZ:NM_000530.8:3_prime_UTR_variant:MODIFIER:exon6/6:c.*761A>G::,MPZ:NM_001315491.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*569A>G::	regulatory_region_variant:promoter,TF_binding_site_variant	159440 [GENE=MPZ PHENOS=Charcot-Marie-Tooth disease,type 2J,607736,Autosomal dominant/Charcot-Marie-Tooth disease,type 1B,118200,Autosomal dominant/Dejerine-Sottas disease,145900,Autosomal recessive,Autosomal dominant/Hypomyelinating neuropathy,congenital,2,618184,Autosomal dominant/Charcot-Marie-Tooth disease,dominant intermediate D,607791,Autosomal dominant/Roussy-Levy syndrome,180800,Autosomal dominant/Charcot-Marie-Tooth disease,type 2I,607677,Autosomal dominant];	293304 [benign DISEASE=Charcot-Marie-Tooth disease, demyelinating, type 1b,Roussy-Levy syndrome,Congenital hypomyelinating neuropathy 1, autosomal recessive,Charcot-Marie-Tooth disease dominant intermediate d,Congenital hypomyelinating neuropathy 2];			rs16832786	0.1364	0.1287	314,.		-1.1460			0.02,0.13	2.86					0.0276	0.9592	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MPZ (inh=AR+AD oe_syn=0.82 oe_mis=0.77 oe_lof=0.25)
chr1	167399868	167399868	-	AG	hom	hom	hom		QUAL=15172;DP=188,177,147;AF=0.99,0.99,0.99;MQM=60;SAP=779;ABP=0	CD247,POU2F1	downstream_gene	CD247:ENST00000362089.5:downstream_gene_variant:MODIFIER::::,POU2F1:ENST00000367862.5:downstream_gene_variant:MODIFIER::::,POU2F1:ENST00000367866.2:downstream_gene_variant:MODIFIER::::,CD247:ENST00000392122.3:downstream_gene_variant:MODIFIER::::		regulatory_region_variant:promoter_flanking_region	186780 [GENE=CD247 PHENOS=Immunodeficiency 25,610163,Autosomal recessive];				rs5778549		0.9883	15342,.						1.93								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					POU2F1 (inh=n/a oe_syn=1.01 oe_mis=0.69 oe_lof=0.18), CD247 (inh=AR oe_syn=0.87 oe_mis=1.09 oe_lof=0.39)
chr1	167399962	167399962	T	C	hom	hom	hom		QUAL=39470;DP=381,464,380;AF=1.00,1.00,1.00;MQM=60;SAP=332;ABP=0	CD247	3'UTR	CD247:ENST00000362089.5:3_prime_UTR_variant:MODIFIER:exon8/8:c.*956A>G::,CD247:ENST00000392122.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*956A>G::	CD247:NM_000734.4:3_prime_UTR_variant:MODIFIER:exon8/8:c.*956A>G::,CD247:NM_198053.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*956A>G::	regulatory_region_variant:promoter_flanking_region	186780 [GENE=CD247 PHENOS=Immunodeficiency 25,610163,Autosomal recessive];				rs947480		0.9884	15346,.		-1.3530			0.00,0.12	7.44					0.005	0.9473	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					POU2F1 (inh=n/a oe_syn=1.01 oe_mis=0.69 oe_lof=0.18), CD247 (inh=AR oe_syn=0.87 oe_mis=1.09 oe_lof=0.39)
chr1	167400074	167400074	T	A	hom	hom	hom		QUAL=44497;DP=400,559,433;AF=1.00,1.00,1.00;MQM=60;SAP=14;ABP=0	CD247	3'UTR	CD247:ENST00000362089.5:3_prime_UTR_variant:MODIFIER:exon8/8:c.*844A>T::,CD247:ENST00000392122.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*844A>T::	CD247:NM_000734.4:3_prime_UTR_variant:MODIFIER:exon8/8:c.*844A>T::,CD247:NM_198053.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*844A>T::	regulatory_region_variant:promoter_flanking_region	186780 [GENE=CD247 PHENOS=Immunodeficiency 25,610163,Autosomal recessive];				rs1052231	0.8111	0.8147	10458,.		-0.1760			0.02,0.15	1.13					-0.019	0.947	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					POU2F1 (inh=n/a oe_syn=1.01 oe_mis=0.69 oe_lof=0.18), CD247 (inh=AR oe_syn=0.87 oe_mis=1.09 oe_lof=0.39)
chr1	167408670	167408670	C	T	het	hom	het	off-target	QUAL=11515;DP=75,288,218;AF=0.52,0.99,0.49;MQM=60;SAP=163;ABP=3	CD247	intron	CD247:ENST00000362089.5:intron_variant:MODIFIER:intron2/7:c.163-33G>A::,CD247:ENST00000392122.3:intron_variant:MODIFIER:intron2/7:c.163-33G>A::	CD247:NM_000734.4:intron_variant:MODIFIER:intron2/7:c.163-33G>A::,CD247:NM_198053.2:intron_variant:MODIFIER:intron2/7:c.163-33G>A::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site	186780 [GENE=CD247 PHENOS=Immunodeficiency 25,610163,Autosomal recessive];				rs840016	0.1907	0.3109	1410,.	0.0805,0.2358,0.1048,0.3992,0.2976	0.5230			0.06,0.20	10.19					-0.0473	0.2431	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CD247 (inh=AR oe_syn=0.87 oe_mis=1.09 oe_lof=0.39)
chr1	167487586	167487586	C	G	het	wt	het	off-target	QUAL=1434;DP=49,87,67;AF=0.53,0.00,0.55;MQM=60;SAP=115;ABP=5	CD247	intron	CD247:ENST00000362089.5:intron_variant:MODIFIER:intron1/7:c.58+59G>C::,CD247:ENST00000392122.3:intron_variant:MODIFIER:intron1/7:c.58+59G>C::	CD247:NM_000734.4:intron_variant:MODIFIER:intron1/7:c.58+59G>C::,CD247:NM_198053.2:intron_variant:MODIFIER:intron1/7:c.58+59G>C::	regulatory_region_variant:promoter	186780 [GENE=CD247 PHENOS=Immunodeficiency 25,610163,Autosomal recessive];			(CCACTC)n (Simple_repeat)	rs35864197	0.1108	0.1398	351,.		0.7990			0.15,0.20	3.27					-0.1116	0.1696	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CD247 (inh=AR oe_syn=0.87 oe_mis=1.09 oe_lof=0.39), AKR1D1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	173795804	173795804	T	-	het	het	het	off-target;low_conf_region	QUAL=773;DP=119,45,20;AF=0.22,0.22,0.35;MQM=60;SAP=96;ABP=116	DARS2	intron	DARS2:ENST00000239457.5:intron_variant:MODIFIER:intron1/15:c.-1127-5del::,DARS2:ENST00000361951.4:intron_variant:MODIFIER:intron1/16:c.128-5del::	DARS2:NM_001365212.1:intron_variant:MODIFIER:intron1/15:c.128-5del::,DARS2:NM_001365213.2:intron_variant:MODIFIER:intron1/13:c.128-5del::,DARS2:NM_018122.5:intron_variant:MODIFIER:intron1/16:c.128-5del::		610956 [GENE=DARS2 PHENOS=Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation,611105,Autosomal recessive];	559192 [benign DISEASE=not provided];		(T)n (Simple_repeat)	rs746151025		0.4237	1,.	0.3542,0.4108,0.4051,0.4329,0.4481	0.8260				1.34					-0.1039	0.1527	0.04	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CENPL (inh=n/a oe_syn=0.92 oe_mis=0.84 oe_lof=0.30), DARS2 (inh=AR oe_syn=0.89 oe_mis=0.82 oe_lof=0.66)
chr1	173819422	173819422	A	-	het	het	het	off-target;low_conf_region	QUAL=473;DP=66,29,19;AF=0.24,0.24,0.26;MQM=60;SAP=64;ABP=67	DARS2	intron	DARS2:ENST00000239457.5:intron_variant:MODIFIER:intron12/15:c.-63-29del::,DARS2:ENST00000361951.4:intron_variant:MODIFIER:intron12/16:c.1192-29del::	DARS2:NM_001365212.1:intron_variant:MODIFIER:intron12/15:c.1192-3051del::,DARS2:NM_001365213.2:intron_variant:MODIFIER:intron12/13:c.1192-29del::,DARS2:NM_018122.5:intron_variant:MODIFIER:intron12/16:c.1192-29del::		610956 [GENE=DARS2 PHENOS=Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation,611105,Autosomal recessive];				rs199872112		0.1305	0,.	0.0973,0.1303,0.0955,0.1534,0.1207	-2.2520				0.50								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DARS2 (inh=AR oe_syn=0.89 oe_mis=0.82 oe_lof=0.66)
chr1	179519638	179519641	TTTC	-	wt	het	wt	off-target	QUAL=485;DP=124,58,52;AF=0.00,0.41,0.00;MQM=60;SAP=55;ABP=7	AXDND1	intron	AXDND1:ENST00000367618.3:intron_variant:MODIFIER:intron25/25:c.3032-4006_3032-4003del::	AXDND1:NM_144696.6:intron_variant:MODIFIER:intron25/25:c.3032-4006_3032-4003del::,AXDND1:NR_073544.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron25/25:n.3080-4006_3080-4003del::						rs147171656		0.2086	845,.		0.8270				10.22							0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AXDND1 (inh=n/a oe_syn=0.99 oe_mis=1.04 oe_lof=0.78), NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179519880	179519880	T	C	hom	hom	hom		QUAL=27854;DP=267,327,272;AF=1.00,1.00,1.00;MQM=60;SAP=214;ABP=0	NPHS2,AXDND1	3'UTR,intron	NPHS2:ENST00000367615.4:3_prime_UTR_variant:MODIFIER:exon8/8:c.*428A>G::,NPHS2:ENST00000367616.4:3_prime_UTR_variant:MODIFIER:exon7/7:c.*428A>G::,AXDND1:ENST00000367618.3:intron_variant:MODIFIER:intron25/25:c.3032-3767T>C::	NPHS2:NM_001297575.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*428A>G::,NPHS2:NM_014625.4:3_prime_UTR_variant:MODIFIER:exon8/8:c.*428A>G::,AXDND1:NM_144696.6:intron_variant:MODIFIER:intron25/25:c.3032-3767T>C::,AXDND1:NR_073544.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron25/25:n.3080-3767T>C::		604766 [GENE=NPHS2 PHENOS=Nephrotic syndrome,type 2,600995,Autosomal recessive];	224486 [benign DISEASE=Idiopathic nephrotic syndrome];			rs1060775		0.9098	13021,.		0.2720			0.03,0.16	0.21					0.0522	0.9067	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AXDND1 (inh=n/a oe_syn=0.99 oe_mis=1.04 oe_lof=0.78), NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179520050	179520050	T	C	het	wt	hom		QUAL=8006;DP=329,177,121;AF=0.46,0.00,1.00;MQM=60;SAP=42;ABP=8	NPHS2,AXDND1	3'UTR,intron	NPHS2:ENST00000367615.4:3_prime_UTR_variant:MODIFIER:exon8/8:c.*258A>G::,NPHS2:ENST00000367616.4:3_prime_UTR_variant:MODIFIER:exon7/7:c.*258A>G::,AXDND1:ENST00000367618.3:intron_variant:MODIFIER:intron25/25:c.3032-3597T>C::	NPHS2:NM_001297575.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*258A>G::,NPHS2:NM_014625.4:3_prime_UTR_variant:MODIFIER:exon8/8:c.*258A>G::,AXDND1:NM_144696.6:intron_variant:MODIFIER:intron25/25:c.3032-3597T>C::,AXDND1:NR_073544.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron25/25:n.3080-3597T>C::		604766 [GENE=NPHS2 PHENOS=Nephrotic syndrome,type 2,600995,Autosomal recessive];	224485 [benign DISEASE=Idiopathic nephrotic syndrome];			rs2274622	0.2831	0.2334	920,.		0.2690			0.13,0.36	7.96					0.0004	0.9058	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AXDND1 (inh=n/a oe_syn=0.99 oe_mis=1.04 oe_lof=0.78), NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179520151	179520151	C	T	hom	hom	hom		QUAL=24153;DP=285,263,194;AF=1.00,0.99,1.00;MQM=60;SAP=29;ABP=0	NPHS2,AXDND1	3'UTR,intron	NPHS2:ENST00000367615.4:3_prime_UTR_variant:MODIFIER:exon8/8:c.*157G>A::,NPHS2:ENST00000367616.4:3_prime_UTR_variant:MODIFIER:exon7/7:c.*157G>A::,AXDND1:ENST00000367618.3:intron_variant:MODIFIER:intron25/25:c.3032-3496C>T::	NPHS2:NM_001297575.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*157G>A::,NPHS2:NM_014625.4:3_prime_UTR_variant:MODIFIER:exon8/8:c.*157G>A::,AXDND1:NM_144696.6:intron_variant:MODIFIER:intron25/25:c.3032-3496C>T::,AXDND1:NR_073544.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron25/25:n.3080-3496C>T::		604766 [GENE=NPHS2 PHENOS=Nephrotic syndrome,type 2,600995,Autosomal recessive];	224483 [benign DISEASE=Idiopathic nephrotic syndrome];			rs1410590	0.9052	0.9126	13107,.		-1.2820			0.00,0.14	0.74					-0.0305	0.9053	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AXDND1 (inh=n/a oe_syn=0.99 oe_mis=1.04 oe_lof=0.78), NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179520254	179520254	C	G	hom	hom	hom		QUAL=22112;DP=389,174,131;AF=0.99,0.99,0.99;MQM=60;SAP=195;ABP=0	NPHS2,AXDND1	3'UTR,intron	NPHS2:ENST00000367615.4:3_prime_UTR_variant:MODIFIER:exon8/8:c.*54G>C::,NPHS2:ENST00000367616.4:3_prime_UTR_variant:MODIFIER:exon7/7:c.*54G>C::,AXDND1:ENST00000367618.3:intron_variant:MODIFIER:intron25/25:c.3032-3393C>G::	NPHS2:NM_001297575.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*54G>C::,NPHS2:NM_014625.4:3_prime_UTR_variant:MODIFIER:exon8/8:c.*54G>C::,AXDND1:NM_144696.6:intron_variant:MODIFIER:intron25/25:c.3032-3393C>G::,AXDND1:NR_073544.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron25/25:n.3080-3393C>G::		604766 [GENE=NPHS2 PHENOS=Nephrotic syndrome,type 2,600995,Autosomal recessive];	293845 [benign DISEASE=Idiopathic nephrotic syndrome];			rs1410591	0.5879	0.6139	5932,.		0.9020			0.00,0.13	3.26					0.0033	0.9058	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AXDND1 (inh=n/a oe_syn=0.99 oe_mis=1.04 oe_lof=0.78), NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179520506	179520506	G	A	hom	hom	hom		QUAL=20705;DP=343,184,128;AF=0.99,1.00,0.99;MQM=60;SAP=29;ABP=0	NPHS2,AXDND1	synonymous,intron	NPHS2:ENST00000367615.4:synonymous_variant:LOW:exon8/8:c.954C>T:p.Ala318=:,NPHS2:ENST00000367616.4:synonymous_variant:LOW:exon7/7:c.750C>T:p.Ala250=:,AXDND1:ENST00000367618.3:intron_variant:MODIFIER:intron25/25:c.3032-3141G>A::	NPHS2:NM_001297575.2:synonymous_variant:LOW:exon7/7:c.750C>T:p.Ala250=:,NPHS2:NM_014625.4:synonymous_variant:LOW:exon8/8:c.954C>T:p.Ala318=:,AXDND1:NM_144696.6:intron_variant:MODIFIER:intron25/25:c.3032-3141G>A::,AXDND1:NR_073544.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron25/25:n.3080-3141G>A::		604766 [GENE=NPHS2 PHENOS=Nephrotic syndrome,type 2,600995,Autosomal recessive];	260432 [benign DISEASE=Steroid-resistant nephrotic syndrome,Idiopathic nephrotic syndrome,not specified,not provided];			rs1410592		0.6190	5903,.	0.6004,0.6654,0.4727,0.6310,0.6037	-0.5630			0.03,0.33	1.65					-0.0069	0.9057	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AXDND1 (inh=n/a oe_syn=0.99 oe_mis=1.04 oe_lof=0.78), NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179521684	179521684	T	C	het	het	wt	off-target	QUAL=3067;DP=146,124,83;AF=0.45,0.47,0.00;MQM=60;SAP=158;ABP=7	NPHS2,AXDND1	intron	NPHS2:ENST00000367615.4:intron_variant:MODIFIER:intron7/7:c.873+54A>G::,NPHS2:ENST00000367616.4:intron_variant:MODIFIER:intron6/6:c.669+54A>G::,AXDND1:ENST00000367618.3:intron_variant:MODIFIER:intron25/25:c.3032-1963T>C::	NPHS2:NM_001297575.2:intron_variant:MODIFIER:intron6/6:c.669+54A>G::,NPHS2:NM_014625.4:intron_variant:MODIFIER:intron7/7:c.873+54A>G::,AXDND1:NM_144696.6:intron_variant:MODIFIER:intron25/25:c.3032-1963T>C::,AXDND1:NR_073544.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron25/25:n.3080-1963T>C::		604766 [GENE=NPHS2 PHENOS=Nephrotic syndrome,type 2,600995,Autosomal recessive];				rs11808359	0.0214	0.0518	49,.		0.1240			0.01,0.16	8.52					0.0613	0.2262	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AXDND1 (inh=n/a oe_syn=0.99 oe_mis=1.04 oe_lof=0.78), NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179521731	179521731	T	C	wt	wt	het		QUAL=1100;DP=136,196,113;AF=0.01,0.00,0.44;MQM=60;SAP=18;ABP=6	NPHS2,AXDND1	splice_region&intron,intron	NPHS2:ENST00000367615.4:splice_region_variant&intron_variant:LOW:intron7/7:c.873+7A>G::,NPHS2:ENST00000367616.4:splice_region_variant&intron_variant:LOW:intron6/6:c.669+7A>G::,AXDND1:ENST00000367618.3:intron_variant:MODIFIER:intron25/25:c.3032-1916T>C::	NPHS2:NM_001297575.2:splice_region_variant&intron_variant:LOW:intron6/6:c.669+7A>G::,NPHS2:NM_014625.4:splice_region_variant&intron_variant:LOW:intron7/7:c.873+7A>G::,AXDND1:NM_144696.6:intron_variant:MODIFIER:intron25/25:c.3032-1916T>C::,AXDND1:NR_073544.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron25/25:n.3080-1916T>C::		604766 [GENE=NPHS2 PHENOS=Nephrotic syndrome,type 2,600995,Autosomal recessive];	260430 [benign/likely benign DISEASE=Idiopathic nephrotic syndrome,not specified];			rs115778946	0.0160	0.0305	18,.	0.0082,0.0236,0.0000,0.0488,0.0103	-1.5420			0.07,0.27	10.31			0.000/0.064		-0.4798	0.2269	0.06	54	1804	0 / 0					AXDND1 (inh=n/a oe_syn=0.99 oe_mis=1.04 oe_lof=0.78), NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179528917	179528917	G	A	wt	het	wt	off-target	QUAL=2053;DP=166,157,134;AF=0.00,0.53,0.00;MQM=60;SAP=12;ABP=4	NPHS2	intron	NPHS2:ENST00000367615.4:intron_variant:MODIFIER:intron3/7:c.452-21C>T::,NPHS2:ENST00000367616.4:intron_variant:MODIFIER:intron3/6:c.452-21C>T::	NPHS2:NM_001297575.2:intron_variant:MODIFIER:intron3/6:c.452-21C>T::,NPHS2:NM_014625.4:intron_variant:MODIFIER:intron3/7:c.452-21C>T::		604766 [GENE=NPHS2 PHENOS=Nephrotic syndrome,type 2,600995,Autosomal recessive];				rs12401708	0.1334	0.2376	879,.	0.0633,0.2414,0.0433,0.2751,0.2021	0.0010			0.04,0.14	0.80					-0.0101	0.0954	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179528942	179528942	G	A	wt	het	wt	off-target	QUAL=1838;DP=144,138,114;AF=0.00,0.54,0.00;MQM=60;SAP=21;ABP=5	NPHS2	intron	NPHS2:ENST00000367615.4:intron_variant:MODIFIER:intron3/7:c.452-46C>T::,NPHS2:ENST00000367616.4:intron_variant:MODIFIER:intron3/6:c.452-46C>T::	NPHS2:NM_001297575.2:intron_variant:MODIFIER:intron3/6:c.452-46C>T::,NPHS2:NM_014625.4:intron_variant:MODIFIER:intron3/7:c.452-46C>T::		604766 [GENE=NPHS2 PHENOS=Nephrotic syndrome,type 2,600995,Autosomal recessive];				rs12401711	0.1334	0.2370	881,.	0.0631,0.2396,0.0434,0.2736,0.2011	-0.2810			0.03,0.18	6.83					0.0047	0.0853	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179544898	179544898	T	C	n/a	hom	hom		QUAL=442;DP=1,13,3;AF=1.00,1.00,1.00;MQM=60;SAP=4;ABP=0	NPHS2	synonymous	NPHS2:ENST00000367615.4:synonymous_variant:LOW:exon1/8:c.102A>G:p.Gly34=:,NPHS2:ENST00000367616.4:synonymous_variant:LOW:exon1/7:c.102A>G:p.Gly34=:	NPHS2:NM_001297575.2:synonymous_variant:LOW:exon1/7:c.102A>G:p.Gly34=:,NPHS2:NM_014625.4:synonymous_variant:LOW:exon1/8:c.102A>G:p.Gly34=:		604766 [GENE=NPHS2 PHENOS=Nephrotic syndrome,type 2,600995,Autosomal recessive];	260424 [benign DISEASE=Idiopathic nephrotic syndrome,not specified];			rs1079292	0.9309	0.9774	14172,.	0.8073,0.9855,0.9753,0.9928,0.9446	-0.4500			0.01,0.06	0.63					-0.2321	0.2202	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76), RNU5F-2P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	179545050	179545050	C	A	n/a	het	wt		QUAL=196;DP=1,18,9;AF=0.00,0.61,0.00;MQM=60;SAP=3;ABP=5	NPHS2	5'UTR	NPHS2:ENST00000367615.4:5_prime_UTR_variant:MODIFIER:exon1/8:c.-51G>T::,NPHS2:ENST00000367616.4:5_prime_UTR_variant:MODIFIER:exon1/7:c.-51G>T::	NPHS2:NM_001297575.2:5_prime_UTR_variant:MODIFIER:exon1/7:c.-51G>T::,NPHS2:NM_014625.4:5_prime_UTR_variant:MODIFIER:exon1/8:c.-51G>T::		604766 [GENE=NPHS2 PHENOS=Nephrotic syndrome,type 2,600995,Autosomal recessive];	225144 [benign DISEASE=Idiopathic nephrotic syndrome,not specified]; 225143 [pathogenic DISEASE=Idiopathic nephrotic syndrome];	CR068160 [CLASS=FP MUT=ALT PHEN="Reduced expression" GENE=NPHS2];		rs12406197	0.1833	0.2545	972,.	0.1427,0.3448,0.0981,0.2766,0.1991	-1.1450			0.01,0.20	10.02					-0.0482	0.2268	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76), RNU5F-2P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	179545115	179545115	G	A	n/a	wt	hom	off-target	QUAL=62;DP=1,7,4;AF=1.00,0.00,1.00;MQM=60;SAP=14;ABP=0	NPHS2,RNU5F-2P	upstream_gene	NPHS2:ENST00000367615.4:upstream_gene_variant:MODIFIER::::,NPHS2:ENST00000367616.4:upstream_gene_variant:MODIFIER::::,RNU5F-2P:ENST00000516066.1:upstream_gene_variant:MODIFIER::::					CR068161 [CLASS=FP MUT=ALT PHEN="Reduced expression" GENE=NPHS2];		rs1079291	0.2746	0.2234	878,.		-3.7360			0.01,0.14	8.54								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76), RNU5F-2P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	180199384	180199384	-	AG	het	wt	hom	off-target	QUAL=185;DP=30,9,8;AF=0.33,0.00,1.00;MQM=60;SAP=42;ABP=10	LHX4	upstream_gene	LHX4:ENST00000263726.2:upstream_gene_variant:MODIFIER::::		regulatory_region_variant:promoter				G-rich (Low_complexity)	rs138033992		0.4080	2632,.						17.89								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LHX4 (inh=AD oe_syn=1.06 oe_mis=0.88 oe_lof=0.35)
chr1	180235728	180235728	C	T	het	het	wt		QUAL=1854;DP=74,107,91;AF=0.51,0.42,0.00;MQM=60;SAP=88;ABP=6	LHX4	splice_region&synonymous	LHX4:ENST00000263726.2:splice_region_variant&synonymous_variant:LOW:exon3/6:c.450C>T:p.Asn150=:	LHX4:NM_033343.4:splice_region_variant&synonymous_variant:LOW:exon3/6:c.450C>T:p.Asn150=:	regulatory_region_variant:promoter_flanking_region	602146 [GENE=LHX4 PHENOS=Pituitary hormone deficiency,combined,4,262700,Autosomal dominant];	262223 [benign DISEASE=Short stature-pituitary and cerebellar defects-small sella turcica syndrome,not specified];			rs16855642	0.0427	0.0366	45,.	0.1045,0.0092,0.0111,0.0105,0.0175	-0.7970			0.16,0.87	11.97		9.89>9.26	0.000/0.054		-0.7863	0.627	0	10	569	0 / 0					LHX4 (inh=AD oe_syn=1.06 oe_mis=0.88 oe_lof=0.35)
chr1	180240510	180240510	T	C	het	wt	het		QUAL=1636;DP=67,115,77;AF=0.52,0.00,0.47;MQM=60;SAP=76;ABP=3	LHX4,RP5-1180C10.2	splice_region&intron,non_coding_transcript_exon	LHX4:ENST00000263726.2:splice_region_variant&intron_variant:LOW:intron3/5:c.452-5T>C::,RP5-1180C10.2:ENST00000415414.1:non_coding_transcript_exon_variant:MODIFIER:exon5/5:n.945A>G::	LHX4:NM_033343.4:splice_region_variant&intron_variant:LOW:intron3/5:c.452-5T>C::,LHX4-AS1:NR_037642.1:non_coding_transcript_exon_variant:MODIFIER:exon5/5:n.945A>G::	regulatory_region_variant:promoter_flanking_region	602146 [GENE=LHX4 PHENOS=Pituitary hormone deficiency,combined,4,262700,Autosomal dominant];	293866 [benign DISEASE=Short stature-pituitary and cerebellar defects-small sella turcica syndrome];			rs2764449	0.0413	0.0658	92,.	0.0140,0.0291,0.0113,0.0780,0.0791	1.9980			0.33,0.91	14.46		10.03>9.20			-0.1859	0.9295	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LHX4 (inh=AD oe_syn=1.06 oe_mis=0.88 oe_lof=0.35)
chr1	180243524	180243524	A	G	het	het	het		QUAL=7700;DP=209,203,155;AF=0.48,0.57,0.48;MQM=60;SAP=6;ABP=4	LHX4,RP5-1180C10.2	missense,intron&non_coding_transcript	LHX4:ENST00000263726.2:missense_variant:MODERATE:exon6/6:c.983A>G:p.Asn328Ser:,RP5-1180C10.2:ENST00000415414.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.31+262T>C::,RP5-1180C10.2:ENST00000440959.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/2:n.1574+262T>C::	LHX4:NM_033343.4:missense_variant:MODERATE:exon6/6:c.983A>G:p.Asn328Ser:,LHX4-AS1:NR_037642.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.31+262T>C::		602146 [GENE=LHX4 PHENOS=Pituitary hormone deficiency,combined,4,262700,Autosomal dominant];	262225 [benign DISEASE=Short stature-pituitary and cerebellar defects-small sella turcica syndrome,not specified];			rs7536561	0.4263	0.4824	3265,.	0.1826,0.2569,0.5889,0.5227,0.6011	2.5300	T(1.00), , 	B(0.00), , 	0.92,0.98	14.98	0.26				-0.001	0.8817	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LHX4 (inh=AD oe_syn=1.06 oe_mis=0.88 oe_lof=0.35)
chr1	180257692	180257692	A	C	hom	hom	hom	off-target	QUAL=19086;DP=249,202,155;AF=1.00,1.00,1.00;MQM=60;SAP=827;ABP=0	ACBD6	intron	ACBD6:ENST00000367595.3:intron_variant:MODIFIER:intron7/7:c.695-40T>G::	ACBD6:NM_032360.4:intron_variant:MODIFIER:intron7/7:c.695-40T>G::	regulatory_region_variant:promoter_flanking_region					rs2254465		0.9569	14376,.	0.9632,0.9680,0.9876,0.9423,0.9138	-3.3430			0.01,0.15	0.38					-0.0109	0.7812	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACBD6 (inh=n/a oe_syn=1.08 oe_mis=0.98 oe_lof=0.68)
chr1	183155228	183155228	C	A	wt	wt	het		QUAL=2642;DP=171,306,249;AF=0.00,0.01,0.49;MQM=60;SAP=59;ABP=3	LAMC2	upstream_gene	LAMC2:ENST00000264144.4:upstream_gene_variant:MODIFIER::::,LAMC2:ENST00000493293.1:upstream_gene_variant:MODIFIER::::		regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant		293975 [benign DISEASE=Junctional epidermolysis bullosa];			rs2276544	0.1603	0.1393	374,.		0.2470			0.35,0.21	7.76								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183155305	183155305	G	A	het	hom	wt		QUAL=19362;DP=265,500,354;AF=0.54,1.00,0.00;MQM=60;SAP=67;ABP=7	LAMC2	upstream_gene	LAMC2:ENST00000264144.4:upstream_gene_variant:MODIFIER::::,LAMC2:ENST00000493293.1:upstream_gene_variant:MODIFIER::::		regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant		293977 [benign DISEASE=Junctional epidermolysis bullosa];			rs2276543	0.2989	0.2739	1252,.		2.8840			0.70,0.90	20.20								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183155399	183155399	A	G	wt	wt	het		QUAL=3319;DP=353,397,283;AF=0.00,0.00,0.48;MQM=60;SAP=3;ABP=4	LAMC2	5'UTR	LAMC2:ENST00000493293.1:5_prime_UTR_variant:MODIFIER:exon1/22:c.-89A>G::	LAMC2:NM_005562.3:5_prime_UTR_variant:MODIFIER:exon1/23:c.-89A>G::,LAMC2:NM_018891.3:5_prime_UTR_variant:MODIFIER:exon1/22:c.-89A>G::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	150292 [GENE=LAMC2 PHENOS=Epidermolysis bullosa,junctional,non-Herlitz type,226650,Autosomal recessive/Epidermolysis bullosa,junctional,Herlitz type,226700,Autosomal recessive];	293979 [benign DISEASE=Junctional epidermolysis bullosa];			rs2276542	0.2091	0.1803	549,.		2.8120			0.62,0.75	14.35					0.0449	0.0848		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183155482	183155482	C	A	wt	het	wt		QUAL=790;DP=25,90,68;AF=0.00,0.47,0.00;MQM=60;SAP=28;ABP=4	LAMC2	5'UTR	LAMC2:ENST00000264144.4:5_prime_UTR_variant:MODIFIER:exon1/23:c.-6C>A::,LAMC2:ENST00000493293.1:5_prime_UTR_variant:MODIFIER:exon1/22:c.-6C>A::	LAMC2:NM_005562.3:5_prime_UTR_variant:MODIFIER:exon1/23:c.-6C>A::,LAMC2:NM_018891.3:5_prime_UTR_variant:MODIFIER:exon1/22:c.-6C>A::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	150292 [GENE=LAMC2 PHENOS=Epidermolysis bullosa,junctional,non-Herlitz type,226650,Autosomal recessive/Epidermolysis bullosa,junctional,Herlitz type,226700,Autosomal recessive];	293983 [benign DISEASE=Junctional epidermolysis bullosa];			rs684527	0.2748	0.3122	1290,.	0.0999,0.3338,0.4192,0.2979,0.3598	1.3870			0.39,0.33	16.48					0.1623	0.0886	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183176970	183176970	-	T	het	het	het	off-target;low_conf_region	QUAL=1124;DP=55,46,54;AF=0.13,0.28,0.39;MQM=60;SAP=84;ABP=78	LAMC2	intron	LAMC2:ENST00000264144.4:intron_variant:MODIFIER:intron1/22:c.80-31dup::,LAMC2:ENST00000493293.1:intron_variant:MODIFIER:intron1/21:c.80-31dup::	LAMC2:NM_005562.3:intron_variant:MODIFIER:intron1/22:c.80-31dup::,LAMC2:NM_018891.3:intron_variant:MODIFIER:intron1/21:c.80-31dup::		150292 [GENE=LAMC2 PHENOS=Epidermolysis bullosa,junctional,non-Herlitz type,226650,Autosomal recessive/Epidermolysis bullosa,junctional,Herlitz type,226700,Autosomal recessive];				rs10668798		0.2688	441,.	0.2697,0.2585,0.3149,0.2623,0.2771					4.56					-0.0693	0.3042	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183176970	183176970	-	TT	wt	het	wt	off-target;low_conf_region	QUAL=1124;DP=55,46,54;AF=0.11,0.39,0.06;MQM=60;SAP=62;ABP=146	LAMC2	intron	LAMC2:ENST00000264144.4:intron_variant:MODIFIER:intron1/22:c.80-32_80-31dup::,LAMC2:ENST00000493293.1:intron_variant:MODIFIER:intron1/21:c.80-32_80-31dup::	LAMC2:NM_005562.3:intron_variant:MODIFIER:intron1/22:c.80-32_80-31dup::,LAMC2:NM_018891.3:intron_variant:MODIFIER:intron1/21:c.80-32_80-31dup::		150292 [GENE=LAMC2 PHENOS=Epidermolysis bullosa,junctional,non-Herlitz type,226650,Autosomal recessive/Epidermolysis bullosa,junctional,Herlitz type,226700,Autosomal recessive];				rs10668798		0.3214	1281,.	0.2093,0.2541,0.2462,0.1999,0.1521					4.11					-0.0233	0.2677	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183177218	183177218	A	G	het	hom	wt	off-target	QUAL=9002;DP=133,242,212;AF=0.47,1.00,0.00;MQM=60;SAP=218;ABP=4	LAMC2	intron	LAMC2:ENST00000264144.4:intron_variant:MODIFIER:intron2/22:c.268+14A>G::,LAMC2:ENST00000493293.1:intron_variant:MODIFIER:intron2/21:c.268+14A>G::	LAMC2:NM_005562.3:intron_variant:MODIFIER:intron2/22:c.268+14A>G::,LAMC2:NM_018891.3:intron_variant:MODIFIER:intron2/21:c.268+14A>G::		150292 [GENE=LAMC2 PHENOS=Epidermolysis bullosa,junctional,non-Herlitz type,226650,Autosomal recessive/Epidermolysis bullosa,junctional,Herlitz type,226700,Autosomal recessive];	259785 [benign DISEASE=Junctional epidermolysis bullosa,not specified];		GA-rich (Low_complexity)	rs647347	0.4962	0.4732	3229,.	0.4660,0.5096,0.5629,0.4381,0.5155	-1.4960			0.00,0.05	0.71				COSV51458451	0.31	0.4098	0.07	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183184616	183184616	C	T	wt	wt	het		QUAL=2921;DP=271,345,244;AF=0.00,0.01,0.48;MQM=60;SAP=3;ABP=4	LAMC2	synonymous	LAMC2:ENST00000264144.4:synonymous_variant:LOW:exon3/23:c.297C>T:p.Ser99=:PF00053 [Laminin EGF domain],LAMC2:ENST00000493293.1:synonymous_variant:LOW:exon3/22:c.297C>T:p.Ser99=:PF00053 [Laminin EGF domain]	LAMC2:NM_005562.3:synonymous_variant:LOW:exon3/23:c.297C>T:p.Ser99=:,LAMC2:NM_018891.3:synonymous_variant:LOW:exon3/22:c.297C>T:p.Ser99=:	regulatory_region_variant:open_chromatin_region	150292 [GENE=LAMC2 PHENOS=Epidermolysis bullosa,junctional,non-Herlitz type,226650,Autosomal recessive/Epidermolysis bullosa,junctional,Herlitz type,226700,Autosomal recessive];	259787 [benign DISEASE=Junctional epidermolysis bullosa,not specified];			rs2274980	0.3137	0.2508	1153,.	0.3883,0.3782,0.3433,0.1766,0.3155	0.0150			0.02,0.16	8.37					-0.1024	0.1421	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183187494	183187494	T	C	wt	wt	het	off-target	QUAL=3529;DP=340,464,294;AF=0.00,0.00,0.48;MQM=60;SAP=8;ABP=4	LAMC2	intron	LAMC2:ENST00000264144.4:intron_variant:MODIFIER:intron3/22:c.405-31T>C::,LAMC2:ENST00000493293.1:intron_variant:MODIFIER:intron3/21:c.405-31T>C::	LAMC2:NM_005562.3:intron_variant:MODIFIER:intron3/22:c.405-31T>C::,LAMC2:NM_018891.3:intron_variant:MODIFIER:intron3/21:c.405-31T>C::	regulatory_region_variant:promoter_flanking_region	150292 [GENE=LAMC2 PHENOS=Epidermolysis bullosa,junctional,non-Herlitz type,226650,Autosomal recessive/Epidermolysis bullosa,junctional,Herlitz type,226700,Autosomal recessive];				rs10911285	0.3139	0.2509	1155,.	0.3884,0.3788,0.3433,0.1766,0.3153	-0.8980			0.00,0.09	0.32					-0.0479	0.2562	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183187603	183187603	C	T	wt	wt	het		QUAL=3069;DP=194,323,249;AF=0.00,0.00,0.50;MQM=60;SAP=28;ABP=3	LAMC2	synonymous	LAMC2:ENST00000264144.4:synonymous_variant:LOW:exon4/23:c.483C>T:p.Val161=:PF00053 [Laminin EGF domain],LAMC2:ENST00000493293.1:synonymous_variant:LOW:exon4/22:c.483C>T:p.Val161=:PF00053 [Laminin EGF domain]	LAMC2:NM_005562.3:synonymous_variant:LOW:exon4/23:c.483C>T:p.Val161=:,LAMC2:NM_018891.3:synonymous_variant:LOW:exon4/22:c.483C>T:p.Val161=:	regulatory_region_variant:promoter_flanking_region	150292 [GENE=LAMC2 PHENOS=Epidermolysis bullosa,junctional,non-Herlitz type,226650,Autosomal recessive/Epidermolysis bullosa,junctional,Herlitz type,226700,Autosomal recessive];	259789 [benign DISEASE=Junctional epidermolysis bullosa,not specified];			rs1129723	0.3139	0.2507	1157,.	0.3875,0.3784,0.3423,0.1762,0.3155	0.7130			0.54,0.97	12.66					-0.1643	0.457	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183192304	183192304	T	G	wt	wt	het		QUAL=2777;DP=225,280,207;AF=0.00,0.00,0.53;MQM=60;SAP=14;ABP=5	LAMC2	synonymous	LAMC2:ENST00000264144.4:synonymous_variant:LOW:exon7/23:c.798T>G:p.Gly266=:PF00052 [Laminin B (Domain IV)],LAMC2:ENST00000493293.1:synonymous_variant:LOW:exon7/22:c.798T>G:p.Gly266=:PF00052 [Laminin B (Domain IV)]	LAMC2:NM_005562.3:synonymous_variant:LOW:exon7/23:c.798T>G:p.Gly266=:,LAMC2:NM_018891.3:synonymous_variant:LOW:exon7/22:c.798T>G:p.Gly266=:		150292 [GENE=LAMC2 PHENOS=Epidermolysis bullosa,junctional,non-Herlitz type,226650,Autosomal recessive/Epidermolysis bullosa,junctional,Herlitz type,226700,Autosomal recessive];	259790 [benign DISEASE=Junctional epidermolysis bullosa,not specified];			rs1047980	0.3550	0.2862	1645,.	0.5145,0.3869,0.3442,0.1779,0.3165	-0.4130			0.12,0.91	12.83					-0.0697	0.273	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183192496	183192496	A	G	wt	wt	het	off-target	QUAL=2028;DP=214,172,137;AF=0.00,0.00,0.59;MQM=60;SAP=123;ABP=13	LAMC2	intron	LAMC2:ENST00000264144.4:intron_variant:MODIFIER:intron7/22:c.953+37A>G::,LAMC2:ENST00000493293.1:intron_variant:MODIFIER:intron7/21:c.953+37A>G::	LAMC2:NM_005562.3:intron_variant:MODIFIER:intron7/22:c.953+37A>G::,LAMC2:NM_018891.3:intron_variant:MODIFIER:intron7/21:c.953+37A>G::		150292 [GENE=LAMC2 PHENOS=Epidermolysis bullosa,junctional,non-Herlitz type,226650,Autosomal recessive/Epidermolysis bullosa,junctional,Herlitz type,226700,Autosomal recessive];				rs3738824	0.1132	0.1334	290,.	0.1116,0.1648,0.1782,0.1267,0.0906	0.7180			0.18,0.19	4.46					-0.1635	0.2773	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183201970	183201970	G	C	wt	wt	het		QUAL=907;DP=128,163,109;AF=0.00,0.00,0.39;MQM=60;SAP=28;ABP=15	LAMC2	missense	LAMC2:ENST00000264144.4:missense_variant:MODERATE:exon14/23:c.2198G>C:p.Ser733Thr:,LAMC2:ENST00000493293.1:missense_variant:MODERATE:exon14/22:c.2198G>C:p.Ser733Thr:	LAMC2:NM_005562.3:missense_variant:MODERATE:exon14/23:c.2198G>C:p.Ser733Thr:,LAMC2:NM_018891.3:missense_variant:MODERATE:exon14/22:c.2198G>C:p.Ser733Thr:		150292 [GENE=LAMC2 PHENOS=Epidermolysis bullosa,junctional,non-Herlitz type,226650,Autosomal recessive/Epidermolysis bullosa,junctional,Herlitz type,226700,Autosomal recessive];	259784 [benign DISEASE=Junctional epidermolysis bullosa,not specified];			rs2296303	0.1450	0.1674	495,.	0.2289,0.1701,0.1797,0.1272,0.0914	1.2080	D(0.05),D(0.05)	B(0.13),B(0.17)	0.35,0.50	11.69	0.07				0.0471	0.4299	0.04	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183206573	183206573	G	A	wt	wt	het		QUAL=3683;DP=362,404,276;AF=0.00,0.00,0.51;MQM=60;SAP=27;ABP=3	LAMC2	synonymous	LAMC2:ENST00000264144.4:synonymous_variant:LOW:exon18/23:c.2688G>A:p.Gln896=:,LAMC2:ENST00000493293.1:synonymous_variant:LOW:exon18/22:c.2688G>A:p.Gln896=:	LAMC2:NM_005562.3:synonymous_variant:LOW:exon18/23:c.2688G>A:p.Gln896=:,LAMC2:NM_018891.3:synonymous_variant:LOW:exon18/22:c.2688G>A:p.Gln896=:		150292 [GENE=LAMC2 PHENOS=Epidermolysis bullosa,junctional,non-Herlitz type,226650,Autosomal recessive/Epidermolysis bullosa,junctional,Herlitz type,226700,Autosomal recessive];	259786 [benign DISEASE=Junctional epidermolysis bullosa,not specified];			rs1047981	0.3524	0.2851	1629,.	0.5110,0.3851,0.3431,0.1779,0.3162	-0.3580			0.01,0.10	0.20					-0.2884	0.4585	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183207603	183207603	T	C	wt	wt	het	off-target	QUAL=1090;DP=197,112,82;AF=0.00,0.00,0.56;MQM=60;SAP=45;ABP=6	LAMC2	intron	LAMC2:ENST00000264144.4:intron_variant:MODIFIER:intron19/22:c.2869+47T>C::,LAMC2:ENST00000493293.1:intron_variant:MODIFIER:intron19/21:c.2869+47T>C::	LAMC2:NM_005562.3:intron_variant:MODIFIER:intron19/22:c.2869+47T>C::,LAMC2:NM_018891.3:intron_variant:MODIFIER:intron19/21:c.2869+47T>C::	regulatory_region_variant:promoter_flanking_region	150292 [GENE=LAMC2 PHENOS=Epidermolysis bullosa,junctional,non-Herlitz type,226650,Autosomal recessive/Epidermolysis bullosa,junctional,Herlitz type,226700,Autosomal recessive];				rs1925043	0.3588	0.2911	1729,.	0.5345,0.3875,0.3445,0.1784,0.3163	-1.2960			0.00,0.09	6.46					0.0028	0.2561	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183210381	183210381	A	-	het	wt	het		QUAL=145;DP=17,4,9;AF=0.29,0.00,0.67;MQM=60;SAP=5;ABP=4	LAMC2	intron,3'UTR	LAMC2:ENST00000264144.4:intron_variant:MODIFIER:intron22/22:c.3328+870del::,LAMC2:ENST00000493293.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*862del::	LAMC2:NM_005562.3:intron_variant:MODIFIER:intron22/22:c.3328+870del::,LAMC2:NM_018891.3:3_prime_UTR_variant:MODIFIER:exon22/22:c.*862del::	regulatory_region_variant:promoter_flanking_region	150292 [GENE=LAMC2 PHENOS=Epidermolysis bullosa,junctional,non-Herlitz type,226650,Autosomal recessive/Epidermolysis bullosa,junctional,Herlitz type,226700,Autosomal recessive];			AluSx1 (SINE/Alu)	rs11318188		0.1977	209,.		0.4810				1.11					0.0051	0.8967	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183212548	183212548	T	G	wt	wt	het		QUAL=2485;DP=213,247,174;AF=0.00,0.00,0.56;MQM=60;SAP=9;ABP=8	LAMC2	3'UTR	LAMC2:ENST00000264144.4:3_prime_UTR_variant:MODIFIER:exon23/23:c.*13T>G::	LAMC2:NM_005562.3:3_prime_UTR_variant:MODIFIER:exon23/23:c.*13T>G::	regulatory_region_variant:promoter_flanking_region	150292 [GENE=LAMC2 PHENOS=Epidermolysis bullosa,junctional,non-Herlitz type,226650,Autosomal recessive/Epidermolysis bullosa,junctional,Herlitz type,226700,Autosomal recessive];	294025 [benign DISEASE=Junctional epidermolysis bullosa];			rs3768593	0.3109	0.2397	969,.	0.3628,0.3779,0.3678,0.1651,0.3129	0.2330			0.00,0.15	9.19					0.0304	0.9461	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48), NMNAT2 (inh=n/a oe_syn=0.99 oe_mis=0.57 oe_lof=0.06)
chr1	183213410	183213410	G	T	wt	wt	het		QUAL=2295;DP=275,200,178;AF=0.00,0.01,0.49;MQM=60;SAP=3;ABP=3	LAMC2	3'UTR	LAMC2:ENST00000264144.4:3_prime_UTR_variant:MODIFIER:exon23/23:c.*875G>T::	LAMC2:NM_005562.3:3_prime_UTR_variant:MODIFIER:exon23/23:c.*875G>T::	regulatory_region_variant:promoter_flanking_region	150292 [GENE=LAMC2 PHENOS=Epidermolysis bullosa,junctional,non-Herlitz type,226650,Autosomal recessive/Epidermolysis bullosa,junctional,Herlitz type,226700,Autosomal recessive];	294036 [benign DISEASE=Junctional epidermolysis bullosa];			rs10797863	0.0913	0.1025	206,.		-0.1180			0.09,0.17	0.48					0.0004	0.9458	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48), NMNAT2 (inh=n/a oe_syn=0.99 oe_mis=0.57 oe_lof=0.06)
chr1	183213933	183213933	C	T	wt	het	wt		QUAL=4919;DP=467,395,284;AF=0.00,0.47,0.00;MQM=60;SAP=3;ABP=6	LAMC2	3'UTR	LAMC2:ENST00000264144.4:3_prime_UTR_variant:MODIFIER:exon23/23:c.*1398C>T::	LAMC2:NM_005562.3:3_prime_UTR_variant:MODIFIER:exon23/23:c.*1398C>T::	regulatory_region_variant:promoter_flanking_region	150292 [GENE=LAMC2 PHENOS=Epidermolysis bullosa,junctional,non-Herlitz type,226650,Autosomal recessive/Epidermolysis bullosa,junctional,Herlitz type,226700,Autosomal recessive];	294053 [uncertain significance DISEASE=Junctional epidermolysis bullosa];			rs564740740	0.0012	0.0031	0,.		0.4840			0.08,0.80	13.68				COSV51452086	-0.0192	0.9455	0	0	37	0 / 0					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48), NMNAT2 (inh=n/a oe_syn=0.99 oe_mis=0.57 oe_lof=0.06)
chr1	183524855	183524855	C	A	hom	hom	hom		QUAL=43528;DP=452,542,380;AF=1.00,0.99,0.99;MQM=60;SAP=112;ABP=0	NCF2	3'UTR	NCF2:ENST00000367536.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*398G>T::,NCF2:ENST00000413720.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*398G>T::,NCF2:ENST00000418089.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*398G>T::	NCF2:NM_000433.3:3_prime_UTR_variant:MODIFIER:exon15/15:c.*398G>T::,NCF2:NM_001127651.3:3_prime_UTR_variant:MODIFIER:exon16/16:c.*398G>T::,NCF2:NM_001190789.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*398G>T::,NCF2:NM_001190794.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*398G>T::		608515 [GENE=NCF2 PHENOS=Chronic granulomatous disease 2,autosomal recessive,233710,Autosomal recessive];	294066 [benign DISEASE=Chronic granulomatous disease, autosomal recessive cytochrome b-positive, type 2];			rs796860	0.9393	0.9052	12853,.		-2.0230			0.00,0.08	0.60					0.019	0.964	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMG7 (inh=n/a oe_syn=0.96 oe_mis=0.75 oe_lof=0.12), NCF2 (inh=AR oe_syn=1.01 oe_mis=0.82 oe_lof=0.49)
chr1	183534935	183534935	C	T	hom	het	hom	off-target	QUAL=13706;DP=146,253,193;AF=1.00,0.51,1.00;MQM=60;SAP=62;ABP=3	NCF2	intron	NCF2:ENST00000367535.3:intron_variant:MODIFIER:intron9/14:c.925-21G>A::,NCF2:ENST00000367536.1:intron_variant:MODIFIER:intron10/15:c.925-21G>A::,NCF2:ENST00000413720.1:intron_variant:MODIFIER:intron8/13:c.790-21G>A::,NCF2:ENST00000418089.1:intron_variant:MODIFIER:intron7/12:c.682-21G>A::	NCF2:NM_000433.3:intron_variant:MODIFIER:intron9/14:c.925-21G>A::,NCF2:NM_001127651.3:intron_variant:MODIFIER:intron10/15:c.925-21G>A::,NCF2:NM_001190789.1:intron_variant:MODIFIER:intron7/12:c.682-21G>A::,NCF2:NM_001190794.1:intron_variant:MODIFIER:intron8/13:c.790-21G>A::		608515 [GENE=NCF2 PHENOS=Chronic granulomatous disease 2,autosomal recessive,233710,Autosomal recessive];				rs2296164	0.4776	0.4930	3292,.	0.3535,0.6456,0.6096,0.4669,0.4657	-3.2360			0.01,0.09	0.01					-0.0667	0.0185	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NCF2 (inh=AR oe_syn=1.01 oe_mis=0.82 oe_lof=0.49)
chr1	183542387	183542387	T	C	hom	het	hom		QUAL=18361;DP=256,266,192;AF=0.99,0.55,1.00;MQM=60;SAP=5;ABP=8	NCF2	missense,intron	NCF2:ENST00000367535.3:missense_variant:MODERATE:exon5/15:c.542A>G:p.Lys181Arg:,NCF2:ENST00000367536.1:missense_variant:MODERATE:exon6/16:c.542A>G:p.Lys181Arg:,NCF2:ENST00000413720.1:missense_variant:MODERATE:exon4/14:c.407A>G:p.Lys136Arg:,NCF2:ENST00000418089.1:intron_variant:MODIFIER:intron3/12:c.367-2413A>G::	NCF2:NM_000433.3:missense_variant:MODERATE:exon5/15:c.542A>G:p.Lys181Arg:,NCF2:NM_001127651.3:missense_variant:MODERATE:exon6/16:c.542A>G:p.Lys181Arg:,NCF2:NM_001190789.1:intron_variant:MODIFIER:intron3/12:c.367-2413A>G::,NCF2:NM_001190794.1:missense_variant:MODERATE:exon4/14:c.407A>G:p.Lys136Arg:		608515 [GENE=NCF2 PHENOS=Chronic granulomatous disease 2,autosomal recessive,233710,Autosomal recessive];	256116 [benign DISEASE=Chronic granulomatous disease, autosomal recessive cytochrome b-positive, type 2,not specified];			rs2274064	0.4916	0.4988	3288,.	0.3588,0.6448,0.6234,0.4659,0.5073	0.5830	T(0.81),T(0.81),T(0.88), 	B(0.00),B(0.00),B(0.00), 	0.46,0.95	14.86	0.08				-0.141	0.2651	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NCF2 (inh=AR oe_syn=1.01 oe_mis=0.82 oe_lof=0.49)
chr1	196642072	196642072	C	T	wt	wt	het	off-target	QUAL=324;DP=121,74,48;AF=0.00,0.00,0.38;MQM=60;SAP=15;ABP=10	CFH	intron	CFH:ENST00000359637.2:intron_variant:MODIFIER:intron1/8:c.59-36C>T::,CFH:ENST00000367429.4:intron_variant:MODIFIER:intron1/21:c.59-36C>T::,CFH:ENST00000439155.2:intron_variant:MODIFIER:intron1/9:c.59-36C>T::	CFH:NM_000186.4:intron_variant:MODIFIER:intron1/21:c.59-36C>T::,CFH:NM_001014975.2:intron_variant:MODIFIER:intron1/9:c.59-36C>T::		134370 [GENE=CFH PHENOS=Complement factor H deficiency,609814,Autosomal recessive,Autosomal dominant/Hemolytic uremic syndrome,atypical,susceptibility to,1,235400,Autosomal recessive,Autosomal dominant/Basal laminar drusen,126700,Autosomal dominant/Macular degeneration,age-related,4,610698];				rs551397	0.4681	0.3936	3073,.	0.7248,0.3721,0.4170,0.2314,0.3114	-0.1960			0.00,0.05	1.88					0.0645	0.7044	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196642233	196642233	G	A	wt	wt	het		QUAL=924;DP=231,138,83;AF=0.00,0.00,0.48;MQM=60;SAP=5;ABP=3	CFH	missense	CFH:ENST00000359637.2:missense_variant:MODERATE:exon2/9:c.184G>A:p.Val62Ile:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000367429.4:missense_variant:MODERATE:exon2/22:c.184G>A:p.Val62Ile:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000439155.2:missense_variant:MODERATE:exon2/10:c.184G>A:p.Val62Ile:PF00084 [Sushi repeat (SCR repeat)]	CFH:NM_000186.4:missense_variant:MODERATE:exon2/22:c.184G>A:p.Val62Ile:,CFH:NM_001014975.2:missense_variant:MODERATE:exon2/10:c.184G>A:p.Val62Ile:		134370 [GENE=CFH PHENOS=Complement factor H deficiency,609814,Autosomal recessive,Autosomal dominant/Hemolytic uremic syndrome,atypical,susceptibility to,1,235400,Autosomal recessive,Autosomal dominant/Basal laminar drusen,126700,Autosomal dominant/Macular degeneration,age-related,4,610698];	16550 [benign DISEASE=Basal laminar drusen,Atypical hemolytic-uremic syndrome 1,Age-related macular degeneration 4,CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II,not provided];			rs800292	0.4681	0.3929	3060,.	0.7254,0.3751,0.4206,0.2350,0.3144	1.7350	T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00)	0.00,0.09	7.11	0.14				-0.0734	0.8614	0.08	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196642969	196642969	-	TT	wt	wt	het	off-target	QUAL=947;DP=98,131,110;AF=0.00,0.00,0.39;MQM=60;SAP=5;ABP=14	CFH	intron	CFH:ENST00000359637.2:intron_variant:MODIFIER:intron2/8:c.245-10_245-9dup::,CFH:ENST00000367429.4:intron_variant:MODIFIER:intron2/21:c.245-10_245-9dup::,CFH:ENST00000439155.2:intron_variant:MODIFIER:intron2/9:c.245-10_245-9dup::	CFH:NM_000186.4:intron_variant:MODIFIER:intron2/21:c.245-10_245-9dup::,CFH:NM_001014975.2:intron_variant:MODIFIER:intron2/9:c.245-10_245-9dup::		134370 [GENE=CFH PHENOS=Complement factor H deficiency,609814,Autosomal recessive,Autosomal dominant/Hemolytic uremic syndrome,atypical,susceptibility to,1,235400,Autosomal recessive,Autosomal dominant/Basal laminar drusen,126700,Autosomal dominant/Macular degeneration,age-related,4,610698];		CI063658 [CLASS=DM MUT=ALT PHEN="Membranoproliferative glomerulonephritis" GENE=CFH];		rs35507625		0.2354	811,.						0.52					0.6214	0.0099	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196654324	196654324	A	C	het	het	het		QUAL=9410;DP=284,266,209;AF=0.49,0.48,0.48;MQM=60;SAP=61;ABP=5	CFH	synonymous	CFH:ENST00000359637.2:synonymous_variant:LOW:exon6/9:c.729A>C:p.Ala243=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000367429.4:synonymous_variant:LOW:exon7/22:c.921A>C:p.Ala307=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000439155.2:synonymous_variant:LOW:exon7/10:c.921A>C:p.Ala307=:PF00084 [Sushi repeat (SCR repeat)]	CFH:NM_000186.4:synonymous_variant:LOW:exon7/22:c.921A>C:p.Ala307=:,CFH:NM_001014975.2:synonymous_variant:LOW:exon7/10:c.921A>C:p.Ala307=:		134370 [GENE=CFH PHENOS=Complement factor H deficiency,609814,Autosomal recessive,Autosomal dominant/Hemolytic uremic syndrome,atypical,susceptibility to,1,235400,Autosomal recessive,Autosomal dominant/Basal laminar drusen,126700,Autosomal dominant/Macular degeneration,age-related,4,610698];	294488 [benign DISEASE=Basal laminar drusen,Atypical hemolytic-uremic syndrome 1,Age-related macular degeneration 4,CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II];			rs1061147	0.7131	0.6762	6137,.	0.5734,0.8312,0.9540,0.6166,0.6976	-0.0870			0.02,0.15	3.57					-0.048	0.2625	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196658497	196658497	G	T	het	het	het	off-target;low_conf_region	QUAL=1473;DP=93,17,15;AF=0.54,0.18,0.53;MQM=60;SAP=135;ABP=3	CFH	intron	CFH:ENST00000359637.2:intron_variant:MODIFIER:intron6/8:c.773-53G>T::,CFH:ENST00000367429.4:intron_variant:MODIFIER:intron7/21:c.965-53G>T::,CFH:ENST00000439155.2:intron_variant:MODIFIER:intron7/9:c.965-53G>T::	CFH:NM_000186.4:intron_variant:MODIFIER:intron7/21:c.965-53G>T::,CFH:NM_001014975.2:intron_variant:MODIFIER:intron7/9:c.965-53G>T::		134370 [GENE=CFH PHENOS=Complement factor H deficiency,609814,Autosomal recessive,Autosomal dominant/Hemolytic uremic syndrome,atypical,susceptibility to,1,235400,Autosomal recessive,Autosomal dominant/Basal laminar drusen,126700,Autosomal dominant/Macular degeneration,age-related,4,610698];				rs482934	0.7816	0.6784	7369,.		-0.0470			0.00,0.13	1.31					0.0051	0.2372	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196659237	196659237	C	T	het	het	het		QUAL=5479;DP=191,108,104;AF=0.57,0.49,0.41;MQM=57;SAP=134;ABP=3	CFH	missense	CFH:ENST00000359637.2:missense_variant:MODERATE:exon8/9:c.1012C>T:p.His338Tyr:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000367429.4:missense_variant:MODERATE:exon9/22:c.1204C>T:p.His402Tyr:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000439155.2:missense_variant:MODERATE:exon9/10:c.1204C>T:p.His402Tyr:PF00084 [Sushi repeat (SCR repeat)]	CFH:NM_000186.4:missense_variant:MODERATE:exon9/22:c.1204C>T:p.His402Tyr:,CFH:NM_001014975.2:missense_variant:MODERATE:exon9/10:c.1204C>T:p.His402Tyr:		134370 [GENE=CFH PHENOS=Complement factor H deficiency,609814,Autosomal recessive,Autosomal dominant/Hemolytic uremic syndrome,atypical,susceptibility to,1,235400,Autosomal recessive,Autosomal dominant/Basal laminar drusen,126700,Autosomal dominant/Macular degeneration,age-related,4,610698];	294490 [benign DISEASE=Basal laminar drusen,Atypical hemolytic-uremic syndrome 1,Age-related macular degeneration 4,CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II];			rs1061170	0.7334	0.6797	6399,.	0.6270,0.8335,0.9541,0.6159,0.6976	-6.7160	T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00)	0.00,0.04	0.00	0.09				-0.104	0.2725	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196682947	196682947	G	A	het	het	het		QUAL=8619;DP=262,257,192;AF=0.42,0.48,0.49;MQM=60;SAP=102;ABP=12	CFH	synonymous	CFH:ENST00000367429.4:synonymous_variant:LOW:exon10/22:c.1419G>A:p.Ala473=:PF00084 [Sushi repeat (SCR repeat)]	CFH:NM_000186.4:synonymous_variant:LOW:exon10/22:c.1419G>A:p.Ala473=:		134370 [GENE=CFH PHENOS=Complement factor H deficiency,609814,Autosomal recessive,Autosomal dominant/Hemolytic uremic syndrome,atypical,susceptibility to,1,235400,Autosomal recessive,Autosomal dominant/Basal laminar drusen,126700,Autosomal dominant/Macular degeneration,age-related,4,610698];	294491 [benign DISEASE=Basal laminar drusen,Atypical hemolytic-uremic syndrome 1,Age-related macular degeneration 4,CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II];	CM062504 [CLASS=DP MUT=ALT PHEN="Membranoproliferative glomerulonephritis association" GENE=CFH];		rs2274700	0.4790	0.4435	2835,.	0.4618,0.4590,0.4312,0.4121,0.5459	0.4760			0.00,0.09	0.16					-0.1124	0.2017	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196705926	196705926	C	A	het	het	het	off-target;low_conf_region	QUAL=139;DP=16,13,4;AF=0.25,0.38,0.50;MQM=60;SAP=19;ABP=11	CFH	intron	CFH:ENST00000367429.4:intron_variant:MODIFIER:intron15/21:c.2414-28C>A::	CFH:NM_000186.4:intron_variant:MODIFIER:intron15/21:c.2414-28C>A::		134370 [GENE=CFH PHENOS=Complement factor H deficiency,609814,Autosomal recessive,Autosomal dominant/Hemolytic uremic syndrome,atypical,susceptibility to,1,235400,Autosomal recessive,Autosomal dominant/Basal laminar drusen,126700,Autosomal dominant/Macular degeneration,age-related,4,610698];			(TTAATT)n (Simple_repeat)	rs375046	0.7748	0.6624	6673,.	0.7404,0.7100,0.9333,0.5543,0.6854	-0.3700			0.00,0.11	0.12					-0.4942	0.7907	0.05	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196709816	196709816	G	T	het	het	wt		QUAL=6952;DP=283,216,187;AF=0.53,0.51,0.00;MQM=60;SAP=42;ABP=5	CFH	missense	CFH:ENST00000367429.4:missense_variant:MODERATE:exon18/22:c.2850G>T:p.Gln950His:PF00084 [Sushi repeat (SCR repeat)]	CFH:NM_000186.4:missense_variant:MODERATE:exon18/22:c.2850G>T:p.Gln950His:		134370 [GENE=CFH PHENOS=Complement factor H deficiency,609814,Autosomal recessive,Autosomal dominant/Hemolytic uremic syndrome,atypical,susceptibility to,1,235400,Autosomal recessive,Autosomal dominant/Basal laminar drusen,126700,Autosomal dominant/Macular degeneration,age-related,4,610698];	294510 [benign/likely benign DISEASE=Basal laminar drusen,Atypical hemolytic-uremic syndrome 1,Age-related macular degeneration 4,CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II,not specified,not provided];	CM034428 [CLASS=DM? MUT=ALT PHEN="Haemolytic uraemic syndrome" GENE=CFH];		rs149474608	0.0016	0.0039	0,.	0.0008,0.0019,0.0000,0.0060,0.0001	-0.2730	D(0.04)	D(0.99)	0.02,0.17	14.24	0.32				-0.0033	0.9298	0	0	187	0 / 0	2	"[2] Ute Grasshoff 30.01.2015%0A[n/a] comment imported from detected variant: conflicting evidence"			CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196712577	196712577	T	C	wt	wt	het	low_conf_region	QUAL=305;DP=179,120,132;AF=0.00,0.00,0.23;MQM=45;SAP=70;ABP=84	CFH	splice_region&intron	CFH:ENST00000367429.4:splice_region_variant&intron_variant:LOW:intron19/21:c.3134-5T>C::	CFH:NM_000186.4:splice_region_variant&intron_variant:LOW:intron19/21:c.3134-5T>C::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	134370 [GENE=CFH PHENOS=Complement factor H deficiency,609814,Autosomal recessive,Autosomal dominant/Hemolytic uremic syndrome,atypical,susceptibility to,1,235400,Autosomal recessive,Autosomal dominant/Basal laminar drusen,126700,Autosomal dominant/Macular degeneration,age-related,4,610698];	875337 [uncertain significance DISEASE=Basal laminar drusen,Atypical hemolytic-uremic syndrome 1,Age-related macular degeneration 4,CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II];			rs513699		0.0468	0,.	0.0370,0.0684,0.1172,0.0401,0.0177	2.9620			0.62,0.39	6.39		9.26>8.55	0.000/0.028		-0.3647	0.7308	0.04	0	5841	0 / 0					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196712586	196712586	C	T	wt	wt	het	low_conf_region	QUAL=513;DP=191,135,149;AF=0.00,0.00,0.26;MQM=47;SAP=57;ABP=76	CFH	synonymous	CFH:ENST00000367429.4:synonymous_variant:LOW:exon20/22:c.3138C>T:p.Thr1046=:	CFH:NM_000186.4:synonymous_variant:LOW:exon20/22:c.3138C>T:p.Thr1046=:	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	134370 [GENE=CFH PHENOS=Complement factor H deficiency,609814,Autosomal recessive,Autosomal dominant/Hemolytic uremic syndrome,atypical,susceptibility to,1,235400,Autosomal recessive,Autosomal dominant/Basal laminar drusen,126700,Autosomal dominant/Macular degeneration,age-related,4,610698];	294519 [benign DISEASE=Basal laminar drusen,Atypical hemolytic-uremic syndrome 1,Age-related macular degeneration 4,CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II];			rs61822181		0.1278	0,.	0.1049,0.1903,0.2414,0.1127,0.0746	-0.0290			0.00,0.17	0.76					-0.0116	0.3151	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	197053373	197053373	G	A	hom	hom	hom		QUAL=18999;DP=240,197,138;AF=1.00,1.00,1.00;MQM=60;SAP=66;ABP=0	ASPM	3'UTR	ASPM:ENST00000294732.7:3_prime_UTR_variant:MODIFIER:exon27/27:c.*81C>T::,ASPM:ENST00000367408.1:3_prime_UTR_variant:MODIFIER:exon23/23:c.*81C>T::,ASPM:ENST00000367409.4:3_prime_UTR_variant:MODIFIER:exon28/28:c.*81C>T::	ASPM:NM_001206846.1:3_prime_UTR_variant:MODIFIER:exon27/27:c.*81C>T::,ASPM:NM_018136.5:3_prime_UTR_variant:MODIFIER:exon28/28:c.*81C>T::		605481 [GENE=ASPM PHENOS=Microcephaly 5,primary,autosomal recessive,608716,Autosomal recessive];	294591 [benign DISEASE=Primary autosomal recessive microcephaly 5];			rs12677	0.7823	0.7918	10517,.		1.4990			0.00,0.17	3.67					-0.0871	0.9455	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197053562	197053562	A	-	het	het	het	low_conf_region	QUAL=335;DP=97,41,26;AF=0.18,0.29,0.12;MQM=59;SAP=42;ABP=135	ASPM	splice_region&intron	ASPM:ENST00000294732.7:splice_region_variant&intron_variant:LOW:intron26/26:c.5577-6del::,ASPM:ENST00000367408.1:splice_region_variant&intron_variant:LOW:intron22/22:c.3327-6del::,ASPM:ENST00000367409.4:splice_region_variant&intron_variant:LOW:intron27/27:c.10332-6del::	ASPM:NM_001206846.1:splice_region_variant&intron_variant:LOW:intron26/26:c.5577-6del::,ASPM:NM_018136.5:splice_region_variant&intron_variant:LOW:intron27/27:c.10332-6del::		605481 [GENE=ASPM PHENOS=Microcephaly 5,primary,autosomal recessive,608716,Autosomal recessive];				rs200839523		0.2071	0,.	0.2939,0.2902,0.2922,0.1565,0.2351	-1.2230				0.04					0.1185	0.8238	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197055925	197055925	T	C	hom	hom	hom		QUAL=13630;DP=168,137,108;AF=1.00,1.00,1.00;MQM=60;SAP=199;ABP=0	ASPM	splice_region&intron	ASPM:ENST00000294732.7:splice_region_variant&intron_variant:LOW:intron26/26:c.5576+8A>G::,ASPM:ENST00000367408.1:splice_region_variant&intron_variant:LOW:intron22/22:c.3326+8A>G::,ASPM:ENST00000367409.4:splice_region_variant&intron_variant:LOW:intron27/27:c.10331+8A>G::	ASPM:NM_001206846.1:splice_region_variant&intron_variant:LOW:intron26/26:c.5576+8A>G::,ASPM:NM_018136.5:splice_region_variant&intron_variant:LOW:intron27/27:c.10331+8A>G::		605481 [GENE=ASPM PHENOS=Microcephaly 5,primary,autosomal recessive,608716,Autosomal recessive];	157775 [benign DISEASE=Primary autosomal recessive microcephaly 5,not specified,not provided];			rs10754213	0.7827	0.8877	10520,.	0.4435,0.9346,0.9998,0.9062,0.8985	-0.2090			0.00,0.34	7.32			0.000/0.000		-0.6175	0.0628	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197059928	197059928	A	G	hom	hom	hom	off-target	QUAL=8867;DP=104,101,80;AF=1.00,1.00,1.00;MQM=60;SAP=483;ABP=0	ASPM	intron	ASPM:ENST00000294732.7:intron_variant:MODIFIER:intron22/26:c.4881+52T>C::,ASPM:ENST00000367408.1:intron_variant:MODIFIER:intron18/22:c.2631+52T>C::,ASPM:ENST00000367409.4:intron_variant:MODIFIER:intron23/27:c.9636+52T>C::	ASPM:NM_001206846.1:intron_variant:MODIFIER:intron22/26:c.4881+52T>C::,ASPM:NM_018136.5:intron_variant:MODIFIER:intron23/27:c.9636+52T>C::		605481 [GENE=ASPM PHENOS=Microcephaly 5,primary,autosomal recessive,608716,Autosomal recessive];	673922 [benign DISEASE=not provided];			rs4915316	0.7564	0.7695	10207,.		0.0220			0.03,0.22	6.50					0.0435	0.3356	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197070521	197070521	C	G	wt	wt	het		QUAL=1189;DP=299,129,97;AF=0.00,0.00,0.49;MQM=60;SAP=12;ABP=3	ASPM	intron,missense	ASPM:ENST00000294732.7:intron_variant:MODIFIER:intron17/26:c.4066-5227G>C::,ASPM:ENST00000367408.1:intron_variant:MODIFIER:intron13/22:c.1816-5227G>C::,ASPM:ENST00000367409.4:missense_variant:MODERATE:exon18/28:c.7860G>C:p.Gln2620His:	ASPM:NM_001206846.1:intron_variant:MODIFIER:intron17/26:c.4066-5227G>C::,ASPM:NM_018136.5:missense_variant:MODERATE:exon18/28:c.7860G>C:p.Gln2620His:		605481 [GENE=ASPM PHENOS=Microcephaly 5,primary,autosomal recessive,608716,Autosomal recessive];	21609 [benign DISEASE=Primary autosomal recessive microcephaly 5,not specified,not provided];			rs12138336	0.0288	0.0507	34,.	0.0130,0.0317,0.0001,0.0715,0.0310	-1.0950	 , ,T(0.10)	 , ,B(0.03)	0.08,0.16	0.04	0.08				-0.002	0.3199	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197070776	197070776	C	T	het	het	het		QUAL=8712;DP=227,246,189;AF=0.55,0.49,0.46;MQM=60;SAP=13;ABP=3	ASPM	intron,synonymous	ASPM:ENST00000294732.7:intron_variant:MODIFIER:intron17/26:c.4066-5482G>A::,ASPM:ENST00000367408.1:intron_variant:MODIFIER:intron13/22:c.1816-5482G>A::,ASPM:ENST00000367409.4:synonymous_variant:LOW:exon18/28:c.7605G>A:p.Val2535=:PF00612 [IQ calmodulin-binding motif]	ASPM:NM_001206846.1:intron_variant:MODIFIER:intron17/26:c.4066-5482G>A::,ASPM:NM_018136.5:synonymous_variant:LOW:exon18/28:c.7605G>A:p.Val2535=:		605481 [GENE=ASPM PHENOS=Microcephaly 5,primary,autosomal recessive,608716,Autosomal recessive];	21603 [benign DISEASE=Primary autosomal recessive microcephaly 5,not specified];			rs10922162	0.2949	0.2570	802,.	0.0395,0.4648,0.7055,0.1568,0.2767	0.1820			0.14,0.43	3.36					-0.0071	0.3196	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197070815	197070815	T	C	hom	hom	hom		QUAL=19678;DP=237,197,155;AF=1.00,1.00,1.00;MQM=60;SAP=35;ABP=0	ASPM	intron,synonymous	ASPM:ENST00000294732.7:intron_variant:MODIFIER:intron17/26:c.4066-5521A>G::,ASPM:ENST00000367408.1:intron_variant:MODIFIER:intron13/22:c.1816-5521A>G::,ASPM:ENST00000367409.4:synonymous_variant:LOW:exon18/28:c.7566A>G:p.Leu2522=:	ASPM:NM_001206846.1:intron_variant:MODIFIER:intron17/26:c.4066-5521A>G::,ASPM:NM_018136.5:synonymous_variant:LOW:exon18/28:c.7566A>G:p.Leu2522=:		605481 [GENE=ASPM PHENOS=Microcephaly 5,primary,autosomal recessive,608716,Autosomal recessive];	21602 [benign DISEASE=Primary autosomal recessive microcephaly 5,not specified];			rs1412640		0.8954	10934,.	0.5426,0.9393,0.9997,0.9064,0.8990	-0.1270			0.06,0.15	2.40					0.0042	0.3201	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197070901	197070901	A	G	hom	hom	hom		QUAL=23171;DP=318,205,167;AF=1.00,1.00,1.00;MQM=60;SAP=17;ABP=0	ASPM	intron,missense	ASPM:ENST00000294732.7:intron_variant:MODIFIER:intron17/26:c.4066-5607T>C::,ASPM:ENST00000367408.1:intron_variant:MODIFIER:intron13/22:c.1816-5607T>C::,ASPM:ENST00000367409.4:missense_variant:MODERATE:exon18/28:c.7480T>C:p.Tyr2494His:	ASPM:NM_001206846.1:intron_variant:MODIFIER:intron17/26:c.4066-5607T>C::,ASPM:NM_018136.5:missense_variant:MODERATE:exon18/28:c.7480T>C:p.Tyr2494His:		605481 [GENE=ASPM PHENOS=Microcephaly 5,primary,autosomal recessive,608716,Autosomal recessive];	21599 [benign DISEASE=Primary autosomal recessive microcephaly 5,not specified];			rs964201	0.9974	0.9963	15559,.	0.9990,0.9992,1.0000,0.9936,0.9974	3.0000	 , ,T(1.00)	 , ,B(0.00)	0.09,0.87	17.11	0.19				0.0031	0.3201	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197091537	197091537	A	T	hom	hom	hom		QUAL=24393;DP=311,250,201;AF=1.00,1.00,1.00;MQM=60;SAP=141;ABP=0	ASPM	synonymous	ASPM:ENST00000294732.7:synonymous_variant:LOW:exon14/27:c.3579T>A:p.Ser1193=:,ASPM:ENST00000367408.1:synonymous_variant:LOW:exon10/23:c.1329T>A:p.Ser443=:,ASPM:ENST00000367409.4:synonymous_variant:LOW:exon14/28:c.3579T>A:p.Ser1193=:	ASPM:NM_001206846.1:synonymous_variant:LOW:exon14/27:c.3579T>A:p.Ser1193=:,ASPM:NM_018136.5:synonymous_variant:LOW:exon14/28:c.3579T>A:p.Ser1193=:		605481 [GENE=ASPM PHENOS=Microcephaly 5,primary,autosomal recessive,608716,Autosomal recessive];	21578 [benign DISEASE=Primary autosomal recessive microcephaly 5,not specified];			rs4915337	0.7825	0.8873	10513,.	0.4432,0.9345,0.9998,0.9060,0.8986	-0.3320			0.05,0.27	6.72					0.0297	0.4388	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197094030	197094030	C	T	het	het	het		QUAL=9365;DP=391,183,152;AF=0.50,0.48,0.48;MQM=60;SAP=296;ABP=4	ASPM	synonymous	ASPM:ENST00000294732.7:synonymous_variant:LOW:exon12/27:c.3138G>A:p.Arg1046=:,ASPM:ENST00000367408.1:synonymous_variant:LOW:exon8/23:c.888G>A:p.Arg296=:,ASPM:ENST00000367409.4:synonymous_variant:LOW:exon12/28:c.3138G>A:p.Arg1046=:	ASPM:NM_001206846.1:synonymous_variant:LOW:exon12/27:c.3138G>A:p.Arg1046=:,ASPM:NM_018136.5:synonymous_variant:LOW:exon12/28:c.3138G>A:p.Arg1046=:		605481 [GENE=ASPM PHENOS=Microcephaly 5,primary,autosomal recessive,608716,Autosomal recessive];	21573 [benign DISEASE=Primary autosomal recessive microcephaly 5,not specified];			rs6676084	0.2167	0.2794	1047,.	0.1541,0.2515,0.1110,0.3145,0.3089	-1.1000			0.03,0.20	7.24				COSV54135932	0.1516	0.2824	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197102745	197102745	A	G	het	het	het	off-target	QUAL=3190;DP=141,73,70;AF=0.48,0.45,0.40;MQM=60;SAP=233;ABP=8	ASPM	intron	ASPM:ENST00000294732.7:intron_variant:MODIFIER:intron5/26:c.2174-20T>C::,ASPM:ENST00000367408.1:intron_variant:MODIFIER:intron1/22:c.-77-20T>C::,ASPM:ENST00000367409.4:intron_variant:MODIFIER:intron5/27:c.2174-20T>C::	ASPM:NM_001206846.1:intron_variant:MODIFIER:intron5/26:c.2174-20T>C::,ASPM:NM_018136.5:intron_variant:MODIFIER:intron5/27:c.2174-20T>C::		605481 [GENE=ASPM PHENOS=Microcephaly 5,primary,autosomal recessive,608716,Autosomal recessive];	95887 [benign DISEASE=Primary autosomal recessive microcephaly 5,not specified];			rs4915344	0.2997	0.2574	806,.	0.0421,0.4639,0.7053,0.1566,0.2815	1.0580			0.04,0.21	12.76		6.91>6.50			-0.3194	0.489	0.18	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197108946	197108946	A	G	het	wt	het		QUAL=4088;DP=256,143,109;AF=0.41,0.00,0.44;MQM=60;SAP=26;ABP=22	ASPM	synonymous	ASPM:ENST00000294732.7:synonymous_variant:LOW:exon4/27:c.1977T>C:p.Ile659=:,ASPM:ENST00000367409.4:synonymous_variant:LOW:exon4/28:c.1977T>C:p.Ile659=:	ASPM:NM_001206846.1:synonymous_variant:LOW:exon4/27:c.1977T>C:p.Ile659=:,ASPM:NM_018136.5:synonymous_variant:LOW:exon4/28:c.1977T>C:p.Ile659=:		605481 [GENE=ASPM PHENOS=Microcephaly 5,primary,autosomal recessive,608716,Autosomal recessive];	21561 [benign DISEASE=Primary autosomal recessive microcephaly 5,not specified];			rs17550662	0.0192	0.0450	36,.	0.0080,0.0217,0.0001,0.0655,0.0106	1.6300			0.85,0.95	6.97					0.5479	0.0604	0.2	66	1954	0 / 0					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197109042	197109042	C	T	hom	hom	hom	off-target	QUAL=12541;DP=234,88,65;AF=1.00,1.00,1.00;MQM=60;SAP=452;ABP=0	ASPM	intron	ASPM:ENST00000294732.7:intron_variant:MODIFIER:intron3/26:c.1922-41G>A::,ASPM:ENST00000367409.4:intron_variant:MODIFIER:intron3/27:c.1922-41G>A::	ASPM:NM_001206846.1:intron_variant:MODIFIER:intron3/26:c.1922-41G>A::,ASPM:NM_018136.5:intron_variant:MODIFIER:intron3/27:c.1922-41G>A::		605481 [GENE=ASPM PHENOS=Microcephaly 5,primary,autosomal recessive,608716,Autosomal recessive];	157788 [benign DISEASE=not specified,not provided];			rs1332663	0.7825	0.8877	10528,.	0.4400,0.9344,0.9998,0.9052,0.8984	-0.7260			0.00,0.06	5.38					-0.0935	0.0502	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197112533	197112533	G	A	hom	hom	hom		QUAL=7441;DP=111,52,61;AF=1.00,1.00,0.98;MQM=60;SAP=10;ABP=0	ASPM	synonymous	ASPM:ENST00000294732.7:synonymous_variant:LOW:exon3/27:c.849C>T:p.Ser283=:,ASPM:ENST00000367409.4:synonymous_variant:LOW:exon3/28:c.849C>T:p.Ser283=:	ASPM:NM_001206846.1:synonymous_variant:LOW:exon3/27:c.849C>T:p.Ser283=:,ASPM:NM_018136.5:synonymous_variant:LOW:exon3/28:c.849C>T:p.Ser283=:		605481 [GENE=ASPM PHENOS=Microcephaly 5,primary,autosomal recessive,608716,Autosomal recessive];	95890 [benign DISEASE=Primary autosomal recessive microcephaly 5,not specified,not provided];			rs6677082	0.7556	0.8802	10211,.	0.3650,0.9303,0.9816,0.9055,0.8983	-0.0770			0.01,0.14	0.31					-0.0148	0.1558	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197113073	197113073	G	A	hom	hom	hom	off-target	QUAL=4415;DP=107,21,14;AF=1.00,1.00,1.00;MQM=60;SAP=311;ABP=0	ASPM	intron	ASPM:ENST00000294732.7:intron_variant:MODIFIER:intron2/26:c.441+14C>T::,ASPM:ENST00000367409.4:intron_variant:MODIFIER:intron2/27:c.441+14C>T::	ASPM:NM_001206846.1:intron_variant:MODIFIER:intron2/26:c.441+14C>T::,ASPM:NM_018136.5:intron_variant:MODIFIER:intron2/27:c.441+14C>T::	regulatory_region_variant:promoter	605481 [GENE=ASPM PHENOS=Microcephaly 5,primary,autosomal recessive,608716,Autosomal recessive];	95888 [benign/likely benign DISEASE=Primary autosomal recessive microcephaly 5,not specified];			rs1571964	0.7556	0.8798	10202,.	0.3621,0.9305,0.9817,0.9049,0.8982	-0.6110			0.05,0.43	7.80					0.0461	0.1786	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	198661668	198661668	G	A	het	wt	het		QUAL=808;DP=56,5,7;AF=0.46,0.00,0.86;MQM=60;SAP=10;ABP=3	PTPRC	intron,3'UTR	PTPRC:ENST00000348564.6:intron_variant:MODIFIER:intron3/29:c.100+166G>A::,PTPRC:ENST00000352140.3:intron_variant:MODIFIER:intron3/31:c.94+166G>A::,PTPRC:ENST00000367364.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*155G>A::,PTPRC:ENST00000367376.2:intron_variant:MODIFIER:intron3/32:c.94+166G>A::,PTPRC:ENST00000413409.2:intron_variant:MODIFIER:intron3/3:c.100+166G>A::,PTPRC:ENST00000442510.2:intron_variant:MODIFIER:intron3/32:c.100+166G>A::,PTPRC:ENST00000594404.1:intron_variant:MODIFIER:intron3/29:c.94+166G>A::,PTPRC:ENST00000598951.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*155G>A::	PTPRC:NM_001267798.2:intron_variant:MODIFIER:intron3/3:c.100+166G>A::,PTPRC:NM_002838.5:intron_variant:MODIFIER:intron3/32:c.100+166G>A::,PTPRC:NM_080921.3:intron_variant:MODIFIER:intron3/29:c.100+166G>A::,PTPRC:NR_052021.2:non_coding_transcript_exon_variant:MODIFIER:exon3/3:n.407G>A::	regulatory_region_variant:promoter_flanking_region	151460 [GENE=PTPRC PHENOS=Hepatitis C virus,susceptibility to,609532/Severe combined immunodeficiency,T cell-negative,B-cell/natural killer-cell positive,608971,Autosomal recessive];				rs115067628	0.0040	0.0118	2,.		-0.7770			0.01,0.10	0.34					-0.0325	0.8621	0	0	94	0 / 0					PTPRC (inh=AR oe_syn=1.07 oe_mis=0.87 oe_lof=0.11)
chr1	198665917	198665917	C	G	wt	wt	het		QUAL=3193;DP=448,293,205;AF=0.00,0.00,0.58;MQM=60;SAP=8;ABP=15	PTPRC	intron,synonymous	PTPRC:ENST00000348564.6:intron_variant:MODIFIER:intron3/29:c.100+4415C>G::,PTPRC:ENST00000352140.3:synonymous_variant:LOW:exon4/32:c.171C>G:p.Pro57=:PF12453 [Protein tyrosine phosphatase N terminal],PTPRC:ENST00000367376.2:synonymous_variant:LOW:exon4/33:c.171C>G:p.Pro57=:PF12453 [Protein tyrosine phosphatase N terminal],PTPRC:ENST00000442510.2:synonymous_variant:LOW:exon4/33:c.177C>G:p.Pro59=:PF12453 [Protein tyrosine phosphatase N terminal],PTPRC:ENST00000594404.1:intron_variant:MODIFIER:intron3/29:c.94+4415C>G::	PTPRC:NM_002838.5:synonymous_variant:LOW:exon4/33:c.177C>G:p.Pro59=:,PTPRC:NM_080921.3:intron_variant:MODIFIER:intron3/29:c.100+4415C>G::		151460 [GENE=PTPRC PHENOS=Hepatitis C virus,susceptibility to,609532/Severe combined immunodeficiency,T cell-negative,B-cell/natural killer-cell positive,608971,Autosomal recessive];	378444 [benign/likely benign DISEASE=Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-positive,not specified,none provided];	CS952043 [CLASS=DFP MUT=ALT PHEN="Defective splicing" GENE=PTPRC];		rs17612648	0.0044	0.0088	2,.	0.0022,0.0038,0.0001,0.0134,0.0117	0.5020			0.10,0.31	6.45					0.1576	0.4298	0	4	492	0 / 0					PTPRC (inh=AR oe_syn=1.07 oe_mis=0.87 oe_lof=0.11)
chr1	198677420	198677420	T	A	wt	het	wt	off-target	QUAL=521;DP=105,45,37;AF=0.00,0.51,0.00;MQM=60;SAP=24;ABP=3	PTPRC	intron	PTPRC:ENST00000348564.6:intron_variant:MODIFIER:intron7/29:c.550+30T>A::,PTPRC:ENST00000352140.3:intron_variant:MODIFIER:intron9/31:c.883+30T>A::,PTPRC:ENST00000367376.2:intron_variant:MODIFIER:intron10/32:c.1027+30T>A::,PTPRC:ENST00000442510.2:intron_variant:MODIFIER:intron10/32:c.1033+30T>A::,PTPRC:ENST00000594404.1:intron_variant:MODIFIER:intron7/29:c.544+30T>A::	PTPRC:NM_002838.5:intron_variant:MODIFIER:intron10/32:c.1033+30T>A::,PTPRC:NM_080921.3:intron_variant:MODIFIER:intron7/29:c.550+30T>A::		151460 [GENE=PTPRC PHENOS=Hepatitis C virus,susceptibility to,609532/Severe combined immunodeficiency,T cell-negative,B-cell/natural killer-cell positive,608971,Autosomal recessive];				rs2274368	0.0845	0.0597	51,.	0.0735,0.1212,0.1401,0.0311,0.0774	-0.3210			0.03,0.14	0.44					-0.0027	0.4958	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTPRC (inh=AR oe_syn=1.07 oe_mis=0.87 oe_lof=0.11)
chr1	198717218	198717218	-	T	het	het	het	off-target;low_conf_region	QUAL=692;DP=50,33,16;AF=0.32,0.24,0.56;MQM=60;SAP=38;ABP=27	PTPRC	intron	PTPRC:ENST00000348564.6:intron_variant:MODIFIER:intron23/29:c.2365-4dup::,PTPRC:ENST00000352140.3:intron_variant:MODIFIER:intron25/31:c.2698-4dup::,PTPRC:ENST00000367376.2:intron_variant:MODIFIER:intron26/32:c.2842-4dup::,PTPRC:ENST00000442510.2:intron_variant:MODIFIER:intron26/32:c.2848-4dup::,PTPRC:ENST00000594404.1:intron_variant:MODIFIER:intron23/29:c.2359-4dup::	PTPRC:NM_002838.5:intron_variant:MODIFIER:intron26/32:c.2848-4dup::,PTPRC:NM_080921.3:intron_variant:MODIFIER:intron23/29:c.2365-4dup::		151460 [GENE=PTPRC PHENOS=Hepatitis C virus,susceptibility to,609532/Severe combined immunodeficiency,T cell-negative,B-cell/natural killer-cell positive,608971,Autosomal recessive];			(T)n (Simple_repeat)	rs57296163		0.2602	795,.	0.1448,0.2047,0.2027,0.2855,0.2463					0.75					-0.0159	0.3683	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTPRC (inh=AR oe_syn=1.07 oe_mis=0.87 oe_lof=0.11)
chr1	198718732	198718732	A	G	het	het	wt	off-target	QUAL=3758;DP=213,108,80;AF=0.46,0.50,0.00;MQM=60;SAP=293;ABP=5	PTPRC	intron	PTPRC:ENST00000348564.6:intron_variant:MODIFIER:intron25/29:c.2589+54A>G::,PTPRC:ENST00000352140.3:intron_variant:MODIFIER:intron27/31:c.2922+54A>G::,PTPRC:ENST00000367376.2:intron_variant:MODIFIER:intron28/32:c.3066+54A>G::,PTPRC:ENST00000442510.2:intron_variant:MODIFIER:intron28/32:c.3072+54A>G::,PTPRC:ENST00000594404.1:intron_variant:MODIFIER:intron25/29:c.2583+54A>G::	PTPRC:NM_002838.5:intron_variant:MODIFIER:intron28/32:c.3072+54A>G::,PTPRC:NM_080921.3:intron_variant:MODIFIER:intron25/29:c.2589+54A>G::		151460 [GENE=PTPRC PHENOS=Hepatitis C virus,susceptibility to,609532/Severe combined immunodeficiency,T cell-negative,B-cell/natural killer-cell positive,608971,Autosomal recessive];				rs549239314	0.0004	0.0009	0,.		-0.9030			0.02,0.23	12.43					-0.0594	0.397	0	0	35	0 / 0					PTPRC (inh=AR oe_syn=1.07 oe_mis=0.87 oe_lof=0.11)
chr1	201008582	201008582	-	G	hom	het	het	off-target	QUAL=1966;DP=45,54,29;AF=0.91,0.50,0.52;MQM=60;SAP=183;ABP=3	RP11-168O16.2	intron&non_coding_transcript	RP11-168O16.2:ENST00000415359.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.211-2397dup::							rs35360610		0.5490	5089,.						0.63								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AR+AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201009556	201009556	A	G	hom	het	het	off-target	QUAL=5821;DP=127,83,63;AF=0.99,0.48,0.52;MQM=60;SAP=119;ABP=3	CACNA1S,RP11-168O16.2	intron,intron&non_coding_transcript	CACNA1S:ENST00000362061.3:intron_variant:MODIFIER:intron42/43:c.5227-54T>C::,CACNA1S:ENST00000367338.3:intron_variant:MODIFIER:intron41/42:c.5170-54T>C::,RP11-168O16.2:ENST00000415359.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.211-1427A>G::	CACNA1S:NM_000069.3:intron_variant:MODIFIER:intron42/43:c.5227-54T>C::		114208 [GENE=CACNA1S PHENOS=Malignant hyperthermia susceptibility 5,601887,Autosomal dominant/Thyrotoxic periodic paralysis,susceptibility to,1,188580,Autosomal dominant/Malignant hyperthermia,susceptibility to,5,601887,Autosomal dominant/Hypokalemic periodic paralysis,type 1,170400,Autosomal dominant];	678243 [benign DISEASE=not provided];			rs1546416	0.3325	0.3573	2068,.		-0.3490			0.03,0.12	3.15					0.0299	0.094	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AR+AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201009897	201009897	T	C	hom	hom	hom	off-target	QUAL=3763;DP=51,46,30;AF=1.00,1.00,1.00;MQM=60;SAP=115;ABP=0	CACNA1S,RP11-168O16.2	intron,intron&non_coding_transcript	CACNA1S:ENST00000362061.3:intron_variant:MODIFIER:intron41/43:c.5135-56A>G::,CACNA1S:ENST00000367338.3:intron_variant:MODIFIER:intron40/42:c.5078-56A>G::,RP11-168O16.2:ENST00000415359.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.211-1086T>C::	CACNA1S:NM_000069.3:intron_variant:MODIFIER:intron41/43:c.5135-56A>G::		114208 [GENE=CACNA1S PHENOS=Malignant hyperthermia susceptibility 5,601887,Autosomal dominant/Thyrotoxic periodic paralysis,susceptibility to,1,188580,Autosomal dominant/Malignant hyperthermia,susceptibility to,5,601887,Autosomal dominant/Hypokalemic periodic paralysis,type 1,170400,Autosomal dominant];	678241 [benign DISEASE=not provided];			rs6427875	0.9970	0.9947	15525,.		-5.3380			0.00,0.06	0.39					-0.0318	0.2119	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AR+AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201012597	201012597	G	A	hom	hom	wt		QUAL=366;DP=10,4,3;AF=1.00,1.00,0.00;MQM=60;SAP=25;ABP=0	CACNA1S	synonymous	CACNA1S:ENST00000362061.3:synonymous_variant:LOW:exon40/44:c.4860C>T:p.Pro1620=:,CACNA1S:ENST00000367338.3:synonymous_variant:LOW:exon39/43:c.4803C>T:p.Pro1601=:	CACNA1S:NM_000069.3:synonymous_variant:LOW:exon40/44:c.4860C>T:p.Pro1620=:	regulatory_region_variant:promoter_flanking_region	114208 [GENE=CACNA1S PHENOS=Malignant hyperthermia susceptibility 5,601887,Autosomal dominant/Thyrotoxic periodic paralysis,susceptibility to,1,188580,Autosomal dominant/Malignant hyperthermia,susceptibility to,5,601887,Autosomal dominant/Hypokalemic periodic paralysis,type 1,170400,Autosomal dominant];	254841 [benign DISEASE=Hypokalemic periodic paralysis 1,not specified];			rs41267497	0.0461	0.1051	202,.	0.0262,0.0673,0.0004,0.1612,0.0264	-1.1950			0.08,0.13	0.03					-0.0794	0.2242	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AR+AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201016296	201016296	G	A	wt	het	wt		QUAL=3275;DP=344,245,183;AF=0.00,0.52,0.00;MQM=60;SAP=14;ABP=4	CACNA1S	missense	CACNA1S:ENST00000362061.3:missense_variant:MODERATE:exon38/44:c.4615C>T:p.Arg1539Cys:PF08763 [Voltage gated calcium channel IQ domain],CACNA1S:ENST00000367338.3:missense_variant:MODERATE:exon37/43:c.4558C>T:p.Arg1520Cys:PF08763 [Voltage gated calcium channel IQ domain]	CACNA1S:NM_000069.3:missense_variant:MODERATE:exon38/44:c.4615C>T:p.Arg1539Cys:		114208 [GENE=CACNA1S PHENOS=Malignant hyperthermia susceptibility 5,601887,Autosomal dominant/Thyrotoxic periodic paralysis,susceptibility to,1,188580,Autosomal dominant/Malignant hyperthermia,susceptibility to,5,601887,Autosomal dominant/Hypokalemic periodic paralysis,type 1,170400,Autosomal dominant];	197021 [benign DISEASE=Hypokalemic periodic paralysis 1,not specified,not provided];			rs3850625	0.0841	0.1157	181,.	0.0206,0.0958,0.0333,0.1184,0.2102	6.1960	D(0.01),D(0.01)	B(0.30),B(0.30)	0.96,0.98	25.90	0.28				-0.2109	0.0828	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AR+AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201020105	201020105	A	G	wt	het	het		QUAL=6114;DP=131,276,211;AF=0.01,0.49,0.53;MQM=60;SAP=98;ABP=3	CACNA1S	splice_region&intron	CACNA1S:ENST00000362061.3:splice_region_variant&intron_variant:LOW:intron33/43:c.4113+7T>C::,CACNA1S:ENST00000367338.3:splice_region_variant&intron_variant:LOW:intron32/42:c.4056+7T>C::	CACNA1S:NM_000069.3:splice_region_variant&intron_variant:LOW:intron33/43:c.4113+7T>C::	regulatory_region_variant:enhancer	114208 [GENE=CACNA1S PHENOS=Malignant hyperthermia susceptibility 5,601887,Autosomal dominant/Thyrotoxic periodic paralysis,susceptibility to,1,188580,Autosomal dominant/Malignant hyperthermia,susceptibility to,5,601887,Autosomal dominant/Hypokalemic periodic paralysis,type 1,170400,Autosomal dominant];	199680 [benign DISEASE=Hypokalemic periodic paralysis 1,not specified,not provided];			rs6702590	0.8804	0.7833	9824,.	0.9371,0.8682,0.9959,0.6687,0.8663	-0.1250			0.01,0.16	0.35			0.000/0.000		0.1246	0.0518	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AR+AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201038687	201038687	A	G	het	het	wt		QUAL=8115;DP=218,426,341;AF=0.47,0.51,0.00;MQM=60;SAP=19;ABP=3	CACNA1S	synonymous	CACNA1S:ENST00000362061.3:synonymous_variant:LOW:exon18/44:c.2403T>C:p.Phe801=:,CACNA1S:ENST00000367338.3:synonymous_variant:LOW:exon18/43:c.2403T>C:p.Phe801=:	CACNA1S:NM_000069.3:synonymous_variant:LOW:exon18/44:c.2403T>C:p.Phe801=:		114208 [GENE=CACNA1S PHENOS=Malignant hyperthermia susceptibility 5,601887,Autosomal dominant/Thyrotoxic periodic paralysis,susceptibility to,1,188580,Autosomal dominant/Malignant hyperthermia,susceptibility to,5,601887,Autosomal dominant/Hypokalemic periodic paralysis,type 1,170400,Autosomal dominant];	254814 [benign DISEASE=Hypokalemic periodic paralysis 1,not specified,not provided];			rs7415038	0.2941	0.4108	2882,.	0.5285,0.2185,0.0030,0.4491,0.1847	5.5810			0.07,0.95	12.48					0.1051	0.3343	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AR+AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201042618	201042618	G	A	het	hom	wt	off-target	QUAL=4971;DP=79,140,101;AF=0.49,1.00,0.00;MQM=60;SAP=127;ABP=3	CACNA1S	intron	CACNA1S:ENST00000362061.3:intron_variant:MODIFIER:intron15/43:c.2157+59C>T::,CACNA1S:ENST00000367338.3:intron_variant:MODIFIER:intron15/42:c.2157+59C>T::	CACNA1S:NM_000069.3:intron_variant:MODIFIER:intron15/43:c.2157+59C>T::		114208 [GENE=CACNA1S PHENOS=Malignant hyperthermia susceptibility 5,601887,Autosomal dominant/Thyrotoxic periodic paralysis,susceptibility to,1,188580,Autosomal dominant/Malignant hyperthermia,susceptibility to,5,601887,Autosomal dominant/Hypokalemic periodic paralysis,type 1,170400,Autosomal dominant];	678298 [benign DISEASE=not provided];			rs9333652		0.4497	3452,.		0.2760			0.04,0.17	3.93					-0.0577	0.1428	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AR+AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201044748	201044748	A	G	het	hom	wt		QUAL=10501;DP=149,278,258;AF=0.52,1.00,0.00;MQM=60;SAP=26;ABP=3	CACNA1S	splice_region&intron	CACNA1S:ENST00000362061.3:splice_region_variant&intron_variant:LOW:intron12/43:c.1828-5T>C::,CACNA1S:ENST00000367338.3:splice_region_variant&intron_variant:LOW:intron12/42:c.1828-5T>C::	CACNA1S:NM_000069.3:splice_region_variant&intron_variant:LOW:intron12/43:c.1828-5T>C::		114208 [GENE=CACNA1S PHENOS=Malignant hyperthermia susceptibility 5,601887,Autosomal dominant/Thyrotoxic periodic paralysis,susceptibility to,1,188580,Autosomal dominant/Malignant hyperthermia,susceptibility to,5,601887,Autosomal dominant/Hypokalemic periodic paralysis,type 1,170400,Autosomal dominant];	254804 [benign DISEASE=Hypokalemic periodic paralysis 1,not specified,not provided];			rs1998721	0.7596	0.7819	8354,.	0.5463,0.7202,0.9604,0.7765,0.8902	-1.1900			0.00,0.12	0.22		11.27>10.69	0.000/0.002		0.3551	0.1955	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AR+AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201046025	201046025	G	T	het	het	wt	off-target	QUAL=4258;DP=79,331,275;AF=0.48,0.52,0.01;MQM=60;SAP=313;ABP=4	CACNA1S	intron	CACNA1S:ENST00000362061.3:intron_variant:MODIFIER:intron12/43:c.1827+23C>A::,CACNA1S:ENST00000367338.3:intron_variant:MODIFIER:intron12/42:c.1827+23C>A::	CACNA1S:NM_000069.3:intron_variant:MODIFIER:intron12/43:c.1827+23C>A::		114208 [GENE=CACNA1S PHENOS=Malignant hyperthermia susceptibility 5,601887,Autosomal dominant/Thyrotoxic periodic paralysis,susceptibility to,1,188580,Autosomal dominant/Malignant hyperthermia,susceptibility to,5,601887,Autosomal dominant/Hypokalemic periodic paralysis,type 1,170400,Autosomal dominant];			L2c (LINE/L2)	rs7549030	0.0457	0.0696	78,.	0.0773,0.0392,0.0001,0.0739,0.0251	0.0950			0.07,0.22	2.94					0.0061	0.0994	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AR+AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201047062	201047062	G	A	hom	het	hom		QUAL=15010;DP=139,266,260;AF=0.99,0.48,1.00;MQM=60;SAP=126;ABP=4	CACNA1S	synonymous	CACNA1S:ENST00000362061.3:synonymous_variant:LOW:exon11/44:c.1564C>T:p.Leu522=:PF00520 [Ion transport protein],CACNA1S:ENST00000367338.3:synonymous_variant:LOW:exon11/43:c.1564C>T:p.Leu522=:PF00520 [Ion transport protein]	CACNA1S:NM_000069.3:synonymous_variant:LOW:exon11/44:c.1564C>T:p.Leu522=:		114208 [GENE=CACNA1S PHENOS=Malignant hyperthermia susceptibility 5,601887,Autosomal dominant/Thyrotoxic periodic paralysis,susceptibility to,1,188580,Autosomal dominant/Malignant hyperthermia,susceptibility to,5,601887,Autosomal dominant/Hypokalemic periodic paralysis,type 1,170400,Autosomal dominant];	254801 [benign DISEASE=Hypokalemic periodic paralysis 1,not specified];	CM023570 [CLASS=DP MUT=ALT PHEN="Hypokalaemic periodic paralysis association with" GENE=CACNA1S];		rs4915476	0.1909	0.2220	801,.	0.2594,0.2751,0.0403,0.2290,0.1119	3.9470			0.93,0.98	9.39					-0.0581	0.1254	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AR+AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201047075	201047075	A	G	hom	het	hom		QUAL=17399;DP=185,286,267;AF=0.99,0.50,1.00;MQM=60;SAP=118;ABP=3	CACNA1S	synonymous	CACNA1S:ENST00000362061.3:synonymous_variant:LOW:exon11/44:c.1551T>C:p.Gly517=:PF00520 [Ion transport protein],CACNA1S:ENST00000367338.3:synonymous_variant:LOW:exon11/43:c.1551T>C:p.Gly517=:PF00520 [Ion transport protein]	CACNA1S:NM_000069.3:synonymous_variant:LOW:exon11/44:c.1551T>C:p.Gly517=:		114208 [GENE=CACNA1S PHENOS=Malignant hyperthermia susceptibility 5,601887,Autosomal dominant/Thyrotoxic periodic paralysis,susceptibility to,1,188580,Autosomal dominant/Malignant hyperthermia,susceptibility to,5,601887,Autosomal dominant/Hypokalemic periodic paralysis,type 1,170400,Autosomal dominant];	254800 [benign DISEASE=Malignant hyperthermia, susceptibility to, 5,Hypokalemic periodic paralysis 1,not specified,not provided];			rs4915477	0.5711	0.6663	7402,.	0.8959,0.5864,0.2246,0.6543,0.3215	-1.5080			0.02,0.47	8.84					0.1246	0.1296	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AR+AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201054197	201054197	G	T	wt	wt	het	off-target	QUAL=923;DP=82,113,88;AF=0.00,0.00,0.50;MQM=60;SAP=19;ABP=3	CACNA1S	intron	CACNA1S:ENST00000362061.3:intron_variant:MODIFIER:intron8/43:c.1151-38C>A::,CACNA1S:ENST00000367338.3:intron_variant:MODIFIER:intron8/42:c.1151-38C>A::	CACNA1S:NM_000069.3:intron_variant:MODIFIER:intron8/43:c.1151-38C>A::		114208 [GENE=CACNA1S PHENOS=Malignant hyperthermia susceptibility 5,601887,Autosomal dominant/Thyrotoxic periodic paralysis,susceptibility to,1,188580,Autosomal dominant/Malignant hyperthermia,susceptibility to,5,601887,Autosomal dominant/Hypokalemic periodic paralysis,type 1,170400,Autosomal dominant];	678295 [benign DISEASE=not provided];			rs41267505	0.1286	0.1585	359,.	0.1434,0.2471,0.0363,0.1667,0.0878	-0.2930			0.07,0.23	4.78					-0.062	0.0824	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AR+AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201060865	201060865	G	A	wt	het	wt		QUAL=2468;DP=166,185,158;AF=0.01,0.54,0.00;MQM=60;SAP=6;ABP=5	CACNA1S	synonymous	CACNA1S:ENST00000362061.3:synonymous_variant:LOW:exon5/44:c.597C>T:p.Ile199=:PF00520 [Ion transport protein],CACNA1S:ENST00000367338.3:synonymous_variant:LOW:exon5/43:c.597C>T:p.Ile199=:PF00520 [Ion transport protein]	CACNA1S:NM_000069.3:synonymous_variant:LOW:exon5/44:c.597C>T:p.Ile199=:		114208 [GENE=CACNA1S PHENOS=Malignant hyperthermia susceptibility 5,601887,Autosomal dominant/Thyrotoxic periodic paralysis,susceptibility to,1,188580,Autosomal dominant/Malignant hyperthermia,susceptibility to,5,601887,Autosomal dominant/Hypokalemic periodic paralysis,type 1,170400,Autosomal dominant];	254852 [benign DISEASE=Hypokalemic periodic paralysis 1,not specified,not provided];			rs2296383	0.3051	0.3897	1979,.	0.1009,0.3501,0.3592,0.4292,0.4506	-0.7520			0.15,0.96	10.71					-0.2141	0.0688	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AR+AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	209788213	209788213	T	C	hom	het	het		QUAL=5650;DP=152,72,41;AF=0.99,0.46,0.59;MQM=60;SAP=455;ABP=3	CAMK1G,LAMB3	downstream_gene	CAMK1G:ENST00000009105.1:downstream_gene_variant:MODIFIER::::,LAMB3:ENST00000356082.4:downstream_gene_variant:MODIFIER::::,CAMK1G:ENST00000361322.2:downstream_gene_variant:MODIFIER::::,LAMB3:ENST00000367030.3:downstream_gene_variant:MODIFIER::::,LAMB3:ENST00000391911.1:downstream_gene_variant:MODIFIER::::		regulatory_region_variant:promoter_flanking_region	150310 [GENE=LAMB3 PHENOS=Amelogenesis imperfecta,type IA,104530,Autosomal dominant/Epidermolysis bullosa,junctional,Herlitz type,226700,Autosomal recessive/Epidermolysis bullosa,junctional,non-Herlitz type,226650,Autosomal recessive];	368859 [benign DISEASE=Junctional epidermolysis bullosa];			rs926387	0.7748	0.7541	9116,.		-1.1700			0.00,0.11	0.70								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CAMK1G (inh=n/a oe_syn=1.14 oe_mis=0.73 oe_lof=0.40), LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55)
chr1	209788514	209788514	G	A	het	het	wt		QUAL=5431;DP=185,262,240;AF=0.52,0.46,0.00;MQM=60;SAP=107;ABP=4	LAMB3	3'UTR	LAMB3:ENST00000356082.4:3_prime_UTR_variant:MODIFIER:exon23/23:c.*102C>T::,LAMB3:ENST00000367030.3:3_prime_UTR_variant:MODIFIER:exon23/23:c.*102C>T::,LAMB3:ENST00000391911.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*102C>T::	LAMB3:NM_000228.3:3_prime_UTR_variant:MODIFIER:exon23/23:c.*102C>T::,LAMB3:NM_001017402.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*102C>T::,LAMB3:NM_001127641.1:3_prime_UTR_variant:MODIFIER:exon23/23:c.*102C>T::	regulatory_region_variant:promoter_flanking_region	150310 [GENE=LAMB3 PHENOS=Amelogenesis imperfecta,type IA,104530,Autosomal dominant/Epidermolysis bullosa,junctional,Herlitz type,226700,Autosomal recessive/Epidermolysis bullosa,junctional,non-Herlitz type,226650,Autosomal recessive];	295059 [benign DISEASE=Junctional epidermolysis bullosa];	CR1010233 [CLASS=DP MUT=ALT PHEN="Cervical cancer increased risk association with" GENE=LAMB3];		rs2566	0.2951	0.2762	1192,.		1.1010			0.10,0.19	6.02					-0.0951	0.9257	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CAMK1G (inh=n/a oe_syn=1.14 oe_mis=0.73 oe_lof=0.40), LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55)
chr1	209792015	209792015	-	C	hom	hom	hom	off-target	QUAL=12580;DP=159,180,131;AF=0.94,0.98,0.94;MQM=60;SAP=690;ABP=0	LAMB3	intron	LAMB3:ENST00000356082.4:intron_variant:MODIFIER:intron18/22:c.2702-12dup::,LAMB3:ENST00000367030.3:intron_variant:MODIFIER:intron18/22:c.2702-12dup::,LAMB3:ENST00000391911.1:intron_variant:MODIFIER:intron17/21:c.2702-12dup::	LAMB3:NM_000228.3:intron_variant:MODIFIER:intron18/22:c.2702-12dup::,LAMB3:NM_001017402.1:intron_variant:MODIFIER:intron17/21:c.2702-12dup::,LAMB3:NM_001127641.1:intron_variant:MODIFIER:intron18/22:c.2702-12dup::	regulatory_region_variant:promoter_flanking_region	150310 [GENE=LAMB3 PHENOS=Amelogenesis imperfecta,type IA,104530,Autosomal dominant/Epidermolysis bullosa,junctional,Herlitz type,226700,Autosomal recessive/Epidermolysis bullosa,junctional,non-Herlitz type,226650,Autosomal recessive];	255590 [benign DISEASE=Junctional epidermolysis bullosa,not specified,not provided];			rs397807887		0.9574	14335,.	0.9896,0.9832,0.9998,0.9314,0.9883					12.13					-0.8706	0.675	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CAMK1G (inh=n/a oe_syn=1.14 oe_mis=0.73 oe_lof=0.40), LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55), MIR4260 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	209799253	209799253	A	G	het	het	hom		QUAL=21363;DP=297,547,382;AF=0.40,0.50,1.00;MQM=60;SAP=300;ABP=11	LAMB3	synonymous	LAMB3:ENST00000356082.4:synonymous_variant:LOW:exon14/23:c.1716T>C:p.Cys572=:PF00053 [Laminin EGF domain],LAMB3:ENST00000367030.3:synonymous_variant:LOW:exon14/23:c.1716T>C:p.Cys572=:PF00053 [Laminin EGF domain],LAMB3:ENST00000391911.1:synonymous_variant:LOW:exon13/22:c.1716T>C:p.Cys572=:PF00053 [Laminin EGF domain]	LAMB3:NM_000228.3:synonymous_variant:LOW:exon14/23:c.1716T>C:p.Cys572=:,LAMB3:NM_001017402.1:synonymous_variant:LOW:exon13/22:c.1716T>C:p.Cys572=:,LAMB3:NM_001127641.1:synonymous_variant:LOW:exon14/23:c.1716T>C:p.Cys572=:	regulatory_region_variant:promoter_flanking_region	150310 [GENE=LAMB3 PHENOS=Amelogenesis imperfecta,type IA,104530,Autosomal dominant/Epidermolysis bullosa,junctional,Herlitz type,226700,Autosomal recessive/Epidermolysis bullosa,junctional,non-Herlitz type,226650,Autosomal recessive];	255587 [benign DISEASE=Junctional epidermolysis bullosa,not specified];			rs2179402	0.7650	0.7542	8634,.	0.7692,0.7728,0.8231,0.7368,0.7431	-0.8090			0.06,0.75	7.05					0.0941	0.2311	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55), MIR4260 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	209804095	209804095	G	A	hom	hom	hom	off-target	QUAL=12047;DP=111,157,124;AF=1.00,1.00,1.00;MQM=60;SAP=152;ABP=0	LAMB3	intron	LAMB3:ENST00000356082.4:intron_variant:MODIFIER:intron8/22:c.823-15C>T::,LAMB3:ENST00000367030.3:intron_variant:MODIFIER:intron8/22:c.823-15C>T::,LAMB3:ENST00000391911.1:intron_variant:MODIFIER:intron7/21:c.823-15C>T::	LAMB3:NM_000228.3:intron_variant:MODIFIER:intron8/22:c.823-15C>T::,LAMB3:NM_001017402.1:intron_variant:MODIFIER:intron7/21:c.823-15C>T::,LAMB3:NM_001127641.1:intron_variant:MODIFIER:intron8/22:c.823-15C>T::	regulatory_region_variant:promoter_flanking_region,TF_binding_site_variant	150310 [GENE=LAMB3 PHENOS=Amelogenesis imperfecta,type IA,104530,Autosomal dominant/Epidermolysis bullosa,junctional,Herlitz type,226700,Autosomal recessive/Epidermolysis bullosa,junctional,non-Herlitz type,226650,Autosomal recessive];	255598 [benign DISEASE=Junctional epidermolysis bullosa,not specified];			rs4844863	0.8233	0.8455	11143,.	0.8295,0.8277,0.8233,0.8546,0.8121	-2.2320			0.01,0.10	0.13		8.37>7.66			0.0118	0.3147	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55)
chr1	209807972	209807972	G	A	hom	hom	hom		QUAL=5396;DP=34,91,58;AF=1.00,1.00,1.00;MQM=60;SAP=81;ABP=0	LAMB3	synonymous	LAMB3:ENST00000356082.4:synonymous_variant:LOW:exon6/23:c.384C>T:p.Pro128=:PF00055 [Laminin N-terminal (Domain VI)],LAMB3:ENST00000367030.3:synonymous_variant:LOW:exon6/23:c.384C>T:p.Pro128=:PF00055 [Laminin N-terminal (Domain VI)],LAMB3:ENST00000391911.1:synonymous_variant:LOW:exon5/22:c.384C>T:p.Pro128=:PF00055 [Laminin N-terminal (Domain VI)]	LAMB3:NM_000228.3:synonymous_variant:LOW:exon6/23:c.384C>T:p.Pro128=:,LAMB3:NM_001017402.1:synonymous_variant:LOW:exon5/22:c.384C>T:p.Pro128=:,LAMB3:NM_001127641.1:synonymous_variant:LOW:exon6/23:c.384C>T:p.Pro128=:	regulatory_region_variant:promoter_flanking_region,regulatory_region_variant:CTCF_binding_site	150310 [GENE=LAMB3 PHENOS=Amelogenesis imperfecta,type IA,104530,Autosomal dominant/Epidermolysis bullosa,junctional,Herlitz type,226700,Autosomal recessive/Epidermolysis bullosa,junctional,non-Herlitz type,226650,Autosomal recessive];	255596 [benign DISEASE=Junctional epidermolysis bullosa,not specified];			rs1130667	0.2454	0.3424	1719,.	0.1309,0.2131,0.2290,0.4051,0.3404	-4.0330			0.08,0.78	3.77					0.0405	0.6778	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55)
chr1	209811886	209811886	T	G	hom	hom	hom		QUAL=18913;DP=251,210,137;AF=1.00,1.00,1.00;MQM=60;SAP=70;ABP=0	LAMB3	synonymous	LAMB3:ENST00000356082.4:synonymous_variant:LOW:exon4/23:c.291A>C:p.Ser97=:PF00055 [Laminin N-terminal (Domain VI)],LAMB3:ENST00000367030.3:synonymous_variant:LOW:exon4/23:c.291A>C:p.Ser97=:PF00055 [Laminin N-terminal (Domain VI)],LAMB3:ENST00000391911.1:synonymous_variant:LOW:exon3/22:c.291A>C:p.Ser97=:PF00055 [Laminin N-terminal (Domain VI)]	LAMB3:NM_000228.3:synonymous_variant:LOW:exon4/23:c.291A>C:p.Ser97=:,LAMB3:NM_001017402.1:synonymous_variant:LOW:exon3/22:c.291A>C:p.Ser97=:,LAMB3:NM_001127641.1:synonymous_variant:LOW:exon4/23:c.291A>C:p.Ser97=:	regulatory_region_variant:promoter_flanking_region	150310 [GENE=LAMB3 PHENOS=Amelogenesis imperfecta,type IA,104530,Autosomal dominant/Epidermolysis bullosa,junctional,Herlitz type,226700,Autosomal recessive/Epidermolysis bullosa,junctional,non-Herlitz type,226650,Autosomal recessive];	255592 [benign DISEASE=Junctional epidermolysis bullosa,not specified];			rs2076356	0.4325	0.5708	5421,.	0.4101,0.4441,0.2859,0.6558,0.4959	-0.9220			0.06,0.45	5.28					0.0483	0.1756	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55)
chr1	209824707	209824707	A	T	hom	hom	hom	off-target	QUAL=9166;DP=163,84,80;AF=0.99,1.00,1.00;MQM=60;SAP=711;ABP=0	LAMB3	intron	LAMB3:ENST00000356082.4:intron_variant:MODIFIER:intron1/22:c.-37-381T>A::,LAMB3:ENST00000367030.3:intron_variant:MODIFIER:intron1/22:c.-37-381T>A::	LAMB3:NM_000228.3:intron_variant:MODIFIER:intron1/22:c.-37-381T>A::,LAMB3:NM_001127641.1:intron_variant:MODIFIER:intron1/22:c.-37-381T>A::	TF_binding_site_variant	150310 [GENE=LAMB3 PHENOS=Amelogenesis imperfecta,type IA,104530,Autosomal dominant/Epidermolysis bullosa,junctional,Herlitz type,226700,Autosomal recessive/Epidermolysis bullosa,junctional,non-Herlitz type,226650,Autosomal recessive];				rs10779510	0.8966	0.8758	12093,.		-0.2920			0.00,0.06	8.98					-0.0459	0.3999	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55)
chr1	209959614	209959614	G	T	het	het	wt		QUAL=6872;DP=336,185,125;AF=0.53,0.50,0.00;MQM=57;SAP=13;ABP=5	IRF6	3'UTR	IRF6:ENST00000367021.3:3_prime_UTR_variant:MODIFIER:exon9/9:c.*2151C>A::	IRF6:NM_001206696.1:3_prime_UTR_variant:MODIFIER:exon7/7:c.*2151C>A::,IRF6:NM_006147.4:3_prime_UTR_variant:MODIFIER:exon9/9:c.*2151C>A::		607199 [GENE=IRF6 PHENOS=Popliteal pterygium syndrome 1,119500,Autosomal dominant/Orofacial cleft 6,608864,Autosomal dominant/van der Woude syndrome,119300,Autosomal dominant];	295175 [benign DISEASE=van der Woude syndrome 1,Orofacial cleft 6, susceptibility to];			rs1044516	0.3099	0.2164	874,.		-0.3100			0.02,0.11	0.78					-0.0022	0.9129	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TRAF3IP3 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.62), C1ORF74 (inh=n/a oe_syn=0.80 oe_mis=0.83 oe_lof=0.48), IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209959872	209959872	G	A	hom	hom	hom		QUAL=19022;DP=311,150,125;AF=1.00,0.99,0.99;MQM=57;SAP=4;ABP=0	IRF6	3'UTR	IRF6:ENST00000367021.3:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1893C>T::	IRF6:NM_001206696.1:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1893C>T::,IRF6:NM_006147.4:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1893C>T::		607199 [GENE=IRF6 PHENOS=Popliteal pterygium syndrome 1,119500,Autosomal dominant/Orofacial cleft 6,608864,Autosomal dominant/van der Woude syndrome,119300,Autosomal dominant];	295178 [benign DISEASE=van der Woude syndrome 1,Orofacial cleft 6, susceptibility to];			rs680331	0.8081	0.8037	10114,.		-0.0130			0.00,0.06	4.61					-0.0137	0.9127	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TRAF3IP3 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.62), C1ORF74 (inh=n/a oe_syn=0.80 oe_mis=0.83 oe_lof=0.48), IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209960087	209960087	A	-	wt	het	wt		QUAL=1633;DP=253,118,130;AF=0.00,0.53,0.00;MQM=60;SAP=3;ABP=4	IRF6	3'UTR	IRF6:ENST00000367021.3:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1678del::	IRF6:NM_001206696.1:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1678del::,IRF6:NM_006147.4:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1678del::		607199 [GENE=IRF6 PHENOS=Popliteal pterygium syndrome 1,119500,Autosomal dominant/Orofacial cleft 6,608864,Autosomal dominant/van der Woude syndrome,119300,Autosomal dominant];	295181 [benign DISEASE=van der Woude syndrome 1,Cleft Lip +/- Cleft Palate, Autosomal Dominant];			rs141112353		0.2010	586,.		0.4150				1.35					0.0047	0.913	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TRAF3IP3 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.62), C1ORF74 (inh=n/a oe_syn=0.80 oe_mis=0.83 oe_lof=0.48), IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209960152	209960152	T	A	wt	het	wt		QUAL=1217;DP=264,104,101;AF=0.00,0.48,0.00;MQM=60;SAP=9;ABP=3	IRF6	3'UTR	IRF6:ENST00000367021.3:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1613A>T::	IRF6:NM_001206696.1:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1613A>T::,IRF6:NM_006147.4:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1613A>T::		607199 [GENE=IRF6 PHENOS=Popliteal pterygium syndrome 1,119500,Autosomal dominant/Orofacial cleft 6,608864,Autosomal dominant/van der Woude syndrome,119300,Autosomal dominant];				rs1195550606					-0.6290			0.05,0.13	2.35					0.0004	0.913	0	0	1	0 / 0					TRAF3IP3 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.62), C1ORF74 (inh=n/a oe_syn=0.80 oe_mis=0.83 oe_lof=0.48), IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209960436	209960436	G	A	het	het	wt		QUAL=6308;DP=254,249,200;AF=0.46,0.51,0.00;MQM=60;SAP=56;ABP=4	IRF6,RP3-434O14.8	3'UTR,non_coding_transcript_exon	IRF6:ENST00000367021.3:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1329C>T::,RP3-434O14.8:ENST00000430751.1:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.479C>T::	IRF6:NM_001206696.1:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1329C>T::,IRF6:NM_006147.4:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1329C>T::		607199 [GENE=IRF6 PHENOS=Popliteal pterygium syndrome 1,119500,Autosomal dominant/Orofacial cleft 6,608864,Autosomal dominant/van der Woude syndrome,119300,Autosomal dominant];	295184 [benign DISEASE=van der Woude syndrome 1,Orofacial cleft 6, susceptibility to];		AluJo (SINE/Alu)	rs2235372	0.2991	0.2097	786,.		-1.0970			0.00,0.09	3.24					-0.043	0.9474	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TRAF3IP3 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.62), C1ORF74 (inh=n/a oe_syn=0.80 oe_mis=0.83 oe_lof=0.48), IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209960922	209960922	A	C	het	wt	hom		QUAL=2821;DP=122,124,44;AF=0.48,0.00,1.00;MQM=60;SAP=13;ABP=4	IRF6,RP3-434O14.8	3'UTR,splice_donor&non_coding_transcript	IRF6:ENST00000367021.3:3_prime_UTR_variant:MODIFIER:exon9/9:c.*843T>G::,RP3-434O14.8:ENST00000430751.1:splice_donor_variant&non_coding_transcript_variant:HIGH:intron1/1:n.115+2T>G::	IRF6:NM_001206696.1:3_prime_UTR_variant:MODIFIER:exon7/7:c.*843T>G::,IRF6:NM_006147.4:3_prime_UTR_variant:MODIFIER:exon9/9:c.*843T>G::		607199 [GENE=IRF6 PHENOS=Popliteal pterygium syndrome 1,119500,Autosomal dominant/Orofacial cleft 6,608864,Autosomal dominant/van der Woude syndrome,119300,Autosomal dominant];	295189 [benign DISEASE=van der Woude syndrome 1,Orofacial cleft 6, susceptibility to];			rs599021	0.3043	0.3677	2220,.		0.2650			0.09,0.22	15.96		0.67>-6.98			-1.3503	0.9982	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF74 (inh=n/a oe_syn=0.80 oe_mis=0.83 oe_lof=0.48), IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209960925	209960925	T	C	het	het	wt		QUAL=3094;DP=127,123,43;AF=0.54,0.45,0.00;MQM=60;SAP=33;ABP=3	IRF6,RP3-434O14.8	3'UTR,splice_region&non_coding_transcript_exon	IRF6:ENST00000367021.3:3_prime_UTR_variant:MODIFIER:exon9/9:c.*840A>G::,RP3-434O14.8:ENST00000430751.1:splice_region_variant&non_coding_transcript_exon_variant:LOW:exon1/2:n.114A>G::	IRF6:NM_001206696.1:3_prime_UTR_variant:MODIFIER:exon7/7:c.*840A>G::,IRF6:NM_006147.4:3_prime_UTR_variant:MODIFIER:exon9/9:c.*840A>G::		607199 [GENE=IRF6 PHENOS=Popliteal pterygium syndrome 1,119500,Autosomal dominant/Orofacial cleft 6,608864,Autosomal dominant/van der Woude syndrome,119300,Autosomal dominant];	295190 [benign DISEASE=van der Woude syndrome 1,Orofacial cleft 6, susceptibility to];			rs742214	0.2971	0.2092	788,.		-1.1730			0.04,0.15	5.30		0.67>-3.49			-2.0602	0.9999	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF74 (inh=n/a oe_syn=0.80 oe_mis=0.83 oe_lof=0.48), IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209961023	209961023	T	A	het	het	wt		QUAL=2214;DP=97,81,51;AF=0.51,0.49,0.02;MQM=60;SAP=19;ABP=3	IRF6,RP3-434O14.8	3'UTR,non_coding_transcript_exon	IRF6:ENST00000367021.3:3_prime_UTR_variant:MODIFIER:exon9/9:c.*742A>T::,RP3-434O14.8:ENST00000430751.1:non_coding_transcript_exon_variant:MODIFIER:exon1/2:n.16A>T::	IRF6:NM_001206696.1:3_prime_UTR_variant:MODIFIER:exon7/7:c.*742A>T::,IRF6:NM_006147.4:3_prime_UTR_variant:MODIFIER:exon9/9:c.*742A>T::		607199 [GENE=IRF6 PHENOS=Popliteal pterygium syndrome 1,119500,Autosomal dominant/Orofacial cleft 6,608864,Autosomal dominant/van der Woude syndrome,119300,Autosomal dominant];	295193 [benign DISEASE=van der Woude syndrome 1,Orofacial cleft 6, susceptibility to];			rs742215	0.3037	0.2151	837,.		0.9660			0.09,0.28	12.54					-0.347	0.9127	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF74 (inh=n/a oe_syn=0.80 oe_mis=0.83 oe_lof=0.48), IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209961314	209961314	T	C	het	het	wt		QUAL=6579;DP=266,239,188;AF=0.51,0.47,0.01;MQM=60;SAP=3;ABP=3	IRF6	3'UTR	IRF6:ENST00000367021.3:3_prime_UTR_variant:MODIFIER:exon9/9:c.*451A>G::	IRF6:NM_001206696.1:3_prime_UTR_variant:MODIFIER:exon7/7:c.*451A>G::,IRF6:NM_006147.4:3_prime_UTR_variant:MODIFIER:exon9/9:c.*451A>G::		607199 [GENE=IRF6 PHENOS=Popliteal pterygium syndrome 1,119500,Autosomal dominant/Orofacial cleft 6,608864,Autosomal dominant/van der Woude syndrome,119300,Autosomal dominant];	295199 [benign DISEASE=van der Woude syndrome 1,Orofacial cleft 6, susceptibility to];			rs17317411	0.0875	0.1004	211,.		0.3060			0.26,0.20	11.62					0.0029	0.913	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF74 (inh=n/a oe_syn=0.80 oe_mis=0.83 oe_lof=0.48), IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209961354	209961354	G	A	wt	het	wt		QUAL=2560;DP=331,207,163;AF=0.00,0.47,0.00;MQM=60;SAP=4;ABP=4	IRF6	3'UTR	IRF6:ENST00000367021.3:3_prime_UTR_variant:MODIFIER:exon9/9:c.*411C>T::	IRF6:NM_001206696.1:3_prime_UTR_variant:MODIFIER:exon7/7:c.*411C>T::,IRF6:NM_006147.4:3_prime_UTR_variant:MODIFIER:exon9/9:c.*411C>T::		607199 [GENE=IRF6 PHENOS=Popliteal pterygium syndrome 1,119500,Autosomal dominant/Orofacial cleft 6,608864,Autosomal dominant/van der Woude syndrome,119300,Autosomal dominant];	295200 [benign DISEASE=van der Woude syndrome 1,Orofacial cleft 6, susceptibility to];		MIR3 (SINE/MIR)	rs187379424	0.0008	0.0068	2,.		1.8560			0.20,0.22	6.23					-0.0073	0.9128	0	0	35	0 / 0					C1ORF74 (inh=n/a oe_syn=0.80 oe_mis=0.83 oe_lof=0.48), IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209963803	209963803	G	A	het	het	wt	off-target	QUAL=3807;DP=194,127,88;AF=0.51,0.52,0.00;MQM=60;SAP=361;ABP=4	IRF6	intron	IRF6:ENST00000367021.3:intron_variant:MODIFIER:intron7/8:c.1060+37C>T::,IRF6:ENST00000542854.1:intron_variant:MODIFIER:intron5/6:c.775+37C>T::	IRF6:NM_001206696.1:intron_variant:MODIFIER:intron5/6:c.775+37C>T::,IRF6:NM_006147.4:intron_variant:MODIFIER:intron7/8:c.1060+37C>T::	regulatory_region_variant:open_chromatin_region	607199 [GENE=IRF6 PHENOS=Popliteal pterygium syndrome 1,119500,Autosomal dominant/Orofacial cleft 6,608864,Autosomal dominant/van der Woude syndrome,119300,Autosomal dominant];				rs2235373	0.2883	0.2356	711,.	0.2316,0.3481,0.4833,0.1761,0.2970	-0.5940			0.04,0.14	1.62					0.0771	0.1236	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209965587	209965587	G	C	het	hom	wt	off-target	QUAL=10463;DP=195,261,213;AF=0.46,1.00,0.00;MQM=60;SAP=256;ABP=6	IRF6	intron	IRF6:ENST00000367021.3:intron_variant:MODIFIER:intron6/8:c.667+27C>G::,IRF6:ENST00000542854.1:intron_variant:MODIFIER:intron4/6:c.382+27C>G::	IRF6:NM_001206696.1:intron_variant:MODIFIER:intron4/6:c.382+27C>G::,IRF6:NM_006147.4:intron_variant:MODIFIER:intron6/8:c.667+27C>G::		607199 [GENE=IRF6 PHENOS=Popliteal pterygium syndrome 1,119500,Autosomal dominant/Orofacial cleft 6,608864,Autosomal dominant/van der Woude syndrome,119300,Autosomal dominant];	259926 [benign DISEASE=not specified];			rs2235375	0.4052	0.4101	2126,.	0.2825,0.5576,0.5725,0.3734,0.4171	0.0930			0.00,0.11	2.94					-0.1024	0.2473	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209968684	209968684	C	A	het	hom	wt		QUAL=18494;DP=338,458,325;AF=0.45,1.00,0.00;MQM=60;SAP=7;ABP=10	IRF6	synonymous	IRF6:ENST00000367021.3:synonymous_variant:LOW:exon5/9:c.459G>T:p.Ser153=:,IRF6:ENST00000542854.1:synonymous_variant:LOW:exon3/7:c.174G>T:p.Ser58=:	IRF6:NM_001206696.1:synonymous_variant:LOW:exon3/7:c.174G>T:p.Ser58=:,IRF6:NM_006147.4:synonymous_variant:LOW:exon5/9:c.459G>T:p.Ser153=:	regulatory_region_variant:promoter_flanking_region	607199 [GENE=IRF6 PHENOS=Popliteal pterygium syndrome 1,119500,Autosomal dominant/Orofacial cleft 6,608864,Autosomal dominant/van der Woude syndrome,119300,Autosomal dominant];	259925 [benign DISEASE=van der Woude syndrome 1,Orofacial cleft 6, susceptibility to,not specified];			rs2013162	0.4038	0.4098	2095,.	0.2750,0.5605,0.5730,0.3733,0.4156	-1.6140			0.07,0.83	10.28					-0.1448	0.2198	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209969902	209969902	G	C	het	hom	wt		QUAL=4766;DP=209,86,51;AF=0.47,0.99,0.02;MQM=60;SAP=344;ABP=5	IRF6	splice_region&intron	IRF6:ENST00000367021.3:splice_region_variant&intron_variant:LOW:intron3/8:c.175-5C>G::,IRF6:ENST00000542854.1:splice_region_variant&intron_variant:LOW:intron1/6:c.-111-5C>G::	IRF6:NM_001206696.1:splice_region_variant&intron_variant:LOW:intron1/6:c.-111-5C>G::,IRF6:NM_006147.4:splice_region_variant&intron_variant:LOW:intron3/8:c.175-5C>G::	regulatory_region_variant:promoter_flanking_region	607199 [GENE=IRF6 PHENOS=Popliteal pterygium syndrome 1,119500,Autosomal dominant/Orofacial cleft 6,608864,Autosomal dominant/van der Woude syndrome,119300,Autosomal dominant];	259923 [benign DISEASE=van der Woude syndrome 1,not specified];			rs7552506	0.2710	0.3223	1659,.	0.2672,0.2976,0.1538,0.3585,0.3323	1.2850			0.47,0.29	9.05		9.65>6.86	0.002/0.074		-0.6717	0.6237	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209975386	209975386	A	G	het	wt	hom		QUAL=11940;DP=283,350,263;AF=0.49,0.00,1.00;MQM=60;SAP=57;ABP=3	IRF6	splice_region&5'UTR,intron	IRF6:ENST00000367021.3:splice_region_variant&5_prime_UTR_variant:LOW:exon2/9:c.-73T>C::,IRF6:ENST00000542854.1:intron_variant:MODIFIER:intron1/6:c.-112+3906T>C::	IRF6:NM_001206696.1:intron_variant:MODIFIER:intron1/6:c.-112+3906T>C::,IRF6:NM_006147.4:splice_region_variant&5_prime_UTR_variant:LOW:exon2/9:c.-73T>C::	regulatory_region_variant:promoter_flanking_region	607199 [GENE=IRF6 PHENOS=Popliteal pterygium syndrome 1,119500,Autosomal dominant/Orofacial cleft 6,608864,Autosomal dominant/van der Woude syndrome,119300,Autosomal dominant];	295214 [benign DISEASE=van der Woude syndrome 1,Orofacial cleft 6, susceptibility to];			rs861019	0.3864	0.4358	3044,.		-0.2130			0.04,0.15	0.68		10.77>11.03			0.4493	0.369	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209979518	209979518	T	A	wt	het	wt		QUAL=1265;DP=34,126,92;AF=0.00,0.54,0.00;MQM=60;SAP=71;ABP=5	IRF6	upstream_gene	IRF6:ENST00000367021.3:upstream_gene_variant:MODIFIER::::,IRF6:ENST00000542854.1:upstream_gene_variant:MODIFIER::::	IRF6:NM_001206696.1:5_prime_UTR_variant:MODIFIER:exon1/7:c.-338A>T::	regulatory_region_variant:promoter,TF_binding_site_variant		295219 [benign DISEASE=van der Woude syndrome 1,Cleft Lip +/- Cleft Palate, Autosomal Dominant];			rs12403006	0.1180	0.1687	530,.		-0.0120			0.01,0.19	9.65								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209979529	209979529	A	T	wt	het	wt		QUAL=1206;DP=25,117,82;AF=0.00,0.53,0.00;MQM=60;SAP=98;ABP=4	IRF6	upstream_gene	IRF6:ENST00000367021.3:upstream_gene_variant:MODIFIER::::,IRF6:ENST00000542854.1:upstream_gene_variant:MODIFIER::::		regulatory_region_variant:promoter,TF_binding_site_variant		368864 [benign DISEASE=van der Woude syndrome 1,Popliteal pterygium syndrome,Cleft Lip +/- Cleft Palate, Autosomal Dominant];	CR173661 [CLASS=R MUT=ALT PHEN="Orofacial clefting" GENE=IRF6];		rs34743335	0.1182	0.1689	531,.		0.0230			0.39,0.86	16.58								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	215796196	215796196	-	TTATT	het	wt	het	off-target	QUAL=620;DP=95,34,18;AF=0.34,0.00,0.22;MQM=60;SAP=81;ABP=35	KCTD3,USH2A	downstream_gene	KCTD3:ENST00000259154.4:downstream_gene_variant:MODIFIER::::,USH2A:ENST00000307340.3:downstream_gene_variant:MODIFIER::::,USH2A:ENST00000366943.2:downstream_gene_variant:MODIFIER::::							rs75551431		0.2235	847,.						0.86								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCTD3 (inh=n/a oe_syn=0.86 oe_mis=0.62 oe_lof=0.25), USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215796350	215796350	T	G	het	hom	wt		QUAL=13518;DP=353,266,178;AF=0.52,1.00,0.00;MQM=60;SAP=222;ABP=4	USH2A	3'UTR	USH2A:ENST00000307340.3:3_prime_UTR_variant:MODIFIER:exon72/72:c.*2773A>C::,USH2A:ENST00000366943.2:3_prime_UTR_variant:MODIFIER:exon73/73:c.*2773A>C::	USH2A:NM_206933.3:3_prime_UTR_variant:MODIFIER:exon72/72:c.*2773A>C::		608400 [GENE=USH2A PHENOS=Retinitis pigmentosa 39,613809/Usher syndrome,type 2A,276901,Autosomal recessive];				rs6667509	0.1030	0.0990	164,.		2.2250			0.13,0.19	5.16					0.0092	0.9495	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCTD3 (inh=n/a oe_syn=0.86 oe_mis=0.62 oe_lof=0.25), USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215798014	215798014	G	A	hom	hom	hom		QUAL=33443;DP=445,327,226;AF=1.00,1.00,1.00;MQM=60;SAP=39;ABP=0	USH2A	3'UTR	USH2A:ENST00000307340.3:3_prime_UTR_variant:MODIFIER:exon72/72:c.*1109C>T::,USH2A:ENST00000366943.2:3_prime_UTR_variant:MODIFIER:exon73/73:c.*1109C>T::	USH2A:NM_206933.3:3_prime_UTR_variant:MODIFIER:exon72/72:c.*1109C>T::		608400 [GENE=USH2A PHENOS=Retinitis pigmentosa 39,613809/Usher syndrome,type 2A,276901,Autosomal recessive];				rs2797255	0.9912	0.9899	15391,.		-0.3140			0.02,0.10	0.30					-0.0022	0.9494	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCTD3 (inh=n/a oe_syn=0.86 oe_mis=0.62 oe_lof=0.25), USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215808007	215808007	G	A	het	wt	het		QUAL=3675;DP=174,193,136;AF=0.48,0.00,0.50;MQM=60;SAP=189;ABP=3	USH2A	missense	USH2A:ENST00000307340.3:missense_variant:MODERATE:exon70/72:c.15091C>T:p.Arg5031Trp:,USH2A:ENST00000366943.2:missense_variant:MODERATE:exon70/73:c.15091C>T:p.Arg5031Trp:	USH2A:NM_206933.3:missense_variant:MODERATE:exon70/72:c.15091C>T:p.Arg5031Trp:		608400 [GENE=USH2A PHENOS=Retinitis pigmentosa 39,613809/Usher syndrome,type 2A,276901,Autosomal recessive];	48455 [benign/likely benign DISEASE=Usher syndrome, type 2A,Retinitis pigmentosa 39,not specified,none provided,not provided];	CM165975 [CLASS=DM? MUT=ALT PHEN="Retinitis pigmentosa" GENE=USH2A];		rs56038610	0.0060	0.0161	5,.	0.0031,0.0030,0.0000,0.0192,0.0102	3.0680	D(0.02),D(0.02)	B(0.15),B(0.30)	0.24,0.45	17.35	0.09				0.0209	0.3603	0.01	6	564	0 / 0	1	"[3] auto-classification 14.09.2017%0A[1] harmuth 08.05.2018"			USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215848062	215848062	C	T	het	wt	het		QUAL=8131;DP=373,314,246;AF=0.51,0.01,0.50;MQM=60;SAP=27;ABP=3	USH2A	synonymous	USH2A:ENST00000307340.3:synonymous_variant:LOW:exon63/72:c.13191G>A:p.Glu4397=:PF00041 [Fibronectin type III domain],USH2A:ENST00000366943.2:synonymous_variant:LOW:exon63/73:c.13191G>A:p.Glu4397=:PF00041 [Fibronectin type III domain]	USH2A:NM_206933.3:synonymous_variant:LOW:exon63/72:c.13191G>A:p.Glu4397=:		608400 [GENE=USH2A PHENOS=Retinitis pigmentosa 39,613809/Usher syndrome,type 2A,276901,Autosomal recessive];	48413 [benign DISEASE=Usher syndrome, type 2A,not specified];			rs2009923	0.2035	0.2029	445,.	0.0531,0.1748,0.3522,0.1842,0.2862	0.2840			0.16,0.61	0.31					0.0066	0.1152	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215848587	215848587	T	C	wt	wt	het		QUAL=3267;DP=276,319,245;AF=0.00,0.00,0.51;MQM=60;SAP=12;ABP=3	USH2A	synonymous	USH2A:ENST00000307340.3:synonymous_variant:LOW:exon63/72:c.12666A>G:p.Thr4222=:PF00041 [Fibronectin type III domain],USH2A:ENST00000366943.2:synonymous_variant:LOW:exon63/73:c.12666A>G:p.Thr4222=:PF00041 [Fibronectin type III domain]	USH2A:NM_206933.3:synonymous_variant:LOW:exon63/72:c.12666A>G:p.Thr4222=:		608400 [GENE=USH2A PHENOS=Retinitis pigmentosa 39,613809/Usher syndrome,type 2A,276901,Autosomal recessive];	48403 [benign DISEASE=Usher syndrome, type 2A,not specified,none provided];			rs2797234	0.3031	0.3698	2039,.	0.2132,0.4699,0.3257,0.3857,0.3019	-0.3630			0.13,0.41	0.71					0.0216	0.1155	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215848641	215848641	T	C	het	hom	het		QUAL=20761;DP=383,374,280;AF=0.48,0.99,0.50;MQM=60;SAP=40;ABP=4	USH2A	synonymous	USH2A:ENST00000307340.3:synonymous_variant:LOW:exon63/72:c.12612A>G:p.Thr4204=:PF00041 [Fibronectin type III domain],USH2A:ENST00000366943.2:synonymous_variant:LOW:exon63/73:c.12612A>G:p.Thr4204=:PF00041 [Fibronectin type III domain]	USH2A:NM_206933.3:synonymous_variant:LOW:exon63/72:c.12612A>G:p.Thr4204=:		608400 [GENE=USH2A PHENOS=Retinitis pigmentosa 39,613809/Usher syndrome,type 2A,276901,Autosomal recessive];	177993 [benign DISEASE=not specified,none provided];			rs2797235	0.6897	0.7669	8791,.	0.6285,0.8089,0.6474,0.8124,0.6953	0.0940			0.10,0.32	0.55					0.019	0.1155	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215853749	215853749	T	-	het	het	het	off-target;low_conf_region	QUAL=3546;DP=147,68,53;AF=0.51,0.87,0.64;MQM=60;SAP=318;ABP=40	USH2A	intron	USH2A:ENST00000307340.3:intron_variant:MODIFIER:intron61/71:c.12067-31del::,USH2A:ENST00000366943.2:intron_variant:MODIFIER:intron61/72:c.12067-31del::	USH2A:NM_206933.3:intron_variant:MODIFIER:intron61/71:c.12067-31del::		608400 [GENE=USH2A PHENOS=Retinitis pigmentosa 39,613809/Usher syndrome,type 2A,276901,Autosomal recessive];				rs5780842		0.8782	10393,.	0.6261,0.6573,0.7264,0.7176,0.6117	0.0640				0.49					0.0412	0.0729	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215901492	215901492	C	T	hom	hom	het		QUAL=39483;DP=410,641,542;AF=0.99,0.99,0.42;MQM=60;SAP=126;ABP=35	USH2A	synonymous	USH2A:ENST00000307340.3:synonymous_variant:LOW:exon61/72:c.11946G>A:p.Leu3982=:PF00041 [Fibronectin type III domain],USH2A:ENST00000366943.2:synonymous_variant:LOW:exon61/73:c.11946G>A:p.Leu3982=:PF00041 [Fibronectin type III domain]	USH2A:NM_206933.3:synonymous_variant:LOW:exon61/72:c.11946G>A:p.Leu3982=:		608400 [GENE=USH2A PHENOS=Retinitis pigmentosa 39,613809/Usher syndrome,type 2A,276901,Autosomal recessive];	48387 [benign DISEASE=Usher syndrome, type 2A,not specified,none provided];			rs2820718	0.1188	0.1772	511,.	0.1669,0.0795,0.0013,0.1845,0.1444	1.0060			0.87,0.94	6.60					-0.0115	0.0814	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215914751	215914751	G	T	het	wt	het		QUAL=5379;DP=207,253,192;AF=0.53,0.00,0.52;MQM=60;SAP=65;ABP=5	USH2A	missense	USH2A:ENST00000307340.3:missense_variant:MODERATE:exon60/72:c.11677C>A:p.Pro3893Thr:,USH2A:ENST00000366943.2:missense_variant:MODERATE:exon60/73:c.11677C>A:p.Pro3893Thr:	USH2A:NM_206933.3:missense_variant:MODERATE:exon60/72:c.11677C>A:p.Pro3893Thr:		608400 [GENE=USH2A PHENOS=Retinitis pigmentosa 39,613809/Usher syndrome,type 2A,276901,Autosomal recessive];	48380 [benign DISEASE=Usher syndrome, type 2A,not specified,none provided,not provided];	CM165987 [CLASS=DM? MUT=ALT PHEN="Usher syndrome 2" GENE=USH2A];		rs41303285	0.0062	0.0158	5,.	0.0033,0.0035,0.0000,0.0225,0.0137	5.6550	D(0.03),D(0.03)	D(0.98),D(1.00)	0.96,0.99	24.70	0.34				-0.0221	0.0909	0.01	12	628	0 / 0	3	"[3] auto-classification 14.09.2017"		"gnomAD: 59 homo cases; ClinVar: Class1 (all 6 entries)"	USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215931928	215931928	T	A	wt	het	wt		QUAL=2193;DP=223,196,176;AF=0.00,0.46,0.00;MQM=60;SAP=42;ABP=6	USH2A	intron	USH2A:ENST00000307340.3:intron_variant:MODIFIER:intron58/71:c.11389+9A>T::,USH2A:ENST00000366943.2:intron_variant:MODIFIER:intron58/72:c.11389+9A>T::	USH2A:NM_206933.3:intron_variant:MODIFIER:intron58/71:c.11389+9A>T::		608400 [GENE=USH2A PHENOS=Retinitis pigmentosa 39,613809/Usher syndrome,type 2A,276901,Autosomal recessive];	48372 [benign DISEASE=not specified,none provided];			rs12095085	0.0749	0.1257	272,.	0.1320,0.0683,0.0003,0.1292,0.0526	-0.0740			0.04,0.21	1.81					0.1341	0.0761	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215932957	215932957	G	A	wt	wt	het	off-target	QUAL=1056;DP=203,122,82;AF=0.00,0.00,0.55;MQM=60;SAP=76;ABP=5	USH2A	intron	USH2A:ENST00000307340.3:intron_variant:MODIFIER:intron57/71:c.11231+45C>T::,USH2A:ENST00000366943.2:intron_variant:MODIFIER:intron57/72:c.11231+45C>T::	USH2A:NM_206933.3:intron_variant:MODIFIER:intron57/71:c.11231+45C>T::		608400 [GENE=USH2A PHENOS=Retinitis pigmentosa 39,613809/Usher syndrome,type 2A,276901,Autosomal recessive];				rs17025373	0.1322	0.1066	163,.	0.0135,0.2038,0.3716,0.0655,0.0847	-1.3270			0.05,0.17	0.47					0.0388	0.2839	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215956304	215956304	A	G	hom	hom	hom	off-target	QUAL=3924;DP=79,27,22;AF=0.99,1.00,1.00;MQM=60;SAP=262;ABP=0	USH2A	intron	USH2A:ENST00000307340.3:intron_variant:MODIFIER:intron52/71:c.10388-27T>C::,USH2A:ENST00000366943.2:intron_variant:MODIFIER:intron52/72:c.10388-27T>C::	USH2A:NM_206933.3:intron_variant:MODIFIER:intron52/71:c.10388-27T>C::		608400 [GENE=USH2A PHENOS=Retinitis pigmentosa 39,613809/Usher syndrome,type 2A,276901,Autosomal recessive];				rs7518466	0.6016	0.5887	5551,.	0.7315,0.5765,0.6322,0.5268,0.4964	-1.5270			0.01,0.13	0.63					-0.2095	0.5561	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215960167	215960167	T	G	hom	hom	hom		QUAL=26812;DP=217,366,286;AF=1.00,1.00,1.00;MQM=60;SAP=228;ABP=0	USH2A	missense	USH2A:ENST00000307340.3:missense_variant:MODERATE:exon52/72:c.10232A>C:p.Glu3411Ala:,USH2A:ENST00000366943.2:missense_variant:MODERATE:exon52/73:c.10232A>C:p.Glu3411Ala:	USH2A:NM_206933.3:missense_variant:MODERATE:exon52/72:c.10232A>C:p.Glu3411Ala:		608400 [GENE=USH2A PHENOS=Retinitis pigmentosa 39,613809/Usher syndrome,type 2A,276901,Autosomal recessive];	48344 [benign DISEASE=Usher syndrome, type 2A,not specified,none provided];			rs10864198	0.5887	0.5788	5329,.	0.6867,0.5749,0.6342,0.5215,0.4946	2.5990	T(1.00),T(1.00)	B(0.00),B(0.00)	0.02,0.80	14.16	0.09				-0.037	0.3081	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215963374	215963374	G	A	wt	het	wt	off-target	QUAL=1532;DP=129,128,110;AF=0.00,0.50,0.00;MQM=60;SAP=109;ABP=3	USH2A	intron	USH2A:ENST00000307340.3:intron_variant:MODIFIER:intron51/71:c.10182+27C>T::,USH2A:ENST00000366943.2:intron_variant:MODIFIER:intron51/72:c.10182+27C>T::	USH2A:NM_206933.3:intron_variant:MODIFIER:intron51/71:c.10182+27C>T::		608400 [GENE=USH2A PHENOS=Retinitis pigmentosa 39,613809/Usher syndrome,type 2A,276901,Autosomal recessive];				rs11120629	0.0805	0.1297	289,.	0.1483,0.0687,0.0004,0.1292,0.0529	-0.0130			0.10,0.24	10.89					0.1209	0.2956	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215987222	215987222	T	C	wt	het	wt		QUAL=3234;DP=271,280,169;AF=0.00,0.46,0.00;MQM=60;SAP=22;ABP=6	USH2A	missense	USH2A:ENST00000307340.3:missense_variant:MODERATE:exon49/72:c.9595A>G:p.Asn3199Asp:,USH2A:ENST00000366943.2:missense_variant:MODERATE:exon49/73:c.9595A>G:p.Asn3199Asp:	USH2A:NM_206933.3:missense_variant:MODERATE:exon49/72:c.9595A>G:p.Asn3199Asp:		608400 [GENE=USH2A PHENOS=Retinitis pigmentosa 39,613809/Usher syndrome,type 2A,276901,Autosomal recessive];	48631 [benign DISEASE=Usher syndrome, type 2A,not specified];			rs4129843	0.0871	0.0549	69,.	0.0814,0.0613,0.1694,0.0373,0.0812	0.1850	T(1.00),T(1.00)	B(0.00),B(0.00)	0.01,0.19	0.30	0.04				0.1219	0.9498	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216011361	216011361	T	C	wt	het	wt		QUAL=3250;DP=340,263,238;AF=0.00,0.49,0.00;MQM=60;SAP=5;ABP=3	USH2A	missense	USH2A:ENST00000307340.3:missense_variant:MODERATE:exon47/72:c.9343A>G:p.Thr3115Ala:,USH2A:ENST00000366943.2:missense_variant:MODERATE:exon47/73:c.9343A>G:p.Thr3115Ala:	USH2A:NM_206933.3:missense_variant:MODERATE:exon47/72:c.9343A>G:p.Thr3115Ala:		608400 [GENE=USH2A PHENOS=Retinitis pigmentosa 39,613809/Usher syndrome,type 2A,276901,Autosomal recessive];	48623 [benign DISEASE=Usher syndrome, type 2A,not specified,not provided];			rs56032526	0.0647	0.0497	39,.	0.0089,0.0581,0.1691,0.0373,0.0814	0.1260	T(1.00),T(1.00)	B(0.00),B(0.00)	0.08,0.28	0.01	0.14				0.1786	0.2469	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216019427	216019427	A	-	wt	het	wt	off-target	QUAL=372;DP=123,44,42;AF=0.02,0.48,0.00;MQM=60;SAP=53;ABP=3	USH2A	intron	USH2A:ENST00000307340.3:intron_variant:MODIFIER:intron44/71:c.8846-52del::,USH2A:ENST00000366943.2:intron_variant:MODIFIER:intron44/72:c.8846-52del::	USH2A:NM_206933.3:intron_variant:MODIFIER:intron44/71:c.8846-52del::		608400 [GENE=USH2A PHENOS=Retinitis pigmentosa 39,613809/Usher syndrome,type 2A,276901,Autosomal recessive];				rs77889398		0.0657	41,.	0.0131,0.0781,0.2087,0.0500,0.1034	0.0630				0.02				COSV56391224	-0.0328	0.4311	0.09	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216051125	216051125	G	A	wt	het	wt		QUAL=2904;DP=195,215,198;AF=0.00,0.52,0.00;MQM=60;SAP=12;ABP=4	USH2A	missense	USH2A:ENST00000307340.3:missense_variant:MODERATE:exon43/72:c.8656C>T:p.Leu2886Phe:PF00041 [Fibronectin type III domain],USH2A:ENST00000366943.2:missense_variant:MODERATE:exon43/73:c.8656C>T:p.Leu2886Phe:PF00041 [Fibronectin type III domain]	USH2A:NM_206933.3:missense_variant:MODERATE:exon43/72:c.8656C>T:p.Leu2886Phe:		608400 [GENE=USH2A PHENOS=Retinitis pigmentosa 39,613809/Usher syndrome,type 2A,276901,Autosomal recessive];	48607 [benign DISEASE=Usher syndrome, type 2A,not specified,none provided,not provided];	CM1413302 [CLASS=R MUT=ALT PHEN="Hearing loss" GENE=USH2A];		rs41277200	0.0777	0.0523	43,.	0.0607,0.0625,0.1561,0.0365,0.0799	6.9270	T(1.00),T(1.00)	B(0.00),B(0.00)	0.20,0.97	20.50	0.14				-0.1496	0.221	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216166454	216166454	T	G	het	wt	het		QUAL=2801;DP=125,98,94;AF=0.48,0.00,0.57;MQM=60;SAP=11;ABP=4	USH2A	missense	USH2A:ENST00000307340.3:missense_variant:MODERATE:exon35/72:c.6713A>C:p.Glu2238Ala:,USH2A:ENST00000366943.2:missense_variant:MODERATE:exon35/73:c.6713A>C:p.Glu2238Ala:	USH2A:NM_206933.3:missense_variant:MODERATE:exon35/72:c.6713A>C:p.Glu2238Ala:	regulatory_region_variant:promoter_flanking_region	608400 [GENE=USH2A PHENOS=Retinitis pigmentosa 39,613809/Usher syndrome,type 2A,276901,Autosomal recessive];	48568 [benign DISEASE=Usher syndrome, type 2A,not specified,none provided,not provided];	CM140482 [CLASS=DM? MUT=ALT PHEN="Retinitis pigmentosa autosomal recessive" GENE=USH2A];		rs41277212	0.0076	0.0222	6,.	0.0052,0.0173,0.0001,0.0284,0.0151	4.8830	D(0.00),D(0.00)	P(0.91),D(0.99)	0.92,0.95	24.50	0.27				-0.0272	0.169	0	20	862	0 / 0	3	"[3] auto-classification 14.09.2017%0A%0A"			USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216172380	216172380	A	G	hom	hom	hom		QUAL=18997;DP=180,228,188;AF=0.99,1.00,1.00;MQM=60;SAP=432;ABP=0	USH2A	missense	USH2A:ENST00000307340.3:missense_variant:MODERATE:exon34/72:c.6506T>C:p.Ile2169Thr:,USH2A:ENST00000366943.2:missense_variant:MODERATE:exon34/73:c.6506T>C:p.Ile2169Thr:	USH2A:NM_206933.3:missense_variant:MODERATE:exon34/72:c.6506T>C:p.Ile2169Thr:		608400 [GENE=USH2A PHENOS=Retinitis pigmentosa 39,613809/Usher syndrome,type 2A,276901,Autosomal recessive];	48562 [benign DISEASE=Usher syndrome, type 2A,not specified,none provided];			rs10864219		0.5628	4207,.	0.4335,0.6697,0.8405,0.5004,0.5979	2.3960	T(0.12),T(0.12)	B(0.02),B(0.08)	0.92,0.96	19.08	0.11				0.2198	0.3067	0.04	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216219781	216219781	A	G	het	hom	het		QUAL=8818;DP=201,147,124;AF=0.49,1.00,0.51;MQM=60;SAP=328;ABP=3	USH2A	missense	USH2A:ENST00000307340.3:missense_variant:MODERATE:exon32/72:c.6317T>C:p.Ile2106Thr:,USH2A:ENST00000366943.2:missense_variant:MODERATE:exon32/73:c.6317T>C:p.Ile2106Thr:	USH2A:NM_206933.3:synonymous_variant:LOW:exon32/72:c.6317T>C:p.Thr2106=:		608400 [GENE=USH2A PHENOS=Retinitis pigmentosa 39,613809/Usher syndrome,type 2A,276901,Autosomal recessive];	167815 [benign DISEASE=Usher syndrome, type 2A,not specified,none provided];			rs6657250	0.5956	0.6760	7257,.	0.7709,0.3526,0.4408,0.6711,0.5082	0.9870	T(1.00),T(1.00)	B(0.00),B(0.00)	0.04,0.66	14.73	0.13				0.1995	0.0789	0.05	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216246676	216246676	G	-	het	het	het	off-target	QUAL=5082;DP=174,132,98;AF=0.51,0.55,0.53;MQM=60;SAP=421;ABP=5	USH2A,RP11-22M7.2	intron,intron&non_coding_transcript	USH2A:ENST00000307340.3:intron_variant:MODIFIER:intron27/71:c.5573-34del::,USH2A:ENST00000366943.2:intron_variant:MODIFIER:intron27/72:c.5573-34del::,RP11-22M7.2:ENST00000430890.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/2:n.78+530del::,RP11-22M7.2:ENST00000445619.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.159+372del::,RP11-22M7.2:ENST00000446411.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/2:n.136+736del::	USH2A:NM_206933.3:intron_variant:MODIFIER:intron27/71:c.5573-34del::,LOC102723833:NR_125992.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/2:n.136+736del::,LOC102723833:NR_125993.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.136+736del::		608400 [GENE=USH2A PHENOS=Retinitis pigmentosa 39,613809/Usher syndrome,type 2A,276901,Autosomal recessive];				rs35944387		0.7336	7945,.	0.7474,0.7849,0.9538,0.6880,0.7713	0.7670				14.91					0.0885	0.0647	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216258194	216258194	G	T	het	het	het		QUAL=5966;DP=155,176,133;AF=0.48,0.51,0.51;MQM=60;SAP=168;ABP=3	USH2A,RP11-22M7.2	synonymous,intron&non_coding_transcript	USH2A:ENST00000307340.3:synonymous_variant:LOW:exon25/72:c.5013C>A:p.Gly1671=:PF02210 [Laminin G domain],USH2A:ENST00000366943.2:synonymous_variant:LOW:exon25/73:c.5013C>A:p.Gly1671=:PF02210 [Laminin G domain],RP11-22M7.2:ENST00000430890.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/2:n.208-1870G>T::,RP11-22M7.2:ENST00000442606.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/2:n.207-1870G>T::,RP11-22M7.2:ENST00000445619.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.160-1870G>T::,RP11-22M7.2:ENST00000446411.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/2:n.266-1870G>T::	USH2A:NM_206933.3:synonymous_variant:LOW:exon25/72:c.5013C>A:p.Gly1671=:,LOC102723833:NR_125992.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/2:n.266-1870G>T::,LOC102723833:NR_125993.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.137-1870G>T::		608400 [GENE=USH2A PHENOS=Retinitis pigmentosa 39,613809/Usher syndrome,type 2A,276901,Autosomal recessive];	48527 [benign DISEASE=Usher syndrome, type 2A,not specified];			rs56110889	0.1058	0.1602	436,.	0.1935,0.0944,0.0001,0.1752,0.0772	0.1420			0.68,0.96	10.06					0.0858	0.3572	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216347452	216347452	C	A	het	wt	het		QUAL=3549;DP=217,121,108;AF=0.41,0.00,0.45;MQM=60;SAP=3;ABP=18	USH2A	intron,3'UTR	USH2A:ENST00000307340.3:intron_variant:MODIFIER:intron21/71:c.4627+1142G>T::,USH2A:ENST00000366942.3:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1128G>T::,USH2A:ENST00000366943.2:intron_variant:MODIFIER:intron21/72:c.4627+1142G>T::	USH2A:NM_007123.5:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1128G>T::,USH2A:NM_206933.3:intron_variant:MODIFIER:intron21/71:c.4627+1142G>T::		608400 [GENE=USH2A PHENOS=Retinitis pigmentosa 39,613809/Usher syndrome,type 2A,276901,Autosomal recessive];	295405 [benign DISEASE=Retinitis pigmentosa,Usher syndrome, type 2A];			rs401269	0.1945	0.1996	669,.		-0.1910			0.04,0.19	1.81					-0.0034	0.9351	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216347556	216347556	A	G	het	wt	het		QUAL=3710;DP=224,55,56;AF=0.48,0.00,0.54;MQM=60;SAP=78;ABP=3	USH2A	intron,3'UTR	USH2A:ENST00000307340.3:intron_variant:MODIFIER:intron21/71:c.4627+1038T>C::,USH2A:ENST00000366942.3:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1024T>C::,USH2A:ENST00000366943.2:intron_variant:MODIFIER:intron21/72:c.4627+1038T>C::	USH2A:NM_007123.5:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1024T>C::,USH2A:NM_206933.3:intron_variant:MODIFIER:intron21/71:c.4627+1038T>C::		608400 [GENE=USH2A PHENOS=Retinitis pigmentosa 39,613809/Usher syndrome,type 2A,276901,Autosomal recessive];	295407 [benign DISEASE=Retinitis pigmentosa,Usher syndrome, type 2A];			rs439940	0.1953	0.2006	677,.		0.7440			0.08,0.22	6.27					0.0071	0.9352	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216348764	216348764	C	T	het	hom	het		QUAL=29557;DP=478,509,455;AF=0.53,1.00,0.49;MQM=60;SAP=152;ABP=4	USH2A	missense	USH2A:ENST00000307340.3:missense_variant:MODERATE:exon21/72:c.4457G>A:p.Arg1486Lys:,USH2A:ENST00000366942.3:missense_variant:MODERATE:exon21/21:c.4457G>A:p.Arg1486Lys:,USH2A:ENST00000366943.2:missense_variant:MODERATE:exon21/73:c.4457G>A:p.Arg1486Lys:	USH2A:NM_007123.5:synonymous_variant:LOW:exon21/21:c.4457G>A:p.Lys1486=:,USH2A:NM_206933.3:synonymous_variant:LOW:exon21/72:c.4457G>A:p.Lys1486=:		608400 [GENE=USH2A PHENOS=Retinitis pigmentosa 39,613809/Usher syndrome,type 2A,276901,Autosomal recessive];	177992 [benign DISEASE=not specified,none provided];			rs1805049	0.6623	0.6605	6437,.	0.5814,0.7160,0.7813,0.6225,0.6986	-1.6250	T(0.56),T(0.30),T(0.57)	B(0.03),B(0.03),B(0.05)	0.03,0.16	9.14	0.02				0.0346	0.9352	0.29	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216370108	216370108	C	T	het	wt	het	off-target	QUAL=3474;DP=188,127,93;AF=0.51,0.00,0.51;MQM=60;SAP=278;ABP=3	USH2A,RP5-1099E6.3	intron,intron&non_coding_transcript	USH2A:ENST00000307340.3:intron_variant:MODIFIER:intron18/71:c.4082-44G>A::,USH2A:ENST00000366942.3:intron_variant:MODIFIER:intron18/20:c.4082-44G>A::,USH2A:ENST00000366943.2:intron_variant:MODIFIER:intron18/72:c.4082-44G>A::,RP5-1099E6.3:ENST00000420867.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/2:n.362+841C>T::	USH2A:NM_007123.5:intron_variant:MODIFIER:intron18/20:c.4082-44G>A::,USH2A:NM_206933.3:intron_variant:MODIFIER:intron18/71:c.4082-44G>A::		608400 [GENE=USH2A PHENOS=Retinitis pigmentosa 39,613809/Usher syndrome,type 2A,276901,Autosomal recessive];				rs447102	0.1645	0.2094	575,.	0.0693,0.1891,0.2103,0.2388,0.2321	-0.7920			0.00,0.10	0.50					-0.171	0.2325	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76), MRPS18BP1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	216371934	216371934	A	C	het	wt	het		QUAL=4091;DP=223,90,82;AF=0.54,0.00,0.55;MQM=60;SAP=336;ABP=7	USH2A,RP5-1099E6.3	splice_region&intron,intron&non_coding_transcript	USH2A:ENST00000307340.3:splice_region_variant&intron_variant:LOW:intron17/71:c.3812-8T>G::,USH2A:ENST00000366942.3:splice_region_variant&intron_variant:LOW:intron17/20:c.3812-8T>G::,USH2A:ENST00000366943.2:splice_region_variant&intron_variant:LOW:intron17/72:c.3812-8T>G::,RP5-1099E6.3:ENST00000420867.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/2:n.362+2667A>C::	USH2A:NM_007123.5:splice_region_variant&intron_variant:LOW:intron17/20:c.3812-8T>G::,USH2A:NM_206933.3:splice_region_variant&intron_variant:LOW:intron17/71:c.3812-8T>G::		608400 [GENE=USH2A PHENOS=Retinitis pigmentosa 39,613809/Usher syndrome,type 2A,276901,Autosomal recessive];	48508 [benign DISEASE=Retinitis pigmentosa,Usher syndrome, type 2A,not specified];			rs646094	0.1977	0.2133	676,.	0.1641,0.1892,0.2059,0.2339,0.2298	1.0410			0.41,0.79	12.48		9.73>8.94	0.003/0.164		-0.5477	0.6848	0.14	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76), MRPS18BP1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	216390694	216390694	C	T	het	hom	het	off-target	QUAL=7339;DP=177,125,110;AF=0.48,1.00,0.52;MQM=60;SAP=358;ABP=3	USH2A	intron	USH2A:ENST00000307340.3:intron_variant:MODIFIER:intron15/71:c.3157+35G>A::,USH2A:ENST00000366942.3:intron_variant:MODIFIER:intron15/20:c.3157+35G>A::,USH2A:ENST00000366943.2:intron_variant:MODIFIER:intron15/72:c.3157+35G>A::	USH2A:NM_007123.5:intron_variant:MODIFIER:intron15/20:c.3157+35G>A::,USH2A:NM_206933.3:intron_variant:MODIFIER:intron15/71:c.3157+35G>A::		608400 [GENE=USH2A PHENOS=Retinitis pigmentosa 39,613809/Usher syndrome,type 2A,276901,Autosomal recessive];			L3b (LINE/CR1)	rs1324330	0.5875	0.6376	5412,.	0.3347,0.7025,0.7786,0.6182,0.6829	0.0420			0.01,0.15	3.50					0.1265	0.1803	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216592003	216592003	T	C	hom	hom	hom		QUAL=18954;DP=160,255,189;AF=1.00,1.00,0.99;MQM=60;SAP=131;ABP=0	USH2A	synonymous	USH2A:ENST00000307340.3:synonymous_variant:LOW:exon3/72:c.504A>G:p.Thr168=:PF13385 [Concanavalin A-like lectin/glucanases superfamily],USH2A:ENST00000366942.3:synonymous_variant:LOW:exon3/21:c.504A>G:p.Thr168=:PF13385 [Concanavalin A-like lectin/glucanases superfamily],USH2A:ENST00000366943.2:synonymous_variant:LOW:exon3/73:c.504A>G:p.Thr168=:PF13385 [Concanavalin A-like lectin/glucanases superfamily]	USH2A:NM_007123.5:synonymous_variant:LOW:exon3/21:c.504A>G:p.Thr168=:,USH2A:NM_206933.3:synonymous_variant:LOW:exon3/72:c.504A>G:p.Thr168=:		608400 [GENE=USH2A PHENOS=Retinitis pigmentosa 39,613809/Usher syndrome,type 2A,276901,Autosomal recessive];	48528 [benign DISEASE=Retinitis pigmentosa,Usher syndrome, type 2A,not specified,none provided];			rs4253963	0.6328	0.6527	6209,.	0.4930,0.6943,0.8390,0.6474,0.6011	-0.6980			0.02,0.14	0.52					0.0542	0.1196	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216595306	216595306	C	T	hom	hom	hom		QUAL=32978;DP=293,442,279;AF=1.00,1.00,1.00;MQM=60;SAP=3;ABP=0	USH2A	missense	USH2A:ENST00000307340.3:missense_variant:MODERATE:exon2/72:c.373G>A:p.Ala125Thr:,USH2A:ENST00000366942.3:missense_variant:MODERATE:exon2/21:c.373G>A:p.Ala125Thr:,USH2A:ENST00000366943.2:missense_variant:MODERATE:exon2/73:c.373G>A:p.Ala125Thr:	USH2A:NM_007123.5:missense_variant:MODERATE:exon2/21:c.373G>A:p.Ala125Thr:,USH2A:NM_206933.3:missense_variant:MODERATE:exon2/72:c.373G>A:p.Ala125Thr:		608400 [GENE=USH2A PHENOS=Retinitis pigmentosa 39,613809/Usher syndrome,type 2A,276901,Autosomal recessive];	48507 [benign DISEASE=Retinitis pigmentosa,Usher syndrome, type 2A,not specified,none provided];			rs10779261	0.7612	0.7390	8544,.	0.7567,0.7303,0.8364,0.7049,0.7321	0.3550	T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00)	0.01,0.12	4.42	0.08				-0.0196	0.3374	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	220323449	220323449	T	-	het	het	het		QUAL=1400;DP=142,47,38;AF=0.27,0.26,0.37;MQM=60;SAP=13;ABP=93	RAB3GAP2	3'UTR	RAB3GAP2:ENST00000358951.2:3_prime_UTR_variant:MODIFIER:exon35/35:c.*1144del::	RAB3GAP2:NM_012414.4:3_prime_UTR_variant:MODIFIER:exon35/35:c.*1144del::		609275 [GENE=RAB3GAP2 PHENOS=Warburg micro syndrome 2,614225,Autosomal recessive/Martsolf syndrome,212720,Autosomal recessive];	295627 [uncertain significance DISEASE=Cataract-intellectual disability-hypogonadism syndrome,Warburg micro syndrome];		FLAM_C (SINE/Alu)	rs11316594		0.4720	2426,.		-2.8180				0.80					0.0012	0.9204	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IARS2 (inh=AR oe_syn=0.94 oe_mis=0.86 oe_lof=0.25), RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220323794	220323794	T	-	het	het	het	low_conf_region	QUAL=624;DP=52,21,14;AF=0.27,0.29,0.43;MQM=60;SAP=36;ABP=34	RAB3GAP2	3'UTR	RAB3GAP2:ENST00000358951.2:3_prime_UTR_variant:MODIFIER:exon35/35:c.*799del::	RAB3GAP2:NM_012414.4:3_prime_UTR_variant:MODIFIER:exon35/35:c.*799del::		609275 [GENE=RAB3GAP2 PHENOS=Warburg micro syndrome 2,614225,Autosomal recessive/Martsolf syndrome,212720,Autosomal recessive];			(T)n (Simple_repeat)	rs35147354		0.1809	399,.		0.1390				5.07					0.0012	0.9204	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IARS2 (inh=AR oe_syn=0.94 oe_mis=0.86 oe_lof=0.25), RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220323794	220323795	TT	-	het	wt	wt	low_conf_region	QUAL=624;DP=52,21,14;AF=0.25,0.14,0.21;MQM=60;SAP=12;ABP=63	RAB3GAP2	3'UTR	RAB3GAP2:ENST00000358951.2:3_prime_UTR_variant:MODIFIER:exon35/35:c.*798_*799del::	RAB3GAP2:NM_012414.4:3_prime_UTR_variant:MODIFIER:exon35/35:c.*798_*799del::		609275 [GENE=RAB3GAP2 PHENOS=Warburg micro syndrome 2,614225,Autosomal recessive/Martsolf syndrome,212720,Autosomal recessive];			(T)n (Simple_repeat)	rs35147354		0.0025	0,.		0.1390				5.16					0.0017	0.9205	0	6	5	0 / 0					IARS2 (inh=AR oe_syn=0.94 oe_mis=0.86 oe_lof=0.25), RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220324189	220324189	A	G	het	het	wt		QUAL=9733;DP=413,267,217;AF=0.54,0.53,0.00;MQM=60;SAP=278;ABP=11	RAB3GAP2	3'UTR	RAB3GAP2:ENST00000358951.2:3_prime_UTR_variant:MODIFIER:exon35/35:c.*404T>C::	RAB3GAP2:NM_012414.4:3_prime_UTR_variant:MODIFIER:exon35/35:c.*404T>C::		609275 [GENE=RAB3GAP2 PHENOS=Warburg micro syndrome 2,614225,Autosomal recessive/Martsolf syndrome,212720,Autosomal recessive];	295635 [benign DISEASE=Cataract-intellectual disability-hypogonadism syndrome,Warburg micro syndrome 2];			rs1059140	0.0627	0.0692	94,.		0.4840			0.01,0.20	9.19					0.0195	0.9207	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IARS2 (inh=AR oe_syn=0.94 oe_mis=0.86 oe_lof=0.25), RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220330672	220330672	C	T	het	het	wt		QUAL=9360;DP=412,288,209;AF=0.55,0.48,0.00;MQM=60;SAP=266;ABP=5	RAB3GAP2	synonymous	RAB3GAP2:ENST00000358951.2:synonymous_variant:LOW:exon31/35:c.3495G>A:p.Leu1165=:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus]	RAB3GAP2:NM_012414.4:synonymous_variant:LOW:exon31/35:c.3495G>A:p.Leu1165=:		609275 [GENE=RAB3GAP2 PHENOS=Warburg micro syndrome 2,614225,Autosomal recessive/Martsolf syndrome,212720,Autosomal recessive];	130080 [benign DISEASE=Cataract-intellectual disability-hypogonadism syndrome,Warburg micro syndrome 2,not specified];			rs11547779	0.0605	0.0866	96,.	0.0150,0.0479,0.0566,0.0976,0.1336	-0.6200			0.14,0.31	6.70					-0.0682	0.0819	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220331205	220331205	C	G	het	het	wt		QUAL=6507;DP=291,248,182;AF=0.45,0.46,0.00;MQM=60;SAP=3;ABP=11	RAB3GAP2	missense	RAB3GAP2:ENST00000358951.2:missense_variant:MODERATE:exon30/35:c.3275G>C:p.Ser1092Thr:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus]	RAB3GAP2:NM_012414.4:missense_variant:MODERATE:exon30/35:c.3275G>C:p.Ser1092Thr:		609275 [GENE=RAB3GAP2 PHENOS=Warburg micro syndrome 2,614225,Autosomal recessive/Martsolf syndrome,212720,Autosomal recessive];	130079 [benign DISEASE=Cataract-intellectual disability-hypogonadism syndrome,Warburg micro syndrome 2,not specified];			rs2289189	0.0603	0.0859	95,.	0.0150,0.0456,0.0565,0.0969,0.1333	7.4320	D(0.05)	P(0.86)	0.99,0.99	27.30	0.18				0.224	0.3687	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220369746	220369746	A	-	wt	wt	het		QUAL=833;DP=163,95,90;AF=0.06,0.01,0.49;MQM=60;SAP=88;ABP=3	RAB3GAP2	splice_region&intron	RAB3GAP2:ENST00000358951.2:splice_region_variant&intron_variant:LOW:intron9/34:c.812-6del::	RAB3GAP2:NM_012414.4:splice_region_variant&intron_variant:LOW:intron9/34:c.812-6del::		609275 [GENE=RAB3GAP2 PHENOS=Warburg micro syndrome 2,614225,Autosomal recessive/Martsolf syndrome,212720,Autosomal recessive];	295665 [benign DISEASE=Cataract-intellectual disability-hypogonadism syndrome,Warburg micro syndrome,not provided];			rs35396665		0.3794	1016,.	0.3400,0.4778,0.4509,0.3419,0.3871	0.3690				0.91					-0.3922	0.9767	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19), SNORA36B (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	223101939	223101939	A	C	het	het	het	off-target	QUAL=5386;DP=179,156,136;AF=0.42,0.50,0.47;MQM=60;SAP=264;ABP=9	DISP1	intron	DISP1:ENST00000284476.6:intron_variant:MODIFIER:intron1/7:c.-18+27A>C::,DISP1:ENST00000360254.2:intron_variant:MODIFIER:intron2/3:c.-18+27A>C::	DISP1:NM_001350630.2:intron_variant:MODIFIER:intron2/8:c.-904-14210A>C::,DISP1:NM_001369594.1:intron_variant:MODIFIER:intron1/7:c.-18+27A>C::,DISP1:NM_032890.5:intron_variant:MODIFIER:intron3/9:c.-18+27A>C::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site					rs35491159	0.2486	0.3307	1795,.		-0.1080			0.03,0.23	5.98					-0.0755	0.3553	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DISP1 (inh=AD oe_syn=1.04 oe_mis=0.91 oe_lof=0.41)
chr1	223116109	223116109	C	T	het	het	het	off-target	QUAL=3241;DP=101,104,91;AF=0.48,0.48,0.51;MQM=60;SAP=316;ABP=3	DISP1	intron	DISP1:ENST00000284476.6:intron_variant:MODIFIER:intron1/7:c.-17-40C>T::,DISP1:ENST00000360254.2:intron_variant:MODIFIER:intron2/3:c.-17-40C>T::	DISP1:NM_001350630.2:intron_variant:MODIFIER:intron2/8:c.-904-40C>T::,DISP1:NM_001369594.1:intron_variant:MODIFIER:intron1/7:c.-17-40C>T::,DISP1:NM_032890.5:intron_variant:MODIFIER:intron3/9:c.-17-40C>T::						rs75109669	0.1220	0.1799	559,.		-0.3380			0.02,0.26	6.27					0.0181	0.8839	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DISP1 (inh=AD oe_syn=1.04 oe_mis=0.91 oe_lof=0.41), NDUFB1P2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	223156382	223156382	C	T	hom	hom	hom	off-target	QUAL=17241;DP=269,154,113;AF=1.00,1.00,1.00;MQM=60;SAP=488;ABP=0	DISP1	intron	DISP1:ENST00000284476.6:intron_variant:MODIFIER:intron2/7:c.510-40C>T::	DISP1:NM_001350630.2:intron_variant:MODIFIER:intron3/8:c.-378-40C>T::,DISP1:NM_001369594.1:intron_variant:MODIFIER:intron2/7:c.510-40C>T::,DISP1:NM_032890.5:intron_variant:MODIFIER:intron4/9:c.510-40C>T::						rs2926159	0.9998	0.9999	15228,.	0.9992,1.0000,1.0000,1.0000,1.0000	0.6990			0.00,0.11	7.24					-0.0407	0.0609	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DISP1 (inh=AD oe_syn=1.04 oe_mis=0.91 oe_lof=0.41)
chr1	223168213	223168213	T	C	wt	het	wt	off-target	QUAL=1100;DP=181,93,56;AF=0.00,0.48,0.00;MQM=60;SAP=7;ABP=3	DISP1	intron	DISP1:ENST00000284476.6:intron_variant:MODIFIER:intron6/7:c.890-14T>C::	DISP1:NM_001350630.2:intron_variant:MODIFIER:intron7/8:c.161-14T>C::,DISP1:NM_001369594.1:intron_variant:MODIFIER:intron6/7:c.890-14T>C::,DISP1:NM_032890.5:intron_variant:MODIFIER:intron8/9:c.890-14T>C::	regulatory_region_variant:promoter_flanking_region		262132 [benign DISEASE=not specified];			rs2609359	0.3796	0.3440	1927,.	0.4328,0.3755,0.3002,0.3011,0.4574	1.5460			0.18,0.46	10.30		10.87>9.80			-0.051	0.4616	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DISP1 (inh=AD oe_syn=1.04 oe_mis=0.91 oe_lof=0.41)
chr1	223177574	223177574	A	G	wt	het	wt		QUAL=5303;DP=502,406,262;AF=0.00,0.50,0.00;MQM=60;SAP=28;ABP=3	DISP1	synonymous	DISP1:ENST00000284476.6:synonymous_variant:LOW:exon8/8:c.2835A>G:p.Lys945=:	DISP1:NM_001350630.2:synonymous_variant:LOW:exon9/9:c.2106A>G:p.Lys702=:,DISP1:NM_001369594.1:synonymous_variant:LOW:exon8/8:c.2835A>G:p.Lys945=:,DISP1:NM_032890.5:synonymous_variant:LOW:exon10/10:c.2835A>G:p.Lys945=:			262128 [benign DISEASE=not specified,none provided];			rs2609355	0.2414	0.2896	1134,.	0.1816,0.2986,0.2129,0.3013,0.3117	-0.6020			0.04,0.19	4.86					0.0046	0.87	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DISP1 (inh=AD oe_syn=1.04 oe_mis=0.91 oe_lof=0.41)
chr1	223178561	223178561	A	C	hom	het	hom		QUAL=20422;DP=189,371,288;AF=1.00,0.53,1.00;MQM=60;SAP=3;ABP=6	DISP1	synonymous	DISP1:ENST00000284476.6:synonymous_variant:LOW:exon8/8:c.3822A>C:p.Pro1274=:	DISP1:NM_001350630.2:synonymous_variant:LOW:exon9/9:c.3093A>C:p.Pro1031=:,DISP1:NM_001369594.1:synonymous_variant:LOW:exon8/8:c.3822A>C:p.Pro1274=:,DISP1:NM_032890.5:synonymous_variant:LOW:exon10/10:c.3822A>C:p.Pro1274=:			262131 [benign DISEASE=not specified,none provided];			rs9441941	0.4980	0.5467	4731,.	0.4474,0.5375,0.5131,0.5771,0.4763	-1.2410			0.04,0.15	0.83					-0.0016	0.8698	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DISP1 (inh=AD oe_syn=1.04 oe_mis=0.91 oe_lof=0.41)
chr1	225589473	225589473	C	T	het	het	wt		QUAL=8367;DP=322,352,266;AF=0.50,0.44,0.00;MQM=60;SAP=8;ABP=9	LBR	3'UTR	LBR:ENST00000272163.4:3_prime_UTR_variant:MODIFIER:exon14/14:c.*1532G>A::,LBR:ENST00000338179.2:3_prime_UTR_variant:MODIFIER:exon14/14:c.*1532G>A::	LBR:NM_002296.4:3_prime_UTR_variant:MODIFIER:exon14/14:c.*1532G>A::,LBR:NM_194442.2:3_prime_UTR_variant:MODIFIER:exon14/14:c.*1532G>A::		600024 [GENE=LBR PHENOS=Pelger-Huet anomaly,169400,Autosomal dominant/Greenberg skeletal dysplasia,215140,Autosomal recessive/Reynolds syndrome,613471,Autosomal dominant/Pelger-Huet anomaly with mild skeletal anomalies,618019];	295917 [benign DISEASE=Greenberg dysplasia];			rs7406	0.2726	0.2485	1414,.		0.7820			0.16,0.37	12.12					-0.0035	0.9293	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DNAH14 (inh=n/a oe_syn=0.79 oe_mis=0.80 oe_lof=1.07), LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	225590750	225590750	G	C	het	het	wt		QUAL=4479;DP=310,55,46;AF=0.47,0.51,0.00;MQM=60;SAP=150;ABP=4	LBR	3'UTR	LBR:ENST00000272163.4:3_prime_UTR_variant:MODIFIER:exon14/14:c.*255C>G::,LBR:ENST00000338179.2:3_prime_UTR_variant:MODIFIER:exon14/14:c.*255C>G::	LBR:NM_002296.4:3_prime_UTR_variant:MODIFIER:exon14/14:c.*255C>G::,LBR:NM_194442.2:3_prime_UTR_variant:MODIFIER:exon14/14:c.*255C>G::		600024 [GENE=LBR PHENOS=Pelger-Huet anomaly,169400,Autosomal dominant/Greenberg skeletal dysplasia,215140,Autosomal recessive/Reynolds syndrome,613471,Autosomal dominant/Pelger-Huet anomaly with mild skeletal anomalies,618019];	295928 [benign DISEASE=Greenberg dysplasia];			rs11551874	0.1020	0.0913	132,.		0.4490			0.18,0.22	4.59					0.0166	0.9296	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DNAH14 (inh=n/a oe_syn=0.79 oe_mis=0.80 oe_lof=1.07), LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	225600352	225600352	A	-	het	het	het	low_conf_region	QUAL=165;DP=83,35,28;AF=0.20,0.17,0.11;MQM=59;SAP=59;ABP=134	LBR	splice_region&intron	LBR:ENST00000272163.4:splice_region_variant&intron_variant:LOW:intron7/13:c.893-5del::,LBR:ENST00000338179.2:splice_region_variant&intron_variant:LOW:intron7/13:c.893-5del::	LBR:NM_002296.4:splice_region_variant&intron_variant:LOW:intron7/13:c.893-5del::,LBR:NM_194442.2:splice_region_variant&intron_variant:LOW:intron7/13:c.893-5del::		600024 [GENE=LBR PHENOS=Pelger-Huet anomaly,169400,Autosomal dominant/Greenberg skeletal dysplasia,215140,Autosomal recessive/Reynolds syndrome,613471,Autosomal dominant/Pelger-Huet anomaly with mild skeletal anomalies,618019];	439855 [benign DISEASE=none provided];			rs78306811		0.3160	1,.	0.3032,0.3126,0.3256,0.3146,0.3230	0.6810				1.20					0.0613	0.1125	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	225607144	225607144	C	T	het	het	hom		QUAL=1839;DP=75,47,20;AF=0.40,0.45,1.00;MQM=60;SAP=45;ABP=10	LBR	missense	LBR:ENST00000272163.4:missense_variant:MODERATE:exon5/14:c.461G>A:p.Ser154Asn:,LBR:ENST00000338179.2:missense_variant:MODERATE:exon5/14:c.461G>A:p.Ser154Asn:	LBR:NM_002296.4:missense_variant:MODERATE:exon5/14:c.461G>A:p.Ser154Asn:,LBR:NM_194442.2:missense_variant:MODERATE:exon5/14:c.461G>A:p.Ser154Asn:		600024 [GENE=LBR PHENOS=Pelger-Huet anomaly,169400,Autosomal dominant/Greenberg skeletal dysplasia,215140,Autosomal recessive/Reynolds syndrome,613471,Autosomal dominant/Pelger-Huet anomaly with mild skeletal anomalies,618019];	258619 [benign DISEASE=Greenberg dysplasia,not specified,not provided];			rs2230419		0.8115	9045,.	0.4185,0.8721,0.9579,0.8381,0.6987	-0.1880	T(0.41),T(0.41)	B(0.01),B(0.01)	0.01,0.10	0.00	0.17				0.0493	0.8795	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	225609884	225609884	A	G	het	het	hom		QUAL=2341;DP=123,17,15;AF=0.57,0.59,1.00;MQM=60;SAP=7;ABP=9	LBR	synonymous	LBR:ENST00000272163.4:synonymous_variant:LOW:exon3/14:c.261T>C:p.Pro87=:,LBR:ENST00000338179.2:synonymous_variant:LOW:exon3/14:c.261T>C:p.Pro87=:	LBR:NM_002296.4:synonymous_variant:LOW:exon3/14:c.261T>C:p.Pro87=:,LBR:NM_194442.2:synonymous_variant:LOW:exon3/14:c.261T>C:p.Pro87=:	regulatory_region_variant:promoter	600024 [GENE=LBR PHENOS=Pelger-Huet anomaly,169400,Autosomal dominant/Greenberg skeletal dysplasia,215140,Autosomal recessive/Reynolds syndrome,613471,Autosomal dominant/Pelger-Huet anomaly with mild skeletal anomalies,618019];	258617 [benign DISEASE=Greenberg dysplasia,not specified,not provided];			rs1056608		0.7631	7849,.	0.3854,0.8478,0.8973,0.7866,0.6557	-0.4330			0.28,0.95	10.63					0.017	0.7009	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	225611661	225611661	C	T	het	hom	het		QUAL=17131;DP=364,283,210;AF=0.53,1.00,0.49;MQM=60;SAP=13;ABP=4	LBR	synonymous	LBR:ENST00000272163.4:synonymous_variant:LOW:exon2/14:c.117G>A:p.Val39=:PF09465 [Lamin-B receptor of TUDOR domain],LBR:ENST00000338179.2:synonymous_variant:LOW:exon2/14:c.117G>A:p.Val39=:PF09465 [Lamin-B receptor of TUDOR domain]	LBR:NM_002296.4:synonymous_variant:LOW:exon2/14:c.117G>A:p.Val39=:,LBR:NM_194442.2:synonymous_variant:LOW:exon2/14:c.117G>A:p.Val39=:		600024 [GENE=LBR PHENOS=Pelger-Huet anomaly,169400,Autosomal dominant/Greenberg skeletal dysplasia,215140,Autosomal recessive/Reynolds syndrome,613471,Autosomal dominant/Pelger-Huet anomaly with mild skeletal anomalies,618019];	258616 [benign DISEASE=Greenberg dysplasia,not specified,none provided,not provided];			rs1056607		0.7259	8324,.	0.6399,0.7860,0.7681,0.7349,0.5212	-2.9810			0.04,0.70	8.92					-0.3089	0.8604	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	225611845	225611845	C	T	wt	het	het	off-target;low_conf_region	QUAL=2276;DP=183,110,83;AF=0.00,0.52,0.43;MQM=60;SAP=114;ABP=4	LBR	intron	LBR:ENST00000272163.4:intron_variant:MODIFIER:intron1/13:c.-14-54G>A::,LBR:ENST00000338179.2:intron_variant:MODIFIER:intron1/13:c.-14-54G>A::	LBR:NM_002296.4:intron_variant:MODIFIER:intron1/13:c.-14-54G>A::,LBR:NM_194442.2:intron_variant:MODIFIER:intron1/13:c.-14-54G>A::		600024 [GENE=LBR PHENOS=Pelger-Huet anomaly,169400,Autosomal dominant/Greenberg skeletal dysplasia,215140,Autosomal recessive/Reynolds syndrome,613471,Autosomal dominant/Pelger-Huet anomaly with mild skeletal anomalies,618019];	810884 [benign DISEASE=not specified];			rs1340867	0.6018	0.6251	6178,.		-0.4700			0.01,0.08	2.45					0.0127	0.865	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	225616378	225616378	G	C	het	wt	het	off-target	QUAL=4073;DP=192,249,179;AF=0.55,0.00,0.50;MQM=60;SAP=299;ABP=5	LBR	intron	LBR:ENST00000338179.2:intron_variant:MODIFIER:intron1/13:c.-15+30C>G::	LBR:NM_194442.2:intron_variant:MODIFIER:intron1/13:c.-15+30C>G::	regulatory_region_variant:promoter,TF_binding_site_variant	600024 [GENE=LBR PHENOS=Pelger-Huet anomaly,169400,Autosomal dominant/Greenberg skeletal dysplasia,215140,Autosomal recessive/Reynolds syndrome,613471,Autosomal dominant/Pelger-Huet anomaly with mild skeletal anomalies,618019];				rs75691342	0.0996	0.0732	88,.		-0.4440			0.05,0.33	6.78					-0.0715	0.3147		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	226548554	226548554	A	G	wt	wt	het		QUAL=860;DP=168,97,77;AF=0.01,0.00,0.49;MQM=60;SAP=38;ABP=3	PARP1	3'UTR	PARP1:ENST00000366794.5:3_prime_UTR_variant:MODIFIER:exon23/23:c.*607T>C::	PARP1:NM_001618.4:3_prime_UTR_variant:MODIFIER:exon23/23:c.*607T>C::				CR122378 [CLASS=DP MUT=ALT PHEN="Bladder cancer increased risk association with" GENE=PARP1];		rs8679	0.1428	0.1525	446,.		-0.4050			0.01,0.20	3.83					-0.0049	0.9683	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226555302	226555302	A	G	het	het	wt		QUAL=5799;DP=195,300,218;AF=0.48,0.47,0.00;MQM=60;SAP=59;ABP=6	PARP1	missense	PARP1:ENST00000366794.5:missense_variant:MODERATE:exon17/23:c.2285T>C:p.Val762Ala:PF02877 [Poly(ADP-ribose) polymerase regulatory domain]	PARP1:NM_001618.4:missense_variant:MODERATE:exon17/23:c.2285T>C:p.Val762Ala:				CM042761 [CLASS=DFP MUT=ALT PHEN="Prostate cancer susceptibility association with" GENE=PARP1];		rs1136410	0.1969	0.2131	552,.	0.0487,0.4231,0.4477,0.1664,0.1026	8.9590	D(0.02)	P(0.68)	0.98,0.98	27.20	0.18				0.1437	0.2977	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226555348	226555348	G	A	wt	wt	het	off-target	QUAL=2128;DP=205,243,175;AF=0.00,0.00,0.49;MQM=60;SAP=37;ABP=3	PARP1	intron	PARP1:ENST00000366794.5:intron_variant:MODIFIER:intron16/22:c.2278-39C>T::	PARP1:NM_001618.4:intron_variant:MODIFIER:intron16/22:c.2278-39C>T::						rs3219123	0.0266	0.0445	28,.	0.0086,0.0237,0.0004,0.0601,0.0452	0.9070			0.07,0.19	1.09					0.0587	0.106	0	71	2021	0 / 0					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226570840	226570840	T	C	het	het	hom		QUAL=4874;DP=92,92,72;AF=0.58,0.51,1.00;MQM=60;SAP=35;ABP=6	PARP1	synonymous	PARP1:ENST00000366794.5:synonymous_variant:LOW:exon8/23:c.1056A>G:p.Lys352=:	PARP1:NM_001618.4:synonymous_variant:LOW:exon8/23:c.1056A>G:p.Lys352=:						rs1805415		0.8241	10763,.	0.9002,0.5748,0.5531,0.8337,0.8974	-0.1150			0.12,0.95	9.97					0.0479	0.2495	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226573364	226573364	A	G	het	het	wt		QUAL=4695;DP=152,247,208;AF=0.55,0.45,0.00;MQM=60;SAP=148;ABP=4	PARP1	synonymous	PARP1:ENST00000366794.5:synonymous_variant:LOW:exon7/23:c.852T>C:p.Ala284=:PF08063 [PADR1 (NUC008) domain]	PARP1:NM_001618.4:synonymous_variant:LOW:exon7/23:c.852T>C:p.Ala284=:				CM071915 [CLASS=DP MUT=ALT PHEN="Colorectal adenoma association with" GENE=PARP1];		rs1805414	0.5166	0.4276	3103,.	0.5525,0.5538,0.8133,0.3377,0.3647	-2.5850			0.12,0.46	5.44					0.0963	0.0958	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226578099	226578099	T	C	hom	hom	het	off-target	QUAL=9066;DP=92,162,121;AF=1.00,0.99,0.55;MQM=60;SAP=439;ABP=5	PARP1	intron	PARP1:ENST00000366794.5:intron_variant:MODIFIER:intron4/22:c.617+12A>G::	PARP1:NM_001618.4:intron_variant:MODIFIER:intron4/22:c.617+12A>G::						rs1805403	0.8576	0.8468	11314,.	0.9411,0.8703,0.9388,0.7678,0.7385	-5.6250			0.01,0.16	0.44					0.1107	0.0907	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226589958	226589958	G	A	het	het	wt		QUAL=9296;DP=294,468,299;AF=0.47,0.49,0.00;MQM=60;SAP=6;ABP=6	PARP1	synonymous	PARP1:ENST00000366790.3:synonymous_variant:LOW:exon2/2:c.243C>T:p.Asp81=:PF00645 [Poly(ADP-ribose) polymerase and DNA-Ligase Zn-finger region],PARP1:ENST00000366791.5:synonymous_variant:LOW:exon2/3:c.243C>T:p.Asp81=:PF00645 [Poly(ADP-ribose) polymerase and DNA-Ligase Zn-finger region],PARP1:ENST00000366792.1:synonymous_variant:LOW:exon2/4:c.243C>T:p.Asp81=:PF00645 [Poly(ADP-ribose) polymerase and DNA-Ligase Zn-finger region],PARP1:ENST00000366794.5:synonymous_variant:LOW:exon2/23:c.243C>T:p.Asp81=:PF00645 [Poly(ADP-ribose) polymerase and DNA-Ligase Zn-finger region]	PARP1:NM_001618.4:synonymous_variant:LOW:exon2/23:c.243C>T:p.Asp81=:						rs1805404	0.2183	0.2184	629,.	0.1230,0.4261,0.4479,0.1663,0.1030	3.3120			0.86,0.92	11.66					-0.0501	0.8927	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226595647	226595647	C	G	het	het	wt		QUAL=2218;DP=40,146,138;AF=0.55,0.50,0.00;MQM=60;SAP=3;ABP=3	PARP1	5'UTR	PARP1:ENST00000366790.3:5_prime_UTR_variant:MODIFIER:exon1/2:c.-17G>C::,PARP1:ENST00000366791.5:5_prime_UTR_variant:MODIFIER:exon1/3:c.-17G>C::,PARP1:ENST00000366792.1:5_prime_UTR_variant:MODIFIER:exon1/4:c.-17G>C::,PARP1:ENST00000366794.5:5_prime_UTR_variant:MODIFIER:exon1/23:c.-17G>C::	PARP1:NM_001618.4:5_prime_UTR_variant:MODIFIER:exon1/23:c.-17G>C::	regulatory_region_variant:promoter,TF_binding_site_variant					rs907187	0.1991	0.2135	582,.	0.0465,0.4177,0.4433,0.1652,0.1020	1.1800			0.12,0.67	11.85					0.0193	0.1514	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	227149203	227149203	G	A	wt	wt	het		QUAL=294;DP=71,35,31;AF=0.00,0.00,0.48;MQM=60;SAP=4;ABP=3	COQ8A	synonymous,splice_region&intron,intron	COQ8A:ENST00000366777.3:synonymous_variant:LOW:exon2/15:c.117G>A:p.Ala39=:,COQ8A:ENST00000366778.1:splice_region_variant&intron_variant:LOW:intron1/14:c.-34-6G>A::,COQ8A:ENST00000366779.1:synonymous_variant:LOW:exon7/20:c.117G>A:p.Ala39=:,COQ8A:ENST00000458507.2:intron_variant:MODIFIER:intron1/11:c.-182-15947G>A::	COQ8A:NM_020247.5:synonymous_variant:LOW:exon2/15:c.117G>A:p.Ala39=:		606980 [GENE=COQ8A PHENOS=Coenzyme Q10 deficiency,primary,4,612016,Autosomal recessive];	128273 [benign DISEASE=Coenzyme Q10 deficiency, primary, 4,Autosomal recessive cerebellar ataxia,not specified,not provided];			rs11549708	0.0807	0.1645	503,.	0.0465,0.0978,0.0005,0.2379,0.0769	-3.4260			0.01,0.13	1.17		-0.47>-4.84			-0.9468	0.9417	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	227152662	227152662	C	T	wt	wt	het	off-target	QUAL=930;DP=83,85,67;AF=0.01,0.00,0.63;MQM=60;SAP=80;ABP=12	COQ8A	intron	COQ8A:ENST00000366777.3:intron_variant:MODIFIER:intron2/14:c.178-39C>T::,COQ8A:ENST00000366778.1:intron_variant:MODIFIER:intron2/14:c.22-39C>T::,COQ8A:ENST00000366779.1:intron_variant:MODIFIER:intron7/19:c.178-39C>T::,COQ8A:ENST00000458507.2:intron_variant:MODIFIER:intron1/11:c.-182-12488C>T::	COQ8A:NM_020247.5:intron_variant:MODIFIER:intron2/14:c.178-39C>T::		606980 [GENE=COQ8A PHENOS=Coenzyme Q10 deficiency,primary,4,612016,Autosomal recessive];				rs759581953		0.0001		0.0000,0.0000,0.0001,0.0001,0.0001	-1.6860			0.01,0.11	0.21					-0.0816	0.0587	0	0	3	0 / 0					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	227165235	227165235	C	T	het	het	wt	off-target	QUAL=433;DP=18,24,31;AF=0.50,0.50,0.00;MQM=60;SAP=3;ABP=3	COQ8A	intron	COQ8A:ENST00000366777.3:intron_variant:MODIFIER:intron5/14:c.730+11C>T::,COQ8A:ENST00000366778.1:intron_variant:MODIFIER:intron5/14:c.574+11C>T::,COQ8A:ENST00000366779.1:intron_variant:MODIFIER:intron10/19:c.730+11C>T::,COQ8A:ENST00000433743.2:intron_variant:MODIFIER:intron2/10:c.-108+11C>T::,COQ8A:ENST00000458507.2:intron_variant:MODIFIER:intron2/11:c.-108+11C>T::	COQ8A:NM_020247.5:intron_variant:MODIFIER:intron5/14:c.730+11C>T::		606980 [GENE=COQ8A PHENOS=Coenzyme Q10 deficiency,primary,4,612016,Autosomal recessive];				rs759489004		0.0001	0,.	0.0000,0.0000,0.0000,0.0001,0.0000	1.0160			0.08,0.16	6.41					-0.5691	0.1175	0	0	3	0 / 0					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	227170543	227170543	C	G	het	wt	het	off-target	QUAL=3761;DP=113,294,177;AF=0.61,0.01,0.47;MQM=60;SAP=90;ABP=4	COQ8A	intron	COQ8A:ENST00000366777.3:intron_variant:MODIFIER:intron7/14:c.940-52C>G::,COQ8A:ENST00000366778.1:intron_variant:MODIFIER:intron7/14:c.784-52C>G::,COQ8A:ENST00000366779.1:intron_variant:MODIFIER:intron12/19:c.940-52C>G::,COQ8A:ENST00000433743.2:intron_variant:MODIFIER:intron4/10:c.102+79C>G::,COQ8A:ENST00000458507.2:intron_variant:MODIFIER:intron4/11:c.103-52C>G::	COQ8A:NM_020247.5:intron_variant:MODIFIER:intron7/14:c.940-52C>G::		606980 [GENE=COQ8A PHENOS=Coenzyme Q10 deficiency,primary,4,612016,Autosomal recessive];	671531 [benign DISEASE=not provided];			rs2297413	0.1983	0.1993	675,.		0.6440			0.00,0.09	1.41					0.0257	0.3473	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	227171210	227171210	G	A	het	hom	wt	off-target	QUAL=5888;DP=82,175,143;AF=0.50,0.99,0.00;MQM=60;SAP=204;ABP=3	COQ8A	intron	COQ8A:ENST00000366777.3:intron_variant:MODIFIER:intron8/14:c.1081-43G>A::,COQ8A:ENST00000366778.1:intron_variant:MODIFIER:intron8/14:c.925-43G>A::,COQ8A:ENST00000366779.1:intron_variant:MODIFIER:intron13/19:c.1081-43G>A::,COQ8A:ENST00000433743.2:intron_variant:MODIFIER:intron4/10:c.103-43G>A::,COQ8A:ENST00000458507.2:intron_variant:MODIFIER:intron5/11:c.244-43G>A::	COQ8A:NM_020247.5:intron_variant:MODIFIER:intron8/14:c.1081-43G>A::		606980 [GENE=COQ8A PHENOS=Coenzyme Q10 deficiency,primary,4,612016,Autosomal recessive];	671619 [benign DISEASE=not provided];			rs12739480	0.0871	0.1248	284,.	0.0331,0.0460,0.0446,0.1408,0.2082	-0.2170			0.10,0.16	1.11					-0.2755	0.634	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	227171585	227171585	T	-	het	wt	hom	off-target	QUAL=1898;DP=102,77,40;AF=0.42,0.00,1.00;MQM=60;SAP=66;ABP=8	COQ8A	intron	COQ8A:ENST00000366777.3:intron_variant:MODIFIER:intron10/14:c.1256+32del::,COQ8A:ENST00000366778.1:intron_variant:MODIFIER:intron10/14:c.1100+32del::,COQ8A:ENST00000366779.1:intron_variant:MODIFIER:intron15/19:c.1256+32del::,COQ8A:ENST00000433743.2:intron_variant:MODIFIER:intron6/10:c.278+32del::,COQ8A:ENST00000458507.2:intron_variant:MODIFIER:intron7/11:c.419+32del::	COQ8A:NM_020247.5:intron_variant:MODIFIER:intron10/14:c.1256+32del::		606980 [GENE=COQ8A PHENOS=Coenzyme Q10 deficiency,primary,4,612016,Autosomal recessive];				rs3215919		0.3635	2172,.	0.2910,0.2790,0.1388,0.4449,0.2053	-0.6290				0.52					0.1323	0.3545	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	227171736	227171736	-	T	wt	wt	het	off-target	QUAL=2208;DP=67,41,57;AF=0.64,0.00,0.53;MQM=60;SAP=4;ABP=3	COQ8A	intron	COQ8A:ENST00000366777.3:intron_variant:MODIFIER:intron10/14:c.1257-59_1257-58insT::,COQ8A:ENST00000366778.1:intron_variant:MODIFIER:intron10/14:c.1101-59_1101-58insT::,COQ8A:ENST00000366779.1:intron_variant:MODIFIER:intron15/19:c.1257-59_1257-58insT::,COQ8A:ENST00000433743.2:intron_variant:MODIFIER:intron6/10:c.279-59_279-58insT::,COQ8A:ENST00000458507.2:intron_variant:MODIFIER:intron7/11:c.420-59_420-58insT::	COQ8A:NM_020247.5:intron_variant:MODIFIER:intron10/14:c.1257-59_1257-58insT::		606980 [GENE=COQ8A PHENOS=Coenzyme Q10 deficiency,primary,4,612016,Autosomal recessive];				rs149374145		0.1563	416,.						1.58					0.0526	0.8195	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	227171737	227171737	G	T	het	wt	het	off-target	QUAL=2208;DP=67,41,57;AF=0.64,0.00,0.53;MQM=60;SAP=58;ABP=11	COQ8A	intron	COQ8A:ENST00000366777.3:intron_variant:MODIFIER:intron10/14:c.1257-58G>T::,COQ8A:ENST00000366778.1:intron_variant:MODIFIER:intron10/14:c.1101-58G>T::,COQ8A:ENST00000366779.1:intron_variant:MODIFIER:intron15/19:c.1257-58G>T::,COQ8A:ENST00000433743.2:intron_variant:MODIFIER:intron6/10:c.279-58G>T::,COQ8A:ENST00000458507.2:intron_variant:MODIFIER:intron7/11:c.420-58G>T::	COQ8A:NM_020247.5:intron_variant:MODIFIER:intron10/14:c.1257-58G>T::		606980 [GENE=COQ8A PHENOS=Coenzyme Q10 deficiency,primary,4,612016,Autosomal recessive];				rs1574184	0.2812	0.2902	767,.		2.3640			0.53,0.16	1.67					0.1203	0.8041	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	227171738	227171738	G	T	wt	wt	het	off-target	QUAL=2208;DP=67,41,57;AF=0.64,0.00,0.53;MQM=60;SAP=4;ABP=3	COQ8A	intron	COQ8A:ENST00000366777.3:intron_variant:MODIFIER:intron10/14:c.1257-57G>T::,COQ8A:ENST00000366778.1:intron_variant:MODIFIER:intron10/14:c.1101-57G>T::,COQ8A:ENST00000366779.1:intron_variant:MODIFIER:intron15/19:c.1257-57G>T::,COQ8A:ENST00000433743.2:intron_variant:MODIFIER:intron6/10:c.279-57G>T::,COQ8A:ENST00000458507.2:intron_variant:MODIFIER:intron7/11:c.420-57G>T::	COQ8A:NM_020247.5:intron_variant:MODIFIER:intron10/14:c.1257-57G>T::		606980 [GENE=COQ8A PHENOS=Coenzyme Q10 deficiency,primary,4,612016,Autosomal recessive];				rs377335668		0.1481	401,.		0.3950			0.34,0.16	2.02					0.1467	0.805	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	227171739	227171739	G	T	het	wt	het	off-target	QUAL=2208;DP=67,41,57;AF=0.64,0.00,0.53;MQM=60;SAP=58;ABP=11	COQ8A	intron	COQ8A:ENST00000366777.3:intron_variant:MODIFIER:intron10/14:c.1257-56G>T::,COQ8A:ENST00000366778.1:intron_variant:MODIFIER:intron10/14:c.1101-56G>T::,COQ8A:ENST00000366779.1:intron_variant:MODIFIER:intron15/19:c.1257-56G>T::,COQ8A:ENST00000433743.2:intron_variant:MODIFIER:intron6/10:c.279-56G>T::,COQ8A:ENST00000458507.2:intron_variant:MODIFIER:intron7/11:c.420-56G>T::	COQ8A:NM_020247.5:intron_variant:MODIFIER:intron10/14:c.1257-56G>T::		606980 [GENE=COQ8A PHENOS=Coenzyme Q10 deficiency,primary,4,612016,Autosomal recessive];				rs1574185	0.2802	0.2305	705,.		-0.0790			0.17,0.13	0.28					0.1396	0.8083	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	227171958	227171958	G	C	wt	wt	het	off-target	QUAL=1013;DP=114,107,75;AF=0.00,0.00,0.53;MQM=60;SAP=4;ABP=4	COQ8A	intron	COQ8A:ENST00000366777.3:intron_variant:MODIFIER:intron11/14:c.1398+22G>C::,COQ8A:ENST00000366778.1:intron_variant:MODIFIER:intron11/14:c.1242+22G>C::,COQ8A:ENST00000366779.1:intron_variant:MODIFIER:intron16/19:c.1398+22G>C::,COQ8A:ENST00000433743.2:intron_variant:MODIFIER:intron7/10:c.420+22G>C::,COQ8A:ENST00000458507.2:intron_variant:MODIFIER:intron8/11:c.561+22G>C::	COQ8A:NM_020247.5:intron_variant:MODIFIER:intron11/14:c.1398+22G>C::		606980 [GENE=COQ8A PHENOS=Coenzyme Q10 deficiency,primary,4,612016,Autosomal recessive];				rs7530213	0.1683	0.2495	1051,.	0.1551,0.2011,0.0930,0.3134,0.1314	0.8940			0.11,0.31	7.87					-0.1247	0.8244	0.32	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	227172290	227172290	C	T	het	wt	hom		QUAL=15680;DP=328,506,380;AF=0.47,0.00,0.98;MQM=60;SAP=5;ABP=5	COQ8A	synonymous	COQ8A:ENST00000366777.3:synonymous_variant:LOW:exon12/15:c.1440C>T:p.Phe480=:,COQ8A:ENST00000366778.1:synonymous_variant:LOW:exon12/15:c.1284C>T:p.Phe428=:,COQ8A:ENST00000366779.1:synonymous_variant:LOW:exon17/20:c.1440C>T:p.Phe480=:,COQ8A:ENST00000433743.2:synonymous_variant:LOW:exon8/11:c.462C>T:p.Phe154=:,COQ8A:ENST00000458507.2:synonymous_variant:LOW:exon9/12:c.603C>T:p.Phe201=:	COQ8A:NM_020247.5:synonymous_variant:LOW:exon12/15:c.1440C>T:p.Phe480=:		606980 [GENE=COQ8A PHENOS=Coenzyme Q10 deficiency,primary,4,612016,Autosomal recessive];	128274 [benign DISEASE=Coenzyme Q10 deficiency, primary, 4,not specified,Coenzyme Q10 deficiency, Spinocerebellar Ataxia Type,not provided];			rs12593	0.2386	0.3534	2080,.	0.1976,0.2696,0.1758,0.4533,0.2031	-0.0650			0.20,0.87	10.92					-0.2767	0.0538	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	227172903	227172903	G	A	het	wt	hom	off-target	QUAL=8108;DP=101,303,230;AF=0.59,0.00,0.98;MQM=60;SAP=97;ABP=11	COQ8A	intron	COQ8A:ENST00000366777.3:intron_variant:MODIFIER:intron13/14:c.1573-52G>A::,COQ8A:ENST00000366778.1:intron_variant:MODIFIER:intron13/14:c.1417-52G>A::,COQ8A:ENST00000366779.1:intron_variant:MODIFIER:intron18/19:c.1573-52G>A::,COQ8A:ENST00000433743.2:intron_variant:MODIFIER:intron9/10:c.595-52G>A::,COQ8A:ENST00000458507.2:intron_variant:MODIFIER:intron10/11:c.736-52G>A::	COQ8A:NM_020247.5:intron_variant:MODIFIER:intron13/14:c.1573-52G>A::	regulatory_region_variant:open_chromatin_region	606980 [GENE=COQ8A PHENOS=Coenzyme Q10 deficiency,primary,4,612016,Autosomal recessive];	676090 [benign DISEASE=not provided];			rs2297415	0.2696	0.3733	2299,.		-0.7670			0.01,0.14	3.01				COSV62017351	0.045	0.093	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69), CDC42BPA (inh=n/a oe_syn=0.95 oe_mis=0.77 oe_lof=0.19)
chr1	227172935	227172935	C	G	het	wt	hom	off-target	QUAL=9640;DP=113,339,265;AF=0.62,0.00,1.00;MQM=60;SAP=20;ABP=17	COQ8A	intron	COQ8A:ENST00000366777.3:intron_variant:MODIFIER:intron13/14:c.1573-20C>G::,COQ8A:ENST00000366778.1:intron_variant:MODIFIER:intron13/14:c.1417-20C>G::,COQ8A:ENST00000366779.1:intron_variant:MODIFIER:intron18/19:c.1573-20C>G::,COQ8A:ENST00000433743.2:intron_variant:MODIFIER:intron9/10:c.595-20C>G::,COQ8A:ENST00000458507.2:intron_variant:MODIFIER:intron10/11:c.736-20C>G::	COQ8A:NM_020247.5:intron_variant:MODIFIER:intron13/14:c.1573-20C>G::	regulatory_region_variant:open_chromatin_region	606980 [GENE=COQ8A PHENOS=Coenzyme Q10 deficiency,primary,4,612016,Autosomal recessive];	518313 [likely benign DISEASE=Coenzyme Q10 deficiency, primary, 4];			rs2297416	0.2652	0.3685	2261,.	0.2678,0.2816,0.1674,0.4597,0.2070	-1.1720			0.10,0.22	3.29		12.28>10.93			-0.2745	0.1269	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69), CDC42BPA (inh=n/a oe_syn=0.95 oe_mis=0.77 oe_lof=0.19)
chr1	227174122	227174122	C	G	wt	wt	het	off-target	QUAL=940;DP=87,139,73;AF=0.00,0.00,0.56;MQM=60;SAP=6;ABP=5	COQ8A	intron	COQ8A:ENST00000366777.3:intron_variant:MODIFIER:intron14/14:c.1660-32C>G::,COQ8A:ENST00000366778.1:intron_variant:MODIFIER:intron14/14:c.1504-32C>G::,COQ8A:ENST00000366779.1:intron_variant:MODIFIER:intron19/19:c.1660-32C>G::,COQ8A:ENST00000433743.2:intron_variant:MODIFIER:intron10/10:c.682-32C>G::,COQ8A:ENST00000458507.2:intron_variant:MODIFIER:intron11/11:c.823-32C>G::	COQ8A:NM_020247.5:intron_variant:MODIFIER:intron14/14:c.1660-32C>G::		606980 [GENE=COQ8A PHENOS=Coenzyme Q10 deficiency,primary,4,612016,Autosomal recessive];	671534 [benign DISEASE=not provided];			rs41303131	0.1136	0.1980	701,.	0.0873,0.1155,0.0030,0.2805,0.1235	-0.8240			0.03,0.13	0.38					-0.0831	0.8655	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69), CDC42BPA (inh=n/a oe_syn=0.95 oe_mis=0.77 oe_lof=0.19)
chr1	227174145	227174145	T	C	het	wt	hom		QUAL=4085;DP=103,168,89;AF=0.54,0.00,1.00;MQM=60;SAP=52;ABP=5	COQ8A	intron	COQ8A:ENST00000366777.3:intron_variant:MODIFIER:intron14/14:c.1660-9T>C::,COQ8A:ENST00000366778.1:intron_variant:MODIFIER:intron14/14:c.1504-9T>C::,COQ8A:ENST00000366779.1:intron_variant:MODIFIER:intron19/19:c.1660-9T>C::,COQ8A:ENST00000433743.2:intron_variant:MODIFIER:intron10/10:c.682-9T>C::,COQ8A:ENST00000458507.2:intron_variant:MODIFIER:intron11/11:c.823-9T>C::	COQ8A:NM_020247.5:intron_variant:MODIFIER:intron14/14:c.1660-9T>C::		606980 [GENE=COQ8A PHENOS=Coenzyme Q10 deficiency,primary,4,612016,Autosomal recessive];	296024 [benign DISEASE=Coenzyme Q10 deficiency, primary, 4,Autosomal recessive cerebellar ataxia,not provided];			rs7552783	0.3516	0.4392	3049,.	0.4148,0.3047,0.2207,0.5014,0.2758	-0.4800			0.04,0.18	10.85		11.51>10.71	0.001/0.006	COSV62011703	-0.278	0.8366	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69), CDC42BPA (inh=n/a oe_syn=0.95 oe_mis=0.77 oe_lof=0.19)
chr1	227174210	227174210	T	C	het	wt	hom		QUAL=5268;DP=157,185,118;AF=0.45,0.00,1.00;MQM=60;SAP=3;ABP=7	COQ8A	synonymous	COQ8A:ENST00000366777.3:synonymous_variant:LOW:exon15/15:c.1716T>C:p.Ser572=:,COQ8A:ENST00000366778.1:synonymous_variant:LOW:exon15/15:c.1560T>C:p.Ser520=:,COQ8A:ENST00000366779.1:synonymous_variant:LOW:exon20/20:c.1716T>C:p.Ser572=:,COQ8A:ENST00000433743.2:synonymous_variant:LOW:exon11/11:c.738T>C:p.Ser246=:,COQ8A:ENST00000458507.2:synonymous_variant:LOW:exon12/12:c.879T>C:p.Ser293=:	COQ8A:NM_020247.5:synonymous_variant:LOW:exon15/15:c.1716T>C:p.Ser572=:		606980 [GENE=COQ8A PHENOS=Coenzyme Q10 deficiency,primary,4,612016,Autosomal recessive];	128275 [benign DISEASE=Coenzyme Q10 deficiency, primary, 4,Autosomal recessive cerebellar ataxia,not specified,not provided];			rs3738725	0.3139	0.4095	2712,.	0.3106,0.2982,0.2240,0.5020,0.2756	-5.9700			0.07,0.08	0.02					0.0436	0.9024	0.18	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69), CDC42BPA (inh=n/a oe_syn=0.95 oe_mis=0.77 oe_lof=0.19)
chr1	227174823	227174823	-	T	het	wt	hom		QUAL=13788;DP=245,474,373;AF=0.46,0.00,1.00;MQM=60;SAP=74;ABP=6	COQ8A	3'UTR	COQ8A:ENST00000366777.3:3_prime_UTR_variant:MODIFIER:exon15/15:c.*389dup::,COQ8A:ENST00000366778.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*389dup::,COQ8A:ENST00000366779.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*389dup::,COQ8A:ENST00000458507.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*389dup::	COQ8A:NM_020247.5:3_prime_UTR_variant:MODIFIER:exon15/15:c.*389dup::		606980 [GENE=COQ8A PHENOS=Coenzyme Q10 deficiency,primary,4,612016,Autosomal recessive];	296038 [benign DISEASE=Autosomal recessive cerebellar ataxia,Coenzyme Q10 deficiency, Spinocerebellar Ataxia Type];			rs11420839		0.3993	2638,.						5.52					-0.0095	0.902	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69), CDC42BPA (inh=n/a oe_syn=0.95 oe_mis=0.77 oe_lof=0.19)
chr1	227175245	227175245	-	T	het	wt	hom		QUAL=7909;DP=162,329,221;AF=0.45,0.00,0.96;MQM=60;SAP=25;ABP=6	COQ8A	3'UTR	COQ8A:ENST00000366779.1:3_prime_UTR_variant:MODIFIER:exon20/20:::			606980 [GENE=COQ8A PHENOS=Coenzyme Q10 deficiency,primary,4,612016,Autosomal recessive];	296050 [benign DISEASE=Autosomal recessive cerebellar ataxia,Coenzyme Q10 deficiency, Spinocerebellar Ataxia Type];			rs3215920		0.3678	2367,.						0.54					0.3358	0.9141	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69), CDC42BPA (inh=n/a oe_syn=0.95 oe_mis=0.77 oe_lof=0.19)
chr1	227175253	227175253	C	T	het	wt	hom		QUAL=8629;DP=165,324,214;AF=0.48,0.00,1.00;MQM=60;SAP=45;ABP=4	CDC42BPA,COQ8A,RP5-1087E8.3	downstream_gene,upstream_gene	CDC42BPA:ENST00000334218.5:downstream_gene_variant:MODIFIER::::,CDC42BPA:ENST00000366764.2:downstream_gene_variant:MODIFIER::::,CDC42BPA:ENST00000366766.2:downstream_gene_variant:MODIFIER::::,CDC42BPA:ENST00000366767.3:downstream_gene_variant:MODIFIER::::,CDC42BPA:ENST00000366769.3:downstream_gene_variant:MODIFIER::::,COQ8A:ENST00000366777.3:downstream_gene_variant:MODIFIER::::,COQ8A:ENST00000366778.1:downstream_gene_variant:MODIFIER::::,COQ8A:ENST00000366779.1:downstream_gene_variant:MODIFIER::::,COQ8A:ENST00000433743.2:downstream_gene_variant:MODIFIER::::,RP5-1087E8.3:ENST00000433837.1:upstream_gene_variant:MODIFIER::::,COQ8A:ENST00000458507.2:downstream_gene_variant:MODIFIER::::			606980 [GENE=COQ8A PHENOS=Coenzyme Q10 deficiency,primary,4,612016,Autosomal recessive];	368867 [benign DISEASE=Autosomal recessive cerebellar ataxia,Coenzyme Q10 deficiency, Spinocerebellar Ataxia Type];			rs10495274	0.4191	0.5227	4474,.		-0.6030			0.03,0.10	0.15								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69), CDC42BPA (inh=n/a oe_syn=0.95 oe_mis=0.77 oe_lof=0.19)
chr1	228346936	228346936	G	A	het	het	wt		QUAL=2230;DP=41,130,92;AF=0.59,0.54,0.00;MQM=60;SAP=27;ABP=7	GJC2	3'UTR	GJC2:ENST00000366714.2:3_prime_UTR_variant:MODIFIER:exon2/2:c.*157G>A::	GJC2:NM_020435.4:3_prime_UTR_variant:MODIFIER:exon2/2:c.*157G>A::		608803 [GENE=GJC2 PHENOS=Spastic paraplegia 44,autosomal recessive,613206,Autosomal recessive/Lymphatic malformation 3,613480,Autosomal dominant/Leukodystrophy,hypomyelinating,2,608804,Autosomal recessive];				rs45491398	0.0234	0.0601	77,.		-1.0290			0.01,0.14	2.23					0.0008	0.9039	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJC2 (inh=AR+AD oe_syn=0.94 oe_mis=0.67 oe_lof=0.54), IBA57-DT (inh=n/a oe_syn=1.01 oe_mis=1.00 oe_lof=n/a)
chr1	228347352	228347352	A	G	hom	hom	hom		QUAL=1499;DP=30,13,8;AF=1.00,1.00,1.00;MQM=60;SAP=105;ABP=0	GJC2	3'UTR	GJC2:ENST00000366714.2:3_prime_UTR_variant:MODIFIER:exon2/2:c.*573A>G::	GJC2:NM_020435.4:3_prime_UTR_variant:MODIFIER:exon2/2:c.*573A>G::		608803 [GENE=GJC2 PHENOS=Spastic paraplegia 44,autosomal recessive,613206,Autosomal recessive/Lymphatic malformation 3,613480,Autosomal dominant/Leukodystrophy,hypomyelinating,2,608804,Autosomal recessive];				rs6668719	0.8043	0.8421	11358,.		-0.0280			0.01,0.11	2.35					0.0025	0.9039	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJC2 (inh=AR+AD oe_syn=0.94 oe_mis=0.67 oe_lof=0.54), IBA57-DT (inh=n/a oe_syn=1.01 oe_mis=1.00 oe_lof=n/a)
chr1	228612838	228612838	G	T	het	hom	het		QUAL=18462;DP=276,384,284;AF=0.51,1.00,0.46;MQM=60;SAP=427;ABP=4	H3-4	synonymous	H3-4:ENST00000366696.1:synonymous_variant:LOW:exon1/1:c.189C>A:p.Ile63=:PF00125 [Core histone H2A/H2B/H3/H4]	HIST3H3:NM_003493.2:synonymous_variant:LOW:exon1/1:c.189C>A:p.Ile63=:						rs2230656		0.8318	8932,.	0.3976,0.9254,0.6604,0.8863,0.8559	2.3090			0.89,0.92	4.43					-0.0133	0.9233	0.06	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					H3-4 (inh=n/a oe_syn=1.79 oe_mis=1.55 oe_lof=1.60)
chr1	228612892	228612892	G	A	wt	het	wt		QUAL=2235;DP=173,259,209;AF=0.00,0.47,0.00;MQM=60;SAP=158;ABP=5	H3-4	synonymous	H3-4:ENST00000366696.1:synonymous_variant:LOW:exon1/1:c.135C>T:p.Gly45=:	HIST3H3:NM_003493.2:synonymous_variant:LOW:exon1/1:c.135C>T:p.Gly45=:						rs56336130	0.0433	0.0708	79,.	0.0128,0.0359,0.0198,0.0923,0.0907	-0.0050			0.72,0.96	7.63					-0.0433	0.9229	0.67	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					H3-4 (inh=n/a oe_syn=1.79 oe_mis=1.55 oe_lof=1.60)
chr1	228613052	228613052	T	C	het	hom	het	off-target	QUAL=1560;DP=56,30,34;AF=0.38,1.00,0.41;MQM=60;SAP=144;ABP=13	H3-4	upstream_gene	H3-4:ENST00000366696.1:upstream_gene_variant:MODIFIER::::							rs1188474		0.8781	12123,.	0.9285,0.9608,0.6693,0.8916,0.8646	-2.7120			0.01,0.16	0.24								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					H3-4 (inh=n/a oe_syn=1.79 oe_mis=1.55 oe_lof=1.60)
chr1	229568231	229568231	T	G	hom	hom	hom	off-target	QUAL=2168;DP=8,46,34;AF=1.00,1.00,1.00;MQM=60;SAP=194;ABP=0	ACTA1	intron	ACTA1:ENST00000366683.2:intron_variant:MODIFIER:intron3/5:c.352+174A>C::,ACTA1:ENST00000366684.3:intron_variant:MODIFIER:intron3/6:c.455-53A>C::	ACTA1:NM_001100.4:intron_variant:MODIFIER:intron3/6:c.455-53A>C::	regulatory_region_variant:promoter_flanking_region	102610 [GENE=ACTA1 PHENOS=Myopathy,actin,congenital,with cores,161800,Autosomal recessive,Autosomal dominant/Nemaline myopathy 3,autosomal dominant or recessive,161800,Autosomal recessive,Autosomal dominant/Myopathy,congenital,with fiber-type disproportion 1,255310,Autosomal recessive,Autosomal dominant/Myopathy,actin,congenital,with excess of thin myofilaments,161800,Autosomal recessive,Autosomal dominant/Myopathy,scapulohumeroperoneal,616852,Autosomal dominant];	676564 [benign DISEASE=not provided];			rs527621	0.9990	0.9992	14550,.		-1.1130			0.02,0.12	6.87					-0.1735	0.0738	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACTA1 (inh=AR+AD oe_syn=0.87 oe_mis=0.21 oe_lof=0.74)
chr1	229569803	229569803	A	G	het	het	het		QUAL=3189;DP=63,110,74;AF=0.57,0.55,0.49;MQM=60;SAP=41;ABP=6	ACTA1	5'UTR	ACTA1:ENST00000366683.2:5_prime_UTR_variant:MODIFIER:exon1/6:c.-65T>C::,ACTA1:ENST00000366684.3:5_prime_UTR_variant:MODIFIER:exon1/7:c.-65T>C::	ACTA1:NM_001100.4:5_prime_UTR_variant:MODIFIER:exon1/7:c.-65T>C::	regulatory_region_variant:promoter_flanking_region	102610 [GENE=ACTA1 PHENOS=Myopathy,actin,congenital,with cores,161800,Autosomal recessive,Autosomal dominant/Nemaline myopathy 3,autosomal dominant or recessive,161800,Autosomal recessive,Autosomal dominant/Myopathy,congenital,with fiber-type disproportion 1,255310,Autosomal recessive,Autosomal dominant/Myopathy,actin,congenital,with excess of thin myofilaments,161800,Autosomal recessive,Autosomal dominant/Myopathy,scapulohumeroperoneal,616852,Autosomal dominant];	296060 [benign DISEASE=Nemaline myopathy 3,Congenital myopathy with fiber type disproportion,Familial restrictive cardiomyopathy];			rs605430	0.6302	0.6045	5836,.		0.4410			0.01,0.32	16.78					-0.2194	0.2227	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACTA1 (inh=AR+AD oe_syn=0.87 oe_mis=0.21 oe_lof=0.74)
chr1	229569804	229569804	G	A	het	het	het		QUAL=3189;DP=63,110,74;AF=0.57,0.55,0.49;MQM=60;SAP=41;ABP=6	ACTA1	5'UTR	ACTA1:ENST00000366683.2:5_prime_UTR_variant:MODIFIER:exon1/6:c.-66C>T::,ACTA1:ENST00000366684.3:5_prime_UTR_variant:MODIFIER:exon1/7:c.-66C>T::	ACTA1:NM_001100.4:5_prime_UTR_variant:MODIFIER:exon1/7:c.-66C>T::	regulatory_region_variant:promoter_flanking_region	102610 [GENE=ACTA1 PHENOS=Myopathy,actin,congenital,with cores,161800,Autosomal recessive,Autosomal dominant/Nemaline myopathy 3,autosomal dominant or recessive,161800,Autosomal recessive,Autosomal dominant/Myopathy,congenital,with fiber-type disproportion 1,255310,Autosomal recessive,Autosomal dominant/Myopathy,actin,congenital,with excess of thin myofilaments,161800,Autosomal recessive,Autosomal dominant/Myopathy,scapulohumeroperoneal,616852,Autosomal dominant];	296062 [benign DISEASE=Nemaline myopathy 3,Congenital myopathy with fiber type disproportion,Familial restrictive cardiomyopathy];			rs605428	0.6436	0.6041	5836,.		-0.0810			0.02,0.41	15.41					0.0481	0.2321	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACTA1 (inh=AR+AD oe_syn=0.87 oe_mis=0.21 oe_lof=0.74)
chr1	231377081	231377081	C	T	hom	het	hom		QUAL=18955;DP=292,316,250;AF=0.98,0.55,0.99;MQM=60;SAP=189;ABP=10	GNPAT	5'UTR	GNPAT:ENST00000366646.3:5_prime_UTR_variant:MODIFIER:exon1/15:c.-44C>T::,GNPAT:ENST00000366647.4:5_prime_UTR_variant:MODIFIER:exon1/16:c.-44C>T::	GNPAT:NM_001316350.2:5_prime_UTR_variant:MODIFIER:exon1/15:c.-44C>T::,GNPAT:NM_014236.4:5_prime_UTR_variant:MODIFIER:exon1/16:c.-44C>T::	regulatory_region_variant:promoter,TF_binding_site_variant	602744 [GENE=GNPAT PHENOS=Rhizomelic chondrodysplasia punctata,type 2,222765,Autosomal recessive];	296108 [benign DISEASE=Rhizomelic chondrodysplasia punctata type 2,not specified];			rs518686	0.5819	0.5542	4406,.	0.5701,0.6072,0.5936,0.5291,0.6243	0.1150			0.03,0.50	12.21					-0.0871	0.2522	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF131 (inh=n/a oe_syn=0.99 oe_mis=1.03 oe_lof=1.12), GNPAT (inh=AR oe_syn=1.01 oe_mis=0.90 oe_lof=0.23)
chr1	231401204	231401204	T	C	hom	het	het	off-target	QUAL=12307;DP=212,232,178;AF=1.00,0.51,0.48;MQM=60;SAP=114;ABP=3	GNPAT	intron	GNPAT:ENST00000366646.3:intron_variant:MODIFIER:intron4/14:c.513+38T>C::,GNPAT:ENST00000366647.4:intron_variant:MODIFIER:intron5/15:c.696+38T>C::	GNPAT:NM_001316350.2:intron_variant:MODIFIER:intron4/14:c.513+38T>C::,GNPAT:NM_014236.4:intron_variant:MODIFIER:intron5/15:c.696+38T>C::		602744 [GENE=GNPAT PHENOS=Rhizomelic chondrodysplasia punctata,type 2,222765,Autosomal recessive];				rs6702011	0.2678	0.2745	1061,.	0.2822,0.3909,0.2137,0.2542,0.2725	-0.6740			0.09,0.20	9.26					0.0346	0.4918	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GNPAT (inh=AR oe_syn=1.01 oe_mis=0.90 oe_lof=0.23)
chr1	231401902	231401902	G	A	hom	het	het		QUAL=17593;DP=348,257,202;AF=1.00,0.50,0.49;MQM=60;SAP=91;ABP=3	GNPAT	synonymous	GNPAT:ENST00000366646.3:synonymous_variant:LOW:exon6/15:c.732G>A:p.Glu244=:,GNPAT:ENST00000366647.4:synonymous_variant:LOW:exon7/16:c.915G>A:p.Glu305=:	GNPAT:NM_001316350.2:synonymous_variant:LOW:exon6/15:c.732G>A:p.Glu244=:,GNPAT:NM_014236.4:synonymous_variant:LOW:exon7/16:c.915G>A:p.Glu305=:		602744 [GENE=GNPAT PHENOS=Rhizomelic chondrodysplasia punctata,type 2,222765,Autosomal recessive];	260363 [benign DISEASE=Rhizomelic chondrodysplasia punctata type 2,not specified,not provided];			rs574553	0.6286	0.5698	5223,.	0.6931,0.6150,0.5972,0.5398,0.6247	1.6170			0.61,0.96	8.48					0.4039	0.6225	0.04	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GNPAT (inh=AR oe_syn=1.01 oe_mis=0.90 oe_lof=0.23)
chr1	231500353	231500353	-	T	hom	hom	het		QUAL=17791;DP=348,185,162;AF=0.97,0.97,0.44;MQM=60;SAP=14;ABP=7	EGLN1	3'UTR	EGLN1:ENST00000366641.3:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1803dup::	EGLN1:NM_022051.2:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1803dup::		606425 [GENE=EGLN1 PHENOS=Hemoglobin,high altitude adaptation,609070,Autosomal dominant/Erythrocytosis,familial,3,609820,Autosomal dominant];				rs541569859		0.5887	5677,.						5.39					0.0012	0.891	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EGLN1 (inh=AD oe_syn=1.29 oe_mis=0.58 oe_lof=0.06)
chr1	231502245	231502245	T	-	het	het	wt	off-target;low_conf_region	QUAL=9713;DP=156,197,167;AF=0.65,0.69,0.32;MQM=60;SAP=52;ABP=575	EGLN1	intron	EGLN1:ENST00000366641.3:intron_variant:MODIFIER:intron4/4:c.1217-24del::	EGLN1:NM_022051.2:intron_variant:MODIFIER:intron4/4:c.1217-24del::		606425 [GENE=EGLN1 PHENOS=Hemoglobin,high altitude adaptation,609070,Autosomal dominant/Erythrocytosis,familial,3,609820,Autosomal dominant];				rs371204614		0.1471	0,.	0.0682,0.1075,0.1613,0.1716,0.1280	-0.0460				0.00								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EGLN1 (inh=AD oe_syn=1.29 oe_mis=0.58 oe_lof=0.06)
chr1	231502245	231502245	T	A	het	het	het	off-target;low_conf_region	QUAL=9713;DP=156,197,167;AF=0.65,0.69,0.32;MQM=60;SAP=204;ABP=18	EGLN1	intron	EGLN1:ENST00000366641.3:intron_variant:MODIFIER:intron4/4:c.1217-24A>T::	EGLN1:NM_022051.2:intron_variant:MODIFIER:intron4/4:c.1217-24A>T::		606425 [GENE=EGLN1 PHENOS=Hemoglobin,high altitude adaptation,609070,Autosomal dominant/Erythrocytosis,familial,3,609820,Autosomal dominant];				rs1435167		0.5696	4953,.	0.3345,0.3784,0.4142,0.4517,0.4127	-0.0460			0.00,0.08	0.01					-0.0674	0.825	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EGLN1 (inh=AD oe_syn=1.29 oe_mis=0.58 oe_lof=0.06)
chr1	231557255	231557255	C	G	het	wt	hom		QUAL=206;DP=3,3,9;AF=0.67,0.00,1.00;MQM=60;SAP=27;ABP=4	EGLN1	missense	EGLN1:ENST00000366641.3:missense_variant:MODERATE:exon1/5:c.380G>C:p.Cys127Ser:	EGLN1:NM_022051.2:missense_variant:MODERATE:exon1/5:c.380G>C:p.Cys127Ser:	regulatory_region_variant:promoter	606425 [GENE=EGLN1 PHENOS=Hemoglobin,high altitude adaptation,609070,Autosomal dominant/Erythrocytosis,familial,3,609820,Autosomal dominant];	242640 [benign DISEASE=Erythrocytosis, familial, 3]; 156155 [affects DISEASE=Hemoglobin, high altitude adaptation];	CM140742 [CLASS=DFP MUT=ALT PHEN="Reduced haemoglobin levels" GENE=EGLN1];	(GCC)n (Simple_repeat)	rs12097901	0.2604	0.1572	626,.	0.4444,0.2239,0.5097,0.0939,0.3281	-0.0300	T(0.74)	B(0.00)	0.00,0.09	10.08	0.21				0.0033	0.2482	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EGLN1 (inh=AD oe_syn=1.29 oe_mis=0.58 oe_lof=0.06)
chr1	231559226	231559226	A	G	het	wt	hom		QUAL=5108;DP=197,82,71;AF=0.51,0.02,1.00;MQM=60;SAP=19;ABP=3	EGLN1	5'UTR	EGLN1:ENST00000366641.3:5_prime_UTR_variant:MODIFIER:exon1/5:c.-1592T>C::	EGLN1:NM_022051.2:5_prime_UTR_variant:MODIFIER:exon1/5:c.-1592T>C::		606425 [GENE=EGLN1 PHENOS=Hemoglobin,high altitude adaptation,609070,Autosomal dominant/Erythrocytosis,familial,3,609820,Autosomal dominant];	296223 [benign DISEASE=Erythrocytosis, familial, 3];			rs12406290	0.2915	0.1902	664,.		3.1480			0.17,0.40	9.37					-0.0008	0.248	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EGLN1 (inh=AD oe_syn=1.29 oe_mis=0.58 oe_lof=0.06)
chr1	231560220	231560220	A	G	het	wt	hom		QUAL=15505;DP=597,205,209;AF=0.54,0.00,1.00;MQM=60;SAP=377;ABP=10	EGLN1	5'UTR	EGLN1:ENST00000366641.3:5_prime_UTR_variant:MODIFIER:exon1/5:c.-2586T>C::	EGLN1:NM_022051.2:5_prime_UTR_variant:MODIFIER:exon1/5:c.-2586T>C::		606425 [GENE=EGLN1 PHENOS=Hemoglobin,high altitude adaptation,609070,Autosomal dominant/Erythrocytosis,familial,3,609820,Autosomal dominant];	296240 [benign DISEASE=Erythrocytosis, familial, 3];			rs2153364	0.2939	0.1905	668,.		0.2300			0.03,0.19	2.71					0.0061	0.2483	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EGLN1 (inh=AD oe_syn=1.29 oe_mis=0.58 oe_lof=0.06)
chr1	235543477	235543480	TGTG	-	wt	het	wt	off-target;low_conf_region	QUAL=1602;DP=22,30,92;AF=0.05,0.00,0.37;MQM=60;SAP=4;ABP=10	TBCE	intron	TBCE:ENST00000366601.3:intron_variant:MODIFIER:intron2/16:c.100+62_100+65del::,TBCE:ENST00000406207.1:intron_variant:MODIFIER:intron2/16:c.100+62_100+65del::,TBCE:ENST00000543662.1:intron_variant:MODIFIER:intron2/17:c.100+62_100+65del::	TBCE:NM_001079515.3:intron_variant:MODIFIER:intron2/16:c.100+62_100+65del::,TBCE:NM_001287801.2:intron_variant:MODIFIER:intron2/17:c.100+62_100+65del::,TBCE:NM_001287802.1:intron_variant:MODIFIER:intron2/15:c.-211+62_-211+65del::,TBCE:NM_003193.5:intron_variant:MODIFIER:intron2/16:c.100+62_100+65del::		604934 [GENE=TBCE PHENOS=Kenny-Caffey syndrome,type 1,244460,Autosomal recessive/Hypoparathyroidism-retardation-dysmorphism syndrome,241410,Autosomal recessive/Encephalopathy,progressive,with amyotrophy and optic atrophy,617207,Autosomal recessive];			(TG)n (Simple_repeat)	rs10524346		0.0673	135,.	0.0194,0.0288,0.0438,0.0234,0.0253	0.5310				6.47					-0.0061	0.1091	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TBCE (inh=AR oe_syn=1.05 oe_mis=0.98 oe_lof=0.54)
chr1	235543477	235543490	TGTGTGTGTGTGTG	-	wt	wt	het	off-target;low_conf_region	QUAL=1602;DP=22,30,92;AF=0.05,0.00,0.37;MQM=60;SAP=8;ABP=40	TBCE	intron	TBCE:ENST00000366601.3:intron_variant:MODIFIER:intron2/16:c.100+52_100+65del::,TBCE:ENST00000406207.1:intron_variant:MODIFIER:intron2/16:c.100+52_100+65del::,TBCE:ENST00000543662.1:intron_variant:MODIFIER:intron2/17:c.100+52_100+65del::	TBCE:NM_001079515.3:intron_variant:MODIFIER:intron2/16:c.100+52_100+65del::,TBCE:NM_001287801.2:intron_variant:MODIFIER:intron2/17:c.100+52_100+65del::,TBCE:NM_001287802.1:intron_variant:MODIFIER:intron2/15:c.-211+52_-211+65del::,TBCE:NM_003193.5:intron_variant:MODIFIER:intron2/16:c.100+52_100+65del::		604934 [GENE=TBCE PHENOS=Kenny-Caffey syndrome,type 1,244460,Autosomal recessive/Hypoparathyroidism-retardation-dysmorphism syndrome,241410,Autosomal recessive/Encephalopathy,progressive,with amyotrophy and optic atrophy,617207,Autosomal recessive];			(TG)n (Simple_repeat)	rs10524346		0.3333	1474,.	0.1041,0.1006,0.0754,0.2091,0.0685	0.8290				6.03					0.0014	0.1091	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TBCE (inh=AR oe_syn=1.05 oe_mis=0.98 oe_lof=0.54)
chr1	235543477	235543492	TGTGTGTGTGTGTGTG	-	het	wt	wt	off-target;low_conf_region	QUAL=1602;DP=22,30,92;AF=0.05,0.00,0.37;MQM=59;SAP=32;ABP=86	TBCE	intron	TBCE:ENST00000366601.3:intron_variant:MODIFIER:intron2/16:c.100+50_100+65del::,TBCE:ENST00000406207.1:intron_variant:MODIFIER:intron2/16:c.100+50_100+65del::,TBCE:ENST00000543662.1:intron_variant:MODIFIER:intron2/17:c.100+50_100+65del::	TBCE:NM_001079515.3:intron_variant:MODIFIER:intron2/16:c.100+50_100+65del::,TBCE:NM_001287801.2:intron_variant:MODIFIER:intron2/17:c.100+50_100+65del::,TBCE:NM_001287802.1:intron_variant:MODIFIER:intron2/15:c.-211+50_-211+65del::,TBCE:NM_003193.5:intron_variant:MODIFIER:intron2/16:c.100+50_100+65del::		604934 [GENE=TBCE PHENOS=Kenny-Caffey syndrome,type 1,244460,Autosomal recessive/Hypoparathyroidism-retardation-dysmorphism syndrome,241410,Autosomal recessive/Encephalopathy,progressive,with amyotrophy and optic atrophy,617207,Autosomal recessive];			(TG)n (Simple_repeat)	rs10524346		0.0770	135,.	0.0784,0.0478,0.0847,0.0917,0.0437	0.8290				5.90					-0.13	0.1096	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TBCE (inh=AR oe_syn=1.05 oe_mis=0.98 oe_lof=0.54)
chr1	235543477	235543494	TGTGTGTGTGTGTGTGTG	-	wt	wt	het	off-target;low_conf_region	QUAL=1602;DP=22,30,92;AF=0.05,0.00,0.37;MQM=60;SAP=5;ABP=9	TBCE	intron	TBCE:ENST00000366601.3:intron_variant:MODIFIER:intron2/16:c.100+48_100+65del::,TBCE:ENST00000406207.1:intron_variant:MODIFIER:intron2/16:c.100+48_100+65del::,TBCE:ENST00000543662.1:intron_variant:MODIFIER:intron2/17:c.100+48_100+65del::	TBCE:NM_001079515.3:intron_variant:MODIFIER:intron2/16:c.100+48_100+65del::,TBCE:NM_001287801.2:intron_variant:MODIFIER:intron2/17:c.100+48_100+65del::,TBCE:NM_001287802.1:intron_variant:MODIFIER:intron2/15:c.-211+48_-211+65del::,TBCE:NM_003193.5:intron_variant:MODIFIER:intron2/16:c.100+48_100+65del::		604934 [GENE=TBCE PHENOS=Kenny-Caffey syndrome,type 1,244460,Autosomal recessive/Hypoparathyroidism-retardation-dysmorphism syndrome,241410,Autosomal recessive/Encephalopathy,progressive,with amyotrophy and optic atrophy,617207,Autosomal recessive];	403520 [benign/likely benign DISEASE=not specified,not provided];		(TG)n (Simple_repeat)	rs10524346		0.1700	591,.	0.1339,0.2137,0.3190,0.0680,0.1604	0.8290				5.78					-0.0918	0.1094	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TBCE (inh=AR oe_syn=1.05 oe_mis=0.98 oe_lof=0.54)
chr1	235612320	235612320	C	T	het	wt	hom	off-target	QUAL=4418;DP=134,91,84;AF=0.54,0.00,0.99;MQM=60;SAP=268;ABP=5	B3GALNT2,TBCE	downstream_gene	B3GALNT2:ENST00000366600.3:downstream_gene_variant:MODIFIER::::,TBCE:ENST00000366601.3:downstream_gene_variant:MODIFIER::::,TBCE:ENST00000406207.1:downstream_gene_variant:MODIFIER::::,TBCE:ENST00000543662.1:downstream_gene_variant:MODIFIER::::	TBCE:NM_001079515.3:3_prime_UTR_variant:MODIFIER:exon17/17:c.*243C>T::,TBCE:NM_001287801.2:3_prime_UTR_variant:MODIFIER:exon18/18:c.*243C>T::,TBCE:NM_003193.5:3_prime_UTR_variant:MODIFIER:exon17/17:c.*243C>T::,B3GALNT2:NM_152490.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1201G>A::						rs704705	0.7446	0.7405	8797,.		0.7840			0.00,0.12	9.49								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TBCE (inh=AR oe_syn=1.05 oe_mis=0.98 oe_lof=0.54), B3GALNT2 (inh=AR oe_syn=0.91 oe_mis=0.84 oe_lof=0.55)
chr1	235825643	235825643	G	A	het	wt	het		QUAL=2737;DP=205,66,30;AF=0.46,0.00,0.33;MQM=60;SAP=18;ABP=9	LYST	3'UTR	LYST:ENST00000389793.2:3_prime_UTR_variant:MODIFIER:exon53/53:c.*597C>T::,LYST:ENST00000389794.3:3_prime_UTR_variant:MODIFIER:exon53/53:c.*597C>T::	LYST:NM_000081.4:3_prime_UTR_variant:MODIFIER:exon53/53:c.*597C>T::,LYST:NM_001301365.1:3_prime_UTR_variant:MODIFIER:exon53/53:c.*597C>T::		606897 [GENE=LYST PHENOS=Chediak-Higashi syndrome,214500,Autosomal recessive];				rs1400168809		0.0001	0,.		1.0370			0.03,0.22	3.98					-0.0309	0.9243	0	0	3	0 / 0					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235826383	235826383	A	-	hom	hom	het		QUAL=15089;DP=233,276,194;AF=0.91,0.89,0.50;MQM=60;SAP=137;ABP=3	LYST	splice_region&intron	LYST:ENST00000389793.2:splice_region_variant&intron_variant:LOW:intron52/52:c.11268-5del::,LYST:ENST00000389794.3:splice_region_variant&intron_variant:LOW:intron52/52:c.11268-5del::	LYST:NM_000081.4:splice_region_variant&intron_variant:LOW:intron52/52:c.11268-5del::,LYST:NM_001301365.1:splice_region_variant&intron_variant:LOW:intron52/52:c.11268-5del::	regulatory_region_variant:enhancer	606897 [GENE=LYST PHENOS=Chediak-Higashi syndrome,214500,Autosomal recessive];	403065 [benign/likely benign DISEASE=Chediak-Higashi syndrome,not specified];	CD181021 [CLASS=DM? MUT=ALT PHEN="Haemophagocytic lymphohistiocytosis" GENE=LYST];		rs36014994		0.5819	5019,.	0.6809,0.4483,0.2392,0.5340,0.4148	0.0090				6.42					-0.0528	0.8749	0.05	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235860340	235860340	C	T	hom	hom	het	off-target	QUAL=3178;DP=67,23,29;AF=1.00,1.00,0.59;MQM=60;SAP=202;ABP=5	LYST	intron	LYST:ENST00000389793.2:intron_variant:MODIFIER:intron46/52:c.10564+43G>A::,LYST:ENST00000389794.3:intron_variant:MODIFIER:intron46/52:c.10564+43G>A::	LYST:NM_000081.4:intron_variant:MODIFIER:intron46/52:c.10564+43G>A::,LYST:NM_001301365.1:intron_variant:MODIFIER:intron46/52:c.10564+43G>A::		606897 [GENE=LYST PHENOS=Chediak-Higashi syndrome,214500,Autosomal recessive];	254908 [benign DISEASE=not specified,not provided];			rs7541057	0.4000	0.5467	5044,.	0.7306,0.2734,0.0498,0.5150,0.1857	-1.5040			0.00,0.07	1.04					0.0974	0.243	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235872665	235872665	T	C	hom	hom	het	off-target;low_conf_region	QUAL=7712;DP=179,56,47;AF=0.99,1.00,0.51;MQM=60;SAP=563;ABP=3	LYST	intron	LYST:ENST00000389793.2:intron_variant:MODIFIER:intron43/52:c.9926-57A>G::,LYST:ENST00000389794.3:intron_variant:MODIFIER:intron43/52:c.9926-57A>G::	LYST:NM_000081.4:intron_variant:MODIFIER:intron43/52:c.9926-57A>G::,LYST:NM_001301365.1:intron_variant:MODIFIER:intron43/52:c.9926-57A>G::		606897 [GENE=LYST PHENOS=Chediak-Higashi syndrome,214500,Autosomal recessive];	684363 [benign DISEASE=not provided];			rs2275856	0.4137	0.5119	4807,.		-0.8160			0.00,0.08	1.98					-0.0316	0.8512	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235887276	235887276	G	T	hom	hom	het	off-target	QUAL=9189;DP=133,116,99;AF=0.99,1.00,0.52;MQM=60;SAP=404;ABP=3	LYST	intron	LYST:ENST00000389793.2:intron_variant:MODIFIER:intron39/52:c.9315+52C>A::,LYST:ENST00000389794.3:intron_variant:MODIFIER:intron39/52:c.9315+52C>A::	LYST:NM_000081.4:intron_variant:MODIFIER:intron39/52:c.9315+52C>A::,LYST:NM_001301365.1:intron_variant:MODIFIER:intron39/52:c.9315+52C>A::		606897 [GENE=LYST PHENOS=Chediak-Higashi syndrome,214500,Autosomal recessive];	684361 [benign DISEASE=not provided];			rs6667717	0.4117	0.5099	4791,.		-2.8510			0.00,0.07	0.15					0.0416	0.1672	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235922228	235922228	T	C	het	het	wt	off-target	QUAL=2263;DP=140,43,28;AF=0.56,0.44,0.04;MQM=60;SAP=216;ABP=4	LYST	intron	LYST:ENST00000389793.2:intron_variant:MODIFIER:intron23/52:c.6881+44A>G::,LYST:ENST00000389794.3:intron_variant:MODIFIER:intron23/52:c.6881+44A>G::	LYST:NM_000081.4:intron_variant:MODIFIER:intron23/52:c.6881+44A>G::,LYST:NM_001301365.1:intron_variant:MODIFIER:intron23/52:c.6881+44A>G::		606897 [GENE=LYST PHENOS=Chediak-Higashi syndrome,214500,Autosomal recessive];	254935 [benign DISEASE=not specified];			rs3738519	0.2300	0.3160	1706,.	0.4262,0.1913,0.0094,0.2694,0.1679	-4.9410			0.02,0.16	0.68					-0.1079	0.3334	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235940450	235940450	C	T	hom	hom	het		QUAL=17711;DP=241,237,202;AF=1.00,1.00,0.43;MQM=60;SAP=222;ABP=13	LYST	synonymous,3'UTR	LYST:ENST00000389793.2:synonymous_variant:LOW:exon17/53:c.5373G>A:p.Lys1791=:,LYST:ENST00000389794.3:synonymous_variant:LOW:exon17/53:c.5373G>A:p.Lys1791=:,LYST:ENST00000536965.1:3_prime_UTR_variant:MODIFIER:exon16/22:c.*797G>A::	LYST:NM_000081.4:synonymous_variant:LOW:exon17/53:c.5373G>A:p.Lys1791=:,LYST:NM_001301365.1:synonymous_variant:LOW:exon17/53:c.5373G>A:p.Lys1791=:		606897 [GENE=LYST PHENOS=Chediak-Higashi syndrome,214500,Autosomal recessive];	254927 [benign DISEASE=Chediak-Higashi syndrome,not specified,not provided];			rs2273584	0.3009	0.4197	2915,.	0.5010,0.2776,0.0588,0.4050,0.2022	0.6140			0.09,0.31	6.02					-0.176	0.1484	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235945186	235945186	G	A	het	het	het	off-target	QUAL=4499;DP=135,151,92;AF=0.44,0.50,0.53;MQM=60;SAP=173;ABP=4	LYST	intron	LYST:ENST00000389793.2:intron_variant:MODIFIER:intron15/52:c.5023+41C>T::,LYST:ENST00000389794.3:intron_variant:MODIFIER:intron15/52:c.5023+41C>T::,LYST:ENST00000536965.1:intron_variant:MODIFIER:intron14/21:c.*447+41C>T::	LYST:NM_000081.4:intron_variant:MODIFIER:intron15/52:c.5023+41C>T::,LYST:NM_001301365.1:intron_variant:MODIFIER:intron15/52:c.5023+41C>T::		606897 [GENE=LYST PHENOS=Chediak-Higashi syndrome,214500,Autosomal recessive];	254924 [benign DISEASE=not specified];		AluJo (SINE/Alu)	rs72763416	0.0707	0.1043	196,.	0.0709,0.0880,0.0493,0.1372,0.0408	-1.1670			0.00,0.14	0.36					0.2112	0.1052	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235945294	235945294	T	C	hom	hom	het		QUAL=15470;DP=184,232,150;AF=0.99,1.00,0.51;MQM=60;SAP=5;ABP=3	LYST	synonymous,3'UTR	LYST:ENST00000389793.2:synonymous_variant:LOW:exon15/53:c.4956A>G:p.Leu1652=:,LYST:ENST00000389794.3:synonymous_variant:LOW:exon15/53:c.4956A>G:p.Leu1652=:,LYST:ENST00000536965.1:3_prime_UTR_variant:MODIFIER:exon14/22:c.*380A>G::	LYST:NM_000081.4:synonymous_variant:LOW:exon15/53:c.4956A>G:p.Leu1652=:,LYST:NM_001301365.1:synonymous_variant:LOW:exon15/53:c.4956A>G:p.Leu1652=:		606897 [GENE=LYST PHENOS=Chediak-Higashi syndrome,214500,Autosomal recessive];	254923 [benign DISEASE=Chediak-Higashi syndrome,not specified,not provided];			rs6696123	0.3035	0.4206	2931,.	0.5020,0.2780,0.0588,0.4053,0.2079	-0.4200			0.05,0.21	5.44					0.0834	0.1076	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235955150	235955150	G	A	wt	het	wt		QUAL=6495;DP=579,522,414;AF=0.00,0.48,0.00;MQM=60;SAP=8;ABP=5	LYST	synonymous,intron	LYST:ENST00000389793.2:synonymous_variant:LOW:exon12/53:c.4392C>T:p.Asn1464=:,LYST:ENST00000389794.3:synonymous_variant:LOW:exon12/53:c.4392C>T:p.Asn1464=:,LYST:ENST00000536965.1:intron_variant:MODIFIER:intron11/21:c.4116+1653C>T::	LYST:NM_000081.4:synonymous_variant:LOW:exon12/53:c.4392C>T:p.Asn1464=:,LYST:NM_001301365.1:synonymous_variant:LOW:exon12/53:c.4392C>T:p.Asn1464=:		606897 [GENE=LYST PHENOS=Chediak-Higashi syndrome,214500,Autosomal recessive];	254921 [benign/likely benign DISEASE=Chediak-Higashi syndrome,not specified];			rs11583387	0.0643	0.0882	147,.	0.0660,0.0778,0.0491,0.1125,0.0381	3.0230			0.93,0.98	9.78					-0.0336	0.9187	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235971763	235971763	A	G	het	het	het		QUAL=8462;DP=203,267,197;AF=0.53,0.51,0.51;MQM=60;SAP=52;ABP=4	LYST	synonymous	LYST:ENST00000389793.2:synonymous_variant:LOW:exon5/53:c.2355T>C:p.Leu785=:,LYST:ENST00000389794.3:synonymous_variant:LOW:exon5/53:c.2355T>C:p.Leu785=:,LYST:ENST00000536965.1:synonymous_variant:LOW:exon5/22:c.2355T>C:p.Leu785=:	LYST:NM_000081.4:synonymous_variant:LOW:exon5/53:c.2355T>C:p.Leu785=:,LYST:NM_001301365.1:synonymous_variant:LOW:exon5/53:c.2355T>C:p.Leu785=:		606897 [GENE=LYST PHENOS=Chediak-Higashi syndrome,214500,Autosomal recessive];	254915 [benign/likely benign DISEASE=Chediak-Higashi syndrome,not specified];			rs3768066	0.0707	0.1048	197,.	0.0716,0.0882,0.0494,0.1374,0.0413	-0.0400			0.44,0.49	9.68					0.0107	0.3621	0.07	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235972435	235972435	T	C	hom	hom	het		QUAL=27832;DP=481,286,195;AF=0.99,1.00,0.52;MQM=60;SAP=25;ABP=4	LYST	synonymous	LYST:ENST00000389793.2:synonymous_variant:LOW:exon5/53:c.1683A>G:p.Leu561=:,LYST:ENST00000389794.3:synonymous_variant:LOW:exon5/53:c.1683A>G:p.Leu561=:,LYST:ENST00000536965.1:synonymous_variant:LOW:exon5/22:c.1683A>G:p.Leu561=:	LYST:NM_000081.4:synonymous_variant:LOW:exon5/53:c.1683A>G:p.Leu561=:,LYST:NM_001301365.1:synonymous_variant:LOW:exon5/53:c.1683A>G:p.Leu561=:	regulatory_region_variant:enhancer	606897 [GENE=LYST PHENOS=Chediak-Higashi syndrome,214500,Autosomal recessive];	254912 [benign DISEASE=Chediak-Higashi syndrome,not specified,not provided];			rs3820553	0.3027	0.4205	2934,.	0.5025,0.2785,0.0589,0.4057,0.2077	-0.4530			0.04,0.73	4.19					0.0057	0.3619	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235972867	235972867	T	C	hom	hom	het		QUAL=27833;DP=454,307,190;AF=1.00,0.99,0.56;MQM=60;SAP=21;ABP=10	LYST	synonymous	LYST:ENST00000389793.2:synonymous_variant:LOW:exon5/53:c.1251A>G:p.Gln417=:,LYST:ENST00000389794.3:synonymous_variant:LOW:exon5/53:c.1251A>G:p.Gln417=:,LYST:ENST00000536965.1:synonymous_variant:LOW:exon5/22:c.1251A>G:p.Gln417=:	LYST:NM_000081.4:synonymous_variant:LOW:exon5/53:c.1251A>G:p.Gln417=:,LYST:NM_001301365.1:synonymous_variant:LOW:exon5/53:c.1251A>G:p.Gln417=:	regulatory_region_variant:enhancer	606897 [GENE=LYST PHENOS=Chediak-Higashi syndrome,214500,Autosomal recessive];	254910 [benign DISEASE=Chediak-Higashi syndrome,not specified,not provided];			rs1063128	0.3033	0.4204	2924,.	0.5029,0.2784,0.0588,0.4057,0.2078	-0.0600			0.52,0.97	8.22					0.001	0.3616	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	236030277	236030277	C	G	n/a	het	n/a	off-target	QUAL=25;DP=0,6,1;AF=,0.50,0.00;MQM=60;SAP=4;ABP=3	LYST	intron	LYST:ENST00000536965.1:intron_variant:MODIFIER:intron1/21:c.-98+16210G>C::	LYST:NM_001301365.1:intron_variant:MODIFIER:intron1/52:c.-98+16210G>C::,LYST:NR_102436.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/3:n.527+16210G>C::	regulatory_region_variant:promoter	606897 [GENE=LYST PHENOS=Chediak-Higashi syndrome,214500,Autosomal recessive];				rs3820556	0.0561	0.0837	156,.		0.8250			0.34,0.83	17.33								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24), RNU5E-2P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	236557771	236557771	G	A	hom	hom	hom		QUAL=24508;DP=250,289,225;AF=1.00,1.00,1.00;MQM=60;SAP=103;ABP=0	EDARADD	missense	EDARADD:ENST00000334232.4:missense_variant:MODERATE:exon1/6:c.27G>A:p.Met9Ile:	EDARADD:NM_145861.3:missense_variant:MODERATE:exon1/6:c.27G>A:p.Met9Ile:		606603 [GENE=EDARADD PHENOS=Ectodermal dysplasia 11B,hypohidrotic/hair/tooth type,autosomal recessive,614941,Autosomal recessive/Ectodermal dysplasia 11A,hypohidrotic/hair/tooth type,autosomal dominant,614940,Autosomal dominant];	262600 [benign DISEASE=Hypohidrotic ectodermal dysplasia,not specified,none provided,Hypohidrotic Ectodermal Dysplasia, Recessive];			rs966365		0.8410	9203,.	0.5373,0.9067,0.9186,0.8370,0.9121	-0.0830	T(0.45)	B(0.00)	0.04,0.21	5.24	0.13				-0.1494	0.2593	0.07	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61)
chr1	236572475	236572475	A	G	het	het	hom	off-target	QUAL=10233;DP=180,161,171;AF=0.49,0.55,1.00;MQM=60;SAP=66;ABP=4	EDARADD	intron	EDARADD:ENST00000334232.4:intron_variant:MODIFIER:intron1/5:c.62-41A>G::,EDARADD:ENST00000359362.5:intron_variant:MODIFIER:intron1/5:c.32-41A>G::	EDARADD:NM_080738.4:intron_variant:MODIFIER:intron1/5:c.32-41A>G::,EDARADD:NM_145861.3:intron_variant:MODIFIER:intron1/5:c.62-41A>G::		606603 [GENE=EDARADD PHENOS=Ectodermal dysplasia 11B,hypohidrotic/hair/tooth type,autosomal recessive,614941,Autosomal recessive/Ectodermal dysplasia 11A,hypohidrotic/hair/tooth type,autosomal dominant,614940,Autosomal dominant];				rs669710	0.4619	0.5436	4755,.	0.4768,0.4369,0.2597,0.5943,0.4913	0.2900			0.09,0.17	5.04					-0.2144	0.2079	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61)
chr1	236590659	236590659	G	C	het	het	hom	off-target	QUAL=6408;DP=150,153,89;AF=0.49,0.51,0.99;MQM=60;SAP=83;ABP=3	EDARADD	intron	EDARADD:ENST00000334232.4:intron_variant:MODIFIER:intron3/5:c.161-33G>C::,EDARADD:ENST00000359362.5:intron_variant:MODIFIER:intron3/5:c.131-33G>C::	EDARADD:NM_080738.4:intron_variant:MODIFIER:intron3/5:c.131-33G>C::,EDARADD:NM_145861.3:intron_variant:MODIFIER:intron3/5:c.161-33G>C::		606603 [GENE=EDARADD PHENOS=Ectodermal dysplasia 11B,hypohidrotic/hair/tooth type,autosomal recessive,614941,Autosomal recessive/Ectodermal dysplasia 11A,hypohidrotic/hair/tooth type,autosomal dominant,614940,Autosomal dominant];			(T)n (Simple_repeat)	rs636048	0.3582	0.4936	3732,.	0.1851,0.4187,0.2266,0.5866,0.4570	0.8840			0.04,0.14	1.72					0.1147	0.0286	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61)
chr1	236645670	236645670	C	T	wt	het	wt		QUAL=5235;DP=208,478,356;AF=0.00,0.44,0.01;MQM=60;SAP=4;ABP=16	EDARADD	synonymous	EDARADD:ENST00000334232.4:synonymous_variant:LOW:exon6/6:c.369C>T:p.Asp123=:,EDARADD:ENST00000359362.5:synonymous_variant:LOW:exon6/6:c.339C>T:p.Asp113=:	EDARADD:NM_080738.4:synonymous_variant:LOW:exon6/6:c.339C>T:p.Asp113=:,EDARADD:NM_145861.3:synonymous_variant:LOW:exon6/6:c.369C>T:p.Asp123=:		606603 [GENE=EDARADD PHENOS=Ectodermal dysplasia 11B,hypohidrotic/hair/tooth type,autosomal recessive,614941,Autosomal recessive/Ectodermal dysplasia 11A,hypohidrotic/hair/tooth type,autosomal dominant,614940,Autosomal dominant];	262602 [benign/likely benign DISEASE=Hypohidrotic ectodermal dysplasia,not specified,none provided,Hypohidrotic Ectodermal Dysplasia, Recessive];			rs604070	0.1332	0.1998	694,.	0.0709,0.1097,0.0906,0.2558,0.1497	0.1880			0.19,0.44	2.11					-0.0325	0.8729	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61), ENO1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	236647511	236647511	T	C	het	hom	het		QUAL=12982;DP=271,225,142;AF=0.54,1.00,0.49;MQM=60;SAP=15;ABP=5	EDARADD,ENO1P1	3'UTR,non_coding_transcript_exon	EDARADD:ENST00000359362.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1562T>C::,ENO1P1:ENST00000366587.4:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.1047T>C::	EDARADD:NM_080738.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1562T>C::,EDARADD:NM_145861.3:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1562T>C::		606603 [GENE=EDARADD PHENOS=Ectodermal dysplasia 11B,hypohidrotic/hair/tooth type,autosomal recessive,614941,Autosomal recessive/Ectodermal dysplasia 11A,hypohidrotic/hair/tooth type,autosomal dominant,614940,Autosomal dominant];	296476 [benign/likely benign DISEASE=Hypohidrotic ectodermal dysplasia,Hypohidrotic Ectodermal Dysplasia, Recessive];			rs7513402	0.2540	0.3104	1623,.		-2.0580			0.01,0.58	4.74					0.0184	0.9316		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61), ENO1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	236647550	236647550	C	G	het	hom	het		QUAL=13816;DP=326,225,127;AF=0.54,1.00,0.53;MQM=60;SAP=3;ABP=8	EDARADD,ENO1P1	3'UTR,non_coding_transcript_exon	EDARADD:ENST00000359362.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1601C>G::,ENO1P1:ENST00000366587.4:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.1086C>G::	EDARADD:NM_080738.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1601C>G::,EDARADD:NM_145861.3:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1601C>G::		606603 [GENE=EDARADD PHENOS=Ectodermal dysplasia 11B,hypohidrotic/hair/tooth type,autosomal recessive,614941,Autosomal recessive/Ectodermal dysplasia 11A,hypohidrotic/hair/tooth type,autosomal dominant,614940,Autosomal dominant];	296479 [benign/likely benign DISEASE=Hypohidrotic ectodermal dysplasia,Hypohidrotic Ectodermal Dysplasia, Recessive];			rs3916983	0.2033	0.2234	846,.		-0.0890			0.15,0.87	3.53					0.013	0.9316		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61), ENO1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	236647736	236647736	C	T	het	hom	het		QUAL=7158;DP=153,129,73;AF=0.54,0.99,0.53;MQM=60;SAP=3;ABP=6	EDARADD,ENO1P1	3'UTR,non_coding_transcript_exon	EDARADD:ENST00000359362.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1787C>T::,ENO1P1:ENST00000366587.4:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.1272C>T::	EDARADD:NM_080738.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1787C>T::,EDARADD:NM_145861.3:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1787C>T::		606603 [GENE=EDARADD PHENOS=Ectodermal dysplasia 11B,hypohidrotic/hair/tooth type,autosomal recessive,614941,Autosomal recessive/Ectodermal dysplasia 11A,hypohidrotic/hair/tooth type,autosomal dominant,614940,Autosomal dominant];	296481 [benign/likely benign DISEASE=Hypohidrotic ectodermal dysplasia,Hypohidrotic Ectodermal Dysplasia, Recessive];			rs6428955	0.1378	0.1741	584,.		0.1490			0.03,0.80	4.90					-0.0208	0.9311		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61), ENO1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	236648008	236648008	G	-	het	wt	het	low_conf_region	QUAL=147;DP=13,19,12;AF=0.15,0.42,0.17;MQM=59;SAP=23;ABP=7	EDARADD	3'UTR	EDARADD:ENST00000359362.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2059del::	EDARADD:NM_080738.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2059del::,EDARADD:NM_145861.3:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2059del::		606603 [GENE=EDARADD PHENOS=Ectodermal dysplasia 11B,hypohidrotic/hair/tooth type,autosomal recessive,614941,Autosomal recessive/Ectodermal dysplasia 11A,hypohidrotic/hair/tooth type,autosomal dominant,614940,Autosomal dominant];	296489 [uncertain significance DISEASE=Hypohidrotic Ectodermal Dysplasia, Recessive];		AluSc (SINE/Alu)	rs886046200		0.0003	0,.		-4.5420				0.04					-0.0095	0.8457		0	0	0 / 0					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61), ENO1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	236648009	236648009	A	-	wt	het	wt	low_conf_region	QUAL=147;DP=13,19,12;AF=0.15,0.42,0.17;MQM=60;SAP=27;ABP=27	EDARADD	3'UTR	EDARADD:ENST00000359362.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2078del::	EDARADD:NM_080738.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2078del::,EDARADD:NM_145861.3:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2078del::		606603 [GENE=EDARADD PHENOS=Ectodermal dysplasia 11B,hypohidrotic/hair/tooth type,autosomal recessive,614941,Autosomal recessive/Ectodermal dysplasia 11A,hypohidrotic/hair/tooth type,autosomal dominant,614940,Autosomal dominant];			AluSc (SINE/Alu)	rs11358746		0.4301	1625,.		-2.6120				0.03					0.0025	0.8461		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61), ENO1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	236648009	236648010	AA	-	het	het	wt	low_conf_region	QUAL=147;DP=13,19,12;AF=0.31,0.00,0.42;MQM=60;SAP=29;ABP=23	EDARADD	3'UTR	EDARADD:ENST00000359362.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2077_*2078del::	EDARADD:NM_080738.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2077_*2078del::,EDARADD:NM_145861.3:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2077_*2078del::		606603 [GENE=EDARADD PHENOS=Ectodermal dysplasia 11B,hypohidrotic/hair/tooth type,autosomal recessive,614941,Autosomal recessive/Ectodermal dysplasia 11A,hypohidrotic/hair/tooth type,autosomal dominant,614940,Autosomal dominant];			AluSc (SINE/Alu)	rs11358746		0.0030	0,.		-2.3350				0.03					0.0044	0.8461		7	10	0 / 0					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61), ENO1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	236958532	236958532	G	T	het	hom	het	off-target	QUAL=1128;DP=14,29,23;AF=0.50,1.00,0.48;MQM=60;SAP=105;ABP=3	MTR	upstream_gene	MTR:ENST00000366577.5:upstream_gene_variant:MODIFIER::::,MTR:ENST00000418145.2:upstream_gene_variant:MODIFIER::::,MTR:ENST00000535889.1:upstream_gene_variant:MODIFIER::::		regulatory_region_variant:promoter					rs28372871	0.4673	0.4682	3460,.		-0.7480			0.01,0.21	6.71								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236978992	236978992	-	TCTG	het	het	het	off-target;low_conf_region	QUAL=7182;DP=161,172,110;AF=0.47,0.90,0.48;MQM=60;SAP=81;ABP=77	MTR	intron	MTR:ENST00000366577.5:intron_variant:MODIFIER:intron7/32:c.669+32_669+33insGTCT::,MTR:ENST00000418145.2:intron_variant:MODIFIER:intron7/7:c.*204+32_*204+33insGTCT::,MTR:ENST00000535889.1:intron_variant:MODIFIER:intron7/31:c.669+32_669+33insGTCT::	MTR:NM_000254.2:intron_variant:MODIFIER:intron7/32:c.669+32_669+33insGTCT::,MTR:NM_001291939.1:intron_variant:MODIFIER:intron7/31:c.669+32_669+33insGTCT::,MTR:NM_001291940.2:intron_variant:MODIFIER:intron7/31:c.-440+32_-440+33insGTCT::		156570 [GENE=MTR PHENOS=Neural tube defects,folate-sensitive,susceptibility to,601634,Autosomal recessive/Homocystinuria-megaloblastic anemia,cblG complementation type,250940,Autosomal recessive];				rs5781924		0.7265	8488,.	0.9264,0.6865,0.8106,0.6222,0.7313					2.29					0.1537	0.4792	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236988593	236988593	-	T	het	hom	het	off-target	QUAL=3933;DP=137,48,36;AF=0.56,1.00,0.67;MQM=60;SAP=209;ABP=14	MTR	intron	MTR:ENST00000366577.5:intron_variant:MODIFIER:intron9/32:c.866-40dup::,MTR:ENST00000535889.1:intron_variant:MODIFIER:intron9/31:c.866-40dup::	MTR:NM_000254.2:intron_variant:MODIFIER:intron9/32:c.866-40dup::,MTR:NM_001291939.1:intron_variant:MODIFIER:intron9/31:c.866-40dup::,MTR:NM_001291940.2:intron_variant:MODIFIER:intron9/31:c.-243-40dup::		156570 [GENE=MTR PHENOS=Neural tube defects,folate-sensitive,susceptibility to,601634,Autosomal recessive/Homocystinuria-megaloblastic anemia,cblG complementation type,250940,Autosomal recessive];				rs5781926		0.3832	2048,.	0.2055,0.4468,0.4037,0.4058,0.3105					3.34					0.0137	0.1681	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236990141	236990141	G	A	wt	wt	het		QUAL=1794;DP=294,221,153;AF=0.00,0.00,0.47;MQM=60;SAP=3;ABP=4	MTR	missense	MTR:ENST00000366577.5:missense_variant:MODERATE:exon11/33:c.940G>A:p.Asp314Asn:PF02574 [Homocysteine S-methyltransferase],MTR:ENST00000535889.1:missense_variant:MODERATE:exon11/32:c.940G>A:p.Asp314Asn:PF02574 [Homocysteine S-methyltransferase]	MTR:NM_000254.2:missense_variant:MODERATE:exon11/33:c.940G>A:p.Asp314Asn:,MTR:NM_001291939.1:missense_variant:MODERATE:exon11/32:c.940G>A:p.Asp314Asn:,MTR:NM_001291940.2:5_prime_UTR_variant:MODIFIER:exon11/32:c.-169G>A::		156570 [GENE=MTR PHENOS=Neural tube defects,folate-sensitive,susceptibility to,601634,Autosomal recessive/Homocystinuria-megaloblastic anemia,cblG complementation type,250940,Autosomal recessive];	296556 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism,not specified,none provided];			rs2229274	0.0084	0.0186	3,.	0.0080,0.0152,0.0001,0.0255,0.0049	4.0180	T(0.26),T(0.26)	B(0.19),B(0.19)	0.97,0.98	22.50	0.12				-0.3288	0.218	0	16	866	0 / 0					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	237001926	237001926	A	G	het	hom	het	off-target	QUAL=12906;DP=177,256,180;AF=0.51,1.00,0.51;MQM=60;SAP=492;ABP=3	MTR	intron	MTR:ENST00000366577.5:intron_variant:MODIFIER:intron15/32:c.1515+27A>G::,MTR:ENST00000535889.1:intron_variant:MODIFIER:intron15/31:c.1515+27A>G::	MTR:NM_000254.2:intron_variant:MODIFIER:intron15/32:c.1515+27A>G::,MTR:NM_001291939.1:intron_variant:MODIFIER:intron15/31:c.1515+27A>G::,MTR:NM_001291940.2:intron_variant:MODIFIER:intron14/31:c.294+27A>G::		156570 [GENE=MTR PHENOS=Neural tube defects,folate-sensitive,susceptibility to,601634,Autosomal recessive/Homocystinuria-megaloblastic anemia,cblG complementation type,250940,Autosomal recessive];				rs3820568	0.3277	0.3931	2250,.	0.2101,0.4522,0.4331,0.4117,0.3140	-1.0070			0.03,0.18	0.47					-0.048	0.0712	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	237037999	237037999	T	-	het	hom	het	off-target;low_conf_region	QUAL=1451;DP=47,46,24;AF=0.30,0.74,0.46;MQM=60;SAP=14;ABP=16	MTR	intron	MTR:ENST00000366577.5:intron_variant:MODIFIER:intron23/32:c.2474-18del::,MTR:ENST00000535889.1:intron_variant:MODIFIER:intron22/31:c.2321-18del::	MTR:NM_000254.2:intron_variant:MODIFIER:intron23/32:c.2474-18del::,MTR:NM_001291939.1:intron_variant:MODIFIER:intron22/31:c.2321-18del::,MTR:NM_001291940.2:intron_variant:MODIFIER:intron22/31:c.1253-18del::		156570 [GENE=MTR PHENOS=Neural tube defects,folate-sensitive,susceptibility to,601634,Autosomal recessive/Homocystinuria-megaloblastic anemia,cblG complementation type,250940,Autosomal recessive];				rs150727404		0.6380	5381,.	0.5590,0.4889,0.5359,0.4505,0.4878	0.1560				2.34					-0.0167	0.2575	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	237038008	237038008	T	A	het	hom	het	off-target;low_conf_region	QUAL=1451;DP=47,46,24;AF=0.30,0.74,0.46;MQM=60;SAP=14;ABP=16	MTR	intron	MTR:ENST00000366577.5:intron_variant:MODIFIER:intron23/32:c.2474-18T>A::,MTR:ENST00000535889.1:intron_variant:MODIFIER:intron22/31:c.2321-18T>A::	MTR:NM_000254.2:intron_variant:MODIFIER:intron23/32:c.2474-18T>A::,MTR:NM_001291939.1:intron_variant:MODIFIER:intron22/31:c.2321-18T>A::,MTR:NM_001291940.2:intron_variant:MODIFIER:intron22/31:c.1253-18T>A::		156570 [GENE=MTR PHENOS=Neural tube defects,folate-sensitive,susceptibility to,601634,Autosomal recessive/Homocystinuria-megaloblastic anemia,cblG complementation type,250940,Autosomal recessive];	378884 [benign DISEASE=not specified];			rs10925256		0.4344	2308,.	0.4750,0.4576,0.4459,0.4159,0.3773	-0.2600			0.08,0.37	5.30		-1.58>-1.77			-0.4993	0.7841	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	237038161	237038161	T	C	het	wt	het	off-target	QUAL=2567;DP=81,168,126;AF=0.47,0.00,0.52;MQM=60;SAP=38;ABP=3	MTR	intron	MTR:ENST00000366577.5:intron_variant:MODIFIER:intron24/32:c.2594+15T>C::,MTR:ENST00000535889.1:intron_variant:MODIFIER:intron23/31:c.2441+15T>C::	MTR:NM_000254.2:intron_variant:MODIFIER:intron24/32:c.2594+15T>C::,MTR:NM_001291939.1:intron_variant:MODIFIER:intron23/31:c.2441+15T>C::,MTR:NM_001291940.2:intron_variant:MODIFIER:intron23/31:c.1373+15T>C::		156570 [GENE=MTR PHENOS=Neural tube defects,folate-sensitive,susceptibility to,601634,Autosomal recessive/Homocystinuria-megaloblastic anemia,cblG complementation type,250940,Autosomal recessive];	138288 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism,not specified];			rs1770449	0.2322	0.3220	1391,.	0.0701,0.3134,0.1923,0.3749,0.2791	-0.0530			0.05,0.22	2.22					-0.0455	0.4271	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	237048562	237048562	G	A	het	hom	het	off-target	QUAL=11045;DP=332,149,113;AF=0.55,1.00,0.50;MQM=60;SAP=434;ABP=8	MTR	intron	MTR:ENST00000366577.5:intron_variant:MODIFIER:intron26/32:c.2775+43G>A::,MTR:ENST00000535889.1:intron_variant:MODIFIER:intron25/31:c.2622+43G>A::	MTR:NM_000254.2:intron_variant:MODIFIER:intron26/32:c.2775+43G>A::,MTR:NM_001291939.1:intron_variant:MODIFIER:intron25/31:c.2622+43G>A::,MTR:NM_001291940.2:intron_variant:MODIFIER:intron25/31:c.1554+43G>A::		156570 [GENE=MTR PHENOS=Neural tube defects,folate-sensitive,susceptibility to,601634,Autosomal recessive/Homocystinuria-megaloblastic anemia,cblG complementation type,250940,Autosomal recessive];				rs2275566		0.7231	8411,.	0.9063,0.6827,0.8081,0.6227,0.7187	-0.8130			0.03,0.11	0.44					0.0562	0.1297	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	237054569	237054569	A	G	het	hom	het		QUAL=7203;DP=98,144,101;AF=0.55,1.00,0.50;MQM=60;SAP=21;ABP=4	MTR	synonymous	MTR:ENST00000366577.5:synonymous_variant:LOW:exon29/33:c.3144A>G:p.Ala1048=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000535889.1:synonymous_variant:LOW:exon28/32:c.2991A>G:p.Ala997=:PF02965 [Vitamin B12 dependent methionine synthase activation domain]	MTR:NM_000254.2:synonymous_variant:LOW:exon29/33:c.3144A>G:p.Ala1048=:,MTR:NM_001291939.1:synonymous_variant:LOW:exon28/32:c.2991A>G:p.Ala997=:,MTR:NM_001291940.2:synonymous_variant:LOW:exon28/32:c.1923A>G:p.Ala641=:		156570 [GENE=MTR PHENOS=Neural tube defects,folate-sensitive,susceptibility to,601634,Autosomal recessive/Homocystinuria-megaloblastic anemia,cblG complementation type,250940,Autosomal recessive];	138290 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism,not specified];			rs2229276	0.3233	0.3896	2189,.	0.1936,0.4474,0.4430,0.4047,0.3210	-1.1260			0.10,0.16	0.22					0.0558	0.157	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	237057608	237057608	G	A	het	hom	het	off-target	QUAL=8014;DP=97,175,140;AF=0.51,1.00,0.50;MQM=60;SAP=510;ABP=3	MTR	intron	MTR:ENST00000366577.5:intron_variant:MODIFIER:intron29/32:c.3205-49G>A::,MTR:ENST00000535889.1:intron_variant:MODIFIER:intron28/31:c.3052-49G>A::	MTR:NM_000254.2:intron_variant:MODIFIER:intron29/32:c.3205-49G>A::,MTR:NM_001291939.1:intron_variant:MODIFIER:intron28/31:c.3052-49G>A::,MTR:NM_001291940.2:intron_variant:MODIFIER:intron28/31:c.1984-49G>A::	regulatory_region_variant:open_chromatin_region	156570 [GENE=MTR PHENOS=Neural tube defects,folate-sensitive,susceptibility to,601634,Autosomal recessive/Homocystinuria-megaloblastic anemia,cblG complementation type,250940,Autosomal recessive];				rs2297965		0.5905	5181,.	0.4581,0.6321,0.5411,0.5949,0.6252	-0.5190			0.03,0.14	3.04					-0.0392	0.1335	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	237058744	237058744	C	A	het	hom	het		QUAL=14682;DP=212,309,222;AF=0.52,1.00,0.45;MQM=60;SAP=11;ABP=4	MTR	synonymous	MTR:ENST00000366577.5:synonymous_variant:LOW:exon31/33:c.3492C>A:p.Arg1164=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000535889.1:synonymous_variant:LOW:exon30/32:c.3339C>A:p.Arg1113=:PF02965 [Vitamin B12 dependent methionine synthase activation domain]	MTR:NM_000254.2:synonymous_variant:LOW:exon31/33:c.3492C>A:p.Arg1164=:,MTR:NM_001291939.1:synonymous_variant:LOW:exon30/32:c.3339C>A:p.Arg1113=:,MTR:NM_001291940.2:synonymous_variant:LOW:exon30/32:c.2271C>A:p.Arg757=:		156570 [GENE=MTR PHENOS=Neural tube defects,folate-sensitive,susceptibility to,601634,Autosomal recessive/Homocystinuria-megaloblastic anemia,cblG complementation type,250940,Autosomal recessive];	138283 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism,not specified];			rs12070777	0.3215	0.3869	2179,.	0.1981,0.4453,0.4322,0.4014,0.3121	0.0720			0.58,0.23	5.48					0.1115	0.2178	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	237058828	237058828	C	T	wt	het	het		QUAL=4192;DP=135,182,168;AF=0.00,0.53,0.43;MQM=60;SAP=117;ABP=4	MTR	synonymous	MTR:ENST00000366577.5:synonymous_variant:LOW:exon31/33:c.3576C>T:p.Leu1192=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000535889.1:synonymous_variant:LOW:exon30/32:c.3423C>T:p.Leu1141=:PF02965 [Vitamin B12 dependent methionine synthase activation domain]	MTR:NM_000254.2:synonymous_variant:LOW:exon31/33:c.3576C>T:p.Leu1192=:,MTR:NM_001291939.1:synonymous_variant:LOW:exon30/32:c.3423C>T:p.Leu1141=:,MTR:NM_001291940.2:synonymous_variant:LOW:exon30/32:c.2355C>T:p.Leu785=:		156570 [GENE=MTR PHENOS=Neural tube defects,folate-sensitive,susceptibility to,601634,Autosomal recessive/Homocystinuria-megaloblastic anemia,cblG complementation type,250940,Autosomal recessive];	138284 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism,not specified];			rs1131449		0.5762	4962,.	0.4608,0.6146,0.5430,0.5720,0.6205	-3.4610			0.02,0.09	0.11					-0.0402	0.2125	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	237060433	237060433	G	T	het	hom	het	off-target	QUAL=12414;DP=204,245,200;AF=0.42,0.99,0.50;MQM=60;SAP=227;ABP=9	MTR	intron	MTR:ENST00000366577.5:intron_variant:MODIFIER:intron32/32:c.3711+15G>T::,MTR:ENST00000535889.1:intron_variant:MODIFIER:intron31/31:c.3558+15G>T::	MTR:NM_000254.2:intron_variant:MODIFIER:intron32/32:c.3711+15G>T::,MTR:NM_001291939.1:intron_variant:MODIFIER:intron31/31:c.3558+15G>T::,MTR:NM_001291940.2:intron_variant:MODIFIER:intron31/31:c.2490+15G>T::		156570 [GENE=MTR PHENOS=Neural tube defects,folate-sensitive,susceptibility to,601634,Autosomal recessive/Homocystinuria-megaloblastic anemia,cblG complementation type,250940,Autosomal recessive];	138285 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism,not specified];			rs3820571	0.7524	0.7166	8242,.	0.8870,0.6808,0.8080,0.6181,0.7188	-0.2760			0.00,0.13	1.87					0.0655	0.117	0.08	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	237060946	237060946	T	-	het	het	het	low_conf_region	QUAL=238;DP=135,97,61;AF=0.15,0.11,0.20;MQM=60;SAP=7;ABP=321	MTR	3'UTR	MTR:ENST00000366577.5:3_prime_UTR_variant:MODIFIER:exon33/33:c.*16del::,MTR:ENST00000535889.1:3_prime_UTR_variant:MODIFIER:exon32/32:c.*16del::	MTR:NM_000254.2:3_prime_UTR_variant:MODIFIER:exon33/33:c.*16del::,MTR:NM_001291939.1:3_prime_UTR_variant:MODIFIER:exon32/32:c.*16del::,MTR:NM_001291940.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*16del::		156570 [GENE=MTR PHENOS=Neural tube defects,folate-sensitive,susceptibility to,601634,Autosomal recessive/Homocystinuria-megaloblastic anemia,cblG complementation type,250940,Autosomal recessive];	296586 [likely benign(replaced by megSAP based on classifications:1x1,1x3) DISEASE=Methylcobalamin deficiency type cblG,Disorders of Intracellular Cobalamin Metabolism];		(T)n (Simple_repeat)	rs67705775		0.4627	305,.	0.4550,0.4608,0.4615,0.4659,0.4674	0.9670				5.96					0.0247	0.9033	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	237061056	237061056	A	C	het	hom	het		QUAL=10712;DP=307,153,80;AF=0.54,1.00,0.53;MQM=60;SAP=19;ABP=8	MTR	3'UTR	MTR:ENST00000366577.5:3_prime_UTR_variant:MODIFIER:exon33/33:c.*112A>C::,MTR:ENST00000535889.1:3_prime_UTR_variant:MODIFIER:exon32/32:c.*112A>C::	MTR:NM_000254.2:3_prime_UTR_variant:MODIFIER:exon33/33:c.*112A>C::,MTR:NM_001291939.1:3_prime_UTR_variant:MODIFIER:exon32/32:c.*112A>C::,MTR:NM_001291940.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*112A>C::		156570 [GENE=MTR PHENOS=Neural tube defects,folate-sensitive,susceptibility to,601634,Autosomal recessive/Homocystinuria-megaloblastic anemia,cblG complementation type,250940,Autosomal recessive];	296587 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];			rs2853522		0.5728	5214,.		-1.1210			0.00,0.05	5.23					0.0184	0.9033	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	237061705	237061705	T	-	het	hom	het		QUAL=2081;DP=95,37,26;AF=0.52,0.84,0.58;MQM=58;SAP=88;ABP=4	MTR	3'UTR	MTR:ENST00000366577.5:3_prime_UTR_variant:MODIFIER:exon33/33:c.*773del::	MTR:NM_000254.2:3_prime_UTR_variant:MODIFIER:exon33/33:c.*773del::,MTR:NM_001291939.1:3_prime_UTR_variant:MODIFIER:exon32/32:c.*773del::,MTR:NM_001291940.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*773del::		156570 [GENE=MTR PHENOS=Neural tube defects,folate-sensitive,susceptibility to,601634,Autosomal recessive/Homocystinuria-megaloblastic anemia,cblG complementation type,250940,Autosomal recessive];	296595 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];		AluY (SINE/Alu)	rs796166778		0.6811	5595,.		0.1060				6.63					0.0054	0.9033	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	237061849	237061849	G	A	het	wt	het		QUAL=1236;DP=80,65,34;AF=0.43,0.00,0.59;MQM=51;SAP=74;ABP=4	MTR	3'UTR	MTR:ENST00000366577.5:3_prime_UTR_variant:MODIFIER:exon33/33:c.*905G>A::	MTR:NM_000254.2:3_prime_UTR_variant:MODIFIER:exon33/33:c.*905G>A::,MTR:NM_001291939.1:3_prime_UTR_variant:MODIFIER:exon32/32:c.*905G>A::,MTR:NM_001291940.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*905G>A::		156570 [GENE=MTR PHENOS=Neural tube defects,folate-sensitive,susceptibility to,601634,Autosomal recessive/Homocystinuria-megaloblastic anemia,cblG complementation type,250940,Autosomal recessive];	296598 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];		AluY (SINE/Alu)	rs1131450	0.2460	0.2755	1337,.		0.1700			0.00,0.07	2.03					-0.0044	0.9031	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	237062198	237062198	A	C	het	hom	het		QUAL=16894;DP=263,297,243;AF=0.55,1.00,0.47;MQM=60;SAP=15;ABP=4	MTR	3'UTR	MTR:ENST00000366577.5:3_prime_UTR_variant:MODIFIER:exon33/33:c.*1254A>C::	MTR:NM_000254.2:3_prime_UTR_variant:MODIFIER:exon33/33:c.*1254A>C::,MTR:NM_001291939.1:3_prime_UTR_variant:MODIFIER:exon32/32:c.*1254A>C::,MTR:NM_001291940.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*1254A>C::		156570 [GENE=MTR PHENOS=Neural tube defects,folate-sensitive,susceptibility to,601634,Autosomal recessive/Homocystinuria-megaloblastic anemia,cblG complementation type,250940,Autosomal recessive];	296610 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];			rs2853523	0.7646	0.7272	8540,.		-0.2270			0.00,0.06	8.40					-0.0063	0.9031	0.08	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	237062305	237062305	A	G	het	hom	het		QUAL=21932;DP=412,370,294;AF=0.52,0.99,0.52;MQM=60;SAP=5;ABP=6	MTR	3'UTR	MTR:ENST00000366577.5:3_prime_UTR_variant:MODIFIER:exon33/33:c.*1361A>G::	MTR:NM_000254.2:3_prime_UTR_variant:MODIFIER:exon33/33:c.*1361A>G::,MTR:NM_001291939.1:3_prime_UTR_variant:MODIFIER:exon32/32:c.*1361A>G::,MTR:NM_001291940.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*1361A>G::		156570 [GENE=MTR PHENOS=Neural tube defects,folate-sensitive,susceptibility to,601634,Autosomal recessive/Homocystinuria-megaloblastic anemia,cblG complementation type,250940,Autosomal recessive];	296611 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];			rs1050993		0.7272	8539,.		-0.4580			0.00,0.06	3.09					-0.0021	0.9031	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	237063335	237063335	G	C	het	hom	het		QUAL=12869;DP=227,221,207;AF=0.49,1.00,0.53;MQM=60;SAP=134;ABP=3	MTR	3'UTR	MTR:ENST00000366577.5:3_prime_UTR_variant:MODIFIER:exon33/33:c.*2391G>C::	MTR:NM_000254.2:3_prime_UTR_variant:MODIFIER:exon33/33:c.*2391G>C::,MTR:NM_001291939.1:3_prime_UTR_variant:MODIFIER:exon32/32:c.*2391G>C::,MTR:NM_001291940.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*2391G>C::	regulatory_region_variant:promoter_flanking_region	156570 [GENE=MTR PHENOS=Neural tube defects,folate-sensitive,susceptibility to,601634,Autosomal recessive/Homocystinuria-megaloblastic anemia,cblG complementation type,250940,Autosomal recessive];	296631 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];		L1ME3F (LINE/L1)	rs1050996	0.7328	0.6980	7755,.		-0.1640			0.00,0.07	3.58					-0.0026	0.9031	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	237063504	237063504	A	G	het	hom	het		QUAL=11917;DP=379,147,107;AF=0.50,1.00,0.54;MQM=60;SAP=7;ABP=3	MTR	3'UTR	MTR:ENST00000366577.5:3_prime_UTR_variant:MODIFIER:exon33/33:c.*2560A>G::	MTR:NM_000254.2:3_prime_UTR_variant:MODIFIER:exon33/33:c.*2560A>G::,MTR:NM_001291939.1:3_prime_UTR_variant:MODIFIER:exon32/32:c.*2560A>G::,MTR:NM_001291940.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*2560A>G::		156570 [GENE=MTR PHENOS=Neural tube defects,folate-sensitive,susceptibility to,601634,Autosomal recessive/Homocystinuria-megaloblastic anemia,cblG complementation type,250940,Autosomal recessive];	296633 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];		L1ME3F (LINE/L1)	rs9779	0.3219	0.3704	2128,.	0.1885,0.4325,0.4310,0.3913,0.2992	-1.1440			0.01,0.12	3.57					0.0048	0.9033	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	237063709	237063709	-	A	het	hom	het		QUAL=13809;DP=188,184,138;AF=0.41,0.94,0.42;MQM=60;SAP=3;ABP=22	MTR	3'UTR	MTR:ENST00000366577.5:3_prime_UTR_variant:MODIFIER:exon33/33:c.*2774dup::	MTR:NM_000254.2:3_prime_UTR_variant:MODIFIER:exon33/33:c.*2774dup::,MTR:NM_001291939.1:3_prime_UTR_variant:MODIFIER:exon32/32:c.*2774dup::,MTR:NM_001291940.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*2774dup::		156570 [GENE=MTR PHENOS=Neural tube defects,folate-sensitive,susceptibility to,601634,Autosomal recessive/Homocystinuria-megaloblastic anemia,cblG complementation type,250940,Autosomal recessive];	296635 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];		L1ME3F (LINE/L1)	rs34686098		0.7250	6621,.						3.74					-0.0986	0.9425	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	237063718	237063719	AG	-	het	wt	het		QUAL=13809;DP=188,184,138;AF=0.41,0.94,0.42;MQM=60;SAP=12;ABP=4	MTR	3'UTR	MTR:ENST00000366577.5:3_prime_UTR_variant:MODIFIER:exon33/33:c.*2775_*2776del::	MTR:NM_000254.2:3_prime_UTR_variant:MODIFIER:exon33/33:c.*2775_*2776del::,MTR:NM_001291939.1:3_prime_UTR_variant:MODIFIER:exon32/32:c.*2775_*2776del::,MTR:NM_001291940.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*2775_*2776del::		156570 [GENE=MTR PHENOS=Neural tube defects,folate-sensitive,susceptibility to,601634,Autosomal recessive/Homocystinuria-megaloblastic anemia,cblG complementation type,250940,Autosomal recessive];	296637 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];		L1ME3F (LINE/L1)	rs1553332314		0.2694	1367,.		0.5860				3.12					-0.0064	0.8987	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	237064626	237064626	T	G	het	hom	het		QUAL=33696;DP=416,670,512;AF=0.49,0.99,0.48;MQM=60;SAP=22;ABP=5	MTR	3'UTR	MTR:ENST00000366577.5:3_prime_UTR_variant:MODIFIER:exon33/33:c.*3682T>G::	MTR:NM_000254.2:3_prime_UTR_variant:MODIFIER:exon33/33:c.*3682T>G::,MTR:NM_001291939.1:3_prime_UTR_variant:MODIFIER:exon32/32:c.*3682T>G::,MTR:NM_001291940.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*3682T>G::		156570 [GENE=MTR PHENOS=Neural tube defects,folate-sensitive,susceptibility to,601634,Autosomal recessive/Homocystinuria-megaloblastic anemia,cblG complementation type,250940,Autosomal recessive];	296655 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];			rs6676866		0.5736	5223,.		1.5630			0.10,0.14	2.17					0.0051	0.8989	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	237065326	237065326	C	T	het	hom	het		QUAL=8100;DP=170,156,112;AF=0.55,1.00,0.47;MQM=60;SAP=144;ABP=4	MTR	3'UTR	MTR:ENST00000366577.5:3_prime_UTR_variant:MODIFIER:exon33/33:c.*4382C>T::	MTR:NM_000254.2:3_prime_UTR_variant:MODIFIER:exon33/33:c.*4382C>T::,MTR:NM_001291939.1:3_prime_UTR_variant:MODIFIER:exon32/32:c.*4382C>T::,MTR:NM_001291940.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*4382C>T::		156570 [GENE=MTR PHENOS=Neural tube defects,folate-sensitive,susceptibility to,601634,Autosomal recessive/Homocystinuria-megaloblastic anemia,cblG complementation type,250940,Autosomal recessive];	296668 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];			rs4659746	0.5447	0.5793	5338,.		-0.6210			0.00,0.10	1.06					-0.0021	0.8988	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	237065583	237065583	G	T	het	hom	het		QUAL=13264;DP=219,256,175;AF=0.52,1.00,0.57;MQM=60;SAP=9;ABP=9	MTR	3'UTR	MTR:ENST00000366577.5:3_prime_UTR_variant:MODIFIER:exon33/33:c.*4639G>T::	MTR:NM_000254.2:3_prime_UTR_variant:MODIFIER:exon33/33:c.*4639G>T::,MTR:NM_001291939.1:3_prime_UTR_variant:MODIFIER:exon32/32:c.*4639G>T::,MTR:NM_001291940.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*4639G>T::		156570 [GENE=MTR PHENOS=Neural tube defects,folate-sensitive,susceptibility to,601634,Autosomal recessive/Homocystinuria-megaloblastic anemia,cblG complementation type,250940,Autosomal recessive];	296673 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];			rs10925264	0.7646	0.7270	8512,.		-0.3240			0.00,0.07	0.81					-0.0007	0.8988	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	237065810	237065810	T	G	het	het	wt		QUAL=4847;DP=177,171,178;AF=0.53,0.55,0.00;MQM=60;SAP=141;ABP=7	MTR	3'UTR	MTR:ENST00000366577.5:3_prime_UTR_variant:MODIFIER:exon33/33:c.*4866T>G::	MTR:NM_000254.2:3_prime_UTR_variant:MODIFIER:exon33/33:c.*4866T>G::,MTR:NM_001291939.1:3_prime_UTR_variant:MODIFIER:exon32/32:c.*4866T>G::,MTR:NM_001291940.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*4866T>G::		156570 [GENE=MTR PHENOS=Neural tube defects,folate-sensitive,susceptibility to,601634,Autosomal recessive/Homocystinuria-megaloblastic anemia,cblG complementation type,250940,Autosomal recessive];	296677 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];		L2c (LINE/L2)	rs45563435	0.0076	0.0136	3,.		-0.3090			0.02,0.12	1.17					0.0017	0.8988	0	3	153	0 / 0					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	237066114	237066114	A	G	het	wt	het		QUAL=3122;DP=156,113,84;AF=0.49,0.00,0.58;MQM=60;SAP=101;ABP=4	MTR	3'UTR	MTR:ENST00000366577.5:3_prime_UTR_variant:MODIFIER:exon33/33:c.*5170A>G::	MTR:NM_000254.2:3_prime_UTR_variant:MODIFIER:exon33/33:c.*5170A>G::,MTR:NM_001291939.1:3_prime_UTR_variant:MODIFIER:exon32/32:c.*5170A>G::,MTR:NM_001291940.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*5170A>G::		156570 [GENE=MTR PHENOS=Neural tube defects,folate-sensitive,susceptibility to,601634,Autosomal recessive/Homocystinuria-megaloblastic anemia,cblG complementation type,250940,Autosomal recessive];	296679 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];			rs6680753	0.0104	0.0204	8,.		0.5380			0.05,0.20	6.87					-0.0023	0.8987	0	0	11	0 / 0					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	240939104	240939104	G	A	het	wt	hom		QUAL=9092;DP=345,165,146;AF=0.48,0.00,0.99;MQM=60;SAP=178;ABP=4	RGS7	intron,3'UTR	RGS7:ENST00000331110.7:intron_variant:MODIFIER:intron17/17:c.*7-7526C>T::,RGS7:ENST00000348120.2:3_prime_UTR_variant:MODIFIER:exon15/15:c.*416C>T::,RGS7:ENST00000366563.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*416C>T::,RGS7:ENST00000366564.1:3_prime_UTR_variant:MODIFIER:exon17/17:c.*359C>T::,RGS7:ENST00000366565.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*359C>T::,RGS7:ENST00000446183.2:3_prime_UTR_variant:MODIFIER:exon18/18:c.*416C>T::	RGS7:NM_001282773.2:3_prime_UTR_variant:MODIFIER:exon16/16:c.*416C>T::,RGS7:NM_001282775.2:3_prime_UTR_variant:MODIFIER:exon18/18:c.*416C>T::,RGS7:NM_001282778.2:3_prime_UTR_variant:MODIFIER:exon17/17:c.*359C>T::,RGS7:NM_001350113.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*416C>T::,RGS7:NM_001350114.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*416C>T::,RGS7:NM_001350115.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*359C>T::,RGS7:NM_001350116.1:3_prime_UTR_variant:MODIFIER:exon17/17:c.*359C>T::,RGS7:NM_001364886.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*416C>T::,RGS7:NM_002924.6:3_prime_UTR_variant:MODIFIER:exon18/18:c.*359C>T::						rs35557904	0.1727	0.1719	600,.		0.5550			0.22,0.93	10.51					-0.0118	0.8893	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20), THAP12P8 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	240939152	240939152	A	G	het	wt	hom		QUAL=9443;DP=317,209,181;AF=0.44,0.00,0.99;MQM=60;SAP=89;ABP=13	RGS7	intron,3'UTR	RGS7:ENST00000331110.7:intron_variant:MODIFIER:intron17/17:c.*7-7574T>C::,RGS7:ENST00000348120.2:3_prime_UTR_variant:MODIFIER:exon15/15:c.*368T>C::,RGS7:ENST00000366563.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*368T>C::,RGS7:ENST00000366564.1:3_prime_UTR_variant:MODIFIER:exon17/17:c.*311T>C::,RGS7:ENST00000366565.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*311T>C::,RGS7:ENST00000446183.2:3_prime_UTR_variant:MODIFIER:exon18/18:c.*368T>C::	RGS7:NM_001282773.2:3_prime_UTR_variant:MODIFIER:exon16/16:c.*368T>C::,RGS7:NM_001282775.2:3_prime_UTR_variant:MODIFIER:exon18/18:c.*368T>C::,RGS7:NM_001282778.2:3_prime_UTR_variant:MODIFIER:exon17/17:c.*311T>C::,RGS7:NM_001350113.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*368T>C::,RGS7:NM_001350114.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*368T>C::,RGS7:NM_001350115.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*311T>C::,RGS7:NM_001350116.1:3_prime_UTR_variant:MODIFIER:exon17/17:c.*311T>C::,RGS7:NM_001364886.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*368T>C::,RGS7:NM_002924.6:3_prime_UTR_variant:MODIFIER:exon18/18:c.*311T>C::						rs16840577	0.1727	0.1711	600,.		2.3800			0.05,0.93	13.11					0.0461	0.8904	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20), THAP12P8 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	240939391	240939391	C	T	het	wt	het		QUAL=12760;DP=503,687,550;AF=0.46,0.00,0.47;MQM=60;SAP=23;ABP=15	RGS7	intron,3'UTR	RGS7:ENST00000331110.7:intron_variant:MODIFIER:intron17/17:c.*7-7813G>A::,RGS7:ENST00000348120.2:3_prime_UTR_variant:MODIFIER:exon15/15:c.*129G>A::,RGS7:ENST00000366563.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*129G>A::,RGS7:ENST00000366564.1:3_prime_UTR_variant:MODIFIER:exon17/17:c.*72G>A::,RGS7:ENST00000366565.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*72G>A::,RGS7:ENST00000446183.2:3_prime_UTR_variant:MODIFIER:exon18/18:c.*129G>A::	RGS7:NM_001282773.2:3_prime_UTR_variant:MODIFIER:exon16/16:c.*129G>A::,RGS7:NM_001282775.2:3_prime_UTR_variant:MODIFIER:exon18/18:c.*129G>A::,RGS7:NM_001282778.2:3_prime_UTR_variant:MODIFIER:exon17/17:c.*72G>A::,RGS7:NM_001350113.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*129G>A::,RGS7:NM_001350114.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*129G>A::,RGS7:NM_001350115.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*72G>A::,RGS7:NM_001350116.1:3_prime_UTR_variant:MODIFIER:exon17/17:c.*72G>A::,RGS7:NM_001364886.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*129G>A::,RGS7:NM_002924.6:3_prime_UTR_variant:MODIFIER:exon18/18:c.*72G>A::						rs12757054	0.0497	0.0599	68,.		1.8120			0.71,0.97	13.16					-0.0103	0.8893	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20), THAP12P8 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	240975213	240975213	T	C	het	hom	wt		QUAL=11074;DP=254,237,201;AF=0.55,1.00,0.00;MQM=60;SAP=138;ABP=9	RGS7	splice_region&intron	RGS7:ENST00000331110.7:splice_region_variant&intron_variant:LOW:intron14/17:c.1004+5A>G::,RGS7:ENST00000348120.2:splice_region_variant&intron_variant:LOW:intron11/14:c.923+5A>G::,RGS7:ENST00000366562.4:splice_region_variant&intron_variant:LOW:intron13/15:c.1082+5A>G::,RGS7:ENST00000366563.1:splice_region_variant&intron_variant:LOW:intron14/17:c.1082+5A>G::,RGS7:ENST00000366564.1:splice_region_variant&intron_variant:LOW:intron14/16:c.1082+5A>G::,RGS7:ENST00000366565.1:splice_region_variant&intron_variant:LOW:intron14/17:c.1082+5A>G::,RGS7:ENST00000401882.1:splice_region_variant&intron_variant:LOW:intron11/13:c.923+5A>G::,RGS7:ENST00000407727.1:splice_region_variant&intron_variant:LOW:intron13/16:c.1082+5A>G::,RGS7:ENST00000446183.2:splice_region_variant&intron_variant:LOW:intron14/17:c.830+5A>G::	RGS7:NM_001282773.2:splice_region_variant&intron_variant:LOW:intron12/15:c.923+5A>G::,RGS7:NM_001282775.2:splice_region_variant&intron_variant:LOW:intron14/17:c.1082+5A>G::,RGS7:NM_001282778.2:splice_region_variant&intron_variant:LOW:intron14/16:c.1082+5A>G::,RGS7:NM_001350113.1:splice_region_variant&intron_variant:LOW:intron15/18:c.1004+5A>G::,RGS7:NM_001350114.1:splice_region_variant&intron_variant:LOW:intron15/18:c.1004+5A>G::,RGS7:NM_001350115.1:splice_region_variant&intron_variant:LOW:intron15/17:c.1004+5A>G::,RGS7:NM_001350116.1:splice_region_variant&intron_variant:LOW:intron14/16:c.1004+5A>G::,RGS7:NM_001364886.1:splice_region_variant&intron_variant:LOW:intron14/18:c.1082+5A>G::,RGS7:NM_002924.6:splice_region_variant&intron_variant:LOW:intron14/17:c.1082+5A>G::						rs2275742	0.4046	0.5076	4239,.	0.2546,0.4101,0.4598,0.5768,0.4338	0.4500			0.04,0.89	12.29		8.38>10.57	0.000/0.002		1.4735	0.0026	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20)
chr1	240977964	240977964	G	T	hom	hom	het	off-target	QUAL=9591;DP=169,108,64;AF=0.99,1.00,0.44;MQM=60;SAP=300;ABP=5	RGS7	intron	RGS7:ENST00000331110.7:intron_variant:MODIFIER:intron12/17:c.767+52C>A::,RGS7:ENST00000348120.2:intron_variant:MODIFIER:intron9/14:c.686+52C>A::,RGS7:ENST00000366562.4:intron_variant:MODIFIER:intron11/15:c.845+52C>A::,RGS7:ENST00000366563.1:intron_variant:MODIFIER:intron12/17:c.845+52C>A::,RGS7:ENST00000366564.1:intron_variant:MODIFIER:intron12/16:c.845+52C>A::,RGS7:ENST00000366565.1:intron_variant:MODIFIER:intron12/17:c.845+52C>A::,RGS7:ENST00000401882.1:intron_variant:MODIFIER:intron9/13:c.686+52C>A::,RGS7:ENST00000407727.1:intron_variant:MODIFIER:intron11/16:c.845+52C>A::,RGS7:ENST00000446183.2:intron_variant:MODIFIER:intron12/17:c.593+52C>A::	RGS7:NM_001282773.2:intron_variant:MODIFIER:intron10/15:c.686+52C>A::,RGS7:NM_001282775.2:intron_variant:MODIFIER:intron12/17:c.845+52C>A::,RGS7:NM_001282778.2:intron_variant:MODIFIER:intron12/16:c.845+52C>A::,RGS7:NM_001350113.1:intron_variant:MODIFIER:intron13/18:c.767+52C>A::,RGS7:NM_001350114.1:intron_variant:MODIFIER:intron13/18:c.767+52C>A::,RGS7:NM_001350115.1:intron_variant:MODIFIER:intron13/17:c.767+52C>A::,RGS7:NM_001350116.1:intron_variant:MODIFIER:intron12/16:c.767+52C>A::,RGS7:NM_001364886.1:intron_variant:MODIFIER:intron12/18:c.845+52C>A::,RGS7:NM_002924.6:intron_variant:MODIFIER:intron12/17:c.845+52C>A::						rs12744536	0.5292	0.6313	6601,.		-1.2830			0.00,0.08	4.12					0.0694	0.0639	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20)
chr1	241146322	241146322	A	G	het	het	wt	off-target	QUAL=4121;DP=215,82,57;AF=0.53,0.54,0.00;MQM=60;SAP=219;ABP=5	RGS7	intron	RGS7:ENST00000331110.7:intron_variant:MODIFIER:intron4/17:c.148+57T>C::,RGS7:ENST00000348120.2:intron_variant:MODIFIER:intron3/14:c.226+57T>C::,RGS7:ENST00000366562.4:intron_variant:MODIFIER:intron3/15:c.226+57T>C::,RGS7:ENST00000366563.1:intron_variant:MODIFIER:intron4/17:c.226+57T>C::,RGS7:ENST00000366564.1:intron_variant:MODIFIER:intron4/16:c.226+57T>C::,RGS7:ENST00000366565.1:intron_variant:MODIFIER:intron4/17:c.226+57T>C::,RGS7:ENST00000401882.1:intron_variant:MODIFIER:intron3/13:c.226+57T>C::,RGS7:ENST00000407727.1:intron_variant:MODIFIER:intron3/16:c.226+57T>C::,RGS7:ENST00000446183.2:intron_variant:MODIFIER:intron4/17:c.-27+57T>C::	RGS7:NM_001282773.2:intron_variant:MODIFIER:intron4/15:c.226+57T>C::,RGS7:NM_001282775.2:intron_variant:MODIFIER:intron4/17:c.226+57T>C::,RGS7:NM_001282778.2:intron_variant:MODIFIER:intron4/16:c.226+57T>C::,RGS7:NM_001350113.1:intron_variant:MODIFIER:intron5/18:c.148+57T>C::,RGS7:NM_001350114.1:intron_variant:MODIFIER:intron5/18:c.148+57T>C::,RGS7:NM_001350115.1:intron_variant:MODIFIER:intron5/17:c.148+57T>C::,RGS7:NM_001350116.1:intron_variant:MODIFIER:intron4/16:c.148+57T>C::,RGS7:NM_001364886.1:intron_variant:MODIFIER:intron4/18:c.226+57T>C::,RGS7:NM_002924.6:intron_variant:MODIFIER:intron4/17:c.226+57T>C::						rs7520707	0.3560	0.3630	2125,.		0.6750			0.03,0.13	2.37					-0.0257	0.1239	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20)
chr1	241519098	241519098	T	A	hom	hom	hom		QUAL=35121;DP=432,418,285;AF=1.00,1.00,1.00;MQM=60;SAP=64;ABP=0	RGS7	5'UTR	RGS7:ENST00000366563.1:5_prime_UTR_variant:MODIFIER:exon2/18:c.-22A>T::,RGS7:ENST00000366564.1:5_prime_UTR_variant:MODIFIER:exon2/17:c.-22A>T::,RGS7:ENST00000366565.1:5_prime_UTR_variant:MODIFIER:exon2/18:c.-22A>T::	RGS7:NM_001282773.2:5_prime_UTR_variant:MODIFIER:exon2/16:c.-22A>T::,RGS7:NM_001282775.2:5_prime_UTR_variant:MODIFIER:exon2/18:c.-22A>T::,RGS7:NM_001282778.2:5_prime_UTR_variant:MODIFIER:exon2/17:c.-22A>T::,RGS7:NM_001350113.1:5_prime_UTR_variant:MODIFIER:exon2/19:c.-204A>T::,RGS7:NM_001350114.1:5_prime_UTR_variant:MODIFIER:exon2/19:c.-172A>T::,RGS7:NM_001350115.1:5_prime_UTR_variant:MODIFIER:exon2/18:c.-204A>T::,RGS7:NM_001350116.1:5_prime_UTR_variant:MODIFIER:exon1/17:c.-172A>T::,RGS7:NM_001364886.1:5_prime_UTR_variant:MODIFIER:exon2/19:c.-22A>T::,RGS7:NM_002924.6:5_prime_UTR_variant:MODIFIER:exon2/18:c.-22A>T::						rs4659599	0.9483	0.9795	14388,.	0.8691,0.9883,0.9973,0.9877,0.9871	1.2450			0.34,0.42	10.88					-0.0706	0.0689	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20)
chr1	241520188	241520188	T	C	n/a	hom	hom	off-target	QUAL=980;DP=0,16,17;AF=,1.00,1.00;MQM=60;SAP=14;ABP=0	RGS7	intron	RGS7:ENST00000366563.1:intron_variant:MODIFIER:intron1/17:c.-51+11A>G::,RGS7:ENST00000366564.1:intron_variant:MODIFIER:intron1/16:c.-51+11A>G::,RGS7:ENST00000366565.1:intron_variant:MODIFIER:intron1/17:c.-51+11A>G::	RGS7:NM_001282773.2:intron_variant:MODIFIER:intron1/15:c.-51+11A>G::,RGS7:NM_001282775.2:intron_variant:MODIFIER:intron1/17:c.-51+11A>G::,RGS7:NM_001282778.2:intron_variant:MODIFIER:intron1/16:c.-51+11A>G::,RGS7:NM_001350113.1:intron_variant:MODIFIER:intron1/18:c.-233+11A>G::,RGS7:NM_001350114.1:intron_variant:MODIFIER:intron1/18:c.-201+11A>G::,RGS7:NM_001350115.1:intron_variant:MODIFIER:intron1/17:c.-233+11A>G::,RGS7:NM_001364886.1:intron_variant:MODIFIER:intron1/18:c.-51+11A>G::,RGS7:NM_002924.6:intron_variant:MODIFIER:intron1/17:c.-51+11A>G::	regulatory_region_variant:promoter					rs1891130	0.9485	0.9565	14020,.		0.5930			0.00,0.25	15.24					0.2632	0.0669	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20)
chr1	241663902	241663902	-	GAGA	wt	het	het	off-target;low_conf_region	QUAL=1139;DP=3,92,57;AF=0.00,0.27,0.18;MQM=60;SAP=36;ABP=94	FH	intron	FH:ENST00000366560.3:intron_variant:MODIFIER:intron8/9:c.1237-16_1237-13dup::	FH:NM_000143.3:intron_variant:MODIFIER:intron8/9:c.1237-16_1237-13dup::		136850 [GENE=FH PHENOS=Fumarase deficiency,606812,Autosomal recessive/Leiomyomatosis and renal cell cancer,150800,Autosomal dominant];	296866 [uncertain significance(replaced by megSAP based on classifications:1x2,4x3) DISEASE=Hereditary leiomyomatosis and renal cell cancer,Fumarase deficiency,not specified,Multiple Cutaneous and Uterine Leiomyomas];		(GA)n (Simple_repeat)	rs144131869		0.2511	802,.						1.71					-0.007	0.2126	0.04	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FH (inh=AR+AD oe_syn=1.04 oe_mis=0.79 oe_lof=0.28)
chr1	241663902	241663902	-	GAGAGA	wt	wt	het	off-target;low_conf_region	QUAL=1139;DP=3,92,57;AF=0.00,0.26,0.00;MQM=60;SAP=18;ABP=196	FH	intron	FH:ENST00000366560.3:intron_variant:MODIFIER:intron8/9:c.1237-18_1237-13dup::	FH:NM_000143.3:intron_variant:MODIFIER:intron8/9:c.1237-18_1237-13dup::		136850 [GENE=FH PHENOS=Fumarase deficiency,606812,Autosomal recessive/Leiomyomatosis and renal cell cancer,150800,Autosomal dominant];	296867 [uncertain significance DISEASE=Hereditary leiomyomatosis and renal cell cancer,Fumarase deficiency,Multiple Cutaneous and Uterine Leiomyomas];		(GA)n (Simple_repeat)	rs144131869		0.2089	574,.						1.63					-0.0047	0.2117	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FH (inh=AR+AD oe_syn=1.04 oe_mis=0.79 oe_lof=0.28)
chr1	241663902	241663902	-	GAGAGAGAGA	wt	het	wt	off-target;low_conf_region	QUAL=1139;DP=3,92,57;AF=0.00,0.07,0.19;MQM=60;SAP=16;ABP=49	FH	intron	FH:ENST00000366560.3:intron_variant:MODIFIER:intron8/9:c.1237-22_1237-13dup::	FH:NM_000143.3:intron_variant:MODIFIER:intron8/9:c.1237-22_1237-13dup::		136850 [GENE=FH PHENOS=Fumarase deficiency,606812,Autosomal recessive/Leiomyomatosis and renal cell cancer,150800,Autosomal dominant];	296869 [uncertain significance DISEASE=Hereditary leiomyomatosis and renal cell cancer,Fumarase deficiency,Multiple Cutaneous and Uterine Leiomyomas];		(GA)n (Simple_repeat)	rs144131869		0.0424	52,.						1.46					0.0362	0.1973	0.08	63	140	0 / 0					FH (inh=AR+AD oe_syn=1.04 oe_mis=0.79 oe_lof=0.28)
chr1	247581560	247581560	A	T	het	het	wt		QUAL=12562;DP=494,452,340;AF=0.51,0.53,0.00;MQM=60;SAP=49;ABP=5	NLRP3	5'UTR	NLRP3:ENST00000336119.3:5_prime_UTR_variant:MODIFIER:exon1/9:c.-537A>T::,NLRP3:ENST00000348069.2:5_prime_UTR_variant:MODIFIER:exon1/7:c.-537A>T::,NLRP3:ENST00000366496.2:5_prime_UTR_variant:MODIFIER:exon1/8:c.-537A>T::,NLRP3:ENST00000366497.2:5_prime_UTR_variant:MODIFIER:exon2/9:c.-537A>T::,NLRP3:ENST00000391828.3:5_prime_UTR_variant:MODIFIER:exon2/11:c.-71A>T::	NLRP3:NM_001079821.2:5_prime_UTR_variant:MODIFIER:exon2/11:c.-71A>T::,NLRP3:NM_001127461.2:5_prime_UTR_variant:MODIFIER:exon2/9:c.-537A>T::,NLRP3:NM_001127462.2:5_prime_UTR_variant:MODIFIER:exon1/8:c.-537A>T::,NLRP3:NM_001243133.1:5_prime_UTR_variant:MODIFIER:exon1/9:c.-543A>T::,NLRP3:NM_004895.4:5_prime_UTR_variant:MODIFIER:exon1/9:c.-537A>T::,NLRP3:NM_183395.2:5_prime_UTR_variant:MODIFIER:exon1/7:c.-537A>T::		606416 [GENE=NLRP3 PHENOS=Familial cold inflammatory syndrome 1,120100,Autosomal dominant/Muckle-Wells syndrome,191900,Autosomal dominant/CINCA syndrome,607115,Autosomal dominant/Deafness,autosomal dominant 34,with or without inflammation,617772,Autosomal dominant/Keratoendothelitis fugax hereditaria,148200,Autosomal dominant];	296927 [benign DISEASE=Familial cold autoinflammatory syndrome 1,Familial amyloid nephropathy with urticaria AND deafness,Chronic infantile neurological, cutaneous and articular syndrome];			rs116502550	0.0030	0.0112	5,.		0.2450			0.03,0.10	0.80					0.0214	0.3995	0.01	0	70	0 / 0					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247581692	247581692	T	C	hom	hom	hom		QUAL=17710;DP=265,168,161;AF=1.00,1.00,1.00;MQM=59;SAP=743;ABP=0	NLRP3	5'UTR,intron	NLRP3:ENST00000336119.3:5_prime_UTR_variant:MODIFIER:exon1/9:c.-405T>C::,NLRP3:ENST00000348069.2:5_prime_UTR_variant:MODIFIER:exon1/7:c.-405T>C::,NLRP3:ENST00000366496.2:5_prime_UTR_variant:MODIFIER:exon1/8:c.-405T>C::,NLRP3:ENST00000366497.2:5_prime_UTR_variant:MODIFIER:exon2/9:c.-405T>C::,NLRP3:ENST00000391828.3:intron_variant:MODIFIER:intron2/10:c.-39+100T>C::	NLRP3:NM_001079821.2:intron_variant:MODIFIER:intron2/10:c.-39+100T>C::,NLRP3:NM_001127461.2:5_prime_UTR_variant:MODIFIER:exon2/9:c.-405T>C::,NLRP3:NM_001127462.2:5_prime_UTR_variant:MODIFIER:exon1/8:c.-405T>C::,NLRP3:NM_001243133.1:5_prime_UTR_variant:MODIFIER:exon1/9:c.-411T>C::,NLRP3:NM_004895.4:5_prime_UTR_variant:MODIFIER:exon1/9:c.-405T>C::,NLRP3:NM_183395.2:5_prime_UTR_variant:MODIFIER:exon1/7:c.-405T>C::		606416 [GENE=NLRP3 PHENOS=Familial cold inflammatory syndrome 1,120100,Autosomal dominant/Muckle-Wells syndrome,191900,Autosomal dominant/CINCA syndrome,607115,Autosomal dominant/Deafness,autosomal dominant 34,with or without inflammation,617772,Autosomal dominant/Keratoendothelitis fugax hereditaria,148200,Autosomal dominant];	296931 [benign DISEASE=Familial cold autoinflammatory syndrome 1,Familial amyloid nephropathy with urticaria AND deafness,Chronic infantile neurological, cutaneous and articular syndrome];		AluSx1 (SINE/Alu)	rs7523422	0.9978	0.9976	15575,.		-2.9100			0.00,0.02	0.30					-0.0234	0.3994	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247581872	247581872	G	A	het	het	het		QUAL=5056;DP=217,85,68;AF=0.54,0.44,0.56;MQM=59;SAP=26;ABP=5	NLRP3	5'UTR,intron	NLRP3:ENST00000336119.3:5_prime_UTR_variant:MODIFIER:exon1/9:c.-225G>A::,NLRP3:ENST00000348069.2:5_prime_UTR_variant:MODIFIER:exon1/7:c.-225G>A::,NLRP3:ENST00000366496.2:5_prime_UTR_variant:MODIFIER:exon1/8:c.-225G>A::,NLRP3:ENST00000366497.2:5_prime_UTR_variant:MODIFIER:exon2/9:c.-225G>A::,NLRP3:ENST00000391828.3:intron_variant:MODIFIER:intron2/10:c.-38-187G>A::	NLRP3:NM_001079821.2:intron_variant:MODIFIER:intron2/10:c.-38-187G>A::,NLRP3:NM_001127461.2:5_prime_UTR_variant:MODIFIER:exon2/9:c.-225G>A::,NLRP3:NM_001127462.2:5_prime_UTR_variant:MODIFIER:exon1/8:c.-225G>A::,NLRP3:NM_001243133.1:5_prime_UTR_variant:MODIFIER:exon1/9:c.-231G>A::,NLRP3:NM_004895.4:5_prime_UTR_variant:MODIFIER:exon1/9:c.-225G>A::,NLRP3:NM_183395.2:5_prime_UTR_variant:MODIFIER:exon1/7:c.-225G>A::		606416 [GENE=NLRP3 PHENOS=Familial cold inflammatory syndrome 1,120100,Autosomal dominant/Muckle-Wells syndrome,191900,Autosomal dominant/CINCA syndrome,607115,Autosomal dominant/Deafness,autosomal dominant 34,with or without inflammation,617772,Autosomal dominant/Keratoendothelitis fugax hereditaria,148200,Autosomal dominant];	296932 [benign DISEASE=Familial cold autoinflammatory syndrome 1,Familial amyloid nephropathy with urticaria AND deafness,Chronic infantile neurological, cutaneous and articular syndrome];		AluSx1 (SINE/Alu)	rs138900557	0.0158	0.0452	52,.		0.3960			0.00,0.07	1.59					-0.0103	0.3989	0	1	26	0 / 0					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247582063	247582063	G	T	het	het	het		QUAL=9885;DP=330,285,231;AF=0.48,0.50,0.41;MQM=60;SAP=31;ABP=10	NLRP3	5'UTR	NLRP3:ENST00000336119.3:5_prime_UTR_variant:MODIFIER:exon1/9:c.-34G>T::,NLRP3:ENST00000348069.2:5_prime_UTR_variant:MODIFIER:exon1/7:c.-34G>T::,NLRP3:ENST00000366496.2:5_prime_UTR_variant:MODIFIER:exon1/8:c.-34G>T::,NLRP3:ENST00000366497.2:5_prime_UTR_variant:MODIFIER:exon2/9:c.-34G>T::,NLRP3:ENST00000391828.3:5_prime_UTR_variant:MODIFIER:exon3/11:c.-34G>T::	NLRP3:NM_001079821.2:5_prime_UTR_variant:MODIFIER:exon3/11:c.-34G>T::,NLRP3:NM_001127461.2:5_prime_UTR_variant:MODIFIER:exon2/9:c.-34G>T::,NLRP3:NM_001127462.2:5_prime_UTR_variant:MODIFIER:exon1/8:c.-34G>T::,NLRP3:NM_001243133.1:5_prime_UTR_variant:MODIFIER:exon1/9:c.-40G>T::,NLRP3:NM_004895.4:5_prime_UTR_variant:MODIFIER:exon1/9:c.-34G>T::,NLRP3:NM_183395.2:5_prime_UTR_variant:MODIFIER:exon1/7:c.-34G>T::		606416 [GENE=NLRP3 PHENOS=Familial cold inflammatory syndrome 1,120100,Autosomal dominant/Muckle-Wells syndrome,191900,Autosomal dominant/CINCA syndrome,607115,Autosomal dominant/Deafness,autosomal dominant 34,with or without inflammation,617772,Autosomal dominant/Keratoendothelitis fugax hereditaria,148200,Autosomal dominant];	296937 [benign DISEASE=Familial cold autoinflammatory syndrome 1,Familial amyloid nephropathy with urticaria AND deafness,Chronic infantile neurological, cutaneous and articular syndrome,none provided];			rs73136263	0.0270	0.0550	60,.	0.0360,0.0125,0.0009,0.0471,0.0219	0.0630			0.07,0.17	2.24					-0.1166	0.4733	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247587477	247587477	G	A	het	het	het		QUAL=6209;DP=160,190,152;AF=0.48,0.57,0.41;MQM=60;SAP=64;ABP=3	NLRP3	synonymous	NLRP3:ENST00000336119.3:synonymous_variant:LOW:exon3/9:c.732G>A:p.Ala244=:PF05729 [NACHT domain],NLRP3:ENST00000348069.2:synonymous_variant:LOW:exon3/7:c.732G>A:p.Ala244=:PF05729 [NACHT domain],NLRP3:ENST00000366496.2:synonymous_variant:LOW:exon3/8:c.732G>A:p.Ala244=:PF05729 [NACHT domain],NLRP3:ENST00000366497.2:synonymous_variant:LOW:exon4/9:c.732G>A:p.Ala244=:PF05729 [NACHT domain],NLRP3:ENST00000391827.2:synonymous_variant:LOW:exon3/8:c.732G>A:p.Ala244=:PF05729 [NACHT domain],NLRP3:ENST00000391828.3:synonymous_variant:LOW:exon5/11:c.732G>A:p.Ala244=:PF05729 [NACHT domain]	NLRP3:NM_001079821.2:synonymous_variant:LOW:exon5/11:c.732G>A:p.Ala244=:,NLRP3:NM_001127461.2:synonymous_variant:LOW:exon4/9:c.732G>A:p.Ala244=:,NLRP3:NM_001127462.2:synonymous_variant:LOW:exon3/8:c.732G>A:p.Ala244=:,NLRP3:NM_001243133.1:synonymous_variant:LOW:exon3/9:c.726G>A:p.Ala242=:,NLRP3:NM_004895.4:synonymous_variant:LOW:exon3/9:c.732G>A:p.Ala244=:,NLRP3:NM_183395.2:synonymous_variant:LOW:exon3/7:c.732G>A:p.Ala244=:		606416 [GENE=NLRP3 PHENOS=Familial cold inflammatory syndrome 1,120100,Autosomal dominant/Muckle-Wells syndrome,191900,Autosomal dominant/CINCA syndrome,607115,Autosomal dominant/Deafness,autosomal dominant 34,with or without inflammation,617772,Autosomal dominant/Keratoendothelitis fugax hereditaria,148200,Autosomal dominant];	138528 [benign DISEASE=Familial cold autoinflammatory syndrome 1,Familial amyloid nephropathy with urticaria AND deafness,Chronic infantile neurological, cutaneous and articular syndrome,not specified,none provided];			rs3806268	0.3874	0.5025	3599,.	0.1030,0.4077,0.5315,0.5585,0.5436	-2.1770			0.01,0.10	0.23					-0.0019	0.7554	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247587531	247587531	A	G	hom	hom	hom		QUAL=14017;DP=154,161,117;AF=1.00,1.00,1.00;MQM=60;SAP=49;ABP=0	NLRP3	synonymous	NLRP3:ENST00000336119.3:synonymous_variant:LOW:exon3/9:c.786A>G:p.Arg262=:PF05729 [NACHT domain],NLRP3:ENST00000348069.2:synonymous_variant:LOW:exon3/7:c.786A>G:p.Arg262=:PF05729 [NACHT domain],NLRP3:ENST00000366496.2:synonymous_variant:LOW:exon3/8:c.786A>G:p.Arg262=:PF05729 [NACHT domain],NLRP3:ENST00000366497.2:synonymous_variant:LOW:exon4/9:c.786A>G:p.Arg262=:PF05729 [NACHT domain],NLRP3:ENST00000391827.2:synonymous_variant:LOW:exon3/8:c.786A>G:p.Arg262=:PF05729 [NACHT domain],NLRP3:ENST00000391828.3:synonymous_variant:LOW:exon5/11:c.786A>G:p.Arg262=:PF05729 [NACHT domain]	NLRP3:NM_001079821.2:synonymous_variant:LOW:exon5/11:c.786A>G:p.Arg262=:,NLRP3:NM_001127461.2:synonymous_variant:LOW:exon4/9:c.786A>G:p.Arg262=:,NLRP3:NM_001127462.2:synonymous_variant:LOW:exon3/8:c.786A>G:p.Arg262=:,NLRP3:NM_001243133.1:synonymous_variant:LOW:exon3/9:c.780A>G:p.Arg260=:,NLRP3:NM_004895.4:synonymous_variant:LOW:exon3/9:c.786A>G:p.Arg262=:,NLRP3:NM_183395.2:synonymous_variant:LOW:exon3/7:c.786A>G:p.Arg262=:		606416 [GENE=NLRP3 PHENOS=Familial cold inflammatory syndrome 1,120100,Autosomal dominant/Muckle-Wells syndrome,191900,Autosomal dominant/CINCA syndrome,607115,Autosomal dominant/Deafness,autosomal dominant 34,with or without inflammation,617772,Autosomal dominant/Keratoendothelitis fugax hereditaria,148200,Autosomal dominant];	403243 [benign DISEASE=not specified,none provided];			rs4925543		0.9463	13681,.	0.8482,0.9714,0.9988,0.9579,0.8828	-0.1580			0.30,0.95	6.18					-0.0062	0.7552	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247597349	247597349	-	GAGCTCTCTGGTCAGATGTGTTCTGAGGCCTTCTCTATTCCA	wt	hom	het	off-target;low_conf_region	QUAL=882;DP=103,31,12;AF=0.00,1.00,0.75;MQM=54;SAP=90;ABP=10	NLRP3	intron	NLRP3:ENST00000336119.3:intron_variant:MODIFIER:intron4/8:c.2328-41_2328-40insATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAG::,NLRP3:ENST00000348069.2:intron_variant:MODIFIER:intron3/6:c.2157-41_2157-40insATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAG::,NLRP3:ENST00000366496.2:intron_variant:MODIFIER:intron4/7:c.2328-41_2328-40insATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAG::,NLRP3:ENST00000366497.2:intron_variant:MODIFIER:intron5/8:c.2328-41_2328-40insATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAG::,NLRP3:ENST00000391827.2:intron_variant:MODIFIER:intron3/7:c.2157-41_2157-40insATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAG::,NLRP3:ENST00000391828.3:intron_variant:MODIFIER:intron6/10:c.2328-41_2328-40insATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAG::	NLRP3:NM_001079821.2:intron_variant:MODIFIER:intron6/10:c.2328-41_2328-40insATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAG::,NLRP3:NM_001127461.2:intron_variant:MODIFIER:intron5/8:c.2328-41_2328-40insATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAG::,NLRP3:NM_001127462.2:intron_variant:MODIFIER:intron3/7:c.2157-41_2157-40insATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAG::,NLRP3:NM_001243133.1:intron_variant:MODIFIER:intron4/8:c.2322-41_2322-40insATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAG::,NLRP3:NM_004895.4:intron_variant:MODIFIER:intron4/8:c.2328-41_2328-40insATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAG::,NLRP3:NM_183395.2:intron_variant:MODIFIER:intron3/6:c.2157-41_2157-40insATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAG::	regulatory_region_variant:promoter_flanking_region	606416 [GENE=NLRP3 PHENOS=Familial cold inflammatory syndrome 1,120100,Autosomal dominant/Muckle-Wells syndrome,191900,Autosomal dominant/CINCA syndrome,607115,Autosomal dominant/Deafness,autosomal dominant 34,with or without inflammation,617772,Autosomal dominant/Keratoendothelitis fugax hereditaria,148200,Autosomal dominant];				rs566064212									0.45					-0.1473	0.1832	0.03	2068	1077	0 / 0					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247597365	247597365	G	A	hom	hom	hom	off-target;low_conf_region	QUAL=8504;DP=131,95,70;AF=1.00,1.00,1.00;MQM=58;SAP=538;ABP=0	NLRP3	intron	NLRP3:ENST00000336119.3:intron_variant:MODIFIER:intron4/8:c.2328-40G>A::,NLRP3:ENST00000348069.2:intron_variant:MODIFIER:intron3/6:c.2157-40G>A::,NLRP3:ENST00000366496.2:intron_variant:MODIFIER:intron4/7:c.2328-40G>A::,NLRP3:ENST00000366497.2:intron_variant:MODIFIER:intron5/8:c.2328-40G>A::,NLRP3:ENST00000391827.2:intron_variant:MODIFIER:intron3/7:c.2157-40G>A::,NLRP3:ENST00000391828.3:intron_variant:MODIFIER:intron6/10:c.2328-40G>A::	NLRP3:NM_001079821.2:intron_variant:MODIFIER:intron6/10:c.2328-40G>A::,NLRP3:NM_001127461.2:intron_variant:MODIFIER:intron5/8:c.2328-40G>A::,NLRP3:NM_001127462.2:intron_variant:MODIFIER:intron3/7:c.2157-40G>A::,NLRP3:NM_001243133.1:intron_variant:MODIFIER:intron4/8:c.2322-40G>A::,NLRP3:NM_004895.4:intron_variant:MODIFIER:intron4/8:c.2328-40G>A::,NLRP3:NM_183395.2:intron_variant:MODIFIER:intron3/6:c.2157-40G>A::	regulatory_region_variant:promoter_flanking_region	606416 [GENE=NLRP3 PHENOS=Familial cold inflammatory syndrome 1,120100,Autosomal dominant/Muckle-Wells syndrome,191900,Autosomal dominant/CINCA syndrome,607115,Autosomal dominant/Deafness,autosomal dominant 34,with or without inflammation,617772,Autosomal dominant/Keratoendothelitis fugax hereditaria,148200,Autosomal dominant];				rs10925022		0.3126	2196,.		-2.1850			0.00,0.06	0.31					-0.2852	0.1757	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247599232	247599232	G	A	het	het	het	off-target	QUAL=1373;DP=46,62,38;AF=0.50,0.50,0.39;MQM=60;SAP=29;ABP=4	NLRP3	intron	NLRP3:ENST00000336119.3:intron_variant:MODIFIER:intron5/8:c.2499-40G>A::,NLRP3:ENST00000348069.2:intron_variant:MODIFIER:intron4/6:c.2327+1657G>A::,NLRP3:ENST00000366496.2:intron_variant:MODIFIER:intron5/7:c.2498+1657G>A::,NLRP3:ENST00000366497.2:intron_variant:MODIFIER:intron6/8:c.2498+1657G>A::,NLRP3:ENST00000391827.2:intron_variant:MODIFIER:intron4/7:c.2328-40G>A::,NLRP3:ENST00000391828.3:intron_variant:MODIFIER:intron7/10:c.2499-40G>A::	NLRP3:NM_001079821.2:intron_variant:MODIFIER:intron7/10:c.2499-40G>A::,NLRP3:NM_001127461.2:intron_variant:MODIFIER:intron6/8:c.2498+1657G>A::,NLRP3:NM_001127462.2:intron_variant:MODIFIER:intron4/7:c.2328-40G>A::,NLRP3:NM_001243133.1:intron_variant:MODIFIER:intron5/8:c.2493-40G>A::,NLRP3:NM_004895.4:intron_variant:MODIFIER:intron5/8:c.2499-40G>A::,NLRP3:NM_183395.2:intron_variant:MODIFIER:intron4/6:c.2327+1657G>A::	regulatory_region_variant:promoter_flanking_region	606416 [GENE=NLRP3 PHENOS=Familial cold inflammatory syndrome 1,120100,Autosomal dominant/Muckle-Wells syndrome,191900,Autosomal dominant/CINCA syndrome,607115,Autosomal dominant/Deafness,autosomal dominant 34,with or without inflammation,617772,Autosomal dominant/Keratoendothelitis fugax hereditaria,148200,Autosomal dominant];				rs10754557	0.4840	0.5915	4901,.	0.2406,0.4940,0.6688,0.6219,0.6035	-0.8120			0.04,0.17	4.79					-0.0539	0.1791	0.09	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247611660	247611661	AG	-	het	wt	het	off-target	QUAL=2087;DP=181,76,39;AF=0.44,0.00,0.54;MQM=60;SAP=197;ABP=6	NLRP3	intron	NLRP3:ENST00000336119.3:intron_variant:MODIFIER:intron8/8:c.3012-45_3012-44del::,NLRP3:ENST00000348069.2:intron_variant:MODIFIER:intron6/6:c.2670-45_2670-44del::,NLRP3:ENST00000366496.2:intron_variant:MODIFIER:intron7/7:c.2841-45_2841-44del::,NLRP3:ENST00000366497.2:intron_variant:MODIFIER:intron8/8:c.2841-45_2841-44del::,NLRP3:ENST00000391827.2:intron_variant:MODIFIER:intron7/7:c.2841-45_2841-44del::,NLRP3:ENST00000391828.3:intron_variant:MODIFIER:intron10/10:c.3012-45_3012-44del::	NLRP3:NM_001079821.2:intron_variant:MODIFIER:intron10/10:c.3012-45_3012-44del::,NLRP3:NM_001127461.2:intron_variant:MODIFIER:intron8/8:c.2841-45_2841-44del::,NLRP3:NM_001127462.2:intron_variant:MODIFIER:intron7/7:c.2841-45_2841-44del::,NLRP3:NM_001243133.1:intron_variant:MODIFIER:intron8/8:c.3006-45_3006-44del::,NLRP3:NM_004895.4:intron_variant:MODIFIER:intron8/8:c.3012-45_3012-44del::,NLRP3:NM_183395.2:intron_variant:MODIFIER:intron6/6:c.2670-45_2670-44del::	regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	606416 [GENE=NLRP3 PHENOS=Familial cold inflammatory syndrome 1,120100,Autosomal dominant/Muckle-Wells syndrome,191900,Autosomal dominant/CINCA syndrome,607115,Autosomal dominant/Deafness,autosomal dominant 34,with or without inflammation,617772,Autosomal dominant/Keratoendothelitis fugax hereditaria,148200,Autosomal dominant];				rs201053423		0.0494	33,.	0.0102,0.0263,0.0341,0.0561,0.0969	-0.3230				3.01					-0.1778	0.8984	0.01	49	1556	0 / 0					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33), OR2B11 (inh=n/a oe_syn=1.03 oe_mis=0.94 oe_lof=0.83)
chr1	247612036	247612036	G	C	hom	hom	hom		QUAL=49934;DP=691,501,384;AF=1.00,1.00,1.00;MQM=60;SAP=972;ABP=0	NLRP3	3'UTR	NLRP3:ENST00000336119.3:3_prime_UTR_variant:MODIFIER:exon9/9:c.*230G>C::,NLRP3:ENST00000348069.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*230G>C::,NLRP3:ENST00000366496.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*230G>C::,NLRP3:ENST00000366497.2:3_prime_UTR_variant:MODIFIER:exon9/9:c.*230G>C::,NLRP3:ENST00000391828.3:3_prime_UTR_variant:MODIFIER:exon11/11:c.*230G>C::	NLRP3:NM_001079821.2:3_prime_UTR_variant:MODIFIER:exon11/11:c.*230G>C::,NLRP3:NM_001127461.2:3_prime_UTR_variant:MODIFIER:exon9/9:c.*230G>C::,NLRP3:NM_001127462.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*230G>C::,NLRP3:NM_001243133.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*230G>C::,NLRP3:NM_004895.4:3_prime_UTR_variant:MODIFIER:exon9/9:c.*230G>C::,NLRP3:NM_183395.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*230G>C::		606416 [GENE=NLRP3 PHENOS=Familial cold inflammatory syndrome 1,120100,Autosomal dominant/Muckle-Wells syndrome,191900,Autosomal dominant/CINCA syndrome,607115,Autosomal dominant/Deafness,autosomal dominant 34,with or without inflammation,617772,Autosomal dominant/Keratoendothelitis fugax hereditaria,148200,Autosomal dominant];	296956 [benign DISEASE=Familial cold autoinflammatory syndrome 1,Familial amyloid nephropathy with urticaria AND deafness,Chronic infantile neurological, cutaneous and articular syndrome];			rs10754558		0.6325	6369,.		0.1530			0.00,0.09	5.71					0.0147	0.9286	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33), OR2B11 (inh=n/a oe_syn=1.03 oe_mis=0.94 oe_lof=0.83)
chr1	247612435	247612435	A	T	hom	n/a	hom	off-target	QUAL=1323;DP=38,1,3;AF=1.00,1.00,1.00;MQM=60;SAP=78;ABP=0	OR2B11,NLRP3	downstream_gene	OR2B11:ENST00000318749.6:downstream_gene_variant:MODIFIER::::,NLRP3:ENST00000336119.3:downstream_gene_variant:MODIFIER::::,NLRP3:ENST00000348069.2:downstream_gene_variant:MODIFIER::::,NLRP3:ENST00000366496.2:downstream_gene_variant:MODIFIER::::,NLRP3:ENST00000366497.2:downstream_gene_variant:MODIFIER::::,NLRP3:ENST00000391827.2:downstream_gene_variant:MODIFIER::::,NLRP3:ENST00000391828.3:downstream_gene_variant:MODIFIER::::							rs4925547	0.4157	0.3578	2111,.		2.0950			0.82,0.94	13.44								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33), OR2B11 (inh=n/a oe_syn=1.03 oe_mis=0.94 oe_lof=0.83)
chrMT	72	72	T	C	hom	wt	hom		QUAL=255543;DP=4339,4566,4374;AF=0.99,0.00,0.99;MQM=55;SAP=1250;ABP=0	MT-ND1,MT-ND2,MT-TL1,MT-TF,MT-TV,MT-RNR2,MT-TI,MT-TQ,MT-TM,MT-RNR1	upstream_gene,downstream_gene	MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::						rs879158303																	543	30	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	73	73	A	G	wt	hom	wt		QUAL=123472;DP=4276,4662,4415;AF=0.01,1.00,0.00;MQM=51;SAP=345;ABP=0	MT-ND1,MT-ND2,MT-TL1,MT-TF,MT-TV,MT-RNR2,MT-TI,MT-TQ,MT-TM,MT-RNR1	upstream_gene,downstream_gene	MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::						rs869183622																	9742	177	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	150	150	C	T	wt	hom	wt		QUAL=128170;DP=4145,3999,3294;AF=0.00,0.99,0.00;MQM=60;SAP=898;ABP=0	MT-ND1,MT-ND2,MT-TL1,MT-TF,MT-TV,MT-RNR2,MT-TI,MT-TQ,MT-TM,MT-RNR1	upstream_gene,downstream_gene	MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::						rs62581312																	1604	86	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	152	152	T	C	wt	hom	wt		QUAL=128170;DP=4145,3999,3294;AF=0.00,0.99,0.00;MQM=60;SAP=898;ABP=0	MT-ND1,MT-ND2,MT-TL1,MT-TF,MT-TV,MT-RNR2,MT-TI,MT-TQ,MT-TM,MT-RNR1	upstream_gene,downstream_gene	MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::						rs117135796																	3631	221	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	195	195	T	C	wt	hom	wt		QUAL=107895;DP=3712,3375,2436;AF=0.00,1.00,0.00;MQM=60;SAP=963;ABP=0	MT-ND1,MT-ND2,MT-TL1,MT-TF,MT-TV,MT-RNR2,MT-TI,MT-TQ,MT-TM,MT-RNR1	upstream_gene,downstream_gene	MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::						rs2857291																	3200	187	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	215	215	A	G	wt	hom	wt		QUAL=100106;DP=3336,3146,2042;AF=0.00,0.99,0.00;MQM=60;SAP=1009;ABP=0	MT-ND1,MT-ND2,MT-TL1,MT-TF,MT-TV,MT-RNR2,MT-TI,MT-TQ,MT-TM,MT-RNR1	upstream_gene,downstream_gene	MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::						rs879219259																	218	18	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	263	263	A	G	hom	hom	hom		QUAL=194497;DP=2654,2347,1157;AF=1.00,1.00,1.00;MQM=60;SAP=2848;ABP=0	MT-ND1,MT-ND2,MT-TL1,MT-TF,MT-TV,MT-RNR2,MT-TI,MT-TQ,MT-TM,MT-RNR1	upstream_gene,downstream_gene	MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::			441147 [not provided DISEASE=not provided];			rs2853515																	17070	30	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	295	295	C	T	wt	hom	wt		QUAL=56603;DP=2162,1905,774;AF=0.00,0.99,0.00;MQM=60;SAP=788;ABP=0	MT-ND1,MT-ND2,MT-TL1,MT-TF,MT-TV,MT-RNR2,MT-TI,MT-TQ,MT-TM,MT-RNR1	upstream_gene,downstream_gene	MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::						rs41528348																	1414	55	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	302	302	-	CC	hom	wt	het		QUAL=47161;DP=746,1287,309;AF=0.04,0.00,0.01;MQM=60;SAP=1734;ABP=176	MT-ND1,MT-ND2,MT-TL1,MT-TF,MT-TV,MT-RNR2,MT-TI,MT-TQ,MT-TM,MT-RNR1	upstream_gene,downstream_gene	MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::																							610	1723	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	302	302	-	CCC	wt	wt	het		QUAL=47161;DP=746,1287,309;AF=0.05,0.00,0.06;MQM=58;SAP=164;ABP=398	MT-ND1,MT-ND2,MT-TL1,MT-TF,MT-TV,MT-RNR2,MT-TI,MT-TQ,MT-TM,MT-RNR1	upstream_gene,downstream_gene	MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::																							38	349	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	310	310	-	C	hom	wt	hom		QUAL=47161;DP=746,1287,309;AF=0.04,0.00,0.01;MQM=59;SAP=40;ABP=640	MT-ND1,MT-ND2,MT-TL1,MT-TF,MT-TV,MT-RNR2,MT-TI,MT-TQ,MT-TM,MT-RNR1	upstream_gene,downstream_gene	MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::						rs369786048																	11188	2882	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	310	310	-	TC	wt	hom	wt		QUAL=47161;DP=746,1287,309;AF=0.05,0.00,0.06;MQM=60;SAP=447;ABP=657	MT-ND1,MT-ND2,MT-TL1,MT-TF,MT-TV,MT-RNR2,MT-TI,MT-TQ,MT-TM,MT-RNR1	upstream_gene,downstream_gene	MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::						rs1556422422																	146	14	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	319	319	T	C	wt	hom	wt		QUAL=49425;DP=1961,1649,476;AF=0.00,0.99,0.00;MQM=60;SAP=361;ABP=0	MT-ND1,MT-ND2,MT-TL1,MT-TF,MT-TV,MT-RNR2,MT-TI,MT-TQ,MT-TM,MT-RNR1	upstream_gene,downstream_gene	MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::						rs879055956																	207	5	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	430	430	T	C	wt	hom	wt		QUAL=54718;DP=2887,1853,1252;AF=0.00,0.99,0.00;MQM=60;SAP=546;ABP=0	MT-ND1,MT-ND2,MT-TL1,MT-TF,MT-TV,MT-RNR2,MT-TI,MT-TQ,MT-TM,MT-RNR1	upstream_gene,downstream_gene	MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::																							12	1	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	489	489	T	C	wt	hom	wt		QUAL=66125;DP=3024,2265,1845;AF=0.00,0.99,0.00;MQM=60;SAP=358;ABP=0	MT-ND1,MT-ND2,MT-TL1,MT-TF,MT-TV,MT-RNR2,MT-TI,MT-TQ,MT-TM,MT-RNR1	upstream_gene,downstream_gene	MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::						rs28625645																	1923	65	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	513	513	G	A	wt	hom	wt		QUAL=66298;DP=3149,2283,1832;AF=0.00,0.99,0.00;MQM=60;SAP=68;ABP=0	MT-ND1,MT-ND2,MT-TL1,MT-TF,MT-TV,MT-RNR2,MT-TI,MT-TQ,MT-TM,MT-TW,MT-RNR1	upstream_gene,downstream_gene	MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-TW:ENST00000387382.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::						rs879162984																	252	14	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	750	750	A	G	hom	hom	hom		QUAL=291152;DP=3337,3123,2664;AF=1.00,1.00,1.00;MQM=59;SAP=170;ABP=0	MT-RNR1	non_coding_transcript_exon	MT-RNR1:ENST00000389680.2:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.103A>G::	::intergenic_variant:MODIFIER::::			441148 [not provided DISEASE=not provided];			rs2853518														-0.0303	0.9179		16924	15	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	1438	1438	A	G	hom	hom	hom		QUAL=708429;DP=8493,7277,6305;AF=1.00,1.00,1.00;MQM=56;SAP=590;ABP=0	MT-RNR1	non_coding_transcript_exon	MT-RNR1:ENST00000389680.2:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.791A>G::	::intergenic_variant:MODIFIER::::			42220 [benign DISEASE=not specified,not provided];			rs2001030														0.0231	0.9187		16439	22	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	1850	1850	T	C	wt	hom	wt		QUAL=121409;DP=5778,3822,3333;AF=0.00,0.99,0.00;MQM=60;SAP=11;ABP=0	MT-RNR2	non_coding_transcript_exon	MT-RNR2:ENST00000387347.2:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.180T>C::	::intergenic_variant:MODIFIER::::						rs878878913														0.0001	0.9599		147	16	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	2706	2706	A	G	hom	hom	hom		QUAL=181193;DP=3096,1452,1272;AF=1.00,1.00,1.00;MQM=60;SAP=240;ABP=0	MT-RNR2	non_coding_transcript_exon	MT-RNR2:ENST00000387347.2:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.1036A>G::	::intergenic_variant:MODIFIER::::						rs2854128														0.0089	0.96		10345	263	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	3109	3109	T	C	het	het	het		QUAL=5853;DP=152,41,44;AF=0.41,0.41,0.57;MQM=60;SAP=12;ABP=10	MT-RNR2	non_coding_transcript_exon	MT-RNR2:ENST00000387347.2:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.1439T>C::	::intergenic_variant:MODIFIER::::																				-0.0045	0.9598		39	79	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	4216	4216	T	C	wt	hom	wt		QUAL=105335;DP=3774,3516,3102;AF=0.00,0.99,0.00;MQM=45;SAP=243;ABP=0	MT-ND1	missense	MT-ND1:ENST00000361390.2:missense_variant:MODERATE:exon1/1:c.910T>C:p.Tyr304His:PF00146 [NADH dehydrogenase]	::intergenic_variant:MODIFIER::::			9724 [benign DISEASE=Leber hereditary optic neuropathy,Leigh syndrome,not provided];			rs1599988						T(1.00)	B(0.01)						COSV62293824	0.0155	0.9434		2674	111	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	4580	4580	G	A	hom	wt	hom		QUAL=102526;DP=2454,1944,1672;AF=0.99,0.00,0.99;MQM=31;SAP=14;ABP=0	MT-ND2	synonymous	MT-ND2:ENST00000361453.3:synonymous_variant:LOW:exon1/1:c.111G>A:p.Met37=:PF00361 [Proton-conducting membrane transporter]	::intergenic_variant:MODIFIER::::						rs28357975														-0.0106	0.9527		346	9	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	4769	4769	A	G	hom	hom	hom		QUAL=170382;DP=2338,2312,2035;AF=1.00,1.00,1.00;MQM=33;SAP=1567;ABP=0	MT-ND2	synonymous	MT-ND2:ENST00000361453.3:synonymous_variant:LOW:exon1/1:c.300A>G:p.Met100=:PF00361 [Proton-conducting membrane transporter]	::intergenic_variant:MODIFIER::::			441150 [not provided DISEASE=not provided];			rs3021086														0.0465	0.9533		13514	21	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	7028	7028	C	T	hom	hom	hom		QUAL=308930;DP=3117,3998,3477;AF=0.99,1.00,1.00;MQM=43;SAP=345;ABP=0	MT-CO1	synonymous	MT-CO1:ENST00000361624.2:synonymous_variant:LOW:exon1/1:c.1125C>T:p.Ala375=:PF00115 [Cytochrome C and Quinol oxidase polypeptide I]	::intergenic_variant:MODIFIER::::						rs2015062														-0.0023	0.9282		9510	598	0 / 0					MT-RNR2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	7476	7476	C	T	wt	hom	wt		QUAL=44924;DP=4053,1599,1392;AF=0.00,0.99,0.00;MQM=43;SAP=193;ABP=0	MT-TS1	non_coding_transcript_exon	MT-TS1:ENST00000387416.2:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.39G>A::	::intergenic_variant:MODIFIER::::			42228 [benign/likely benign DISEASE=Juvenile myopathy, encephalopathy, lactic acidosis AND stroke,not specified];			rs201950015														0.0255	0.9418		252	14	0 / 0					MT-RNR2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	7789	7789	G	A	wt	hom	wt		QUAL=141895;DP=7810,4960,5635;AF=0.00,0.99,0.00;MQM=58;SAP=4485;ABP=0	MT-CO2	synonymous	MT-CO2:ENST00000361739.1:synonymous_variant:LOW:exon1/1:c.204G>A:p.Leu68=:PF02790 [Cytochrome C oxidase subunit II transmembrane domain]	::intergenic_variant:MODIFIER::::			376897 [benign DISEASE=not provided];			rs386829014														-0.0166	0.9288		259	33	0 / 0					MT-RNR2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	8860	8860	A	G	hom	hom	hom		QUAL=172415;DP=1890,2330,2140;AF=1.00,1.00,1.00;MQM=34;SAP=12;ABP=0	MT-ATP6	missense	MT-ATP6:ENST00000361899.2:missense_variant:MODERATE:exon1/1:c.334A>G:p.Thr112Ala:PF00119 [ATP synthase A chain]	::intergenic_variant:MODIFIER::::			693004 [benign DISEASE=Leigh syndrome];			rs2001031						T(0.10)	B(0.00)							0.0214	0.946		14054	36	0 / 0					MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	10398	10398	A	G	wt	hom	wt		QUAL=119820;DP=4702,3733,3105;AF=0.00,0.99,0.00;MQM=60;SAP=202;ABP=0	MT-ND3	missense	MT-ND3:ENST00000361227.2:missense_variant:MODERATE:exon1/1:c.340A>G:p.Thr114Ala:	::intergenic_variant:MODIFIER::::			9713 [benign DISEASE=Leigh syndrome,Parkinson disease, resistance to];			rs2853826						T(1.00)	B(0.00)							0.0231	0.9351		3182	113	0 / 0					MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	10499	10499	A	G	wt	hom	wt		QUAL=122618;DP=4621,3751,3081;AF=0.00,0.99,0.00;MQM=60;SAP=7;ABP=0	MT-ND4L	synonymous	MT-ND4L:ENST00000361335.1:synonymous_variant:LOW:exon1/1:c.30A>G:p.Leu10=:PF00420 [NADH-ubiquinone/plastoquinone oxidoreductase chain 4L]	::intergenic_variant:MODIFIER::::			376866 [benign DISEASE=not provided];			rs1057520074														0.1619	0.9489		185	13	0 / 0					MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	11251	11251	A	G	wt	hom	wt		QUAL=178194;DP=6484,5623,4780;AF=0.00,0.99,0.00;MQM=60;SAP=80;ABP=0	MT-ND4	synonymous	MT-ND4:ENST00000361381.2:synonymous_variant:LOW:exon1/1:c.492A>G:p.Leu164=:PF00361 [Proton-conducting membrane transporter]	::intergenic_variant:MODIFIER::::						rs869096886													COSV62293827	0.0325	0.9405		2961	313	0 / 0					MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	11377	11377	G	A	wt	hom	wt		QUAL=145189;DP=6134,4559,4068;AF=0.00,0.99,0.00;MQM=60;SAP=410;ABP=0	MT-ND4	synonymous	MT-ND4:ENST00000361381.2:synonymous_variant:LOW:exon1/1:c.618G>A:p.Lys206=:PF00361 [Proton-conducting membrane transporter]	::intergenic_variant:MODIFIER::::						rs193302938														-0.0261	0.9398		296	62	0 / 0					MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	11719	11719	G	A	wt	hom	wt		QUAL=165746;DP=6929,5317,4181;AF=0.00,1.00,0.01;MQM=57;SAP=16;ABP=0	MT-ND4	synonymous	MT-ND4:ENST00000361381.2:synonymous_variant:LOW:exon1/1:c.960G>A:p.Gly320=:PF00361 [Proton-conducting membrane transporter]	::intergenic_variant:MODIFIER::::						rs2853495														0.0239	0.9404		8862	558	0 / 0					MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	12612	12612	A	G	wt	hom	wt		QUAL=164296;DP=7620,5136,4364;AF=0.00,0.99,0.00;MQM=60;SAP=168;ABP=0	MT-ND5	synonymous	MT-ND5:ENST00000361567.2:synonymous_variant:LOW:exon1/1:c.276A>G:p.Val92=:PF00662 [NADH-Ubiquinone oxidoreductase (complex I) chain 5 N-terminus]	::intergenic_variant:MODIFIER::::						rs28359172														0.0206	0.9514		1272	207	0 / 0					MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	13708	13708	G	A	wt	hom	wt		QUAL=51206;DP=4548,1714,1554;AF=0.00,0.99,0.00;MQM=60;SAP=5;ABP=0	MT-ND5	missense	MT-ND5:ENST00000361567.2:missense_variant:MODERATE:exon1/1:c.1372G>A:p.Ala458Thr:PF06455 [NADH dehydrogenase subunit 5 C-terminus]	::intergenic_variant:MODIFIER::::			9696 [benign DISEASE=Leber hereditary optic neuropathy,Leigh syndrome];			rs28359178						T(0.19)	B(0.00)							0.0016	0.9512		1654	107	0 / 0					MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	13722	13722	A	G	wt	hom	wt		QUAL=53850;DP=4635,1805,1669;AF=0.00,0.99,0.00;MQM=60;SAP=29;ABP=0	MT-ND5	synonymous	MT-ND5:ENST00000361567.2:synonymous_variant:LOW:exon1/1:c.1386A>G:p.Leu462=:PF06455 [NADH dehydrogenase subunit 5 C-terminus]	::intergenic_variant:MODIFIER::::			377244 [benign DISEASE=not provided];			rs386829190														0.0028	0.9512		200	18	0 / 0					MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	14133	14133	A	G	wt	hom	wt		QUAL=97052;DP=3880,3080,2747;AF=0.00,1.00,0.00;MQM=60;SAP=27;ABP=0	MT-ND5	synonymous	MT-ND5:ENST00000361567.2:synonymous_variant:LOW:exon1/1:c.1797A>G:p.Leu599=:PF06455 [NADH dehydrogenase subunit 5 C-terminus]	::intergenic_variant:MODIFIER::::			377029 [benign DISEASE=not provided];			rs879100848														0.0079	0.9513		195	20	0 / 0					MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	14370	14370	A	G	hom	wt	hom		QUAL=191347;DP=3931,2351,2175;AF=0.99,0.00,0.99;MQM=60;SAP=47;ABP=0	MT-ND6	synonymous	MT-ND6:ENST00000361681.2:synonymous_variant:LOW:exon1/1:c.304T>C:p.Leu102=:PF00499 [NADH-ubiquinone/plastoquinone oxidoreductase chain 6]	::intergenic_variant:MODIFIER::::																				0.0003	0.9341		18	1	0 / 0					MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	14766	14766	C	T	wt	hom	wt		QUAL=71223;DP=3282,2284,2100;AF=0.00,1.00,0.01;MQM=60;SAP=262;ABP=0	MT-CYB	missense	MT-CYB:ENST00000361789.2:missense_variant:MODERATE:exon1/1:c.20C>T:p.Thr7Ile:	::intergenic_variant:MODIFIER::::			140587 [benign DISEASE=Leigh syndrome,Familial cancer of breast];			rs193302980						D(0.04)	B(0.00)							-0.01	0.9364		8885	251	0 / 0					MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	15257	15257	G	A	wt	hom	wt		QUAL=122431;DP=4492,3827,3613;AF=0.00,0.99,0.00;MQM=60;SAP=24;ABP=0	MT-CYB	missense	MT-CYB:ENST00000361789.2:missense_variant:MODERATE:exon1/1:c.511G>A:p.Asp171Asn:PF13631 [Cytochrome b(N-terminal)/b6/petB]	::intergenic_variant:MODIFIER::::			9674 [benign DISEASE=Leber hereditary optic neuropathy,Leigh syndrome];			rs41518645						D(0.01)	B(0.01)						COSV62378578	-0.0056	0.9364		300	52	0 / 0					MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	15326	15326	A	G	hom	hom	hom		QUAL=369220;DP=4425,3647,3479;AF=1.00,1.00,1.00;MQM=60;SAP=196;ABP=0	MT-CYB	missense	MT-CYB:ENST00000361789.2:missense_variant:MODERATE:exon1/1:c.580A>G:p.Thr194Ala:PF13631 [Cytochrome b(N-terminal)/b6/petB]	::intergenic_variant:MODIFIER::::			140592 [benign DISEASE=Leigh syndrome,Familial cancer of breast];			rs2853508						T(0.28)	B(0.01)							0.0039	0.9366		16881	58	0 / 0	1	"[1] harmuth 09.04.2018"		"most likely WT variant; in 98,6% of all full length sequences (MitoMap); FH 09.04.2018"	MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	15452	15452	C	A	wt	hom	wt		QUAL=107082;DP=6642,3390,3237;AF=0.00,0.99,0.00;MQM=60;SAP=14;ABP=0	MT-CYB	missense	MT-CYB:ENST00000361789.2:missense_variant:MODERATE:exon1/1:c.706C>A:p.Leu236Ile:PF13631 [Cytochrome b(N-terminal)/b6/petB]	::intergenic_variant:MODIFIER::::			143925 [benign DISEASE=Neoplasm of ovary,Leigh syndrome];			rs193302994						T(0.51)	B(0.24)							-0.0131	0.9364		2990	250	0 / 0					MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	15904	15904	C	T	hom	wt	hom		QUAL=300923;DP=5963,3771,3321;AF=0.99,0.00,0.99;MQM=60;SAP=20;ABP=0	MT-TT	non_coding_transcript_exon	MT-TT:ENST00000387460.2:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.17C>T::	::intergenic_variant:MODIFIER::::			690224 [benign DISEASE=Juvenile myopathy, encephalopathy, lactic acidosis AND stroke];			rs35788393														-0.4242	0.9362		411	15	0 / 0					MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	16069	16069	C	T	wt	hom	wt		QUAL=118988;DP=5759,3738,3605;AF=0.00,0.99,0.00;MQM=60;SAP=21;ABP=0	MT-ND4,MT-ND5,MT-ND6,MT-CYB,MT-TH,MT-TS2,MT-TL2,MT-TE,MT-TT,MT-TP	downstream_gene,upstream_gene	MT-ND4:ENST00000361381.2:downstream_gene_variant:MODIFIER::::,MT-ND5:ENST00000361567.2:downstream_gene_variant:MODIFIER::::,MT-ND6:ENST00000361681.2:upstream_gene_variant:MODIFIER::::,MT-CYB:ENST00000361789.2:downstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441.1:downstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449.1:downstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456.1:downstream_gene_variant:MODIFIER::::,MT-TE:ENST00000387459.1:upstream_gene_variant:MODIFIER::::,MT-TT:ENST00000387460.2:downstream_gene_variant:MODIFIER::::,MT-TP:ENST00000387461.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::						rs147903261																	1351	75	0 / 0					MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	16126	16126	T	C	wt	hom	wt		QUAL=123539;DP=5704,3904,4012;AF=0.00,0.99,0.00;MQM=60;SAP=161;ABP=0	MT-ND4,MT-ND5,MT-ND6,MT-CYB,MT-TH,MT-TS2,MT-TL2,MT-TE,MT-TT,MT-TP	downstream_gene,upstream_gene	MT-ND4:ENST00000361381.2:downstream_gene_variant:MODIFIER::::,MT-ND5:ENST00000361567.2:downstream_gene_variant:MODIFIER::::,MT-ND6:ENST00000361681.2:upstream_gene_variant:MODIFIER::::,MT-CYB:ENST00000361789.2:downstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441.1:downstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449.1:downstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456.1:downstream_gene_variant:MODIFIER::::,MT-TE:ENST00000387459.1:upstream_gene_variant:MODIFIER::::,MT-TT:ENST00000387460.2:downstream_gene_variant:MODIFIER::::,MT-TP:ENST00000387461.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::						rs147029798																	3058	344	0 / 0					MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	16145	16145	G	A	wt	hom	wt		QUAL=123948;DP=5649,3930,4045;AF=0.00,0.99,0.00;MQM=60;SAP=144;ABP=0	MT-ND4,MT-ND5,MT-ND6,MT-CYB,MT-TH,MT-TS2,MT-TL2,MT-TE,MT-TT,MT-TP	downstream_gene,upstream_gene	MT-ND4:ENST00000361381.2:downstream_gene_variant:MODIFIER::::,MT-ND5:ENST00000361567.2:downstream_gene_variant:MODIFIER::::,MT-ND6:ENST00000361681.2:upstream_gene_variant:MODIFIER::::,MT-CYB:ENST00000361789.2:downstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441.1:downstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449.1:downstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456.1:downstream_gene_variant:MODIFIER::::,MT-TE:ENST00000387459.1:upstream_gene_variant:MODIFIER::::,MT-TT:ENST00000387460.2:downstream_gene_variant:MODIFIER::::,MT-TP:ENST00000387461.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::						rs41419246																	540	92	0 / 0					MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	16231	16231	T	C	wt	hom	wt		QUAL=148528;DP=6558,4763,4459;AF=0.00,0.99,0.00;MQM=60;SAP=109;ABP=0	MT-ND4,MT-ND5,MT-ND6,MT-CYB,MT-TH,MT-TS2,MT-TL2,MT-TE,MT-TT,MT-TP	downstream_gene,upstream_gene	MT-ND4:ENST00000361381.2:downstream_gene_variant:MODIFIER::::,MT-ND5:ENST00000361567.2:downstream_gene_variant:MODIFIER::::,MT-ND6:ENST00000361681.2:upstream_gene_variant:MODIFIER::::,MT-CYB:ENST00000361789.2:downstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441.1:downstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449.1:downstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456.1:downstream_gene_variant:MODIFIER::::,MT-TE:ENST00000387459.1:upstream_gene_variant:MODIFIER::::,MT-TT:ENST00000387460.2:downstream_gene_variant:MODIFIER::::,MT-TP:ENST00000387461.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::						rs386829286																	187	33	0 / 0					MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	16261	16261	C	T	wt	hom	wt		QUAL=148285;DP=7100,4737,4283;AF=0.00,0.99,0.00;MQM=60;SAP=26;ABP=0	MT-ND4,MT-ND5,MT-ND6,MT-CYB,MT-TH,MT-TS2,MT-TL2,MT-TE,MT-TT,MT-TP	downstream_gene,upstream_gene	MT-ND4:ENST00000361381.2:downstream_gene_variant:MODIFIER::::,MT-ND5:ENST00000361567.2:downstream_gene_variant:MODIFIER::::,MT-ND6:ENST00000361681.2:upstream_gene_variant:MODIFIER::::,MT-CYB:ENST00000361789.2:downstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441.1:downstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449.1:downstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456.1:downstream_gene_variant:MODIFIER::::,MT-TE:ENST00000387459.1:upstream_gene_variant:MODIFIER::::,MT-TT:ENST00000387460.2:downstream_gene_variant:MODIFIER::::,MT-TP:ENST00000387461.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::						rs138126107																	636	116	0 / 0					MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	16298	16298	T	C	hom	wt	hom		QUAL=331902;DP=6100,4783,4217;AF=0.99,0.00,0.99;MQM=60;SAP=106;ABP=0	MT-ND4,MT-ND5,MT-ND6,MT-CYB,MT-TH,MT-TS2,MT-TL2,MT-TE,MT-TT,MT-TP	downstream_gene,upstream_gene	MT-ND4:ENST00000361381.2:downstream_gene_variant:MODIFIER::::,MT-ND5:ENST00000361567.2:downstream_gene_variant:MODIFIER::::,MT-ND6:ENST00000361681.2:upstream_gene_variant:MODIFIER::::,MT-CYB:ENST00000361789.2:downstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441.1:downstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449.1:downstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456.1:downstream_gene_variant:MODIFIER::::,MT-TE:ENST00000387459.1:upstream_gene_variant:MODIFIER::::,MT-TT:ENST00000387460.2:downstream_gene_variant:MODIFIER::::,MT-TP:ENST00000387461.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::						rs148377232																	730	112	0 / 0					MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	16519	16519	T	C	hom	wt	hom		QUAL=371271;DP=6983,4912,4513;AF=1.00,0.01,1.00;MQM=58;SAP=5;ABP=0	MT-ND4,MT-ND5,MT-ND6,MT-CYB,MT-TH,MT-TS2,MT-TL2,MT-TE,MT-TT,MT-TP	downstream_gene,upstream_gene	MT-ND4:ENST00000361381.2:downstream_gene_variant:MODIFIER::::,MT-ND5:ENST00000361567.2:downstream_gene_variant:MODIFIER::::,MT-ND6:ENST00000361681.2:upstream_gene_variant:MODIFIER::::,MT-CYB:ENST00000361789.2:downstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441.1:downstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449.1:downstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456.1:downstream_gene_variant:MODIFIER::::,MT-TE:ENST00000387459.1:upstream_gene_variant:MODIFIER::::,MT-TT:ENST00000387460.2:downstream_gene_variant:MODIFIER::::,MT-TP:ENST00000387461.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::						rs3937033																	10907	269	0 / 0					MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
